Clustering O 0 0.0005882770055904984
of O 0 0.00034285010769963264
missense O 0 0.0009421975701116025
mutations O 0 5.219614104134962e-05
in O 0 4.936941695632413e-05
the O 0 0.00019457493908703327
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9980002045631409
telangiectasia I-Disease 1 0.967122495174408
gene O 0 2.2332951630232856e-05
in O 0 1.907621481223032e-05
a O 0 2.839408625732176e-05
sporadic B-Disease 0 0.0006417835829779506
T I-Disease 1 0.9998893737792969
- I-Disease 1 0.9512704014778137
cell I-Disease 0 0.07490669190883636
leukaemia I-Disease 1 0.9994939565658569
. O 0 0.000574490986764431

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999756813049316
telangiectasia I-Disease 1 0.9999974966049194
( O 0 0.0011208256473764777
A B-Disease 1 0.9999886751174927
- I-Disease 1 0.9324848055839539
T I-Disease 1 0.9979286193847656
) O 0 6.248172667255858e-06
is O 0 2.263765054522082e-06
a O 0 9.481374945607968e-06
recessive B-Disease 0 0.00028779314015991986
multi I-Disease 0 0.37739843130111694
- I-Disease 1 0.9977778792381287
system I-Disease 0 0.025107359513640404
disorder I-Disease 1 0.9999997615814209
caused O 0 0.018253397196531296
by O 0 1.241992686118465e-05
mutations O 0 8.827511010167655e-06
in O 0 1.0737502634583507e-05
the O 0 2.3900021915324032e-05
ATM O 0 0.0005159570137038827
gene O 0 2.958915865747258e-05
at O 0 0.0002158722054446116
11q22 O 0 0.0010949965799227357
- O 0 0.0002844189293682575
q23 O 0 0.00045201563625596464
( O 0 3.342275886097923e-05
ref O 0 0.0007759398431517184
. O 0 1.1029599590983707e-05
3 O 0 7.945707329781726e-05
) O 0 2.854730155377183e-05
. O 0 9.426051110494882e-05

The O 0 0.0002088725013891235
risk O 0 0.00018737834761850536
of O 0 0.00033233134308829904
cancer B-Disease 1 0.9999877214431763
, O 0 6.540953472722322e-05
especially O 0 0.0001769042864907533
lymphoid B-Disease 0 0.4609963893890381
neoplasias I-Disease 0 0.031744584441185
, O 0 2.155544098059181e-05
is O 0 7.007619387877639e-06
substantially O 0 7.892544090282172e-05
elevated O 0 0.0011383681558072567
in O 0 8.683700434630737e-05
A B-Disease 1 0.9999152421951294
- I-Disease 1 0.999920129776001
T I-Disease 1 0.9999997615814209
patients O 0 4.168600935372524e-05
and O 0 6.407551609299844e-06
has O 0 6.277820830291603e-06
long O 0 1.4837448361504357e-05
been O 0 4.5083443183102645e-06
associated O 0 7.830928552721161e-06
with O 0 3.3096577681135386e-05
chromosomal O 1 0.9999996423721313
instability O 1 1.0
. O 0 0.009900635108351707

By O 0 0.00023369734117295593
analysing O 0 0.0019387650536373258
tumour B-Disease 1 0.9999991655349731
DNA O 0 0.0003702764224726707
from O 0 5.975808380753733e-05
patients O 0 2.0271305402275175e-05
with O 0 1.262756995856762e-05
sporadic B-Disease 0 0.0011005894048139453
T I-Disease 1 0.9995490908622742
- I-Disease 0 0.007132921367883682
cell I-Disease 0 0.0009227452683262527
prolymphocytic I-Disease 1 0.9644069075584412
leukaemia I-Disease 1 0.9999611377716064
( O 0 0.0005164772737771273
T B-Disease 1 0.9982321858406067
- I-Disease 0 0.004595060832798481
PLL I-Disease 1 0.6714279055595398
) O 0 1.6523115846212022e-05
, O 0 3.75679860553646e-06
a O 0 9.455568942939863e-06
rare O 0 4.2119852878386155e-05
clonal B-Disease 0 0.0012693088501691818
malignancy I-Disease 0 0.0047323089092969894
with O 0 5.122856691741617e-06
similarities O 0 3.0200342735042796e-05
to O 0 2.287624556629453e-05
a O 0 8.463773701805621e-05
mature B-Disease 0 0.0007792992400936782
T I-Disease 1 0.9827600717544556
- I-Disease 0 0.0027017733082175255
cell I-Disease 0 0.0005828222492709756
leukaemia I-Disease 0 0.023075591772794724
seen O 0 0.0001382681803079322
in O 0 5.822182720294222e-05
A B-Disease 1 0.9780054688453674
- I-Disease 0 0.05763641372323036
T I-Disease 1 0.9965831637382507
, O 0 1.0847332305274904e-05
we O 0 3.071632136197877e-06
demonstrate O 0 9.580805453879293e-06
a O 0 8.74439410836203e-06
high O 0 2.311289972567465e-05
frequency O 0 5.626076017506421e-06
of O 0 4.142240868532099e-05
ATM O 0 0.001333431457169354
mutations O 0 9.842359577305615e-05
in O 0 0.00038206527824513614
T B-Disease 1 0.9985950589179993
- I-Disease 0 0.013664724305272102
PLL I-Disease 1 0.9887179136276245
. O 0 0.00017952042981050909

In O 0 0.00011755432933568954
marked O 0 0.0002544660528656095
contrast O 0 3.561234552762471e-05
to O 0 1.5566414731438272e-05
the O 0 4.572930993163027e-05
ATM O 0 0.0008222950273193419
mutation O 0 1.6607826182735153e-05
pattern O 0 8.491899643559009e-05
in O 0 0.00010210288019152358
A B-Disease 1 0.9990196228027344
- I-Disease 0 0.35001814365386963
T I-Disease 1 0.9956934452056885
, O 0 7.739165084785782e-06
the O 0 4.091592018085066e-06
most O 0 1.821815203584265e-06
frequent O 0 2.858258994820062e-06
nucleotide O 0 5.081463314127177e-06
changes O 0 2.2181618533068104e-06
in O 0 8.126259672280867e-06
this O 0 1.1744869880203623e-05
leukaemia B-Disease 1 0.6897113919258118
were O 0 0.0001235836825799197
missense O 0 0.0005451864562928677
mutations O 0 0.0002604376059025526
. O 0 0.0003194873279426247

These O 0 6.216426845639944e-05
clustered O 0 0.00018731474119704217
in O 0 1.1489216376503464e-05
the O 0 1.1269425158388913e-05
region O 0 2.570588912931271e-05
corresponding O 0 6.629142717429204e-06
to O 0 7.62587023928063e-06
the O 0 2.7215755835641176e-05
kinase O 0 3.241568265366368e-05
domain O 0 2.6266356144333258e-05
, O 0 4.306481969251763e-06
which O 0 1.454657422073069e-06
is O 0 2.0969557681382867e-06
highly O 0 1.2854256056016311e-05
conserved O 0 4.149701271671802e-05
in O 0 2.92618806270184e-05
ATM O 0 0.0010852864943444729
- O 0 0.00014913312043063343
related O 0 3.2163243304239586e-05
proteins O 0 1.699383028608281e-05
in O 0 3.660908623714931e-05
mouse O 0 4.783238910022192e-05
, O 0 7.715877472946886e-06
yeast O 0 4.1160750697599724e-05
and O 0 2.2613981855101883e-05
Drosophila O 0 0.00021003963775001466
. O 0 7.940526847960427e-05

The O 0 0.00020766833040397614
resulting O 0 0.0001813089766073972
amino O 0 6.86015555402264e-05
- O 0 0.0002133380330633372
acid O 0 1.530151530459989e-05
substitutions O 0 1.8200533304479904e-05
are O 0 1.441603899365873e-06
predicted O 0 2.113560913130641e-05
to O 0 5.890084139537066e-06
interfere O 0 3.035082045244053e-05
with O 0 2.0563287762342952e-05
ATP O 0 0.015513802878558636
binding O 0 3.861732693621889e-05
or O 0 2.9132128474884667e-05
substrate O 0 0.00016907782992348075
recognition O 0 0.00028568701236508787
. O 0 0.00039798763464204967

Two O 0 4.5799490180797875e-05
of O 0 0.00014371288125403225
seventeen O 0 0.001515605952590704
mutated O 0 0.0015673261368647218
T B-Disease 0 0.05355435237288475
- I-Disease 0 0.0011823299573734403
PLL I-Disease 0 0.004079621750861406
samples O 0 6.905296231707325e-06
had O 0 1.0798645234899595e-05
a O 0 2.8206518436491024e-06
previously O 0 1.7114491129177622e-05
reported O 0 5.31720434082672e-05
A B-Disease 0 0.04031989723443985
- I-Disease 0 0.11966051906347275
T I-Disease 1 0.999483585357666
allele O 0 0.00022153611644171178
. O 0 0.00011124477896373719

In O 0 0.00021316092170309275
contrast O 0 9.744991984916851e-05
, O 0 1.7505914001958445e-05
no O 0 1.0489151463843882e-05
mutations O 0 1.4306295270216651e-05
were O 0 2.219617090304382e-05
detected O 0 3.7720597902080044e-05
in O 0 3.2327759527106537e-06
the O 0 6.270006906561321e-06
p53 O 0 6.0759298321499955e-06
gene O 0 3.4983047498826636e-06
, O 0 1.5512031268372084e-06
suggesting O 0 7.967184501467273e-06
that O 0 1.5207562000796315e-06
this O 0 1.3686601050721947e-05
tumour B-Disease 1 1.0
suppressor O 0 0.0013271510833874345
is O 0 1.257797975995345e-05
not O 0 1.6093556496343808e-06
frequently O 0 6.7850273808289785e-06
altered O 0 1.5854429875616916e-05
in O 0 1.1209786862309556e-05
this O 0 3.183264925610274e-05
leukaemia B-Disease 1 0.9926376342773438
. O 0 0.000637030927464366

Occasional O 0 0.0009663127129897475
missense O 0 0.0011710675898939371
mutations O 0 8.929694740800187e-05
in O 0 0.00012468737259041518
ATM O 0 0.001029656850732863
were O 0 2.596168633317575e-05
also O 0 3.150290922349086e-06
found O 0 2.4771777589194244e-06
in O 0 1.4646950148744509e-05
tumour B-Disease 1 0.9999797344207764
DNA O 0 4.5313354348763824e-05
from O 0 1.0941012078546919e-05
patients O 0 5.705175681214314e-06
with O 0 5.101006536278874e-06
B B-Disease 0 0.04035269469022751
- I-Disease 0 0.0016288652550429106
cell I-Disease 0 0.00032129560713656247
non I-Disease 0 0.0006547577795572579
- I-Disease 1 0.602475106716156
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9992324113845825
( O 0 0.00019030168186873198
B B-Disease 0 0.0023171810898929834
- I-Disease 0 0.00022575876209884882
NHL I-Disease 0 0.0003064705815631896
) O 0 3.277308906035614e-06
and O 0 1.2688813058048254e-06
a O 0 1.9955170500907116e-05
B B-Disease 0 0.0020534945651888847
- I-Disease 0 0.0011196625418961048
NHL I-Disease 0 0.004277084954082966
cell O 0 0.0011344985105097294
line O 0 0.0008565802127122879
. O 0 0.000183153388206847

The O 0 8.247490040957928e-05
evidence O 0 4.287934280000627e-05
of O 0 2.3724303900962695e-05
a O 0 1.0673285942175426e-05
significant O 0 1.6384892660425976e-05
proportion O 0 1.7713497072691098e-05
of O 0 4.747529965243302e-05
loss O 0 0.0008099619299173355
- O 0 0.00029957288643345237
of O 0 5.7651977840578184e-05
- O 0 0.00014767191896680743
function O 0 1.300504391110735e-05
mutations O 0 7.032087978586787e-06
and O 0 3.857989213429391e-06
a O 0 9.115961802308448e-06
complete O 0 4.654243457480334e-05
absence O 0 8.919124957174063e-05
of O 0 5.678160596289672e-05
the O 0 4.654021540773101e-05
normal O 0 2.780274735414423e-05
copy O 0 1.884730409074109e-05
of O 0 2.37641143030487e-05
ATM O 0 0.00037855777190998197
in O 0 1.0206383194599766e-05
the O 0 8.320949746121187e-06
majority O 0 3.357626610522857e-06
of O 0 7.821448525646701e-05
mutated O 0 0.001196012133732438
tumours B-Disease 1 0.9999995231628418
establishes O 0 0.00049167824909091
somatic O 0 0.00015596332377754152
inactivation O 0 0.00040066763176582754
of O 0 4.8232130211545154e-05
this O 0 4.017978881165618e-06
gene O 0 2.928848971350817e-06
in O 0 3.8115078950795578e-06
the O 0 1.2656529179366771e-05
pathogenesis O 0 0.001927144592627883
of O 0 0.0003649172722361982
sporadic B-Disease 0 0.26859384775161743
T I-Disease 1 0.9999929666519165
- I-Disease 0 0.15104559063911438
PLL I-Disease 1 0.7653169631958008
and O 0 1.3941536053607706e-05
suggests O 0 8.059359970502555e-06
that O 0 2.639113063196419e-06
ATM O 0 0.00025190989254042506
acts O 0 3.174916128045879e-05
as O 0 9.173974831355736e-05
a O 0 0.0006174142472445965
tumour B-Disease 1 1.0
suppressor O 1 0.8308958411216736
. O 0 0.0008511916385032237

As O 0 0.00012591252743732184
constitutional O 0 7.065624959068373e-05
DNA O 0 5.3674462833441794e-05
was O 0 5.601286466117017e-05
not O 0 9.147854598268168e-07
available O 0 7.944763069644978e-07
, O 0 2.1888351966481423e-06
a O 0 1.1535964404174592e-05
putative O 0 0.0004619190003722906
hereditary O 1 0.9997929930686951
predisposition O 1 0.9999876022338867
to O 1 0.8811138272285461
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9651086926460266
PLL I-Disease 1 0.5608683824539185
will O 0 5.1030497161264066e-06
require O 0 9.477835192228667e-07
further O 0 4.792054369318066e-06
investigation O 0 3.473262404440902e-05
. O 0 2.3312017219723202e-05
. O 0 8.029354648897424e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.001846802537329495
kinase O 0 0.00026609780616126955
is O 0 1.7465976270614192e-05
involved O 0 8.66766094986815e-06
in O 0 3.3992205317190383e-06
the O 0 2.101219479300198e-06
modulation O 0 4.778783022629796e-06
of O 0 8.578125743952114e-06
the O 0 1.7057755030691624e-05
Ca2 O 0 0.00018834418733604252
+ O 0 0.0004349776718299836
homeostasis O 0 0.0023027576971799135
in O 0 0.00035611746716313064
skeletal O 1 0.9999688863754272
muscle O 1 0.9699241518974304
cells O 0 0.0017709663370624185
. O 0 0.00036524617462418973

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9997904896736145
DM B-Disease 1 1.0
) O 0 8.158519631251693e-05
, O 0 5.199555744184181e-06
the O 0 8.900861757865641e-06
most O 0 2.047390262305271e-05
prevalent O 0 0.39121901988983154
muscular B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
in O 0 0.0031625842675566673
adults O 0 8.251643885159865e-05
, O 0 1.2082942703273147e-05
is O 0 1.0494755770196207e-05
caused O 0 9.106860670726746e-05
by O 0 1.2976846846868284e-05
( O 0 5.652811159961857e-05
CTG O 0 0.010765274055302143
) O 0 2.4328530344064347e-05
n O 0 7.774541154503822e-05
- O 0 9.635292371967807e-05
repeat O 0 4.517812703852542e-05
expansion O 0 4.332970274845138e-05
in O 0 2.2481219730252633e-06
a O 0 1.13374028387625e-06
gene O 0 4.437563063675043e-07
encoding O 0 8.336941732522973e-07
a O 0 5.607750608760398e-06
protein O 0 1.1101972631877288e-05
kinase O 0 4.0607388655189425e-05
( O 0 3.977391679654829e-05
DM B-Disease 1 0.9997809529304504
protein O 0 8.127264300128445e-05
kinase O 0 8.543361764168367e-05
; O 0 1.2071907804056536e-05
DMPK O 0 0.006706940475851297
) O 0 9.614001100999303e-06
and O 0 2.438103138047154e-06
involves O 0 5.521058028534753e-06
changes O 0 5.831798262079246e-06
in O 0 3.839037162833847e-05
cytoarchitecture O 0 0.002864296082407236
and O 0 0.00010668807954061776
ion O 0 0.002742023905739188
homeostasis O 0 0.04547925293445587
. O 0 0.0005909461178816855

To O 0 7.178253144957125e-05
obtain O 0 2.8170765290269628e-05
clues O 0 7.099136564647779e-05
to O 0 7.832803021301515e-06
the O 0 1.555605740577448e-05
normal O 0 2.829364711942617e-05
biological O 0 2.878960731322877e-05
role O 0 2.5424424165976234e-05
of O 0 0.00010440370533615351
DMPK O 1 0.998557984828949
in O 0 0.00011918303061975166
cellular O 0 0.0003878906136378646
ion O 0 0.0005614434485323727
homeostasis O 0 0.0008351053693331778
, O 0 9.616494935471565e-06
we O 0 2.2334111235977616e-06
have O 0 7.39005372452084e-07
compared O 0 7.505380381189752e-06
the O 0 1.8245820683659986e-05
resting O 0 0.0003917808353435248
[ O 0 0.00015961912868078798
Ca2 O 0 0.0002602941240184009
+ O 0 0.0004016044840682298
] O 0 0.00023790141858626157
i O 0 4.394482675706968e-05
, O 0 2.6494240046304185e-06
the O 0 5.983877144899452e-06
amplitude O 0 2.240646608697716e-05
and O 0 6.501704774564132e-06
shape O 0 3.438771818764508e-05
of O 0 7.99449990154244e-05
depolarization O 0 0.0007051541469991207
- O 0 0.0007845627260394394
induced O 0 0.0004384207131806761
Ca2 O 0 0.00024712138110771775
+ O 0 0.00018466004985384643
transients O 0 0.000277817394817248
, O 0 1.8081206007991568e-06
and O 0 7.407248290292046e-07
the O 0 2.5015065148181748e-06
content O 0 3.7083671031723497e-06
of O 0 5.8976878790417686e-05
ATP O 0 0.048039380460977554
- O 0 0.0008447807049378753
driven O 0 0.00021832011407241225
ion O 0 0.00027276817127130926
pumps O 0 0.00027695155586116016
in O 0 7.552159513579682e-05
cultured O 0 0.0011953144567087293
skeletal O 0 0.16901172697544098
muscle O 0 0.0008019937667995691
cells O 0 8.10664496384561e-05
of O 0 0.00014389031275641173
wild O 0 0.00014135379751678556
- O 0 0.00011771091521950439
type O 0 3.490325252641924e-05
and O 0 2.2548067136085592e-05
DMPK O 1 0.9701989889144897
[ O 0 0.0004954059841111302
- O 0 0.0006102517363615334
/ O 0 0.0004895443562418222
- O 0 0.0007059657946228981
] O 0 0.0008544509764760733
knockout O 0 0.10768460482358932
mice O 0 0.001140907290391624
. O 0 0.00018469206406734884

In O 0 0.0002580728323664516
vitro O 0 0.0004039013874717057
- O 0 0.0004446945386007428
differentiated O 0 0.0003041605814360082
DMPK O 1 0.9861487150192261
[ O 0 0.0008039265521802008
- O 0 0.000860125757753849
/ O 0 0.0006134607829153538
- O 0 0.00042289329576306045
] O 0 0.00016464888176415116
myotubes O 0 0.0004276926047168672
exhibit O 0 3.7785368476761505e-05
a O 0 1.3981826668896247e-05
higher O 0 2.7689608032233082e-05
resting O 0 0.0002721784985624254
[ O 0 9.129179670708254e-05
Ca2 O 0 0.00016789733490440995
+ O 0 0.00017172670050058514
] O 0 0.0001479196798754856
i O 0 3.8333811971824616e-05
than O 0 5.024424353905488e-06
do O 0 8.418519428232685e-06
wild O 0 4.675971285905689e-05
- O 0 6.8645465944428e-05
type O 0 3.522600309224799e-05
myotubes O 0 0.0004103643004782498
because O 0 3.0237345072237076e-06
of O 0 9.635902642912697e-06
an O 0 3.7409181459224783e-06
altered O 0 1.704258465906605e-05
open O 0 1.263853300770279e-05
probability O 0 1.6575389736317447e-06
of O 0 3.053232285310514e-05
voltage O 0 0.00042999142897315323
- O 0 0.0002740146592259407
dependent O 0 5.295273513183929e-05
l O 0 0.0001127465147874318
- O 0 5.701709596905857e-05
type O 0 2.013674020417966e-05
Ca2 O 0 7.373048720182851e-05
+ O 0 8.034978236537427e-05
and O 0 2.2190795789356343e-05
Na O 0 0.002705527702346444
+ O 0 0.00016011438856367022
channels O 0 0.0001565136481076479
. O 0 9.329624299425632e-05

The O 0 0.000638525583781302
mutant O 0 0.0018691718578338623
myotubes O 0 0.003538217395544052
exhibit O 0 0.00018922402523458004
smaller O 0 2.5674311473267153e-05
and O 0 8.911842996894848e-06
slower O 0 4.52362401119899e-05
Ca2 O 0 8.926579175749794e-05
+ O 0 4.905292371404357e-05
responses O 0 5.731614237447502e-06
upon O 0 3.0461822461802512e-05
triggering O 0 9.762943955138326e-05
by O 0 7.807849215168972e-06
acetylcholine O 0 0.0001857512106653303
or O 0 2.5108822228503413e-05
high O 0 0.000260900123976171
external O 0 0.00010714052768889815
K O 0 0.0008050684118643403
+ O 0 0.0006376572418957949
. O 0 0.00016074831364676356

In O 0 0.00016502104699611664
addition O 0 2.7045382012147456e-05
, O 0 6.617722192459041e-06
we O 0 2.6605241600918816e-06
observed O 0 3.06489027934731e-06
that O 0 6.916446864124737e-07
these O 0 1.4449237824010197e-06
Ca2 O 0 0.0001980493398150429
+ O 0 0.0004269937635399401
transients O 0 0.0007462952053174376
partially O 0 4.9741705879569054e-05
result O 0 3.8179837247298565e-06
from O 0 4.4677863115794025e-06
an O 0 2.341264462302206e-06
influx O 0 2.2964113668422215e-05
of O 0 1.6404575944761746e-05
extracellular O 0 5.874315320397727e-05
Ca2 O 0 8.112660725601017e-05
+ O 0 2.466760815877933e-05
through O 0 3.3419858027627924e-06
the O 0 1.0636107617756352e-05
l O 0 5.609732397715561e-05
- O 0 4.887301838607527e-05
type O 0 1.8200307749793865e-05
Ca2 O 0 7.698794797761366e-05
+ O 0 0.0001489605929236859
channel O 0 0.0002476053487043828
. O 0 7.8230383223854e-05

Neither O 0 0.00036380314850248396
the O 0 3.701571040437557e-05
content O 0 1.4631508747697808e-05
nor O 0 1.7437849237467162e-05
the O 0 4.9847526497615036e-06
activity O 0 1.0381831089034677e-05
of O 0 3.272741014370695e-05
Na O 0 0.005512171890586615
+ O 0 0.00015600108599755913
/ O 0 0.0001041014984366484
K O 0 0.00025772026856429875
+ O 0 0.00012243886885698885
ATPase O 0 0.00017849801224656403
and O 0 1.824658647819888e-05
sarcoplasmic O 0 0.0007461198838427663
reticulum O 0 0.0002872914483305067
Ca2 O 0 0.0003298286464996636
+ O 0 0.00038963317638263106
- O 0 0.00027643394423648715
ATPase O 0 9.917996794683859e-05
are O 0 2.6286006686859764e-06
affected O 0 1.884547236841172e-05
by O 0 2.3234137188410386e-05
DMPK O 1 0.8896178603172302
absence O 0 0.0022259270772337914
. O 0 0.0004990912275388837

In O 0 0.00018581657786853611
conclusion O 0 6.476948328781873e-05
, O 0 9.407430297869723e-06
our O 0 3.180787189194234e-06
data O 0 4.043896751682041e-06
suggest O 0 8.646195055916905e-06
that O 0 7.146212738007307e-06
DMPK O 0 0.007616129703819752
is O 0 1.0745862709882203e-05
involved O 0 6.857246262370609e-06
in O 0 7.4406057137821335e-06
modulating O 0 0.000103505612059962
the O 0 1.115478062274633e-05
initial O 0 6.2320327742781956e-06
events O 0 1.0155759810004383e-05
of O 0 4.475165042094886e-05
excitation O 0 0.00046464597107842565
- O 0 0.0019706038292497396
contraction O 0 0.0015081600286066532
coupling O 0 0.0007169691962189972
in O 0 0.0004735228721983731
skeletal O 1 0.9999659061431885
muscle O 0 0.17657946050167084
. O 0 0.00027724640676751733
. O 0 0.00033898811670951545

Constitutional O 0 0.005536070559173822
RB1 O 1 0.9999760389328003
- O 0 0.0018315197667106986
gene O 0 3.689064396894537e-05
mutations O 0 1.5670917491661385e-05
in O 0 2.097417200275231e-05
patients O 0 2.667906301212497e-05
with O 0 1.96298242371995e-05
isolated O 0 0.0005883348057977855
unilateral B-Disease 0 0.0005231170798651874
retinoblastoma I-Disease 1 0.9994243383407593
. O 0 0.0011331355199217796

In O 0 0.000240817986195907
most O 0 4.217483365209773e-05
patients O 0 3.155994272674434e-05
with O 0 1.2783487363776658e-05
isolated O 0 0.0004482986987568438
unilateral B-Disease 0 0.00023203037562780082
retinoblastoma I-Disease 1 0.9999854564666748
, O 0 0.0003587873943615705
tumor B-Disease 1 0.9998936653137207
development O 0 7.467156683560461e-05
is O 0 6.99242491464247e-06
initiated O 0 2.524914816603996e-05
by O 0 1.3885046428185888e-06
somatic O 0 2.028832386713475e-05
inactivation O 0 0.0001887691905722022
of O 0 2.5697921955725178e-05
both O 0 9.282999599236064e-06
alleles O 0 1.0200797987636179e-05
of O 0 0.00010631942132022232
the O 0 0.0005219663144089282
RB1 O 1 0.999405026435852
gene O 0 0.00030647352105006576
. O 0 0.00022321024152915925

However O 0 9.151335689239204e-05
, O 0 5.230695023783483e-06
some O 0 1.2708770782410284e-06
of O 0 1.2323722330620512e-05
these O 0 6.42565282760188e-06
patients O 0 3.785573426284827e-05
can O 0 1.3778878383163828e-05
transmit O 0 0.00042216305155307055
retinoblastoma B-Disease 1 0.7969746589660645
predisposition O 0 0.010405784472823143
to O 0 0.00018688623094931245
their O 0 0.00011184083996340632
offspring O 0 0.0005117586115375161
. O 0 0.00017570033378433436

To O 0 3.366760938661173e-05
determine O 0 9.212973054673057e-06
the O 0 9.486187082075048e-06
frequency O 0 1.1319899385853205e-05
and O 0 3.849620497931028e-06
nature O 0 1.3293679330672603e-05
of O 0 4.0276838262798265e-05
constitutional O 0 0.0008399231010116637
RB1 O 1 0.9999563694000244
- O 0 0.0007274386589415371
gene O 0 2.173382745240815e-05
mutations O 0 1.4782845937588718e-05
in O 0 1.7051395843736827e-05
patients O 0 1.9417551811784506e-05
with O 0 1.2319233064772561e-05
isolated O 0 0.00021529974765144289
unilateral B-Disease 0 0.0001322062744293362
retinoblastoma I-Disease 0 0.0269110556691885
, O 0 1.2554360182548407e-05
we O 0 3.910372925020056e-06
analyzed O 0 6.289158591243904e-06
DNA O 0 1.3172502804081887e-05
from O 0 2.3161113858805038e-05
peripheral O 0 0.0019591902382671833
blood O 0 0.0002500756236258894
and O 0 5.43789537914563e-05
from O 0 0.0017007305286824703
tumor B-Disease 1 1.0
tissue O 1 0.9940651655197144
. O 0 0.000597214384470135

The O 0 4.927337431581691e-05
analysis O 0 1.066984623321332e-05
of O 0 0.00018966008792631328
tumors B-Disease 1 0.9999977350234985
from O 0 9.931587555911392e-05
54 O 0 0.00011184105096617714
( O 0 1.286883980355924e-05
71 O 0 3.152102362946607e-05
% O 0 4.91815444547683e-06
) O 0 3.0745629828743404e-06
of O 0 1.681203684711363e-05
76 O 0 0.00017202268645633012
informative O 0 8.68255810928531e-05
patients O 0 4.236049426253885e-05
showed O 0 7.395991997327656e-05
loss O 0 0.00017272745026275516
of O 0 0.0001380671455990523
constitutional O 0 0.0007583328406326473
heterozygosity O 1 0.9976418018341064
( O 0 0.00201145326718688
LOH O 1 0.9999990463256836
) O 0 0.0001223270664922893
at O 0 0.0005715079023502767
intragenic O 0 0.006672081537544727
loci O 0 0.0008219573646783829
. O 0 0.0002948702604044229

Three O 0 6.92876783432439e-05
of O 0 0.0001635342341614887
13 O 0 0.0013097628252580762
uninformative O 0 0.33481842279434204
patients O 0 0.00045940245036035776
had O 0 0.000531769182998687
constitutional O 0 0.0006702003302052617
deletions O 0 0.0015483790775761008
. O 0 0.0007152068428695202

For O 0 4.741900920635089e-05
39 O 0 7.591974281240255e-05
randomly O 0 1.2882150258519687e-05
selected O 0 0.00020673741528298706
tumors B-Disease 1 0.9999998807907104
, O 0 0.00025709837791509926
SSCP O 1 0.9999591112136841
, O 0 0.00024770310847088695
hetero O 0 0.004432738292962313
- O 0 0.00025534533779136837
duplex O 0 0.00015521676687058061
analysis O 0 3.2146431294677313e-06
, O 0 3.414009370317217e-06
sequencing O 0 8.287229320558254e-06
, O 0 3.840046701952815e-06
and O 0 2.919005737567204e-06
Southern O 0 2.3568929464090616e-05
blot O 0 2.8054331778548658e-05
analysis O 0 1.0551349305387703e-06
were O 0 3.192347321601119e-06
used O 0 3.1026040687720524e-06
to O 0 8.709937901585363e-06
identify O 0 5.050518302596174e-05
mutations O 0 0.00017090453184209764
. O 0 0.0003140631888527423

Mutations O 0 0.0002961078134831041
were O 0 0.00012093597615603358
detected O 0 0.0001569784653838724
in O 0 2.3044893168844283e-05
21 O 0 8.224376506404951e-05
( O 0 6.020018190611154e-06
91 O 0 2.5162516976706684e-05
% O 0 5.544961368286749e-06
) O 0 6.050874162610853e-06
of O 0 7.980790542205796e-05
23 O 1 0.8988096117973328
tumors B-Disease 1 1.0
with O 0 0.002607721835374832
LOH O 1 1.0
. O 0 0.0010376401478424668

In O 0 0.00024352547188755125
6 O 0 0.00016992665769066662
( O 0 1.0569059668341652e-05
38 O 0 1.2947079994773958e-05
% O 0 2.786620825645514e-06
) O 0 4.580833774525672e-06
of O 0 5.911917469347827e-05
16 O 0 0.4683202803134918
tumors B-Disease 1 1.0
without O 0 0.0007304218597710133
LOH O 1 0.9999990463256836
, O 0 1.764141234161798e-05
one O 0 3.6495860058494145e-06
mutation O 0 5.318814601196209e-06
was O 0 8.887584408512339e-05
detected O 0 5.6840766774257645e-05
, O 0 2.5051972443179693e-06
and O 0 1.8069277984977816e-06
in O 0 6.8861459112667944e-06
9 O 0 3.73059774574358e-05
( O 0 3.028132596227806e-06
56 O 0 9.442790542379953e-06
% O 0 1.945758867805125e-06
) O 0 2.5384242690051906e-06
of O 0 2.6205954782199115e-05
the O 0 0.0005919667310081422
tumors B-Disease 1 1.0
without O 0 0.0006700681406073272
LOH O 1 0.9999996423721313
, O 0 2.3189599232864566e-05
both O 0 9.357484486827161e-06
mutations O 0 3.9373288018396124e-05
were O 0 0.00010001267946790904
found O 0 9.851055801846087e-05
. O 0 0.00020412604499142617

Thus O 0 0.0002054732176475227
, O 0 6.329291409201687e-06
a O 0 1.8569730855233502e-06
total O 0 2.702328401937848e-06
of O 0 1.0496656614122912e-05
45 O 0 2.5425491912756115e-05
mutations O 0 1.1094277397205587e-05
were O 0 1.5011113646323793e-05
identified O 0 2.2776850528316572e-05
in O 0 6.578963075298816e-05
tumors B-Disease 1 0.9999995231628418
of O 0 0.0004794232954736799
36 O 0 0.0013316654367372394
patients O 0 0.000877111335285008
. O 0 0.00030405737925320864

Thirty O 0 0.0036359885707497597
- O 0 0.0003052668471354991
nine O 0 3.159108018735424e-05
of O 0 2.3773043722030707e-05
the O 0 2.7371375836082734e-05
mutations O 0 2.2981113943387754e-05
- O 0 3.587296305340715e-05
including O 0 5.13032728122198e-06
34 O 0 2.9357473977142945e-05
small O 0 5.725998107664054e-06
mutations O 0 1.1204891052329913e-05
, O 0 5.426641564554302e-06
2 O 0 4.3306732550263405e-05
large O 0 3.976576044806279e-05
structural O 0 0.0010408814996480942
alterations O 0 0.00044392773997969925
, O 0 3.372146238689311e-05
and O 0 3.091113831032999e-05
hypermethylation O 0 0.005505324807018042
in O 0 0.0003683892427943647
3 O 0 0.01668204367160797
tumors O 1 1.0
- O 0 0.0005431812023743987
were O 0 2.3475435227737762e-05
not O 0 2.6876248284679605e-06
detected O 0 1.332453393843025e-05
in O 0 2.735601583481184e-06
the O 0 4.737047220260138e-06
corresponding O 0 2.8704569558613002e-05
peripheral O 0 0.0037856479175388813
blood O 0 0.0008218814618885517
DNA O 0 0.0009534001001156867
. O 0 0.0004468246770557016

In O 0 0.0003586344828363508
6 O 0 0.000285276590147987
( O 0 1.814926326915156e-05
17 O 0 4.2054431105498224e-05
% O 0 4.111807356821373e-06
) O 0 2.435951046209084e-06
of O 0 8.758582225709688e-06
the O 0 2.863293957489077e-05
36 O 0 8.341525244759396e-05
patients O 0 2.1101812308188528e-05
, O 0 7.672308129258454e-06
a O 0 1.5819901818758808e-05
mutation O 0 1.0513889719732106e-05
was O 0 8.205356425605714e-05
detected O 0 2.3742501070955768e-05
in O 0 4.972417627868708e-06
constitutional O 0 1.0702804502216168e-05
DNA O 0 1.8373917555436492e-05
, O 0 2.5329250092909206e-06
and O 0 9.5321325943587e-07
1 O 0 1.2660126230912283e-05
of O 0 1.0097448466694914e-05
these O 0 2.3821380636945833e-06
mutations O 0 4.1779053390200716e-06
is O 0 2.239126615677378e-06
known O 0 6.32409637546516e-06
to O 0 4.1118937588180415e-06
be O 0 4.292344328860054e-06
associated O 0 5.823528226756025e-06
with O 0 1.307713955611689e-05
reduced O 0 0.0005327982944436371
expressivity O 0 0.01214890368282795
. O 0 0.0007560696103610098

The O 0 0.00015806833107490093
presence O 0 5.2496401622192934e-05
of O 0 3.945921707781963e-05
a O 0 3.951487087761052e-05
constitutional O 0 5.6128090363927186e-05
mutation O 0 1.3210938050178811e-05
was O 0 4.720505603472702e-05
not O 0 1.5436811509061954e-06
associated O 0 1.810759044929e-06
with O 0 8.829951525513025e-07
an O 0 4.1440644054091536e-06
early O 0 6.872825179016218e-05
age O 0 0.0001800884201657027
at O 0 0.0010930881835520267
treatment O 0 0.0009048333158716559
. O 0 0.0003897572751156986

In O 0 0.00032519170781597495
1 O 0 0.00047057002666406333
patient O 0 0.00016580098599661142
, O 0 3.4300006518606097e-05
somatic O 0 0.00031648395815864205
mosaicism O 1 0.7385019063949585
was O 0 0.0004942170344293118
demonstrated O 0 4.616594378603622e-05
by O 0 1.6327829825968365e-06
molecular O 0 2.884816922232858e-06
analysis O 0 5.449930995382601e-07
of O 0 9.617687283025589e-06
DNA O 0 3.1943949579726905e-05
and O 0 1.3692345419258345e-05
RNA O 0 0.00021760996605735272
from O 0 0.000142448436236009
peripheral O 0 0.11215167492628098
blood O 0 0.00210363301448524
. O 0 0.0008133603841997683

In O 0 0.0002473364002071321
2 O 0 0.00038660704740323126
patients O 0 5.474901263369247e-05
without O 0 1.6633232007734478e-05
a O 0 3.8285405025817454e-05
detectable O 0 0.0004672037612181157
mutation O 0 2.0586579921655357e-05
in O 0 6.651761941611767e-05
peripheral O 0 0.17745329439640045
blood O 0 0.0006516615394502878
, O 0 7.419883331749588e-05
mosaicism O 0 0.3264217674732208
was O 0 0.00018708876450546086
suggested O 0 1.047271962306695e-05
because O 0 1.1369170351827051e-06
1 O 0 7.1889758146426175e-06
of O 0 9.486159797233995e-06
the O 0 2.840806519088801e-05
patients O 0 0.0001841634657466784
showed O 0 0.09603596478700638
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 3.5622397263068706e-05
the O 0 2.305491580045782e-05
other O 0 2.54894030149444e-06
later O 0 6.817172834416851e-05
developed O 0 0.00015388985048048198
bilateral B-Disease 0 0.09674014151096344
retinoblastoma I-Disease 1 0.9990172386169434
. O 0 0.0005553962546400726

In O 0 0.0002066286251647398
conclusion O 0 8.252249244833365e-05
, O 0 9.319741366198286e-06
our O 0 5.128605153004173e-06
results O 0 2.51271285378607e-06
emphasize O 0 1.4433219803322572e-05
that O 0 1.4433867363550235e-06
the O 0 1.3235691767476965e-05
manifestation O 0 0.0005885815480723977
and O 0 4.2431325709912926e-05
transmissibility O 0 0.004121529404073954
of O 0 0.00036207554512657225
retinoblastoma B-Disease 0 0.003960236441344023
depend O 0 4.4826138037024066e-05
on O 0 3.003327401529532e-05
the O 0 5.602923465630738e-06
nature O 0 3.4311517538299086e-06
of O 0 6.901201231812593e-06
the O 0 1.1912473382835742e-05
first O 0 1.9128661733702756e-05
mutation O 0 2.7121550374431536e-06
, O 0 1.517950863672013e-06
its O 0 1.0403151691207313e-06
time O 0 4.666587301471736e-06
in O 0 9.908949323289562e-06
development O 0 1.998430525418371e-05
, O 0 2.5900603759509977e-06
and O 0 1.3892675951865385e-06
the O 0 5.0912863116536755e-06
number O 0 3.1506665436609183e-06
and O 0 2.5632612050685566e-06
types O 0 5.121439698996255e-06
of O 0 5.913490895181894e-05
cells O 0 2.200482049374841e-05
that O 0 2.1894322799198562e-06
are O 0 7.555281058557739e-07
affected O 0 1.0136986929865088e-05
. O 0 9.885861800285056e-06
. O 0 3.985719013144262e-05

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.13726603984832764
the I-Disease 0 0.0005476559163071215
fifth I-Disease 0 0.0003270846209488809
component I-Disease 0 6.651724106632173e-05
of I-Disease 0 5.111740392749198e-05
complement I-Disease 0 0.00013611743634101003
in O 0 0.00019298338156659156
man O 0 0.0007377304136753082
. O 0 0.0001002106728265062

I O 0 0.4441906213760376
. O 0 0.0012799594551324844

Clinical O 0 0.0027193694841116667
, O 0 0.0002776595647446811
immunochemical O 0 0.008105211891233921
, O 0 4.094504038221203e-05
and O 0 2.5754939997568727e-05
family O 0 8.112583600450307e-05
studies O 0 8.06124007795006e-05
. O 0 0.00016506259271409363

The O 0 9.556059376336634e-05
first O 0 5.635925481328741e-05
recognized O 0 5.874281850992702e-05
human O 0 4.1796345612965524e-05
kindred O 0 0.0009513266268186271
with O 0 0.0001042149233398959
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9519467353820801
the I-Disease 0 0.00036516209365800023
fifth I-Disease 0 0.00018898890994023532
component I-Disease 0 2.996292823809199e-05
of I-Disease 0 2.9196487957960926e-05
complement I-Disease 0 0.0001458162732888013
( O 0 0.00017220780136995018
C5 O 1 0.998744010925293
) O 0 4.546918353298679e-05
is O 0 1.869004699983634e-05
described O 0 0.00011307187378406525
. O 0 8.87250280356966e-05

The O 0 0.0005650096572935581
proband O 0 0.0038702066522091627
, O 0 3.390778510947712e-05
a O 0 2.6539013560977764e-05
20 O 0 0.0001009800034807995
- O 0 0.0001296401023864746
year O 0 5.199667066335678e-05
- O 0 0.00012977888400200754
old O 0 5.461114051286131e-05
black O 0 2.560132634243928e-05
female O 0 2.5283969080192037e-05
with O 0 0.00012597639579325914
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999964237213135
age O 0 0.262016236782074
11 O 0 0.0007630377076566219
, O 0 3.5775119613390416e-05
lacked O 0 0.0009295070776715875
serum O 0 0.005218848120421171
hemolytic O 1 0.9999997615814209
complement O 0 0.00046399247366935015
activity O 0 0.00012522748147603124
, O 0 1.0928019037237391e-05
even O 0 2.069848960672971e-05
during O 0 0.0003475612320471555
remission O 0 0.001295862952247262
. O 0 0.0004463680961634964

C5 O 1 0.9999569654464722
was O 0 0.00912117213010788
undetectable O 0 0.003983162809163332
in O 0 4.7123066906351596e-05
her O 0 2.641309765749611e-05
serum O 0 9.661531657911837e-05
by O 0 8.005044037417974e-06
both O 0 2.6852480004890822e-05
immunodiffusion O 0 0.0613732635974884
and O 0 0.0003090090467594564
hemolytic O 1 0.9999998807907104
assays O 0 0.0016218200325965881
. O 0 0.0009881264995783567

Other O 0 2.6797451937454753e-05
complement O 0 5.483784116222523e-05
components O 0 6.822233262937516e-05
were O 0 4.093012466910295e-05
normal O 0 2.4597675292170607e-05
during O 0 9.690910519566387e-05
remission O 0 0.0003317688242532313
of O 0 0.0005544207524508238
lupus O 1 0.9999995231628418
, O 0 0.00012714472541119903
but O 0 6.456824485212564e-05
C1 O 1 0.9999853372573853
, O 0 0.0003741084656212479
C4 O 1 0.9999971389770508
, O 0 0.0002105617750203237
C2 O 1 0.9956933856010437
, O 0 6.316808139672503e-05
and O 0 7.874305447330698e-05
C3 O 1 0.9999865293502808
levels O 0 0.0016489664558321238
fell O 1 0.894468367099762
during O 0 0.0015553559642285109
exacerbations O 0 0.08317538350820541
. O 0 0.0005873728077858686

A O 0 0.0017362654907628894
younger O 0 0.0005185619811527431
half O 0 0.00015303966938517988
- O 0 0.0002616045530885458
sister O 0 4.103102764929645e-05
, O 0 3.9216292861965485e-06
who O 0 5.015614988224115e-06
had O 0 3.94194976252038e-05
no O 0 5.6003889767453074e-05
underlying O 1 0.9999476671218872
disease O 1 0.9999997615814209
, O 0 3.5621786082629114e-05
was O 0 0.0001865237718448043
also O 0 5.566259915212868e-06
found O 0 3.004435484399437e-06
to O 0 8.421690836257767e-06
lack O 0 0.00027101635350845754
immunochemically O 1 0.9994768500328064
detectable O 1 0.9986205101013184
C5 O 1 0.9999865293502808
. O 0 0.0007834093412384391

By O 0 0.0005239831516519189
hemolytic O 1 0.9999986886978149
assay O 0 0.0005337600014172494
, O 0 6.740442768204957e-05
she O 0 3.1256891816155985e-05
exhibited O 0 0.0001302965683862567
1 O 0 0.00013702380238100886
- O 0 6.091868272051215e-05
2 O 0 1.3697700524062384e-05
% O 0 2.010765456361696e-06
of O 0 1.0745759936980903e-05
the O 0 5.972862709313631e-05
normal O 0 0.00020328076789155602
serum O 0 0.0010155197232961655
C5 O 0 0.11666933447122574
level O 0 0.0001872702850960195
and O 0 9.464030881645158e-06
normal O 0 1.2700878869509324e-05
concentrations O 0 2.1770314560853876e-05
of O 0 1.2649554264498875e-05
other O 0 8.540250746591482e-06
complement O 0 8.140427235048264e-05
components O 0 0.00045369056169874966
. O 0 0.0003374176158104092

C5 O 1 0.9832049012184143
levels O 0 0.0002613913675304502
of O 0 4.9969155952567235e-05
other O 0 4.854814960708609e-06
family O 0 6.19868023932213e-06
members O 0 1.1166807780682575e-06
were O 0 4.905590685666539e-06
either O 0 4.5493229663406964e-06
normal O 0 1.6035162843763828e-05
or O 0 4.6675800149387214e-06
approximately O 0 3.8062142266426235e-05
half O 0 6.100611426518299e-05
- O 0 6.268317520152777e-05
normal O 0 6.5981435000139754e-06
, O 0 1.337195499218069e-06
consistent O 0 9.242021405952983e-06
with O 0 6.901319920871174e-06
autosomal O 0 0.0004633593198377639
codominant O 0 0.008332294411957264
inheritance O 0 0.00012402425636537373
of O 0 3.937355359084904e-05
the O 0 5.2135401347186416e-05
gene O 0 0.0001317332498729229
determining O 0 0.013607208617031574
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.01975429430603981

Normal O 0 0.00922876875847578
hemolytic O 1 0.9999997615814209
titers O 0 0.01145111583173275
were O 0 8.873011393006891e-05
restored O 0 0.0001507244014646858
to O 0 5.904897534492193e-06
both O 0 2.2435760911321267e-05
homozygous O 0 0.0011807121336460114
C5 B-Disease 1 1.0
- I-Disease 1 0.999972939491272
deficient I-Disease 1 0.9999996423721313
( O 0 0.0010521749500185251
C5D B-Disease 1 1.0
) O 0 7.86638047429733e-05
sera O 0 0.0005332839791662991
by O 0 3.004527343364316e-06
addition O 0 2.3770862753735855e-06
of O 0 4.803287811228074e-05
highly O 0 0.0005809770082123578
purified O 0 0.0022980407811701298
human O 0 0.0008387950365431607
C5 O 1 0.9999151229858398
. O 0 0.0003718323423527181

In O 0 0.0004814449930563569
specific O 0 0.00021313654724508524
C5 O 1 0.9999289512634277
titrations O 0 0.007761637680232525
, O 0 4.389385867398232e-05
however O 0 1.337639241683064e-05
, O 0 4.956646534992615e-06
it O 0 2.136846660505398e-06
was O 0 4.0087925299303606e-05
noted O 0 9.837896868702956e-06
that O 0 1.0534618013480213e-06
when O 0 2.4924813715188066e-06
limited O 0 2.5012298010551604e-06
amounts O 0 1.4730971997778397e-05
of O 0 0.0001400084438500926
C5 O 1 0.9961912631988525
were O 0 0.0001255973766092211
assayed O 0 0.00011189118231413886
in O 0 4.654732947528828e-06
the O 0 4.383737177704461e-06
presence O 0 6.6480215537012555e-06
of O 0 2.317103098903317e-05
low O 0 0.0001388480595778674
dilutions O 0 0.0004711317305918783
of O 0 0.0001867348182713613
either O 0 0.0005817105993628502
C5D B-Disease 1 1.0
serum O 0 0.0018781144171953201
, O 0 3.088122684857808e-05
curving O 0 0.00018076020933222026
rather O 0 3.556086085154675e-06
than O 0 3.828579338005511e-06
linear O 0 5.330922795110382e-05
dose O 0 0.0002331378636881709
- O 0 0.00012952926044818014
response O 0 6.996741376497084e-06
plots O 0 2.7311540179653093e-05
were O 0 1.3912103895563632e-05
consistently O 0 2.1670372007065453e-05
obtained O 0 1.2213519767101388e-05
, O 0 4.955791155225597e-06
suggesting O 0 1.416602299286751e-05
some O 0 8.87137957761297e-06
inhibitory O 0 0.0003806031891144812
effect O 0 0.0005802715313620865
. O 0 0.00032964636920951307

Further O 0 0.00012327016156632453
studies O 0 2.1579979147645645e-05
suggested O 0 1.8631748389452696e-05
that O 0 3.4620024962350726e-06
low O 0 5.945108932792209e-05
dilutions O 0 0.000609407143201679
of O 0 0.00036618628655560315
C5D B-Disease 1 0.9999996423721313
serum O 0 0.00040013701072894037
contain O 0 3.930073216906749e-05
a O 0 1.7901182218338363e-05
factor O 0 2.599424078653101e-05
( O 0 7.014612947386922e-06
or O 0 5.909568244533148e-06
factors O 0 1.7279722669627517e-05
) O 0 1.0040334018412977e-05
interfering O 0 2.446288453938905e-05
at O 0 5.216513454797678e-05
some O 0 3.118658469247748e-06
step O 0 5.0610193284228444e-05
in O 0 2.5437568183406256e-05
the O 0 9.3421149358619e-05
hemolytic O 1 0.999806821346283
assay O 0 0.0003664469695650041
of O 0 0.0010438667377457023
C5 O 1 0.9999381303787231
, O 0 3.2111205655382946e-05
rather O 0 6.204967121448135e-06
than O 0 2.558514097472653e-06
a O 0 2.493976899131667e-05
true O 0 0.00030117001733742654
C5 O 1 0.9997977614402771
inhibitor O 0 0.001651216996833682
or O 0 0.00037021571188233793
inactivator O 0 0.018396291881799698
. O 0 0.0004987141583114862

Of O 0 0.00019356278062332422
clinical O 0 0.00020028447033837438
interest O 0 6.727958680130541e-05
are O 0 3.3372468806192046e-06
( O 0 5.317120667314157e-06
a O 0 5.1419456212897785e-06
) O 0 8.831282798382745e-07
the O 0 1.7631018636166118e-06
documentation O 0 2.5610876036807895e-05
of O 0 0.0003862999437842518
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9963988065719604
vasculitis B-Disease 1 1.0
, O 0 0.012007968500256538
and O 0 0.029547326266765594
arthritis B-Disease 1 1.0
in O 0 0.000689141801558435
an O 0 3.779325925279409e-05
individual O 0 2.797564957290888e-05
lacking O 0 0.0017438301583752036
C5 O 1 0.999879002571106
( O 0 4.286715920898132e-05
and O 0 6.067128651920939e-06
its O 0 1.0317398846382275e-05
biologic O 0 0.000391831825254485
functions O 0 1.104433431464713e-05
) O 0 9.188649528368842e-06
, O 0 3.939404450647999e-06
and O 0 3.287500931037357e-06
( O 0 6.540861249959562e-06
b O 0 2.3074688215274364e-05
) O 0 3.0458222681772895e-06
a O 0 6.177358045533765e-06
remarkable O 0 7.972377352416515e-05
propensity O 0 0.0002636507560964674
to O 0 0.00025887598167173564
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999997615814209
in O 0 0.00020802069047931582
the O 0 0.00010183171252720058
proband O 0 0.0013404543278738856
, O 0 4.8523293116886634e-06
even O 0 3.7642582810804015e-06
during O 0 2.7512904125615023e-05
periods O 0 4.923260348732583e-05
of O 0 7.85085212555714e-05
low O 0 0.0004906745161861181
- O 0 0.00029025491676293314
dose O 0 5.141945803188719e-05
or O 0 6.6692819018498994e-06
alternate O 0 4.646393426810391e-05
- O 0 0.0002456419460941106
day O 0 0.00019309474737383425
corticosteroid O 0 0.05551571026444435
therapy O 0 0.005578655283898115
. O 0 0.0004416785668581724

Other O 0 2.9643240850418806e-05
observations O 0 2.845160270226188e-05
indicate O 0 2.5411673050257377e-05
that O 0 3.3400676784367533e-06
the O 0 3.2553351047681645e-05
C5D B-Disease 1 0.9998449087142944
state O 0 2.10655816772487e-05
is O 0 4.0790505408949684e-06
compatible O 0 8.579107998230029e-06
with O 0 2.288844598297146e-06
normal O 0 3.230427682865411e-05
coagulation O 0 0.00044222624273970723
function O 0 2.347507506783586e-05
and O 0 7.43678219805588e-06
the O 0 1.3238696737971622e-05
capacity O 0 7.022473437245935e-05
to O 0 1.422441073373193e-05
mount O 0 0.0010410507675260305
a O 0 0.00016019257600419223
neutrophilic O 1 0.9861495494842529
leukocytosis O 1 0.9882733225822449
during O 1 0.8729151487350464
pyogenic B-Disease 1 0.9999347925186157
infection I-Disease 1 0.7187060117721558
. O 0 9.873702219920233e-05
. O 0 0.0001268967753276229

Susceptibility O 1 0.9938219785690308
to O 1 0.9494009613990784
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.10970167070627213
twins O 0 0.00040507977246306837
: O 0 2.990497023347416e-06
the O 0 3.848442247544881e-06
role O 0 8.836170309223235e-06
of O 0 3.0547467758879066e-05
genes O 0 4.680985875893384e-05
, O 0 5.003800833947025e-05
HLA O 1 0.8888576030731201
, O 0 3.456588456174359e-05
and O 0 1.5607010936946608e-05
the O 0 9.049052459886298e-05
environment O 0 0.00016359207802452147
. O 0 0.00011718477617250755

OBJECTIVE O 0 0.0005873996415175498
To O 0 1.1392938176868483e-05
determine O 0 2.5777935661608353e-06
the O 0 3.3673943562462227e-06
relative O 0 1.0949321222142316e-05
effects O 0 2.0819052224396728e-05
of O 0 2.4637045498820953e-05
genetic O 0 5.587681880570017e-05
and O 0 1.0244024451822042e-05
environmental O 0 1.9936414901167154e-05
factors O 0 6.048987415852025e-06
in O 0 2.236538966826629e-05
susceptibility O 0 0.0014287518570199609
to O 0 0.118487149477005
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9981424808502197
AS B-Disease 1 0.9999996423721313
) O 0 0.0002481072733644396
. O 0 0.00017067395674530417

METHODS O 0 0.0010725070023909211
Twins O 0 0.00037735901423729956
with O 0 1.0099046448885929e-05
AS B-Disease 0 0.007067103870213032
were O 0 1.1965725207119249e-05
identified O 0 3.594547024476924e-06
from O 0 1.980225988518214e-06
the O 0 6.738668162142858e-06
Royal O 0 0.00017647165805101395
National O 0 0.0021352008916437626
Hospital O 1 0.9999939203262329
for O 0 0.3188509941101074
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.18340271711349487
. O 0 0.0009171714773401618

Clinical O 0 0.001387518597766757
and O 0 6.804923032177612e-05
radiographic O 0 0.0005300705088302493
examinations O 0 0.00018557487055659294
were O 0 5.3505151299759746e-05
performed O 0 5.909217361477204e-05
to O 0 1.5884335880400613e-05
establish O 0 0.0002173126704292372
diagnoses O 0 0.001102935173548758
, O 0 9.271718590753153e-05
and O 0 0.00022192808683030307
disease O 1 0.9999998807907104
severity O 0 0.41451847553253174
was O 0 0.0011530974879860878
assessed O 0 3.3712523872964084e-05
using O 0 2.19878347706981e-06
a O 0 8.273851562989876e-06
combination O 0 1.4997147445683368e-05
of O 0 4.950028596795164e-05
validated O 0 0.00012118416634621099
scoring O 0 0.00025224155979231
systems O 0 0.0009336682851426303
. O 0 0.00019074641750194132

HLA O 0 0.40875259041786194
typing O 0 0.0009352289489470422
for O 0 0.00026550935581326485
HLA O 1 0.9982923865318298
- O 0 0.0019724539015442133
B27 O 0 0.00119684636592865
, O 0 7.591409666929394e-05
HLA O 0 0.026072537526488304
- O 0 0.0006998094613663852
B60 O 0 0.0004937741323374212
, O 0 1.898791379062459e-05
and O 0 5.006015635444783e-05
HLA O 1 0.9998028874397278
- O 0 0.010939096100628376
DR1 O 1 0.9880600571632385
was O 0 0.00021815761283505708
performed O 0 3.468479189905338e-05
by O 0 3.2499503959115827e-06
polymerase O 0 8.922901906771585e-05
chain O 0 3.007773011631798e-05
reaction O 0 2.776625706246705e-06
with O 0 1.9144913494528737e-06
sequence O 0 1.276232796953991e-05
- O 0 4.6273842599475756e-05
specific O 0 1.8415929616821813e-06
primers O 0 3.894481051247567e-05
, O 0 8.977253855846357e-06
and O 0 1.0023830327554606e-05
zygosity O 0 0.0012776381336152554
was O 0 0.00020723752095364034
assessed O 0 6.617723556701094e-05
using O 0 2.400972334726248e-05
microsatellite O 0 0.0021665620151907206
markers O 0 0.002713023452088237
. O 0 0.0005865188431926072

Genetic O 0 0.0008294864092022181
and O 0 5.060937473899685e-05
environmental O 0 3.622336589614861e-05
variance O 0 5.634011358779389e-06
components O 0 3.1858526199357584e-05
were O 0 2.106662759615574e-05
assessed O 0 2.8249696697457694e-05
with O 0 3.44685508935072e-06
the O 0 2.619311271701008e-05
program O 0 3.6869121686322615e-05
Mx O 0 0.00038124033017084
, O 0 1.5723796877864515e-06
using O 0 5.627860559798137e-07
data O 0 1.6513035916432273e-06
from O 0 2.3871639314165805e-06
this O 0 1.000967358777416e-06
and O 0 1.326213691754674e-06
previous O 0 3.6864485082332976e-06
studies O 0 4.416316187416669e-06
of O 0 4.686801548814401e-05
twins O 0 0.00030259063350968063
with O 0 5.79403385927435e-05
AS B-Disease 1 0.9999347925186157
. O 0 0.0006412198999896646

RESULTS O 0 0.00015222901129163802
Six O 0 5.0959806685568765e-05
of O 0 6.349844625219703e-05
8 O 0 0.00041526168934069574
monozygotic O 0 0.001557751907967031
( O 0 0.00033816409995779395
MZ O 1 0.9931607246398926
) O 0 9.887335181701928e-05
twin O 0 0.00042361169471405447
pairs O 0 4.4391465053195134e-05
were O 0 0.0001694244856480509
disease O 1 0.7834822535514832
concordant O 0 0.0011165878968313336
, O 0 2.3364655135083012e-05
compared O 0 2.3913287805044092e-05
with O 0 6.252261300687678e-06
4 O 0 7.456538878614083e-05
of O 0 7.267614273587242e-05
15 O 0 0.00017064204439520836
B27 O 0 0.0007662876741960645
- O 0 0.0001430407864972949
positive O 0 1.5261583030223846e-05
dizygotic O 0 0.0009871338261291385
( O 0 0.00011424563854234293
DZ O 0 0.03825298696756363
) O 0 4.517140769166872e-05
twin O 0 0.00012964998313691467
pairs O 0 1.2821456948586274e-05
( O 0 1.0341523193346802e-05
27 O 0 6.423838931368664e-05
% O 0 8.544878255634103e-06
) O 0 5.8539312703942414e-06
and O 0 7.721825568296481e-06
4 O 0 6.402543658623472e-05
of O 0 0.00012471566151361912
32 O 0 0.00097937963437289
DZ O 1 0.9890282154083252
twin O 0 0.0009475463884882629
pairs O 0 3.749443931155838e-05
overall O 0 6.896920967847109e-05
( O 0 2.8820759325753897e-05
12 O 0 4.8873578634811565e-05
. O 0 6.445549843192566e-06
5 O 0 2.776824840111658e-05
% O 0 1.8436277969158255e-05
) O 0 4.1568266169633716e-05
. O 0 0.00011846626148326322

Nonsignificant O 0 0.00781067693606019
increases O 0 6.309241143753752e-05
in O 0 9.167940334009472e-06
similarity O 0 7.780504347465467e-06
with O 0 1.7826195062298211e-06
regard O 0 2.9650027499883436e-05
to O 0 1.2996141776966397e-05
age O 0 0.00022652072948403656
at O 1 0.942677915096283
disease O 1 0.9999991655349731
onset O 1 0.9988120794296265
and O 0 1.1497941159177572e-05
all O 0 5.4278530114970636e-06
of O 0 4.46416343038436e-05
the O 0 0.00029247274505905807
disease O 1 0.9998990297317505
severity O 0 0.00044718835852108896
scores O 0 6.363672582665458e-05
assessed O 0 4.839670509682037e-05
were O 0 1.9443863493506797e-05
noted O 0 4.0188973798649386e-05
in O 0 0.0001602234406163916
disease O 1 0.9999905824661255
- O 0 0.009934383444488049
concordant O 0 0.01351593341678381
MZ O 1 0.9995869994163513
twins O 0 0.00045435057836584747
compared O 0 0.00011241093307035044
with O 0 6.897183629916981e-05
concordant O 0 0.03375623747706413
DZ O 1 0.9999949932098389
twins O 0 0.01638040691614151
. O 0 0.0010787396458908916

HLA O 1 0.9999657869338989
- O 0 0.010634434409439564
B27 O 0 0.001405083923600614
and O 0 2.4599999960628338e-05
B60 O 0 0.00031165790278464556
were O 0 1.456934023735812e-05
associated O 0 8.664850611239672e-06
with O 0 5.2390623750397936e-06
the O 0 0.0001389859535265714
disease O 1 0.999976396560669
in O 0 0.00011952287604799494
probands O 0 0.006423112936317921
, O 0 5.919884642935358e-06
and O 0 1.5564042996629723e-06
the O 0 6.8496974563458934e-06
rate O 0 1.556475217512343e-05
of O 0 5.579322896664962e-05
disease O 1 0.697458803653717
concordance O 0 0.0001373394625261426
was O 0 0.00020866410341113806
significantly O 0 4.57864734926261e-05
increased O 0 6.368128379108384e-05
among O 0 0.00011633026588242501
DZ O 1 0.8125131726264954
twin O 0 0.0005259196041151881
pairs O 0 1.2100791536795441e-05
in O 0 1.1441281458246522e-05
which O 0 3.8254697756201494e-06
the O 0 2.617618338263128e-05
co O 0 0.0002707781968638301
- O 0 0.0001620943221496418
twin O 0 7.053379522403702e-05
was O 0 2.5166502382489853e-05
positive O 0 1.995555294342921e-06
for O 0 4.569376415020088e-06
both O 0 2.9645560061908327e-05
B27 O 0 0.0022164108231663704
and O 0 0.00029332892154343426
DR1 O 1 0.9991183876991272
. O 0 0.0005760558415204287

Additive O 0 0.0003502675681374967
genetic O 0 0.00016159108781721443
effects O 0 0.00010358203144278377
were O 0 2.6721842004917562e-05
estimated O 0 1.3148344805813394e-05
to O 0 2.2347919639287284e-06
contribute O 0 4.953731149726082e-06
97 O 0 2.122269870596938e-05
% O 0 2.395816864009248e-06
of O 0 1.004016121441964e-05
the O 0 1.2006968063360546e-05
population O 0 5.164488356967922e-06
variance O 0 1.1533918041095603e-05
. O 0 0.00010185802238993347

CONCLUSION O 0 0.00196970347315073
Susceptibility O 0 0.0010867515811696649
to O 0 7.804178312653676e-05
AS B-Disease 0 0.060784999281167984
is O 0 1.5380297554656863e-05
largely O 0 3.0283226806204766e-05
genetically O 0 9.871532711258624e-06
determined O 0 3.360958544362802e-06
, O 0 8.662947834636725e-07
and O 0 9.203087074638461e-07
the O 0 6.596777893719263e-06
environmental O 0 2.882163789763581e-05
trigger O 0 2.0069868696737103e-05
for O 0 7.179562089731917e-06
the O 0 9.797170787351206e-05
disease O 1 0.9999433755874634
is O 0 3.114115315838717e-05
probably O 0 0.000146512858918868
ubiquitous O 0 0.0004718427371699363
. O 0 0.00010615286009851843

HLA O 1 0.999742329120636
- O 0 0.003537049051374197
B27 O 0 0.0006384117878042161
accounts O 0 4.8560928007646e-06
for O 0 1.5107301578609622e-06
a O 0 4.5397100620903075e-06
minority O 0 2.5527085654175607e-06
of O 0 5.741253971791593e-06
the O 0 1.2658532796194777e-05
overall O 0 5.601190059678629e-05
genetic O 0 0.00011576888937270269
susceptibility O 0 0.0005432756734080613
to O 0 0.0002975839888677001
AS B-Disease 1 0.9999610185623169
. O 0 0.0004677500401157886

Cell O 0 0.004945586901158094
cycle O 0 0.00040149330743588507
- O 0 0.0002226537762908265
dependent O 0 3.7754496588604525e-05
colocalization O 0 0.0004696887044701725
of O 0 0.0001938135683303699
BARD1 O 1 0.9963440299034119
and O 0 5.436599167296663e-05
BRCA1 O 0 0.00012092030374333262
proteins O 0 7.217759502964327e-06
in O 0 1.2775736649928149e-05
discrete O 0 4.6549354010494426e-05
nuclear O 0 0.0008719723555259407
domains O 0 0.0007200459949672222
. O 0 0.00027545556076802313

Germ O 1 0.9999891519546509
- O 0 0.00200492050498724
line O 0 0.00011533552606124431
mutations O 0 7.706287760811392e-06
of O 0 1.230406360264169e-05
the O 0 5.098012479720637e-05
BRCA1 O 0 0.00039640150498598814
gene O 0 5.7467881561024114e-05
predispose O 0 0.00016677439271006733
women O 0 5.327799954102375e-06
to O 0 6.492560260085156e-06
early O 0 0.00011288561654509977
- O 0 0.001004244084469974
onset O 1 0.9999951124191284
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9998430013656616
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.00010507967817829922
compromising O 0 0.00030797289218753576
the O 0 5.685626820195466e-05
genes O 0 3.8487512938445434e-05
presumptive O 0 0.0007459642947651446
function O 0 4.2794214095920324e-05
as O 0 6.964374188100919e-05
a O 0 0.0003237566852476448
tumor B-Disease 1 0.9999297857284546
suppressor O 0 0.015844246372580528
. O 0 0.0004362121399026364

Although O 0 8.458714000880718e-05
the O 0 2.7720516300178133e-05
biochemical O 0 0.00013459997717291117
properties O 0 0.00017369893612340093
of O 0 0.00045093457447364926
BRCA1 O 0 0.0011190525256097317
polypeptides O 0 8.39991625980474e-05
are O 0 3.837506028503412e-06
not O 0 3.3153837648569606e-06
understood O 0 2.8035528885084204e-05
, O 0 3.6768071822734782e-06
their O 0 4.4047910705558024e-06
expression O 0 3.812095019384287e-05
pattern O 0 0.00015275173063855618
and O 0 5.081267954665236e-05
subcellular O 0 0.0005372713203541934
localization O 0 0.0004245669988449663
suggest O 0 2.0379988200147636e-05
a O 0 9.724265510158148e-06
role O 0 2.7067984774475917e-05
in O 0 5.0530961743788794e-05
cell O 0 0.0003013070090673864
- O 0 0.00041316423448733985
cycle O 0 0.00014953038771636784
regulation O 0 0.00021015782840549946
. O 0 9.10831950022839e-05

When O 0 0.0007631293847225606
resting O 0 0.003919899929314852
cells O 0 7.037939940346405e-05
are O 0 8.494796929880977e-06
induced O 0 0.00023609123309142888
to O 0 3.0418861570069566e-05
proliferate O 0 0.0001294348039664328
, O 0 4.793709194927942e-06
the O 0 1.1297531273157801e-05
steady O 0 0.00015673258167225868
- O 0 2.816106643876992e-05
state O 0 3.991751782450592e-06
levels O 0 1.1681232535920572e-05
of O 0 2.522652539482806e-05
BRCA1 O 0 0.00012736761709675193
increase O 0 1.5459261703654192e-05
in O 0 3.395217936486006e-05
late O 0 0.0004275476676411927
G1 O 0 0.0026889939326792955
and O 0 6.312906407401897e-06
reach O 0 1.8244429156766273e-05
a O 0 6.673825282632606e-06
maximum O 0 2.2166766939335503e-05
during O 0 0.0003774892829824239
S O 0 0.0027670220006257296
phase O 0 0.0018737501231953502
. O 0 0.00037935582804493606

Moreover O 0 0.0003950728860218078
, O 0 2.5141696823993698e-05
in O 0 2.1476631445693783e-05
S O 0 0.0007633707718923688
phase O 0 0.0007690705824643373
cells O 0 7.855705916881561e-05
, O 0 1.9171833628206514e-05
BRCA1 O 0 0.00013623974518850446
polypeptides O 0 3.538485543685965e-05
are O 0 5.3327112254919484e-06
hyperphosphorylated O 0 0.00048704398795962334
and O 0 1.1711395018210169e-05
accumulate O 0 3.9728918636683375e-05
into O 0 1.2367353519948665e-05
discrete O 0 3.703029142343439e-05
subnuclear O 0 0.0024743371177464724
foci O 0 0.002152276923879981
termed O 0 0.0010566918645054102
" O 0 0.0012229791609570384
BRCA1 O 0 0.0031825725454837084
nuclear O 0 0.010710690170526505
dots O 0 0.002470528008416295
. O 0 0.0002184366894653067

" O 0 0.002547523472458124
BRCA1 O 0 0.0024415114894509315
associates O 0 0.00043548396206460893
in O 0 4.077670018887147e-05
vivo O 0 0.00010439683683216572
with O 0 6.190527528815437e-06
a O 0 4.39315008406993e-05
structurally O 0 0.0007913618464954197
related O 0 0.0001265952450921759
protein O 0 0.0002705237711779773
termed O 0 0.003538263961672783
BARD1 O 1 0.99993896484375
. O 0 0.0005158264539204538

Here O 0 0.00024127581855282187
we O 0 7.3657542998262215e-06
show O 0 4.52181302534882e-06
that O 0 6.457865424636111e-07
the O 0 5.071340638096444e-06
steady O 0 0.00010083930828841403
- O 0 1.965513001778163e-05
state O 0 2.405638952041045e-06
levels O 0 2.2131534933578223e-05
of O 0 4.182856355328113e-05
BARD1 O 1 0.5583289861679077
, O 0 9.331107321486343e-06
unlike O 0 5.989689270791132e-06
those O 0 2.4918349481595214e-06
of O 0 3.237665805500001e-05
BRCA1 O 0 0.00039541235310025513
, O 0 1.1999366506643128e-05
remain O 0 2.2988018827163614e-05
relatively O 0 6.296996616583783e-06
constant O 0 2.295421654707752e-05
during O 0 0.00040253877523355186
cell O 0 0.0009166463860310614
cycle O 0 0.0008522108546458185
progression O 0 0.06123781204223633
. O 0 0.0003910492523573339

However O 0 0.0001924670214066282
, O 0 4.3941639887634665e-05
immunostaining O 0 0.0019064059015363455
revealed O 0 0.00027106725610792637
that O 0 2.5698755052872002e-05
BARD1 O 1 0.8429099917411804
resides O 0 0.00036204844946041703
within O 0 6.441518053179607e-05
BRCA1 O 0 0.0007997539360076189
nuclear O 0 0.0014471847098320723
dots O 0 0.00035089821903966367
during O 0 0.00016439631872344762
S O 0 0.00026312313275411725
phase O 0 6.027126801200211e-05
of O 0 2.589996438473463e-05
the O 0 6.713167385896668e-05
cell O 0 0.0001174873104901053
cycle O 0 1.8843709767679684e-05
, O 0 1.998213974729879e-06
but O 0 5.521350772141886e-07
not O 0 5.096738391330291e-07
during O 0 1.575322494318243e-05
the O 0 3.8983529520919546e-05
G1 O 0 0.012163259088993073
phase O 0 0.0010354532860219479
. O 0 0.00020725018111988902

Nevertheless O 0 0.0035188039764761925
, O 0 0.00026454083854332566
BARD1 O 0 0.03791800141334534
polypeptides O 0 0.0001029001796268858
are O 0 2.262618863824173e-06
found O 0 2.1990331333654467e-06
exclusively O 0 3.1170175134320743e-06
in O 0 1.9640031041490147e-06
the O 0 2.8193878733873134e-06
nuclear O 0 2.240800495201256e-05
fractions O 0 4.132193225814262e-06
of O 0 1.3366343409870751e-05
both O 0 2.529110679461155e-05
G1 O 0 0.020045040175318718
- O 0 0.00028993963496759534
and O 0 2.1654896045220084e-05
S O 0 0.0012733094627037644
- O 0 0.00028954874142073095
phase O 0 0.0008556111133657396
cells O 0 0.00023773270368110389
. O 0 0.00010042628855444491

Therefore O 0 0.0003533821436576545
, O 0 5.2062114264117554e-05
progression O 0 0.000884385546669364
to O 0 5.5318534577963874e-05
S O 0 0.000954607967287302
phase O 0 0.0002706522645894438
is O 0 7.790112249494996e-06
accompanied O 0 1.0894867045863066e-05
by O 0 6.389693680830533e-07
the O 0 2.836545718309935e-06
aggregation O 0 1.2477908967412077e-05
of O 0 8.087319292826578e-05
nuclear O 0 0.003615556051954627
BARD1 O 0 0.39773955941200256
polypeptides O 0 0.0001846741361077875
into O 0 0.00012596581655088812
BRCA1 O 0 0.002334452932700515
nuclear O 0 0.007877831347286701
dots O 0 0.0027694653254002333
. O 0 0.0003159446350764483

This O 0 0.00024723546812310815
cell O 0 0.0007410463877022266
cycle O 0 0.0003209417045582086
- O 0 0.00023772954591549933
dependent O 0 4.623100903700106e-05
colocalization O 0 0.0006102598272264004
of O 0 0.0001199208345497027
BARD1 O 1 0.9980687499046326
and O 0 5.493404023582116e-05
BRCA1 O 0 0.00021266378462314606
indicates O 0 2.5668214220786467e-05
a O 0 5.712187430617632e-06
role O 0 1.4623473362007644e-05
for O 0 1.8544600607128814e-05
BARD1 O 1 0.9762632250785828
in O 0 0.00026093542692251503
BRCA1 O 0 0.005655691027641296
- O 0 0.008606290444731712
mediated O 0 0.38295185565948486
tumor B-Disease 1 0.9999959468841553
suppression O 1 0.9946833252906799
. O 0 0.0009503826731815934

Ethnic O 0 0.0002787332341540605
differences O 0 0.00025338964769616723
in O 0 9.492151002632454e-05
the O 0 0.0001765551423886791
HFE O 0 0.015244768932461739
codon O 0 0.00023490322928410023
282 O 0 0.0008547613397240639
( O 0 0.0008214766276068985
Cys O 1 0.9950775504112244
/ O 0 0.007552553433924913
Tyr O 0 0.010385481640696526
) O 0 0.00017694865528028458
polymorphism O 0 0.0003948939556721598
. O 0 0.0001886212994577363

Recent O 0 3.571096749510616e-05
studies O 0 4.650557912100339e-06
have O 0 1.5119637737370795e-06
shown O 0 1.558319854666479e-05
that O 0 4.63467113149818e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999767541885376
HH B-Disease 1 1.0
) O 0 6.127245433162898e-05
is O 0 4.92705976284924e-06
likely O 0 3.871087301376974e-06
to O 0 2.8285498956392985e-06
be O 0 4.3842555896844715e-06
caused O 0 2.972672700707335e-05
by O 0 6.038739229552448e-06
homozygosity O 0 0.0003724382841028273
for O 0 1.2068592695868574e-05
a O 0 6.634378951275721e-05
Cys282Tyr O 0 0.0023627697955816984
mutation O 0 2.3031227101455443e-05
in O 0 2.5852978069451638e-05
the O 0 7.330648077186197e-05
HFE O 0 0.01265383418649435
gene O 0 7.097965863067657e-05
located O 0 0.00024073304666671902
4 O 0 0.0002920358383562416
. O 0 0.00012625950330402702

5 O 0 0.0017344556981697679
Mb O 0 0.011089036241173744
telomeric O 0 0.006651538889855146
to O 0 0.0005655969143845141
HLA O 1 0.9993890523910522
- O 0 0.0038874943275004625
A O 0 0.0017865500412881374
. O 0 0.0002067139866994694

Population O 0 2.1249958081170917e-05
studies O 0 5.076426077721408e-06
of O 0 9.64340415521292e-06
this O 0 4.128773980482947e-06
polymorphism O 0 1.0802208635141142e-05
are O 0 1.62935930347885e-06
facilitated O 0 3.533046765369363e-05
by O 0 1.8015695104622864e-06
the O 0 4.320538209867664e-06
fact O 0 3.025222895303159e-06
that O 0 1.063433728631935e-06
the O 0 1.8285016267327592e-05
Cys282Tyr O 0 0.0020651565864682198
mutation O 0 2.3238570065586828e-05
creates O 0 6.76732452120632e-05
a O 0 8.887389412848279e-05
Rsal O 0 0.0036907976027578115
restriction O 0 0.0001610396575415507
site O 0 0.0006136379088275135
. O 0 0.00016527740808669478

We O 0 8.327457908308133e-05
have O 0 7.018413725745631e-06
studied O 0 3.928252408513799e-05
the O 0 2.7552739993552677e-05
codon O 0 4.659883416024968e-05
282 O 0 0.0004014119622297585
( O 0 0.0004187827289570123
Cys O 1 0.987673819065094
/ O 0 0.004122787620872259
Tyr O 0 0.0033759514335542917
) O 0 1.761663042998407e-05
polymorphism O 0 1.4431773706746753e-05
in O 0 7.514870048908051e-06
different O 0 9.118936645791109e-07
ethnic O 0 2.037060221482534e-05
groups O 0 2.3435326511389576e-05
. O 0 0.00016522669466212392

In O 0 0.0001415569131495431
agreement O 0 5.3034149459563196e-05
with O 0 7.923992598080076e-06
previous O 0 3.210988870705478e-05
observations O 0 6.136243609944358e-05
the O 0 0.0001049918428179808
Tyr O 0 0.001408881857059896
allele O 0 2.9477827411028557e-05
appeared O 0 5.4521646234206855e-05
to O 0 8.421281563641969e-06
be O 0 7.48943557482562e-06
rare O 0 3.422400914132595e-05
or O 0 2.647150176926516e-05
absent O 0 0.00019829005759675056
in O 0 3.554143768269569e-05
Asiatic O 0 0.0004606060974765569
( O 0 2.3828742996556684e-05
Indian O 0 2.456684705975931e-05
, O 0 1.0782757271954324e-05
Chinese O 0 7.487064431188628e-05
) O 0 1.4750510672456585e-05
populations O 0 2.2112189981271513e-05
. O 0 4.9308717279927805e-05

The O 0 8.643829642096534e-05
highest O 0 9.018796845339239e-05
allele O 0 6.453152764152037e-06
frequency O 0 8.067327144090086e-06
( O 0 6.559751454915386e-06
7 O 0 1.6845177015056834e-05
. O 0 1.6324449916282902e-06
5 O 0 6.538478828588268e-06
% O 0 3.526448153934325e-06
) O 0 5.5790783335396554e-06
was O 0 8.210631494875997e-05
found O 0 9.351132575829979e-06
in O 0 2.6938632800010964e-05
Swedes O 0 0.0008663899498060346
. O 0 0.0003071052778977901

Saamis O 0 0.012240877375006676
( O 0 0.00010973666212521493
2 O 0 0.00012513785623013973
% O 0 3.062517134821974e-05
) O 0 1.543367761769332e-05
and O 0 1.595340836502146e-05
Mordvinians O 0 0.0009703641990199685
( O 0 1.6745600078138523e-05
1 O 0 4.261940921423957e-05
. O 0 2.8986278266529553e-06
8 O 0 1.6976953702396713e-05
% O 0 3.822800408670446e-06
) O 0 5.704338036593981e-06
had O 0 2.3947568479343317e-05
significantly O 0 2.535246494517196e-05
lower O 0 2.1229823687463067e-05
frequencies O 0 8.567791155655868e-06
of O 0 4.25464786530938e-05
the O 0 0.00021462950098793954
Tyr O 0 0.004186462145298719
allele O 0 0.00021626795933116227
. O 0 0.00027144610066898167

Comparisons O 0 8.776038885116577e-05
with O 0 7.136650765460217e-06
allele O 0 5.810258244309807e-06
frequencies O 0 6.105483407736756e-06
based O 0 2.5268307126680156e-06
on O 0 1.4165010725264437e-05
prevalence O 0 8.579979476053268e-05
estimates O 0 9.865538231679238e-06
of O 0 6.564949580933899e-05
HH B-Disease 1 0.9998118281364441
showed O 0 0.00021124148042872548
some O 0 9.863807463261764e-06
disagreements O 0 0.00011313314462313429
with O 0 4.657441877498059e-06
the O 0 4.015365266241133e-05
RFLP O 0 0.000436451897257939
data O 0 2.014280835282989e-05
, O 0 1.3536659025703557e-05
particularly O 0 4.787482976098545e-05
in O 0 0.00010112126619787887
Finns O 0 0.0032221563160419464
. O 0 0.0002993208181578666

The O 0 0.00035998295061290264
newly O 0 0.0019207251025363803
described O 0 0.0007830808754079044
HFE O 0 0.38496947288513184
marker O 0 0.00045964340097270906
provides O 0 6.280407887970796e-06
a O 0 5.06115566167864e-06
new O 0 1.6237129329965683e-06
approach O 0 3.2254158668365562e-06
to O 0 1.9070257621933706e-06
the O 0 7.78977027948713e-06
screening O 0 2.0045194105478004e-05
of O 0 0.0001172157353721559
HH B-Disease 1 0.9981781244277954
as O 0 4.382086990517564e-05
well O 0 4.971336693415651e-06
as O 0 2.992248482769355e-06
studies O 0 1.3323862049219315e-06
of O 0 8.732459718885366e-06
the O 0 2.12828326766612e-05
relationship O 0 5.6431810662616044e-05
between O 0 0.0002179386792704463
the O 0 0.00023902776592876762
HFE O 1 0.9988671541213989
Tyr O 0 0.002145092934370041
allele O 0 2.3853161110309884e-05
and O 0 1.2256352420081384e-05
different O 0 2.3263848561327904e-05
disorders O 1 1.0
including O 1 0.9999079704284668
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999841451644897
dominant I-Disease 1 0.999998927116394
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999430179595947
associated O 0 0.00011122632713522762
with O 0 9.812748430704232e-06
a O 0 3.078916415688582e-05
missense O 0 7.254541560541838e-05
mutation O 0 5.484334906213917e-06
encoding O 0 4.1493887692922726e-05
Gly23 O 0 0.008841974660754204
- O 0 0.0008092297939583659
- O 0 0.00024780514650046825
> O 0 0.00011309043475193903
Val O 0 0.0008441177778877318
in O 0 0.0001929646241478622
neurophysin O 0 0.19773311913013458
II O 1 1.0
. O 0 0.000885097892023623

Autosomal B-Disease 1 0.999506950378418
dominant I-Disease 1 0.9999550580978394
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 0.0019249765900895
ADNDI B-Disease 1 0.9999884366989136
) O 0 1.9598417566157877e-05
is O 0 5.5536720537929796e-06
an O 0 3.824854866252281e-05
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999990463256836
by O 0 0.0005362063529901206
progressive O 1 0.9999750852584839
degeneration O 1 1.0
of O 1 0.9030469655990601
the O 0 0.016205372288823128
magnocellular O 1 0.9122040271759033
neurons O 0 0.0003558434545993805
of O 0 0.0001805345673346892
the O 0 0.00023906287970021367
hypothalamus O 0 0.0008113060030154884
leading O 0 0.00011664316843962297
to O 0 1.918456473504193e-05
decreased O 0 8.827175770420581e-05
ability O 0 5.600919848802732e-06
to O 0 7.645888217666652e-06
produce O 0 1.232092563441256e-05
the O 0 4.9622318329056725e-05
hormone O 0 0.00033468991750851274
arginine O 0 0.00027692539151757956
vasopressin O 0 0.0009511624812148511
( O 0 0.0003324270364828408
AVP O 0 0.026574473828077316
) O 0 0.00016060918278526515
. O 0 0.00017034147458616644

Affected O 0 0.00017288677918259054
individuals O 0 7.4707741077872925e-06
are O 0 2.5892256871884456e-06
not O 0 5.290536137181334e-06
symptomatic O 0 0.002169305458664894
at O 0 0.0006909515941515565
birth O 0 0.00020071497419849038
, O 0 9.653424058342353e-06
but O 0 4.069643637194531e-06
usually O 0 1.438165327272145e-05
develop O 0 0.0005738227628171444
diabetes B-Disease 1 0.9999878406524658
insipidus I-Disease 1 0.9949304461479187
at O 0 0.0035657028201967478
1 O 0 0.0007385280332528055
- O 0 0.000710546737536788
6 O 0 0.00020998275431338698
yr O 0 0.0024696507025510073
of O 0 0.0001972453756025061
age O 0 0.001152676297351718
. O 0 0.00030961798620410264

The O 0 7.932216976769269e-05
genetic O 0 4.695681855082512e-05
locus O 0 4.844907016376965e-05
of O 0 4.809099482372403e-05
the O 0 0.00016927430988289416
disease O 1 0.9948272109031677
is O 0 1.8223161532660015e-05
the O 0 4.7318360884673893e-05
AVP O 0 0.26413995027542114
- O 0 0.00046844908501952887
neurophysin O 0 0.0029941594693809748
II O 1 0.9999998807907104
( O 0 0.00011537016689544544
NPII O 1 0.8248504400253296
) O 0 1.2536808753793593e-05
gene O 0 5.86857640882954e-06
, O 0 2.06094819077407e-06
and O 0 3.6990916214563185e-06
mutations O 0 1.397414871462388e-05
that O 0 1.4171725524647627e-05
cause O 0 0.00035256106639280915
ADNDI B-Disease 1 0.9997914433479309
have O 0 6.634898454649374e-06
been O 0 3.670844080261304e-06
found O 0 1.1044439816032536e-06
in O 0 1.5051388118081377e-06
both O 0 7.040335958663491e-07
the O 0 3.4321465136599727e-06
signal O 0 2.8783626476069912e-05
peptide O 0 1.4955216101952828e-05
of O 0 1.8741753592621535e-05
the O 0 0.00011922305566258729
prepro O 0 0.06689413636922836
- O 0 0.0035625139717012644
AVP O 1 0.982769250869751
- O 0 0.0017132440116256475
NPII O 1 0.6337305903434753
precursor O 0 0.0006098725716583431
and O 0 2.2577825802727602e-05
within O 0 8.799148781690747e-05
NPII O 1 0.9918810725212097
itself O 0 0.0005752553697675467
. O 0 0.0001420027983840555

An O 0 0.00020486405992414802
affected O 0 0.0002021600812440738
girl O 0 0.00014851184096187353
who O 0 1.0333134014217649e-05
presented O 0 3.0359826268977486e-05
at O 0 0.00010265086166327819
9 O 0 7.463355723302811e-05
months O 0 2.2428999727708288e-05
of O 0 3.644418393378146e-05
age O 0 0.00011947809980483726
and O 0 2.2167443603393622e-05
her O 0 2.7952797609032132e-05
similarly O 0 5.372274972614832e-05
affected O 0 0.00010231312626274303
younger O 0 0.00022857858857605606
brother O 0 0.00027096050325781107
and O 0 1.9606044588726945e-05
father O 0 6.68250213493593e-05
were O 0 1.1268436537648086e-05
all O 0 1.7137238046416314e-06
found O 0 2.095580157401855e-06
to O 0 4.226467353873886e-06
have O 0 2.221532440671581e-06
a O 0 7.238659691211069e-06
novel O 0 3.1255789508577436e-05
missense O 0 8.247560617746785e-05
mutation O 0 2.6109491955139674e-05
( O 0 4.518209243542515e-05
G1758 O 0 0.0008275549043901265
- O 0 0.00037744358996860683
- O 0 0.00015713692118879408
> O 0 0.00011898794764420018
T O 0 0.00018729869043454528
) O 0 1.2640815612030565e-06
encoding O 0 1.1446860526120872e-06
the O 0 1.1925169928872492e-05
amino O 0 1.07036930785398e-05
acid O 0 1.8926897610072047e-05
substitution O 0 0.00010553659376455471
Gly23 O 0 0.014664825983345509
- O 0 0.0012574782595038414
- O 0 0.000429413077654317
> O 0 0.00028325425228103995
Val O 0 0.002702487865462899
within O 0 0.0003395104722585529
NPII O 1 0.9950072765350342
. O 0 0.0004107014392502606

The O 0 0.00022823319886811078
mutation O 0 3.570715489331633e-05
was O 0 0.00010276319517288357
confirmed O 0 1.3869263966626022e-05
by O 0 3.8091529859229922e-06
restriction O 0 2.0063343981746584e-05
endonuclease O 0 0.0001661840215092525
analysis O 0 2.7333506295690313e-05
. O 0 0.0001951464801095426

A O 0 0.013077824376523495
T1 O 1 0.9997413754463196
- O 0 0.0009367708116769791
weighted O 0 0.0001058886045939289
magnetic O 0 0.0001843458303483203
resonance O 0 7.413249113596976e-05
imaging O 0 0.00010955129255307838
of O 0 0.00018234556773677468
the O 0 0.0007031025015749037
fathers O 0 0.013450142927467823
pituitary O 1 0.9999946355819702
gland O 1 0.9826723337173462
demonstrates O 0 0.0009802833665162325
an O 0 0.00014984869631007314
attenuated O 0 0.0460355319082737
posterior O 1 0.6820482611656189
pituitary O 1 0.9999995231628418
bright O 1 0.8260315656661987
spot O 0 0.0066125039011240005
. O 0 0.0005486491718329489

This O 0 6.140874756965786e-05
mutation O 0 3.015308902831748e-05
may O 0 2.3939071979839355e-05
be O 0 3.415051196498098e-06
valuable O 0 1.2059089385729749e-05
for O 0 2.3458323994418606e-06
developing O 0 1.4132531759969424e-05
models O 0 4.241390797687927e-06
of O 0 9.900118311634287e-05
dominantly B-Disease 1 0.9998998641967773
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 6.928787479409948e-05
as O 0 1.3056042917014565e-05
the O 0 5.709214292437537e-06
early O 0 1.1794717465818394e-05
age O 0 2.2717391402693465e-05
of O 0 4.804900163435377e-05
onset O 1 0.9998311996459961
of O 0 0.011660981923341751
symptoms O 1 0.9990983009338379
suggests O 0 5.2719347877427936e-05
that O 0 3.0145668006298365e-06
this O 0 2.2871493001730414e-06
mutation O 0 6.063467480998952e-06
may O 0 9.2759901235695e-06
be O 0 3.846630079351598e-06
particularly O 0 9.052943823917303e-06
deleterious O 0 9.495001722825691e-05
to O 0 3.399099296075292e-05
the O 0 0.00027011759812012315
magnocellular O 0 0.04315899685025215
neuron O 0 0.0019637388177216053
. O 0 0.00017118197865784168
. O 0 0.00024369639868382365

Frequent O 0 0.000214024621527642
inactivation O 0 0.0020652911625802517
of O 0 0.001870442763902247
PTEN O 1 0.9999988079071045
/ O 0 0.365387886762619
MMAC1 O 1 0.9999673366546631
in O 0 0.0001676925312494859
primary O 1 0.9998082518577576
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007580734323710203

Sporadic B-Disease 1 0.9999963045120239
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0005218388978391886
the O 0 5.7046465371968225e-05
most O 0 1.7280464817304164e-05
common O 0 3.277526411693543e-05
male B-Disease 0 0.00015068647917360067
cancer I-Disease 0 0.002650638110935688
in O 0 4.1237515688408166e-05
the O 0 4.618866660166532e-05
Western O 0 5.7257278967881575e-05
world O 0 2.457903428876307e-05
, O 0 1.4410733228942263e-06
yet O 0 9.867766266324907e-07
many O 0 2.842238302491751e-07
of O 0 5.167537892702967e-06
the O 0 1.3139207112544682e-05
major O 0 0.0001009158804663457
genetic O 0 2.7008882170775905e-05
events O 0 2.0336168745416217e-05
involved O 0 1.4488435226667207e-05
in O 0 1.2083633009751793e-05
the O 0 1.7541695342515595e-05
progression O 0 0.00022075722517911345
of O 0 3.323326745885424e-05
this O 0 1.0532485248404555e-05
often O 0 3.398496482986957e-05
fatal O 1 0.9990956783294678
cancer B-Disease 1 0.9992313385009766
remain O 0 0.0001947425480466336
to O 0 3.170069248881191e-05
be O 0 5.910784238949418e-05
elucidated O 0 0.0025640542153269053
. O 0 0.0002852885518223047

Numerous O 0 0.0006778663955628872
cytogenetic O 0 0.008116609416902065
and O 0 0.00014098212704993784
allelotype O 0 0.006634786259382963
studies O 0 2.0772527932422236e-05
have O 0 4.187414560874458e-06
reported O 0 1.3601296814158559e-05
frequent O 0 8.751802852202673e-06
loss O 0 0.00011351762805134058
of O 0 0.00011861274833790958
heterozygosity O 1 0.7613092660903931
on O 0 0.0012002416187897325
chromosomal O 0 0.25723859667778015
arm O 0 0.005844226107001305
10q O 0 0.002549470169469714
in O 0 0.0002303819201188162
sporadic B-Disease 1 0.9999793767929077
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.1695735901594162

Deletion O 0 0.0008477885858155787
mapping O 0 0.00024505340843461454
studies O 0 3.847404150292277e-05
have O 0 7.744702998024877e-06
unambiguously O 0 6.367327296175063e-05
identified O 0 1.0185673090745695e-05
a O 0 6.218734142748872e-06
region O 0 3.5146480513503775e-05
of O 0 5.432872421806678e-05
chromosome O 0 0.00028529425617307425
10q23 O 0 0.00035501530510373414
to O 0 1.0897506399487611e-05
be O 0 4.364548203739105e-06
the O 0 6.472110726463143e-06
minimal O 0 3.385931995580904e-05
area O 0 6.0246333305258304e-05
of O 0 0.00012420392886269838
loss O 0 0.014767942950129509
. O 0 0.0006201926153153181

A O 0 0.0007968578138388693
new O 0 0.00013296988618094474
tumor B-Disease 1 0.8417854905128479
suppressor O 0 0.001907272613607347
gene O 0 8.587174670537934e-05
, O 0 9.472617966821417e-05
PTEN O 1 0.9990424513816833
/ O 0 0.005021385848522186
MMAC1 O 1 0.9970303773880005
, O 0 2.330141796846874e-05
was O 0 0.00011713559797499329
isolated O 0 2.8128939447924495e-05
recently O 0 1.4317378372652456e-05
at O 0 1.2699716535280459e-05
this O 0 6.711634341627359e-07
region O 0 2.0390154531924054e-05
of O 0 3.944484342355281e-05
chromosome O 0 0.00028851814568042755
10q23 O 0 0.0005635838024318218
and O 0 5.242410679784371e-06
found O 0 2.3810569018678507e-06
to O 0 3.0833070923108608e-06
be O 0 1.781273567758035e-06
inactivated O 0 3.2460910006193444e-05
by O 0 9.354095595881518e-07
mutation O 0 1.8429369674777263e-06
in O 0 1.1933611858694348e-05
three O 0 0.0001959502842510119
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999815225601196
lines O 0 0.0037889801897108555
. O 0 0.0002483910939190537

We O 0 0.00013784457405563444
screened O 0 0.0006860677385702729
80 O 0 0.0022985790856182575
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 6.305139686446637e-05
microsatellite O 0 0.0003773770004045218
analysis O 0 8.538784641132224e-06
and O 0 1.3557653801399283e-05
found O 0 2.5038834792212583e-05
chromosome O 0 0.0001725909678498283
10q23 O 0 0.00024850029149092734
to O 0 1.664313458604738e-05
be O 0 9.445645446248818e-06
deleted O 0 7.764058682369068e-05
in O 0 3.7667719880118966e-05
23 O 0 0.00027622951893135905
cases O 0 8.698170859133825e-05
. O 0 0.0002361984079470858

We O 0 6.447871419368312e-05
then O 0 1.2015651009278372e-05
proceeded O 0 2.1056061086710542e-05
with O 0 3.1017705737212964e-07
sequence O 0 8.419574442086741e-07
analysis O 0 4.331135130541952e-07
of O 0 1.0260215276503004e-05
the O 0 4.035988240502775e-05
entire O 0 0.0007151073077693582
PTEN O 1 0.9977139234542847
/ O 0 0.0017047751462087035
MMAC1 O 1 0.5870231986045837
coding O 0 0.00019300401618238539
region O 0 0.0001308597275055945
and O 0 7.70850783737842e-06
tested O 0 1.2821445125155151e-05
for O 0 2.3991642592591234e-06
homozygous O 0 2.0748808310599998e-05
deletion O 0 3.853290036204271e-05
with O 0 9.05025899555767e-06
new O 0 3.023711178684607e-05
intragenic O 0 0.0016750410431995988
markers O 0 0.0003276214702054858
in O 0 3.686156196636148e-05
these O 0 5.762470664194552e-06
23 O 0 6.722173566231504e-05
cases O 0 8.814927241473924e-06
with O 0 1.1694274689943995e-05
10q23 O 0 0.0012228243285790086
loss O 0 0.0007625034777447581
of O 0 0.0008699697791598737
heterozygosity O 1 0.9974911212921143
. O 0 0.0014111418277025223

The O 0 3.5845911042997614e-05
identification O 0 6.567112905031536e-06
of O 0 3.143061258015223e-05
the O 0 3.660629226942547e-05
second O 0 9.400073759024963e-05
mutational O 0 0.00044013714068569243
event O 0 9.860134014161304e-05
in O 0 1.5033275303721894e-05
10 O 0 1.07765381471836e-05
( O 0 4.3959948925476056e-06
43 O 0 1.9105909814243205e-05
% O 0 3.4104243241017684e-05
) O 0 0.00025846881908364594
tumors B-Disease 1 1.0
establishes O 0 0.17728830873966217
PTEN O 1 0.9999946355819702
/ O 0 0.004814098123461008
MMAC1 O 1 0.9167757630348206
as O 0 3.2833639124874026e-05
a O 0 1.59607134264661e-05
main O 0 6.552191189257428e-05
inactivation O 0 0.00024113345716614276
target O 0 1.3755468899034895e-05
of O 0 4.1117906221188605e-05
10q O 0 0.0009713025647215545
loss O 0 0.0006095245480537415
in O 0 0.0002569204370956868
sporadic B-Disease 1 0.9999372959136963
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0008616306004114449
. O 0 0.0002652242546901107

Risk O 0 0.0006363009451888502
reversals O 0 0.0003106507647316903
in O 0 1.673030601523351e-05
predictive O 0 1.7622143786866218e-05
testing O 0 4.5132008381187916e-05
for O 0 0.0003283635014668107
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0023774767760187387

The O 0 4.817200533580035e-05
first O 0 1.0965351066261064e-05
predictive O 0 1.0323657988919877e-05
testing O 0 1.3499751730705611e-05
for O 0 8.363747474504635e-05
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.00016109432908706367
HD B-Disease 0 0.004094136878848076
) O 0 4.807709501619684e-06
was O 0 1.3162897630536463e-05
based O 0 2.4929065034484665e-07
on O 0 1.404315867148398e-06
analysis O 0 5.787965733361489e-07
of O 0 1.2591805898409802e-05
linked O 0 0.0001172158372355625
polymorphic O 0 5.862116449861787e-05
DNA O 0 6.719661178067327e-05
markers O 0 0.00010324309550924227
to O 0 6.24171025265241e-06
estimate O 0 6.2841822909831535e-06
the O 0 5.213314580032602e-06
likelihood O 0 1.1406831617932767e-05
of O 0 1.888750193757005e-05
inheriting O 0 0.0003426243201829493
the O 0 4.978882861905731e-05
mutation O 0 1.6429044990218244e-05
for O 0 5.208054062677547e-05
HD B-Disease 0 0.0344376415014267
. O 0 0.00029068641015328467

Limits O 0 5.174528996576555e-05
to O 0 6.6189468270749785e-06
accuracy O 0 1.1255591743974946e-05
included O 0 7.931446816655807e-06
recombination O 0 1.876351780083496e-05
between O 0 3.4740674891509116e-05
the O 0 3.583938450901769e-05
DNA O 0 6.240850780159235e-05
markers O 0 0.0001153316770796664
and O 0 8.262544724857435e-06
the O 0 2.2480993720819242e-05
mutation O 0 1.8836810340872034e-05
, O 0 1.7557058527017944e-05
pedigree O 0 0.00014101884153205901
structure O 0 0.00010110217408509925
, O 0 7.100100901880069e-06
and O 0 2.1983180431561777e-06
whether O 0 3.4571787637105444e-06
DNA O 0 7.160730547184357e-06
samples O 0 1.8678661035664845e-06
were O 0 3.731589686140069e-06
available O 0 1.1521323131091776e-06
from O 0 7.854054274503142e-06
family O 0 2.4346354621229693e-05
members O 0 1.1722791896318085e-05
. O 0 9.09755690372549e-05

With O 0 1.7019472579704598e-05
direct O 0 9.6924359240802e-06
tests O 0 1.9407143554417416e-06
for O 0 3.860477136186091e-06
the O 0 3.990126060671173e-05
HD B-Disease 0 0.0028171876911073923
mutation O 0 1.2260349649295676e-05
, O 0 3.0556038836948574e-06
we O 0 1.4526777931678225e-06
have O 0 5.766548838437302e-07
assessed O 0 3.740896545423311e-06
the O 0 2.1003099845984252e-06
accuracy O 0 1.5182868082774803e-06
of O 0 4.6781819946772885e-06
results O 0 3.474303184702876e-06
obtained O 0 1.3662397577718366e-05
by O 0 1.0765145816549193e-05
linkage O 0 0.00018143365741707385
approaches O 0 2.623676300572697e-05
when O 0 8.413960131292697e-06
requested O 0 7.646151061635464e-06
to O 0 6.536396540468559e-06
do O 0 2.3889404019428184e-06
so O 0 1.4791270359637565e-06
by O 0 1.2203564665469457e-06
the O 0 1.083059669326758e-05
test O 0 1.4409838513529394e-05
individuals O 0 2.6391548090032302e-05
. O 0 0.00020018171926494688

For O 0 3.944484342355281e-05
six O 0 1.914302265504375e-05
such O 0 1.4619839703300386e-06
individuals O 0 2.6881198209594004e-06
, O 0 4.429569344210904e-06
there O 0 6.774720986868488e-06
was O 0 9.498705912847072e-05
significant O 0 6.197716720635071e-05
disparity O 0 0.0008324950467795134
between O 0 0.00013371702516451478
the O 0 9.146058437181637e-05
tests O 0 6.728613516315818e-05
. O 0 0.0001554602786200121

Three O 0 0.0001590888132341206
went O 0 0.00015337303921114653
from O 0 2.442239383526612e-05
a O 0 1.9192066247342154e-05
decreased O 0 0.00017206482880283147
risk O 0 2.366997614444699e-05
to O 0 7.030297638266347e-06
an O 0 6.099652182456339e-06
increased O 0 2.9340961191337556e-05
risk O 0 3.586132879718207e-05
, O 0 2.4627806851640344e-06
while O 0 2.222689317932236e-06
in O 0 3.5913467399950605e-06
another O 0 5.510663868335541e-06
three O 0 2.760585630312562e-06
the O 0 1.5229929886118043e-05
risk O 0 7.234493386931717e-05
was O 0 0.0005552970105782151
decreased O 0 0.0018311834428459406
. O 0 0.0002528828044887632

Knowledge O 0 0.00023084871645551175
of O 0 7.653835928067565e-05
the O 0 4.018387699034065e-05
potential O 0 4.117963180760853e-05
reasons O 0 3.5454193039186066e-06
for O 0 7.813167144377076e-07
these O 0 4.1406175910196907e-07
changes O 0 1.2997701333006262e-06
in O 0 4.281453584553674e-06
results O 0 4.52997983302339e-06
and O 0 3.987878699263092e-06
impact O 0 1.7421574739273638e-05
of O 0 1.4662520698038861e-05
these O 0 6.336562819342362e-06
risk O 0 5.3176201618043706e-05
reversals O 0 0.00029090899624861777
on O 0 6.73316972097382e-05
both O 0 1.684143535385374e-05
patients O 0 1.3135449080436956e-05
and O 0 4.201438969175797e-06
the O 0 1.1471348443592433e-05
counseling O 0 2.0473120457609184e-05
team O 0 1.0006094271375332e-05
can O 0 1.0382436812506057e-06
assist O 0 6.468913852586411e-06
in O 0 3.350065753693343e-06
the O 0 4.869254098593956e-06
development O 0 8.62726847117301e-06
of O 0 9.003127161122393e-06
strategies O 0 1.670180427026935e-05
for O 0 4.360620550869498e-06
the O 0 5.028915620641783e-05
prevention O 0 0.00017848984862212092
and O 0 9.50531193666393e-06
, O 0 4.09235326515045e-06
where O 0 7.443196409440134e-06
necessary O 0 5.6900375966506545e-06
, O 0 5.000102646590676e-06
management O 0 1.7625134205445647e-05
of O 0 4.191785410512239e-05
a O 0 9.286301792599261e-05
risk O 0 9.408684127265587e-05
reversal O 0 0.00015780025569256395
in O 0 1.8574637579149567e-05
any O 0 1.0810804269567598e-05
predictive O 0 3.4418557333992794e-05
testing O 0 5.253125345916487e-05
program O 0 6.362494605127722e-05
. O 0 2.185108132835012e-05
. O 0 6.915941776242107e-05

A O 0 0.0007459906046278775
novel O 0 0.00011734332656487823
common O 0 2.1869991542189382e-05
missense O 0 0.00019602857355494052
mutation O 0 2.293966645083856e-05
G301C O 0 0.0002452343178447336
in O 0 1.2918690117658116e-05
the O 0 1.753279684635345e-05
N O 0 0.00045343031524680555
- O 0 0.0002470278413966298
acetylgalactosamine O 0 0.0008400664664804935
- O 0 0.00015912539674900472
6 O 0 0.0001913369633257389
- O 0 0.00029442133381962776
sulfate O 0 0.0006257643108256161
sulfatase O 0 0.004592812620103359
gene O 0 0.00013349864457268268
in O 0 0.00018947949865832925
mucopolysaccharidosis B-Disease 1 0.7239266633987427
IVA I-Disease 1 0.9998326301574707
. O 0 0.0009098323644138873

Mucopolysaccharidosis B-Disease 1 0.9997289776802063
IVA I-Disease 1 0.9999996423721313
( O 0 0.002075877273455262
MPS B-Disease 1 0.9998695850372314
IVA I-Disease 1 1.0
) O 0 2.7697715268004686e-05
is O 0 3.6459437069424894e-06
an O 0 7.251358965731924e-06
autosomal B-Disease 1 0.9986463189125061
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999251365661621
by O 0 3.1568251870339736e-05
a O 0 8.114038064377382e-05
genetic B-Disease 1 0.9349162578582764
defect I-Disease 1 0.9999257326126099
in O 0 0.0002804726827889681
N O 0 0.004541694652289152
- O 0 0.0009325036080554128
acetylgalactosamine O 0 0.002679716097190976
- O 0 0.0002841571404132992
6 O 0 0.00021956846467219293
- O 0 0.00040764559525996447
sulfate O 0 0.0010110291186720133
sulfatase O 0 0.014186783693730831
( O 0 0.0003864526515826583
GALNS O 1 0.9976670742034912
) O 0 0.0001009305051411502
. O 0 0.00011059040116379037

In O 0 0.00012225720274727792
previous O 0 2.871064680221025e-05
studies O 0 1.1538253602338955e-05
, O 0 2.7656844849843765e-06
we O 0 1.6418269979112665e-06
have O 0 5.751812750531826e-07
found O 0 9.927989594871178e-07
two O 0 1.1427282515796833e-06
common O 0 6.305181159405038e-06
mutations O 0 2.5454723072471097e-05
in O 0 7.427351374644786e-05
Caucasians O 0 0.0005192831158638
and O 0 2.0984376533306204e-05
Japanese O 0 0.00032947229919955134
, O 0 2.9977849408169277e-05
respectively O 0 0.00015553974662907422
. O 0 0.00011345626262482256

To O 0 0.00019511075515765697
characterize O 0 0.00039259338518604636
the O 0 9.58869350142777e-05
mutational O 0 0.0009807284222915769
spectrum O 0 0.00011043716222047806
in O 0 8.658440492581576e-06
various O 0 2.3169382075138856e-06
ethnic O 0 6.528696303575998e-06
groups O 0 1.6648947394060087e-06
, O 0 2.6384609554952476e-06
mutations O 0 4.5383080760075245e-06
in O 0 9.956956091627944e-06
the O 0 2.9883824026910588e-05
GALNS O 0 0.007326117716729641
gene O 0 1.3763513379672077e-05
in O 0 1.4568993719876744e-05
Colombian O 0 0.00020289116946514696
MPS B-Disease 1 0.9990503191947937
IVA I-Disease 1 1.0
patients O 0 0.00033199440804310143
were O 0 5.500533734448254e-05
investigated O 0 0.00013333314564079046
, O 0 1.0423111234558746e-05
and O 0 3.2968225696095033e-06
genetic O 0 1.8003887817030773e-05
backgrounds O 0 1.639766378502827e-05
were O 0 2.4626428057672456e-05
extensively O 0 4.513002568273805e-05
analyzed O 0 1.114097085519461e-05
to O 0 4.86406997879385e-06
identify O 0 6.307574494712753e-06
racial O 0 2.6959014576277696e-05
origin O 0 6.137428499641828e-06
, O 0 2.3504860564571572e-06
based O 0 1.3103540368319955e-06
on O 0 1.655693631619215e-05
mitochondrial O 0 3.498063233564608e-05
DNA O 0 6.048183058737777e-05
( O 0 2.046743975370191e-05
mtDNA O 0 2.4402790586464107e-05
) O 0 2.6791116397362202e-05
lineages O 0 0.00021642389765474945
. O 0 0.00014590166392736137

Three O 0 0.00025776398251764476
novel O 0 0.00039403417031280696
missense O 0 0.0009935625130310655
mutations O 0 0.00020074867643415928
never O 0 0.00011720308975782245
identified O 0 1.726937625790015e-05
previously O 0 1.2097540093236603e-05
in O 0 4.4286061893217266e-06
other O 0 1.2689612276517437e-06
populations O 0 2.0596239664882887e-06
and O 0 1.2191338782940875e-06
found O 0 2.201773668275564e-06
in O 0 4.420066034072079e-06
16 O 0 2.0195608158246614e-05
out O 0 2.871252490876941e-06
of O 0 1.7890481103677303e-05
19 O 0 0.00032972177723422647
Colombian O 0 0.0007500112405978143
MPS B-Disease 1 0.9067654609680176
IVA I-Disease 1 0.9999992847442627
unrelated O 0 0.00021656385797541589
alleles O 0 1.2931213859701529e-05
account O 0 1.037078800436575e-05
for O 0 2.1432188077596948e-05
84 O 0 0.0004963310202583671
. O 0 0.0002748209808487445

2 O 0 0.00023344169312622398
% O 0 1.9292259821668267e-05
of O 0 3.894830297213048e-05
the O 0 4.972378155798651e-05
alleles O 0 1.1361777978891041e-05
in O 0 1.5415585949085653e-05
this O 0 1.0279273737978656e-05
study O 0 4.7903969971230254e-05
. O 0 0.00010889669647440314

The O 0 0.00040051294490695
G301C O 0 0.0017434152541682124
and O 0 3.4066441003233194e-05
S162F O 0 0.00045767505071125925
mutations O 0 2.1582944100373425e-05
account O 0 1.3862335435987916e-05
for O 0 2.333287920919247e-05
68 O 0 0.0005811453447677195
. O 0 0.00037662009708583355

4 O 0 0.000824271934106946
% O 0 0.00010393346019554883
and O 0 9.181309724226594e-05
10 O 0 0.000542941561434418
. O 0 0.0003184904344379902

5 O 0 0.00020409064018167555
% O 0 3.231312075513415e-05
of O 0 8.787745900917798e-05
mutations O 0 9.796376980375499e-05
, O 0 3.623746306402609e-05
respectively O 0 4.8001551476772875e-05
, O 0 5.932137355557643e-06
whereas O 0 8.785619684203994e-06
the O 0 1.3442864656099118e-05
remaining O 0 0.00012196345051052049
F69V O 0 0.013443317264318466
is O 0 7.855567673686892e-06
limited O 0 3.233512870792765e-06
to O 0 5.522901119547896e-06
a O 0 2.0879937437712215e-05
single O 0 1.7055104763130657e-05
allele O 0 6.126859079813585e-05
. O 0 0.00014307598758023232

The O 0 0.00020528015738818794
skewed O 0 0.00012707356654573232
prevalence O 0 0.00027367184520699084
of O 0 0.00013457892055157572
G301C O 0 0.0008209585794247687
in O 0 1.4079140782996546e-05
only O 0 9.275052434531972e-06
Colombian O 0 6.753548223059624e-05
patients O 0 2.0602996301022358e-05
and O 0 6.2035351220401935e-06
haplotype O 0 6.931477400939912e-05
analysis O 0 4.861050911131315e-06
by O 0 7.655074114154559e-06
restriction O 0 3.7125832022866234e-05
fragment O 0 7.594030466862023e-05
length O 0 2.65511389443418e-05
polymorphisms O 0 3.095384454354644e-05
in O 0 1.6112146113300696e-05
the O 0 3.9713733713142574e-05
GALNS O 0 0.0766705796122551
gene O 0 1.76752291736193e-05
suggest O 0 1.278100080526201e-05
that O 0 3.809102508967044e-06
G301C O 0 0.00024382563424296677
originated O 0 4.86633216496557e-05
from O 0 9.459989087190479e-06
a O 0 2.2228963644010946e-05
common O 0 4.020480628241785e-05
ancestor O 0 0.0008595989202149212
. O 0 0.0002876252692658454

Investigation O 0 7.849490066291764e-05
of O 0 3.594514782889746e-05
the O 0 2.5461544282734394e-05
genetic O 0 2.7055055397795513e-05
background O 0 5.806990429846337e-06
by O 0 2.2128883756522555e-06
means O 0 9.935785783454776e-06
of O 0 1.865674312284682e-05
mtDNA O 0 2.3494114429922774e-05
lineages O 0 3.402160291443579e-05
indicate O 0 1.1652415196294896e-05
that O 0 1.5907079387034173e-06
all O 0 2.423119667582796e-06
our O 0 8.207710379792843e-06
patients O 0 1.0421351362310816e-05
are O 0 1.058647512763855e-06
probably O 0 1.551723835291341e-05
of O 0 2.0075116481166333e-05
native O 0 8.628445357317105e-05
American O 0 0.00020126996969338506
descent O 0 0.002870489377528429

Low O 0 0.0004637364763766527
frequency O 0 3.315154026495293e-05
of O 0 0.00011452191392891109
BRCA1 O 0 0.0006670645670965314
germline O 0 0.0004623423737939447
mutations O 0 8.922660526877735e-06
in O 0 5.466799393616384e-06
45 O 0 2.6851865186472423e-05
German O 1 0.8123355507850647
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.000871004187501967
. O 0 0.00042905425652861595

In O 0 6.565738294739276e-05
this O 0 2.394053581156186e-06
study O 0 1.5372830830528983e-06
we O 0 8.375991455977783e-07
investigated O 0 6.236409262783127e-06
45 O 0 1.2546150173875503e-05
German O 1 0.742107629776001
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.783424785477109e-05
for O 0 2.7957297788816504e-05
germline O 0 0.0006733284681104124
mutations O 0 2.316193058504723e-05
in O 0 2.3096812583389692e-05
the O 0 0.00010076972102979198
BRCA1 O 0 0.001103804330341518
gene O 0 0.0001479089551139623
. O 0 0.00019781794981099665

We O 0 7.295194518519565e-05
identified O 0 3.905810081050731e-05
four O 0 1.946087650139816e-05
germline O 0 0.0002224678755737841
mutations O 0 2.645171662152279e-05
in O 0 2.7274501917418092e-05
three O 0 6.541359471157193e-05
breast B-Disease 1 0.9991899132728577
cancer I-Disease 0 0.4248064458370209
families O 0 7.48867114452878e-06
and O 0 3.5475131880957633e-06
in O 0 1.8152482880395837e-05
one O 0 8.3216953498777e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.00022376679407898337
. O 0 5.36560492037097e-06
among O 0 2.9546699806815013e-06
these O 0 8.408725875597156e-07
were O 0 8.73916633281624e-06
one O 0 1.1356003597029485e-05
frameshift O 0 0.0002645870263222605
mutation O 0 1.785222048056312e-05
, O 0 8.992754374048673e-06
one O 0 1.0486341125215404e-05
nonsense O 0 0.00019863272609654814
mutation O 0 1.1923919373657554e-05
, O 0 5.5949672059796285e-06
one O 0 4.982699465472251e-06
novel O 0 4.225374141242355e-05
splice O 0 0.00020420918008312583
site O 0 0.00014412953169085085
mutation O 0 1.8865071979234926e-05
, O 0 1.0331557859899476e-05
and O 0 9.590594345354475e-06
one O 0 4.108916982659139e-05
missense O 0 0.0007157534128054976
mutation O 0 0.00018869360792450607
. O 0 0.00031540801865048707

The O 0 0.00030024771695025265
missense O 0 0.0006115908618085086
mutation O 0 3.50055233866442e-05
was O 0 0.00019012470147572458
also O 0 1.2712293937511276e-05
found O 0 6.998790013312828e-06
in O 0 3.523043778841384e-05
2 O 0 0.0002681617916096002
. O 0 0.00013994758774060756

8 O 0 0.00022106389224063605
% O 0 1.4370232747751288e-05
of O 0 1.92130701179849e-05
the O 0 1.655799314903561e-05
general O 0 1.3124979886924848e-05
population O 0 2.7409917038312415e-06
, O 0 1.6920774896789226e-06
suggesting O 0 3.8616258279944304e-06
that O 0 5.457623615257035e-07
it O 0 1.1300830919935834e-06
is O 0 3.3983453704422573e-06
not O 0 1.2513349247456063e-05
disease O 1 0.9983803033828735
associated O 0 0.00029048218857496977
. O 0 0.00033762099337764084

The O 0 9.81456323643215e-05
average O 0 5.502836575033143e-05
age O 0 8.121299470076337e-05
of O 0 0.0002851256576832384
disease O 1 0.9999997615814209
onset O 1 0.9999632835388184
in O 0 0.00013721287541557103
those O 0 1.819511817302555e-05
families O 0 3.274477057857439e-05
harbouring O 0 0.004976870957762003
causative O 0 0.0009738350636325777
mutations O 0 0.00012840171984862536
was O 0 0.0005775049212388694
between O 0 0.00021765354904346168
32 O 0 0.0003171823045704514
. O 0 0.00015467099728994071

3 O 0 0.0011371965520083904
and O 0 0.00016760925063863397
37 O 0 0.0005811947048641741
. O 0 0.00027650195988826454

4 O 0 0.0006787171005271375
years O 0 0.0001033564840327017
, O 0 8.51391268952284e-06
whereas O 0 6.748025498382049e-06
the O 0 2.2497119061881676e-05
family O 0 4.6548117097700015e-05
harbouring O 0 0.0015995412832126021
the O 0 6.282248796196654e-05
missense O 0 0.00023797333415132016
mutation O 0 2.426240280328784e-05
had O 0 2.620780469442252e-05
an O 0 3.841515535896178e-06
average O 0 7.391374765575165e-06
age O 0 1.6532463632756844e-05
of O 0 4.399220779305324e-05
onset O 0 0.4168698787689209
of O 0 0.0013488925760611892
51 O 0 0.00422965083271265
. O 0 0.0006905717309564352

2 O 0 0.0028380840085446835
years O 0 0.0017690639942884445
. O 0 0.0003863226156681776

These O 0 3.7699093809351325e-05
findings O 0 2.291860982950311e-05
show O 0 4.777421781909652e-05
that O 0 9.521915671939496e-06
BRCA1 O 0 0.00016020418843254447
is O 0 8.541081115254201e-06
implicated O 0 8.852658356772736e-05
in O 0 8.904146852728445e-06
a O 0 3.451848670010804e-06
small O 0 6.95942787842796e-07
fraction O 0 6.19389948042226e-06
of O 0 8.75782934599556e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.6396879295352846e-05
suggesting O 0 1.7220041627297178e-05
the O 0 5.983592018310446e-06
involvement O 0 2.1096802811371163e-05
of O 0 2.7857209715875797e-05
another O 0 4.04094134864863e-05
susceptibility O 0 0.00031476430012844503
gene O 0 7.882014324422926e-05
( O 0 8.619367145001888e-05
s O 0 0.0009133265120908618
) O 0 0.00029226482729427516

Paternal O 0 0.01484195701777935
transmission O 1 0.9993391633033752
of O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999759197235107

We O 0 3.562627171049826e-05
report O 0 3.974794708483387e-06
a O 0 3.5836831102642464e-06
rare O 0 8.015295861696359e-06
case O 0 8.015013008844107e-06
of O 0 6.995924195507541e-05
paternally O 1 0.9999997615814209
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999994039535522
DM B-Disease 1 1.0
) O 0 0.001651919912546873
. O 0 0.0002726636594161391

The O 0 0.00041306146886199713
proband O 0 0.0019208384910598397
is O 0 1.5762692783027887e-05
a O 0 1.2612994396477006e-05
23 O 0 4.9310267058899626e-05
year O 0 2.4850076442817226e-05
old O 0 0.0003082234470639378
, O 0 0.00010139760706806555
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.0038544991984963417
who O 0 0.0020247388165444136
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9942606687545776

He O 0 0.0005263275816105306
presented O 0 0.0005471394397318363
with O 0 0.00038848567055538297
respiratory O 1 1.0
and O 0 0.0009007813641801476
feeding O 0 0.0015675014583393931
difficulties O 0 0.4527991712093353
at O 0 0.010568993166089058
birth O 0 0.0018638346809893847
. O 0 0.0003332650812808424

His O 0 0.001204300089739263
two O 0 0.00029539078241214156
sibs O 1 0.9947355389595032
suffer O 0 0.028826259076595306
from O 0 0.0008412366732954979
childhood O 1 0.9999819993972778
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.012787563726305962

Their O 0 7.325169281102717e-05
late O 0 0.00046789858606643975
father O 0 0.0001523387763882056
had O 0 1.4976008969824761e-05
the O 0 4.030056061310461e-06
adult O 0 3.927520083379932e-06
type O 0 1.935207546921447e-05
of O 0 0.00016282705473713577
DM B-Disease 1 1.0
, O 0 2.8749171178787947e-05
with O 0 9.023671736940742e-06
onset O 1 0.9737894535064697
around O 0 0.00048026698641479015
30 O 0 0.0001775376294972375
years O 0 0.0002172882086597383
. O 0 9.939487790688872e-05

Only O 0 4.110379086341709e-05
six O 0 1.145041733252583e-05
other O 0 8.203197694456321e-07
cases O 0 1.886815198304248e-06
of O 0 3.0856292141834274e-05
paternal O 0 0.0012486790074035525
transmission O 1 0.7558947205543518
of O 1 0.9998964071273804
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.00039704330265522003
been O 0 6.651724106632173e-05
reported O 0 4.929169517708942e-05
recently O 0 9.706689161248505e-05
. O 0 5.345232057152316e-05

We O 0 3.571845809346996e-05
review O 0 5.270563633530401e-06
the O 0 1.193106345453998e-05
sex O 0 2.5903178539010696e-05
related O 0 3.5547946026781574e-05
effects O 0 0.00019653762865345925
on O 0 0.00033415431971661747
transmission O 0 0.0029445451218634844
of O 1 0.9835241436958313
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9958301186561584

Decreased O 0 0.006572989746928215
fertility O 0 0.0005443501868285239
of O 0 4.859533510170877e-05
males O 0 1.0160099009226542e-05
with O 0 1.0245842531730887e-05
adult O 0 0.00016470163245685399
onset O 1 0.9999994039535522
DM B-Disease 1 1.0
and O 0 0.00023362872889265418
contraction O 0 0.00039591154200024903
of O 0 6.13299707765691e-05
the O 0 4.51400555903092e-05
repeat O 0 0.0001304301986237988
upon O 0 6.222340743988752e-05
male O 0 5.512128336704336e-05
transmission O 0 4.415966759552248e-05
contribute O 0 6.302241217781557e-06
to O 0 2.9871218885091366e-06
the O 0 5.40425344297546e-06
almost O 0 9.137625966104679e-06
absent O 0 1.1347678992024157e-05
occurrence O 0 5.951403181825299e-06
of O 0 1.5736422938061878e-05
paternal O 0 0.0005714036524295807
transmission O 1 0.5364081859588623
of O 1 0.9999624490737915
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9987959861755371

Also O 0 0.0001025588862830773
the O 0 3.96156137867365e-05
fathers O 0 2.9435013857437298e-05
of O 0 1.9953722585341893e-05
the O 0 7.032432040432468e-05
reported O 0 0.0002724833320826292
congenitally O 0 0.004541561007499695
affected O 0 7.08543520886451e-05
children O 0 1.6060077541624196e-05
showed O 0 4.141415047342889e-05
, O 0 5.660265287588118e-06
on O 0 2.9604458177345805e-05
average O 0 2.3732449335511774e-05
, O 0 2.495842272765003e-05
shorter O 0 0.00034164320095442235
CTG O 0 0.043127499520778656
repeat O 0 0.0006747371517121792
lengths O 0 0.0006099312449805439
and O 0 1.6028070604079403e-05
hence O 0 4.5441618567565456e-05
less O 0 6.39295976725407e-05
severe O 0 0.30814260244369507
clinical O 0 0.004983378574252129
symptoms O 0 0.44194886088371277
than O 0 3.325038778712042e-05
the O 0 4.560536763165146e-05
mothers O 0 4.728538988274522e-05
of O 0 3.329941682750359e-05
children O 0 9.88344254437834e-05
with O 0 0.009972152300179005
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999167919158936

We O 0 3.888940409524366e-05
conclude O 0 6.492382090073079e-05
that O 0 5.462056833493989e-06
paternal O 0 0.0003242475213482976
transmission O 0 0.0029788538813591003
of O 1 0.9997056126594543
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.0014148622285574675
rare O 0 8.929831528803334e-05
and O 0 4.22855191573035e-06
preferentially O 0 5.897492428630358e-06
occurs O 0 2.2003923731972463e-06
with O 0 2.132168674506829e-06
onset O 0 0.06994509696960449
of O 0 0.0034762825816869736
DM B-Disease 1 1.0
past O 0 0.0007123940740711987
30 O 0 8.065299334703013e-05
years O 0 3.548494350980036e-05
in O 0 1.7671924069873057e-05
the O 0 4.9838472477858886e-05
father O 0 0.00028851372189819813
. O 0 3.964334973716177e-05
. O 0 0.00010371853568358347

The O 0 0.0012038476997986436
RB1 O 1 0.7876643538475037
gene O 0 0.0001074782048817724
mutation O 0 1.33332296172739e-05
in O 0 1.2997405974601861e-05
a O 0 3.391729114810005e-05
child O 0 0.00013412439147941768
with O 0 8.64740795805119e-05
ectopic B-Disease 1 0.9993680119514465
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.013930882327258587

The O 0 0.0015584068605676293
RB1 O 1 0.9816805124282837
gene O 0 0.0001380413305014372
mutation O 0 2.3624106688657776e-05
was O 0 0.00010996103083016351
investigated O 0 8.524189615854993e-05
in O 0 2.5764202291611582e-05
a O 0 5.31502410012763e-05
child O 0 0.0001910396240418777
with O 0 6.851062062196434e-05
ectopic B-Disease 1 0.8890168070793152
intracranial I-Disease 1 0.9999996423721313
retinoblastoma I-Disease 1 0.9939780235290527
using O 0 6.38312121736817e-05
DNA O 0 4.284386886865832e-05
obtained O 0 1.2776906260114629e-05
from O 0 1.4524114703817759e-05
both O 0 8.049044481595047e-06
the O 0 0.00010613911581458524
pineal B-Disease 1 0.9704785346984863
and I-Disease 0 0.00037028652150183916
retinal I-Disease 1 0.999998927116394
tumours I-Disease 1 1.0
of O 1 0.9875261187553406
the O 0 0.22232799232006073
patient O 0 0.0029205253813415766
. O 0 0.00038085432606749237

A O 0 0.0019604074768722057
nonsense O 0 0.0006836251122877002
mutation O 0 6.25726897851564e-05
in O 0 9.448405035072938e-05
exon O 0 0.00045441678958013654
17 O 0 0.00014073324564378709
( O 0 1.714839345368091e-05
codon O 0 1.7063417544704862e-05
556 O 0 7.027939864201471e-05
) O 0 4.794605047209188e-06
of O 0 1.5155155779211782e-05
the O 0 0.00011485064896987751
RB1 O 1 0.5941910743713379
gene O 0 4.1147875890601426e-05
was O 0 8.501500997226685e-05
found O 0 2.5879912755044643e-06
to O 0 1.6674387097737053e-06
be O 0 2.3716788746241946e-06
present O 0 1.382494610879803e-05
homozygously O 0 0.0003585603553801775
in O 0 1.2448978850443382e-05
both O 0 6.657024641754106e-06
the O 0 7.313708192668855e-05
retinal B-Disease 0 0.17728006839752197
and I-Disease 0 0.00027958571445196867
the I-Disease 0 0.031450144946575165
pineal I-Disease 1 0.9999996423721313
tumours I-Disease 1 1.0
. O 0 0.003671681974083185

The O 0 0.00012912071542814374
same O 0 2.569360913184937e-05
mutation O 0 2.0149995179963298e-05
was O 0 0.0001357393484795466
present O 0 3.191648647771217e-05
heterozygously O 0 0.00037505224463529885
in O 0 1.0030820703832433e-05
the O 0 7.749032192805316e-06
DNA O 0 9.759849490365013e-06
from O 0 3.958603429055074e-06
the O 0 9.960299394151662e-06
constitutional O 0 4.8298315959982574e-05
cells O 0 1.1551574971235823e-05
of O 0 1.8031088984571397e-05
the O 0 2.889220013457816e-05
patient O 0 3.636187466327101e-05
, O 0 3.899364855897147e-06
proving O 0 4.266243558959104e-05
it O 0 8.634211781100021e-07
to O 0 1.2186479807496653e-06
be O 0 3.163887640766916e-06
of O 0 3.853430098388344e-05
germline O 0 0.000877285550814122
origin O 0 0.00015950821398291737
. O 0 0.0002281722699990496

The O 0 5.0192091293865815e-05
initial O 0 2.929574839072302e-05
mutation O 0 1.3537111044570338e-05
was O 0 4.147541039856151e-05
shown O 0 8.514001820003614e-06
to O 0 3.8459288589365315e-06
have O 0 2.873517814805382e-06
occurred O 0 4.167904990026727e-05
in O 0 6.473777375504142e-06
the O 0 2.166898593713995e-05
paternally O 0 0.00047614675713703036
derived O 0 0.00020393151498865336
RB1 O 0 0.3194579482078552
allele O 0 0.00035255454713478684
. O 0 0.0002199208684032783

The O 0 0.00011660980817396194
mutation O 0 1.3046398635196965e-05
is O 0 4.728308795165503e-06
in O 0 2.330042661924381e-06
an O 0 1.6057746279329876e-06
area O 0 1.6068137483671308e-05
of O 0 7.3287451414216775e-06
the O 0 6.133589977252996e-06
gene O 0 1.955568222911097e-06
that O 0 3.6966613947697624e-07
encodes O 0 1.0361229669797467e-06
the O 0 4.120301582588581e-06
protein O 0 9.606265848560724e-06
- O 0 1.8212405848316848e-05
binding O 0 2.9468976663338253e-06
region O 0 2.2580108634429052e-05
known O 0 1.7172320440295152e-05
as O 0 1.0889673831115942e-05
the O 0 3.5059380024904385e-05
pocket O 0 0.0002681379846762866
region O 0 7.10845852154307e-05
and O 0 4.3827253648487385e-06
has O 0 5.351765594241442e-06
been O 0 1.077917931979755e-05
detected O 0 2.3063799744704738e-05
in O 0 3.7417030398501083e-06
other O 0 1.495352648817061e-06
cases O 0 5.698954737454187e-06
of O 0 0.00016713113291189075
retinoblastoma B-Disease 1 0.9646893739700317
. O 0 0.00017952523194253445
. O 0 0.00018735797493718565

Low O 0 0.0006014046375639737
levels O 0 5.430474266177043e-05
of O 0 4.6095465222606435e-05
beta O 0 0.00018403041758574545
hexosaminidase O 0 0.0010070028947666287
A O 0 0.00010498133633518592
in O 0 1.5592639101669192e-05
healthy O 0 2.5082859792746603e-05
individuals O 0 1.8506033256926457e-06
with O 0 1.6596806744928472e-05
apparent O 1 0.9726914763450623
deficiency O 1 1.0
of O 0 0.008105969987809658
this O 0 0.00011942751007154584
enzyme O 0 0.00019131178851239383
. O 0 0.00023721062461845577

Appreciable O 0 0.00612234603613615
beta O 0 0.0014896492939442396
hexosaminidase O 0 0.00419325428083539
A O 0 0.0006971764960326254
( O 0 5.051361222285777e-05
hex O 0 0.00030988879734650254
A O 0 0.0001302199234487489
) O 0 5.566891559283249e-06
activity O 0 8.768460247665644e-06
has O 0 4.328394879848929e-06
been O 0 8.957155841926578e-06
detected O 0 6.416124233510345e-05
in O 0 7.019815529929474e-05
cultured O 0 0.0020387093536555767
skin O 0 0.07003330439329147
fibroblasts O 0 0.0018607457168400288
and O 0 0.00034726582816801965
melanoma B-Disease 1 1.0
tissue O 1 0.9989877343177795
from O 0 0.00028752817888744175
healthy O 0 0.00011008861474692822
individuals O 0 2.5675842607597588e-06
previously O 0 2.4004868464544415e-05
reported O 0 1.9578039427869953e-05
as O 0 2.9122489650035277e-05
having O 0 0.0002475210640113801
deficiency B-Disease 1 0.9999947547912598
of I-Disease 0 0.0018765113782137632
hex I-Disease 0 0.003850133391097188
A I-Disease 0 0.00022212789917830378
activity O 0 2.123828926414717e-05
indistinguishable O 0 1.7214064428117126e-05
from O 0 1.5348997521869023e-06
that O 0 2.2027219870324188e-07
of O 0 5.0014668886433356e-06
patients O 0 3.255018236814067e-05
with O 0 0.00010670618939911947
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0017210973892360926
TSD B-Disease 1 0.9999816417694092
) O 0 0.0006074390257708728
. O 0 0.00043725644354708493

Identification O 0 0.00022842128237243742
and O 0 0.00011114226072095335
quantitation O 0 0.002221394795924425
of O 0 0.0005831550224684179
hex O 0 0.0025380344595760107
A O 0 0.0005645014462061226
, O 0 1.4514587746816687e-05
amounting O 0 0.00012509965745266527
to O 0 4.553313920041546e-05
3 O 0 0.0004308042407501489
. O 0 0.0002407541760476306

5 O 0 0.0007847628439776599
% O 0 0.00020135367230977863
- O 0 0.001009613275527954
6 O 0 0.0008081609848886728
. O 0 0.0002023621927946806

9 O 0 0.0002762363583315164
% O 0 1.4026190910954028e-05
of O 0 2.881485124817118e-05
total O 0 5.539185804082081e-05
beta O 0 0.00029800416086800396
hexosaminidase O 0 0.0007358014117926359
activity O 0 1.9576376871555112e-05
, O 0 2.1030480183981126e-06
has O 0 1.0704352462198585e-06
been O 0 1.7678598851489369e-06
obtained O 0 4.359219929028768e-06
by O 0 1.2954923477082048e-05
cellulose O 0 0.0014279248425737023
acetate O 0 0.0008746842504478991
gel O 0 0.0014315942535176873
electrophoresis O 0 0.0005790984141640365
, O 0 0.00015093598631210625
DEAE O 1 0.9964690208435059
- O 0 0.001477186568081379
cellulose O 0 0.001346914330497384
ion O 0 0.0003442967135924846
- O 0 0.00038792629493400455
exchange O 0 0.00012958139996044338
chromatography O 0 0.0021297570783644915
, O 0 6.523549382109195e-05
radial O 0 0.0008034770144149661
immunodiffusion O 0 0.006355540361255407
, O 0 7.500627543777227e-05
and O 0 7.954744796734303e-05
radioimmunoassay O 0 0.0382903553545475
. O 0 0.00033071881625801325

Previous O 0 0.0002382682723691687
family O 0 5.203813998377882e-05
studies O 0 1.0184468919760548e-05
suggested O 0 1.27080993479467e-05
that O 0 1.0114575843545026e-06
these O 0 9.962246849681833e-07
individuals O 0 3.3887340578075964e-06
may O 0 3.3477754186606035e-05
be O 0 1.5430940038640983e-05
compound O 0 8.327537216246128e-05
heterozygotes O 0 0.00010212654888164252
for O 0 8.794338100415189e-06
the O 0 2.75919956038706e-05
common O 0 3.314158311695792e-05
mutant O 0 0.0004497570334933698
TSD B-Disease 1 0.9577015042304993
gene O 0 4.8306472308468074e-05
and O 0 6.889299129397841e-06
a O 0 1.8582379198051058e-05
rare O 0 5.9179699746891856e-05
( O 0 2.485441291355528e-05
allelic O 0 0.0002439265517750755
) O 0 5.1838538638548926e-05
mutant O 0 0.00030181388137862086
gene O 0 0.00013693001528736204
. O 0 0.00011767185787903145

Thus O 0 0.0002924894797615707
, O 0 1.5034323041618336e-05
the O 0 1.076029093383113e-05
postulated O 0 0.00013616222713608295
rate O 0 2.6793850338435732e-05
mutant O 0 4.7585799620719627e-05
gene O 0 8.081904525170103e-06
appears O 0 9.371352462039795e-06
to O 0 1.063958166014345e-06
code O 0 7.576002758469258e-07
for O 0 9.536934157949872e-07
the O 0 6.364482942444738e-06
expression O 0 5.378165951697156e-06
of O 0 3.6103556340094656e-05
low O 0 0.00011784432717831805
amounts O 0 2.4566284992033616e-05
of O 0 0.00015557343431282789
hex O 0 0.0025359676219522953
A O 0 0.001673937658779323
. O 0 0.00022944173542782664

Heterozygotes O 0 0.002156077418476343
for O 0 5.246327418717556e-05
the O 0 8.022145630093291e-05
rare O 0 7.11794855305925e-05
mutant O 0 0.00010010790720116347
may O 0 2.437815783196129e-05
be O 0 6.17060459262575e-06
indistinguishable O 0 4.948886271449737e-05
from O 0 1.0063542504212819e-05
heterozygotes O 0 6.327244045678526e-05
for O 0 5.831392172694905e-06
the O 0 5.8690635341918096e-05
common O 0 0.00016170358867384493
TSD B-Disease 1 0.9998633861541748
mutant O 0 0.0030433221254497766
. O 0 0.0004267565091140568

However O 0 0.00019451005209702998
, O 0 1.8062133676721714e-05
direct O 0 2.690040855668485e-05
visualization O 0 0.0003732280165422708
and O 0 6.752987974323332e-05
quantitation O 0 0.0016471281414851546
of O 0 0.0003776202502194792
hex O 0 0.0012312304461374879
A O 0 0.00012495266855694354
by O 0 2.622981583044748e-06
the O 0 6.051572654541815e-06
methods O 0 7.989599907887168e-06
described O 0 6.225367542356253e-05
may O 0 6.234730244614184e-05
prevent O 0 8.677947334945202e-05
false O 0 5.707290620193817e-05
- O 0 0.0001628525205887854
positive O 0 1.53585151565494e-05
prenatal O 0 0.00031914576538838446
diagnosis O 0 0.000484920950839296
of O 0 0.0007060465286485851
TSD B-Disease 1 0.9999984502792358
in O 0 0.0004408066743053496
fetuses O 0 0.0004240245616529137
having O 0 3.5394172300584614e-05
the O 0 2.8250127797946334e-05
incomplete O 0 9.216651960741729e-05
hex B-Disease 0 0.0014101221458986402
A I-Disease 0 0.005884099751710892
deficiency I-Disease 1 0.9999943971633911
of O 0 0.00026044630794785917
the O 0 0.00015986939251888543
type O 0 8.473019988741726e-05
described O 0 3.8348360249074176e-05
in O 0 1.1888345397892408e-05
the O 0 2.4229664632002823e-05
four O 0 3.775910590775311e-05
healthy O 0 0.00024051073705777526
individuals O 0 6.24923050054349e-05

The O 0 0.0011892295442521572
tumor B-Disease 1 0.999106228351593
suppressor O 0 0.004671672359108925
gene O 0 0.0003167353861499578
Smad4 O 0 0.30472904443740845
/ O 0 0.0011496542720124125
Dpc4 O 0 0.0017815890023484826
is O 0 7.013315553194843e-06
required O 0 3.3892188184836414e-06
for O 0 1.0097736776515376e-05
gastrulation O 0 0.0004558924410957843
and O 0 8.844702279020566e-06
later O 0 3.657324850792065e-05
for O 0 1.3959191164758522e-05
anterior O 0 0.00042639666935428977
development O 0 9.140129259321839e-05
of O 0 0.00013714864326175302
the O 0 0.0002717185125220567
mouse O 0 0.0002148039493476972
embryo O 0 0.00011240127787459642
. O 0 6.933599070180207e-05

Mutations O 0 9.648624836700037e-05
in O 0 4.0827708289725706e-05
the O 0 8.250818063970655e-05
SMAD4 O 1 0.9999955892562866
/ O 0 0.41466519236564636
DPC4 O 1 0.9999992847442627
tumor B-Disease 1 0.9997472167015076
suppressor O 0 0.0007941232761368155
gene O 0 1.574455927766394e-05
, O 0 4.403413640829967e-06
a O 0 8.772675755608361e-06
key O 0 7.245774759212509e-05
signal O 0 0.0001446860987925902
transducer O 0 0.00010037593165179715
in O 0 1.789387533790432e-05
most O 0 1.7286185538978316e-05
TGFbeta O 0 0.00586964376270771
- O 0 0.0002283533540321514
related O 0 3.1429652153747156e-05
pathways O 0 8.34063466754742e-05
, O 0 6.858148026367417e-06
are O 0 5.960230282653356e-07
involved O 0 5.095590040582465e-06
in O 0 6.500018571387045e-06
50 O 0 1.968657124962192e-05
% O 0 2.461628355376888e-05
of O 0 0.0014674928970634937
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.004527077544480562

Homozygous O 0 0.003553949296474457
Smad4 O 0 0.30994436144828796
mutant O 0 0.004482362885028124
mice O 0 0.0018573091365396976
die O 0 0.0008653479162603617
before O 0 7.659719994990155e-05
day O 0 7.865135557949543e-05
7 O 0 0.0003228924178984016
. O 0 0.00010328269127057865

5 O 0 0.0012515754206106067
of O 0 0.0008865673444233835
embryogenesis O 0 0.015347978100180626
. O 0 0.000986876548267901

Mutant O 0 0.0008851767051964998
embryos O 0 5.459026579046622e-05
have O 0 3.3196486128872493e-06
reduced O 0 1.3127408237778582e-05
size O 0 1.624263313715346e-05
, O 0 6.941597348486539e-06
fail O 0 3.149043914163485e-05
to O 0 2.1027366528869607e-05
gastrulate O 0 0.0008696648292243481
or O 0 1.9885259462171234e-05
express O 0 2.8240510800969787e-05
a O 0 4.1922608943423256e-05
mesodermal O 0 0.0014419573126360774
marker O 0 0.0009606177918612957
, O 0 2.853208570741117e-05
and O 0 1.628264544706326e-05
show O 0 0.00019301137945149094
abnormal O 0 0.0012020721333101392
visceral O 0 0.29994112253189087
endoderm O 1 0.9956105351448059
development O 0 0.002956125885248184
. O 0 0.00044945787522010505

Growth B-Disease 1 0.9999276399612427
retardation I-Disease 1 0.9999972581863403
of O 0 0.0020901712123304605
the O 0 0.0024390413891524076
Smad4 O 1 0.999911904335022
- O 0 0.0034430883824825287
deficient O 0 0.0004755194531753659
embryos O 0 5.8059272305399645e-06
results O 0 2.0248903638275806e-06
from O 0 9.7772326626e-06
reduced O 0 8.222023461712524e-05
cell O 0 0.0002520177513360977
proliferation O 0 0.000589738308917731
rather O 0 1.1706236364261713e-05
than O 0 7.87484532338567e-06
increased O 0 0.00011831452866317704
apoptosis O 0 0.0020143361762166023
. O 0 0.0002552377700340003

Aggregation O 0 0.00024515879340469837
of O 0 0.0002725976228248328
mutant O 0 0.0007338632713072002
Smad4 O 1 0.9278755187988281
ES O 0 0.13022033870220184
cells O 0 2.5016424842760898e-05
with O 0 6.73199519951595e-06
wild O 0 0.0001003885772661306
- O 0 0.0001281441218452528
type O 0 8.957379031926394e-05
tetraploid O 0 0.0005504437140189111
morulae O 0 0.003691782709211111
rescues O 0 0.0007772581884637475
the O 0 0.000269870477495715
gastrulation B-Disease 1 0.5729968547821045
defect I-Disease 1 0.8589450120925903
. O 0 0.0006970910471864045

These O 0 1.5823614376131445e-05
results O 0 1.292366778216092e-05
indicate O 0 3.023463250428904e-05
that O 0 8.892690857464913e-06
Smad4 O 0 0.0005796843324787915
is O 0 4.423161499289563e-06
initially O 0 5.528645033336943e-06
required O 0 8.187292905859067e-07
for O 0 9.912832865666132e-07
the O 0 6.692499482596759e-06
differentiation O 0 4.9617541662883013e-05
of O 0 9.004996536532417e-05
the O 0 0.00020536177908070385
visceral O 0 0.005561730358749628
endoderm O 0 0.005619104020297527
and O 0 2.4728236894588917e-05
that O 0 3.8088335259089945e-06
the O 0 6.156419112812728e-05
gastrulation B-Disease 0 0.006242791656404734
defect I-Disease 0 0.0013114080065861344
in O 0 4.509023347054608e-05
the O 0 5.076578963780776e-05
epiblast O 0 0.003283717669546604
is O 0 1.4547847058565821e-05
secondary O 0 8.925131987780333e-05
and O 0 1.915241045935545e-05
non O 0 0.0005363108939491212
- O 0 0.0023400101345032454
cell O 0 0.000604531611315906
autonomous O 0 0.00045820590457879007
. O 0 0.00019371602684259415

Rescued O 0 0.00711905537173152
embryos O 0 0.00046752137131989
show O 0 0.0006951834075152874
severe O 0 0.039550986140966415
anterior O 0 0.10382894426584244
truncations O 0 0.03377881646156311
, O 0 9.902932652039453e-05
indicating O 0 0.00013496214523911476
a O 0 1.8456545149092562e-05
second O 0 3.345643199281767e-05
important O 0 1.674767554504797e-05
role O 0 3.022638520633336e-05
for O 0 2.6135976440855302e-05
Smad4 O 1 0.631912887096405
in O 0 0.00024947026395238936
anterior O 0 0.2200065553188324
patterning O 0 0.07072100043296814
during O 1 0.7520917654037476
embryogenesis O 0 0.10158650577068329
. O 0 0.0007606411818414927

Prevalence O 0 0.003518899204209447
of O 0 0.0005631393869407475
p16 O 0 0.0023353670258075
and O 0 0.00015094935952220112
CDK4 O 1 0.9989468455314636
germline O 0 0.001493081683292985
mutations O 0 8.440714736934751e-05
in O 0 0.00013189512537792325
48 O 0 0.0012126859510317445
melanoma B-Disease 1 0.9999998807907104
- O 0 0.2412939816713333
prone O 0 0.0012067252537235618
families O 0 2.3646827685297467e-05
in O 0 8.633153629489243e-05
France O 0 0.0006709001027047634
. O 0 0.00027988842339254916

The O 0 0.00036922181607224047
French O 0 0.0017499784007668495
Familial B-Disease 1 0.999984860420227
Melanoma I-Disease 1 1.0
Study O 0 0.0013796193525195122
Group O 0 0.00036480685230344534
. O 0 0.00022986695694271475

Germline O 0 0.011318821460008621
mutations O 0 0.00028258588281460106
in O 0 7.218346581794322e-05
the O 0 6.620955537073314e-05
p16 O 0 0.0004328278300818056
and O 0 3.979512621299364e-05
CDK4 O 1 0.6774775981903076
genes O 0 1.9189870727132075e-05
have O 0 1.6973772289929911e-06
been O 0 4.256460215401603e-06
reported O 0 3.2372311125072883e-06
in O 0 1.5480907222809037e-06
a O 0 4.4530511331686284e-06
subset O 0 2.5961910068872385e-05
of O 0 0.00019980267097707838
melanoma B-Disease 1 0.9999995231628418
pedigrees O 0 0.0017726545920595527
, O 0 2.457401751598809e-05
but O 0 2.2135066046757856e-06
their O 0 2.2998985969024943e-06
prevalence O 0 7.825992361176759e-05
is O 0 7.472299330402166e-06
not O 0 3.67863435712934e-06
well O 0 2.063184183498379e-05
known O 0 0.0001530186418676749
. O 0 0.00016160310769919306

We O 0 6.542314076796174e-05
searched O 0 3.697996726259589e-05
for O 0 2.4946882604126586e-06
such O 0 4.305611582822166e-06
germline O 0 0.0004742980236187577
mutations O 0 3.990772893303074e-05
in O 0 4.781228199135512e-05
48 O 0 0.0002792034938465804
French O 0 0.011817168444395065
melanoma B-Disease 1 1.0
- O 0 0.0594867542386055
prone O 0 0.0003954645071644336
families O 0 2.4781843421806116e-06
selected O 0 2.5899837510223733e-06
according O 0 9.447945785723277e-07
to O 0 1.687222493274021e-06
two O 0 1.5885552784311585e-06
major O 0 3.0437518944381736e-05
criteria O 0 5.506430170498788e-06
families O 0 2.2505632841784973e-06
with O 0 1.359629550279351e-06
at O 0 4.6289154852274805e-05
least O 0 4.073549462191295e-06
three O 0 3.27713996739476e-06
affected O 0 6.856434993096627e-06
members O 0 3.081637487412081e-06
( O 0 9.335059985460248e-06
n O 0 4.621404150384478e-05
= O 0 8.869068551575765e-05
20 O 0 6.8457200541161e-05
) O 0 4.164833171671489e-06
or O 0 2.70625127996027e-06
families O 0 2.2621052266913466e-06
with O 0 3.5785635645879665e-06
two O 0 9.261671038984787e-06
affected O 0 1.948291901499033e-05
members O 0 3.3363746752002044e-06
, O 0 1.7507865095467423e-06
one O 0 8.808319762465544e-07
of O 0 2.97587371278496e-06
them O 0 2.8181675588712096e-06
affected O 0 8.809951395960525e-06
before O 0 9.823337677516975e-06
the O 0 4.6795157686574385e-06
age O 0 1.2497964235080872e-05
of O 0 1.5488732969970442e-05
50 O 0 2.022951412072871e-05
( O 0 5.768255050497828e-06
n O 0 2.823165232257452e-05
= O 0 6.304177804850042e-05
28 O 0 7.954592729220167e-05
) O 0 5.906801561650354e-06
, O 0 2.3928485006763367e-06
and O 0 1.977219881155179e-06
one O 0 1.9657363736769184e-06
additional O 0 1.0848088095372077e-05
minor O 0 0.00046001793816685677
criterion O 0 0.03516793251037598
. O 0 0.0005236509023234248

Sixteen O 0 0.0011977244867011905
different O 0 2.3686459826421924e-05
p16 O 0 0.0008407358545809984
germline O 0 0.0007694718660786748
mutations O 0 3.786674642469734e-05
were O 0 2.639889862621203e-05
found O 0 6.721897534589516e-06
in O 0 9.33922638068907e-06
21 O 0 5.8327299484517425e-05
families O 0 4.622017513611354e-06
, O 0 4.183558758086292e-06
while O 0 1.184081247629365e-05
one O 0 2.3729509848635644e-05
germline O 0 0.000841720262542367
mutation O 0 3.912513057002798e-05
, O 0 3.688227661768906e-05
Arg24His O 0 0.002202959032729268
, O 0 2.0148130715824664e-05
was O 0 0.00010730054054874927
detected O 0 3.877353447023779e-05
in O 0 1.296687696594745e-05
the O 0 5.368255006032996e-05
CDK4 O 1 0.9832890629768372
gene O 0 0.0001928358688019216
. O 0 0.00014290444960352033

The O 0 6.48258937872015e-05
frequency O 0 2.2180260202731006e-05
of O 0 5.074628643342294e-05
p16 O 0 0.0002688304230105132
gene O 0 1.5673427697038278e-05
mutation O 0 3.5121508972224547e-06
in O 0 3.5152604596078163e-06
our O 0 2.420189048280008e-06
sample O 0 7.0388784934039e-07
( O 0 2.719946451179567e-06
44 O 0 1.4882894902257249e-05
% O 0 7.791181815264281e-06
) O 0 5.87371641813661e-06
is O 0 3.0503340440191096e-06
among O 0 2.512226501494297e-06
the O 0 4.4621147026191466e-06
highest O 0 6.196971662575379e-05
rates O 0 9.058316209120676e-06
yet O 0 6.934888460818911e-06
reported O 0 6.738134743500268e-06
and O 0 3.2018083402363118e-06
the O 0 3.0278317353804596e-05
CDK4 O 0 0.02124314196407795
mutation O 0 7.77227251091972e-06
is O 0 2.641215360199567e-06
the O 0 4.640713541448349e-06
second O 0 1.5588342648698017e-05
mutation O 0 3.8985544961178675e-06
detected O 0 1.7047721485141665e-05
in O 0 4.922739208268467e-06
this O 0 4.280343091522809e-06
gene O 0 2.8705582735710777e-05
worldwide O 0 5.829660585732199e-05
. O 0 0.0001408997632097453

In O 0 0.00013423697964753956
summary O 0 0.00012211310968268663
, O 0 7.610670763824601e-06
our O 0 4.5402989599097054e-06
results O 0 1.8504056242818478e-06
show O 0 4.9596678763919044e-06
frequent O 0 3.440706905166735e-06
involvement O 0 1.25937031043577e-05
of O 0 1.996343235077802e-05
the O 0 5.5102304031606764e-05
p16 O 0 0.00026649312349036336
gene O 0 2.6074731067637913e-05
in O 0 6.623316585319117e-05
familial B-Disease 1 0.8263387680053711
melanoma I-Disease 1 0.9999988079071045
and O 0 4.754171095555648e-05
confirm O 0 2.2429212549468502e-05
the O 0 8.124833584588487e-06
role O 0 1.5224615708575584e-05
of O 0 3.808356268564239e-05
the O 0 5.4586467740591615e-05
CDK4 O 1 0.9544633030891418
gene O 0 2.7931453587370925e-05
as O 0 3.222166924388148e-05
a O 0 0.00013498531188815832
melanoma B-Disease 1 0.9999852180480957
- O 0 0.0030796050559729338
predisposing O 0 0.0015543826157227159
gene O 0 0.00010171980102313682
. O 0 4.5872653572587296e-05
. O 0 0.00015722714306320995

Progression O 0 0.02299359254539013
of O 0 0.0011857259087264538
somatic O 0 0.007744850590825081
CTG O 1 0.9975468516349792
repeat O 0 0.0003151173877995461
length O 0 2.480423790984787e-05
heterogeneity O 0 4.1658469854155555e-05
in O 0 1.0965665751427878e-05
the O 0 1.6961384972091764e-05
blood O 0 0.00012933487596455961
cells O 0 0.00017716121510602534
of O 1 0.9784722328186035
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999641180038452
. O 0 0.0017251921817660332

The O 0 4.927891859551892e-05
genetic O 0 4.6322980779223144e-05
basis O 0 9.61193727562204e-05
of O 1 0.8744376301765442
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9996440410614014
DM B-Disease 1 1.0
) O 0 4.6846344048390165e-05
is O 0 4.918548256682698e-06
the O 0 4.574145805236185e-06
expansion O 0 4.353529948275536e-05
of O 0 2.988584674312733e-05
an O 0 5.134771708981134e-05
unstable O 0 0.011280338279902935
CTG O 0 0.2980380654335022
repeat O 0 0.00014365644892677665
in O 0 1.9591932868934236e-05
the O 0 1.0968886272166856e-05
34 O 0 3.462952736299485e-05
UTR O 0 0.0009176880703307688
of O 0 2.9181175705161877e-05
the O 0 9.306850552093238e-05
DM B-Disease 1 0.9999456405639648
protein O 0 0.00010395100980531424
kinase O 0 8.060025720624253e-05
gene O 0 2.4970326194306836e-05
on O 0 0.00012263937969692051
chromosome O 0 0.0003943434276152402
19 O 0 0.000673169270157814
. O 0 0.00022822295431979

One O 0 3.1236002541845664e-05
of O 0 2.849570410035085e-05
the O 0 2.596713420643937e-05
principal O 0 5.353358210413717e-05
features O 0 5.105035597807728e-06
of O 0 2.8936148737557232e-05
the O 0 0.00020753689750563353
DM B-Disease 1 1.0
mutation O 0 3.420019129407592e-05
is O 0 5.177097591513302e-06
an O 0 4.812682163901627e-06
extraordinarily O 0 0.0001842073688749224
high O 0 6.891543307574466e-05
level O 0 7.482074579456821e-05
of O 0 0.0001375120336888358
somatic O 0 0.0012058928841724992
mosaicism O 0 0.10781020671129227
, O 0 2.5904610083671287e-05
due O 0 5.672996849170886e-05
to O 0 7.769278454361483e-06
an O 0 5.697628694179002e-06
extremely O 0 2.728532490436919e-05
high O 0 3.9712067518848926e-05
degree O 0 3.457501588854939e-05
of O 0 5.947468525846489e-05
somatic O 0 0.0003106208750978112
instability O 0 0.000528598262462765
both O 0 7.515450761275133e-06
within O 0 9.65571598499082e-06
and O 0 5.479331321112113e-06
between O 0 7.083125092322007e-05
different O 0 1.9397302821744233e-05
tissues O 0 0.00072486512362957
. O 0 0.0004044306115247309

This O 0 0.00010203271813225001
instability O 0 0.0012632230063900352
appears O 0 7.443482172675431e-05
to O 0 9.427349141333252e-06
be O 0 6.17939713265514e-06
biased O 0 1.2331363905104809e-05
towards O 0 3.5687819035956636e-05
further O 0 1.9097456970484927e-05
expansion O 0 7.179759995779023e-05
and O 0 4.7802050175960176e-06
continuous O 0 2.9319922759896144e-05
throughout O 0 7.899448974058032e-06
the O 0 9.071031854546163e-06
life O 0 1.0357266546634492e-05
of O 0 6.558775567100383e-06
an O 0 4.346973128122045e-06
individual O 0 4.759380317409523e-06
, O 0 4.811874532606453e-06
features O 0 3.081120439674123e-06
that O 0 6.16056411217869e-07
could O 0 1.4956806353438878e-06
be O 0 4.97614792038803e-07
associated O 0 7.266168609021406e-07
with O 0 6.907014835633163e-07
the O 0 2.886531910917256e-05
progressive O 0 0.00018258148338645697
nature O 0 7.298994023585692e-05
of O 0 0.00014573161024600267
the O 0 0.001351183862425387
disease O 1 0.9999996423721313
. O 0 0.0005815695622004569

Although O 0 6.18267513345927e-05
increasing O 0 4.0747076127445325e-05
measured O 0 4.145943603361957e-05
allele O 0 7.274146810232196e-06
size O 0 1.1882008948305156e-05
between O 0 5.886360304430127e-05
patients O 0 2.8436794309527613e-05
clearly O 0 2.9271814128151163e-05
correlates O 0 2.2801454178988934e-05
with O 0 1.529704832137213e-06
an O 0 3.6558494684868492e-06
increased O 0 3.440332875470631e-05
severity O 0 0.00029263616306707263
of O 0 0.00022997370979283005
symptoms O 0 0.020404793322086334
and O 0 2.492516978236381e-05
an O 0 1.0439234756631777e-05
earlier O 0 4.463806180865504e-05
age O 0 8.957924728747457e-05
of O 0 0.0001330893865088001
onset O 1 0.9873747825622559
, O 0 2.8285605367273092e-05
this O 0 4.902980890619801e-06
correlation O 0 1.3462519746099133e-05
is O 0 3.8165417208801955e-06
not O 0 1.2151060673204483e-06
precise O 0 5.2775699259655084e-06
and O 0 5.056755981058814e-06
measured O 0 3.810045018326491e-05
allele O 0 6.3549241531291045e-06
length O 0 1.1270682989561465e-05
cannot O 0 3.232110202588956e-06
be O 0 9.855906455413788e-07
used O 0 1.116059024752758e-06
as O 0 2.5627507511671865e-06
an O 0 1.0650343256202177e-06
accurate O 0 6.367360128933797e-06
predictor O 0 0.00015819122199900448
of O 0 6.435402610804886e-05
age O 0 0.0005077585228718817
of O 0 0.0011472540209069848
onset O 1 0.9999977350234985
. O 0 0.002817647298797965

In O 0 6.0648333601420745e-05
order O 0 7.486235972464783e-06
to O 0 2.9294103569554863e-06
further O 0 5.826361302752048e-06
characterize O 0 4.765018820762634e-05
the O 0 1.787359724403359e-05
dynamics O 0 0.00020860781660303473
of O 0 0.0007627549348399043
DM B-Disease 1 1.0
CTG O 1 0.9999827146530151
repeat O 0 0.002551845507696271
somatic O 0 0.0010682588908821344
instability O 0 0.001698442385531962
, O 0 2.121517354680691e-05
we O 0 5.736393632105319e-06
have O 0 1.6539072476007277e-06
studied O 0 3.104735878878273e-05
repeat O 0 5.7781981013249606e-05
length O 0 1.2868507837993093e-05
changes O 0 1.541422989248531e-06
over O 0 5.661345312546473e-06
time O 0 1.2282608622626867e-05
in O 0 4.877743049291894e-05
111 O 1 0.9996974468231201
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0007045939564704895
with O 0 1.3600505553768016e-05
varying O 0 4.409266330185346e-05
clinical O 0 0.0009730008896440268
severity O 1 0.8654676079750061
and O 0 0.00044716382399201393
CTG O 1 0.9949924349784851
repeat O 0 0.00024413829669356346
size O 0 1.34822530526435e-05
over O 0 6.8227136580389924e-06
time O 0 4.050234110763995e-06
intervals O 0 4.128250566282077e-06
of O 0 1.7561262211529538e-05
1 O 0 0.00022196849749889225
- O 0 0.00036474698572419584
7 O 0 0.000167723250342533
years O 0 0.00024211140407714993
. O 0 0.00011340511991875246

We O 0 6.405114254448563e-05
have O 0 3.0677445010951487e-06
found O 0 2.3291115667234408e-06
a O 0 3.5550212942325743e-06
direct O 0 6.375137672876008e-06
progression O 0 0.00024084416509140283
of O 0 3.4441145544406027e-05
the O 0 3.818589902948588e-05
size O 0 1.9130924556520768e-05
heterogeneity O 0 2.4508137357770465e-05
over O 0 1.6953332306002267e-05
time O 0 1.1624301805568393e-05
related O 0 1.139198229793692e-05
to O 0 1.1355495189491194e-05
initial O 0 0.00012197368050692603
CTG O 0 0.014084098860621452
repeat O 0 0.00018428712792228907
size O 0 1.7595206372789107e-05
and O 0 1.9295860056445235e-06
the O 0 5.003670594305731e-06
time O 0 6.9726884248666465e-06
interval O 0 1.768301626725588e-05
and O 0 7.997467037057504e-06
always O 0 1.2535445421235636e-05
biased O 0 1.0907798241532873e-05
towards O 0 3.883429235429503e-05
further O 0 8.908228483051062e-05
expansion O 0 0.0012184004299342632
. O 0 0.00021986571664456278

Attempts O 0 0.00016638459055684507
to O 0 2.20058918785071e-05
mathematically O 0 3.5400313208810985e-05
model O 0 7.534770247730194e-06
the O 0 1.115133363782661e-05
dynamics O 0 0.00010107825801242143
have O 0 6.087616839067778e-06
proved O 0 0.00019831425743177533
only O 0 9.869142559182364e-06
partially O 0 7.862292841309682e-05
successful O 0 1.785422682587523e-05
suggesting O 0 5.630563009617617e-06
that O 0 2.0705884651306405e-07
individual O 0 2.0967266323168587e-07
specific O 0 1.0894095794355962e-06
genetic O 0 4.2350515286671e-05
and O 0 3.528110755723901e-05
/ O 0 0.0006947562796995044
or O 0 3.843630838673562e-05
environmental O 0 7.200802065199241e-05
factors O 0 1.2380382031551562e-05
also O 0 6.169198513816809e-06
play O 0 1.3784922884951811e-05
a O 0 1.3977934031572659e-05
role O 0 5.958787733106874e-05
in O 0 5.9756090195151046e-05
somatic O 0 0.0011607209453359246
mosaicism O 1 0.9889066219329834
. O 0 0.00022524896485265344
. O 0 0.0002926281013060361

Aspartylglucosaminuria B-Disease 1 0.99994957447052
among O 0 0.000277834857115522
Palestinian O 0 0.00044529905426315963
Arabs O 0 0.001219398807734251
. O 0 0.00048825674457475543

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.21230794489383698
AGU B-Disease 1 0.9999998807907104
) O 0 2.512321952963248e-05
is O 0 4.275284481991548e-06
a O 0 7.59741487854626e-06
rare O 0 8.499603427480906e-05
disorder B-Disease 1 0.9999994039535522
of I-Disease 1 0.9995936751365662
glycoprotein I-Disease 1 0.9999980926513672
metabolism I-Disease 1 0.8132338523864746
caused O 0 0.0018159695900976658
by O 0 1.7154347005998716e-05
the O 0 6.359413237078115e-05
deficiency B-Disease 1 0.999671459197998
of I-Disease 0 0.00013704066805075854
the I-Disease 0 0.0001785777130862698
lysosomal I-Disease 1 0.7329971194267273
enzyme I-Disease 0 0.00022300094133242965
aspartylglucosaminidase I-Disease 0 0.03927222266793251
( O 0 0.0002939302648883313
AGA O 1 0.5428964495658875
) O 0 0.00015323869592975825
. O 0 0.0001416843879269436

AGU B-Disease 1 1.0
is O 0 0.00015459198039025068
inherited O 1 0.6043218970298767
as O 0 4.804776835953817e-05
an O 0 4.0523253119317815e-05
autosomal O 1 0.9926776885986328
recessive O 1 0.9989625215530396
trait O 0 0.47785425186157227
and O 0 9.819243132369593e-05
occurs O 0 3.23670610669069e-05
with O 0 7.278837983903941e-06
a O 0 1.9332926967763342e-05
high O 0 5.427264841273427e-05
frequency O 0 6.8891936280124355e-06
in O 0 5.533931016543647e-06
Finland O 0 3.150803968310356e-05
because O 0 2.081566208289587e-06
of O 0 1.1346683095325716e-05
a O 0 5.667665755026974e-05
founder O 0 0.0008909589960239828
effect O 0 0.0001979605876840651
. O 0 0.00013343096361495554

While O 0 0.00017680245218798518
very O 0 2.8731245038216002e-05
few O 0 4.311519660404883e-05
patients O 0 6.187393591972068e-05
with O 0 7.476647442672402e-05
AGU B-Disease 1 1.0
have O 0 3.481436215224676e-05
been O 0 2.3167318431660533e-05
reported O 0 1.2520321433839854e-05
from O 0 1.1789634299930185e-05
non O 0 0.00012986132060177624
- O 0 0.0001256196410395205
Finnish O 0 0.00024704175302758813
origin O 0 1.536658965051174e-05
, O 0 1.0455833944433834e-05
we O 0 2.459516872477252e-05
diagnosed O 1 0.8554359078407288
the O 0 0.00013509011478163302
disorder O 1 0.999992847442627
in O 0 0.0002897790400311351
8 O 0 0.0006117488956078887
patients O 0 2.6552608687779866e-05
originating O 0 4.254554369254038e-05
from O 0 1.935307045641821e-05
3 O 0 5.948670150246471e-05
unrelated O 0 1.9672495909617282e-05
families O 0 2.022686203417834e-06
, O 0 1.049746060743928e-06
all O 0 6.490348027909931e-07
Palestinian O 0 1.2240395335538778e-05
Arabs O 0 3.616203321143985e-05
from O 0 1.2397867976687849e-05
the O 0 1.8657883629202843e-05
region O 0 7.70014594309032e-05
of O 0 8.456328214379027e-05
Jerusalem O 0 0.003207101719453931
. O 0 0.00031272522755898535

The O 0 0.0002066451997961849
clinical O 0 0.0010094456374645233
diagnosis O 1 0.9747081995010376
of O 1 0.9997610449790955
AGU B-Disease 1 1.0
is O 0 0.00018812342023011297
often O 0 1.3319669051270466e-05
difficult O 0 2.0138468244113028e-05
, O 0 4.446380444278475e-06
in O 0 2.9058319341856986e-06
particular O 0 3.0776373023400083e-06
early O 0 1.6182009858312085e-05
in O 0 4.211921805108432e-06
the O 0 3.4228960430482402e-06
course O 0 1.525788593426114e-05
of O 0 2.031147960224189e-05
the O 0 0.00015455573156941682
disease O 1 0.999768078327179
, O 0 8.670058377902023e-06
and O 0 1.6164512999239378e-06
most O 0 1.428023210792162e-06
of O 0 1.1011627975676674e-05
the O 0 3.8791655242675915e-05
patients O 0 3.271174864494242e-05
are O 0 1.015380348690087e-05
diagnosed O 0 0.3973655700683594
after O 0 0.00010268043115502223
the O 0 2.50835764745716e-05
age O 0 6.258462235564366e-05
of O 0 7.466488023055717e-05
5 O 0 0.0002987008192576468
years O 0 0.00033112798701040447
. O 0 0.00021248783741611987

However O 0 0.00013186810247134417
, O 0 1.532005626359023e-05
since O 0 4.991219248040579e-05
these O 0 8.712770068086684e-06
patients O 0 6.0000253142789006e-05
excrete O 0 0.0004984209081158042
early O 0 7.224966248031706e-05
large O 0 1.6156149285961874e-05
amounts O 0 1.7286050933762453e-05
of O 0 6.718937220284715e-05
aspartylglucosamine O 0 0.0016413656994700432
in O 0 6.64097533444874e-05
urine O 0 6.992469570832327e-05
, O 0 9.201979082718026e-06
biochemical O 0 7.04531921655871e-05
screening O 0 2.0858919015154243e-05
is O 0 9.950455023499671e-06
easy O 0 1.2726559361908585e-05
by O 0 7.4821250564127695e-06
urine O 0 0.0001015875895973295
chromatography O 0 0.00302688404917717
. O 0 0.00012105747009627521
. O 0 0.00017617340199649334

Detection O 0 0.000428771716542542
of O 0 0.00011222638568142429
heterozygous O 0 4.612928387359716e-05
carriers O 0 2.2771158910472877e-05
of O 0 5.548221088247374e-05
the O 0 0.000630706490483135
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999521970748901
telangiectasia I-Disease 1 0.9999178647994995
( O 0 0.0002890150644816458
ATM O 0 0.001578083261847496
) O 0 1.3363131984078791e-05
gene O 0 7.289354925887892e-06
by O 0 8.635384801891632e-06
G2 O 0 0.009292760863900185
phase O 0 0.0011752661084756255
chromosomal O 0 0.0038942901883274317
radiosensitivity O 0 0.07241295278072357
of O 0 0.0013820258900523186
peripheral O 1 0.9999982118606567
blood O 1 0.9957593083381653
lymphocytes O 0 0.016580967232584953
. O 0 0.0007636684458702803

In O 0 0.002457680879160762
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998883008956909
telangiectasia I-Disease 1 0.9999904632568359
( O 0 0.0005410580197349191
A B-Disease 1 0.9999970197677612
- I-Disease 1 0.9997103810310364
T I-Disease 1 0.9999978542327881
) O 0 1.9534190869308077e-05
patients O 0 9.178787877317518e-06
, O 0 2.8684005428658566e-06
mutations O 0 4.483552856981987e-06
in O 0 9.132058949035127e-06
a O 0 1.3061523532087449e-05
single O 0 1.0116049452335574e-05
gene O 0 1.4650973753305152e-05
, O 0 9.029920875036623e-06
ATM O 0 0.0003220208454877138
, O 0 3.945864136767341e-06
result O 0 3.5487141758494545e-06
in O 0 1.2944611626153346e-05
an O 0 9.145274088950828e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.0013614309718832374
embraces O 0 0.0005356965120881796
a O 0 3.1398558348882943e-05
variety O 0 1.4258839655667543e-05
of O 0 5.694102219422348e-05
clinical O 0 0.0002418769581709057
features O 0 9.617281466489658e-05
and O 0 3.716025821631774e-05
manifests O 0 0.000436687667388469
extreme O 0 0.0006560885813087225
radiosensitivity O 0 0.008696543984115124
and O 0 2.2187748982105404e-05
a O 0 2.190058512496762e-05
strong O 0 2.532347025407944e-05
pre O 0 0.0008168376516550779
- O 0 0.0005547686014324427
disposition O 0 0.0005349011044017971
to O 0 0.00022569527209270746
malignancy B-Disease 1 0.9996939897537231
. O 0 0.00038202101131901145

Heterozygotes O 0 0.0021044183522462845
for O 0 3.173862205585465e-05
the O 0 8.687957597430795e-05
ATM O 0 0.0013770294608548284
gene O 0 1.2934739061165601e-05
have O 0 2.1288994958013063e-06
no O 0 1.62191452091065e-06
clinical O 0 7.829748938092962e-06
expression O 0 1.102603528124746e-05
of O 0 0.0001409113174304366
A B-Disease 1 0.9999971389770508
- I-Disease 1 0.9997684359550476
T I-Disease 1 0.9999842643737793
but O 0 7.895592716522515e-06
may O 0 3.9465390727855265e-05
be O 0 2.5959458071156405e-05
cancer B-Disease 0 0.0033502636943012476
prone O 0 0.00023656779376324266
with O 0 5.981925824016798e-06
a O 0 2.8437225410016254e-05
moderate O 0 6.38972851447761e-05
increase O 0 2.330712777620647e-05
in O 0 2.3815566237317398e-05
in O 0 4.365020140539855e-05
vitro O 0 0.0002922815037891269
radiosensitivity O 0 0.005712205544114113
. O 0 0.0002039311220869422

We O 0 0.00012725024134851992
performed O 0 0.00011164222087245435
a O 0 5.334812885848805e-05
blind O 0 0.00023890154261607677
chromosomal O 0 0.00022544944658875465
analysis O 0 1.136745595431421e-05
on O 0 0.0003124352660961449
G2 O 1 0.8777099847793579
- O 0 0.00017629002104513347
phase O 0 0.0001219608893734403
lymphocytes O 0 3.678535722428933e-05
from O 0 1.3267362191982102e-05
7 O 0 7.013746653683484e-05
unrelated O 0 9.924684854922816e-05
A B-Disease 1 0.9715705513954163
- I-Disease 1 0.8202512860298157
T I-Disease 1 0.999974250793457
patients O 0 3.723361805896275e-05
, O 0 7.5036336966149975e-06
13 O 0 5.025597783969715e-05
obligate O 0 7.660947449039668e-05
A B-Disease 1 0.9999041557312012
- I-Disease 1 0.9982917904853821
T I-Disease 1 0.9999775886535645
heterozygotes O 0 0.00045022781705483794
( O 0 1.1781709872593638e-05
parents O 0 1.3652139614350745e-06
of O 0 6.460726581281051e-06
the O 0 3.2884025131352246e-05
patients O 0 3.446121991146356e-05
) O 0 9.040071745403111e-06
, O 0 5.4907927733438555e-06
and O 0 4.107613676751498e-06
14 O 0 5.243896157480776e-05
normal O 0 2.1109803128638305e-05
controls O 0 1.6601698007434607e-05
following O 0 3.114934952463955e-05
X O 0 0.0006000380381010473
- O 0 0.00016581191448494792
irradiation O 0 4.2607629438862205e-05
with O 0 7.531300070695579e-06
1 O 0 0.0001675912062637508
Gy O 0 0.001081429305486381
in O 0 7.322254987229826e-06
order O 0 2.9323314265639056e-06
to O 0 2.2479118797491537e-06
evaluate O 0 8.497210728819482e-06
this O 0 3.033311713807052e-06
cytogenetic O 0 8.330024138558656e-05
method O 0 3.926269528164994e-06
as O 0 6.526641755044693e-06
a O 0 5.204417448112508e-06
tool O 0 1.4413424651138484e-05
for O 0 3.243330866098404e-06
detection O 0 5.132901424076408e-05
of O 0 0.0002659542369656265
ATM O 0 0.16856110095977783
carriers O 0 0.0005252413102425635
. O 0 0.00017006702546495944

Both O 0 0.0006690669688396156
A B-Disease 1 0.9999808073043823
- I-Disease 1 0.9999392032623291
T I-Disease 1 0.9999970197677612
homozygotes O 0 0.002358738100156188
and O 0 3.257446951465681e-05
heterozygotes O 0 0.00030752428574487567
showed O 0 4.287038973416202e-05
significantly O 0 2.918546124419663e-05
increased O 0 2.2843023543828167e-05
levels O 0 6.454947288148105e-05
of O 0 0.00018842393183149397
radiation O 1 0.9994627833366394
- O 0 0.023196514695882797
induced O 0 0.00801207683980465
chromatid O 0 0.006524727214127779
damage O 0 0.00028187118005007505
relative O 0 3.9432055928045884e-05
to O 0 4.95242238685023e-06
that O 0 2.8296076379774604e-06
of O 0 4.25618163717445e-05
normal O 0 0.00017901310638990253
controls O 0 0.00025573905440978706
. O 0 0.00016885613149497658

These O 0 7.061132691887906e-06
results O 0 4.701151738117915e-06
show O 0 1.6313202650053427e-05
that O 0 2.808457793435082e-06
the O 0 2.9199103664723225e-05
G2 O 1 0.7121541500091553
- O 0 0.0004510850412771106
phase O 0 0.0004943847307004035
chromosomal O 0 0.0008991953218355775
radiosensitivity O 0 0.0009594958391971886
assay O 0 1.3337298696569633e-05
can O 0 1.4366274854182848e-06
be O 0 4.4510838392852747e-07
used O 0 3.887624870912987e-07
for O 0 3.880953443058388e-07
the O 0 5.079578386357753e-06
detection O 0 1.6107856936287135e-05
of O 0 0.00014053090126253664
A B-Disease 1 0.9999839067459106
- I-Disease 1 0.9998165965080261
T I-Disease 1 0.9999959468841553
heterozygotes O 0 0.005842294543981552
. O 0 0.00044943642569705844

In O 0 0.00016112488810904324
combination O 0 6.099076199461706e-05
with O 0 1.5649875422241166e-05
molecular O 0 8.744543447392061e-05
genetic O 0 4.5101463911123574e-05
analyses O 0 2.1015059246565215e-05
, O 0 5.7557926993467845e-06
this O 0 1.3872472663933877e-06
test O 0 3.2636944524711e-06
may O 0 9.569946996634826e-06
be O 0 6.964374392737227e-07
of O 0 2.3710206278337864e-06
value O 0 4.533722403721185e-06
in O 0 4.502337560552405e-06
studies O 0 3.279853672211175e-06
of O 0 3.2560928957536817e-05
familial B-Disease 0 0.0022152026649564505
and I-Disease 0 0.00023144885199144483
sporadic I-Disease 1 0.5104267001152039
cancers I-Disease 1 0.9998712539672852
aimed O 0 0.0007029554690234363
at O 0 0.00012015996617265046
determination O 0 1.7865299014374614e-05
of O 0 1.4105200534686446e-05
the O 0 1.5191214515652973e-05
potential O 0 2.8777560146409087e-05
involvement O 0 4.78436159028206e-05
of O 0 0.0001009579500532709
ATM O 0 0.007791668642312288
mutations O 0 0.0001418923493474722
in O 0 0.0002511235943529755
tumor B-Disease 1 0.9999736547470093
risk O 0 0.000127667241031304
or O 0 2.208877594966907e-05
development O 0 0.00011322962382109836
. O 0 3.1434508855454624e-05
. O 0 7.700072455918416e-05

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999780654907227
telangiectasia I-Disease 1 0.9994614720344543
: O 0 2.7888574550161138e-05
identification O 0 9.486530871072318e-06
and O 0 5.583176971413195e-06
detection O 0 6.32811279501766e-05
of O 0 0.00027429143665358424
founder O 0 0.004957684315741062
- O 0 0.0003734812780749053
effect O 0 2.318871338502504e-05
mutations O 0 4.089017693331698e-06
in O 0 5.48936895938823e-06
the O 0 1.248957596544642e-05
ATM O 0 0.00028813822427764535
gene O 0 6.6208535827172454e-06
in O 0 9.081522875931114e-06
ethnic O 0 2.7953197786700912e-05
populations O 0 4.907454058411531e-05
. O 0 9.275911725126207e-05

To O 0 4.157516741543077e-05
facilitate O 0 2.6904514015768655e-05
the O 0 6.8532458499248605e-06
evaluation O 0 7.0216137828538194e-06
of O 0 5.106936805532314e-05
ATM O 0 0.001792707946151495
heterozygotes O 0 0.00019652825722005218
for O 0 1.7277203369303606e-05
susceptibility O 0 0.00014596106484532356
to O 0 3.3340529626002535e-05
other O 0 3.872342495014891e-05
diseases O 1 0.9999414682388306
, O 0 7.54784468881553e-06
such O 0 3.803305389737943e-06
as O 0 0.0005579300341196358
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999959468841553
, O 0 2.0792625946342014e-05
we O 0 4.714050191978458e-06
have O 0 1.6197831200770452e-06
attempted O 0 1.7214591935044155e-05
to O 0 4.021716449642554e-06
define O 0 1.6432179108960554e-05
the O 0 1.3830366697220597e-05
most O 0 4.621343123289989e-06
common O 0 5.105483523948351e-06
mutations O 0 7.0718278948334046e-06
and O 0 3.1262461561709642e-06
their O 0 3.706107918333146e-06
frequencies O 0 1.9890758267138153e-05
in O 0 0.0001193065254483372
ataxia B-Disease 1 0.9999980926513672
- I-Disease 1 0.9979597330093384
telangiectasia I-Disease 1 0.9998043179512024
( O 0 0.0003381123533472419
A B-Disease 1 0.9998412132263184
- I-Disease 1 0.613815188407898
T I-Disease 1 0.9983383417129517
) O 0 2.078416036965791e-05
homozygotes O 0 0.00017632669187150896
from O 0 1.948124736372847e-05
10 O 0 2.3652151867281646e-05
ethnic O 0 2.7814816348836757e-05
populations O 0 5.342729855328798e-05
. O 0 0.00011301410995656624

Both O 0 4.273988452041522e-05
genomic O 0 7.26106227375567e-05
mutations O 0 4.1945964767364785e-05
and O 0 9.054377187567297e-06
their O 0 6.635771569563076e-06
effects O 0 9.889210923574865e-05
on O 0 0.00012990379764232785
cDNA O 0 0.00015800519031472504
were O 0 6.173296424094588e-05
characterized O 0 0.00019963279191870242
. O 0 0.00015530825476162136

Protein O 0 0.0009498511790297925
- O 0 0.0002857829094864428
truncation O 0 0.00012669172429013997
testing O 0 1.436324691894697e-05
of O 0 2.3041684471536428e-05
the O 0 3.263493999838829e-05
entire O 0 0.0001238490076502785
ATM O 0 0.0004802244366146624
cDNA O 0 8.725802035769448e-05
detected O 0 5.43648493476212e-05
92 O 0 3.641618604888208e-05
( O 0 7.994926818355452e-06
66 O 0 3.622395161073655e-05
% O 0 9.649788808019366e-06
) O 0 1.0043006113846786e-05
truncating O 0 0.00017486335127614439
mutations O 0 1.562742909300141e-05
in O 0 1.7326519810012542e-05
140 O 0 4.5721895730821416e-05
mutant O 0 7.84612275310792e-05
alleles O 0 4.079392965650186e-05
screened O 0 0.00047078897478058934
. O 0 0.00018057589477393776

The O 0 0.0002704848302528262
haplotyping O 0 0.002235909691080451
of O 0 0.00011404471297282726
patients O 0 4.5663593482458964e-05
with O 0 8.101111234282143e-06
identical O 0 1.8054834072245285e-05
mutations O 0 1.4458320038102102e-05
indicates O 0 2.4268883862532675e-05
that O 0 1.2139755654061446e-06
almost O 0 2.418520807623281e-06
all O 0 5.225242603046354e-07
of O 0 3.822639882855583e-06
these O 0 1.4881668448651908e-06
represent O 0 7.869109140301589e-06
common O 0 1.143505323852878e-05
ancestry O 0 2.2701473426423036e-05
and O 0 1.297157632507151e-05
that O 0 5.319403044268256e-06
very O 0 1.0097313861479051e-05
few O 0 4.084682950633578e-05
spontaneously O 0 0.0003424542082939297
recurring O 0 0.0016238588141277432
ATM O 0 0.023984426632523537
mutations O 0 0.00024848987231962383
exist O 0 0.0004045023233629763
. O 0 0.0002997131960000843

Assays O 0 0.00018247355183120817
requiring O 0 3.9302085497183725e-05
minimal O 0 7.036080933175981e-05
amounts O 0 1.3339220458874479e-05
of O 0 2.4063703676802106e-05
genomic O 0 2.3122334823710844e-05
DNA O 0 4.263709706719965e-05
were O 0 1.6938947737799026e-05
designed O 0 1.4954117432353087e-05
to O 0 3.1565884910378372e-06
allow O 0 3.989464858022984e-06
rapid O 0 5.216513454797678e-05
screening O 0 6.091612704040017e-06
for O 0 5.35899744136259e-06
common O 0 2.1375690266722813e-05
ethnic O 0 7.416147855110466e-05
mutations O 0 0.00040709899622015655
. O 0 0.00038137860246933997

These O 0 6.477083661593497e-05
rapid O 0 0.0005374966422095895
assays O 0 7.082841329975054e-05
detected O 0 0.0001543648395454511
mutations O 0 1.2204588529129978e-05
in O 0 9.68564381764736e-06
76 O 0 4.2740699427668005e-05
% O 0 7.04163085174514e-06
of O 0 5.3880208724876866e-05
Costa O 0 0.00023286016948986799
Rican O 0 0.00020092770864721388
patients O 0 2.3935785065987147e-05
( O 0 9.068220606422983e-06
3 O 0 4.154416819801554e-05
) O 0 3.1349820801551687e-06
, O 0 1.2316802440182073e-06
50 O 0 2.235885403933935e-06
% O 0 1.211237190545944e-06
of O 0 2.2402042304747738e-05
Norwegian O 0 0.0001686133473413065
patients O 0 2.375106305407826e-05
( O 0 6.854918410681421e-06
1 O 0 2.790616053971462e-05
) O 0 1.916477231134195e-06
, O 0 8.850404356053332e-07
25 O 0 4.724333848571405e-06
% O 0 2.3895099729998037e-06
of O 0 2.641854007379152e-05
Polish O 0 0.05835491046309471
patients O 0 0.00013623481208924204
( O 0 4.250665369909257e-05
4 O 0 9.113340638577938e-05
) O 0 5.904548743274063e-06
, O 0 2.6898173928202596e-06
and O 0 2.119877990480745e-06
14 O 0 1.2313701517996378e-05
% O 0 3.11173653244623e-06
of O 0 3.1371411751024425e-05
Italian O 0 0.00044911206350661814
patients O 0 9.112976840697229e-05
( O 0 3.169663978042081e-05
1 O 0 8.953262295108289e-05
) O 0 4.499375791056082e-06
, O 0 1.7113557078118902e-06
as O 0 3.4940637760882964e-06
well O 0 2.941366346931318e-06
as O 0 5.095162578072632e-06
in O 0 1.32983459479874e-05
patients O 0 2.7049765776610002e-05
of O 0 0.00019235696527175605
Amish O 0 0.002360208425670862
/ O 0 0.0009443783201277256
Mennonite O 0 0.00035135066718794405
and O 0 1.7876820493256673e-05
Irish O 0 0.0002649727393873036
English O 0 0.00018541091412771493
backgrounds O 0 0.0002194016706198454
. O 0 0.0003195680328644812

Additional O 0 0.00011117776011815295
mutations O 0 7.125826232368127e-05
were O 0 4.0092203562380746e-05
observed O 0 1.9842598703689873e-05
in O 0 1.5608780813636258e-05
Japanese O 0 0.00017252661928068846
, O 0 1.0385831956227776e-05
Utah O 0 0.00014413008466362953
Mormon O 0 7.415143772959709e-05
, O 0 3.3135188459709752e-06
and O 0 2.6687146146286977e-06
African O 0 6.923529872437939e-05
American O 0 5.764658999396488e-05
patients O 0 0.00010058960469905287
. O 0 0.00014331890270113945

These O 0 1.2957110811839812e-05
assays O 0 6.908167961228173e-06
should O 0 3.0074286314629717e-06
facilitate O 0 4.9847526497615036e-06
screening O 0 8.393515599891543e-06
for O 0 1.654801599215716e-05
A B-Disease 1 0.9981086254119873
- I-Disease 1 0.5272213816642761
T I-Disease 1 0.9987963438034058
heterozygotes O 0 0.00025844215997494757
in O 0 1.3801444765704218e-05
the O 0 1.6272430002572946e-05
populations O 0 8.970064300228842e-06
studied O 0 8.193050598492846e-05
. O 0 2.5878707674564794e-05
. O 0 7.463966903742403e-05

The O 0 0.0004802056646440178
von B-Disease 1 0.9804304242134094
Hippel I-Disease 1 0.999934196472168
- I-Disease 1 0.9980940222740173
Lindau I-Disease 1 0.9999972581863403
tumor I-Disease 1 0.9998267292976379
suppressor O 0 0.0011674732668325305
gene O 0 2.1909441784373485e-05
is O 0 2.84702855424257e-06
required O 0 2.369838512095157e-06
for O 0 1.090183013729984e-05
cell O 0 0.00011170600919285789
cycle O 0 3.30592920363415e-05
exit O 0 6.467985804192722e-05
upon O 0 8.467003499390557e-05
serum O 0 0.0004613843630068004
withdrawal O 0 0.0005904143326915801
. O 0 0.0003370941849425435

The O 0 8.096685633063316e-05
inactivation O 0 0.0005995732499286532
of O 0 0.00015555073332507163
the O 0 0.00023884576512500644
von B-Disease 1 0.8912978768348694
Hippel I-Disease 1 0.999541163444519
- I-Disease 1 0.740926206111908
Lindau I-Disease 1 0.9999258518218994
( I-Disease 0 0.0005595250986516476
VHL I-Disease 1 0.999954342842102
) I-Disease 0 0.0002207281650044024
tumor I-Disease 1 0.9992433786392212
suppressor O 0 0.003327356418594718
gene O 0 8.714559226064011e-05
predisposes O 0 0.00036369526060298085
affected O 0 1.4790940440434497e-05
individuals O 0 8.766259611547866e-07
to O 0 4.2108331399504095e-06
the O 0 3.729953823494725e-05
human O 0 0.045459531247615814
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.9973445634823292e-05
is O 0 6.988411769270897e-06
associated O 0 3.883958925143816e-06
with O 0 5.48759408047772e-06
sporadic B-Disease 1 0.9970428347587585
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999724626541138
RCC B-Disease 1 1.0
) O 0 0.00029046062263660133
and O 0 0.00019783944298978895
brain B-Disease 1 0.9999563694000244
hemangioblastomas I-Disease 1 0.9996272325515747
. O 0 0.0004397373122628778

VHL O 1 0.9970430731773376
- O 0 0.0030417453963309526
negative O 0 0.00023555364168714732
786 O 0 0.0045045833103358746
- O 0 0.0015171886188909411
0 O 0 0.00048597040586173534
RCC B-Disease 1 0.9999775886535645
cells O 0 0.00013380756718106568
are O 0 1.4704824934597127e-05
tumorigenic O 0 0.0019554158207029104
in O 0 9.366565063828602e-05
nude O 0 0.0013799964217469096
mice O 0 0.00012912883539684117
which O 0 7.765189366182312e-06
is O 0 7.033435849734815e-06
suppressed O 0 6.26186520094052e-05
by O 0 1.9846461327688303e-06
the O 0 1.538682590762619e-05
reintroduction O 0 0.00026245295885019004
of O 0 0.00037927698576822877
VHL B-Disease 1 0.9997968077659607
. O 0 0.0007855847361497581

Remarkably O 0 0.0019419739255681634
, O 0 1.2361670087557286e-05
this O 0 1.8701654198594042e-06
occurs O 0 3.818282038992038e-06
without O 0 3.386523985682288e-06
affecting O 0 1.4516318515234161e-05
the O 0 1.4467534128925763e-05
growth O 0 2.8494236175902188e-05
rate O 0 1.0704397936933674e-05
and O 0 4.9080149437941145e-06
cell O 0 3.1647861760575324e-05
cycle O 0 1.722252090985421e-05
profile O 0 6.1302098401938565e-06
of O 0 1.4890050806570798e-05
these O 0 4.792438176082214e-06
cells O 0 2.5633698896854185e-05
in O 0 2.9961700420244597e-05
culture O 0 0.00016357323329430073
. O 0 0.00011520220868987963

The O 0 0.0004973341128788888
786 O 0 0.0038519075606018305
- O 0 0.0005372395389713347
0 O 0 0.00010240916890325025
cell O 0 0.00011324603110551834
line O 0 5.2959298045607284e-05
, O 0 4.561674359138124e-06
like O 0 4.810314749192912e-06
many O 0 1.2161007362010423e-05
cancer B-Disease 1 0.9988929629325867
cells O 0 3.937088331440464e-05
, O 0 6.558838322234806e-06
fails O 0 1.624089782126248e-05
to O 0 3.2491511774423998e-06
exit O 0 4.641805571736768e-05
the O 0 3.227529668947682e-05
cell O 0 8.236448047682643e-05
cycle O 0 3.419781205593608e-05
upon O 0 5.150465221959166e-05
serum O 0 0.00038258390850387514
withdrawal O 0 0.0005395275074988604
. O 0 0.0002666753134690225

Here O 0 0.00043563180952332914
, O 0 1.5794486898812465e-05
it O 0 1.2758513321387e-06
is O 0 1.0036762887466466e-06
shown O 0 2.154173216695199e-06
that O 0 5.019769560021814e-07
reintroduction O 0 1.815134055505041e-05
of O 0 1.1851489034597762e-05
the O 0 3.746942093130201e-05
wild O 0 0.00014439735969062895
- O 0 0.0002157201524823904
type O 0 0.00012730144953820854
VHL B-Disease 0 0.00938771478831768
gene O 0 1.3732688785239588e-05
restores O 0 2.2176960555952974e-05
the O 0 5.141602287039859e-06
ability O 0 7.584904778923374e-06
of O 0 0.00012569621321745217
VHL O 1 0.9999972581863403
- O 0 0.005368508398532867
negative O 0 0.0006221471703611314
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9477847814559937
cells O 0 3.1009512895252556e-05
to O 0 7.4831382335105445e-06
exit O 0 5.5089643865358084e-05
the O 0 3.1330480851465836e-05
cell O 0 8.117242396110669e-05
cycle O 0 3.595872476580553e-05
and O 0 1.410226832376793e-05
enter O 0 0.00027347460854798555
G0 O 0 0.3000890910625458
/ O 0 0.0007299115532077849
quiescence O 0 0.0012536668218672276
in O 0 0.000141939555760473
low O 0 0.0008084691362455487
serum O 0 0.0015185399679467082
. O 0 0.00024175246653612703

Both O 0 0.0013643644051626325
VHL O 1 0.9996634721755981
- O 0 0.0016061539063230157
positive O 0 7.419430039590225e-05
and O 0 0.0001095514016924426
VHL O 1 0.9996033310890198
- O 0 0.0014570319326594472
negative O 0 0.0002506322634872049
RCC B-Disease 1 0.9997469782829285
cells O 0 7.074417226249352e-05
exit O 0 8.07778415037319e-05
the O 0 3.711117824423127e-05
cell O 0 9.847279579844326e-05
cycle O 0 5.1908689783886075e-05
by O 0 1.2002387848042417e-05
contact O 0 8.216992137022316e-05
inhibition O 0 0.0006757797091268003
. O 0 0.0006577915046364069

The O 0 0.00045591892558149993
cyclin O 0 0.0027942198794335127
- O 0 0.0003501215251162648
dependent O 0 4.171197360847145e-05
kinase O 0 9.278229117626324e-05
inhibitor O 0 0.00027908317861147225
, O 0 2.2694763174513355e-05
p27 O 0 0.00044313943362794816
, O 0 1.1084938705607783e-05
accumulates O 0 8.86214547790587e-05
upon O 0 2.4433251383015886e-05
serum O 0 0.00012065423652529716
withdrawal O 0 5.892876288271509e-05
, O 0 6.729607321176445e-06
only O 0 2.1602174911095062e-06
in O 0 3.4931906611745944e-06
the O 0 1.096275809686631e-05
presence O 0 3.1248662708094344e-05
of O 0 0.0002014247002080083
VHL B-Disease 1 0.9875291585922241
, O 0 2.0586066966643557e-05
as O 0 1.0075113095808774e-05
a O 0 5.25787208971451e-06
result O 0 2.7638336632662686e-06
of O 0 7.087653557391604e-06
the O 0 1.1366458238626365e-05
stabilization O 0 8.809298742562532e-05
of O 0 4.87472971144598e-05
the O 0 9.37610020628199e-05
protein O 0 0.00012661998334806412
. O 0 0.00013042098726145923

We O 0 3.890383231919259e-05
propose O 0 1.1312851711409166e-05
that O 0 7.435835982505523e-07
the O 0 6.119783392932732e-06
loss O 0 6.783685239497572e-05
of O 0 7.446151721524075e-05
wild O 0 0.00023160778800956905
- O 0 0.00043932287371717393
type O 0 0.00014349624689202756
VHL B-Disease 0 0.007306018378585577
gene O 0 7.4861932262138e-06
results O 0 2.2235267351788934e-06
in O 0 2.884082277887501e-06
a O 0 4.5369142753770575e-06
specific O 0 4.867995812674053e-06
cellular O 0 0.0005877790972590446
defect O 0 0.002185026416555047
in O 0 0.00014812604058533907
serum O 0 0.0005947891040705144
- O 0 0.00017537965322844684
dependent O 0 1.638298635953106e-05
growth O 0 1.5239344975270797e-05
control O 0 1.0822006515809335e-05
, O 0 2.532490270823473e-06
which O 0 4.672937848226866e-06
may O 0 4.717553747468628e-05
initiate O 0 0.00032061233650892973
tumor B-Disease 1 0.997882068157196
formation O 0 0.006553254090249538
. O 0 0.0005944054573774338

This O 0 3.0354178306879476e-05
is O 0 1.46084203151986e-05
corrected O 0 5.0265229219803587e-05
by O 0 1.4249731066229288e-06
the O 0 4.318173978390405e-06
reintroduction O 0 8.150315989041701e-05
of O 0 5.40358159923926e-05
wild O 0 0.0002023251581704244
- O 0 0.0007171421311795712
type O 0 0.0005496711237356067
VHL B-Disease 1 0.9999865293502808
, O 0 0.00022089239791966975
implicating O 0 0.38422951102256775
VHL B-Disease 1 0.9964572787284851
as O 0 6.41769147478044e-05
the O 0 2.6993564461008646e-05
first O 0 0.00010087951523019001
tumor B-Disease 1 0.6158730387687683
suppressor O 0 0.000417979434132576
involved O 0 2.082330138364341e-05
in O 0 1.0255909728584811e-05
the O 0 1.533082831883803e-05
regulation O 0 1.5490446457988583e-05
of O 0 3.473192919045687e-05
cell O 0 0.0001005023586913012
cycle O 0 4.259487468516454e-05
exit O 0 4.660221384256147e-05
, O 0 3.5869452403858304e-06
which O 0 1.195454501612403e-06
is O 0 1.2917649883092963e-06
consistent O 0 2.716713652262115e-06
with O 0 7.2126283612306e-07
its O 0 6.929394658072852e-06
gatekeeper O 0 0.0003015351830981672
function O 0 1.8376966181676835e-05
in O 0 3.764922439586371e-05
the O 0 0.00018913204257842153
kidney O 1 0.9999890327453613
. O 0 0.0001873322471510619
. O 0 0.0002915470686275512

Piebaldism B-Disease 1 1.0
with O 0 0.0026156576350331306
deafness B-Disease 1 1.0
: O 0 0.00014221254969015718
molecular O 0 4.178694143774919e-05
evidence O 0 2.0401708752615377e-05
for O 0 9.539166967442725e-06
an O 0 3.0198212698451243e-05
expanded O 0 0.08778335154056549
syndrome O 1 1.0
. O 0 0.0012993371346965432

In O 0 0.00017584043962415308
a O 0 8.920350228436291e-05
South O 0 0.0002943180443253368
African O 0 8.032548794290051e-05
girl O 0 5.4297182941809297e-05
of O 0 3.1276391382561997e-05
Xhosa O 0 0.0033485626336187124
stock O 0 0.00022393288963939995
with O 0 2.657287404872477e-05
severe O 1 0.9999829530715942
piebaldism B-Disease 1 0.9999995231628418
and O 0 0.047350578010082245
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.49462178349494934
identified O 0 8.760744822211564e-05
a O 0 1.7038035366567783e-05
novel O 0 1.9948547560488805e-05
missense O 0 5.303237776388414e-05
substitution O 0 2.5355509933433495e-05
at O 0 0.00011724959767889231
a O 0 1.3087357729091309e-05
highly O 0 4.923307278659195e-05
conserved O 0 5.5589454859727994e-05
residue O 0 3.708004442160018e-05
in O 0 5.148609488969669e-06
the O 0 7.351389285759069e-06
intracellular O 0 1.9589895600802265e-05
kinase O 0 2.0797306206077337e-05
domain O 0 1.0598168046271894e-05
of O 0 3.5560355172492564e-05
the O 0 0.00012790558685082942
KIT O 0 0.007300224155187607
proto O 0 0.005234670825302601
- O 0 0.0011110160266980529
oncogene O 0 0.002300278516486287
, O 0 6.114497227827087e-05
R796G O 0 0.0017444819677621126
. O 0 0.00012744514970108867

Though O 0 0.0003685030387714505
auditory B-Disease 0 0.008575656451284885
anomalies I-Disease 0 0.0213018711656332
have O 0 1.57296108227456e-05
been O 0 1.240217261511134e-05
observed O 0 9.141016562352888e-06
in O 0 1.3383079021878075e-05
mice O 0 6.92952744429931e-05
with O 0 8.824017641018145e-06
dominant O 0 0.00029914340120740235
white O 0 0.00013319222489371896
spotting O 0 0.0005901644472032785
( O 0 7.286990148713812e-05
W O 0 0.05167396739125252
) O 0 9.461983609071467e-06
due O 0 2.918485006375704e-05
to O 0 2.3120792320696637e-05
KIT O 0 0.0064651924185454845
mutations O 0 0.00012938423606101424
, O 0 0.00011083479330409318
deafness B-Disease 1 1.0
is O 0 0.00010087374539580196
not O 0 9.519700142845977e-06
typical O 0 4.665423693950288e-05
in O 0 5.719189721276052e-05
human O 0 0.00013465338270179927
piebaldism B-Disease 0 0.009448250755667686
. O 0 0.00036454800283536315

Thus O 0 0.0002790164144244045
, O 0 1.564508602314163e-05
the O 0 2.293579382239841e-05
occurrence O 0 0.0001822176418500021
of O 0 0.004468690138310194
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.1441248655319214
this O 0 7.605002610944211e-05
patient O 0 7.130536687327549e-05
extends O 0 3.790652408497408e-05
considerably O 0 2.501890412531793e-05
the O 0 3.745544745470397e-06
phenotypic O 0 3.282499892520718e-05
range O 0 2.715630762395449e-05
of O 0 6.786234735045582e-05
piebaldism B-Disease 0 0.0017764996737241745
due O 0 0.000159532850375399
to O 0 4.4840249756816775e-05
KIT O 0 0.0011113568907603621
gene O 0 2.6412242732476443e-05
mutation O 0 1.0258727343170904e-05
in O 0 2.095589843520429e-05
humans O 0 2.986747131217271e-05
and O 0 4.837059350393247e-06
tightens O 0 1.5876021279837005e-05
the O 0 3.499052354527521e-06
clinical O 0 1.5991276086424477e-05
similarity O 0 4.885932139586657e-05
between O 0 0.000388039683457464
piebaldism B-Disease 0 0.003796698758378625
and O 0 8.675690878590103e-06
the O 0 7.709625606366899e-06
various O 0 5.931583018536912e-06
forms O 0 4.8950121708912775e-05
of O 1 0.9853233098983765
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0015392752829939127
. O 0 0.0004076863988302648

Cycloheximide O 0 0.011838112026453018
facilitates O 0 0.00012758230150211602
the O 0 2.626430068630725e-05
identification O 0 7.302087851712713e-06
of O 0 4.3964944779872894e-05
aberrant O 0 0.0002982520090881735
transcripts O 0 0.00027386550209484994
resulting O 0 5.604048783425242e-05
from O 0 2.2827171051176265e-05
a O 0 2.1075005861348473e-05
novel O 0 4.7465200623264536e-05
splice O 0 0.0003032623790204525
- O 0 0.00013192569895181805
site O 0 4.5979781134519726e-05
mutation O 0 8.25725874165073e-06
in O 0 2.2259508114075288e-05
COL17A1 O 0 0.02637558802962303
in O 0 1.8380962501396425e-05
a O 0 1.7361187929054722e-05
patient O 0 5.164728645468131e-05
with O 0 2.9775412258459255e-05
generalized O 1 0.9976186156272888
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
. O 0 0.011218814179301262

Patients O 0 0.0010595886269584298
with O 0 0.0001230148773174733
generalized O 1 0.9999831914901733
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999974966049194
often O 0 9.551704715704545e-05
show O 0 9.053384565049782e-05
decreased O 0 0.00012129700917284936
expression O 0 1.5611878552590497e-05
of O 0 0.00011897683725692332
type O 0 0.003931608982384205
XVII O 1 1.0
collagen O 1 0.9444475769996643
, O 0 4.8397447244497016e-05
a O 0 5.327111284714192e-05
transmembrane O 0 0.0006532748229801655
hemidesmosomal O 0 0.001266604638658464
protein O 0 3.8673384551657364e-05
encoded O 0 2.0200039216433652e-05
by O 0 5.3400301112560555e-05
COL17A1 O 1 0.5748835802078247
. O 0 0.00034017692087218165

This O 0 2.6048086510854773e-05
report O 0 9.039933502208441e-06
documents O 0 2.5837278371909633e-05
a O 0 2.3335482183028944e-05
novel O 0 7.474066660506651e-05
splice O 0 0.0006270006997510791
- O 0 0.00021199285401962698
site O 0 9.114123531617224e-05
mutation O 0 9.349920219392516e-06
in O 0 3.013270725205075e-05
COL17A1 O 0 0.016210725530982018
in O 0 2.2967704353504814e-05
a O 0 1.793819865270052e-05
patient O 0 2.9516444556065835e-05
with O 0 2.024734567385167e-05
generalized O 1 0.9992837309837341
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
, O 0 0.00022831892420072109
and O 0 9.760593457031064e-06
applies O 0 5.050133950135205e-06
a O 0 4.967962013324723e-06
new O 0 1.4810566426604055e-06
methodology O 0 3.730970547621837e-06
to O 0 4.9101499826065265e-06
define O 0 2.270160439366009e-05
and O 0 8.619801519671455e-06
characterize O 0 0.00011142450966872275
the O 0 3.898181967088021e-05
resulting O 0 5.015438364353031e-05
mRNA O 0 0.0001005213416647166
splice O 0 0.00020707162912003696
variants O 0 0.00010860872134799138
. O 0 0.00011682840704452246

Mutational O 0 0.0019660897087305784
analysis O 0 1.3643571037391666e-05
of O 0 0.00011574372183531523
COL17A1 O 1 0.8847905397415161
identified O 0 4.8768266424303874e-05
a O 0 2.527377182559576e-05
maternally O 0 0.00041150706238113344
inherited O 0 0.01696542464196682
G O 0 0.005216591060161591
- O 0 0.0006237166817300022
to O 0 6.774919165764004e-05
- O 0 0.000603747321292758
T O 0 0.000811468344181776
transversion O 0 0.0003491085662972182
at O 0 6.149054388515651e-05
the O 0 1.6470807167934254e-05
- O 0 2.8609138098545372e-05
1 O 0 2.3767308448441327e-05
position O 0 1.8733300748863257e-05
of O 0 8.03208167781122e-05
exon O 0 0.0011748787946999073
32 O 0 0.00048423270345665514
. O 0 0.00025788097991608083

This O 0 3.650881626526825e-05
acceptor O 0 3.107427983195521e-05
splice O 0 0.0009241970255970955
- O 0 0.00034049845999106765
site O 0 7.040093623800203e-05
mutation O 0 3.085513526457362e-06
led O 0 1.2291408893361222e-05
to O 0 3.5877183108823374e-06
the O 0 9.226426300301682e-06
formation O 0 6.521410250570625e-05
of O 0 5.7274864957435057e-05
aberrant O 0 0.00017424783436581492
transcripts O 0 0.00019453860295470804
present O 0 6.966140063013881e-05
at O 0 0.0003335219225846231
extremely O 0 0.00011046043800888583
low O 0 0.0002578898274805397
levels O 0 0.00026198342675343156
. O 0 9.798907558433712e-05

Based O 0 2.5538636691635475e-05
on O 0 3.449758514761925e-05
our O 0 5.5637497098359745e-06
recent O 0 5.973625320621068e-06
finding O 0 5.76020738662919e-06
that O 0 2.1519883830478648e-06
cycloheximide O 0 0.001563849626109004
stabilized O 0 0.001399101223796606
mutant O 0 0.00036029351758770645
COL17A1 O 0 0.03558683022856712
transcripts O 0 0.000184331409400329
in O 0 4.194996290607378e-05
keratinocytes O 0 8.924944268073887e-05
homozygous O 0 2.817737367877271e-05
for O 0 7.990300218807533e-06
a O 0 6.386335735442117e-05
frameshift O 0 0.0006455636466853321
mutation O 0 2.114804919983726e-05
, O 0 6.493371529359138e-06
the O 0 1.3586337445303798e-05
effects O 0 5.1819111831719056e-05
of O 0 6.047386705176905e-05
the O 0 0.00011361606448190287
splice O 0 0.0008379382197745144
- O 0 0.0002040696272160858
site O 0 5.595221955445595e-05
mutation O 0 3.0627195428678533e-06
on O 0 1.2577043889905326e-05
splicing O 0 1.7107264284277335e-05
of O 0 6.978693272685632e-05
COL17A1 O 0 0.008361010812222958
transcripts O 0 0.00017132355424109846
were O 0 1.4641922462033108e-05
determined O 0 6.236177341634175e-06
using O 0 1.7851032225735253e-06
reverse O 0 2.0048941223649308e-05
transcriptase O 0 4.679552876041271e-05
polymerase O 0 4.2647709051379934e-05
chain O 0 1.4232620742404833e-05
reaction O 0 1.1515666074046749e-06
of O 0 5.693348612112459e-06
total O 0 2.6212805096292868e-05
RNA O 0 0.0001475262688472867
from O 0 3.0375549613381736e-05
keratinocytes O 0 0.0001245157909579575
incubated O 0 7.735945109743625e-05
for O 0 9.846316061157268e-06
2 O 0 0.00024253001902252436
. O 0 0.00012118613085476682

5 O 0 0.0006782424752600491
h O 0 0.00019334549142513424
in O 0 2.0102086637052707e-05
the O 0 1.4180662219587248e-05
presence O 0 1.3873550415155478e-05
or O 0 7.742546586086974e-06
absence O 0 3.602318975026719e-05
of O 0 8.089886250672862e-05
10 O 0 0.0003280055825598538
microg O 0 0.005675957538187504
cycloheximide O 0 0.0045511722564697266
per O 0 0.00012922294263262302
ml O 0 0.0014777015894651413
. O 0 0.00021863006986677647

Using O 0 3.789423863054253e-05
this O 0 1.0051197932625655e-05
approach O 0 1.62376763910288e-05
, O 0 5.05096249980852e-06
an O 0 7.720396752119996e-06
abnormally O 0 0.0004086867847945541
spliced O 0 0.00025583073147572577
transcript O 0 0.00015277489728759974
was O 0 8.451990288449451e-05
identified O 0 4.771669409819879e-06
that O 0 3.891816504619783e-07
contains O 0 1.4295096661953721e-06
an O 0 9.105787626140227e-07
extra O 0 4.874188562098425e-06
264 O 0 1.997355866478756e-05
bases O 0 1.3807000868837349e-05
upstream O 0 7.118525536498055e-05
from O 0 1.8345448552281596e-05
exon O 0 0.00010846940858755261
32 O 0 2.375058647885453e-05
, O 0 3.7214610983937746e-06
resulting O 0 1.0616639883664902e-05
in O 0 2.5590439690859057e-05
a O 0 4.9568541726330295e-05
premature O 0 0.00021845169248990715
termination O 0 0.0002671010443009436
codon O 0 0.00014023225230630487
27 O 0 0.0004179039679002017
bp O 0 0.0003359722322784364
downstream O 0 0.0002178217109758407
from O 0 2.274548569403123e-05
the O 0 5.095301094115712e-05
cryptic O 0 0.0006851317593827844
splice O 0 0.0015439799753949046
site O 0 0.0012752320617437363
. O 0 0.00028800201835110784

Three O 0 5.9051897551398724e-05
other O 0 5.828512257721741e-06
splice O 0 9.772845078259706e-05
variants O 0 1.6877882444532588e-05
, O 0 4.378464382170932e-06
including O 0 1.7150072153526708e-06
one O 0 2.9184545837779297e-06
derived O 0 3.6035810353496345e-06
from O 0 7.711095349804964e-06
the O 0 1.3971736734674778e-05
skipping O 0 5.0739272410282865e-05
of O 0 6.0913338529644534e-05
exon O 0 0.00046734651550650597
32 O 0 9.160792251350358e-05
, O 0 1.3046809726802167e-05
were O 0 2.626605419209227e-05
also O 0 2.138294803444296e-05
identified O 0 0.00010781797755043954
. O 0 0.00012015664106002077

These O 0 2.185906305385288e-05
results O 0 1.6692982171662152e-05
indicate O 0 2.612388925626874e-05
the O 0 1.607978811080102e-05
usefulness O 0 0.0001296094706049189
of O 0 9.596651216270402e-05
cycloheximide O 0 0.011336466297507286
treatment O 0 0.0001006821112241596
in O 0 1.611653897271026e-05
evaluating O 0 1.4526497579936404e-05
the O 0 1.691586476226803e-05
abnormal O 0 2.676001713552978e-05
processing O 0 1.8667922631721012e-05
of O 0 2.8997144909226336e-05
mRNA O 0 3.888283754349686e-05
due O 0 4.377192453830503e-05
to O 0 1.3791825949738268e-05
splice O 0 0.00028231009491719306
- O 0 0.00011192853708053008
site O 0 4.915885074296966e-05
mutations O 0 7.345194262597943e-06
, O 0 5.3804183153260965e-06
because O 0 7.303104666789295e-06
( O 0 2.161759402952157e-05
i O 0 9.791417687665671e-05
) O 0 1.3956568182038609e-05
aberrant O 0 4.913907469017431e-05
splicing O 0 4.213351712678559e-05
often O 0 6.435366231016815e-06
generates O 0 1.2112175681977533e-05
a O 0 2.508101715648081e-05
premature O 0 0.00013419627794064581
termination O 0 0.00011813460878329352
codon O 0 5.535251693800092e-05
, O 0 1.3210760698711965e-05
( O 0 1.6835558199090883e-05
ii O 0 0.013735574670135975
) O 0 1.806657928682398e-05
transcripts O 0 6.913633842486888e-05
with O 0 1.1577426448639017e-05
premature O 0 0.00012178818724351004
termination O 0 0.00011883374099852517
codons O 0 5.901626354898326e-05
can O 0 5.696281277778326e-06
occur O 0 1.338131733064074e-05
at O 0 0.00013953543384559453
low O 0 0.00012862794392276555
or O 0 3.338071473990567e-05
undetectable O 0 0.0008154580718837678
levels O 0 6.598755135200918e-05
due O 0 6.280391971813515e-05
to O 0 2.1094045223435387e-05
nonsense O 0 0.0002643182233441621
- O 0 0.00011275984434178099
mediated O 0 0.00011832355812657624
mRNA O 0 9.995260916184634e-05
decay O 0 0.00022730328782927245
, O 0 8.230347702919971e-06
and O 0 6.115127689554356e-06
( O 0 2.5877348889480345e-05
iii O 0 0.0024095261469483376
) O 0 1.1789443306042813e-05
the O 0 1.0527153790462762e-05
levels O 0 1.3845568901160732e-05
of O 0 5.541916380025214e-06
these O 0 1.5197847460513003e-06
transcripts O 0 4.415751755004749e-05
can O 0 1.5444660448338254e-06
be O 0 3.4292086183995707e-06
increased O 0 1.7605947505217046e-05
by O 0 2.8083935831091367e-05
cycloheximide O 0 0.0057063293643295765
. O 0 0.00040585090755485

A O 0 0.0014847421552985907
deletion O 0 0.0005882257246412337
mutation O 0 8.763561345404014e-05
in O 0 0.0001064226744347252
COL17A1 O 0 0.027322763577103615
in O 0 2.2740192434866913e-05
five O 0 1.2642535693885293e-05
Austrian O 0 8.633729885332286e-05
families O 0 5.9736139519372955e-06
with O 0 1.633029205549974e-05
generalized O 1 0.9987531900405884
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999841451644897
represents O 0 0.0006681945524178445
propagation O 0 0.00017417276103515178
of O 0 8.508020982844755e-05
an O 0 4.9219928769161925e-05
ancestral O 0 0.0015707651618868113
allele O 0 0.00018446118338033557
. O 0 0.0002492047206033021

Patients O 0 0.000775497464928776
with O 0 0.00016231132030952722
generalized O 1 0.9999864101409912
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
, O 0 0.0001452592114219442
a O 0 2.2518755940836854e-05
usually O 0 4.906039976049215e-06
nonlethal O 0 6.359280814649537e-05
form O 0 3.2628468034090474e-05
of O 0 0.0012479727156460285
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999514818191528
, O 0 4.7821722546359524e-05
have O 0 8.127034561766777e-06
generalized O 0 0.0001793127739802003
blistering B-Disease 0 0.06291487067937851
, O 0 0.06646882742643356
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.003711251076310873
patchy B-Disease 1 0.9999986886978149
alopecia I-Disease 1 1.0
, O 0 0.011598247103393078
and O 0 0.06169135123491287
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9724645018577576

Skin B-Disease 1 0.9997034668922424
fragility I-Disease 1 0.9876992702484131
in O 0 0.00026815617457032204
most O 0 2.54528786172159e-05
cases O 0 7.307855867111357e-06
is O 0 4.990251454728423e-06
due O 0 1.8064010873786174e-05
to O 0 3.9554220165882725e-06
mutations O 0 2.7955379664490465e-06
in O 0 2.4961875624285312e-06
the O 0 3.4596127989061642e-06
gene O 0 3.0248045277403435e-06
encoding O 0 7.261711743922206e-06
type O 0 0.00030377513030543923
XVII O 1 0.9999998807907104
collagen O 1 0.9997093081474304
( O 0 0.000832600868307054
COL17A1 O 1 0.9999294281005859
) O 0 0.00023543914721813053
. O 0 0.00017012024181894958

Recently O 0 0.0007962726522237062
, O 0 1.5562496628263034e-05
we O 0 4.621188509190688e-06
reported O 0 7.5066973295179196e-06
five O 0 4.262964466761332e-06
Austrian O 0 9.72597990767099e-05
families O 0 1.019056981022004e-05
with O 0 3.819485573330894e-05
generalized O 1 0.996189534664154
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999947547912598
who O 0 0.00040092147537507117
share O 0 6.257824134081602e-05
the O 0 7.10624226485379e-05
same O 0 9.238156781066209e-05
COL17A1 O 1 0.999203622341156
mutation O 0 0.00031030946411192417
. O 0 0.00030083884485065937

Affected O 0 0.0001746663765516132
individuals O 0 6.9956672632542904e-06
in O 0 1.1841196283057798e-05
three O 0 4.308889401727356e-06
families O 0 1.1345861139488989e-06
are O 0 6.647620693911449e-07
homozygous O 0 4.653259566111956e-06
for O 0 7.17050943421782e-06
4003delTC O 0 0.0005782071966677904
, O 0 9.902932106342632e-06
whereas O 0 9.050087101059034e-06
those O 0 2.6852346763917012e-06
in O 0 7.148993972805329e-06
two O 0 4.6875425141479354e-06
others O 0 8.458628144580871e-06
are O 0 4.033885488752276e-06
compound O 0 0.00034436234273016453
heterozygotes O 0 0.002103926381096244
. O 0 0.0003717747167684138

To O 0 0.00012036694533890113
determine O 0 3.9239992474904284e-05
if O 0 8.012437319848686e-06
the O 0 7.974694199219812e-06
occurrence O 0 2.3880837034084834e-05
of O 0 5.0661717978073284e-05
4003delTC O 0 0.000606079469434917
in O 0 2.1637019017362036e-05
these O 0 3.133403879473917e-06
unrelated O 0 5.0828573876060545e-05
families O 0 1.1652048669930082e-05
signifies O 0 0.0001788394438335672
propagation O 0 4.001634079031646e-05
of O 0 4.072874435223639e-05
an O 0 1.881505158962682e-05
ancestral O 0 0.0005552782095037401
allele O 0 2.616410711198114e-05
or O 0 2.152518391085323e-05
a O 0 6.292507896432653e-05
mutational O 0 0.0012904572067782283
hot O 0 0.0002756402245722711
spot O 0 7.130564335966483e-05
, O 0 4.36050868302118e-06
haplotypes O 0 1.779093327058945e-05
were O 0 9.555484211887233e-06
determined O 0 1.0379337254562415e-05
for O 0 5.569488166656811e-06
polymorphisms O 0 5.563017839449458e-05
both O 0 1.1741320122382604e-05
within O 0 4.573724072542973e-05
and O 0 6.66517298668623e-05
flanking O 1 0.822618305683136
COL17A1 O 1 0.9999978542327881
. O 0 0.0008647963986732066

Five O 0 0.00048108986811712384
intragenic O 0 0.0033183437772095203
polymorphisms O 0 0.00019658241944853216
were O 0 1.890952444227878e-05
chosen O 0 8.387154593947344e-06
based O 0 4.70768463856075e-06
on O 0 3.8728372601326555e-05
their O 0 2.3124981453293003e-05
informativeness O 0 0.0049171107821166515
. O 0 0.000315362645778805

One O 0 5.107988545205444e-05
of O 0 2.852805846487172e-05
these O 0 4.669311692850897e-06
, O 0 4.860072749579558e-06
not O 0 1.5442716403413215e-06
previously O 0 1.5488672943320125e-05
reported O 0 1.3245781701698434e-05
, O 0 3.6519745663099457e-06
was O 0 0.0001428139948984608
2988 O 0 0.0010001107584685087
A O 0 0.00021460987045429647
or O 0 2.6001825972343795e-05
C O 0 0.00019343178428243846
that O 0 2.567533101682784e-06
introduces O 0 9.69547727436293e-06
a O 0 3.5927307635574834e-06
new O 0 2.911687943196739e-06
restriction O 0 7.832504707039334e-06
site O 0 5.6495991884730756e-05
for O 0 2.4662855139467865e-05
Eco0109 O 0 0.004237297456711531
I O 0 0.0046812668442726135
. O 0 0.00024048850173130631

All O 0 4.696868563769385e-05
the O 0 6.75386399962008e-05
4003delTC O 0 0.0007370937382802367
alleles O 0 1.9880253603332676e-05
showed O 0 3.066067802137695e-05
the O 0 1.024978882924188e-05
same O 0 5.094336756883422e-06
haplotype O 0 3.362230563652702e-05
for O 0 8.750716915528756e-06
these O 0 6.415806637960486e-06
five O 0 4.473927401704714e-05
polymorphic O 0 0.00031208604923449457
markers O 0 0.0029927650466561317
. O 0 0.0007516780169680715

Fourteen O 0 0.0021607091184705496
microsatellite O 0 0.0030811645556241274
polymorphisms O 0 0.00015396764501929283
were O 0 2.1457652110257186e-05
selected O 0 1.0184176971961278e-05
based O 0 2.540914010751294e-06
on O 0 1.4227952306100633e-05
their O 0 6.350780040520476e-06
high O 0 0.0001970016019186005
heterozygosity O 0 0.0008087981841526926
and O 0 1.1179924513271544e-05
their O 0 4.865735263592796e-06
location O 0 6.469761865446344e-05
within O 0 4.72903047921136e-05
10q23 O 0 0.0014917032094672322
- O 0 0.0006518388399854302
q25 O 0 0.0017675193957984447
near O 0 0.003092358820140362
COL17A1 O 1 0.9938674569129944
. O 0 0.0003417674743104726

Three O 0 7.144545088522136e-05
families O 0 1.7683183614281006e-05
shared O 0 9.549802052788436e-05
microsatellite O 0 0.0012968705268576741
polymorphisms O 0 0.0004568052536342293
covering O 0 0.0005690725520253181
at O 0 0.00038612858043052256
most O 0 2.6131488993996754e-05
19 O 0 0.00021954857220407575
cM O 0 0.00028465740615502
, O 0 7.533246844104724e-06
whereas O 0 9.003616469271947e-06
the O 0 1.1925034414161928e-05
others O 0 7.5738307714345865e-06
shared O 0 1.9796481865341775e-05
smaller O 0 1.605857687536627e-05
regions O 0 1.980758497666102e-05
consistent O 0 3.4281332773389295e-05
with O 0 1.1212823665118776e-05
cross O 0 0.00017814230523072183
- O 0 0.00014995403762441128
over O 0 1.900117604236584e-05
events O 0 1.5560952306259423e-05
during O 0 4.02363293687813e-05
passage O 0 1.0193251000600867e-05
of O 0 6.021326043992303e-06
this O 0 1.9507458546286216e-06
mutation O 0 4.080369308212539e-06
through O 0 7.455229933839291e-06
several O 0 2.479458817106206e-05
generations O 0 0.000291488686343655
. O 0 0.0001466529065510258

These O 0 1.254541984962998e-05
results O 0 1.1214299775019754e-05
indicate O 0 2.9966013244120404e-05
that O 0 6.237110937945545e-06
4003delTC O 0 0.00033012061612680554
occurs O 0 1.1316758900647983e-05
on O 0 2.1036552425357513e-05
a O 0 1.4864966033201199e-05
single O 0 1.5786325093358755e-05
ancestral O 0 0.00036783964606001973
allele O 0 5.623824108624831e-05
. O 0 4.737842391477898e-05
. O 0 0.00013815985585097224

The O 0 0.0004623639688361436
haptoglobin O 0 0.0068350681103765965
- O 0 0.0005543266888707876
gene O 0 2.8675072826445103e-05
deletion O 0 9.904584294417873e-05
responsible O 0 0.00012405654706526548
for O 0 0.00013293008669279516
anhaptoglobinemia B-Disease 0 0.2572028636932373
. O 0 0.000668524531647563

We O 0 7.979542715474963e-05
have O 0 3.578519226721255e-06
found O 0 2.6164432256337022e-06
an O 0 1.7540855878905859e-06
allelic O 0 6.370400660671294e-05
deletion O 0 6.071280222386122e-05
of O 0 0.00011172935046488419
the O 0 0.00019420853641349822
haptoglobin O 0 0.0024251125287264585
( O 0 4.178857125225477e-05
Hp O 0 6.806493183830753e-05
) O 0 5.496267476701178e-06
gene O 0 4.083495696249884e-06
from O 0 4.80385506307357e-06
an O 0 4.875801550952019e-06
individual O 0 5.442329438665183e-06
with O 0 2.6400735805509612e-05
anhaptoglobinemia B-Disease 1 0.6820188164710999
. O 0 0.0004170695901848376

The O 0 0.0005293788271956146
Hp O 0 0.00048637291183695197
gene O 0 2.651207432791125e-05
cluster O 0 4.9532580305822194e-05
consists O 0 1.4545807061949745e-05
of O 0 2.8838025173172355e-05
coding O 0 6.419257988454774e-05
regions O 0 3.883777390001342e-05
of O 0 4.923945743939839e-05
the O 0 8.674794662510976e-05
alpha O 0 0.000169219434610568
chain O 0 3.288258449174464e-05
and O 0 2.7774094633059576e-06
beta O 0 2.930287337221671e-05
chain O 0 9.558601050230209e-06
of O 0 7.492750228266232e-06
the O 0 3.928536898456514e-05
haptoglobin O 0 0.0005936549860052764
gene O 0 2.240088906546589e-05
( O 0 1.1276412806182634e-05
Hp O 0 5.6910568673629314e-05
) O 0 1.9579567833716283e-06
and O 0 1.048710373652284e-06
of O 0 1.296920163440518e-05
the O 0 3.9921967982081696e-05
alpha O 0 0.00013968042912892997
chain O 0 2.9290355087141506e-05
and O 0 3.3668484320514835e-06
beta O 0 3.441251828917302e-05
chain O 0 1.0563286195974797e-05
of O 0 9.986674740503076e-06
the O 0 3.100868343608454e-05
haptoglobin O 0 0.0017738684546202421
- O 0 0.0001370644458802417
related O 0 2.8333144655334763e-05
gene O 0 2.2276115487329662e-05
( O 0 2.6375697416369803e-05
Hpr O 0 0.0005753575824201107
) O 0 1.2673015589825809e-05
, O 0 6.5191024987143464e-06
in O 0 1.899316703202203e-05
tandem O 0 0.00015442607400473207
from O 0 2.481342016835697e-05
the O 0 7.351187377935275e-05
5 O 0 0.00022835857816971838
side O 0 0.00027631063130684197
. O 0 0.00014489125169347972

Southern O 0 0.00135222845710814
blot O 0 0.000638903642538935
and O 0 1.162737316917628e-05
PCR O 0 2.3741369659546763e-05
analyses O 0 5.8159525906376075e-06
have O 0 8.998114822134085e-07
indicated O 0 2.2252386315813055e-06
that O 0 2.5523624458401173e-07
the O 0 2.2913955035619438e-06
individual O 0 1.0881427670028643e-06
with O 0 4.143076239415677e-06
anhaptoglobinemia B-Disease 0 0.0011389409191906452
was O 0 9.804366709431633e-05
homozygous O 0 6.068315087759402e-06
for O 0 1.5616408290952677e-06
the O 0 9.828529073274694e-06
gene O 0 7.145913514250424e-06
deletion O 0 1.380979210807709e-05
and O 0 2.221409431513166e-06
that O 0 6.976320037210826e-07
the O 0 4.393614744913066e-06
gene O 0 3.949576239392627e-06
deletion O 0 1.8732585886027664e-05
was O 0 7.519590872107074e-05
included O 0 7.357069989666343e-06
at O 0 3.805938467849046e-05
least O 0 2.1233095139905345e-06
from O 0 3.946240212826524e-06
the O 0 1.4872750398353674e-05
promoter O 0 0.0007316734408959746
region O 0 0.0001393713610013947
of O 0 0.00010795068374136463
Hp O 0 0.00031762654543854296
to O 0 3.862893208861351e-05
Hpr O 0 0.0010914691956713796
alpha O 0 0.00010737699631135911
but O 0 1.453373442927841e-06
not O 0 7.164625799305213e-07
to O 0 5.129974852025043e-06
Hpr O 0 0.0009166921954602003
beta O 0 0.000399381504394114
( O 0 0.0001387658849125728
Hpdel O 0 0.00798769947141409
) O 0 0.00016621887334622443
. O 0 0.00015031464863568544

In O 0 0.00017436948837712407
addition O 0 2.4769726223894395e-05
, O 0 1.1303179235255811e-05
we O 0 5.487369435286382e-06
found O 0 2.960844767585513e-06
seven O 0 3.4024119486275595e-06
individuals O 0 1.0329559927413356e-06
with O 0 6.885285529278917e-06
hypohaptoglobinemia B-Disease 0 0.0009888026397675276
in O 0 2.3283178961719386e-05
three O 0 5.5549858188896906e-06
families O 0 2.2040762814867776e-06
, O 0 1.8391323237665347e-06
and O 0 2.0812960883631604e-06
the O 0 1.1402003110561054e-05
genotypes O 0 4.229457408655435e-05
of O 0 2.90844382107025e-05
six O 0 1.450735089747468e-05
of O 0 1.2559293281810824e-05
the O 0 1.1008016372215934e-05
seven O 0 6.079813829273917e-06
individuals O 0 6.835359727119794e-07
were O 0 5.049238097853959e-06
found O 0 2.124863158314838e-06
to O 0 6.470450443885056e-06
be O 0 2.991884139191825e-05
Hp2 O 0 0.12579286098480225
/ O 0 0.004541879519820213
Hpdel O 1 0.5014431476593018
. O 0 0.0006143735372461379

The O 0 0.0006475374102592468
phenotypes O 0 0.0007369195809587836
and O 0 5.0698741688393056e-05
genotypes O 0 0.00020269356900826097
in O 0 1.7766620658221655e-05
one O 0 4.647374225896783e-06
of O 0 1.1446803910075687e-05
these O 0 2.3183217763289576e-06
three O 0 2.8470094548538327e-06
families O 0 2.0670916001108708e-06
showed O 0 1.9036686353501864e-05
the O 0 1.2591805898409802e-05
father O 0 4.13166344515048e-05
to O 0 9.074691661226097e-06
be O 0 1.8949818695546128e-05
hypohaptoglobinemic B-Disease 0 0.0009831790812313557
( O 0 7.615539652761072e-05
Hp2 O 0 0.002673715353012085
) O 0 3.2833890145411715e-05
and O 0 3.9984377508517355e-05
Hp2 O 0 0.03784819319844246
/ O 0 0.000937177159357816
Hpdel O 0 0.003536482574418187
, O 0 1.232706108567072e-05
the O 0 8.302575224661268e-06
mother O 0 1.5206796888378449e-05
to O 0 4.371016984805465e-06
be O 0 1.1869641639350448e-05
Hp2 O 0 0.0015817363746464252
- O 0 0.00017553154611960053
1 O 0 9.959582530427724e-05
and O 0 2.4793405827949755e-05
Hp1 O 0 0.006061637308448553
/ O 0 0.0005091892671771348
Hp2 O 0 0.0014047968434169888
, O 0 5.442318979476113e-06
one O 0 7.883853072598868e-07
of O 0 4.575525053951424e-06
the O 0 9.467028576182202e-06
two O 0 3.1701756597612984e-06
children O 0 3.4762420000333805e-06
to O 0 4.628020633390406e-06
be O 0 1.1342809557390865e-05
hypohaptoglobinemic B-Disease 0 0.0006423823651857674
( O 0 3.175315578118898e-05
Hp2 O 0 0.0018035140819847584
) O 0 1.704167516436428e-05
and O 0 1.9655260985018685e-05
Hp2 O 0 0.4733273983001709
/ O 0 0.0011849518632516265
Hpdel O 0 0.005247093737125397
, O 0 9.688184945844114e-06
and O 0 1.6650456018396653e-06
the O 0 6.208861577761127e-06
other O 0 2.253776528959861e-06
child O 0 1.8969345546793193e-05
to O 0 8.684060048835818e-06
be O 0 1.80483784788521e-05
Hp1 O 0 0.0015945944469422102
and O 0 4.750233347294852e-05
Hp1 O 1 0.861882209777832
/ O 0 0.0025282790884375572
Hpdel O 0 0.019687822088599205
, O 0 2.2287060346570797e-05
showing O 0 7.246707536978647e-05
an O 0 2.005716487474274e-05
anomalous O 0 0.0005938453832641244
inheritance O 0 0.0005249074893072248
of O 0 0.0005680854083038867
Hp O 0 0.0011069054016843438
phenotypes O 0 0.00013407322694547474
in O 0 2.7867145035997964e-05
the O 0 6.746113649569452e-05
child O 0 0.00012395900557748973
with O 0 4.953418465447612e-05
Hp1 O 1 0.9309371113777161
. O 0 0.0007433400605805218

The O 0 0.0008116845856420696
Hp2 O 1 0.9816991090774536
/ O 0 0.002401866717264056
Hpdel O 0 0.003334111999720335
individuals O 0 9.356949703942519e-06
had O 0 5.371793304220773e-05
an O 0 6.546627446368802e-06
extremely O 0 2.6386263925815e-05
low O 0 4.030707714264281e-05
level O 0 6.192098226165399e-05
of O 0 4.033222285215743e-05
Hp O 0 7.489848940167576e-05
( O 0 8.27860367280664e-06
mean O 0 2.1104913685121574e-05
+ O 0 6.727676372975111e-05
/ O 0 0.00010750834189821035
- O 0 0.00014567645848728716
SD O 0 0.0011485239956527948
= O 0 5.942773350398056e-05
0 O 0 1.1914597962459084e-05
. O 0 5.029505700804293e-06
049 O 0 0.00015259029169101268
+ O 0 5.275867079035379e-05
/ O 0 6.958385347388685e-05
- O 0 5.9558111388469115e-05
0 O 0 1.2473113201849628e-05
. O 0 4.307015842641704e-06
043 O 0 0.00032035232288762927
mg O 0 0.00038871532888151705
/ O 0 0.00016156611673068255
ml O 0 8.997460099635646e-05
; O 0 4.193384938844247e-06
n O 0 2.7365480491425842e-05
= O 0 5.686245276592672e-05
6 O 0 5.01290887768846e-05
) O 0 2.2600265765504446e-06
, O 0 9.377408218824712e-07
compared O 0 1.5387792018373148e-06
with O 0 6.9585126993843e-07
the O 0 7.754103535262402e-06
level O 0 4.2716746975202113e-05
( O 0 4.693089067586698e-06
1 O 0 2.0186385881970637e-05
. O 0 1.3824148936691927e-06
64 O 0 1.1162079317728058e-05
+ O 0 4.260584319126792e-05
/ O 0 6.379847036441788e-05
- O 0 6.201027281349525e-05
1 O 0 4.4945736590307206e-05
. O 0 7.292880127351964e-06
07 O 0 0.00030551079544238746
mg O 0 0.0004072944284416735
/ O 0 0.00019737519323825836
ml O 0 0.00010928200208581984
) O 0 3.515133130349568e-06
obtained O 0 6.3094516917772125e-06
from O 0 1.562325815029908e-05
52 O 0 0.00012218764459248632
healthy O 0 0.00011097671813331544
volunteers O 0 7.081314834067598e-05
having O 0 8.460449316771701e-05
phenotype O 0 0.00017159886192530394
Hp2 O 0 0.004011804237961769
, O 0 3.480795567156747e-05
whereas O 0 2.1054333046777174e-05
the O 0 3.805226879194379e-05
serum O 0 0.00023883960966486484
Hp O 0 0.00010078162449644879
level O 0 3.63601757271681e-05
of O 0 1.6994057659758255e-05
an O 0 5.218388196226442e-06
individual O 0 3.4724578199529788e-06
with O 0 1.709133357508108e-05
Hp1 O 1 0.7832474112510681
/ O 0 0.0019066663226112723
Hpdel O 0 0.027031566947698593
was O 0 0.0010314283426851034
0 O 0 0.00020733752171508968
. O 0 0.00011306260421406478

50 O 0 0.0009683892130851746
mg O 0 0.00373326288536191
/ O 0 0.0014920171815901995
ml O 0 0.00043615326285362244
, O 0 1.2013497325824574e-05
which O 0 2.8835020202677697e-06
was O 0 3.63092367479112e-05
approximately O 0 1.5489293218706734e-05
half O 0 4.844898739975179e-06
the O 0 5.898346898902673e-06
level O 0 3.5325985663803294e-05
of O 0 3.739780731848441e-05
Hp O 0 0.00014698006270918995
in O 0 2.675922769412864e-05
control O 0 8.335149323102087e-05
sera O 0 0.000551066012121737
from O 0 2.15675936487969e-05
the O 0 2.8116708563175052e-05
Hp1 O 0 0.0012439987622201443
phenotype O 0 2.9312572223716415e-05
( O 0 1.2658460946113337e-05
1 O 0 4.9864906031871215e-05
. O 0 4.712961981567787e-06
26 O 0 5.2229846914997324e-05
+ O 0 5.1093527872581035e-05
/ O 0 4.685970634454861e-05
- O 0 3.421467772568576e-05
0 O 0 6.8790964178333525e-06
. O 0 3.5608711641543778e-06
33 O 0 3.2587082387181e-05
mg O 0 0.000221357709961012
/ O 0 0.00016927205433603376
ml O 0 0.00010248947364743799
; O 0 6.293508704402484e-06
n O 0 3.8205384043976665e-05
= O 0 9.385753219248727e-05
9 O 0 9.195047459797934e-05
) O 0 5.539845005841926e-06
, O 0 1.6754628404669347e-06
showing O 0 1.0344413567509037e-05
a O 0 2.4614597350591794e-05
gene O 0 5.282654092297889e-05
- O 0 0.00026089788298122585
dosage O 0 0.00020364043302834034
effect O 0 0.00026576389791443944
. O 0 0.00021949957590550184

The O 0 0.00010413146810606122
other O 0 9.885767212836072e-06
allele O 0 2.234151543234475e-05
( O 0 5.021306060370989e-05
Hp2 O 0 0.0016048874240368605
) O 0 6.076208137528738e-06
of O 0 1.3559696526499465e-05
individuals O 0 5.980762580293231e-06
with O 0 2.6125857402803376e-05
Hp2 O 1 0.9995936751365662
/ O 0 0.002065516309812665
Hpdel O 0 0.006607753690332174
was O 0 0.00013706156460102648
found O 0 1.6606971939836512e-06
to O 0 2.659154688444687e-06
have O 0 1.6219687495322432e-06
, O 0 8.494695293848054e-07
in O 0 1.7609072529012337e-06
all O 0 1.902865392366948e-06
exons O 0 3.9920294511830434e-05
, O 0 4.1219955164706334e-06
no O 0 2.5452552563365316e-06
mutation O 0 2.208739033449092e-06
, O 0 2.4125267827912467e-06
by O 0 2.51654500971199e-06
DNA O 0 4.1368286474607885e-05
sequencing O 0 0.00012718315701931715
. O 0 0.00010402953921584412

On O 0 0.00021317331993486732
the O 0 1.4313050087366719e-05
basis O 0 4.895000984106446e-06
of O 0 8.672291187394876e-06
the O 0 8.653983059048187e-06
present O 0 1.381906713504577e-05
study O 0 4.911124051432125e-06
, O 0 3.2924708648351952e-06
the O 0 9.25921540329e-06
mechanism O 0 2.427480649203062e-05
of O 0 3.264537008362822e-05
anhaptoglobinemia B-Disease 0 0.001766793429851532
and O 0 9.518093065707944e-06
the O 0 1.995265847654082e-05
mechanism O 0 4.381351755000651e-05
of O 0 4.303353853174485e-05
anomalous O 0 0.000503583753015846
inheritance O 0 0.00038297439459711313
of O 0 0.00029441574588418007
Hp O 0 0.000772874744143337
phenotypes O 0 0.00018349387391936034
were O 0 7.549459405709058e-05
well O 0 5.441712710307911e-05
explained O 0 0.00017187725461553782
. O 0 0.00011047814041376114

However O 0 0.00014113883662503213
, O 0 1.3389537343755364e-05
the O 0 1.5152858395595104e-05
mechanism O 0 7.479243504349142e-05
of O 0 0.0001478565245633945
hypohaptoglobinemia B-Disease 1 0.8340086340904236
remains O 0 0.005995503161102533
unknown O 0 0.0026743689086288214

ATM O 0 0.012519840151071548
mutations O 0 0.00025225477293133736
and O 0 0.00010117517376784235
phenotypes O 0 0.0008842051611281931
in O 0 0.0015705660916864872
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999947547912598
telangiectasia I-Disease 1 0.9999381303787231
families O 0 2.550115459598601e-05
in O 0 1.7887188732856885e-05
the O 0 8.624356269137934e-06
British O 0 7.065598765620962e-06
Isles O 0 2.8306545573286712e-05
: O 0 1.9133397017867537e-06
expression O 0 3.016798473254312e-06
of O 0 3.153614670736715e-05
mutant O 0 0.0001467102556489408
ATM O 0 0.0003701137029565871
and O 0 2.9522534532588907e-06
the O 0 6.929249138920568e-06
risk O 0 1.979013904929161e-05
of O 0 0.00015232687292154878
leukemia B-Disease 1 1.0
, O 1 0.9998862743377686
lymphoma B-Disease 1 1.0
, O 1 0.9880556464195251
and O 1 0.9282904267311096
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0032479881774634123

We O 0 6.977309385547414e-05
report O 0 8.901565706764814e-06
the O 0 7.647084203199483e-06
spectrum O 0 4.578843800118193e-05
of O 0 5.8141366025665775e-05
59 O 0 0.0004153166082687676
ATM O 0 0.0016031640116125345
mutations O 0 4.229195474181324e-05
observed O 0 4.8851401516003534e-05
in O 0 0.00015886250184848905
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9983554482460022
telangiectasia I-Disease 1 0.9999033212661743
( O 0 0.0004387248191051185
A B-Disease 1 0.9999895095825195
- I-Disease 1 0.9992977380752563
T I-Disease 1 0.9999920129776001
) O 0 2.4947476049419492e-05
patients O 0 8.834602340357378e-06
in O 0 1.4569354789273348e-05
the O 0 4.44024772150442e-05
British O 0 0.0001354443229502067
Isles O 0 0.0012596907326951623
. O 0 0.00034535970189608634

Of O 0 0.0007153996848501265
51 O 0 0.0015068879583850503
ATM O 0 0.0049213506281375885
mutations O 0 6.688590656267479e-05
identified O 0 1.5220797649817541e-05
in O 0 9.391993444296531e-06
families O 0 2.2450903998105787e-06
native O 0 7.815231583663262e-06
to O 0 4.733253717859043e-06
the O 0 1.8921267837868072e-05
British O 0 2.953201692434959e-05
Isles O 0 6.359365943353623e-05
, O 0 7.383963293250417e-06
11 O 0 3.6295532481744885e-05
were O 0 2.902223786804825e-05
founder O 0 0.0002691851113922894
mutations O 0 2.0071094695595093e-05
, O 0 7.341539003391517e-06
and O 0 3.876162281812867e-06
2 O 0 2.851293538697064e-05
of O 0 1.581809192430228e-05
these O 0 3.9383676266879775e-06
11 O 0 5.848480577697046e-05
conferred O 0 0.00012648267147596925
a O 0 1.4488849956251215e-05
milder O 0 1.7469574231654406e-05
clinical O 0 2.5986431865021586e-05
phenotype O 0 9.820012564887293e-06
with O 0 2.285352593389689e-06
respect O 0 1.3396728718362283e-05
to O 0 3.3082880690926686e-05
both O 0 0.00021209534315858036
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9939427971839905
cellular O 1 0.9974672794342041
features O 0 0.0005358765483833849
. O 0 0.0003460192820057273

We O 0 7.125928095774725e-05
report O 0 6.7562932599685155e-06
, O 0 2.6348802748543676e-06
in O 0 6.125429536041338e-06
two O 0 1.1442874892964028e-05
A B-Disease 0 0.32207465171813965
- I-Disease 0 0.004832128528505564
T I-Disease 1 0.7854296565055847
families O 0 6.123642378952354e-06
, O 0 3.8676776057400275e-06
an O 0 3.475817493381328e-06
ATM O 0 0.0007353106630034745
mutation O 0 1.8912031009676866e-05
( O 0 3.269674925832078e-05
7271T O 0 0.0008283226052299142
- O 0 0.00021970101806800812
- O 0 0.00010248702892567962
> O 0 7.318669668165967e-05
G O 0 0.0002371678565395996
) O 0 4.597578481480014e-06
that O 0 8.693587005836889e-07
may O 0 3.916837613360258e-06
be O 0 1.0159799330722308e-06
associated O 0 7.30562874196039e-07
with O 0 2.648580448294524e-07
an O 0 1.7414513422409073e-06
increased O 0 2.448316809022799e-05
risk O 0 6.746956205461174e-05
of O 0 0.0003903116739820689
breast B-Disease 1 0.9999973773956299
cancer I-Disease 1 0.9997379183769226
in O 0 7.12828041287139e-05
both O 0 2.9575305234175175e-05
homozygotes O 0 0.0007041260250844061
and O 0 2.1257093976601027e-05
heterozygotes O 0 0.00023225549375638366
( O 0 2.067769855784718e-05
relative O 0 8.773695299169049e-05
risk O 0 6.064821718609892e-05
12 O 0 4.843110218644142e-05
. O 0 5.292826699587749e-06
7 O 0 3.736491271411069e-05
; O 0 5.240441623755032e-06
P O 0 0.0006479973089881241
= O 0 0.0001315864792559296
. O 0 2.2054950022720732e-05
0025 O 0 0.00082072161603719
) O 0 4.851389803661732e-06
, O 0 1.4324015182864969e-06
although O 0 1.412550886925601e-06
there O 0 2.117768417519983e-06
is O 0 1.5445529015778448e-06
a O 0 8.06355819804594e-06
less O 0 3.9617614675080404e-05
severe O 1 0.7416728734970093
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9998489618301392
T I-Disease 1 0.9998959302902222
phenotype O 0 2.004102680075448e-05
in O 0 3.355674152771826e-06
terms O 0 2.1690734683943447e-06
of O 0 5.244110980129335e-06
the O 0 1.307702677877387e-05
degree O 0 0.00015344457642640918
of O 0 0.026562698185443878
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9662197828292847

This O 0 6.518288137158379e-05
mutation O 0 5.3251606004778296e-05
( O 0 5.700383189832792e-05
7271T O 0 0.00169084663502872
- O 0 0.0005119935376569629
- O 0 0.00023867796699050814
> O 0 0.00013796186249237508
G O 0 0.0003313644847366959
) O 0 6.460985787271056e-06
also O 0 1.26660472687945e-06
allows O 0 3.4665245607357065e-07
expression O 0 1.4220773891793215e-06
of O 0 9.804965884541161e-06
full O 0 2.398409014858771e-05
- O 0 0.0001268575870199129
length O 0 2.893247983593028e-05
ATM O 0 0.00039880722761154175
protein O 0 1.447662816644879e-05
at O 0 3.6434383218875155e-05
a O 0 4.485990302782739e-06
level O 0 2.0656412743846886e-05
comparable O 0 1.5598247046000324e-05
with O 0 1.9255087408964755e-06
that O 0 2.5168067168124253e-06
in O 0 2.5614051992306486e-05
unaffected O 0 0.00024505361216142774
individuals O 0 2.7330430384608917e-05
. O 0 0.00020041187235619873

In O 0 0.00011368205741746351
addition O 0 1.8506336346035823e-05
, O 0 4.979165169061162e-06
we O 0 1.4389090665645199e-06
have O 0 8.393335519940592e-07
studied O 0 3.260547964600846e-05
18 O 0 0.00019443697237875313
A B-Disease 1 0.9995001554489136
- I-Disease 1 0.997638463973999
T I-Disease 1 0.9999970197677612
patients O 0 5.508485992322676e-05
, O 0 4.37811422671075e-06
in O 0 6.351021966111148e-06
15 O 0 1.324205550190527e-05
families O 0 1.6308470094372751e-06
, O 0 2.0177540136501193e-06
who O 0 5.614819656329928e-06
developed O 0 0.0006659456412307918
leukemia B-Disease 1 1.0
, O 1 0.8881307244300842
lymphoma B-Disease 1 1.0
, O 1 0.6890835165977478
preleukemic O 1 1.0
T O 1 0.9999998807907104
- O 1 0.9959455132484436
cell O 0 0.004048321396112442
proliferation O 1 0.9191988706588745
, O 0 4.51607265858911e-05
or O 0 0.0038205941673368216
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.001994165824726224
mostly O 0 0.00014673710393253714
in O 0 0.00012971852265764028
childhood O 0 0.24632585048675537
. O 0 0.00039611331885680556

A O 0 0.0016111977165564895
wide O 0 0.00024260008649434894
variety O 0 3.215349352103658e-05
of O 0 0.00011247042857576162
ATM O 0 0.0028296757955104113
mutation O 0 1.668890763539821e-05
types O 0 9.645832506066654e-06
, O 0 6.4166260926867835e-06
including O 0 7.201293556136079e-06
missense O 0 0.00023816742759663612
mutations O 0 7.716318214079365e-05
and O 0 5.3144765843171626e-05
in O 0 0.00018751848256215453
- O 0 0.001022367738187313
frame O 0 0.00033096608240157366
deletions O 0 8.645659545436502e-05
, O 0 1.1427410754549783e-05
were O 0 2.0482339095906354e-05
seen O 0 3.8662474253214896e-05
in O 0 1.4657039173471276e-05
these O 0 1.558319854666479e-05
patients O 0 0.00016549961583223194
. O 0 0.00023637819685973227

We O 0 5.236160723143257e-05
also O 0 6.362983640428865e-06
show O 0 6.520258921227651e-06
that O 0 5.784268068964593e-07
25 O 0 3.900871433870634e-06
% O 0 9.341490567749133e-07
of O 0 8.320981578435749e-06
all O 0 2.7204157959204167e-05
A B-Disease 1 0.9999525547027588
- I-Disease 1 0.9995279312133789
T I-Disease 1 0.9999969005584717
patients O 0 4.087426350452006e-05
carried O 0 3.817031756625511e-05
in O 0 4.5646265789400786e-05
- O 0 0.0003342967538628727
frame O 0 0.00021181566989980638
deletions O 0 9.293458424508572e-05
or O 0 2.5122189981630072e-05
missense O 0 0.0002940479898825288
mutations O 0 3.0286750188679434e-05
, O 0 4.693724349635886e-06
many O 0 1.3505987226380967e-06
of O 0 8.504036486556288e-06
which O 0 4.64309960079845e-06
were O 0 5.448187039291952e-06
also O 0 1.863403895185911e-06
associated O 0 2.815572543113376e-06
with O 0 1.5341547623393126e-06
expression O 0 1.458357564843027e-05
of O 0 0.00011930309847230092
mutant O 0 0.000850158859975636
ATM O 0 0.006911509204655886
protein O 0 0.0003871549270115793
. O 0 0.00017784260853659362

The O 0 0.0004482457006815821
DMPK O 1 0.9906883239746094
gene O 0 0.00013980928633827716
of O 0 0.0007193288765847683
severely O 1 0.9999997615814209
affected O 1 0.9999991655349731
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9995755553245544
is O 0 0.00028947339160367846
hypermethylated O 0 0.036643486469984055
proximal O 0 0.0022337427362799644
to O 0 3.0421471819863655e-05
the O 0 4.9708418373484164e-05
largely O 0 9.53238777583465e-05
expanded O 0 0.0003421537985559553
CTG O 0 0.043850865215063095
repeat O 0 0.0017208099598065019
. O 0 0.0003110651159659028

Using O 0 0.00019299756968393922
methylation O 0 0.0004078072961419821
- O 0 0.0005299419281072915
sensitive O 0 0.00014961170381866395
restriction O 0 2.048269016086124e-05
enzymes O 0 1.186812460218789e-05
, O 0 5.086937562737148e-06
we O 0 2.8392469175742008e-06
characterized O 0 1.2421064639056567e-05
the O 0 8.742209502088372e-06
methylation O 0 1.7725105863064528e-05
pattern O 0 4.613711644196883e-05
on O 0 4.941877705277875e-05
the O 0 2.1042451407993212e-05
5 O 0 5.2317034715088084e-05
side O 0 2.067174318653997e-05
of O 0 3.878662391798571e-05
the O 0 9.849552589002997e-05
CTG O 0 0.013457490131258965
repeat O 0 0.0001183752465294674
in O 0 2.158662937290501e-05
the O 0 2.3454040274373256e-05
DMPK O 0 0.003185966284945607
gene O 0 6.098913218011148e-06
of O 0 9.840016900852788e-06
normal O 0 9.125024007516913e-06
individuals O 0 8.7626153799647e-07
and O 0 2.762184067250928e-06
of O 0 6.368480535456911e-05
patients O 0 0.0006656768964603543
affected O 0 0.0032863859087228775
with O 1 0.5842736959457397
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.00033952275407500565
showing O 0 0.00032951877801679075
expansions O 0 0.0003882307792082429
of O 0 0.00010283150913892314
the O 0 0.00010979633225360885
repetitive O 0 0.0005848678410984576
sequence O 0 0.00018398479733150452
. O 0 0.0003851435030810535

The O 0 0.000129484455101192
gene O 0 2.517845859983936e-05
segment O 0 3.34274118358735e-05
analyzed O 0 7.749807991785929e-06
corresponds O 0 8.91163927008165e-06
to O 0 5.708887329092249e-06
the O 0 1.764508124324493e-05
genomic O 0 0.00013521952496375889
SacI O 0 0.011514193378388882
- O 0 0.0005731441196985543
HindIII O 0 0.0015882335137575865
fragment O 0 7.29121602489613e-05
carrying O 0 3.0211520424927585e-05
exons O 0 0.0001907083933474496
11 O 0 0.00031805288745090365
- O 0 0.0004335317062214017
15 O 0 0.0002684549253899604
. O 0 0.00014740013284608722

There O 0 0.000111729561467655
is O 0 1.1317406460875645e-05
constitutive O 0 8.32094083307311e-05
methylation O 0 4.230086778989062e-05
in O 0 6.194927118485793e-05
intron O 0 0.00125031522475183
12 O 0 8.473229536321014e-05
at O 0 8.040695684030652e-05
restriction O 0 5.028661689721048e-06
sites O 0 8.979368431027979e-06
of O 0 4.8217279982054606e-05
SacII O 0 0.0027811217587441206
and O 0 3.206719702575356e-05
HhaI O 0 0.0012915059924125671
, O 0 1.1764722330553923e-05
localized O 0 6.470218067988753e-05
1 O 0 9.01860767044127e-05
, O 0 1.0422802915854845e-05
159 O 0 2.823668546625413e-05
- O 0 6.577056046808138e-05
1 O 0 3.55795600626152e-05
, O 0 3.549580924300244e-06
232 O 0 1.664435512793716e-05
bp O 0 3.709058364620432e-05
upstream O 0 4.133066249778494e-05
of O 0 1.397942742187297e-05
the O 0 4.865441587753594e-05
CTG O 0 0.01008149329572916
repeat O 0 7.741716399323195e-05
, O 0 5.112109647598118e-06
whereas O 0 5.730357315769652e-06
most O 0 3.196734496668796e-06
, O 0 2.243420794911799e-06
if O 0 4.5225274902804813e-07
not O 0 3.15189993216336e-07
all O 0 6.131684813226457e-07
, O 0 1.0466181947776931e-06
of O 0 4.553950475383317e-06
the O 0 7.5803195613843855e-06
other O 0 1.4478590628641541e-06
sites O 0 1.1370448191883042e-05
of O 0 7.555659976787865e-05
SacII O 0 0.009699421934783459
, O 0 5.1678223826456815e-05
HhaI O 0 0.0023513888008892536
, O 0 2.013965968217235e-05
and O 0 6.737517651345115e-06
HpaII O 0 0.0008309321710839868
in O 0 8.622498171462212e-06
this O 0 2.6530929062573705e-06
region O 0 4.672342765843496e-05
are O 0 3.106073791059316e-06
unmethylated O 0 0.00023673071700613946
, O 0 6.2862327467883006e-06
in O 0 6.8287413341749925e-06
normal O 0 1.1185353287146427e-05
individuals O 0 1.3158140745872515e-06
and O 0 3.604736093620886e-06
most O 0 6.706588010274572e-06
of O 0 5.737916944781318e-05
the O 0 0.00020898009825032204
patients O 0 0.0003485436027403921
. O 0 0.00032874406315386295

In O 0 4.131478272029199e-05
a O 0 6.94303435011534e-06
number O 0 2.017076667470974e-06
of O 0 3.002296398335602e-05
young O 0 0.0001344111660728231
and O 0 3.849690983770415e-05
severely O 1 0.6323646306991577
affected O 0 5.6145916460081935e-05
patients O 0 2.4102035240503028e-05
, O 0 4.9024197323888075e-06
however O 0 3.874595222441712e-06
, O 0 1.6442510286651668e-06
complete O 0 8.037945917749312e-06
methylation O 0 9.688276804808993e-06
of O 0 1.6511698049725965e-05
these O 0 4.210897714074235e-06
restriction O 0 1.1833383723569568e-05
sites O 0 2.5172119421768002e-05
was O 0 5.230576061876491e-05
found O 0 2.56991893365921e-06
in O 0 2.6146649361180607e-06
the O 0 1.4227924111764878e-05
mutated O 0 5.795709148515016e-05
allele O 0 3.060268863919191e-05
. O 0 9.48149390751496e-05

In O 0 7.093492604326457e-05
most O 0 9.067684914043639e-06
of O 0 1.7522015696158633e-05
these O 0 7.141219612094574e-06
patients O 0 1.4896882930770516e-05
, O 0 4.527612873062026e-06
the O 0 9.459826287638862e-06
onset O 0 0.0015817636158317327
of O 0 0.0001364077179459855
the O 0 0.045941855758428574
disease O 1 1.0
was O 1 0.9999998807907104
congenital O 1 1.0
. O 1 0.7953729629516602

Preliminary O 0 0.000345858366927132
in O 0 0.00040086990338750184
vivo O 0 0.002256012987345457
footprinting O 0 0.002756767673417926
data O 0 2.0986737581552006e-05
gave O 0 1.2984670320292935e-05
evidence O 0 1.0692113391996827e-05
for O 0 5.424727532954421e-06
protein O 0 4.520527727436274e-05
- O 0 0.0001075549007509835
DNA O 0 2.2030080799595453e-05
contact O 0 1.1064154023188166e-05
in O 0 8.264112693723291e-06
normal O 0 1.951977719727438e-05
genes O 0 7.622212251590099e-06
at O 0 6.63651735521853e-05
an O 0 1.3522480912797619e-05
Sp1 O 0 0.0012246296973899007
consensus O 0 5.301488272380084e-05
binding O 0 7.936894689919427e-06
site O 0 5.452434561448172e-05
upstream O 0 6.0464124544523656e-05
of O 0 1.892870568553917e-05
the O 0 6.164178921608254e-05
CTG O 0 0.006882698740810156
repeat O 0 6.908650539116934e-05
and O 0 3.664471250885981e-06
for O 0 2.4725989078433486e-06
a O 0 7.853455826989375e-06
significant O 0 1.6618188965367153e-05
reduction O 0 2.9444729079841636e-05
of O 0 1.5870691640884615e-05
this O 0 4.722981884697219e-06
interaction O 0 9.14752217795467e-06
in O 0 9.399861482961569e-06
cells O 0 7.692813596804626e-06
with O 0 3.0126127512630774e-06
a O 0 6.135640433058143e-05
hypermethylated O 0 0.008956796489655972
DMPK O 1 0.9942008852958679
gene O 0 0.0001904734381241724
. O 0 4.6490800741594285e-05
. O 0 0.00013251183554530144

The O 0 0.0017476310022175312
hemochromatosis B-Disease 1 1.0
gene O 0 0.00016405167116317898
product O 0 4.065896791871637e-05
complexes O 0 0.00017523556016385555
with O 0 8.235074346885085e-06
the O 0 4.6115692384773865e-05
transferrin O 0 0.0007300290744751692
receptor O 0 7.811796967871487e-05
and O 0 1.121047080232529e-05
lowers O 0 4.021059794467874e-05
its O 0 2.8987878977204673e-06
affinity O 0 1.621721821720712e-05
for O 0 2.8526752430479974e-05
ligand O 0 0.000406814826419577
binding O 0 0.0001940654474310577
. O 0 0.0003729461459442973

We O 0 0.00013333467359188944
recently O 0 6.812300125602633e-05
reported O 0 1.084512950910721e-05
the O 0 8.83135089679854e-06
positional O 0 0.00010608294542180374
cloning O 0 4.7286110202549025e-05
of O 0 1.93040759768337e-05
a O 0 1.1229152732994407e-05
candidate O 0 2.094902447424829e-05
gene O 0 2.9287451980053447e-05
for O 0 0.00010373247641837224
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 1.0
. O 0 0.0020165001042187214

The O 0 0.00017025005945470184
gene O 0 3.752556222025305e-05
product O 0 1.6756588593125343e-05
, O 0 3.946157448808663e-06
a O 0 3.7148870433156844e-06
member O 0 4.115785031899577e-06
of O 0 1.3837820006301627e-05
the O 0 5.5564385547768325e-05
major O 0 0.0015973030822351575
histocompatibility O 1 0.9999985694885254
complex O 1 0.7066950798034668
class O 0 0.0006159028271213174
I O 0 0.0036698717158287764
- O 0 0.0001765133929438889
like O 0 6.1568730416183826e-06
family O 0 6.231064617168158e-06
, O 0 2.5782558168430114e-06
was O 0 4.067137706442736e-05
found O 0 2.4722453417780343e-06
to O 0 2.744868652371224e-06
have O 0 1.3432025980364415e-06
a O 0 8.773145054874476e-06
mutation O 0 9.73176156549016e-06
, O 0 3.0007535315235145e-05
Cys O 0 0.01086833979934454
- O 0 0.0005067443707957864
282 O 0 0.00036814066697843373
- O 0 0.0005158500862307847
- O 0 0.0002878477389458567
> O 0 0.0001657796383369714
Tyr O 0 0.0014133903896436095
( O 0 3.653751264209859e-05
C282Y O 0 0.00038488328573293984
) O 0 6.8314770942379255e-06
, O 0 2.682826107047731e-06
in O 0 3.7569634514511563e-06
85 O 0 1.6717134712962434e-05
% O 0 1.3163903531676624e-05
of O 0 0.00019144846010021865
patient O 0 0.000511628168169409
chromosomes O 0 0.0005615929840132594
. O 0 0.0002662774932105094

This O 0 3.6296882171882316e-05
mutation O 0 2.0071171093150042e-05
eliminates O 0 3.195830140612088e-05
the O 0 9.57390966505045e-06
ability O 0 6.348345777951181e-06
of O 0 4.2700532503658906e-05
HFE O 0 0.008859367109835148
to O 0 3.0317642085719854e-05
associate O 0 5.239196980255656e-05
with O 0 1.1301238373562228e-05
beta2 O 0 0.016723167151212692
- O 0 0.0010898696491494775
microglobulin O 0 0.003283137222751975
( O 0 5.597452400252223e-05
beta2m O 0 0.001638650894165039
) O 0 1.8367225493420847e-05
and O 0 2.0450210286071524e-05
prevents O 0 0.00017630145885050297
cell O 0 0.000994025613181293
- O 0 0.0010192323243245482
surface O 0 0.0004272068908903748
expression O 0 0.00019554395112209022
. O 0 0.00022614160843659192

A O 0 0.0006003351882100105
second O 0 0.00011539868137333542
mutation O 0 8.654048542666715e-06
that O 0 1.971463689187658e-06
has O 0 3.44237423632876e-06
no O 0 3.2064406241261167e-06
effect O 0 1.6973164747469127e-05
on O 0 9.694285108707845e-05
beta2m O 0 0.004169366788119078
association O 0 7.258334517246112e-05
, O 0 3.4640430385479704e-05
H63D O 1 0.7400073409080505
, O 0 2.08652072615223e-05
was O 0 6.328577728709206e-05
found O 0 3.3942258141905768e-06
in O 0 3.5300079161970643e-06
eight O 0 5.689749741577543e-06
out O 0 2.0143354504398303e-06
of O 0 1.920338036143221e-05
nine O 0 5.214405246078968e-05
patients O 0 1.2691508345596958e-05
heterozygous O 0 3.291441089459113e-06
for O 0 5.447781859402312e-06
the O 0 7.328677747864276e-05
C282Y O 0 0.0014131509233266115
mutant O 0 0.0005083681899122894
. O 0 0.00023337425955105573

In O 0 0.00011158486449858174
this O 0 8.508401151630096e-06
report O 0 4.3558579818636645e-06
, O 0 2.194733951910166e-06
we O 0 1.984082246053731e-06
demonstrate O 0 1.698560117802117e-05
in O 0 4.073317177244462e-05
cultured O 0 0.00028089521219953895
293 O 0 0.0006202413933351636
cells O 0 0.00025203218683600426
overexpressing O 0 0.002918000565841794
wild O 0 0.00022616593923885375
- O 0 0.00020605846657417715
type O 0 5.975888416287489e-05
or O 0 2.5977833502111025e-05
mutant O 0 0.00029971060575917363
HFE O 0 0.00618708273395896
proteins O 0 1.0590145393507555e-05
that O 0 2.334504642931279e-06
both O 0 3.58671923095244e-06
the O 0 2.2120097128208727e-05
wild O 0 8.23462542030029e-05
- O 0 0.00014012999599799514
type O 0 9.30628229980357e-05
and O 0 0.00011566792818484828
H63D O 1 0.9998555183410645
HFE O 0 0.4482361972332001
proteins O 0 4.680351776187308e-05
form O 0 2.058628342638258e-05
stable O 0 0.00017650632071308792
complexes O 0 7.389907113974914e-05
with O 0 5.358854650694411e-06
the O 0 3.266844942118041e-05
transferrin O 0 0.0007836168515495956
receptor O 0 0.000284543726593256
( O 0 0.00013297394616529346
TfR O 0 0.005250088404864073
) O 0 0.0001068894998752512
. O 0 0.00012088318180758506

The O 0 0.0006733641494065523
C282Y O 0 0.0028414621483534575
mutation O 0 7.240042759804055e-05
nearly O 0 0.00011697198351612315
completely O 0 0.00010018831380875781
prevents O 0 1.1910258763236925e-05
the O 0 1.0836361980182119e-05
association O 0 1.2071378478140105e-05
of O 0 2.4549470253987238e-05
the O 0 8.356094622286037e-05
mutant O 0 0.00051789206918329
HFE O 0 0.01744070276618004
protein O 0 8.014668128453195e-05
with O 0 2.343642154301051e-05
the O 0 0.00019131251610815525
TfR O 0 0.07219606637954712
. O 0 0.0002714295405894518

Studies O 0 0.00024360418319702148
on O 0 0.00045589375076815486
cell O 0 0.0003990827826783061
- O 0 0.00017458744696341455
associated O 0 1.804150997486431e-05
transferrin O 0 0.00015991299005690962
at O 0 7.8536533692386e-05
37 O 0 2.0735693397000432e-05
degrees O 0 2.4794826458673924e-05
C O 0 0.0001749857619870454
suggest O 0 1.4668226867797785e-05
that O 0 2.8038734853907954e-06
the O 0 4.2633273551473394e-05
overexpressed O 0 0.0017665966879576445
wild O 0 0.00017278461018577218
- O 0 0.00018020746938418597
type O 0 0.00010902928625000641
HFE O 0 0.0046924203634262085
protein O 0 2.8895536161144264e-05
decreases O 0 1.6920930647756904e-05
the O 0 6.2280637393996585e-06
affinity O 0 9.31727026909357e-06
of O 0 2.9172049835324287e-05
the O 0 9.710261656437069e-05
TfR O 0 0.003997712396085262
for O 0 0.00014358000771608204
transferrin O 0 0.006668769754469395
. O 0 0.00038079640944488347

The O 0 0.0010555947665125132
overexpressed O 0 0.02030741609632969
H63D O 1 0.9659915566444397
protein O 0 4.00504723074846e-05
does O 0 1.8275072761753108e-06
not O 0 5.974247301310243e-07
have O 0 3.472440539553645e-07
this O 0 5.416360409071785e-07
effect O 0 6.600188953598263e-06
, O 0 1.547498868603725e-06
providing O 0 3.4218712698930176e-06
the O 0 3.7898903428867925e-06
first O 0 5.405542196967872e-06
direct O 0 1.8210266716778278e-06
evidence O 0 4.507553057919722e-06
for O 0 1.8104983610101044e-06
a O 0 7.941475814732257e-06
functional O 0 1.6039659385569394e-05
consequence O 0 9.78598473011516e-05
of O 0 7.741694571450353e-05
the O 0 0.0004765095072798431
H63D O 1 0.9999476671218872
mutation O 0 0.00017979179392568767
. O 0 0.00020224721811246127

Addition O 0 0.00019629810412880033
of O 0 0.0008295883308164775
soluble O 0 0.005643502809107304
wild O 0 0.0007453936850652099
- O 0 0.0010761880548670888
type O 0 0.0007622495759278536
HFE O 1 0.9999954700469971
/ O 0 0.04833078384399414
beta2m O 0 0.012337029911577702
heterodimers O 0 0.0026037374045699835
to O 0 0.00015350543253589422
cultured O 0 0.00038222974399104714
cells O 0 3.4977059840457514e-05
also O 0 5.4808315326226875e-06
decreased O 0 4.92521830892656e-05
the O 0 1.4044354429643136e-05
apparent O 0 0.00011049373279092833
affinity O 0 3.7886868085479364e-05
of O 0 6.72516252961941e-05
the O 0 0.00014921504771336913
TfR O 0 0.0016685351729393005
for O 0 1.2664690984820481e-05
its O 0 1.6231468180194497e-05
ligand O 0 0.00012436437828000635
under O 0 0.00012497375428210944
steady O 0 0.0007069547427818179
- O 0 6.589467375306413e-05
state O 0 8.526725650881417e-06
conditions O 0 3.1357802072307095e-05
, O 0 3.479313136267592e-06
both O 0 3.6088463275518734e-06
in O 0 2.2579526557819918e-05
293 O 0 0.0001461642823414877
cells O 0 2.5421562895644456e-05
and O 0 1.1969515071541537e-05
in O 0 0.00010018039029091597
HeLa O 0 0.022212229669094086
cells O 0 0.00017254555132240057
. O 0 8.647622598800808e-05

Furthermore O 0 0.00031970214331522584
, O 0 1.827915730245877e-05
at O 0 7.050494605209678e-05
4 O 0 3.582448698580265e-05
degrees O 0 4.7405170334968716e-05
C O 0 0.0001774083502823487
, O 0 3.982463113061385e-06
the O 0 8.305275514430832e-06
added O 0 5.858679651282728e-05
soluble O 0 0.0001805015344871208
complex O 0 0.00032404850935563445
of O 0 0.0006656309706158936
HFE O 1 0.9999920129776001
/ O 0 0.013578018173575401
beta2m O 0 0.009388536214828491
inhibited O 0 0.0002984062011819333
binding O 0 1.7294198187300935e-05
of O 0 0.00010459910845384002
transferrin O 0 0.0016370494849979877
to O 0 0.0002413796028122306
HeLa O 0 0.03850017488002777
cell O 0 0.00039999248110689223
TfR O 0 0.0012500034645199776
in O 0 3.1209143344312906e-05
a O 0 3.9250473491847515e-05
concentration O 0 0.0031756823882460594
- O 0 0.0006633311859332025
dependent O 0 6.685491825919598e-05
manner O 0 8.862575487000868e-05
. O 0 0.00015828733739908785

Scatchard O 0 0.0013954018941149116
plots O 0 0.00014768348773941398
of O 0 2.8222175387782045e-05
these O 0 3.4997328839381225e-06
data O 0 6.11684845353011e-06
indicate O 0 1.1289970643701963e-05
that O 0 1.4492087530015851e-06
the O 0 1.2648975825868547e-05
added O 0 5.334731758921407e-05
heterodimer O 0 0.0003011921071447432
substantially O 0 7.317657582461834e-05
reduced O 0 1.706131843093317e-05
the O 0 1.2632495781872422e-05
affinity O 0 5.320100171957165e-05
of O 0 0.00025776890106499195
TfR O 0 0.018530044704675674
for O 0 0.0003096693835686892
transferrin O 0 0.009428564459085464
. O 0 0.0005463335546664894

These O 0 1.3470686099026352e-05
results O 0 8.499674549966585e-06
establish O 0 4.133015318075195e-05
a O 0 2.631343886605464e-05
molecular O 0 0.00010910937271546572
link O 0 0.0004915180616080761
between O 0 0.0008714093128219247
HFE O 1 0.9365191459655762
and O 0 1.8110154996975325e-05
a O 0 1.4545364138029981e-05
key O 0 6.981821934459731e-05
protein O 0 1.920180511660874e-05
involved O 0 2.7849477191921324e-05
in O 0 6.90905872033909e-05
iron O 1 0.9903880953788757
transport O 0 0.0002574832469690591
, O 0 1.8001948774326593e-05
the O 0 5.61962224310264e-05
TfR O 0 0.0035286135971546173
, O 0 1.6464950022054836e-05
and O 0 6.668232799711404e-06
raise O 0 1.4768471373827197e-05
the O 0 8.95746416063048e-06
possibility O 0 1.4444290172832552e-05
that O 0 1.3622538972413167e-06
alterations O 0 3.6685763916466385e-05
in O 0 7.731993719062302e-06
this O 0 2.6028023967228364e-06
regulatory O 0 2.9890665246057324e-05
mechanism O 0 5.1651917601702735e-05
may O 0 1.8855180314858444e-05
play O 0 6.465743808803381e-06
a O 0 2.645916993060382e-06
role O 0 7.531968549301382e-06
in O 0 3.842156729660928e-06
the O 0 1.7750480765243992e-05
pathogenesis O 1 0.9996817111968994
of O 1 0.5883811116218567
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9996277093887329
. O 0 0.0013762271264567971

Genomic O 0 0.00026646695914678276
organization O 0 4.605754656950012e-05
of O 0 0.00011526296293595806
the O 0 0.0003854169917758554
UBE3A O 1 0.9998503923416138
/ O 0 0.00696983840316534
E6 O 1 0.9938720464706421
- O 0 0.000951707421336323
AP O 0 0.00026744839851744473
gene O 0 8.918254025047645e-06
and O 0 5.095604592497693e-06
related O 0 6.354527431540191e-05
pseudogenes O 0 0.0013780323788523674
. O 0 0.00025969723355956376

The O 0 0.0006656328914687037
UBE3A O 0 0.021381791681051254
gene O 0 4.954500400344841e-05
encodes O 0 3.3019023248925805e-05
the O 0 7.47029043850489e-05
E6 O 0 0.013985137455165386
- O 0 0.0005636514397338033
AP O 0 0.0005151095101609826
ubiquitin O 0 0.00037499360041692853
- O 0 0.00015687641280237585
protein O 0 1.3282490726851393e-05
ligase O 0 2.6722453185357153e-05
and O 0 2.239867853859323e-06
has O 0 3.0984349450591253e-06
recently O 0 9.865208994597197e-06
been O 0 1.6383482943638228e-06
shown O 0 1.1902023970833397e-06
to O 0 2.3719185264781117e-06
be O 0 7.555723641416989e-06
mutated O 0 0.0001588999293744564
in O 0 0.0012184933293610811
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9990014433860779
who O 0 0.0002487785823177546
lack O 0 0.0010856533190235496
15q11 O 0 0.011053483001887798
- O 0 0.0010377082508057356
q13 O 0 0.0007538666250184178
deletions O 0 0.00014295571600086987
or O 0 6.892660894664004e-05
chromosome O 0 0.0004464525554794818
15 O 0 0.0007371816318482161
paternal O 0 0.006887602154165506
uniparental B-Disease 1 0.9999277591705322
disomy I-Disease 1 0.9971436858177185
. O 0 0.0019285088637843728

Previous O 0 0.0011158451670780778
UBE3A O 0 0.015445754863321781
cDNA O 0 0.00011121868737973273
analysis O 0 3.1952897643350298e-06
has O 0 2.367529987168382e-06
shown O 0 2.6624763904692372e-06
a O 0 3.405450570426183e-06
coding O 0 1.6081719877547584e-05
region O 0 4.014982550870627e-05
of O 0 2.9082440960337408e-05
approximately O 0 0.00023215165128931403
2 O 0 0.0005615719710476696
. O 0 0.00020217667042743415

6 O 0 0.0013151078019291162
kb O 0 0.0016917339526116848
and O 0 2.735131602094043e-05
a O 0 4.7200737753883004e-05
3 O 0 0.00014537395327351987
- O 0 0.00016803636390250176
untranslated O 0 0.0006355630466714501
region O 0 0.0001260595308849588
( O 0 2.2292393623501994e-05
UTR O 0 0.001682565314695239
) O 0 7.315526090678759e-06
of O 0 2.9460175937856548e-05
< O 0 0.0006130340625531971
50 O 0 9.060795127879828e-05
bp O 0 0.00013670614862348884
, O 0 3.828134140348993e-06
whereas O 0 4.51390269518015e-06
Northern O 0 8.326665010827128e-06
analysis O 0 1.386731355523807e-06
has O 0 2.177562691940693e-06
indicated O 0 4.075348897458753e-06
mRNA O 0 4.410941073729191e-06
sizes O 0 1.6058955907283234e-06
of O 0 1.559931661176961e-05
5 O 0 0.00010201461554970592
- O 0 0.00026437820633873343
8 O 0 0.00019067656830884516
kb O 0 0.0020914096385240555
. O 0 0.00024531662347726524

We O 0 4.3840180296683684e-05
have O 0 3.903659035131568e-06
analyzed O 0 5.856588813912822e-06
additional O 0 3.947670393245062e-06
cDNA O 0 0.0001106678246287629
clones O 0 7.282933074748144e-05
and O 0 1.4083004771237029e-06
provide O 0 1.169789356936235e-06
evidence O 0 3.2792656838864787e-06
for O 0 1.7423683402739698e-06
an O 0 3.2766088224889245e-06
additional O 0 9.821276762522757e-06
0 O 0 0.00012379408872220665
. O 0 0.00011453732440713793

5 O 0 0.000804835231974721
kb O 0 0.0016369807999581099
of O 0 0.00033424573484808207
5 O 0 0.0006134224240668118
- O 0 0.0007147984579205513
UTR O 0 0.0033257247414439917
and O 0 1.0020075023930985e-05
> O 0 3.8452435546787456e-05
2 O 0 5.280035475152545e-05
kb O 0 0.0003111751575488597
of O 0 0.00012183104990981519
3 O 0 0.000820336164906621
- O 0 0.0023278733715415
UTR O 0 0.028120433911681175
. O 0 0.00033688757685013115

We O 0 6.354381912387908e-05
have O 0 8.367261216335464e-06
established O 0 1.7051688701030798e-05
the O 0 5.5312507356575225e-06
genomic O 0 1.1281372280791402e-05
organization O 0 9.716201020637527e-06
of O 0 5.821860395371914e-05
UBE3A O 0 0.007369717117398977
and O 0 5.724529273720691e-06
the O 0 5.890274678677088e-06
sequence O 0 5.356146630219882e-06
of O 0 0.00010834544809767976
intron O 0 0.012545617297291756
- O 0 0.002457914873957634
exon O 0 0.0010405504144728184
borders O 0 0.00011726145021384582
. O 0 0.00013801726163364947

We O 0 0.00010046344686998054
have O 0 8.030115168367047e-06
also O 0 4.534293111646548e-06
mapped O 0 2.2219277525437064e-05
two O 0 5.837640401296085e-06
highly O 0 4.0568185795564204e-05
homologous O 0 6.563097122125328e-05
processed O 0 8.565199095755816e-05
pseudogenes O 0 0.00037211261224001646
, O 0 6.089649104978889e-05
UBE3AP1 O 0 0.21174117922782898
and O 0 4.9754802603274584e-05
UBE3AP2 O 0 0.04378431662917137
, O 0 1.2223037629155442e-05
to O 0 4.344325134297833e-06
chromosomes O 0 7.68908103054855e-06
2 O 0 3.0319290090119466e-05
and O 0 3.865066901198588e-06
21 O 0 6.224928074516356e-05
, O 0 5.493358912644908e-06
respectively O 0 1.666501884756144e-05
, O 0 4.794248525286093e-06
and O 0 3.1838646918913582e-06
determined O 0 7.65830191085115e-06
their O 0 5.120892637933139e-06
genomic O 0 5.240076643531211e-05
organization O 0 7.462358917109668e-05
. O 0 8.022551628528163e-05

These O 0 2.2566480765817687e-05
results O 0 9.289234185416717e-06
will O 0 2.9170744255679892e-06
form O 0 9.383643373439554e-07
the O 0 1.6973642686934909e-06
basis O 0 1.871896188276878e-06
for O 0 1.502522991359001e-06
studies O 0 3.730878233909607e-06
of O 0 3.103762355749495e-05
mutation O 0 1.83052325155586e-05
and O 0 2.7177395168109797e-05
imprinting O 0 0.0005317110335454345
of O 0 0.002347643254324794
UBE3A O 1 0.9999606609344482
. O 0 0.0017359514022246003

Mutation O 0 0.00021253223530948162
spectrum O 0 0.0003104867646470666
and O 0 4.2822422983590513e-05
genotype O 0 0.0002241806942038238
- O 0 0.00019972263544332236
phenotype O 0 1.2795391739928164e-05
analyses O 0 1.6024188880692236e-05
in O 0 7.612199988216162e-05
Cowden B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999996423721313
and O 0 0.00017616382683627307
Bannayan B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.081451571546495e-05
two O 0 9.711317397886887e-05
hamartoma B-Disease 1 0.9999997615814209
syndromes I-Disease 1 0.9999997615814209
with O 0 0.008577752858400345
germline O 1 0.9999971389770508
PTEN O 1 0.9999997615814209
mutation O 0 0.0013617693912237883
. O 0 0.00046931099495850503

The O 0 0.004044869914650917
tumour B-Disease 1 1.0
suppressor O 1 0.9424263834953308
gene O 0 0.0010763381142169237
PTEN O 0 0.029784878715872765
, O 0 2.2379577785613947e-05
which O 0 4.384272415336454e-06
maps O 0 2.367415072512813e-05
to O 0 7.701688446104527e-05
10q23 O 0 0.003536943346261978
. O 0 0.00024207514070440084

3 O 0 0.00041347925434820354
and O 0 3.1164563552010804e-05
encodes O 0 1.5852825526962988e-05
a O 0 1.4744210602657404e-05
403 O 0 1.9097638869425282e-05
amino O 0 8.045415597734973e-06
acid O 0 9.59451062954031e-06
dual O 0 2.369988214923069e-05
specificity O 0 6.275297346292064e-05
phosphatase O 0 0.0007295901887118816
( O 0 5.0415441364748403e-05
protein O 0 7.638049282832071e-05
tyrosine O 0 0.0001477502373745665
phosphatase O 0 0.0005033197812736034
; O 0 2.1277335690683685e-05
PTPase O 0 0.0011309668188914657
) O 0 9.904565558827017e-06
, O 0 2.9035854822723195e-06
was O 0 4.6222368837334216e-05
shown O 0 8.680548489792272e-06
recently O 0 1.2200539458717685e-05
to O 0 3.084898480665288e-06
play O 0 1.224691095558228e-05
a O 0 1.4041850590729155e-05
broad O 0 3.415951505303383e-05
role O 0 0.00012201369099784642
in O 0 0.00015704492398072034
human O 0 0.0005049087922088802
malignancy B-Disease 1 0.9997252821922302
. O 0 0.0006187196122482419

Somatic O 0 0.018002156168222427
PTEN O 1 0.9921401143074036
deletions O 0 0.0005818834179081023
and O 0 2.775646498776041e-05
mutations O 0 1.56470705405809e-05
were O 0 1.6038007743190974e-05
observed O 0 1.4710981304233428e-05
in O 0 1.6699161278665997e-05
sporadic B-Disease 0 0.00035348563687875867
breast I-Disease 1 0.9771054983139038
, I-Disease 0 7.961999654071406e-05
brain I-Disease 1 0.9999808073043823
, I-Disease 0 0.0001770360831869766
prostate I-Disease 1 1.0
and I-Disease 1 0.9999854564666748
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9994408488273621
lines O 0 0.00011336986062815413
and O 0 4.1905145735654514e-06
in O 0 5.075346507510403e-06
several O 0 5.601192242465913e-06
primary O 0 0.0002648464869707823
tumours B-Disease 1 0.9999998807907104
such O 0 2.8323876904323697e-05
as O 0 0.47582507133483887
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999998807907104
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9998224377632141

In O 0 0.00022761861328035593
addition O 0 5.9851670812349766e-05
, O 0 5.648521982948296e-05
PTEN O 0 0.012914562597870827
was O 0 0.00012751028407365084
identified O 0 5.089460955787217e-06
as O 0 1.16464661914506e-06
the O 0 1.4735684317201958e-06
susceptibility O 0 1.0187052794208284e-05
gene O 0 3.0594703730457695e-06
for O 0 4.0943987187347375e-06
two O 0 6.171588756842539e-05
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0012370020849630237
CD B-Disease 0 0.02333536557853222
; O 0 5.77054415771272e-05
MIM O 1 0.7797614336013794
158350 O 0 0.0011307838140055537
) O 0 1.1952450222452171e-05
and O 0 1.7330619812128134e-05
Bannayan B-Disease 0 0.05328566953539848
- I-Disease 0 0.0033485416788607836
Zonana I-Disease 1 0.7715517282485962
( I-Disease 0 0.00011182676098542288
BZS I-Disease 0 0.1832616776227951
) I-Disease 0 4.6529654355254024e-05
or I-Disease 0 6.27532135695219e-05
Ruvalcaba I-Disease 0 0.006759661715477705
- I-Disease 0 0.0013086862163618207
Riley I-Disease 0 0.0018354825442656875
- I-Disease 0 0.002844094065949321
Smith I-Disease 0 0.019277483224868774
syndrome I-Disease 1 1.0
( O 0 0.005592838861048222
MIM O 1 0.9999924898147583
153480 O 0 0.10754985362291336
) O 0 0.000216983855352737
. O 0 0.00019671105837915093

Constitutive O 0 0.0035700765438377857
DNA O 0 0.0005421389942057431
from O 0 0.00015126404468901455
37 O 0 0.0001939189387485385
CD B-Disease 0 0.0006606652168557048
families O 0 1.4140458915790077e-05
and O 0 1.2712694115180057e-05
seven O 0 8.181385783245787e-05
BZS B-Disease 0 0.06482590734958649
families O 0 1.8755146811599843e-05
was O 0 0.00012137510930188
screened O 0 8.400917431572452e-05
for O 0 6.788499740650877e-05
germline O 0 0.012537780217826366
PTEN O 1 0.9986373782157898
mutations O 0 0.0009553932468406856
. O 0 0.0006105704815126956

PTEN O 0 0.1316290944814682
mutations O 0 0.00016484776278957725
were O 0 6.121089245425537e-05
identified O 0 1.7956304873223417e-05
in O 0 1.2822507414966822e-05
30 O 0 3.1255578505806625e-05
of O 0 3.4731030609691516e-05
37 O 0 6.754256901331246e-05
( O 0 1.3436379049380776e-05
81 O 0 6.958053563721478e-05
% O 0 1.3837741789757274e-05
) O 0 1.605810393812135e-05
CD B-Disease 0 0.0002938310499303043
families O 0 5.716683972423198e-06
, O 0 4.211194664094364e-06
including O 0 8.188829269784037e-06
missense O 0 0.00020804963423870504
and O 0 4.235859159962274e-05
nonsense O 0 0.0004973725299350917
point O 0 0.000586102542001754
mutations O 0 0.00011270996037637815
, O 0 2.1772493710159324e-05
deletions O 0 0.00018175329023506492
, O 0 2.8302387363510206e-05
insertions O 0 0.00018121133325621486
, O 0 1.3774437320535071e-05
a O 0 2.6047939172713086e-05
deletion O 0 0.00037334259832277894
/ O 0 0.000691703986376524
insertion O 0 0.00024106424825731665
and O 0 6.505496276076883e-05
splice O 0 0.0008222123724408448
site O 0 0.0011450687889009714
mutations O 0 0.0002471553161740303
. O 0 0.0002840894157998264

These O 0 3.639681017375551e-05
mutations O 0 5.759000123362057e-05
were O 0 2.984748425660655e-05
scattered O 0 2.195273555116728e-05
over O 0 8.670727766002528e-06
the O 0 1.1210320735699497e-05
entire O 0 3.7581070500891656e-05
length O 0 2.3982513084774837e-05
of O 0 8.541553688701242e-05
PTEN O 0 0.009499235078692436
, O 0 7.4473146014497615e-06
with O 0 1.0352952131142956e-06
the O 0 3.5707364531845087e-06
exception O 0 3.6989927139075007e-06
of O 0 8.435186828137375e-06
the O 0 1.5031599104986526e-05
first O 0 2.545231836847961e-05
, O 0 7.270401511050295e-06
fourth O 0 5.549786510528065e-05
and O 0 1.5202068425423931e-05
last O 0 0.0001847990060923621
exons O 0 0.0006367923342622817
. O 0 0.00021750459563918412

A O 0 0.0026324624195694923
hot O 0 0.0008104402222670615
spot O 0 0.0002111218636855483
for O 0 3.704307528096251e-05
PTEN O 0 0.005463312845677137
mutation O 0 2.7046027753385715e-05
in O 0 3.10559116769582e-05
CD B-Disease 0 0.0004915451863780618
was O 0 0.00015797144442331046
identified O 0 1.10985420178622e-05
in O 0 1.3408282939053606e-05
exon O 0 9.027849591802806e-05
5 O 0 1.5256998267432209e-05
that O 0 1.1919903499801876e-06
contains O 0 3.993465270468732e-06
the O 0 1.8862805518438108e-05
PTPase O 0 0.002015703823417425
core O 0 0.0003630805585999042
motif O 0 5.852229878655635e-05
, O 0 2.488477093720576e-06
with O 0 1.262759838027705e-06
13 O 0 2.4675468011992052e-05
of O 0 3.099526293226518e-05
30 O 0 7.037315663183108e-05
( O 0 1.041141695168335e-05
43 O 0 2.7473632144392468e-05
% O 0 1.0994503099936992e-05
) O 0 1.422632431058446e-05
CD B-Disease 0 0.00026101406547240913
mutations O 0 1.9368191715329885e-05
identified O 0 1.2076398888893891e-05
in O 0 1.4789810848014895e-05
this O 0 1.7270102034672163e-05
exon O 0 0.0008668804657645524
. O 0 0.00012055454135406762

Seven O 0 0.00021894651581533253
of O 0 0.0001548389409435913
30 O 0 0.00019908268586732447
( O 0 2.7507974664331414e-05
23 O 0 7.300372089957818e-05
% O 0 8.609614269516896e-06
) O 0 3.869603460771032e-06
were O 0 4.606329639500473e-06
within O 0 3.654545935205533e-06
the O 0 1.4023463336343411e-05
core O 0 0.0003013061359524727
motif O 0 5.797362246084958e-05
, O 0 1.8509174424252706e-06
the O 0 3.3868341233755928e-06
majority O 0 1.9199858343199594e-06
( O 0 2.7781034077634104e-06
five O 0 2.89827380584029e-06
of O 0 1.0365508387621958e-05
seven O 0 1.8603286662255414e-05
) O 0 2.177413307435927e-06
of O 0 7.366133559116861e-06
which O 0 1.0184682651015464e-05
were O 0 2.9628998163389042e-05
missense O 0 0.00029378794715739787
mutations O 0 7.967430428834632e-05
, O 0 1.8759188606054522e-05
possibly O 0 4.8520323616685346e-05
pointing O 0 3.5071952879661694e-05
to O 0 3.7035320019640494e-06
the O 0 7.858970093366224e-06
functional O 0 2.3852340746088885e-05
significance O 0 8.207781502278522e-05
of O 0 5.8342873671790585e-05
this O 0 2.9502798497560434e-05
region O 0 0.000768216501455754
. O 0 0.00019176634668838233

Germline O 1 0.7243648171424866
PTEN O 1 0.8507436513900757
mutations O 0 0.00020005200349260122
were O 0 4.3626398110063747e-05
identified O 0 1.0693459444155451e-05
in O 0 6.626285994570935e-06
four O 0 2.7313838018017123e-06
of O 0 1.6225880244746804e-05
seven O 0 3.415703395148739e-05
( O 0 9.287710781791247e-06
57 O 0 6.906523776706308e-05
% O 0 3.061693496420048e-05
) O 0 7.641263073310256e-05
BZS B-Disease 0 0.03266884759068489
families O 0 6.949817907297984e-05
studied O 0 0.0005236975848674774
. O 0 0.00027592474361881614

Interestingly O 0 0.0012825087178498507
, O 0 2.6876870833802968e-05
none O 0 1.5265979527612217e-05
of O 0 1.5447043551830575e-05
these O 0 6.1422579165082425e-06
mutations O 0 3.286957144155167e-05
was O 0 0.0001600850810064003
observed O 0 1.9911371055059135e-05
in O 0 1.696659455774352e-05
the O 0 6.147014210000634e-05
PTPase O 0 0.021576296538114548
core O 0 0.0032493036706000566
motif O 0 0.0007971426821313798
. O 0 0.00024036539252847433

It O 0 4.527322016656399e-05
is O 0 7.201670996437315e-06
also O 0 1.933443400048418e-06
worthy O 0 2.519046756788157e-05
of O 0 1.1141980394313578e-05
note O 0 7.324321813939605e-06
that O 0 1.1919119060621597e-06
a O 0 5.854790742887417e-06
single O 0 8.923562745621894e-06
nonsense O 0 0.0001050251885317266
point O 0 9.297332871938124e-05
mutation O 0 9.164793482341338e-06
, O 0 8.506599442625884e-06
R233X O 0 0.00011311835987726226
, O 0 3.6759870454261545e-06
was O 0 2.17292872548569e-05
observed O 0 2.7735716230381513e-06
in O 0 2.7294413484924007e-06
the O 0 1.1274413736828137e-05
germline O 0 0.00012393630458973348
DNA O 0 2.3375978344120085e-05
from O 0 1.83341144293081e-05
two O 0 6.584766197192948e-06
unrelated O 0 5.3128907893551514e-05
CD B-Disease 0 0.00033924548188224435
families O 0 1.2101830179744866e-05
and O 0 1.4090276636125054e-05
one O 0 5.444111593533307e-05
BZS B-Disease 1 0.9978541731834412
family O 0 0.00021075201220810413
. O 0 0.00011352130968589336

Genotype O 0 0.004152779467403889
- O 0 0.0012947944924235344
phenotype O 0 5.8178753533866256e-05
studies O 0 7.5855705290450715e-06
were O 0 1.3235464393801522e-05
not O 0 1.69507200098451e-06
performed O 0 2.3672457245993428e-05
on O 0 1.560744203743525e-05
this O 0 3.1296228826249717e-06
small O 0 6.420654244720936e-06
group O 0 7.008675765973749e-06
of O 0 0.00012694614997599274
BZS B-Disease 1 0.9991994500160217
families O 0 0.0002290057163918391
. O 0 0.00022551394067704678

However O 0 0.00024124636547639966
, O 0 6.214335735421628e-05
genotype O 0 0.0002892052580136806
- O 0 0.0002928938192781061
phenotype O 0 3.338154056109488e-05
analysis O 0 5.2327704906929284e-06
inthe O 0 0.00042498321272432804
group O 0 1.5075930605235044e-05
of O 0 6.852563819848001e-05
CD B-Disease 0 0.0009414612432010472
families O 0 1.2980833162146155e-05
revealed O 0 4.631993579096161e-05
two O 0 2.4974353891593637e-06
possible O 0 6.227660378499422e-06
associations O 0 4.730104137706803e-06
worthy O 0 9.293219773098826e-05
of O 0 5.907893137191422e-05
follow O 0 5.3264102461980656e-05
- O 0 0.00010033344733528793
up O 0 2.2304388039628975e-05
in O 0 8.740024895814713e-06
independent O 0 9.073082765098661e-06
analyses O 0 4.473185254028067e-05
. O 0 0.00010120518709300086

The O 0 0.00012174406583653763
first O 0 5.662814510287717e-05
was O 0 0.00010127546556759626
an O 0 5.7034349083551206e-06
association O 0 1.6306670659105293e-05
noted O 0 1.2819280527764931e-05
in O 0 5.086015789856901e-06
the O 0 6.394499905582052e-06
group O 0 3.0823839551885612e-06
of O 0 2.766460966086015e-05
CD B-Disease 0 0.0007799715385772288
families O 0 3.599708725232631e-05
with O 0 0.00013427998055703938
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.002606153255328536

A O 0 0.00057031842879951
correlation O 0 5.8737834478961304e-05
was O 0 0.00013788767682854086
observed O 0 9.427421900909394e-06
between O 0 1.4893956176820211e-05
the O 0 1.159324892796576e-05
presence O 0 1.564019294164609e-05
/ O 0 4.524676478467882e-05
absence O 0 2.7005122319678776e-05
of O 0 5.192719618207775e-05
a O 0 0.0001274910755455494
PTEN O 0 0.07027527689933777
mutation O 0 9.463923561270349e-06
and O 0 3.84777467843378e-06
the O 0 9.348903404315934e-06
type O 0 4.052441363455728e-05
of O 0 0.000166983314557001
breast O 1 0.9067137241363525
involvement O 0 0.005429396405816078
( O 0 0.00027341939858160913
unaffected O 0 0.0011427041608840227
versus O 0 0.003019664203748107
benign O 1 0.9987314343452454
versus O 1 0.9992005228996277
malignant O 1 1.0
) O 0 0.0010267356410622597
. O 0 0.0005086432793177664

Specifically O 0 0.0001673990918789059
and O 0 1.2510127817222383e-05
more O 0 3.753117880478385e-06
directly O 0 1.1699874448822811e-05
, O 0 3.909202405338874e-06
an O 0 4.114238890906563e-06
association O 0 2.0362949726404622e-05
was O 0 9.400809358339757e-05
also O 0 3.2025411655922653e-06
observed O 0 3.160491814924171e-06
between O 0 9.883033271762542e-06
the O 0 4.220353275741218e-06
presence O 0 5.143201178725576e-06
of O 0 1.7731428670231253e-05
a O 0 0.00010536584886722267
PTEN O 1 0.9991814494132996
mutation O 0 0.00018154839926864952
and O 0 0.0007553930045105517
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.002421319019049406

Secondly O 0 0.00242842105217278
, O 0 3.0445182346738875e-05
there O 0 8.442219950666185e-06
appeared O 0 2.234935891465284e-05
to O 0 3.931605078832945e-06
be O 0 2.6457930744072655e-06
an O 0 4.841577720071655e-06
interdependent O 0 0.0002794860629364848
association O 0 5.3989351727068424e-05
between O 0 0.00023817627516109496
mutations O 0 6.969933747313917e-05
upstream O 0 0.00032184927840717137
and O 0 9.854601557890419e-06
within O 0 1.7485974240116775e-05
the O 0 5.104570300318301e-05
PTPase O 0 0.007958238013088703
core O 0 0.0009986868826672435
motif O 0 0.00010021181515185162
, O 0 6.4818204918992706e-06
the O 0 1.940433503477834e-05
core O 0 0.0001987708528758958
motif O 0 2.2100659407442436e-05
containing O 0 5.70451720705023e-06
the O 0 4.0291643017553724e-06
majority O 0 1.4014286762176198e-06
of O 0 3.408935299376026e-05
missense O 0 0.00040862333844415843
mutations O 0 4.428288957569748e-05
, O 0 8.42772533360403e-06
and O 0 3.0773967409913894e-06
the O 0 6.708538876409875e-06
involvement O 0 2.1760910385637544e-05
of O 0 1.9618762962636538e-05
all O 0 9.556686563882977e-06
major O 0 0.0008794046589173377
organ O 1 0.9998455047607422
systems O 0 0.00124654290266335
( O 0 4.4773882109439e-05
central O 0 0.0003706988354679197
nervous O 0 0.0007882786449044943
system O 0 0.00017019844381138682
, O 0 0.00012280180817469954
thyroid O 1 1.0
, O 1 0.7938333749771118
breast O 1 1.0
, O 1 0.9764624238014221
skin O 1 0.9999997615814209
and O 1 0.9997878670692444
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.42383140325546265
. O 0 0.0008891654433682561

However O 0 0.00013459354522638023
, O 0 7.39426559448475e-06
these O 0 1.542831910228415e-06
observations O 0 9.50850335357245e-06
would O 0 2.7707110348274e-06
need O 0 2.6899660952039994e-06
to O 0 2.7733094611903653e-06
be O 0 3.697384727274766e-06
confirmed O 0 4.637510301108705e-06
by O 0 1.5817676057849894e-06
studying O 0 6.633190423599444e-06
a O 0 5.3396879593492486e-06
larger O 0 4.792154868482612e-06
number O 0 2.2684241685055895e-06
of O 0 4.0667306166142225e-05
CD B-Disease 0 0.0014325331430882215
families O 0 6.550578837050125e-05
. O 0 0.00015467424236703664

Molecular O 0 0.20946332812309265
defects O 1 0.9993078708648682
leading O 0 0.0003136583254672587
to O 0 1.301668362430064e-05
human O 0 1.8163080312660895e-05
complement B-Disease 0 0.00014802705845795572
component I-Disease 1 0.9999693632125854
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00016846825019456446
an O 0 2.2065109078539535e-05
African O 0 0.00015127312508411705
- O 0 0.00017552550707478076
American O 0 3.2528307201573625e-05
family O 0 5.747785326093435e-05
. O 0 8.182150486391038e-05

Complement B-Disease 0 0.004889102187007666
component I-Disease 1 0.9999942779541016
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.0075205108150839806
C6D B-Disease 1 0.9999935626983643
) O 0 9.63299535214901e-05
was O 0 0.0005477525410242379
diagnosed O 0 0.0018505562329664826
in O 0 2.5167366402456537e-05
a O 0 3.4433527616783977e-05
16 O 0 8.750968117965385e-05
- O 0 7.977838686201721e-05
year O 0 2.336345278308727e-05
- O 0 3.734150595846586e-05
old O 0 4.649376933230087e-05
African O 0 3.6474360967986286e-05
- O 0 4.903469016426243e-05
American O 0 1.118659110943554e-05
male O 0 5.835589035996236e-05
with O 0 0.00011562039435375482
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.004074651747941971

The O 0 0.0006140685873106122
patients O 0 0.00033046226599253714
father O 0 0.00027814338682219386
and O 0 1.4856392226647586e-05
two O 0 1.5672667359467596e-05
brothers O 0 0.00024659678456373513
also O 0 1.5398598407045938e-05
had O 0 0.00011589148925850168
C6D B-Disease 1 0.9946020841598511
, O 0 6.572237907676026e-06
but O 0 1.0733649560279446e-06
gave O 0 3.2350274068448925e-06
no O 0 2.456606580381049e-06
history O 0 4.071856528753415e-05
of O 0 0.00021963818289805204
meningitis B-Disease 1 0.9999997615814209
or O 0 0.00025848878431133926
other O 0 0.0001940328802447766
neisserial B-Disease 1 0.9999979734420776
infection I-Disease 1 0.9997138381004333
. O 0 0.00036032008938491344

By O 0 4.131525565753691e-05
using O 0 2.7594051061896607e-05
exon O 0 0.00022805354092270136
- O 0 4.352969699539244e-05
specific O 0 1.0692618843677337e-06
polymerase O 0 5.534692536457442e-05
chain O 0 4.1424340452067554e-05
reaction O 0 7.577355972898658e-06
( O 0 1.1847929272335023e-05
PCR O 0 2.8882723199785687e-05
) O 0 1.5428027836605906e-05
/ O 0 0.00011542189167812467
single O 0 3.222046871087514e-05
- O 0 0.00020574397058226168
strand O 0 6.387529720086604e-05
conformation O 0 2.2406507923733443e-05
polymorphism O 0 9.647230399423279e-06
as O 0 7.570190973638091e-06
a O 0 6.270162430155324e-06
screening O 0 6.629579274886055e-06
step O 0 1.842202436819207e-05
and O 0 2.141557388313231e-06
nucleotide O 0 3.742773515114095e-06
sequencing O 0 6.30046270089224e-06
of O 0 1.0813649168994743e-05
target O 0 1.4194612049323041e-05
exons O 0 6.509046215796843e-05
, O 0 3.804868811130291e-06
we O 0 1.2929777994941105e-06
determined O 0 2.458214339640108e-06
that O 0 6.073920530980104e-07
the O 0 9.864390449365601e-06
proband O 0 0.0005828439025208354
was O 0 0.00012903872993774712
a O 0 1.3252781172923278e-05
compound O 0 4.873767466051504e-05
heterozygote O 0 9.478202991886064e-05
for O 0 1.3714090528083034e-05
two O 0 5.789864371763542e-05
C6 O 1 0.9998558759689331
gene O 0 0.00018312370229978114
mutations O 0 0.00016993185272440314
. O 0 0.00017059520178008825

The O 0 0.00021962476603221148
first O 0 0.00010516770271351561
, O 0 1.9701952624018304e-05
1195delC O 0 0.0003354586660861969
located O 0 0.00011207357601961121
in O 0 1.707976480247453e-05
exon O 0 0.00015441961295437068
7 O 0 5.076143497717567e-05
, O 0 2.3005327420833055e-06
is O 0 1.7431378864785074e-06
a O 0 2.701133098526043e-06
novel O 0 5.73640454604174e-06
mutation O 0 1.6698526223990484e-06
, O 0 1.7459312857681653e-06
while O 0 1.8543804571891087e-06
the O 0 5.702738690160913e-06
second O 0 1.9823684851871803e-05
, O 0 6.7187957029091194e-06
1936delG O 0 0.00018082745373249054
in O 0 4.453324800124392e-05
exon O 0 0.00028996728360652924
12 O 0 5.215548299020156e-05
, O 0 6.08934169576969e-06
has O 0 3.4804879760486074e-06
been O 0 5.209089977142867e-06
described O 0 1.0192784429818857e-05
before O 0 2.485166442056652e-05
to O 0 2.6001580408774316e-05
cause O 0 0.0002589646028354764
C6D B-Disease 1 0.9132495522499084
in O 0 3.858776472043246e-05
an O 0 1.0525225661695004e-05
unrelated O 0 0.0001662111171754077
African O 0 0.00030327800777740777
- O 0 0.00023142367717809975
American O 0 2.3323156710830517e-05
individual O 0 1.81945797521621e-05
. O 0 0.00012413902732077986

Both O 0 0.00010034914157586172
mutations O 0 8.251101098721847e-05
result O 0 8.416024502366781e-05
in O 0 0.00011432432074798271
premature O 0 0.0006358359241858125
termination O 0 0.0005769316921941936
codons O 0 0.0008931566262617707
and O 0 0.0005050873733125627
C6 O 1 0.9972078204154968
null O 0 0.001209263689815998
alleles O 0 0.00032550719333812594
. O 0 0.0004607216105796397

Allele O 0 0.000304115324979648
- O 0 0.0001430144620826468
specific O 0 2.172097765651415e-06
PCR O 0 2.1451452994369902e-05
indicated O 0 9.24860705708852e-06
that O 0 1.0816399935720256e-06
the O 0 8.300295121443924e-06
probands O 0 0.000461461313534528
two O 0 1.2402113497955725e-05
brothers O 0 0.0001377347216475755
also O 0 1.630999759072438e-05
inherited O 0 0.002472058404237032
the O 0 7.530469156336039e-05
1195delC O 0 0.000500204274430871
mutation O 0 7.9964902397478e-06
from O 0 1.3102157026878558e-05
their O 0 6.16631587035954e-06
heterozygous O 0 2.39894197875401e-05
mother O 0 3.1206018320517614e-05
and O 0 3.5761413528234698e-06
the O 0 1.6444500943180174e-05
1936delG O 0 0.00041403991053812206
mutation O 0 8.758406693232246e-06
from O 0 1.5554218407487497e-05
their O 0 8.631433047412429e-06
homozygous O 0 0.00013721770665142685
father O 0 0.0004259594716131687
. O 0 5.735619197366759e-05
. O 0 0.00011045306746382266

PAX6 O 1 0.9836506247520447
mutations O 0 0.001334958360530436
reviewed O 0 0.001198678044602275
. O 0 0.00047801397158764303

Mutations O 0 0.0005091705825179815
in O 0 0.0002244135830551386
PAX6 O 0 0.00970552023500204
are O 0 4.88427667733049e-06
responsible O 0 1.7555787053424865e-05
for O 0 9.632429282646626e-06
human O 0 8.1952843174804e-05
aniridia B-Disease 1 0.999987006187439
and O 0 1.0739018762251362e-05
have O 0 1.8944618886962417e-06
also O 0 1.472750795983302e-06
been O 0 2.9191171506681712e-06
found O 0 1.1468769116618205e-06
in O 0 3.6108531276113354e-06
patients O 0 1.0669835319276899e-05
with O 0 1.828396852943115e-05
Peters B-Disease 1 0.9999990463256836
anomaly I-Disease 1 0.9999998807907104
, O 0 0.00032351911067962646
with O 1 0.9994445443153381
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.999925971031189
with O 1 0.9507784247398376
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.00022554576571565121
and O 0 2.6922942197415978e-05
with O 0 0.00013355659029912204
isolated B-Disease 1 0.9999921321868896
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.014544932171702385

No O 0 0.00016612761828582734
locus O 0 0.00018306958372704685
other O 0 1.16206119855633e-05
than O 0 2.5946983441826887e-05
chromosome O 0 0.0002511836646590382
11p13 O 0 0.0005141958245076239
has O 0 1.2202750440337695e-05
been O 0 1.338251695415238e-05
implicated O 0 0.00014808282139711082
in O 0 7.6437478128355e-05
aniridia B-Disease 1 0.9999961853027344
, O 0 3.7623165553668514e-05
and O 0 1.608417551324237e-05
PAX6 O 0 0.05309442803263664
is O 0 1.3313128874870017e-05
clearly O 0 1.60267863975605e-05
the O 0 9.190025593852624e-06
major O 0 5.1892202463932335e-05
, O 0 5.129671535542002e-06
if O 0 1.0392799367764383e-06
not O 0 5.684737516276073e-07
only O 0 1.666589810156438e-06
, O 0 4.388329671201063e-06
gene O 0 2.3088092348189093e-05
responsible O 0 0.00013620142999570817
. O 0 0.00023390933347400278

Twenty O 0 0.002181069925427437
- O 0 0.0002628443471621722
eight O 0 1.724551293591503e-05
percent O 0 1.0913042387983296e-05
of O 0 2.0863972167717293e-05
identified O 0 7.685188029427081e-05
PAX6 O 0 0.00405536824837327
mutations O 0 6.687965651508421e-05
are O 0 1.2957654689671472e-05
C O 0 0.001668037031777203
- O 0 0.001003510900773108
T O 0 0.0007027337560430169
changes O 0 9.475229489908088e-06
at O 0 0.00018646474927663803
CpG O 0 0.000514294661115855
dinucleotides O 0 0.0006842805305495858
, O 0 7.476719019905431e-06
20 O 0 1.2204333870613482e-05
% O 0 2.796914031932829e-06
are O 0 1.7340518070341204e-06
splicing O 0 2.5460743927396834e-05
errors O 0 9.407122706761584e-05
, O 0 8.701004844624549e-06
and O 0 2.4219830265792552e-06
more O 0 7.417301048917579e-07
than O 0 1.1512031505844789e-06
30 O 0 6.923390174051747e-06
% O 0 2.572528046584921e-06
are O 0 9.441650377084443e-07
deletion O 0 2.9237502531032078e-05
or O 0 2.812115963024553e-05
insertion O 0 0.00022543333761859685
events O 0 0.0004439055628608912
. O 0 0.0003239728102926165

There O 0 0.00018300082592759281
is O 0 3.985167859354988e-05
a O 0 5.698681707144715e-05
noticeably O 0 0.0011648462386801839
elevated O 0 0.0020171795040369034
level O 0 0.00010785931226564571
of O 0 3.2425206882180646e-05
mutation O 0 8.752436770009808e-06
in O 0 8.944369255914353e-06
the O 0 1.2557389709400013e-05
paired O 0 1.4171482689562254e-05
domain O 0 1.180439539893996e-05
compared O 0 1.013605924526928e-05
with O 0 1.8520262301535695e-06
the O 0 1.1326335879857652e-05
rest O 0 2.3111973860068247e-05
of O 0 2.414869231870398e-05
the O 0 6.236646004253998e-05
gene O 0 0.00010134995682165027
. O 0 9.523665357846767e-05

Increased O 0 0.00033274732413701713
mutation O 0 1.8938075299956836e-05
in O 0 1.4643319445895031e-05
the O 0 2.5093884687521495e-05
homeodomain O 0 0.00027422007406130433
is O 0 7.001020094321575e-06
accounted O 0 1.8262671801494434e-05
for O 0 3.092814040428493e-06
by O 0 7.101136816345388e-06
the O 0 7.226612069644034e-05
hypermutable O 0 0.005412467289716005
CpG O 0 0.0017972899368032813
dinucleotide O 0 0.001372526865452528
in O 0 0.00014297667075879872
codon O 0 0.0001758498401613906
240 O 0 0.0003012578818015754
. O 0 0.0001739001163514331

Very O 0 9.742242400534451e-05
nearly O 0 3.929481317754835e-05
all O 0 4.488999366003554e-06
mutations O 0 1.8170876501244493e-05
appear O 0 3.237202690797858e-05
to O 0 1.6606052668066695e-05
cause O 0 3.673694664030336e-05
loss O 0 6.24782478553243e-05
of O 0 1.4075958461035043e-05
function O 0 1.0668474715203047e-05
of O 0 1.9374840121599846e-05
the O 0 1.9858993255184032e-05
mutant O 0 2.9794642614433542e-05
allele O 0 4.689876732300036e-06
, O 0 1.4125105280982098e-06
and O 0 3.056048001326417e-07
more O 0 2.57819152693628e-07
than O 0 6.350903731799917e-07
80 O 0 8.04115097707836e-06
% O 0 3.7756590245408006e-06
of O 0 5.0951064622495323e-05
exonic O 0 0.0025889973621815443
substitutions O 0 0.0001459862687624991
result O 0 6.684216350549832e-05
in O 0 9.445018076803535e-05
nonsense O 0 0.000816400395706296
codons O 0 0.0006218173075467348
. O 0 0.00033936320687644184

In O 0 0.00016213282651733607
a O 0 6.23205560259521e-05
gene O 0 2.2590034859604202e-05
with O 0 4.406185780680971e-06
such O 0 6.997976015554741e-06
extraordinarily O 0 0.00024711198057048023
high O 0 8.922799315769225e-05
sequence O 0 6.204866167536238e-06
conservation O 0 6.349193427013233e-06
throughout O 0 2.614290679048281e-06
evolution O 0 1.1260960491199512e-05
, O 0 1.4746143506272347e-06
there O 0 1.3313903082234901e-06
are O 0 1.2499934882725938e-06
presumed O 0 0.00019120895012747496
undiscovered O 0 0.011167557910084724
missense O 0 0.0004498419293668121
mutations O 0 4.8685880756238475e-05
, O 0 4.479658855416346e-06
these O 0 1.3419017932392308e-06
are O 0 1.463473950025218e-06
hypothesized O 0 3.442341403570026e-05
to O 0 7.807336260157172e-06
exist O 0 2.2993763195700012e-05
in O 0 2.1622377971652895e-05
as O 0 6.44897882011719e-05
- O 0 0.00022562038793694228
yet O 0 3.459335493971594e-05
unidentified O 0 0.00016525380488019437
phenotypes O 0 0.00018911146617028862
. O 0 4.799596717930399e-05
. O 0 0.00013686776219401509

Genetic O 0 0.001738634193316102
heterogeneity O 0 0.0007877455209381878
and O 0 4.3266765715088695e-05
penetrance O 0 0.0003207257541362196
analysis O 0 2.7862702154379804e-06
of O 0 3.0317756682052277e-05
the O 0 7.692674989812076e-05
BRCA1 O 0 0.00036555039696395397
and O 0 2.6296129362890497e-05
BRCA2 O 0 0.0003578114847186953
genes O 0 5.661075920215808e-05
in O 0 0.00017351699352730066
breast B-Disease 1 0.9998632669448853
cancer I-Disease 1 0.9994919300079346
families O 0 0.00020062965631950647
. O 0 0.0004076679761055857

The O 0 0.03585709631443024
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.999941349029541
Consortium O 0 0.005384269170463085
. O 0 0.00039117567939683795

The O 0 2.8217789804330096e-05
contribution O 0 4.7909998102113605e-05
of O 0 0.00011198202992090955
BRCA1 O 0 0.0006597362225875258
and O 0 3.177472171955742e-05
BRCA2 O 0 0.0008882774272933602
to O 0 0.00028342902078293264
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.6303310990333557
assessed O 0 7.442289643222466e-05
by O 0 6.74762623020797e-06
linkage O 0 7.713293598499149e-05
and O 0 5.789726856164634e-06
mutation O 0 1.6130973108374747e-06
analysis O 0 1.0067112725664629e-06
in O 0 7.873996764828917e-06
237 O 0 2.8816473786719143e-05
families O 0 2.684973424038617e-06
, O 0 1.2290096265132888e-06
each O 0 3.1730840532873117e-07
with O 0 8.746110324864276e-07
at O 0 3.4276530641363934e-05
least O 0 2.8614551865757676e-06
four O 0 1.5314986967496225e-06
cases O 0 4.215164608467603e-06
of O 0 0.00018525542691349983
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9992029070854187
, O 0 7.632650522282347e-06
collected O 0 5.628823601000477e-06
by O 0 6.158211817819392e-06
the O 0 0.0001838725438574329
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9998688697814941
Consortium O 0 0.002296257298439741
. O 0 0.0002536158717703074

Families O 0 3.955974170821719e-05
were O 0 2.187645441154018e-05
included O 0 7.963036296132486e-06
without O 0 6.387484972947277e-06
regard O 0 2.4939150534919463e-05
to O 0 8.479466487187892e-06
the O 0 1.6447231246274896e-05
occurrence O 0 6.22988081886433e-05
of O 0 0.0005508179310709238
ovarian B-Disease 1 1.0
or I-Disease 0 0.003263874677941203
other I-Disease 0 0.0009651488508097827
cancers I-Disease 1 0.9999992847442627
. O 0 0.0014920355752110481

Overall O 0 0.0009387651807628572
, O 0 0.00016524498641956598
disease O 1 0.9998648166656494
was O 0 0.001128972857259214
linked O 0 0.00021706457482650876
to O 0 2.097125252475962e-05
BRCA1 O 0 0.00011225452908547595
in O 0 6.6341390265733935e-06
an O 0 1.5987212691470631e-06
estimated O 0 8.100122613541316e-06
52 O 0 6.607393515878357e-06
% O 0 1.47359367019817e-06
of O 0 1.1130489838251378e-05
families O 0 7.498533250327455e-06
, O 0 6.7573628257378004e-06
to O 0 1.3860114449926186e-05
BRCA2 O 0 0.00012439474812708795
in O 0 1.213357609231025e-05
32 O 0 1.6504080122103915e-05
% O 0 3.270783054176718e-06
of O 0 1.4105508853390347e-05
families O 0 6.109164132794831e-06
, O 0 5.055877863924252e-06
and O 0 1.7558562603881e-06
to O 0 4.653783435060177e-06
neither O 0 1.2628484910237603e-05
gene O 0 3.4784341096383287e-06
in O 0 6.576281521120109e-06
16 O 0 2.3070353563525714e-05
% O 0 5.735464128520107e-06
( O 0 4.996670668333536e-06
95 O 0 1.7012089301715605e-05
% O 0 6.21587605564855e-06
confidence O 0 0.00010615752398734912
interval O 0 0.00018023668962996453
[ O 0 0.0006226718542166054
CI O 0 0.28666526079177856
] O 0 0.00012113034608773887
6 O 0 6.163896614452824e-05
% O 0 1.3970417057862505e-05
- O 0 6.687901623081416e-05
28 O 0 4.855670340475626e-05
% O 0 8.685500688443426e-06
) O 0 5.7312317949254066e-06
, O 0 4.9829463932837825e-06
suggesting O 0 2.654387390066404e-05
other O 0 1.4059403838473372e-05
predisposition O 0 0.005933425854891539
genes O 0 0.0005468546878546476
. O 0 0.0003249082074034959

The O 0 6.0840771766379476e-05
majority O 0 1.580234857101459e-05
( O 0 1.3895768461225089e-05
81 O 0 2.6873078240896575e-05
% O 0 3.857330739265308e-06
) O 0 1.4879426544212038e-06
of O 0 1.0025160008808598e-05
the O 0 0.00022539205383509398
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.647286601131782e-05
were O 0 3.785725130001083e-05
due O 0 9.958937880583107e-05
to O 0 4.2971289076376706e-05
BRCA1 O 0 0.000284377223579213
, O 0 7.92027549323393e-06
with O 0 2.564608621469233e-06
most O 0 5.973294719296973e-06
others O 0 7.764181646052748e-06
( O 0 8.506851372658275e-06
14 O 0 4.6650591684738174e-05
% O 0 1.3406991456577089e-05
) O 0 1.6589699953328818e-05
due O 0 0.00019000255269929767
to O 0 0.00018677079060580581
BRCA2 O 0 0.003811327973380685
. O 0 0.00031227804720401764

Conversely O 0 0.0004158694064244628
, O 0 9.566662811266724e-06
the O 0 5.292897640174488e-06
majority O 0 2.5039457796083298e-06
of O 0 1.4301002920547035e-05
families O 0 7.755582373647485e-06
with O 0 1.266962044610409e-05
male B-Disease 0 0.0001454725570511073
and I-Disease 0 5.962016439298168e-05
female I-Disease 0 0.001193757401779294
breast I-Disease 1 0.9999797344207764
cancer I-Disease 1 0.9998062252998352
were O 0 7.974902109708637e-05
due O 0 0.0001723495515761897
to O 0 3.60744415957015e-05
BRCA2 O 0 0.000315450452035293
( O 0 2.7432997740106657e-05
76 O 0 0.00021496250701602548
% O 0 7.07924846210517e-05
) O 0 8.764547237660736e-05
. O 0 0.00020759152539540082

The O 0 0.00026057398645207286
largest O 0 0.00023887446150183678
proportion O 0 4.863557842327282e-05
( O 0 1.0577872672001831e-05
67 O 0 3.468068825895898e-05
% O 0 9.19271678867517e-06
) O 0 4.962942512065638e-06
of O 0 1.6859530660440214e-05
families O 0 6.214679160621017e-06
due O 0 4.9031415983336046e-05
to O 0 8.021788744372316e-06
other O 0 2.666760792635614e-06
genes O 0 9.36297328735236e-06
was O 0 5.938428876106627e-05
found O 0 2.3830241389077855e-06
in O 0 1.7691384073259542e-06
families O 0 9.797998927751905e-07
with O 0 1.1847992027469445e-06
four O 0 4.340846317063551e-06
or O 0 3.711091267177835e-06
five O 0 6.510962521133479e-06
cases O 0 5.5418845477106515e-06
of O 0 0.00014704217028338462
female O 1 0.5027409195899963
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999922513961792
only O 0 0.00020453402248676866
. O 0 0.00017996346286963671

These O 0 4.2020430555567145e-05
estimates O 0 3.9033380744513124e-05
were O 0 2.6266205168212764e-05
not O 0 6.762843440810684e-06
substantially O 0 5.952211722615175e-05
affected O 0 1.132376473833574e-05
either O 0 4.214593900542241e-06
by O 0 2.0922411749779712e-06
changing O 0 8.458959200652316e-06
the O 0 1.2520045856945217e-05
assumed O 0 8.94906188477762e-05
penetrance O 0 0.0002442593686282635
model O 0 8.879472261469346e-06
for O 0 1.2593462997756433e-05
BRCA1 O 0 0.0002236162545159459
or O 0 9.739904271555133e-06
by O 0 4.0020277083385736e-06
including O 0 1.0331784324080218e-05
or O 0 3.03930246445816e-05
excluding O 0 0.00025340678985230625
BRCA1 O 0 0.0006921298918314278
mutation O 0 4.6825218305457383e-05
data O 0 8.451829489786178e-05
. O 0 0.0001412198762409389

Among O 0 9.727222641231492e-05
those O 0 1.1437899047450628e-05
families O 0 1.128069379774388e-05
with O 0 5.630355735775083e-05
disease O 1 0.9999816417694092
due O 0 0.0010867950040847063
to O 0 9.034635149873793e-05
BRCA1 O 0 0.0002624754561111331
that O 0 2.9742677725153044e-06
were O 0 7.626153546880232e-06
tested O 0 5.98705128140864e-06
by O 0 1.034860929394199e-06
one O 0 1.1869922218465945e-06
of O 0 7.570451543870149e-06
the O 0 1.0908641343121417e-05
standard O 0 1.6084573871921748e-05
screening O 0 1.0474276677996386e-05
methods O 0 8.613457794126589e-06
, O 0 6.327861228783149e-06
mutations O 0 1.1285728760412894e-05
were O 0 2.2023023120709695e-05
detected O 0 6.701449456159025e-05
in O 0 4.19463322032243e-06
the O 0 4.107237600692315e-06
coding O 0 1.0275138265569694e-05
sequence O 0 4.383553005027352e-06
or O 0 4.5679994400416035e-06
splice O 0 3.83700207748916e-05
sites O 0 1.2619383596756961e-05
in O 0 4.678685854742071e-06
an O 0 2.885262347263051e-06
estimated O 0 1.4350567653309554e-05
63 O 0 1.8604847355163656e-05
% O 0 4.745565547636943e-06
( O 0 5.127773874846753e-06
95 O 0 2.2863181584398262e-05
% O 0 2.6872821763390675e-05
CI O 0 0.009365648031234741
51 O 0 0.00013360154116526246
% O 0 4.660905688069761e-05
- O 0 0.00012997331214137375
77 O 0 9.426950418855995e-05
% O 0 3.441251828917302e-05
) O 0 6.719821249134839e-05
. O 0 7.573232869617641e-05

The O 0 0.00013349813525564969
estimated O 0 0.00010920908971456811
sensitivity O 0 9.06103741726838e-05
was O 0 0.00010066627146443352
identical O 0 2.8404060685716104e-06
for O 0 2.4282785489049274e-06
direct O 0 7.892468602221925e-06
sequencing O 0 2.4465194655931555e-05
and O 0 9.382682947034482e-06
other O 0 8.874002560332883e-06
techniques O 0 0.00015665817772969604
. O 0 0.00021468233899213374

The O 0 0.00034972786670550704
penetrance O 0 0.001689339755102992
of O 0 0.00030101730953902006
BRCA2 O 0 0.0018074765102937818
was O 0 0.00031392424716614187
estimated O 0 4.243796138325706e-05
by O 0 4.312494638725184e-06
maximizing O 0 5.3328451031120494e-05
the O 0 4.744877151097171e-05
LOD O 0 0.007565274368971586
score O 0 8.224423072533682e-05
in O 0 9.100185707211494e-05
BRCA2 O 0 0.0008674142300151289
- O 0 0.0001697550032986328
mutation O 0 3.3441856430727057e-06
families O 0 1.7965871847991366e-06
, O 0 1.8699728343563038e-06
over O 0 5.5682771744614e-06
all O 0 2.792202167256619e-06
possible O 0 3.561458652256988e-05
penetrance O 0 0.0009073866531252861
functions O 0 0.00019726756727322936
. O 0 0.0004895187448710203

The O 0 6.483287870651111e-05
estimated O 0 5.108641562401317e-05
cumulative O 0 9.987505472963676e-05
risk O 0 9.091935498872772e-05
of O 0 0.00023600278655067086
breast B-Disease 1 0.9998830556869507
cancer I-Disease 1 0.9918428659439087
reached O 0 0.0003570950066205114
28 O 0 9.925394260790199e-05
% O 0 4.763676315633347e-06
( O 0 5.469850293593481e-06
95 O 0 2.626142122608144e-05
% O 0 2.393670001765713e-05
CI O 0 0.01862381026148796
9 O 0 0.00017381440557073802
% O 0 1.1332645954098552e-05
- O 0 3.802926585194655e-05
44 O 0 1.3385170859692153e-05
% O 0 5.384406449593371e-06
) O 0 3.4334921110712457e-06
by O 0 3.92169658880448e-06
age O 0 4.189104220131412e-05
50 O 0 2.8060459953849204e-05
years O 0 3.208898124285042e-05
and O 0 4.8250808504235465e-06
84 O 0 4.6260560338851064e-05
% O 0 9.124520147452131e-06
( O 0 1.0946356269414537e-05
95 O 0 4.5325712562771514e-05
% O 0 4.390646063257009e-05
CI O 0 0.011685512959957123
43 O 0 0.00010850199032574892
% O 0 1.6954076272668317e-05
- O 0 6.436200783355162e-05
95 O 0 2.1765061319456436e-05
% O 0 7.790542440488935e-06
) O 0 5.483576387632638e-06
by O 0 5.061348929302767e-06
age O 0 0.00014137427206151187
70 O 0 0.00025388054200448096
years O 0 0.0006683251122012734
. O 0 0.00032682003802619874

The O 0 0.00024142077018041164
corresponding O 1 0.587348461151123
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9967040419578552
were O 0 0.00036816069041378796
0 O 0 0.00032099371310323477
. O 0 0.0002016706857830286

4 O 0 0.00029477186035364866
% O 0 4.0305309084942564e-05
( O 0 2.786337245197501e-05
95 O 0 6.375115481205285e-05
% O 0 5.0753595132846385e-05
CI O 0 0.006398383527994156
0 O 0 4.1462677472736686e-05
% O 0 1.8864207959268242e-05
- O 0 6.955505523364991e-05
1 O 0 3.964380084653385e-05
% O 0 5.033565230405657e-06
) O 0 3.3386220366082853e-06
by O 0 2.3763948320265627e-06
age O 0 2.0414008758962154e-05
50 O 0 1.4277970876719337e-05
years O 0 2.120404678862542e-05
and O 0 4.12611325373291e-06
27 O 0 3.545646904967725e-05
% O 0 6.961625331314281e-06
( O 0 6.501860298158135e-06
95 O 0 3.6307956179371104e-05
% O 0 2.421869066893123e-05
CI O 0 0.004464070312678814
0 O 0 3.739709791261703e-05
% O 0 1.8126551367458887e-05
- O 0 5.5422558943973854e-05
47 O 0 2.156710070266854e-05
% O 0 5.48911748410319e-06
) O 0 3.019060841324972e-06
by O 0 3.8207190300454386e-06
age O 0 8.406736014876515e-05
70 O 0 0.00014413308235816658
years O 0 0.0003265409613959491
. O 0 0.00022011720284353942

The O 0 0.00011470050230855122
lifetime O 0 0.00026075911591760814
risk O 0 0.00018996158905792981
of O 0 0.0011300870683044195
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999818801879883
appears O 0 4.4163625716464594e-05
similar O 0 8.925043744056893e-07
to O 0 2.0324357592471642e-06
the O 0 7.97790471551707e-06
risk O 0 2.101381505781319e-05
in O 0 2.6124662326765247e-05
BRCA1 O 0 0.0002255648869322613
carriers O 0 1.5657533367630094e-05
, O 0 2.6708153200161178e-06
but O 0 8.264390771728358e-07
there O 0 2.3581917503179284e-06
was O 0 3.174891753587872e-05
some O 0 1.468917275815329e-06
suggestion O 0 8.34528236737242e-06
of O 0 1.584468009241391e-05
a O 0 3.6581863241735846e-05
lower O 0 8.017419168027118e-05
risk O 0 5.207199865253642e-05
in O 0 4.709206405095756e-05
BRCA2 O 0 0.000525144103448838
carriers O 0 8.169161446858197e-05
< O 0 0.000246342271566391
50 O 0 4.978270590072498e-05
years O 0 8.260524191427976e-05
of O 0 0.00014722399646416306
age O 0 0.0013298188569024205
. O 0 0.00048423177213408053

Eye B-Disease 1 0.9999654293060303
movement I-Disease 0 0.002752642147243023
abnormalities I-Disease 0 0.16472633183002472
correlate O 0 0.00011599453137023374
with O 0 2.1452291548484936e-05
genotype O 0 0.0002011679025599733
in O 0 0.0002988720079883933
autosomal O 1 0.9992865920066833
dominant O 1 0.9999922513961792
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.0011857976205646992

We O 0 0.00023721037723589689
compared O 0 0.0006441593868657947
horizontal O 0 0.0022852164693176746
eye O 0 0.03965821489691734
movements O 0 0.00024482220760546625
( O 0 0.00012212357250973582
visually O 0 0.0003096719738095999
guided O 0 0.0006585467490367591
saccades O 0 0.007041879463940859
, O 0 8.938384416978806e-05
antisaccades O 0 0.0017655860865488648
, O 0 1.9170336599927396e-05
and O 0 1.2391131349431816e-05
smooth O 0 0.00015222000365611166
pursuit O 0 0.0002568915078882128
) O 0 1.1307771274005063e-05
in O 0 1.159488510893425e-05
control O 0 3.108275996055454e-05
subjects O 0 6.175816815812141e-05
( O 0 1.9011016775039025e-05
n O 0 5.823714309372008e-05
= O 0 8.252297266153619e-05
14 O 0 5.12397127749864e-05
) O 0 5.339020844985498e-06
and O 0 2.68416442850139e-06
patients O 0 3.7486679502762854e-06
with O 0 1.174856151919812e-06
three O 0 4.300305590732023e-06
forms O 0 1.4526692211802583e-05
of O 0 0.0005900678224861622
autosomal O 1 0.9997461438179016
dominant O 1 0.9999325275421143
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999990463256836
type I-Disease 1 0.9961262345314026
I I-Disease 1 0.9997938275337219
spinocerebellar B-Disease 1 0.9999219179153442
ataxias I-Disease 0 0.00364817027002573
1 I-Disease 0 0.00014462706167250872
and I-Disease 0 1.0794268746394664e-05
2 I-Disease 0 8.217038703151047e-05
( O 0 2.4496688638464548e-05
SCA1 B-Disease 0 0.004069643095135689
, O 0 1.0993318028340582e-05
n O 0 2.148753083019983e-05
= O 0 4.431076013133861e-05
11 O 0 5.521839557331987e-05
; O 0 7.238052148750285e-06
SCA2 B-Disease 0 0.0023469622246921062
, O 0 6.288295026024571e-06
n O 0 1.2059503205819055e-05
= O 0 2.9504144549719058e-05
10 O 0 1.533473187009804e-05
) O 0 5.342117219697684e-06
and O 0 2.5204835765180178e-05
SCA3 B-Disease 1 0.9999997615814209
/ O 0 0.0016956304898485541
Machado B-Disease 0 0.0018818078096956015
- I-Disease 0 0.0009148464305326343
Joseph I-Disease 1 0.8591856360435486
disease I-Disease 1 0.999901294708252
( O 0 0.0001677709078649059
MJD B-Disease 1 0.9999996423721313
) O 0 3.7940593756502494e-05
( O 0 1.2435534699761774e-05
n O 0 3.519484744174406e-05
= O 0 0.0001044959353748709
16 O 0 0.00012324853742029518
) O 0 4.8207624786300585e-05
. O 0 8.556195098208264e-05

In O 0 0.001206069253385067
SCA1 B-Disease 1 0.9226004481315613
, O 0 4.710872963187285e-05
saccade O 0 0.0002875923819374293
amplitude O 0 0.00015096503193490207
was O 0 0.00028001575265079737
significantly O 0 7.002526399446651e-05
increased O 0 3.86785832233727e-05
, O 0 1.4762403225176968e-05
resulting O 0 7.243522850330919e-05
in O 0 0.00013814007979817688
hypermetria B-Disease 0 0.011973603628575802
. O 0 0.0004197599191684276

The O 0 0.00045119639253243804
smooth O 0 0.000467765232315287
pursuit O 0 0.0004483570228330791
gain O 0 0.0005684696952812374
was O 0 0.001955244457349181
decreased O 0 0.0026116238441318274
. O 0 0.00022272257774602622

In O 0 0.0016960800858214498
SCA2 B-Disease 1 0.9802225232124329
, O 0 7.050958083709702e-05
saccade O 0 0.0003755320212803781
velocity O 0 0.00015727945719845593
was O 0 0.0005702279740944505
markedly O 0 0.0015999410534277558
decreased O 0 0.0016039869515225291
. O 0 0.00027057150145992637

The O 0 0.00014952753554098308
percentage O 0 0.00010037152969744056
of O 0 0.00010582641698420048
errors O 0 0.0004457776958588511
in O 0 0.00020111115009058267
antisaccades O 0 0.009781691245734692
was O 0 0.00022175841149874032
greatly O 0 5.758813495049253e-05
increased O 0 9.199294254358392e-06
and O 0 2.6457325930095976e-06
was O 0 2.5705225198180415e-05
significantly O 0 6.319990461634006e-06
correlated O 0 8.616291779617313e-06
with O 0 2.7918506475543836e-06
age O 0 0.0002827216812875122
at O 1 0.983951210975647
disease O 1 0.9999998807907104
onset O 1 0.9999991655349731
. O 0 0.002243372844532132

In O 0 0.00013973316526971757
addition O 0 2.1683412342099473e-05
, O 0 4.118007382203359e-06
a O 0 6.38192568658269e-06
correlation O 0 1.604085264261812e-05
between O 0 7.958810601849109e-05
smooth O 0 0.00028223099070601165
pursuit O 0 0.00023838299966882914
gain O 0 9.039048018166795e-05
and O 0 4.415743660501903e-06
the O 0 9.431522812519688e-06
number O 0 6.92146295477869e-06
of O 0 0.00010480110358912498
trinucleotide O 1 0.8524041175842285
repeats O 0 0.0005561858997680247
was O 0 0.0008991841459646821
found O 0 8.844069816404954e-05
. O 0 0.00011824753892142326

In O 0 0.0036701455246657133
SCA3 B-Disease 1 1.0
, O 0 0.00041678856359794736
gaze B-Disease 0 0.006456214934587479
- I-Disease 0 0.0020756826270371675
evoked I-Disease 0 0.0017169765196740627
nystagmus I-Disease 0 0.002372983144596219
was O 0 0.0003187516995240003
often O 0 5.509423772309674e-06
present O 0 1.2057341336912941e-05
as O 0 2.717742245295085e-05
was O 0 0.00023376198078040034
saccade O 0 0.0008040177053771913
hypometria O 0 0.00221824343316257
and O 0 3.9519090933026746e-05
smooth O 0 0.00029498894582502544
pursuit O 0 0.0005289939581416547
gain O 0 0.000594884913880378
was O 0 0.0018168868264183402
markedly O 0 0.0019846484065055847
decreased O 0 0.0021258187480270863
. O 0 0.00024389632744714618

Three O 0 0.00014779448974877596
major O 0 0.000279859610600397
criteria O 0 6.570662662852556e-05
, O 0 3.0517185223288834e-05
saccade O 0 0.0003670690057333559
amplitude O 0 0.00020772854622919112
, O 0 3.323434430058114e-05
saccade O 0 0.00027249165577813983
velocity O 0 4.323179382481612e-05
, O 0 7.99315057520289e-06
and O 0 3.646044660854386e-06
presence O 0 2.2694763174513355e-05
of O 0 0.0001961149537237361
gaze B-Disease 0 0.014114621095359325
- I-Disease 0 0.002785033779218793
evoked I-Disease 0 0.001448599505238235
nystagmus I-Disease 0 0.0010910829296335578
, O 0 1.6112298908410594e-05
permitted O 0 1.1712891136994585e-05
the O 0 9.24703726923326e-06
correct O 0 8.16682859294815e-06
assignment O 0 9.727362339617684e-06
of O 0 1.3520405445888173e-05
90 O 0 2.0334229702712037e-05
% O 0 5.338776645658072e-06
of O 0 3.622284566517919e-05
the O 0 0.00011045601422665641
SCA1 B-Disease 0 0.027895117178559303
, O 0 8.813783097139094e-06
90 O 0 8.212142347474582e-06
% O 0 4.1092785068030935e-06
of O 0 2.9746890504611656e-05
the O 0 0.0001218542893184349
SCA2 B-Disease 1 0.816238522529602
, O 0 1.0314663995814044e-05
and O 0 1.6965647091637948e-06
93 O 0 1.5495321349590085e-05
% O 0 2.902123696912895e-06
of O 0 1.317644910159288e-05
the O 0 5.009807864553295e-05
patients O 0 4.6964654757175595e-05
with O 0 2.3466660422855057e-05
SCA3 B-Disease 1 1.0
to O 0 1.8545590137364343e-05
their O 0 3.3859168979688548e-06
genetically O 0 1.0707725778047461e-05
confirmed O 0 1.0478593139851e-05
patient O 0 1.5355044524767436e-05
group O 0 3.159557536491775e-06
and O 0 4.17908449890092e-06
, O 0 5.37477217221749e-06
therefore O 0 7.87782028055517e-06
, O 0 6.070989456929965e-06
may O 0 2.6926099963020533e-05
help O 0 3.769186878344044e-05
orient O 0 0.002435472793877125
diagnoses O 0 0.0006334921345114708
of O 0 0.0013177921064198017
SCA1 B-Disease 1 0.9999992847442627
, O 0 0.00022113241720944643
SCA2 B-Disease 1 0.9995467066764832
, O 0 3.1157669582171366e-05
and O 0 2.92267413897207e-05
SCA3 B-Disease 1 0.9999998807907104
at O 0 0.00023333220451604575
early O 0 4.157813964411616e-05
clinical O 0 2.7050849894294515e-05
stages O 0 9.789680916583166e-05
of O 0 0.00012028594937874004
the O 0 0.0017818654887378216
diseases O 1 0.9999998807907104
. O 0 0.00014971272321417928
. O 0 0.00021484243916347623

Genetic O 0 0.00014495897630695254
basis O 0 2.2567428459296934e-05
and O 0 1.295066158490954e-05
molecular O 0 3.6172656109556556e-05
mechanism O 0 0.00021587798255495727
for O 0 0.0006112895789556205
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999359846115112

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999998807907104
causes O 0 0.005683674942702055
more O 0 2.990805842273403e-05
than O 0 1.4657235624326859e-05
300 O 0 3.5473578464007005e-05
, O 0 7.040113359835232e-06
000 O 0 0.00010676562669686973
sudden O 0 0.00016788067296147346
deaths O 0 2.539699198678136e-05
each O 0 1.584946176080848e-06
year O 0 1.105670708057005e-05
in O 0 1.3401903743215371e-05
the O 0 5.85844500164967e-05
USA O 0 0.0007149190059863031
alone O 0 0.00021594938880298287
. O 0 8.612909005023539e-05

In O 0 0.00014298022142611444
approximately O 0 0.0001099574874388054
5 O 0 9.259473154088482e-05
- O 0 7.990370795596391e-05
12 O 0 1.2824390978494193e-05
% O 0 1.9377405351406196e-06
of O 0 1.007613172987476e-05
these O 0 2.252358171972446e-06
cases O 0 4.3400887079769745e-06
, O 0 3.0423391308431746e-06
there O 0 2.4770383788563777e-06
are O 0 5.005218213227636e-07
no O 0 1.2971365322300699e-05
demonstrable O 1 0.7522180676460266
cardiac O 1 0.9999992847442627
or O 0 0.008103647269308567
non O 1 0.9999436140060425
- O 1 0.9999949932098389
cardiac O 1 0.9999896287918091
causes O 0 0.00015083439939189702
to O 0 7.485258265660377e-06
account O 0 2.8480226319516078e-06
for O 0 9.514803878118983e-07
the O 0 4.565230028674705e-06
episode O 0 2.0648218196583912e-05
, O 0 1.1450212014096905e-06
which O 0 6.852231422271871e-07
is O 0 4.529196075964137e-07
therefore O 0 1.0443908422530512e-06
classified O 0 2.500898153812159e-05
as O 0 0.00012459323625080287
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999994039535522
IVF B-Disease 1 1.0
) O 0 0.0004278249107301235
. O 0 0.000265518989181146

A O 0 0.0003191819996573031
distinct O 0 1.564362355566118e-05
group O 0 1.975770283024758e-05
of O 0 0.00019362442253623158
IVF B-Disease 1 0.9999998807907104
patients O 0 0.00010161771206185222
has O 0 9.653139386500698e-06
been O 0 4.572231318888953e-06
found O 0 8.422200608038111e-07
to O 0 7.670761874578602e-07
present O 0 3.0602086553699337e-06
with O 0 5.4000602176529355e-06
a O 0 4.661523780669086e-05
characteristic O 0 0.0005280506447888911
electrocardiographic O 1 0.9996702671051025
pattern O 0 0.003947805613279343
. O 0 0.0007303839665837586

Because O 0 8.630041702417657e-05
of O 0 5.439119559014216e-05
the O 0 4.649265974876471e-05
small O 0 1.389706721965922e-05
size O 0 1.0256282621412538e-05
of O 0 1.3700051567866467e-05
most O 0 9.540194696455728e-06
pedigrees O 0 7.554276817245409e-05
and O 0 5.508488811756251e-06
the O 0 2.4585409846622497e-05
high O 0 0.00015598948812112212
incidence O 0 0.00028204830596223474
of O 0 0.00012165075895609334
sudden B-Disease 0 0.003955001011490822
death I-Disease 0 0.0003045801422558725
, O 0 5.022632194595644e-06
however O 0 2.6910720407613553e-06
, O 0 1.3380373502513976e-06
molecular O 0 5.9029721342085395e-06
genetic O 0 1.1449260455265176e-05
studies O 0 1.3236853192211129e-05
of O 0 9.262192907044664e-05
IVF B-Disease 1 0.9991831183433533
have O 0 6.837904038548004e-06
not O 0 2.3410609628626844e-06
yet O 0 8.2099968494731e-06
been O 0 1.5172885468928143e-05
done O 0 5.473873170558363e-05
. O 0 9.075721027329564e-05

Because O 0 0.00277287932112813
IVF B-Disease 1 1.0
causes O 1 0.9999946355819702
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.999916672706604
, O 0 3.5464985558064654e-05
we O 0 1.2954602425452322e-05
investigated O 0 5.4122247092891484e-05
whether O 0 1.630160113563761e-05
malfunction O 0 0.0013044493971392512
of O 0 5.850661909789778e-05
ion O 0 0.00023315496218856424
channels O 0 8.424968837061897e-05
could O 0 2.4963850592030212e-05
cause O 0 3.815081072389148e-05
the O 0 2.977776966872625e-05
disorder O 0 0.11133462190628052
by O 0 1.3139332622813527e-05
studying O 0 2.426198625471443e-05
mutations O 0 8.478868039674126e-06
in O 0 1.1223843102925457e-05
the O 0 4.0758735849522054e-05
cardiac O 0 0.0018672922160476446
sodium O 0 0.00016316880646627396
channel O 0 0.0006550008547492325
gene O 0 0.00033498776610940695
SCN5A O 0 0.4000931978225708
. O 0 0.00039920490235090256

We O 0 8.215472917072475e-05
have O 0 7.960879884194583e-06
now O 0 1.4544170880981255e-05
identified O 0 1.6050402336986735e-05
a O 0 2.794610736600589e-05
missense O 0 0.00019177970534656197
mutation O 0 2.468191451043822e-05
, O 0 1.418739884684328e-05
a O 0 5.066050653113052e-05
splice O 0 0.000975134433247149
- O 0 0.00030653842259198427
donor O 0 2.6757312298286706e-05
mutation O 0 7.543167157564312e-06
, O 0 5.33497950527817e-06
and O 0 5.416409749159357e-06
a O 0 3.326167643535882e-05
frameshift O 0 0.0002526762546040118
mutation O 0 6.42763825453585e-06
in O 0 6.509671493404312e-06
the O 0 1.1175330655532889e-05
coding O 0 4.865576192969456e-05
region O 0 0.00014961739361751825
of O 0 0.00010343239409849048
SCN5A O 1 0.9707716703414917
in O 0 8.830670412862673e-05
three O 0 5.895433059777133e-05
IVF B-Disease 0 0.47463035583496094
families O 0 6.463305908255279e-05
. O 0 0.00015444787277374417

We O 0 5.6435361329931766e-05
show O 0 2.2052216081647202e-05
that O 0 1.8019957224169048e-06
sodium O 0 5.672775387211004e-06
channels O 0 6.307767307589529e-06
with O 0 1.4919054365236661e-06
the O 0 2.1520194422919303e-05
missense O 0 0.00019527008407749236
mutation O 0 2.4194936486310326e-05
recover O 0 0.00031765649328008294
from O 0 3.275866765761748e-05
inactivation O 0 0.0004832399426959455
more O 0 1.0772848327178508e-05
rapidly O 0 0.00010151020978810266
than O 0 2.715514256124152e-06
normal O 0 4.439842086867429e-06
and O 0 1.1407835245336173e-06
that O 0 1.1452789294708055e-06
the O 0 1.742456697684247e-05
frameshift O 0 0.00022681010887026787
mutation O 0 7.744584763713647e-06
causes O 0 1.8559001546236686e-05
the O 0 1.7747162928571925e-05
sodium O 0 9.083194527192973e-06
channel O 0 2.6620713470038027e-05
to O 0 8.017780601221602e-06
be O 0 9.223364941135515e-06
non O 0 0.00010659635881893337
- O 0 0.00025059879408217967
functional O 0 0.00022972171427682042
. O 0 0.00020172836957499385

Our O 0 5.122720540384762e-05
results O 0 6.808238595112925e-06
indicate O 0 1.0192435183853377e-05
that O 0 1.7740785551723093e-06
mutations O 0 7.995103260327596e-06
in O 0 4.4752247049473226e-05
cardiac O 0 0.0025024893693625927
ion O 0 0.0004741791635751724
- O 0 0.00023692082322668284
channel O 0 3.2891868613660336e-05
genes O 0 2.6042525860248134e-06
contribute O 0 3.5027815101784654e-06
to O 0 2.1901716991123976e-06
the O 0 8.900836292013992e-06
risk O 0 3.093837949563749e-05
of O 0 9.694183245301247e-05
developing O 0 0.001358503825031221
IVF B-Disease 1 0.9995139837265015
. O 0 0.0001111772216972895
. O 0 8.939168765209615e-05

Molecular O 0 0.0007662357529625297
heterogeneity O 0 0.00143901607953012
in O 0 0.0004613546479959041
mucopolysaccharidosis B-Disease 1 0.7558230757713318
IVA I-Disease 1 0.9957438111305237
in O 0 7.17004295438528e-05
Australia O 0 1.6192152543226257e-05
and O 0 2.786708591884235e-06
Northern O 0 1.5422701835632324e-05
Ireland O 0 1.862224416981917e-05
: O 0 3.584270871215267e-06
nine O 0 1.701741166471038e-05
novel O 0 2.9446411645039916e-05
mutations O 0 1.2769766726705711e-05
including O 0 1.8479880964150652e-05
T312S O 0 0.0005436190986074507
, O 0 7.761050255794544e-06
a O 0 1.2018493180221412e-05
common O 0 7.354053650487913e-06
allele O 0 1.1125681339763105e-05
that O 0 3.585720605769893e-06
confers O 0 0.0001466097019147128
a O 0 9.45258725550957e-05
mild O 0 0.0007251073257066309
phenotype O 0 0.0006759581156075001
. O 0 0.00045803707325831056

Mucopolysaccharidosis B-Disease 1 0.9997761845588684
IVA I-Disease 1 0.9999990463256836
( O 0 0.002267698524519801
MPS B-Disease 1 0.999812662601471
IVA I-Disease 1 1.0
) O 0 4.405954678077251e-05
is O 0 7.004906819929602e-06
an O 0 1.7189819118357264e-05
autosomal B-Disease 1 0.9987202882766724
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9998929500579834
by O 0 2.8242906410014257e-05
a O 0 6.917089922353625e-05
genetic B-Disease 1 0.977295458316803
defect I-Disease 1 0.9999700784683228
in O 0 0.00028205313719809055
N O 0 0.002756675472483039
- O 0 0.000822646077722311
acetylgalactosamine O 0 0.001239081029780209
- O 0 0.00023373767908196896
6 O 0 0.0002272018900839612
- O 0 0.0004128541622776538
sulfate O 0 0.0011556860990822315
sulfatase O 0 0.03490390628576279
( O 0 0.000589397270232439
GALNS O 1 0.9963108897209167
) O 0 0.0002122942532878369
. O 0 0.00017803431546781212

Previous O 0 0.00010891498095588759
studies O 0 2.202474388468545e-05
of O 0 4.670859198085964e-05
patients O 0 3.331882180646062e-05
from O 0 2.6157620595768094e-05
a O 0 2.4767670765868388e-05
British O 0 3.723936970345676e-05
- O 0 5.786458496004343e-05
Irish O 0 2.8877655495307408e-05
population O 0 1.6429405604867497e-06
showed O 0 6.936595127626788e-06
that O 0 6.907073952788778e-07
the O 0 6.712608865200309e-06
I113F O 0 0.00020963548740837723
mutation O 0 3.0089947813394247e-06
is O 0 1.7654741668593488e-06
the O 0 3.124439899693243e-06
most O 0 2.3127238364395453e-06
common O 0 4.190051186014898e-06
single O 0 8.664107554068323e-06
mutation O 0 1.3552018572227098e-05
among O 0 7.875642768340185e-05
MPS B-Disease 1 0.9999881982803345
IVA I-Disease 1 1.0
patients O 0 0.0007325064507313073
and O 0 3.2742023904575035e-05
produces O 0 3.9042497519403696e-05
a O 0 9.749201853992417e-05
severe O 1 0.8463687896728516
clinical O 0 0.0036879319231957197
phenotype O 0 0.0016134728211909533
. O 0 0.0005651494138874114

We O 0 8.999931742437184e-05
studied O 0 8.810651343083009e-05
mutations O 0 9.448069249629043e-06
in O 0 1.1571841241675429e-05
the O 0 2.933989708253648e-05
GALNS O 0 0.003490081522613764
gene O 0 8.392499694309663e-06
from O 0 9.131083061220124e-06
23 O 0 5.306940875016153e-05
additional O 0 3.116872176178731e-05
MPS B-Disease 1 0.972916305065155
IVA I-Disease 1 1.0
patients O 0 0.0002745289821177721
( O 0 2.8314128940110095e-05
15 O 0 3.3402942790417e-05
from O 0 1.2211563443997875e-05
Australia O 0 9.275406227970961e-06
, O 0 2.1106227450218285e-06
8 O 0 1.0205896614934318e-05
from O 0 6.007171577948611e-06
Northern O 0 2.538883018132765e-05
Ireland O 0 1.651251659495756e-05
) O 0 2.8843985546700424e-06
, O 0 9.482627092438634e-07
with O 0 7.709646183684526e-07
various O 0 6.345597739709774e-06
clinical O 0 0.00047725936747156084
phenotypes O 0 0.0015364448772743344
( O 0 0.0003406780306249857
severe O 1 0.5354868769645691
, O 0 4.098609133507125e-05
16 O 0 6.632816803175956e-05
cases O 0 9.804030923987739e-06
; O 0 3.6989927139075007e-06
intermediate O 0 9.365502774016932e-05
, O 0 1.242494909092784e-05
4 O 0 3.818466211669147e-05
cases O 0 1.29113977891393e-05
; O 0 5.429266366263619e-06
mild O 0 6.916660640854388e-05
, O 0 2.130547545675654e-05
3 O 0 7.950140570756048e-05
cases O 0 3.98166521335952e-05
) O 0 5.6345284974668175e-05
. O 0 0.00014841162192169577

We O 0 5.331787178874947e-05
found O 0 4.709093900601147e-06
two O 0 1.8185673980042338e-06
common O 0 3.725416945599136e-06
mutations O 0 6.785370260331547e-06
that O 0 2.7985308861389058e-06
together O 0 5.563902959693223e-06
accounted O 0 1.770842936821282e-05
for O 0 4.134113169129705e-06
32 O 0 1.1920621545868926e-05
% O 0 2.0740326363011263e-06
of O 0 8.695727956364863e-06
the O 0 2.2202353648026474e-05
44 O 0 3.887045750161633e-05
unrelated O 0 3.4816555853467435e-05
alleles O 0 1.1498435014800634e-05
in O 0 2.2844504201202653e-05
these O 0 1.8009366613114253e-05
patients O 0 0.00016929337289184332
. O 0 0.0002905265137087554

One O 0 9.034652612172067e-05
is O 0 9.069604857359082e-06
the O 0 1.5048968634800985e-05
T312S O 0 0.0002968011249322444
mutation O 0 8.900335160433315e-06
, O 0 2.5656875095592113e-06
a O 0 5.930519364483189e-06
novel O 0 1.266338767891284e-05
mutation O 0 6.1383648244373035e-06
found O 0 3.449087671469897e-06
exclusively O 0 1.5231207726174034e-05
in O 0 4.363788684713654e-05
milder O 0 0.00030986484489403665
patients O 0 0.00023553073697257787
. O 0 0.0002465737343300134

The O 0 0.00013530980504583567
other O 0 9.913240319292527e-06
is O 0 6.607658178836573e-06
the O 0 8.441969839623198e-06
previously O 0 4.50878324045334e-05
described O 0 6.161615601740777e-05
I113F O 0 0.0002999063872266561
that O 0 6.724673312419327e-06
produces O 0 2.410332308500074e-05
a O 0 8.336143218912184e-05
severe O 1 0.7463018298149109
phenotype O 0 0.0009959946619346738
. O 0 0.0005900483811274171

The O 0 0.0004053884476888925
I113F O 0 0.00145993591286242
and O 0 3.164517693221569e-05
T312S O 0 0.0003082051989622414
mutations O 0 1.800189602363389e-05
accounted O 0 3.166373790008947e-05
for O 0 8.10542405815795e-06
8 O 0 7.21414980944246e-05
( O 0 8.403648280363996e-06
18 O 0 2.730529013206251e-05
% O 0 6.424696493922966e-06
) O 0 5.4297320275509264e-06
and O 0 5.559018518397352e-06
6 O 0 5.552385846385732e-05
( O 0 9.095572750084102e-06
14 O 0 2.053927892120555e-05
% O 0 3.4568688533909153e-06
) O 0 2.9757231914118165e-06
of O 0 1.9089664419880137e-05
44 O 0 6.274106272030622e-05
unrelated O 0 8.075412188190967e-05
alleles O 0 2.249703356937971e-05
, O 0 4.211616032989696e-05
respectively O 0 0.0003514174895826727
. O 0 0.00016132075688801706

The O 0 0.0003868993662763387
relatively O 0 0.0002103514998452738
high O 0 0.0005203593173064291
residual O 0 0.0025474941357970238
GALNS O 1 0.9992635846138
activity O 0 0.0001541701058158651
seen O 0 9.811661584535614e-05
when O 0 6.567976470250869e-06
the O 0 7.14455745765008e-06
T312S O 0 0.0001348701334791258
mutant O 0 3.652636951301247e-05
cDNA O 0 6.922308239154518e-05
is O 0 1.287711438635597e-05
overexpressed O 0 0.00027215355657972395
in O 0 1.2371410775813274e-05
mutant O 0 6.559518806170672e-05
cells O 0 5.147254341864027e-06
provides O 0 1.033031821862096e-06
an O 0 1.0176331670663785e-06
explanation O 0 2.3279280867427588e-06
for O 0 2.1674543404515134e-06
the O 0 3.3736901968950406e-05
mild O 0 0.00021139378077350557
phenotype O 0 0.0001326182682532817
in O 0 4.277046537026763e-05
patients O 0 2.3641732695978135e-05
with O 0 8.730510671739466e-06
this O 0 1.7665623090579174e-05
mutation O 0 9.830878843786195e-05
. O 0 0.0001978926593437791

The O 0 5.8854402595898136e-05
distribution O 0 1.2014756975986529e-05
and O 0 4.189295850665076e-06
relative O 0 1.429598341928795e-05
frequencies O 0 6.5935328166233376e-06
of O 0 2.6043071557069197e-05
the O 0 6.074592238292098e-05
I113F O 0 0.0005711038247682154
and O 0 1.1981082025158685e-05
T312S O 0 0.00034489313839003444
mutations O 0 1.0204708814853802e-05
in O 0 1.0890525118156802e-05
Australia O 0 9.24559026316274e-06
corresponded O 0 2.4666385797900148e-05
to O 0 6.2224003158917185e-06
those O 0 3.829608886007918e-06
observed O 0 1.307221464230679e-05
in O 0 1.0685568668122869e-05
Northern O 0 3.510340684442781e-05
Ireland O 0 1.77753645402845e-05
and O 0 2.7896282972506015e-06
are O 0 6.043517259968212e-07
unique O 0 1.7922882307175314e-06
to O 0 3.289426558694686e-06
these O 0 1.5005011846369598e-06
two O 0 2.655651996974484e-06
populations O 0 1.4962283785280306e-06
, O 0 9.446342232877214e-07
suggesting O 0 3.5591667710832553e-06
that O 0 5.19405205068324e-07
both O 0 2.164659463232965e-06
mutations O 0 5.885294285690179e-06
were O 0 1.7383388694725e-05
probably O 0 2.7386678993934765e-05
introduced O 0 3.3946048461075407e-06
to O 0 1.7257290210181964e-06
Australia O 0 3.1777187814441277e-06
by O 0 1.4436965329878149e-06
Irish O 0 3.375737287569791e-05
migrants O 0 9.171840247290675e-06
during O 0 4.463078221306205e-05
the O 0 3.0992512620287016e-05
19th O 0 0.00046953652054071426
century O 0 0.000818039639852941
. O 0 0.00019244021677877754

Haplotype O 0 0.0007159211672842503
analysis O 0 2.8297745302552357e-05
using O 0 2.999743628606666e-05
6 O 0 0.0004223743744660169
RFLPs O 0 0.001221572165377438
provides O 0 4.635361619875766e-06
additional O 0 1.9411550056247506e-06
data O 0 3.92490301237558e-06
that O 0 1.6629159063086263e-06
the O 0 1.4125985217106063e-05
I113F O 0 0.0003585321537684649
mutation O 0 9.305078492616303e-06
originated O 0 3.620419738581404e-05
from O 0 9.49427794694202e-06
a O 0 1.946130214491859e-05
common O 0 3.316488437121734e-05
ancestor O 0 0.0007416970329359174
. O 0 0.0003753047785721719

The O 0 9.576402953825891e-05
other O 0 5.7235738495364785e-06
9 O 0 9.025311010191217e-05
novel O 0 2.4734745238674805e-05
mutations O 0 6.509075774374651e-06
identified O 0 6.787337952118833e-06
in O 0 4.105318566871574e-06
these O 0 1.5286780126189115e-06
23 O 0 4.573323531076312e-05
patients O 0 9.608189429854974e-06
were O 0 7.298036052816315e-06
each O 0 9.263217748411989e-07
limited O 0 5.0759222176566254e-06
to O 0 9.871580004983116e-06
a O 0 3.238638964830898e-05
single O 0 4.952814560965635e-05
family O 0 9.720509115140885e-05
. O 0 0.0001430074917152524

These O 0 2.3266866264748387e-05
data O 0 1.0854576430574525e-05
provide O 0 3.2071839086711407e-06
further O 0 3.771329602386686e-06
evidence O 0 6.915451194799971e-06
for O 0 4.037111011712113e-06
extensive O 0 0.00011588088818825781
allelic O 0 0.00041832102579064667
heterogeneity O 0 0.0005437518120743334
in O 0 0.0002784108219202608
MPS B-Disease 1 0.8939567804336548
IVA I-Disease 1 0.9999991655349731
in O 0 0.00011914371134480461
British O 0 0.0001300052972510457
- O 0 0.00037411166704259813
Irish O 0 0.00012719407095573843
patients O 0 1.0941555046883877e-05
and O 0 2.2156609702506103e-06
provide O 0 3.65991013495659e-06
evidence O 0 1.0896154890360776e-05
for O 0 4.513007297646254e-06
their O 0 6.834878604422556e-06
transmission O 0 3.863858728436753e-05
to O 0 8.909803000278771e-06
Australia O 0 5.5139394135039765e-06
by O 0 1.4648227306679473e-06
British O 0 2.2755833924748003e-05
- O 0 6.863485759822652e-05
Irish O 0 8.951913332566619e-05
migrants O 0 2.077910721709486e-05
. O 0 1.6359846995328553e-05
. O 0 4.586828072206117e-05

Identification O 0 4.9537869927007705e-05
of O 0 0.0002297022147104144
constitutional O 0 0.0017334123840555549
WT1 O 1 0.9995688796043396
mutations O 0 7.685620948905125e-05
, O 0 1.0387516340415459e-05
in O 0 1.9140521544613875e-05
patients O 0 3.310623287688941e-05
with O 0 2.50273533310974e-05
isolated O 1 0.9990233182907104
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0001413109275745228
and O 0 8.050679753068835e-06
analysis O 0 2.4427486096101347e-06
of O 0 5.21179499628488e-05
genotype O 0 0.0004902513464912772
/ O 0 0.0007840007892809808
phenotype O 0 4.619320316123776e-05
correlations O 0 6.471860251622275e-05
by O 0 3.3402525332348887e-06
use O 0 2.342220113860094e-06
of O 0 2.6512429030844942e-05
a O 0 3.4037730074487627e-05
computerized O 0 0.0002259545144625008
mutation O 0 2.7034808226744644e-05
database O 0 9.475437400396913e-05
. O 0 0.0001463610678911209

Constitutional O 0 0.0007133366889320314
mutations O 0 9.236896585207433e-05
of O 0 0.00014548766193911433
the O 0 0.00020938378293067217
WT1 O 0 0.015116821974515915
gene O 0 2.5876559448079206e-05
, O 0 4.497736881603487e-06
encoding O 0 1.1013822586392052e-05
a O 0 7.754896796541288e-05
zinc O 0 0.013152341358363628
- O 0 0.00045078975381329656
finger O 0 0.00011521977285156026
transcription O 0 6.904976180521771e-05
factor O 0 2.4712675440241583e-05
involved O 0 1.640994378249161e-05
in O 0 9.919765579979867e-05
renal O 1 1.0
and O 0 0.0015715641202405095
gonadal O 1 0.9999991655349731
development O 0 0.0009565407526679337
, O 0 1.1720377187884878e-05
are O 0 6.176788929224131e-07
found O 0 1.4211365169103374e-06
in O 0 2.5928925424523186e-06
most O 0 3.6585349789675092e-06
patients O 0 1.0309079698345158e-05
with O 0 1.2890999641967937e-05
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.012163103558123112
DDS B-Disease 1 1.0
) O 0 5.1523664296837524e-05
, O 0 1.4597198060073424e-05
or O 0 7.258348341565579e-05
diffuse B-Disease 1 0.9999948740005493
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9997790455818176
DMS B-Disease 1 1.0
) O 0 3.997934254584834e-05
associated O 0 1.6373645848943852e-05
with O 0 1.661424175836146e-05
pseudohermaphroditism B-Disease 1 0.9999984502792358
and O 0 8.766687096795067e-05
/ O 0 0.01013276819139719
or O 0 0.0012139601167291403
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.002858937717974186
WT B-Disease 1 0.9999992847442627
) O 0 0.00023356167366728187
. O 0 0.0001621847623027861

Most O 0 0.00015297518984880298
mutations O 0 0.00021744468540418893
in O 0 0.00047969372826628387
DDS B-Disease 1 1.0
patients O 0 0.0010847211815416813
lie O 0 0.0020559378899633884
in O 0 0.0001095025145332329
exon O 0 0.00031250916072167456
8 O 0 9.312904876424e-05
or O 0 1.3092525477986783e-05
exon O 0 0.00015973940026015043
9 O 0 0.00010233800276182592
, O 0 8.31279521662509e-06
encoding O 0 4.9377940740669146e-05
zinc O 0 0.008505912497639656
finger O 0 0.0015248017152771354
2 O 0 0.000561077322345227
or O 0 0.00016141755622811615
zinc O 0 0.017273688688874245
finger O 0 0.0006987908273003995
3 O 0 9.724013216327876e-05
, O 0 1.0138360266864765e-05
respectively O 0 1.783356856321916e-05
, O 0 3.349139205965912e-06
with O 0 3.051003204745939e-06
a O 0 3.7150974094402045e-05
hot O 0 0.00032197203836403787
spot O 0 0.00020667948410846293
( O 0 2.4930661311373115e-05
R394W O 0 0.0003607120888773352
) O 0 1.511123809905257e-05
in O 0 6.094471973483451e-05
exon O 0 0.0010368392104282975
9 O 0 0.0009549291571602225
. O 0 0.0002531551872380078

We O 0 4.926453766529448e-05
analyzed O 0 1.4629151337430812e-05
a O 0 3.6295866721047787e-06
series O 0 4.287075626052683e-06
of O 0 1.677537693467457e-05
24 O 0 0.00012568544480018318
patients O 0 2.2418415028369054e-05
, O 0 7.62860463510151e-06
10 O 0 1.859452277130913e-05
with O 0 1.4551981621480081e-05
isolated B-Disease 0 0.0019469127291813493
DMS I-Disease 1 0.9999986886978149
( O 0 0.0007525477558374405
IDMS B-Disease 1 0.9975951313972473
) O 0 4.8549620260018855e-05
, O 0 8.159853678080253e-06
10 O 0 2.003048030019272e-05
with O 0 1.5825275113456883e-05
DDS B-Disease 1 0.9999871253967285
, O 0 3.399679553695023e-05
and O 0 9.822784704738297e-06
4 O 0 0.00017027017020154744
with O 0 0.00011700655159074813
urogenital B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9999998807907104
and O 0 0.012255489826202393
/ O 1 0.9999085664749146
or O 0 0.10495121031999588
WT B-Disease 1 1.0
. O 0 0.0016089963028207421

We O 0 0.00026938514201901853
report O 0 0.00011421688395785168
WT1 O 0 0.007439018692821264
heterozygous O 0 7.184039714047685e-05
mutations O 0 5.012588371755555e-05
in O 0 4.794235428562388e-05
16 O 0 0.00016041757771745324
patients O 0 3.420058419578709e-05
, O 0 8.606231858721003e-06
4 O 0 3.8325259083649144e-05
of O 0 3.380788621143438e-05
whom O 0 8.88845679583028e-05
presented O 0 0.0002702077617868781
with O 0 0.00021941149316262454
IDMS B-Disease 1 0.9999955892562866
. O 0 0.0015180590562522411

One O 0 0.00021837236999999732
male O 0 0.00015965747297741473
and O 0 2.319771738257259e-05
two O 0 4.63964170194231e-05
female O 0 0.001119672553613782
IDMS B-Disease 1 0.9999988079071045
patients O 0 0.0005183360772207379
with O 0 0.00026217856793664396
WT1 O 1 0.9999992847442627
mutations O 0 0.0032242981251329184
underwent O 1 0.9999861717224121
normal O 0 0.007094416301697493
puberty O 0 0.16425105929374695
. O 0 0.00047029039706103504

Two O 0 0.00012286973651498556
mutations O 0 0.0001488242851337418
associated O 0 6.842163566034287e-05
with O 0 5.718982356484048e-05
IDMS B-Disease 1 0.9971390962600708
are O 0 3.359753463882953e-06
different O 0 8.934717925512814e-07
from O 0 1.3125481018505525e-05
those O 0 1.7034866687026806e-05
described O 0 0.0002568438067100942
in O 0 0.0005025101127102971
DDS B-Disease 1 1.0
patients O 0 0.00519054988399148
. O 0 0.0007806791109032929

No O 0 0.001525403349660337
WT1 O 1 0.7935991287231445
mutations O 0 0.00018744124099612236
were O 0 7.784252375131473e-05
detected O 0 7.292175723705441e-05
in O 0 6.553574166900944e-06
the O 0 1.2148963833169546e-05
six O 0 2.101602149195969e-05
other O 0 2.596109152364079e-05
IDMS B-Disease 1 0.9999995231628418
patients O 0 0.00016204100393224508
, O 0 1.229263943969272e-05
suggesting O 0 2.2597017959924415e-05
genetic O 0 2.855451384675689e-05
heterogeneity O 0 0.0001061504299286753
of O 0 0.0001803491177270189
this O 0 0.0002322322252439335
disease O 1 0.9999994039535522
. O 0 0.00042322257650084794

We O 0 0.0001221724960487336
analyzed O 0 0.00019018305465579033
genotype O 0 0.00043919283780269325
/ O 0 0.0005826738779433072
phenotype O 0 9.113531996263191e-05
correlations O 0 0.0001902454678202048
, O 0 8.652612450532615e-06
on O 0 1.2621622772712726e-05
the O 0 3.4995262012671446e-06
basis O 0 2.6343277568230405e-06
of O 0 7.4752924774657e-06
the O 0 1.4565936908184085e-05
constitution O 0 6.0339498304529116e-06
of O 0 2.3501328541897237e-05
a O 0 8.15211096778512e-05
WT1 O 0 0.0034831673838198185
mutation O 0 5.482159394887276e-06
database O 0 4.907851234747795e-06
of O 0 5.703401257051155e-05
84 O 0 0.0015081556048244238
germ O 1 0.9999939203262329
- O 0 0.0021357506047934294
line O 0 0.00027172965928912163
mutations O 0 1.4197333257470746e-05
, O 0 4.0499676288163755e-06
to O 0 3.2001569252315676e-06
compare O 0 6.793340617150534e-06
the O 0 9.800515726965386e-06
distribution O 0 7.820972314220853e-06
and O 0 4.263793925929349e-06
type O 0 2.2144202375784516e-05
of O 0 7.014656148385257e-05
mutations O 0 4.5748063712380826e-05
, O 0 7.338283921853872e-06
according O 0 1.5449639931830461e-06
to O 0 3.5828049931296846e-06
the O 0 2.2494459699373692e-05
different O 0 1.11402478069067e-05
symptoms O 0 0.003740353276953101
. O 0 0.0007797968573868275

This O 0 2.7925594622502103e-05
demonstrated O 0 0.00010431693226564676
( O 0 2.222303010057658e-05
1 O 0 5.424418850452639e-05
) O 0 3.606874770412105e-06
the O 0 8.652150427224115e-06
association O 0 1.147952389146667e-05
between O 0 5.12698243255727e-05
mutations O 0 2.184228833357338e-05
in O 0 4.403279672260396e-05
exons O 0 0.00015943277685437351
8 O 0 7.386166544165462e-05
and O 0 1.0180409844906535e-05
9 O 0 0.00013772973034065217
and O 0 3.247636414016597e-05
DMS B-Disease 0 0.3530488908290863
; O 0 1.153532684838865e-05
( O 0 1.517881901236251e-05
2 O 0 5.775696627097204e-05
) O 0 5.381198661780218e-06
among O 0 7.690811798966024e-06
patients O 0 1.3404741366684902e-05
with O 0 2.6637322662281804e-05
DMS B-Disease 1 0.9999291896820068
, O 0 2.23274346353719e-05
a O 0 1.2415414857969154e-05
higher O 0 5.058164333604509e-06
frequency O 0 4.535798325377982e-06
of O 0 2.255998333566822e-05
exon O 0 0.0001784871274139732
8 O 0 5.1980903663206846e-05
mutations O 0 7.134105999284657e-06
among O 0 8.853461622493342e-06
46 O 0 6.396319076884538e-05
, O 0 2.9882852686569095e-05
XY O 0 0.011131305247545242
patients O 0 5.1505536248441786e-05
with O 0 1.3615962416224647e-05
female O 0 5.3632607887266204e-05
phenotype O 0 1.530120789539069e-05
than O 0 4.694378276326461e-06
among O 0 1.4335577361634932e-05
46 O 0 6.16468460066244e-05
, O 0 3.0211691409931518e-05
XY O 0 0.4088674783706665
patients O 0 3.008843123097904e-05
with O 0 6.3093675635172985e-06
sexual O 0 0.00010177540389122441
ambiguity O 0 0.0004741557058878243
or O 0 0.0001390551624353975
male O 0 0.000129712832858786
phenotype O 0 4.4373562559485435e-05
; O 0 4.55230019724695e-06
and O 0 6.504756584035931e-06
( O 0 8.197784154617693e-06
3 O 0 1.9291854187031277e-05
) O 0 1.2764037364831893e-06
statistically O 0 1.1514754305608221e-06
significant O 0 3.3441281175328186e-06
evidence O 0 6.656497589574428e-06
that O 0 2.0327263428043807e-06
mutations O 0 6.049391231499612e-06
in O 0 1.8773595002130605e-05
exons O 0 0.00010057655890705064
8 O 0 6.565506919287145e-05
and O 0 6.744885467924178e-06
9 O 0 5.3703231969848275e-05
preferentially O 0 1.3360456250666175e-05
affect O 0 1.0254639164486434e-05
amino O 0 4.113775958103361e-06
acids O 0 1.8122809706255794e-06
with O 0 9.340831752524537e-07
different O 0 9.91481897472113e-07
functions O 0 1.9740939023904502e-05
. O 0 4.513704334385693e-05
. O 0 0.00012971999240107834

The O 0 0.00100423872936517
185delAG O 0 0.014050211757421494
BRCA1 O 0 0.002955645089969039
mutation O 0 7.610168540850282e-05
originated O 0 0.00010098076745634899
before O 0 1.7214788385899737e-05
the O 0 7.879645636421628e-06
dispersion O 0 1.9385226551094092e-05
of O 0 2.6185969545622356e-05
Jews O 0 0.00013056957686785609
in O 0 1.9834993508993648e-05
the O 0 1.4754971743968781e-05
diaspora O 0 3.112615740974434e-05
and O 0 5.807688012282597e-06
is O 0 3.2968821415124694e-06
not O 0 1.784395180948195e-06
limited O 0 6.227518042578595e-06
to O 0 4.576084756990895e-05
Ashkenazim O 0 0.00627850042656064
. O 0 0.00043457746505737305

The O 0 0.0003841598518192768
185delAG O 0 0.002089093206450343
mutation O 0 3.6925837775925174e-05
in O 0 6.890931399539113e-05
BRCA1 O 0 0.00026152425562031567
is O 0 1.2106932445021812e-05
detected O 0 4.171173713984899e-05
in O 0 7.289090717677027e-06
Ashkenazi O 0 2.3906675778562203e-05
Jews O 0 2.4531309463782236e-05
both O 0 5.481814241647953e-06
in O 0 2.984224738611374e-05
familial B-Disease 1 0.9998917579650879
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00018492148956283927
in O 0 3.296383874840103e-05
the O 0 1.3966075130156241e-05
general O 0 2.5512150386930443e-05
population O 0 2.8184254915686324e-05
. O 0 8.323186921188608e-05

All O 0 7.220439874799922e-05
tested O 0 9.103283809963614e-05
Ashkenazi O 0 9.389485057909042e-05
mutation O 0 1.1650981832644902e-05
carriers O 0 1.5227331459755078e-05
share O 0 6.720038527419092e-06
the O 0 1.3118472452333663e-05
same O 0 1.0077226761495695e-05
allelic O 0 0.00020781648345291615
pattern O 0 0.00018293400353286415
at O 0 0.0002510924532543868
the O 0 0.00012287349090911448
BRCA1 O 0 0.000858001527376473
locus O 0 0.0005333190783858299
. O 0 0.00019022368360310793

Our O 0 9.852520452113822e-05
previous O 0 2.1249106794130057e-05
study O 0 7.935547728266101e-06
showed O 0 1.0224874131381512e-05
that O 0 7.669035539947799e-07
this O 0 9.400096701028815e-07
Ashkenazi O 0 2.5496243324596435e-05
mutation O 0 5.558208158618072e-06
also O 0 4.548524884739891e-06
occurs O 0 4.927459485770669e-06
in O 0 5.744605459767627e-06
Iraqi O 0 2.663018494786229e-05
Jews O 0 4.790177627000958e-05
with O 0 7.015763912932016e-06
a O 0 2.2248979803407565e-05
similar O 0 2.0978333850507624e-05
allelic O 0 0.0012194784358143806
pattern O 0 0.0018554370617493987
. O 0 0.0004773471737280488

We O 0 0.00011392210581107065
extended O 0 4.7004894440760836e-05
our O 0 7.233677479234757e-06
analysis O 0 2.924985665231361e-06
to O 0 6.120261787145864e-06
other O 0 6.381000730470987e-06
non O 0 0.0001325956400251016
- O 0 0.00017238868167623878
Ashkenazi O 0 4.099770376342349e-05
subsets O 0 2.921525992860552e-05
354 O 0 6.489610677817836e-05
of O 0 3.327430385979824e-05
Moroccan O 0 0.0001420000771759078
origin O 0 1.221770162374014e-05
, O 0 1.6500427591381595e-05
200 O 0 3.808770270552486e-05
Yemenites O 0 0.0005689746467396617
and O 0 1.1756534149753861e-05
150 O 0 3.5672983358381316e-05
Iranian O 0 0.00010084286623168737
Jews O 0 0.0003931518585886806
. O 0 0.00017720142204780132

Heteroduplex O 0 0.005289699882268906
analysis O 0 2.6649082428775728e-05
complemented O 0 5.0104576075682417e-05
by O 0 2.3077468540577684e-06
direct O 0 5.9834833336935844e-06
DNA O 0 2.451596810715273e-05
sequencing O 0 2.7953834432992153e-05
of O 0 5.6753942772047594e-05
abnormally O 0 0.0005742351058870554
migrating O 0 3.820738857029937e-05
bands O 0 4.846566298510879e-05
were O 0 3.4185650292783976e-05
employed O 0 0.00015842865104787052
. O 0 0.00015174553846009076

Four O 0 7.562898099422455e-05
of O 0 6.622053479077294e-05
Moroccan O 0 0.00021205998200457543
origin O 0 6.880579348944593e-06
( O 0 5.5626724133617245e-06
1 O 0 2.32594338740455e-05
. O 0 1.953594164660899e-06
1 O 0 1.4440144695981871e-05
% O 0 3.087962568315561e-06
) O 0 4.0137315409083385e-06
and O 0 3.689276354634785e-06
none O 0 1.5793839338584803e-05
of O 0 2.8205440685269423e-05
the O 0 0.00010852610284928232
Yemenites O 0 0.0029789472464472055
or O 0 3.025891783181578e-05
Iranians O 0 0.00015384628204628825
was O 0 8.986776083474979e-05
a O 0 8.601965419074986e-06
carrier O 0 2.0596376998582855e-05
of O 0 1.854000220191665e-05
the O 0 0.0001163377019111067
185delAG O 0 0.002317226491868496
mutation O 0 0.00016732007497921586
. O 0 0.00015804768190719187

BRCA1 O 0 0.008137380704283714
allelic O 0 0.0016322293085977435
patterns O 0 9.825406596064568e-05
were O 0 2.359362224524375e-05
determined O 0 1.1306240594421979e-05
for O 0 2.1329783521650825e-06
four O 0 4.067998361279024e-06
of O 0 1.07816676973016e-05
these O 0 1.79662993105012e-06
individuals O 0 1.6412774357377202e-06
and O 0 3.028028459084453e-06
for O 0 4.21186950916308e-06
12 O 0 2.107970794895664e-05
additional O 0 6.011699042574037e-06
non O 0 0.00010149434820050374
- O 0 0.00012640716158784926
Ashkenazi O 0 5.715460792998783e-05
185delAG O 0 0.0002332312287762761
mutation O 0 6.590125394723145e-06
carriers O 0 1.009039260679856e-05
who O 0 1.6159170627361163e-05
had O 0 0.0006244530086405575
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.42367443442344666

Six O 0 0.0006663630483672023
non O 0 0.0008825949626043439
- O 0 0.00032914828625507653
Ashkenazi O 0 5.2893985412083566e-05
individuals O 0 2.5330989501526346e-06
shared O 0 1.0193056368734688e-05
the O 0 1.8240183635498397e-05
common O 0 1.0532074156799354e-05
Ashkenazi O 0 9.23696716199629e-05
haplotype O 0 0.00013110553845763206
, O 0 1.2238632734806743e-05
four O 0 1.266904018848436e-05
had O 0 2.947124812635593e-05
a O 0 1.4472640032181516e-05
closely O 0 1.506552507635206e-05
related O 0 4.138067379244603e-05
pattern O 0 7.743989408481866e-05
, O 0 1.069970221578842e-05
and O 0 6.18814874542295e-06
the O 0 2.4715222025406547e-05
rest O 0 5.902819611947052e-05
( O 0 1.000059910438722e-05
n O 0 4.944942338624969e-05
= O 0 0.00011948106839554384
6 O 0 0.00011471680772956461
) O 0 9.564062565914355e-06
displayed O 0 5.668725134455599e-05
a O 0 3.5595567169366404e-05
distinct O 0 7.963183452375233e-05
BRCA1 O 0 0.0028897239826619625
allelic O 0 0.0029947031289339066
pattern O 0 0.0021491944789886475
. O 0 0.0006727806758135557

We O 0 7.525359251303598e-05
conclude O 0 0.00011666864884318784
that O 0 4.984961833542911e-06
the O 0 2.9289574740687385e-05
185delAG O 0 0.0014735021395608783
BRCA1 O 0 0.0005547021864913404
mutation O 0 1.2292768587940373e-05
occurs O 0 6.403434326784918e-06
in O 0 8.405667358601931e-06
some O 0 4.856764462601859e-06
non O 0 8.35739410831593e-05
- O 0 0.00011915382492588833
Ashkenazi O 0 3.139972614008002e-05
populations O 0 3.882866167259635e-06
at O 0 2.191069688706193e-05
rates O 0 3.512365083224722e-06
comparable O 0 4.476494723348878e-06
with O 0 1.5379722526631667e-06
that O 0 3.927374109480297e-06
of O 0 0.00012398904073052108
Ashkenazim O 0 0.09617987275123596
. O 0 0.000505564734339714

The O 0 5.539296762435697e-05
majority O 0 9.846982720773667e-06
of O 0 4.199391696602106e-05
Jewish O 0 0.00011668666411424056
185delAG O 0 0.001261980039998889
mutation O 0 3.15833676722832e-05
carriers O 0 2.1768652004539035e-05
have O 0 2.9228581297502387e-06
a O 0 9.686410521680955e-06
common O 0 1.1270134564256296e-05
allelic O 0 0.0002447495935484767
pattern O 0 0.00012339046224951744
, O 0 1.1709607861121185e-05
supporting O 0 2.7129903173772618e-05
the O 0 6.0102127463323995e-05
founder O 0 0.0004251173522789031
effect O 0 3.183884473401122e-05
notion O 0 2.6020432414952666e-05
, O 0 4.1352527659910265e-06
but O 0 1.5436855846928665e-06
dating O 0 2.168759237974882e-05
the O 0 4.866802555625327e-06
mutations O 0 3.715255616043578e-06
origin O 0 1.626808170840377e-06
to O 0 3.822749022219796e-06
an O 0 2.6540697035670746e-06
earlier O 0 1.1523769899213221e-05
date O 0 1.913898995553609e-05
than O 0 2.306426722498145e-06
currently O 0 1.1280350008746609e-05
estimated O 0 0.00010585346899461001
. O 0 0.0001106603376683779

However O 0 0.00010118415229953825
, O 0 7.954246939334553e-06
the O 0 3.8668845263600815e-06
different O 0 6.691285534543567e-07
allelic O 0 8.982157305581495e-05
pattern O 0 6.850826321169734e-05
at O 0 0.00013335350377019495
the O 0 4.480476854951121e-05
BRCA1 O 0 0.0001980096858460456
locus O 0 7.765384361846372e-05
even O 0 5.286248779157177e-06
in O 0 2.9309305773495e-06
some O 0 1.5213770439004293e-06
Jewish O 0 2.578320163593162e-05
mutation O 0 2.044163557002321e-05
carriers O 0 3.2875621400307864e-05
, O 0 4.3801978790725116e-06
might O 0 5.1220554269093554e-06
suggest O 0 4.890428499493282e-06
that O 0 1.08675931187463e-06
the O 0 7.501909749407787e-06
mutation O 0 5.565867013501702e-06
arose O 0 6.68355351081118e-05
independently O 0 1.64632383530261e-05
. O 0 2.1828815079061314e-05
. O 0 8.039085514610633e-05

Crystal O 0 0.012314164079725742
structure O 0 0.0006718016811646521
of O 0 0.00036638128221966326
the O 0 0.003314778208732605
hemochromatosis B-Disease 1 1.0
protein O 0 0.010211097076535225
HFE O 1 0.9977686405181885
and O 0 2.717107236094307e-05
characterization O 0 5.0823633500840515e-05
of O 0 3.224822648917325e-05
its O 0 1.0833252417796757e-05
interaction O 0 2.2544907551491633e-05
with O 0 1.2952564247825649e-05
transferrin O 0 0.0012043011374771595
receptor O 0 0.0005265899817459285
. O 0 0.0003204879758413881

HFE O 0 0.4298649728298187
is O 0 0.00012598336616065353
an O 0 7.90153571870178e-05
MHC O 0 0.00950974877923727
- O 0 0.00042562177986837924
related O 0 2.2299283955362625e-05
protein O 0 6.571617177542066e-06
that O 0 9.065894346349523e-07
is O 0 9.193473147206532e-07
mutated O 0 2.1213745640125126e-06
in O 0 2.8971408028155565e-06
the O 0 6.985257641645148e-05
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999933242797852

HFE O 0 0.06167972832918167
binds O 0 0.0003726479772012681
to O 0 8.436432108283043e-05
transferrin O 0 0.0009798831306397915
receptor O 0 0.00019881520711351186
( O 0 9.044427133630961e-05
TfR O 0 0.001778804580681026
) O 0 1.1243747394473758e-05
and O 0 4.390984031488188e-06
reduces O 0 1.0013062819780316e-05
its O 0 6.16739816905465e-06
affinity O 0 3.990392360719852e-05
for O 0 7.69897160353139e-05
iron O 1 0.9997928738594055
- O 0 0.0015953569673001766
loaded O 0 0.00027320178924128413
transferrin O 0 0.0008678684826008976
, O 0 7.260778511408716e-05
implicating O 0 0.08707040548324585
HFE O 1 0.9999876022338867
in O 0 0.013628710992634296
iron O 1 0.9999998807907104
metabolism O 0 0.20000697672367096
. O 0 0.0006428585620597005

The O 0 0.0006313072517514229
2 O 0 0.0011346600949764252
. O 0 0.0002602921740617603

6 O 0 0.00312013435177505
A O 0 0.0016609065933153033
crystal O 0 0.009773151017725468
structure O 0 0.0008850953308865428
of O 0 0.0005628896178677678
HFE O 1 0.9966572523117065
reveals O 0 0.00011867157445522025
the O 0 1.0740412108134478e-05
locations O 0 1.6816271454445086e-05
of O 0 0.00026130140759050846
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0005648486549034715
and O 0 6.631216820096597e-05
a O 0 0.00011711147817550227
patch O 0 0.047108497470617294
of O 0 0.0001386394287692383
histidines O 0 0.0027888333424925804
that O 0 3.4453958051017253e-06
could O 0 2.3930197130539455e-06
be O 0 1.3335684343473986e-06
involved O 0 5.0932480917254e-06
in O 0 5.007128129363991e-05
pH O 0 0.0008710585534572601
- O 0 0.0006057136342860758
dependent O 0 0.00011736021406250075
interactions O 0 0.0001083388488041237
. O 0 0.00012409122427925467

We O 0 6.970818503759801e-05
also O 0 8.89747570909094e-06
demonstrate O 0 4.724640166386962e-05
that O 0 2.578512066975236e-05
soluble O 0 0.0018402973655611277
TfR O 1 0.6572439074516296
and O 0 0.00015243249072227627
HFE O 1 0.9936500191688538
bind O 0 0.00023088879243005067
tightly O 0 0.00014503777492791414
at O 0 4.2521493014646694e-05
the O 0 1.0290652426192537e-05
basic O 0 3.059023219975643e-05
pH O 0 0.00010222096170764416
of O 0 5.812229937873781e-05
the O 0 0.00011455675848992541
cell O 0 0.0001781052997102961
surface O 0 6.989303074078634e-05
, O 0 6.602939720323775e-06
but O 0 1.053955202223733e-06
not O 0 6.963916234781209e-07
at O 0 1.8119102605851367e-05
the O 0 1.309717208641814e-05
acidic O 0 0.00011233099940000102
pH O 0 0.00031673902412876487
of O 0 0.0003217998892068863
intracellular O 0 0.002746472368016839
vesicles O 0 0.011975702829658985
. O 0 0.0005772809963673353

TfR O 1 0.937341570854187
HFE O 0 0.12109261751174927
stoichiometry O 0 0.0011202252935618162
( O 0 0.00013405777281150222
2 O 0 0.00017324437794741243
1 O 0 0.00011026301945094019
) O 0 1.0353493962611537e-05
differs O 0 1.0007048331317492e-05
from O 0 2.7489302738104016e-05
TfR O 0 0.0021164282225072384
transferrin O 0 0.00048668106319382787
stoichiometry O 0 8.262754272436723e-05
( O 0 1.7283200577367097e-05
2 O 0 5.1164814067306e-05
2 O 0 3.976307198172435e-05
) O 0 3.987658601545263e-06
, O 0 2.2442063709604554e-06
implying O 0 1.0976526027661748e-05
a O 0 3.057142748730257e-06
different O 0 5.620662477667793e-07
mode O 0 1.3465831216308288e-05
of O 0 1.801340295060072e-05
binding O 0 1.2555617104226258e-05
for O 0 4.2360086808912456e-05
HFE O 1 0.9687800407409668
and O 0 4.6884822950232774e-05
transferrin O 0 0.0007993451436050236
to O 0 4.357604120741598e-05
TfR O 0 0.003127294359728694
, O 0 9.900154509523418e-06
consistent O 0 8.817767593427561e-06
with O 0 3.0531307402270613e-06
our O 0 1.70049042935716e-05
demonstration O 0 0.0001509912544861436
that O 0 1.2646466529986355e-05
HFE O 0 0.08490686118602753
, O 0 4.186683872831054e-05
transferrin O 0 0.0010613736230880022
, O 0 2.7581132599152625e-05
and O 0 1.742887070577126e-05
TfR O 0 0.0024391866754740477
form O 0 4.830637772101909e-05
a O 0 0.00011547010944923386
ternary O 0 0.002461420139297843
complex O 0 0.0671364814043045
. O 0 0.0006796947563998401

Identification O 0 8.058948878897354e-05
of O 0 0.0001173017080873251
three O 0 3.964058851124719e-05
novel O 0 6.935292185517028e-05
mutations O 0 2.080416561511811e-05
and O 0 4.475482910493156e-06
a O 0 1.0397267942607868e-05
high O 0 4.188864477328025e-05
frequency O 0 5.6751778174657375e-06
of O 0 1.9825973140541464e-05
the O 0 5.0111408199882135e-05
Arg778Leu O 0 0.0009079306619241834
mutation O 0 5.993037575535709e-06
in O 0 1.0684774679248221e-05
Korean O 0 0.003090095706284046
patients O 0 2.9530719984904863e-05
with O 0 3.30010152538307e-05
Wilson B-Disease 1 0.9998912811279297
disease I-Disease 1 0.9999998807907104
. O 0 0.0007037256727926433

Four O 0 0.0004012055869679898
mutations O 0 0.00038617398240603507
- O 0 0.0009664720273576677
- O 0 0.0004507119592744857
R778L O 0 0.0005167550407350063
, O 0 1.617267662368249e-05
A874V O 0 0.00026492172037251294
, O 0 1.3708964615943842e-05
L1083F O 0 0.00030213402351364493
, O 0 7.841727892810013e-06
and O 0 8.67961352923885e-06
2304delC O 0 0.0010122330859303474
- O 0 0.00029606549651362
- O 0 8.318870823131874e-05
in O 0 1.8964061382575892e-05
the O 0 6.368529284372926e-05
copper O 0 0.002267257310450077
- O 0 0.00012360372056718916
transporting O 0 6.141624180600047e-05
enzyme O 0 1.4026779354026075e-05
, O 0 2.495656553946901e-05
P O 0 0.000928046996705234
- O 0 0.00025385344633832574
type O 0 0.00010850324179045856
ATPase O 0 0.0004982367972843349
( O 0 9.153622522717342e-05
ATP7B O 0 0.012352518737316132
) O 0 7.278824341483414e-06
, O 0 1.6199606989175663e-06
were O 0 2.507396175133181e-06
identified O 0 4.772452030010754e-06
in O 0 1.4508873391605448e-05
Korean O 0 0.02902871184051037
Patients O 0 8.119364065350965e-05
with O 0 5.676634100382216e-05
Wilson B-Disease 1 0.9999864101409912
disease I-Disease 1 1.0
. O 0 0.0005230829701758921

Arg778Leu O 0 0.022578779608011246
, O 0 3.803630170295946e-05
the O 0 1.532867827336304e-05
most O 0 6.811492312408518e-06
frequently O 0 8.284227078547701e-06
reported O 0 9.07839694264112e-06
mutation O 0 9.954687811841723e-07
of O 0 5.508499270945322e-06
this O 0 4.5091696847521234e-06
enzyme O 0 1.0043359907285776e-05
, O 0 7.678032488911413e-06
was O 0 6.998579920036718e-05
found O 0 3.4377385418338235e-06
in O 0 3.582446197469835e-06
six O 0 6.7663463596545625e-06
of O 0 1.604885619599372e-05
eight O 0 6.679119542241096e-05
unrelated O 0 0.00016064044029917568
patients O 0 4.1115239582723007e-05
studied O 0 0.00011289519170532003
, O 0 6.6043317019648384e-06
an O 0 1.915662096507731e-06
allele O 0 5.0064013521478046e-06
frequency O 0 1.063090530806221e-05
of O 0 0.00012033126404276118
37 O 0 0.0008574462844990194
. O 0 0.00029619704582728446

5 O 0 0.00030651327688246965
% O 0 3.4691242035478354e-05
, O 0 7.056386948534055e-06
which O 0 2.708463853196008e-06
is O 0 3.5642824514070526e-06
considerably O 0 1.6083253285614774e-05
higher O 0 3.382947397767566e-06
than O 0 1.06043910363951e-06
those O 0 1.5652251477149548e-06
in O 0 8.74829765962204e-06
other O 0 7.618862127856119e-06
Asian O 0 0.00011552760406630114
populations O 0 2.5950348572223447e-05
. O 0 5.339077688404359e-05

The O 0 0.00011744430230464786
novel O 0 4.543134491541423e-05
single O 0 1.0144753105123527e-05
nucleotide O 0 2.7000078262062743e-05
deletion O 0 9.570970723871142e-05
, O 0 3.6515641113510355e-05
2304delC O 0 0.00055545853683725
, O 0 1.3336624760995619e-05
was O 0 9.301820682594553e-05
found O 0 7.584390914416872e-06
in O 0 1.7611020666663535e-05
one O 0 2.266530464112293e-05
patient O 0 0.0001490202557761222
. O 0 0.00013445001968648285

Since O 0 0.0002333226439077407
a O 0 1.9783288735197857e-05
mutation O 0 4.589325726556126e-06
at O 0 6.857690459582955e-05
cDNA O 0 0.00010953604942187667
nucleotide O 0 0.00011068333697039634
2302 O 0 0.0037636037450283766
( O 0 2.9879747671657242e-05
2302insC O 0 0.0006158644100651145
) O 0 1.2612357750185765e-05
had O 0 3.2165145967155695e-05
been O 0 1.5108457773749251e-05
previously O 0 2.170130937884096e-05
described O 0 1.5082055142556783e-05
, O 0 1.3668553719980991e-06
this O 0 6.91756838477886e-07
region O 0 1.2711312592728063e-05
of O 0 1.4189279681886546e-05
the O 0 6.463176396209747e-05
ATP7B O 1 0.9995898604393005
gene O 0 4.3471740355016664e-05
may O 0 2.120853605447337e-05
be O 0 5.9115354815730825e-06
susceptible O 0 1.8306962374481373e-05
to O 0 9.837277502811048e-06
gene O 0 8.064730354817584e-05
rearrangements O 0 0.03264395520091057
causing O 1 0.9999444484710693
Wilson B-Disease 1 0.9999953508377075
disease I-Disease 1 0.9999998807907104
. O 0 0.0004733279347419739

Disruption O 0 0.0025565442629158497
of O 0 0.00019069021800532937
splicing O 0 0.00012827126192860305
regulated O 0 3.328230377519503e-05
by O 0 4.6517466216755565e-06
a O 0 3.2976979127852246e-05
CUG O 0 0.21371646225452423
- O 0 0.0001838094467530027
binding O 0 1.641695598664228e-05
protein O 0 0.0001689920900389552
in O 0 0.002513502025976777
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.005267654079943895

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9996917247772217
DM B-Disease 1 1.0
) O 0 0.00012595235602930188
is O 0 2.1897367332712747e-05
caused O 0 5.0631580961635336e-05
by O 0 3.9763149288774e-06
a O 0 2.4050237698247656e-05
CTG O 0 0.006032273173332214
expansion O 0 0.00011550931230885908
in O 0 8.713161150808446e-06
the O 0 1.1176663065270986e-05
3 O 0 3.412389196455479e-05
untranslated O 0 0.0004156518552917987
region O 0 5.846585190738551e-05
of O 0 3.10784307657741e-05
the O 0 0.00027802883414551616
DM B-Disease 1 1.0
gene O 0 0.0007042172946967185
. O 0 0.00028632371686398983

One O 0 6.108033994678408e-05
model O 0 3.6223882489139214e-05
of O 0 0.0005123277078382671
DM B-Disease 1 1.0
pathogenesis O 1 0.9999887943267822
suggests O 0 0.00017132028006017208
that O 0 6.335342732199933e-06
RNAs O 0 7.664908480364829e-05
from O 0 4.350572908151662e-06
the O 0 4.998576969228452e-06
expanded O 0 1.4760980775463395e-05
allele O 0 3.411369561945321e-06
create O 0 6.537568424391793e-06
a O 0 1.4262348486226983e-05
gain O 0 0.00013403552293311805
- O 0 7.505814573960379e-05
of O 0 3.5694898542715237e-05
- O 0 0.00010544645192567259
function O 0 7.944187018438242e-06
mutation O 0 2.6192169571004342e-06
by O 0 1.4049603578314418e-06
the O 0 5.680771664628992e-06
inappropriate O 0 1.9269127733423375e-05
binding O 0 2.5964038741221884e-06
of O 0 2.001371467486024e-05
proteins O 0 7.3780506681941915e-06
to O 0 1.5241714208968915e-05
the O 0 0.00012690295989159495
CUG O 1 0.7853173017501831
repeats O 0 0.0011562873842194676
. O 0 0.00023251250968314707

Data O 0 9.606099047232419e-05
presented O 0 8.802070806268603e-05
here O 0 2.4978398869279772e-05
indicate O 0 6.789442068111384e-06
that O 0 8.046251878113253e-07
the O 0 6.846726137155201e-06
conserved O 0 8.947611058829352e-05
heterogeneous O 0 0.0003008047060575336
nuclear O 0 0.00343801686540246
ribonucleoprotein O 0 0.018146483227610588
, O 0 5.744673399021849e-05
CUG O 0 0.016114838421344757
- O 0 0.00015384700964204967
binding O 0 1.3129837498127017e-05
protein O 0 2.970221612486057e-05
( O 0 3.8150592445163056e-05
CUG O 0 0.4253617227077484
- O 0 0.0005670267855748534
BP O 0 0.0007472599390894175
) O 0 6.970807135076029e-06
, O 0 2.836935436789645e-06
may O 0 1.4010362065164372e-05
mediate O 0 9.875057730823755e-05
the O 0 8.732577407499775e-05
trans O 0 0.0006804417353123426
- O 0 0.00018419719708617777
dominant O 0 5.628916187561117e-05
effect O 0 1.456049176340457e-05
of O 0 1.8450826246407814e-05
the O 0 9.590842091711238e-05
RNA O 0 0.0007551235030405223
. O 0 0.00012061351299053058

CUG O 1 0.9999206066131592
- O 0 0.009369874373078346
BP O 0 0.0023935087956488132
was O 0 0.00012545996287371963
found O 0 4.050925781484693e-06
to O 0 3.0783007787249517e-06
bind O 0 6.1200926211313345e-06
to O 0 4.429298769537127e-06
the O 0 2.6931980755762197e-05
human O 0 0.00011649890075204894
cardiac O 1 0.9999781847000122
troponin O 1 0.99998939037323
T O 1 0.99887615442276
( O 0 0.00016266736201941967
cTNT O 0 0.0016431332333013415
) O 0 1.92574443644844e-05
pre O 0 0.0003031947708223015
- O 0 0.00020847818814218044
messenger O 0 4.587694274960086e-05
RNA O 0 4.486009129323065e-05
and O 0 3.894414930982748e-06
regulate O 0 1.1195342267455999e-05
its O 0 4.6954887693573255e-06
alternative O 0 9.819244041864295e-06
splicing O 0 0.00011608193744905293
. O 0 0.00012001739378320053

Splicing O 0 0.000399417505832389
of O 0 0.00029862963128834963
cTNT O 0 0.022656280547380447
was O 0 0.002134065143764019
disrupted O 0 0.005346023943275213
in O 0 0.0005726870731450617
DM B-Disease 1 1.0
striated O 1 0.9978749752044678
muscle O 0 0.004315306898206472
and O 0 5.912543201702647e-05
in O 0 5.2675928600365296e-05
normal O 0 9.040970326168463e-05
cells O 0 2.0468376533244736e-05
expressing O 0 2.4011051209527068e-05
transcripts O 0 0.00011999793059658259
that O 0 1.29692625705502e-05
contain O 0 0.0002554198435973376
CUG O 1 0.9663241505622864
repeats O 0 0.0016087436815723777
. O 0 0.00034298317041248083

Altered O 0 0.0002897489757742733
expression O 0 1.8545271814218722e-05
of O 0 6.294146442087367e-05
genes O 0 6.847130134701729e-05
regulated O 0 9.621814388083294e-05
posttranscriptionally O 0 0.0010716051328927279
by O 0 3.496222052490339e-05
CUG O 1 0.9994468092918396
- O 0 0.0008533835061825812
BP O 0 0.00077429274097085
therefore O 0 1.1737379281839821e-05
may O 0 1.2543589946290012e-05
contribute O 0 3.189220660715364e-05
to O 0 0.00012179539044154808
DM B-Disease 1 1.0
pathogenesis O 1 0.9999945163726807
. O 0 0.00023717172734905034
. O 0 0.0002108197077177465

Identification O 0 8.810567669570446e-05
of O 0 0.00012659246567636728
a O 0 9.895003313431516e-05
novel O 0 0.00015016910037957132
nonsense O 0 0.0002740433847066015
mutation O 0 1.6407659131800756e-05
and O 0 5.940748451394029e-06
a O 0 2.00867962121265e-05
missense O 0 8.075766527326778e-05
substitution O 0 2.124465027009137e-05
in O 0 3.363663927302696e-05
the O 0 4.6579727495554835e-05
vasopressin O 0 0.00043158436892554164
- O 0 0.000462314608739689
neurophysin O 0 0.0014712124830111861
II O 1 0.9999656677246094
gene O 0 1.5889061614871025e-05
in O 0 6.361509349517291e-06
two O 0 2.165035311918473e-06
Spanish O 0 2.6504490961087868e-05
kindreds O 0 0.0001508220302639529
with O 0 2.027710434049368e-05
familial B-Disease 1 0.9999964237213135
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.004924176726490259

Familial B-Disease 1 0.9999964237213135
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.8355004191398621
FNDI B-Disease 1 1.0
) O 0 2.428453262837138e-05
is O 0 2.48009951064887e-06
an O 0 4.375546723167645e-06
autosomal B-Disease 1 0.9883818030357361
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 0.9999986886978149
by O 0 0.00041706563206389546
deficiency O 1 1.0
in O 0 0.00039189084782265127
the O 0 0.0004425806982908398
antidiuretic O 0 0.003956057131290436
hormone O 0 0.0005240910104475915
arginine O 0 0.00015645319945178926
vasopressin O 0 0.0003546150983311236
( O 0 6.270231097005308e-05
AVP O 0 0.0008798745111562312
) O 0 2.4107466742862016e-06
encoded O 0 1.8251993196827243e-06
by O 0 1.1362817531335168e-06
the O 0 2.693686110433191e-05
AVP O 0 0.007296078372746706
- O 0 0.0006075029959902167
neurophysin O 0 0.005423597991466522
II O 1 0.9999998807907104
( O 0 0.0006742300465703011
AVP O 1 0.9101240634918213
- O 0 0.0011211322853341699
NPII O 0 0.017442401498556137
) O 0 1.789046473277267e-05
gene O 0 2.3854843675508164e-05
on O 0 9.878240234684199e-05
chromosome O 0 0.0008172710076905787
20p13 O 0 0.003126564435660839
. O 0 0.0002501445123925805

In O 0 7.604769780300558e-05
this O 0 3.717693971339031e-06
study O 0 6.639531875407556e-06
, O 0 2.5879614895529812e-06
we O 0 1.5954207128743292e-06
analyzed O 0 2.4957187179097673e-06
two O 0 1.0658675364538794e-06
families O 0 3.872088200296275e-06
with O 0 1.799604251573328e-05
FNDI B-Disease 1 0.999994158744812
using O 0 3.5963494156021625e-05
direct O 0 5.750011405325495e-05
automated O 0 0.0003398488915991038
fluorescent O 0 7.626586011610925e-05
, O 0 1.0156049938814249e-05
solid O 0 6.30906070000492e-05
phase O 0 0.00016042675997596234
, O 0 1.1863214240293019e-05
single O 0 8.817229172564112e-06
- O 0 2.704795952013228e-05
stranded O 0 1.2496057024691254e-05
DNA O 0 2.566832790762419e-06
sequencing O 0 1.3768034250460914e-06
of O 0 1.3121288247930352e-05
PCR O 0 0.00022581344819627702
- O 0 0.0010938174091279507
amplified O 0 0.0010629082098603249
AVP O 0 0.040906473994255066
- O 0 0.0017098791431635618
NPII O 0 0.0326894111931324
DNA O 0 0.0005469712777994573
. O 0 0.0001585864374646917

In O 0 9.361789125250652e-05
one O 0 8.211375643440988e-06
of O 0 1.0680260857043322e-05
the O 0 1.202385828946717e-05
families O 0 3.958947218052344e-06
, O 0 3.565948418327025e-06
affected O 0 5.942454208707204e-06
individuals O 0 1.030691805681272e-06
presented O 0 3.382078284630552e-05
a O 0 1.7391979781677946e-05
novel O 0 2.7023210350307636e-05
nonsense O 0 8.839347719913349e-05
mutation O 0 6.275025498325704e-06
in O 0 1.7300762920058332e-05
exon O 0 8.160767902154475e-05
3 O 0 1.2220414646435529e-05
of O 0 8.64073899720097e-06
the O 0 1.5735071428935044e-05
gene O 0 7.489949894079473e-06
, O 0 2.0107963791815564e-06
consisting O 0 3.85352541343309e-06
in O 0 8.257912668341305e-06
a O 0 2.5495757654425688e-05
G O 0 0.00024163334455806762
to O 0 5.210011295275763e-05
T O 0 0.0013431181432679296
transition O 0 0.0002819682122208178
at O 0 0.00028390041552484035
nucleotide O 0 0.00014322107017505914
2101 O 0 0.0011075716465711594
, O 0 4.6072959776211064e-06
which O 0 2.891415988415247e-06
produces O 0 2.9127434117981466e-06
a O 0 8.533802429155912e-06
stop O 0 1.950215664692223e-05
signal O 0 4.964825347997248e-05
in O 0 1.566078935866244e-05
codon O 0 2.3222661184263416e-05
82 O 0 0.00015609126421622932
( O 0 0.00011791673023253679
Glu O 0 0.005399232730269432
) O 0 4.7376164729939774e-05
of O 0 0.00031159076024778187
NPII O 1 0.9996880292892456
. O 0 0.0009171438287012279

The O 0 0.0011462190886959434
premature O 0 0.0014083774294704199
termination O 0 0.00039488193579018116
eliminates O 0 0.00010573402687441558
part O 0 2.4447166651953012e-05
of O 0 4.911611904390156e-05
the O 0 8.612407691543922e-05
C O 0 0.001359166344627738
- O 0 0.00028813796234317124
terminal O 0 0.0002404307306278497
domain O 0 3.100977846770547e-05
of O 0 0.00011011465539922938
NPII O 1 0.9395748376846313
, O 0 1.880050331237726e-05
including O 0 7.035931957943831e-06
a O 0 2.42372443608474e-05
cysteine O 0 3.149164331262e-05
residue O 0 0.00012288779544178396
in O 0 1.8975531929754652e-05
position O 0 4.223021096549928e-05
85 O 0 3.781806299230084e-05
, O 0 4.146926585235633e-06
which O 0 2.426782884867862e-06
could O 0 3.2610093967377907e-06
be O 0 1.5377406725747278e-06
involved O 0 5.43047781320638e-06
in O 0 6.965218290133635e-06
the O 0 1.7330421542283148e-05
correct O 0 8.320710912812501e-05
folding O 0 0.0006280260276980698
of O 0 0.00023368642723653466
the O 0 0.0008523326832801104
prohormone O 1 0.9933410286903381
. O 0 0.0009564465726725757

In O 0 0.000135142428916879
the O 0 4.765091580338776e-05
second O 0 8.39417552924715e-05
family O 0 1.7329131878796034e-05
, O 0 5.089932074042736e-06
a O 0 1.010646519716829e-05
G279A O 0 0.00016204998246394098
substitution O 0 1.6904381482163444e-05
at O 0 0.00010721983562689275
position O 0 5.841090023750439e-05
- O 0 3.7593832530546933e-05
1 O 0 1.1223007277294528e-05
of O 0 9.397423127666116e-06
the O 0 1.3431100342131685e-05
signal O 0 0.00013925075472798198
peptide O 0 0.00010045464296126738
was O 0 7.477930921595544e-05
observed O 0 9.03988166101044e-06
in O 0 6.008397576806601e-06
all O 0 4.050813458889024e-06
affected O 0 2.53576163231628e-05
individuals O 0 2.370878792135045e-05
. O 0 0.0002552085788920522

This O 0 0.00012531218817457557
missense O 0 0.0006687144632451236
mutation O 0 4.5544868044089526e-05
, O 0 1.3995768313179724e-05
which O 0 1.4362452930072322e-05
replaces O 0 0.0004319564322941005
Ala O 0 0.001262619742192328
with O 0 3.375399319338612e-05
Thr O 1 0.6892631649971008
, O 0 2.8986638426431455e-05
is O 0 9.07347202883102e-06
frequent O 0 2.724062869674526e-05
among O 0 0.00016290608618874103
FNDI B-Disease 1 1.0
patients O 0 0.00032760054455138743
and O 0 1.730855365167372e-05
is O 0 7.626014848938212e-06
thought O 0 5.852803042216692e-06
to O 0 2.407098463663715e-06
reduce O 0 8.082629392447416e-06
the O 0 1.2541496289486531e-05
efficiency O 0 2.362045597692486e-05
of O 0 3.4048283851007e-05
cleavage O 0 0.0003197539481334388
by O 0 4.146524588577449e-05
signal O 0 0.0010709490161389112
peptidases O 0 0.002081682439893484
. O 0 7.264441228471696e-05
. O 0 0.00011843169340863824

Genetic O 0 0.00017260150343645364
heterogeneity O 0 0.0003322562843095511
of O 0 0.0012808033498004079
Saethre B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.2582174248527735e-05
due O 0 0.00014577983529306948
to O 0 5.2972380217397586e-05
TWIST O 0 0.0012830181512981653
and O 0 6.497126742033288e-05
FGFR O 1 0.9999737739562988
mutations O 0 0.0003274088376201689
. O 0 0.0001724141329759732

Thirty O 0 0.004855644889175892
- O 0 0.0005768159753642976
two O 0 1.3560887055064086e-05
unrelated O 0 5.880178650841117e-05
patients O 0 7.531752544309711e-06
with O 0 1.9506417174852686e-06
features O 0 1.136061837314628e-05
of O 0 0.0003479694132693112
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.1210896850097924e-05
a O 0 3.830052446573973e-05
common O 0 4.175073991063982e-05
autosomal B-Disease 1 0.6722585558891296
dominant I-Disease 1 0.9994819760322571
condition I-Disease 1 0.9999377727508545
of O 1 0.9999752044677734
craniosynostosis B-Disease 1 1.0
and O 1 0.9999890327453613
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999736547470093
, O 0 7.134467159630731e-05
were O 0 3.627961632446386e-05
screened O 0 4.295833787182346e-05
for O 0 7.111899321898818e-06
mutations O 0 2.3658378268009983e-05
in O 0 8.299315959447995e-05
TWIST O 0 0.0019857545848935843
, O 0 8.878172957338393e-05
FGFR2 O 1 0.9969922304153442
, O 0 6.582452624570578e-05
and O 0 0.00011577860277611762
FGFR3 O 1 0.9999064207077026
. O 0 0.0005634685512632132

Nine O 0 0.00047375180292874575
novel O 0 8.337104372913018e-05
and O 0 1.267725838260958e-05
three O 0 1.3135962035448756e-05
recurrent O 0 0.0008616351406089962
TWIST O 0 0.0015935167903080583
mutations O 0 4.5041932025924325e-05
were O 0 3.7952027923893183e-05
found O 0 9.445817340747453e-06
in O 0 1.7935564756044187e-05
12 O 0 0.00010209199535893276
families O 0 4.467369944904931e-05
. O 0 0.0001603652781341225

Seven O 0 0.00014570090570487082
families O 0 8.68278402776923e-06
were O 0 1.3394032066571526e-05
found O 0 4.4482808334578294e-06
to O 0 4.2531696635705885e-06
have O 0 4.665350388677325e-06
the O 0 4.154975977144204e-05
FGFR3 O 1 0.9938347339630127
P250R O 0 0.001130169490352273
mutation O 0 1.641933704377152e-05
, O 0 4.947678917233134e-06
and O 0 2.5302404083049623e-06
one O 0 2.1233784082141938e-06
individual O 0 1.7094242821258376e-06
was O 0 7.903102959971875e-05
found O 0 3.149095618937281e-06
to O 0 4.6273626139736734e-06
have O 0 3.1185338684736053e-06
an O 0 1.9101902580587193e-05
FGFR2 O 1 0.9832725524902344
VV269 O 0 0.003849796950817108
- O 0 0.0005417975480668247
270 O 0 0.0001658691471675411
deletion O 0 0.00036119608557783067
. O 0 0.0002884925343096256

To O 0 0.0001018414186546579
date O 0 9.40321187954396e-05
, O 0 5.517646968655754e-06
our O 0 4.780140898219543e-06
detection O 0 9.467497875448316e-06
rate O 0 8.000838533916976e-06
for O 0 6.463425961555913e-06
TWIST O 0 0.0004298029525671154
or O 0 3.8974088965915143e-05
FGFR O 0 0.08607518672943115
mutations O 0 2.4262957595055923e-05
is O 0 6.639050297962967e-06
68 O 0 2.3539461835753173e-05
% O 0 6.637126261921367e-06
in O 0 2.091528949677013e-05
our O 0 0.0001367250515613705
Saethre B-Disease 1 0.999976634979248
- I-Disease 1 0.9999384880065918
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.00043260055826976895
, O 0 1.7809641576604918e-05
including O 0 8.156258445524145e-06
our O 0 2.4210192350437865e-05
five O 0 2.0245839550625533e-05
patients O 0 1.4204822946339846e-05
elsewhere O 0 1.9970149878645316e-05
reported O 0 2.3788144972058944e-05
with O 0 1.4705455214425456e-05
TWIST O 0 0.0026540106628090143
mutations O 0 0.00041664953459985554
. O 0 0.0003482566389720887

More O 0 2.090645648422651e-05
than O 0 5.118900389788905e-06
35 O 0 1.6578504073549993e-05
different O 0 1.5592909221595619e-06
TWIST O 0 0.0002648282970767468
mutations O 0 1.4876070054015145e-05
are O 0 2.154678668375709e-06
now O 0 1.0246730198559817e-05
known O 0 1.3712142390431836e-05
in O 0 6.6014354160870425e-06
the O 0 1.9682178390212357e-05
literature O 0 6.741553806932643e-05
. O 0 0.0001294286485062912

The O 0 0.00016823355690576136
most O 0 3.33004973072093e-05
common O 0 1.1592231203394476e-05
phenotypic O 0 8.276854350697249e-05
features O 0 2.71345106739318e-05
, O 0 4.143495061725844e-06
present O 0 6.24396716375486e-06
in O 0 5.178391347726574e-06
more O 0 1.0017217846325366e-06
than O 0 1.2359125776129076e-06
a O 0 3.908855433110148e-06
third O 0 1.0157812539546285e-05
of O 0 1.480570062994957e-05
our O 0 4.42088748968672e-05
patients O 0 3.036419911950361e-05
with O 0 2.1450388885568827e-05
TWIST O 0 0.0012498712167143822
mutations O 0 8.971431088866666e-05
, O 0 1.816626900108531e-05
are O 0 9.439909263164736e-06
coronal B-Disease 0 0.004176663234829903
synostosis I-Disease 0 0.45666325092315674
, O 0 8.758112380746752e-05
brachycephaly B-Disease 0 0.016939319670200348
, O 0 0.00011032674956368282
low B-Disease 0 0.0031860906165093184
frontal I-Disease 1 0.9999984502792358
hairline I-Disease 1 1.0
, O 0 0.01935551129281521
facial B-Disease 1 0.9999995231628418
asymmetry I-Disease 1 0.9999977350234985
, O 0 0.004536917433142662
ptosis B-Disease 1 0.9999901056289673
, O 0 0.00044638855615630746
hypertelorism B-Disease 1 0.9977791905403137
, O 0 0.00014826960978098214
broad B-Disease 0 0.0016716985264793038
great I-Disease 1 0.9999200105667114
toes I-Disease 1 0.9991753697395325
, O 0 8.324934606207535e-05
and O 0 0.00011582872684812173
clinodactyly B-Disease 1 0.7578827142715454
. O 0 0.00040548332617618144

Significant O 0 0.0015500334557145834
intra O 0 0.025732211768627167
- O 0 0.0011499696411192417
and O 0 2.747750659182202e-05
interfamilial O 0 0.0007239089463837445
phenotypic O 0 0.00010039469634648412
variability O 0 0.00010103912791237235
is O 0 3.3864855595311383e-06
present O 0 2.957633341793553e-06
for O 0 3.2494856441189768e-06
either O 0 3.68506989616435e-05
TWIST O 0 0.0007777635473757982
mutations O 0 9.269756264984608e-05
or O 0 0.00028050661785528064
FGFR O 1 0.9999051094055176
mutations O 0 0.0009346944862045348
. O 0 0.0005116771790198982

The O 0 9.328200394520536e-05
overlap O 0 3.922203541151248e-05
in O 0 1.7610231225262396e-05
clinical O 0 5.2694416808662936e-05
features O 0 1.6643387425574474e-05
and O 0 5.309423158905702e-06
the O 0 8.934837751439773e-06
presence O 0 1.3199263776186854e-05
, O 0 3.036026555491844e-06
in O 0 2.116502400895115e-06
the O 0 2.4039509298745543e-06
same O 0 2.147101213267888e-06
genes O 0 2.44032230511948e-06
, O 0 1.2692662494373508e-06
of O 0 6.305553597485414e-06
mutations O 0 3.563595782907214e-06
for O 0 2.9846589768567355e-06
more O 0 2.8281938284635544e-06
than O 0 4.581419489113614e-06
one O 0 1.3737129847868346e-05
craniosynostotic B-Disease 0 0.0010996656492352486
condition I-Disease 0 0.00012079445878043771
- O 0 7.174132770160213e-05
such O 0 3.1175022741081193e-06
as O 0 6.107690569479018e-05
Saethre B-Disease 1 0.7062863111495972
- I-Disease 0 0.0007491101277992129
Chotzen I-Disease 0 0.002552054123952985
, I-Disease 0 1.8997079678229056e-05
Crouzon I-Disease 0 0.0020656175911426544
, I-Disease 0 2.5058878236450255e-05
and I-Disease 0 8.107820031000301e-05
Pfeiffer I-Disease 1 0.9999980926513672
syndromes I-Disease 1 0.999997615814209
- O 0 0.0010367853101342916
support O 0 2.9581342460005544e-05
the O 0 3.322629345348105e-05
hypothesis O 0 1.5856547179282643e-05
that O 0 2.429858341201907e-06
TWIST O 0 0.00017855079204309732
and O 0 9.73166879703058e-06
FGFRs O 0 0.0004933532909490168
are O 0 8.36365131817729e-07
components O 0 6.159686108730966e-06
of O 0 1.166749370895559e-05
the O 0 9.933379260473885e-06
same O 0 3.7768654692627024e-06
molecular O 0 8.278279892692808e-06
pathway O 0 2.5757299226825126e-05
involved O 0 6.882259185658768e-06
in O 0 6.719641078234417e-06
the O 0 1.4703239685331937e-05
modulation O 0 0.00016036955639719963
of O 0 0.0007825125358067453
craniofacial O 1 1.0
and O 0 0.44995155930519104
limb O 1 0.9999980926513672
development O 0 0.0009335766080766916
in O 0 0.00018553646805230528
humans O 0 0.00016633620543871075
. O 0 2.8722530259983614e-05
. O 0 5.442128167487681e-05

Mutation O 0 2.8911381377838552e-05
analysis O 0 5.879207492398564e-06
of O 0 0.00027097886777482927
UBE3A O 1 0.9999997615814209
in O 1 0.9999750852584839
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999904632568359
. O 0 0.004284109454602003

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9944446682929993
AS B-Disease 1 0.9999997615814209
) O 0 3.8732512621209025e-05
is O 0 1.0206811566604301e-05
caused O 0 5.322814831743017e-05
by O 0 9.131100341619458e-06
chromosome O 0 0.0002936462115030736
15q11 O 0 0.001862490433268249
- O 0 0.0003946205833926797
q13 O 0 0.0002781545335892588
deletions O 0 2.4618866518721916e-05
of O 0 2.487985693733208e-05
maternal O 0 8.142873411998153e-05
origin O 0 1.1383011951693334e-05
, O 0 6.935033979971195e-06
by O 0 1.1216588063689414e-05
paternal O 0 0.0013290971983224154
uniparental B-Disease 1 0.9999450445175171
disomy I-Disease 1 0.9998401403427124
( O 0 0.002209629863500595
UPD B-Disease 1 0.9999822378158569
) O 0 6.579176260856912e-05
15 O 0 6.344222492771223e-05
, O 0 7.747162271698471e-06
by O 0 1.2414147931849584e-05
imprinting O 0 0.0017102258279919624
defects O 1 0.996852457523346
, O 0 2.6562283892417327e-05
and O 0 6.525123353640083e-06
by O 0 5.360883733374067e-06
mutations O 0 1.0310721336281858e-05
in O 0 2.8523489163490012e-05
the O 0 0.00015832764620427042
UBE3A O 1 0.9962383508682251
gene O 0 0.0004304103786125779
. O 0 0.00022084143711254

UBE3A O 0 0.06836095452308655
encodes O 0 0.00033649502438493073
a O 0 0.00017075632058549672
ubiquitin O 0 0.0006411669892258942
- O 0 0.0002565669419709593
protein O 0 2.552129990363028e-05
ligase O 0 8.028252341318876e-05
and O 0 1.0089170245919377e-05
shows O 0 0.00012863210577052087
brain O 0 0.08150989562273026
- O 0 0.0003393955994397402
specific O 0 3.2200321584241465e-05
imprinting O 0 0.0015745169948786497
. O 0 0.0005573990638367832

Here O 0 0.000458040798548609
we O 0 3.536710937623866e-05
describe O 0 0.00019532778242137283
UBE3A O 0 0.029925979673862457
coding O 0 0.0007173669873736799
- O 0 0.0005262946942821145
region O 0 0.00013292173389345407
mutations O 0 2.3336328013101593e-05
detected O 0 5.316575334290974e-05
by O 0 4.463634013518458e-06
SSCP O 0 0.0018238930497318506
analysis O 0 4.872315003012773e-06
in O 0 1.8879254639614373e-05
13 O 0 0.0001080664515029639
AS B-Disease 0 0.02988412417471409
individuals O 0 1.0522265256440733e-05
or O 0 3.520465179462917e-05
families O 0 3.9308004488702863e-05
. O 0 0.00013245560694485903

Two O 0 0.00013422008487395942
identical O 0 8.613828686065972e-05
de O 0 0.0010530921863391995
novo O 0 0.0010510379215702415
5 O 0 0.0006128909881226718
- O 0 0.0003794589138124138
bp O 0 0.00029001233633607626
duplications O 0 0.0002748277911450714
in O 0 5.3619824029738083e-05
exon O 0 0.0003338381357025355
16 O 0 0.00010380984895164147
were O 0 4.4500480726128444e-05
found O 0 4.678932236856781e-05
. O 0 0.0001310736552113667

Among O 0 0.00010473236034158617
the O 0 2.3917758880998008e-05
other O 0 4.160545813647332e-06
11 O 0 3.4789736673701555e-05
unique O 0 1.0836837645911146e-05
mutations O 0 2.4155924620572478e-05
, O 0 1.3055918316240422e-05
8 O 0 8.48558556754142e-05
were O 0 2.6629499188857153e-05
small O 0 1.971671008504927e-05
deletions O 0 6.32680967100896e-05
or O 0 2.7664238587021828e-05
insertions O 0 0.00015833909856155515
predicted O 0 0.00014594481035601348
to O 0 3.6614324926631525e-05
cause O 0 0.0002375942567596212
frameshifts O 0 0.0017343508079648018
, O 0 1.3043226317677181e-05
1 O 0 3.7083937058923766e-05
was O 0 5.724477887270041e-05
a O 0 5.314195732353255e-06
mutation O 0 1.551158788970497e-06
to O 0 3.5615912565845065e-06
a O 0 8.998545126814861e-06
stop O 0 2.0347848476376384e-05
codon O 0 1.1282297236903105e-05
, O 0 4.886568149231607e-06
1 O 0 2.9105389330652542e-05
was O 0 6.958266021683812e-05
a O 0 8.984944543044548e-06
missense O 0 3.031752748938743e-05
mutation O 0 3.165348289257963e-06
, O 0 2.733025212364737e-06
and O 0 1.9991935005236883e-06
1 O 0 6.764183490304276e-05
was O 0 0.00014127294707577676
predicted O 0 5.4187006753636524e-05
to O 0 1.0678111721063033e-05
cause O 0 3.9914928493089974e-05
insertion O 0 4.640137558453716e-05
of O 0 0.00011116376845166087
an O 0 8.823381358524784e-05
isoleucine O 0 0.0013464142102748156
in O 0 6.129605753812939e-05
the O 0 5.809476351714693e-05
hect O 0 0.0006894328398630023
domain O 0 5.3547671996057034e-05
of O 0 5.8726574934553355e-05
the O 0 7.364820339716971e-05
UBE3A O 0 0.02162148617208004
protein O 0 4.160558455623686e-05
, O 0 3.1855047382123303e-06
which O 0 1.1035828038075124e-06
functions O 0 4.522378276305972e-06
in O 0 5.6541324738645926e-05
E2 O 0 0.003076439956203103
binding O 0 3.666092743515037e-05
and O 0 3.0411667466978543e-05
ubiquitin O 0 0.0005077776149846613
transfer O 0 0.00048373863683082163
. O 0 0.00032772860140539706

Eight O 0 9.218927880283445e-05
of O 0 3.818582626990974e-05
the O 0 3.6497676774160936e-05
cases O 0 1.2754431736539118e-05
were O 0 2.3549426259705797e-05
familial O 0 0.0002843631082214415
, O 0 4.052889198646881e-05
and O 0 1.637077184568625e-05
five O 0 4.4117779907537624e-05
were O 0 8.41727523948066e-05
sporadic O 0 0.0007478861371055245
. O 0 0.00038851104909554124

In O 0 0.00034408768988214433
two O 0 4.16701877838932e-05
familial O 0 0.000757298432290554
cases O 0 7.414535502903163e-05
and O 0 3.7906091165496036e-05
one O 0 1.9499571862979792e-05
sporadic O 0 0.0001703699235804379
case O 0 8.509903273079544e-05
, O 0 2.4222734282375313e-05
mosaicism O 0 0.00419962452724576
for O 0 0.00011653544061118737
UBE3A O 1 0.9995613694190979
mutations O 0 0.00016878177120815963
was O 0 0.00032139825634658337
detected O 0 5.3428320825332776e-05
in O 0 8.632898243376985e-06
the O 0 9.500626219960395e-06
mother O 0 1.4172631381370593e-05
of O 0 1.4415225450647995e-05
three O 0 2.962334838230163e-05
AS B-Disease 1 0.9975268244743347
sons O 0 0.0008823595708236098
, O 0 8.456353498331737e-06
in O 0 6.103958185121883e-06
the O 0 1.3742645933234598e-05
maternal O 0 0.00012282899115234613
grandfather O 0 0.00019843531481456012
of O 0 3.6129975342191756e-05
two O 0 2.5891322366078384e-05
AS B-Disease 1 0.922393798828125
first O 0 0.0001103259128285572
cousins O 0 9.855038661044091e-05
, O 0 4.166950475337217e-06
and O 0 2.6574357434583362e-06
in O 0 6.9488105509663e-06
the O 0 1.837759918998927e-05
mother O 0 1.935797990881838e-05
of O 0 2.046683403023053e-05
an O 0 6.207179831108078e-05
AS B-Disease 1 0.9999946355819702
daughter O 0 0.004859112203121185
. O 0 0.0003343037678860128

The O 0 8.176409028237686e-05
frequencies O 0 1.2130301001889165e-05
with O 0 2.282797368025058e-06
which O 0 4.511527095019119e-06
we O 0 3.8031203075661324e-06
detected O 0 2.2737740437150933e-05
mutations O 0 3.408523980397149e-06
were O 0 1.1818801795016043e-05
5 O 0 2.5532159270369448e-05
( O 0 7.24759138392983e-06
14 O 0 2.0963292627129704e-05
% O 0 4.218864432914415e-06
) O 0 1.8229814031656133e-06
of O 0 1.341555889666779e-05
35 O 0 2.659888741618488e-05
in O 0 1.0779591320897453e-05
sporadic O 0 3.506158464006148e-05
cases O 0 5.550686182687059e-06
and O 0 6.037829734850675e-06
8 O 0 3.4449953091097996e-05
( O 0 5.441909252112964e-06
80 O 0 1.4984166227804963e-05
% O 0 4.226991677569458e-06
) O 0 3.1892070637695724e-06
of O 0 1.7149570339825004e-05
10 O 0 4.93291299790144e-05
in O 0 3.848534470307641e-05
familial O 0 0.0006914489204064012
cases O 0 0.00018965103663504124
. O 0 0.00016917652101255953
. O 0 0.0003338756796438247

The O 0 0.004637547302991152
hemochromatosis B-Disease 1 1.0
845 O 1 0.8766525983810425
G O 0 0.08022337406873703
- O 0 0.001313297776505351
- O 0 0.00014787004329264164
> O 0 2.4370467144763097e-05
A O 0 3.44674990628846e-05
and O 0 3.711317503984901e-06
187 O 0 2.301943641214166e-05
C O 0 0.00023052321921568364
- O 0 0.00014763434592168778
- O 0 5.5522854381706566e-05
> O 0 4.9331294576404616e-05
G O 0 0.00021496127010323107
mutations O 0 1.5913750758045353e-05
: O 0 9.75545663095545e-06
prevalence O 0 0.00016721592692192644
in O 0 7.563229883089662e-05
non O 0 0.000393311696825549
- O 0 0.0008766580722294748
Caucasian O 0 0.0006723072729073465
populations O 0 5.563606828218326e-05
. O 0 6.56230840831995e-05

Hemochromatosis B-Disease 1 0.9999996423721313
, O 0 0.000276915350696072
the O 0 0.001999057363718748
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999889135360718
, O 0 6.941697938600555e-05
leads O 0 0.00011561377323232591
, O 0 1.2596249689522665e-05
if O 0 1.557374889671337e-05
untreated O 1 0.9928567409515381
, O 0 3.2678326533641666e-05
to O 0 0.00010857857705559582
progressive O 1 0.9999911785125732
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.0010873563587665558
premature B-Disease 0 0.1844872236251831
death I-Disease 0 0.02163383923470974
. O 0 0.0003712767211254686

The O 0 0.0015845599118620157
hemochromatosis B-Disease 1 1.0
gene O 0 0.0011165097821503878
, O 0 0.00021676735195796937
HFE O 1 0.9992121458053589
, O 0 3.1583491363562644e-05
recently O 0 2.1876619939575903e-05
has O 0 3.291177563369274e-06
been O 0 7.658813046873547e-06
identified O 0 9.688294994703028e-06
, O 0 2.319498207725701e-06
and O 0 1.5186719792836811e-06
characterization O 0 1.3883159226679709e-05
of O 0 1.7933580238604918e-05
this O 0 8.862280992616434e-06
gene O 0 8.720992809685413e-06
has O 0 2.0522045360849006e-06
shown O 0 1.994935018956312e-06
that O 0 4.6795909725005913e-07
it O 0 2.4193113290493784e-07
contains O 0 7.622973043908132e-07
two O 0 5.469591997098178e-07
mutations O 0 1.5937813486743835e-06
that O 0 7.743963692519173e-07
result O 0 4.009014446637593e-06
in O 0 8.550600796297658e-06
amino O 0 5.180288098927122e-06
acid O 0 6.645955181738827e-06
substitutions O 0 3.28869755321648e-05
- O 0 0.00011610430374275893
cDNA O 0 4.638203972717747e-05
nucleotides O 0 2.4088891223073006e-05
845 O 0 0.00028005021158605814
G O 0 0.0003690993180498481
- O 0 0.0001337522262474522
- O 0 4.508817437454127e-05
> O 0 2.7729771318263374e-05
A O 0 7.978689973242581e-05
( O 0 1.071019778464688e-05
C282Y O 0 0.0001033802327583544
) O 0 2.5534266114846105e-06
and O 0 2.3180257358035306e-06
187 O 0 2.4193919671233743e-05
C O 0 0.00025640169042162597
- O 0 0.00014405173715204
- O 0 0.0001310690277023241
> O 0 0.0001085885232896544
G O 0 0.0011727287201210856
( O 0 0.0002021323307417333
H63D O 1 0.9658329486846924
) O 0 0.0001779481244739145
. O 0 0.00017380744975525886

Although O 0 0.0025886769872158766
hemochromatosis B-Disease 1 1.0
is O 0 9.79229444055818e-05
common O 0 3.5611254133982584e-05
in O 0 6.769416359020397e-05
Caucasians O 0 0.0004589273012243211
, O 0 2.1778161681140773e-05
affecting O 0 5.3627289162250236e-05
> O 0 7.436919258907437e-05
= O 0 9.201835928251967e-05
1 O 0 8.165391773218289e-05
/ O 0 5.854283881490119e-05
300 O 0 1.3309841051523108e-05
individuals O 0 7.279805345206114e-07
of O 0 9.932620741892606e-06
northern O 0 1.2714161130134016e-05
European O 0 4.821272341359872e-06
origin O 0 3.2366874620493036e-06
, O 0 2.1437804207380395e-06
it O 0 5.914056373512722e-07
has O 0 9.433666150471254e-07
not O 0 3.8264661839093606e-07
been O 0 2.5126194032054627e-06
recognized O 0 6.189423402247485e-06
in O 0 1.2560612049128395e-05
other O 0 7.215144250949379e-06
populations O 0 1.6081628928077407e-05
. O 0 6.484413461294025e-05

The O 0 9.696050983620808e-05
present O 0 3.2441133953398094e-05
study O 0 7.890195774962194e-06
used O 0 1.185647397505818e-05
PCR O 0 4.3742045818362385e-05
and O 0 1.5082169738889206e-05
restriction O 0 2.8066722734365612e-05
- O 0 8.398907084483653e-05
enzyme O 0 6.453041805798421e-06
digestion O 0 1.907701516756788e-05
to O 0 2.594985289761098e-06
analyze O 0 4.333086963015376e-06
the O 0 2.977719077534857e-06
frequency O 0 4.086803073732881e-06
of O 0 1.4511875633616e-05
the O 0 3.5685367038240656e-05
845 O 0 0.000891522562596947
G O 0 0.0009682949748821557
- O 0 0.00026892885216511786
- O 0 8.184561011148617e-05
> O 0 2.7177993615623564e-05
A O 0 4.606396396411583e-05
and O 0 5.351153049559798e-06
187 O 0 3.5003853554371744e-05
C O 0 0.0002881700929719955
- O 0 0.00016622077964711934
- O 0 0.0001129197480622679
> O 0 8.226870704675093e-05
G O 0 0.00044612333294935524
mutations O 0 2.980373756145127e-05
in O 0 7.676567474845797e-05
HLA O 0 0.012797264382243156
- O 0 0.00022756589169148356
typed O 0 1.5415878806379624e-05
samples O 0 3.98541533286334e-06
from O 0 1.315979716309812e-05
non O 0 0.00010810953244799748
- O 0 0.00022983869712334126
Caucasian O 0 0.00010678333637770265
populations O 0 4.0162512959796e-06
, O 0 2.1878920506424038e-06
comprising O 0 1.0004490832216106e-05
Australian O 0 3.9267211832338944e-05
Aboriginal O 0 9.48699307627976e-05
, O 0 1.2923717804369517e-05
Chinese O 0 9.38283556024544e-05
, O 0 1.5715277186245658e-05
and O 0 2.724650221352931e-05
Pacific O 0 0.0011051817564293742
Islanders O 0 0.001040710136294365
. O 0 0.0001715173857519403

Results O 0 7.083178934408352e-05
showed O 0 9.92260393104516e-05
that O 0 5.112392500450369e-06
the O 0 6.230082362890244e-05
845 O 0 0.0014213162939995527
G O 0 0.0030936365947127342
- O 0 0.0009959451854228973
- O 0 0.0002874840865842998
> O 0 4.778661605087109e-05
A O 0 6.575713632628322e-05
mutation O 0 5.262155809759861e-06
was O 0 2.7323472750140354e-05
present O 0 4.914544206258142e-06
in O 0 5.0586950237629935e-06
these O 0 1.1753134003811283e-06
populations O 0 2.313295226485934e-06
( O 0 1.2644360367630725e-06
allele O 0 6.667970637863618e-07
frequency O 0 1.9099816199741326e-06
0 O 0 4.970103873347398e-06
. O 0 1.340829726359516e-06
32 O 0 4.154304861003766e-06
% O 0 2.9996829198353225e-06
) O 0 5.2545633479894605e-06
, O 0 3.2605742035229923e-06
and O 0 3.4779066027113004e-06
, O 0 6.075130386307137e-06
furthermore O 0 1.5538118532276712e-05
, O 0 3.714631930051837e-06
it O 0 2.5047386316146003e-06
was O 0 4.1329247324028984e-05
always O 0 5.268472705211025e-06
seen O 0 7.162089787016157e-06
in O 0 2.952577233372722e-06
conjunction O 0 1.767947651387658e-05
with O 0 2.431716347928159e-05
HLA O 1 0.9997254014015198
haplotypes O 0 0.000749225786421448
common O 0 6.803288124501705e-05
in O 0 6.58674689475447e-05
Caucasians O 0 0.00038965384010225534
, O 0 1.0694040611269884e-05
suggesting O 0 2.176657653762959e-05
that O 0 7.686193384870421e-06
845 O 0 0.0007246821187436581
G O 0 0.0020453433971852064
- O 0 0.0007356713176704943
- O 0 0.0002488048921804875
> O 0 6.255204061744735e-05
A O 0 8.918360254028812e-05
may O 0 1.1886384527315386e-05
have O 0 9.561704246152658e-07
been O 0 2.398356627963949e-06
introduced O 0 9.389829642714176e-07
into O 0 1.1926088063773932e-06
these O 0 5.151926529833872e-07
populations O 0 1.3626203099192935e-06
by O 0 3.5088162348984042e-06
Caucasian O 0 0.0006481125019490719
admixture O 0 0.0013294921955093741
. O 0 0.0008840341470204294

187 O 0 0.0005786791443824768
C O 0 0.0017055526841431856
- O 0 0.0003584725200198591
- O 0 0.00010926803952315822
> O 0 6.002314330544323e-05
G O 0 0.00011137247201986611
was O 0 4.111335510970093e-05
present O 0 4.513032763497904e-06
at O 0 2.3424803657690063e-05
an O 0 1.833320084188017e-06
allele O 0 2.3389166017295793e-06
frequency O 0 4.56907991974731e-06
of O 0 4.8554386012256145e-05
2 O 0 0.0006291287136264145
. O 0 0.0001498846831964329

68 O 0 0.00040666788117960095
% O 0 2.7922773369937204e-05
in O 0 1.6091093129944056e-05
the O 0 9.161263733403757e-06
two O 0 1.9291187527414877e-06
populations O 0 2.22644644054526e-06
analyzed O 0 8.335642633028328e-06
( O 0 5.739140760852024e-06
Australian O 0 2.1554844352067448e-05
Aboriginal O 0 6.33302770438604e-05
and O 0 2.157763265131507e-05
Chinese O 0 0.0002822842507157475
) O 0 5.580908327829093e-05
. O 0 0.000112877220090013

In O 0 0.0001426410162821412
the O 0 3.653813837445341e-05
Australian O 0 3.2834203011589125e-05
Aboriginal O 0 2.5466693841735832e-05
samples O 0 2.435049736959627e-06
, O 0 2.8650952117459383e-06
187 O 0 1.688704469415825e-05
C O 0 0.0003348392783664167
- O 0 0.00018475654360372573
- O 0 0.00013850096729584038
> O 0 0.00010028389806393534
G O 0 0.00026414013700559735
was O 0 5.124215385876596e-05
found O 0 1.0918932957793004e-06
to O 0 1.278077434108127e-06
be O 0 1.6624354657324147e-06
associated O 0 6.201369615155272e-06
with O 0 1.5343728591687977e-05
HLA O 1 0.999854326248169
haplotypes O 0 0.000791471975389868
common O 0 7.8279321314767e-05
in O 0 0.00012494635302573442
Caucasians O 0 0.0009277411154471338
, O 0 1.2319326742726844e-05
suggesting O 0 1.9344213797012344e-05
that O 0 1.3514078318621614e-06
it O 0 1.5984483070496935e-06
was O 0 3.73968796338886e-05
introduced O 0 5.255756150290836e-06
by O 0 3.159394964313833e-06
recent O 0 2.3217391571961343e-05
admixture O 0 0.0007028737454675138
. O 0 0.0004165089630987495

In O 0 8.295011502923444e-05
the O 0 2.6269462978234515e-05
Chinese O 0 5.505828085006215e-05
samples O 0 2.8248377930140123e-06
analyzed O 0 7.925935278763063e-06
, O 0 3.1272959404304856e-06
187 O 0 1.7545142327435315e-05
C O 0 0.0002937784302048385
- O 0 0.00021180133626330644
- O 0 0.0001215989250340499
> O 0 9.34662384679541e-05
G O 0 0.0002806826669257134
was O 0 7.672893116250634e-05
present O 0 1.2575654182001017e-05
in O 0 1.1588981578825042e-05
association O 0 7.919324161775876e-06
with O 0 2.012212007684866e-06
a O 0 1.1079569958383217e-05
wide O 0 5.476436854223721e-05
variety O 0 2.8434787964215502e-05
of O 0 0.0003485886554699391
HLA O 1 0.9999805688858032
haplotypes O 0 0.0006531515973620117
, O 0 1.3472998034558259e-05
showing O 0 1.820292709453497e-05
this O 0 1.6111507648020051e-06
mutation O 0 1.6286570598822436e-06
to O 0 2.698962134672911e-06
be O 0 1.9614817574620247e-06
widespread O 0 1.5653413356631063e-05
and O 0 6.80485027260147e-06
likely O 0 1.3669513464265037e-05
to O 0 6.92486946718418e-06
predate O 0 0.00017409870633855462
the O 0 8.219288247346412e-06
more O 0 1.7304025732300943e-06
genetically O 0 5.529794634639984e-06
restricted O 0 7.516784080507932e-06
845 O 0 0.00041071069426834583
G O 0 0.0016924289520829916
- O 0 0.000576305203139782
- O 0 0.00030172697734087706
> O 0 0.00012107675865991041
A O 0 0.0002472130872774869
mutation O 0 6.351716001518071e-05
. O 0 8.936100493883714e-05

Genotype O 0 0.005949754733592272
- O 0 0.0016865570796653628
phenotype O 0 0.0001155101926997304
correlations O 0 0.00031014299020171165
in O 0 0.000434219284215942
attenuated B-Disease 1 0.9664813876152039
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999984502792358
. O 0 0.002303746063262224

Germ O 1 0.9999939203262329
- O 0 0.002547796117141843
line O 0 0.0002519022091291845
mutations O 0 1.3479348126566038e-05
of O 0 3.6317687772680074e-05
the O 0 0.00022498324688058347
tumor B-Disease 1 0.9999446868896484
suppressor O 0 0.003194395685568452
APC O 0 0.000717853254172951
are O 0 2.4612170363980113e-06
implicated O 0 0.00013071979628875852
in O 0 9.772341581992805e-05
attenuated B-Disease 0 0.06502359360456467
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.7198535203933716
AAPC B-Disease 1 1.0
) O 0 4.759269722853787e-05
, O 0 3.709081283886917e-06
a O 0 5.770813913841266e-06
variant O 0 2.830128141795285e-05
of O 0 0.00018046883633360267
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998511075973511
FAP B-Disease 1 0.9999821186065674
) O 0 0.0004970397567376494
. O 0 0.00025495560839772224

AAPC B-Disease 1 0.9999748468399048
is O 0 7.669471233384684e-05
recognized O 0 1.8091339370585047e-05
by O 0 1.4259912859415635e-06
the O 0 7.980072950886097e-06
occurrence O 0 2.0142040739301592e-05
of O 0 6.127268716227263e-05
< O 0 0.0027964874170720577
100 O 0 0.0009337087394669652
colonic B-Disease 1 0.9968658089637756
adenomas I-Disease 0 0.01954692229628563
and O 0 1.3503048648999538e-05
a O 0 9.56898929871386e-06
later O 0 4.685465682996437e-05
onset O 1 0.9492567181587219
of O 1 0.9999072551727295
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0009347755112685263
age O 0 0.0004883758956566453
> O 0 0.00022983299277257174
40 O 0 9.674789180280641e-05
years O 0 0.00018288884893991053
) O 0 4.2347404814790934e-05
. O 0 8.405172411585227e-05

The O 0 0.00011709429236361757
aim O 0 6.600164488190785e-05
of O 0 1.2395870726322755e-05
this O 0 2.902649612224195e-06
study O 0 3.937443580070976e-06
was O 0 2.6507525035412982e-05
to O 0 4.027773684356362e-06
assess O 0 5.678778325091116e-05
genotype O 0 0.000250014360062778
- O 0 0.00041543514817021787
phenotype O 0 6.668313289992511e-05
correlations O 0 0.0005020007374696434
in O 0 0.0008649480296298862
AAPC B-Disease 1 0.9999995231628418
families O 0 0.0003140017797704786
. O 0 0.00039379962254315615

By O 0 0.00013349686923902482
protein O 0 0.0001328728103544563
- O 0 0.0001228041510330513
truncation O 0 9.572961425874382e-05
test O 0 1.7073267372325063e-05
( O 0 2.10196685657138e-05
PTT O 0 0.0002616247220430523
) O 0 3.011891749338247e-06
assay O 0 3.5988896343042143e-06
, O 0 1.1770273431466194e-06
the O 0 3.0237920327635948e-06
entire O 0 1.7290734831476584e-05
coding O 0 2.165524711017497e-05
region O 0 4.739983705803752e-05
of O 0 1.9142638848279603e-05
the O 0 5.382448944146745e-05
APC B-Disease 0 0.0005374018801376224
gene O 0 1.731710472085979e-05
was O 0 5.938910544500686e-05
screened O 0 2.7629488613456488e-05
in O 0 3.7415852602862287e-06
affected O 0 6.020522960170638e-06
individuals O 0 1.8268189023729065e-06
from O 0 9.553190466249362e-05
11 O 0 0.02000926248729229
AAPC B-Disease 1 1.0
kindreds O 0 0.0020487362053245306
, O 0 2.0836492694797926e-05
and O 0 5.042463271820452e-06
their O 0 4.2537940316833556e-06
phenotypic O 0 0.00015585895744152367
differences O 0 0.00037554933805949986
were O 0 0.0003622766525950283
examined O 0 0.0009179364424198866
. O 0 0.00043146591633558273

Five O 0 0.000506811251398176
novel O 0 0.0009210070711560547
germ O 1 0.9998631477355957
- O 0 0.0012741552200168371
line O 0 0.00047291620285250247
APC B-Disease 0 0.00044356289436109364
mutations O 0 2.1831272533745505e-05
were O 0 2.502339157217648e-05
identified O 0 2.9543003620347008e-05
in O 0 4.056214675074443e-05
seven O 0 0.00017707877850625664
kindreds O 0 0.003107272321358323
. O 0 0.00028054084395989776

Mutations O 0 0.00035989820025861263
were O 0 0.00010328514326829463
located O 0 9.58574892138131e-05
in O 0 5.733134003094165e-06
three O 0 1.3666613085661083e-06
different O 0 1.985688271588515e-07
regions O 0 1.953335186044569e-06
of O 0 7.0539244916290045e-06
the O 0 3.681753878481686e-05
APC B-Disease 0 0.0002551511279307306
gene O 0 9.149240213446319e-06
( O 0 5.296043127600569e-06
1 O 0 2.6424058887641877e-05
) O 0 3.057906951653422e-06
at O 0 2.2790409275330603e-05
the O 0 6.1989812820684165e-06
5 O 0 1.5861052816035226e-05
end O 0 4.159495438216254e-05
spanning O 0 0.0002973120426759124
exons O 0 7.171931065386161e-05
4 O 0 4.769401493831538e-05
and O 0 4.909475592285162e-06
5 O 0 1.861281634774059e-05
, O 0 2.9342279503907776e-06
( O 0 2.4769130959612085e-06
2 O 0 1.572256223880686e-05
) O 0 3.238107638026122e-06
within O 0 6.188432053022552e-06
exon O 0 7.698148692725226e-05
9 O 0 5.848402724950574e-05
, O 0 4.792099844053155e-06
and O 0 3.932865183742251e-06
( O 0 9.404721822647844e-06
3 O 0 3.626256147981621e-05
) O 0 4.83008943774621e-06
at O 0 4.309299765736796e-05
the O 0 1.5738509318907745e-05
3 O 0 6.626184767810628e-05
distal O 0 0.00039135379483923316
end O 0 0.0002568859199527651
of O 0 0.00012964379857294261
the O 0 0.00020938216766808182
gene O 0 0.0002201323222834617
. O 0 0.00017405289690941572

Variability O 0 0.00039181162719614804
in O 0 2.0204372049192898e-05
the O 0 1.2251957741682418e-05
number O 0 1.9830606106552295e-05
of O 0 0.00200481154024601
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.994474470615387
most O 0 3.401096546440385e-05
apparent O 0 7.108120189514011e-05
in O 0 5.560550562222488e-06
individuals O 0 1.3377032246353338e-06
with O 0 3.0387261631403817e-06
mutations O 0 1.134494141297182e-05
in O 0 2.748162114585284e-05
region O 0 0.00018410623306408525
1 O 0 0.00018303081742487848
, O 0 1.6091908037196845e-05
and O 0 2.0956658772774972e-05
upper O 1 0.9870957136154175
- O 1 0.9997474551200867
gastrointestinal O 1 0.9999507665634155
manifestations O 1 0.7817134857177734
were O 0 0.00034640313242562115
more O 0 4.564043047139421e-05
severe O 0 0.002230815589427948
in O 0 0.00013097333430778235
them O 0 6.35559408692643e-05
. O 0 0.00013858710008207709

In O 0 4.8666479415260255e-05
individuals O 0 3.9045303310558666e-06
with O 0 5.083349151391303e-06
mutations O 0 2.38736884057289e-05
in O 0 2.911241062975023e-05
either O 0 2.4590148314018734e-05
region O 0 7.877933967392892e-05
2 O 0 5.8579029428074136e-05
or O 0 1.1081471711804625e-05
region O 0 4.8611742386128753e-05
3 O 0 2.7156098440173082e-05
, O 0 1.9128526673739543e-06
the O 0 2.134716169166495e-06
average O 0 4.025646376248915e-06
number O 0 2.907461976064951e-06
of O 0 8.256751607405022e-05
adenomas B-Disease 0 0.07408992946147919
tended O 0 0.00016284304729197174
to O 0 2.0572388166328892e-05
be O 0 9.212463737640064e-06
lower O 0 1.5292791431420483e-05
than O 0 1.2695954865193926e-06
those O 0 6.17464536389889e-07
in O 0 2.668941078809439e-06
individuals O 0 8.413217642555537e-07
with O 0 2.107822638208745e-06
mutations O 0 6.577799467777368e-06
in O 0 1.5771700418554246e-05
region O 0 7.359632581938058e-05
1 O 0 4.952814560965635e-05
, O 0 4.075434389960719e-06
although O 0 2.647307610459393e-06
age O 0 3.720653694472276e-05
at O 0 0.00025342515436932445
diagnosis O 0 0.0005358175840228796
was O 0 0.0008513379143550992
similar O 0 5.6375869462499395e-05
. O 0 0.0002259124885313213

In O 0 0.0005992070073261857
all O 0 0.0003941436589229852
AAPC B-Disease 1 0.9999997615814209
kindreds O 0 0.002483240095898509
, O 0 1.9881597836501896e-05
a O 0 1.7915357602760196e-05
predominance O 0 0.0005315694725140929
of O 0 0.0003472832322586328
right O 0 0.1082499772310257
- O 1 0.9999995231628418
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999998927116394
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 0.007633484899997711
was O 0 0.0026663141325116158
observed O 0 0.00020173568918835372
. O 0 0.00011829502182081342

No O 0 0.003179080318659544
desmoid B-Disease 1 0.999992847442627
tumors I-Disease 1 1.0
were O 0 0.00021728570573031902
found O 0 2.9560982511611655e-05
in O 0 4.1668001358630136e-05
these O 0 3.537668817443773e-05
kindreds O 0 0.0027018622495234013
. O 0 0.000410488952184096

Our O 0 0.00013028475223109126
data O 0 3.1433130061486736e-05
suggest O 0 1.915394386742264e-05
that O 0 5.4470706345455255e-06
, O 0 1.5974372217897326e-05
in O 0 0.00012773298658430576
AAPC B-Disease 1 0.9999990463256836
families O 0 1.5264378816937096e-05
, O 0 3.1635736377211288e-06
the O 0 2.993592943312251e-06
location O 0 7.3071728365903255e-06
of O 0 1.7128908439190127e-05
the O 0 6.127063534222543e-05
APC B-Disease 0 0.0015693972818553448
mutation O 0 4.6108350943541154e-05
may O 0 8.252501720562577e-05
partially O 0 0.00011198064021300524
predict O 0 1.293513378186617e-05
specific O 0 2.270374352519866e-06
phenotypic O 0 0.00013796868734061718
expression O 0 0.000248045107582584
. O 0 0.00037879656883887947

This O 0 2.555871287768241e-05
should O 0 1.2228972991579212e-05
help O 0 7.629041647305712e-06
in O 0 4.378222456580261e-06
the O 0 5.790046543552307e-06
design O 0 9.144015166384634e-06
of O 0 2.5161629309877753e-05
tailored O 0 6.583394133485854e-05
clinical O 0 0.00033707631519064307
- O 0 0.0006817302200943232
management O 0 0.00011286677181487903
protocols O 0 9.535078424960375e-05
in O 0 8.895947757991962e-06
this O 0 3.0359569791471586e-06
subset O 0 2.7017566026188433e-05
of O 0 0.00019372120732441545
FAP B-Disease 1 0.999752938747406
patients O 0 0.00044246113975532353
. O 0 0.00011574592645047233
. O 0 0.0001655496598687023

Wilms B-Disease 1 0.9999973773956299
' I-Disease 0 0.029861582443118095
tumor I-Disease 1 0.962035596370697
1 O 0 0.0007489772979170084
and O 0 0.0001026591780828312
Dax O 1 0.9987049102783203
- O 0 0.0002998921263497323
1 O 0 5.3207138989819214e-05
modulate O 0 6.113966082921252e-05
the O 0 3.210998329450376e-05
orphan O 0 0.00030269191483967006
nuclear O 0 0.0008765365346334875
receptor O 0 0.0003404949093237519
SF O 0 0.02460421808063984
- O 0 0.00012713442265521735
1 O 0 4.9520305765327066e-05
in O 0 1.4811434994044248e-05
sex O 0 3.052085230592638e-05
- O 0 4.139129305258393e-05
specific O 0 3.837718395516276e-06
gene O 0 3.14121825795155e-05
expression O 0 5.7741002819966525e-05
. O 0 0.0001550972374388948

Products O 0 0.00011084599827881902
of O 0 0.0001251162466360256
steroidogenic O 0 0.0027596447616815567
factor O 0 0.00011887204891536385
1 O 0 0.00018393043137621135
( O 0 4.683834777097218e-05
SF O 0 0.013461098074913025
- O 0 8.013705519260839e-05
1 O 0 4.533302126219496e-05
) O 0 1.0529422070248984e-05
and O 0 2.6132436687476e-05
Wilms B-Disease 1 0.9999935626983643
tumor I-Disease 1 0.9972019195556641
1 O 0 0.0006954212440177798
( O 0 0.000112528694444336
WT1 O 0 0.00418923981487751
) O 0 7.403375548165059e-06
genes O 0 2.668900378921535e-06
are O 0 5.177973321224272e-07
essential O 0 6.446127827075543e-06
for O 0 7.121136150090024e-06
mammalian O 0 0.0001061577204382047
gonadogenesis O 0 0.0009526573121547699
prior O 0 6.842254515504465e-05
to O 0 3.320158793940209e-05
sexual O 0 0.0001881391799543053
differentiation O 0 0.0020524754654616117
. O 0 0.0007880800403654575

In O 0 0.00039265051600523293
males O 0 9.579973993822932e-05
, O 0 0.00010431354166939855
SF O 1 0.9974660873413086
- O 0 0.00036516645923256874
1 O 0 4.9859012506203726e-05
participates O 0 1.4707418813486584e-05
in O 0 9.38121502258582e-06
sexual O 0 2.1923657186562195e-05
development O 0 3.0849998438498005e-05
by O 0 3.888143055519322e-06
regulating O 0 3.4245233109686524e-05
expression O 0 6.196310096129309e-06
of O 0 3.276210554759018e-05
the O 0 0.00017494638450443745
polypeptide O 0 0.00529493298381567
hormone O 0 0.002693325048312545
Mullerian O 1 0.9847602248191833
inhibiting O 0 0.002827548189088702
substance O 0 0.004438709933310747
( O 0 0.0009999859612435102
MIS O 1 0.9980787038803101
) O 0 0.00022380438167601824
. O 0 0.00030319966026581824

Here O 0 0.0004057381593156606
, O 0 1.6394582416978665e-05
we O 0 4.100865680811694e-06
show O 0 1.6719781342544593e-05
that O 0 1.1044881830457598e-05
WT1 O 0 0.24652084708213806
- O 0 0.0020797490142285824
KTS O 0 0.051557958126068115
isoforms O 0 2.2635969799011946e-05
associate O 0 4.2295905586797744e-05
and O 0 1.5126506696105935e-05
synergize O 0 0.0013564054388552904
with O 0 6.829470657976344e-05
SF O 1 0.9998061060905457
- O 0 0.0005224600899964571
1 O 0 0.00010374711564509198
to O 0 4.5912573114037514e-05
promote O 0 0.0006488708313554525
MIS O 1 0.9371910691261292
expression O 0 0.000274573772912845
. O 0 0.00022289271873887628

In O 0 0.0003217161283828318
contrast O 0 0.0002288326359121129
, O 0 0.000139281022711657
WT1 O 0 0.2094477415084839
missense O 0 0.0007355079869739711
mutations O 0 5.63647918170318e-05
, O 0 1.090449313778663e-05
associated O 0 8.599618922744412e-06
with O 0 6.267950539040612e-06
male B-Disease 0 0.0002090012130793184
pseudohermaphroditism I-Disease 1 0.9999964237213135
in O 0 0.00048099635750986636
Denys B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999982118606567
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.439161031972617e-05
fail O 0 7.55972505430691e-05
to O 0 3.116691004834138e-05
synergize O 0 0.0022386719938367605
with O 0 0.00013891654089093208
SF O 1 0.9999990463256836
- O 0 0.0034086862578988075
1 O 0 0.0006717677460983396
. O 0 9.919973672367632e-05

Additionally O 0 0.0001706967450445518
, O 0 1.2831193089368753e-05
the O 0 2.1450307031045668e-05
X O 0 0.0009154362487606704
- O 0 0.00041749837691895664
linked O 0 0.0001890103449113667
, O 0 1.359758880425943e-05
candidate O 0 2.1007625036872923e-05
dosage O 0 0.00014598292182199657
- O 0 0.00018703920068219304
sensitive O 0 0.00011621130397543311
sex O 0 3.060794188058935e-05
- O 0 6.229838618310168e-05
reversal O 0 4.614732461050153e-05
gene O 0 1.3777931599179283e-05
, O 0 1.3500743079930544e-05
Dax O 1 0.8153963685035706
- O 0 0.00018292912864126265
1 O 0 6.70481167617254e-05
, O 0 1.0632345038175117e-05
antagonizes O 0 0.00036238529719412327
synergy O 0 0.0006531992112286389
between O 0 0.001571007538586855
SF O 1 0.9999111890792847
- O 0 0.0008924560970626771
1 O 0 0.00020988707547076046
and O 0 4.445704325917177e-05
WT1 O 0 0.006058322265744209
, O 0 7.08504512658692e-06
most O 0 1.3419606830211706e-06
likely O 0 1.6699370917194756e-06
through O 0 8.841108183332835e-07
a O 0 1.6932156086113537e-06
direct O 0 2.730675305429031e-06
interaction O 0 1.5643743608961813e-05
with O 0 3.7666857679141685e-05
SF O 1 0.999968409538269
- O 0 0.0017908717272803187
1 O 0 0.0006880193832330406
. O 0 0.00017776869935914874

We O 0 8.006661664694548e-05
propose O 0 4.5482061977963895e-05
that O 0 1.604783028597012e-05
WT1 O 0 0.015293940901756287
and O 0 8.519533002981916e-05
Dax O 1 0.9996691942214966
- O 0 0.00045286223758012056
1 O 0 0.00011615921539487317
functionally O 0 8.432733739027753e-05
oppose O 0 5.578971922659548e-06
each O 0 6.901753977217595e-07
other O 0 1.8962458625537693e-06
in O 0 1.7557946193846874e-05
testis O 0 0.0006601375644095242
development O 0 4.2006369767477736e-05
by O 0 2.381138619966805e-05
modulating O 0 0.001961072674021125
SF O 1 0.9996899366378784
- O 0 0.0008077737293206155
1 O 0 0.0003917638387065381
- O 0 0.00032448655110783875
mediated O 0 0.000298718165140599
transactivation O 0 0.001809961162507534
. O 0 7.52395935705863e-05
. O 0 0.00010165008279727772

A O 0 0.0008142610895447433
mouse O 0 9.94088186416775e-05
model O 0 1.1715640539478045e-05
for O 0 4.8552072257734835e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999855756759644
- O 1 0.9999492168426514
centre O 0 0.21246804296970367
mutations O 0 0.000330675597069785
. O 0 0.00027986016357317567

Imprinting O 0 0.002497337991371751
in O 0 0.0001620383991394192
the O 0 0.0001974638580577448
15q11 O 0 0.002848496660590172
- O 0 0.000447341037215665
q13 O 0 0.0004578633524943143
region O 0 7.02856996213086e-05
involves O 0 1.5639774574083276e-05
an O 0 1.7121821656473912e-05
imprinting O 0 0.0007755898404866457
centre O 0 0.0019705926533788443
( O 0 0.00013729858619626611
IC O 0 0.0034793380182236433
) O 0 1.5722846001153812e-05
, O 0 3.6910146263835486e-06
mapping O 0 8.556246029911563e-06
in O 0 5.413053258962464e-06
part O 0 1.2125883586122654e-05
to O 0 6.01068995820242e-06
the O 0 3.00162337225629e-05
promoter O 0 0.00047133988118730485
and O 0 8.227829312090762e-06
first O 0 7.592068868689239e-05
exon O 0 0.00047600059770047665
of O 0 0.0005434761405922472
SNRPN O 1 0.9999630451202393
. O 0 0.0008480189135298133

Deletion O 0 0.0011201704619452357
of O 0 0.0002969715278595686
this O 0 0.00012797889939974993
IC O 0 0.00895790383219719
abolishes O 0 0.0008132681250572205
local O 0 5.847593638463877e-05
paternally O 0 0.0003285877173766494
derived O 0 1.3805763046548236e-05
gene O 0 6.729504548275145e-06
expression O 0 2.650167061801767e-06
and O 0 1.6788472976259072e-06
results O 0 4.672474915423663e-06
in O 0 9.010914072860032e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999942779541016
PWS B-Disease 1 1.0
) O 0 0.0008345366222783923
. O 0 0.0003319238603580743

We O 0 6.17823243374005e-05
have O 0 3.5355467389308615e-06
created O 0 1.0315509825886693e-05
two O 0 2.1845976334589068e-06
deletion O 0 5.2357012464199215e-05
mutations O 0 5.66314956813585e-05
in O 0 5.900725955143571e-05
mice O 0 0.00019653161871246994
to O 0 4.167817678535357e-05
understand O 0 0.00046692302566953003
PWS B-Disease 1 0.9999998807907104
and O 0 2.32776965276571e-05
the O 0 2.151119042537175e-05
mechanism O 0 2.9912165700807236e-05
of O 0 3.873354580719024e-05
this O 0 7.797254511388019e-05
IC O 0 0.04776054993271828
. O 0 0.0006327769951894879

Mice O 0 0.009984791278839111
harbouring O 0 0.011164863593876362
an O 0 6.933665281394497e-05
intragenic O 0 0.003652897896245122
deletion O 0 0.0003096002619713545
in O 0 0.00012758302909787744
Snrpn O 0 0.0054774354211986065
are O 0 1.3778220818494447e-05
phenotypically O 0 0.000318193924613297
normal O 0 2.340339051443152e-05
, O 0 3.4754232274281094e-06
suggesting O 0 6.3694192249386106e-06
that O 0 1.6534593214601045e-06
mutations O 0 1.4045252100913785e-05
of O 0 7.020538760116324e-05
SNRPN O 1 0.9863870143890381
are O 0 3.8803786992502864e-06
not O 0 1.7613472209632164e-06
sufficient O 0 3.683594331960194e-05
to O 0 0.00012651353608816862
induce O 0 0.011100275442004204
PWS B-Disease 1 1.0
. O 0 0.00234389491379261

Mice O 0 0.0008295895531773567
with O 0 1.0735414434748236e-05
a O 0 1.3911467249272391e-05
larger O 0 1.2977440746908542e-05
deletion O 0 6.771805783500895e-05
involving O 0 0.00011957736569456756
both O 0 3.650394137366675e-05
Snrpn O 0 0.004178191069513559
and O 0 2.0321631382103078e-05
the O 0 0.00012410424824338406
putative O 1 0.8332197070121765
PWS O 1 1.0
- O 1 0.8256521224975586
IC O 0 0.008661315776407719
lack O 0 7.641190313734114e-05
expression O 0 9.467479685554281e-06
of O 0 2.3592316210852005e-05
the O 0 4.267358235665597e-05
imprinted O 0 0.00040647233254276216
genes O 0 9.429702186025679e-05
Zfp127 O 0 0.003835144219920039
( O 0 7.444504444720224e-05
mouse O 0 9.775762737262994e-05
homologue O 0 0.00010178044612985104
of O 0 8.28941265353933e-05
ZNF127 O 1 0.9966686367988586
) O 0 7.571802416350693e-05
, O 0 4.828132296097465e-05
Ndn O 0 0.0030562691390514374
and O 0 4.5433862396748737e-05
Ipw O 0 0.0011164263123646379
, O 0 1.1739753063011449e-05
and O 0 7.159650976973353e-06
manifest O 0 0.0001141093234764412
several O 0 3.4420296287862584e-05
phenotypes O 0 0.00020108756143599749
common O 0 0.00019546528346836567
to O 0 0.003039606148377061
PWS B-Disease 1 1.0
infants O 1 0.99979168176651
. O 0 0.001689578639343381

These O 0 1.588922896189615e-05
data O 0 1.6240030163316987e-05
demonstrate O 0 1.7793496226659045e-05
that O 0 1.7735237634042278e-06
both O 0 1.8799521512846695e-06
the O 0 6.150658009573817e-06
position O 0 1.1858238394779619e-05
of O 0 2.3817610781406984e-05
the O 0 6.699992081848904e-05
IC O 0 0.0018823446007445455
and O 0 8.88496833795216e-06
its O 0 5.046465503255604e-06
role O 0 1.8116719729732722e-05
in O 0 3.851960173051339e-06
the O 0 2.2112217266112566e-06
coordinate O 0 3.0254884677560767e-06
expression O 0 2.4723465230636066e-06
of O 0 1.1923760212084744e-05
genes O 0 8.24867129267659e-06
is O 0 3.4110214528482175e-06
conserved O 0 2.752502950897906e-05
between O 0 5.805150794913061e-05
mouse O 0 7.17881484888494e-05
and O 0 4.968852863385109e-06
human O 0 7.3334635999344755e-06
, O 0 3.912406100425869e-06
and O 0 1.7148977349279448e-06
indicate O 0 1.0074631973111536e-05
that O 0 1.5994868363122805e-06
the O 0 1.1489085409266409e-05
mouse O 0 3.326624573674053e-05
is O 0 3.1988570299290586e-06
a O 0 3.3626383810769767e-06
suitable O 0 1.0746302905317862e-05
model O 0 6.313653102552053e-06
system O 0 5.673733085131971e-06
in O 0 3.090737891398021e-06
which O 0 1.100125587072398e-06
to O 0 2.039997070824029e-06
investigate O 0 6.9140469349804334e-06
the O 0 1.1062782505177893e-05
molecular O 0 3.105377982137725e-05
mechanisms O 0 3.216373443137854e-05
of O 0 6.037769344402477e-05
imprinting O 0 0.0002723428187891841
in O 0 3.648737401817925e-05
this O 0 4.1619146031735e-06
region O 0 3.083726187469438e-05
of O 0 1.4610342077503446e-05
the O 0 3.745777576114051e-05
genome O 0 7.652193016838282e-05
. O 0 1.5194924344541505e-05
. O 0 3.965802170569077e-05

Mutations O 0 0.0001508295099483803
of O 0 0.00011870564776472747
the O 0 0.00014475840725935996
ATM O 0 0.001424709684215486
gene O 0 3.1313156796386465e-05
detected O 0 4.87871075165458e-05
in O 0 2.394779585301876e-05
Japanese O 0 0.0032210219651460648
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 0.9999997615814209
patients O 0 0.0001813103590393439
: O 0 1.0690706403693184e-05
possible O 0 8.589849130657967e-06
preponderance O 0 0.00016667995078023523
of O 0 2.6820031052920967e-05
the O 0 2.5575584004400298e-05
two O 0 1.6652595149935223e-05
founder O 0 0.0004696681280620396
mutations O 0 6.690957525279373e-05
4612del165 O 0 0.001321784220635891
and O 0 0.00011227402137592435
7883del5 O 0 0.0033731318544596434
. O 0 0.00032859647762961686

The O 0 0.0004026683163829148
ATM O 0 0.002886255271732807
( O 0 0.0001858560717664659
A O 1 0.9788797497749329
- O 0 0.013806228525936604
T O 1 0.9638389945030212
, O 0 1.2874339518020861e-05
mutated O 0 1.6942954971455038e-05
) O 0 2.4355003915843554e-06
gene O 0 6.405956355592934e-06
on O 0 4.315719706937671e-05
human O 0 6.154387665446848e-05
chromosome O 0 0.000638213474303484
11q22 O 0 0.002493219915777445
. O 0 0.000261185341514647

3 O 0 0.00028406991623342037
has O 0 1.6751315342844464e-05
recently O 0 1.4777390788367484e-05
been O 0 2.6362426979176234e-06
identified O 0 1.3114142802805873e-06
as O 0 1.501798124081688e-06
the O 0 2.458200469845906e-06
gene O 0 1.5075019064170192e-06
responsible O 0 2.1244559320621192e-06
for O 0 1.4752895367564633e-06
the O 0 1.4059940440347418e-05
human O 0 0.00010914599261013791
recessive B-Disease 1 0.999995231628418
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.001648070989176631
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.9997157454490662
T I-Disease 1 0.9999951124191284
) O 0 0.00010213717177975923
. O 0 8.918393723433837e-05

In O 0 0.0001090752484742552
order O 0 1.2987010450160597e-05
to O 0 5.455893187900074e-06
define O 0 1.2911988960695453e-05
the O 0 1.2472101843741257e-05
types O 0 2.257089363411069e-05
of O 0 0.0007232280913740396
disease O 1 1.0
- O 0 0.0860368013381958
causing O 0 0.0007282880251295865
ATM O 0 0.0007771952077746391
mutations O 0 1.307258935412392e-05
in O 0 1.333935961156385e-05
Japanese O 0 0.0003611690190155059
A B-Disease 1 0.9995079040527344
- I-Disease 1 0.9965769648551941
T I-Disease 1 0.9999964237213135
patients O 0 3.1683463021181524e-05
as O 0 1.862078715930693e-05
well O 0 5.969024186924798e-06
as O 0 7.263886800501496e-06
to O 0 5.3108260544831865e-06
look O 0 5.8584769249137025e-06
for O 0 3.5506373023963533e-06
possible O 0 5.355870598577894e-05
mutational O 0 0.0017823422094807029
hotspots O 0 0.0012787171872332692
, O 0 2.4400043912464753e-05
reverse O 0 0.0001031442079693079
- O 0 0.00012604946095962077
transcribed O 0 6.006918192724697e-05
RNA O 0 4.437521056388505e-05
derived O 0 8.288216122309677e-06
from O 0 1.2621694622794166e-05
ten O 0 4.38360839325469e-05
patients O 0 1.2163548490207177e-05
belonging O 0 1.560515011078678e-05
to O 0 6.210555511643179e-06
eight O 0 1.8242340956931002e-05
unrelated O 0 5.593920286628418e-05
Japanese O 0 0.00045033899368718266
A B-Disease 1 0.9992977380752563
- I-Disease 0 0.1774105280637741
T I-Disease 1 0.9637342691421509
families O 0 4.657259978557704e-06
was O 0 2.1095776901347563e-05
analyzed O 0 2.8160504825791577e-06
for O 0 1.391946398143773e-06
mutations O 0 4.110517693334259e-06
by O 0 2.766243824225967e-06
the O 0 1.5821968190721236e-05
restriction O 0 2.8323445803835057e-05
endonuclease O 0 0.00010037593165179715
fingerprinting O 0 8.620534208603203e-05
method O 0 4.221918061375618e-05
. O 0 0.0001091085359803401

As O 0 0.000127457533380948
has O 0 8.502495802531485e-06
been O 0 4.756720954901539e-06
reported O 0 3.582159251891426e-06
by O 0 1.0574810858088313e-06
others O 0 2.437424427625956e-06
, O 0 1.80995618848101e-06
mutations O 0 2.466390924382722e-06
that O 0 2.358990286666085e-06
lead O 0 3.567614476196468e-05
to O 0 6.441997538786381e-05
exon O 0 0.0006307280855253339
skipping O 0 0.0003626515972428024
or O 0 4.5986886107129976e-05
premature O 0 0.00022512850409839302
protein O 0 4.536117194220424e-05
truncation O 0 0.00016666468582116067
were O 0 5.24643728567753e-05
also O 0 1.2955356396560092e-05
predominant O 0 9.206400864059106e-05
in O 0 2.971581488964148e-05
our O 0 7.30456376913935e-05
mutants O 0 0.0005428771837614477
. O 0 0.00012370335753075778

Six O 0 5.613328539766371e-05
different O 0 2.7782568849943345e-06
mutations O 0 1.1321519195917062e-05
were O 0 9.514490557194222e-06
identified O 0 6.177841441967757e-06
on O 0 1.5512414393015206e-05
12 O 0 1.550265369587578e-05
of O 0 1.1544659173523542e-05
the O 0 3.533879134920426e-05
16 O 0 0.00013485897216014564
alleles O 0 4.6686815039720386e-05
examined O 0 0.0004239033441990614
. O 0 0.00018146340153180063

Four O 0 9.993660933105275e-05
were O 0 7.358271250268444e-05
deletions O 0 0.00010446047963341698
involving O 0 8.848759898683056e-05
a O 0 5.444163252832368e-05
loss O 0 0.0001386841177009046
of O 0 7.460295455530286e-05
a O 0 4.871448618359864e-05
single O 0 2.679581848497037e-05
exon O 0 0.0002678500604815781
exon O 0 0.00024025930906645954
7 O 0 0.00016095676983240992
, O 0 2.0804543964914046e-05
exon O 0 0.00015513952530454844
16 O 0 0.00010663222928997129
, O 0 1.6737776604713872e-05
exon O 0 0.00020787536050193012
33 O 0 0.00013729413331020623
or O 0 8.294172585010529e-05
exon O 0 0.0008908571326173842
35 O 0 0.000371619506040588
. O 0 0.00014525519509334117

The O 0 0.00019251219055149704
others O 0 2.5723031285451725e-05
were O 0 2.874385245377198e-05
minute O 0 4.944593092659488e-05
deletions O 0 8.140994032146409e-05
, O 0 1.8873621229431592e-05
4649delA O 0 0.0004369418602436781
in O 0 6.134154682513326e-05
exon O 0 0.0005449700984172523
33 O 0 0.00013672713248524815
and O 0 2.3842105292715132e-05
7883del5 O 0 0.000512566592078656
in O 0 7.068387640174478e-05
exon O 0 0.0005084373406134546
55 O 0 0.00032334213028661907
. O 0 0.00013198131637182087

The O 0 0.0003558381868060678
mutations O 0 0.00033601545146666467
4612del165 O 0 0.0012431299546733499
and O 0 3.180521889589727e-05
7883del5 O 0 0.00038318196311593056
were O 0 2.2057325622881763e-05
found O 0 3.4925344607472653e-06
in O 0 4.129144144826569e-06
more O 0 9.347746754428954e-07
than O 0 1.084529117179045e-06
two O 0 2.2781346160627436e-06
unrelated O 0 1.5223163245536853e-05
families O 0 5.078924459667178e-06
; O 0 1.6695898921170738e-06
44 O 0 1.887723738036584e-05
% O 0 1.1809935131168459e-05
( O 0 1.4780844139750116e-05
7 O 0 5.376754415920004e-05
of O 0 3.244599429308437e-05
16 O 0 5.991991201881319e-05
) O 0 2.521041778891231e-06
of O 0 6.1559280766232405e-06
the O 0 1.295822312386008e-05
mutant O 0 2.9043694667052478e-05
alleles O 0 4.226406872476218e-06
had O 0 1.396631523675751e-05
one O 0 2.9571508548542624e-06
of O 0 1.2164730833319481e-05
the O 0 2.608243994473014e-05
two O 0 2.1726118575315922e-05
mutations O 0 8.951230847742409e-05
. O 0 0.00021917940466664732

The O 0 0.00042058498365804553
4612del165 O 0 0.0007932342705316842
mutations O 0 2.2125497707747854e-05
in O 0 9.14425982045941e-06
three O 0 2.0114637209189823e-06
different O 0 3.4321689668104227e-07
families O 0 1.2927483794555883e-06
were O 0 3.3567300761205843e-06
all O 0 1.0637288596626604e-06
ascribed O 0 3.511934482958168e-05
to O 0 6.329086318146437e-06
the O 0 1.5116571375983767e-05
same O 0 2.7695441531250253e-05
T O 0 0.0022174837067723274
- O 0 0.00026615490787662566
- O 0 0.00010639365063980222
> O 0 3.484572152956389e-05
A O 0 3.34695796482265e-05
substitution O 0 9.1350721049821e-06
at O 0 4.924744280287996e-05
the O 0 1.27327739392058e-05
splice O 0 9.332392073702067e-05
donor O 0 1.7990998458117247e-05
site O 0 8.576747495681047e-05
in O 0 3.262268000980839e-05
intron O 0 0.0026752036064863205
33 O 0 0.0007271739304997027
. O 0 0.00031870094244368374

Microsatellite O 0 0.016450604423880577
genotyping O 0 0.002928640227764845
around O 0 0.0002266024093842134
the O 0 6.285748531809077e-05
ATM O 0 0.0005578668205998838
locus O 0 7.720851135673001e-05
also O 0 6.713453785778256e-06
indicated O 0 1.3589602531283163e-05
that O 0 1.6808465943540796e-06
a O 0 8.637475730211008e-06
common O 0 1.1363576959411148e-05
haplotype O 0 0.00016425247304141521
was O 0 0.00019480552873574197
shared O 0 1.2049490578647237e-05
by O 0 2.7808705453935545e-06
the O 0 9.713367035146803e-06
mutant O 0 3.405685492907651e-05
alleles O 0 6.207310434547253e-06
in O 0 1.438907565898262e-05
both O 0 3.0689319828525186e-05
mutations O 0 9.832079376792535e-05
. O 0 0.00019633647752925754

This O 0 2.6246674678986892e-05
suggests O 0 1.2232763765496202e-05
that O 0 7.25266204426589e-07
these O 0 6.750856869075506e-07
two O 0 6.193698482093168e-06
founder O 0 0.00032977055525407195
mutations O 0 2.9670622097910382e-05
may O 0 4.436391100171022e-05
be O 0 1.1391286534490064e-05
predominant O 0 7.608513988088816e-05
among O 0 2.239424611616414e-05
Japanese O 0 0.00023107971355784684
ATM O 0 0.001239653560332954
mutant O 0 0.000289318326395005
alleles O 0 0.00014453771291300654
. O 0 0.00018550730601418763

W474C O 0 0.0044615124352276325
amino O 0 0.00013868253154214472
acid O 0 6.930255040060729e-05
substitution O 0 5.500943007064052e-05
affects O 0 4.6598564949817955e-05
early O 0 1.2690383300650865e-05
processing O 0 9.358054740005173e-06
of O 0 9.190420314553194e-06
the O 0 1.2629882803594228e-05
alpha O 0 2.2204512788448483e-05
- O 0 7.724182069068775e-06
subunit O 0 1.1933847190448432e-06
of O 0 9.003436389320996e-06
beta O 0 0.00012852862710133195
- O 0 0.0001871997519629076
hexosaminidase O 0 0.000596931844484061
A O 0 6.0778951592510566e-05
and O 0 2.717643837968353e-06
is O 0 2.4398896130151115e-06
associated O 0 4.740445547213312e-06
with O 0 1.0769325854198541e-05
subacute O 1 0.999852180480957
G B-Disease 1 0.9996480941772461
( I-Disease 0 0.0010019561741501093
M2 I-Disease 1 0.9999818801879883
) I-Disease 0 0.000157522750669159
gangliosidosis I-Disease 0 0.004387245047837496
. O 0 0.00023670948576182127

Mutations O 0 0.0004479166236706078
in O 0 0.00016056050662882626
the O 0 0.00021942048624623567
HEXA O 0 0.016368910670280457
gene O 0 2.192390638811048e-05
, O 0 2.101475956806098e-06
encoding O 0 1.911468416437856e-06
the O 0 7.902696779638063e-06
alpha O 0 2.6623252779245377e-05
- O 0 6.624150046263821e-06
subunit O 0 1.2213052968945703e-06
of O 0 9.894227332551964e-06
beta O 0 9.97891984297894e-05
- O 0 0.00016670154582243413
hexosaminidase O 0 0.0007846337975934148
A O 0 0.00021878874395042658
( O 0 2.2483478460344486e-05
Hex O 0 0.00026528770104050636
A O 0 0.00013407437654677778
) O 0 6.489403403975302e-06
, O 0 2.8206222850712948e-06
that O 0 1.3388913657763624e-06
abolish O 0 6.543386552948505e-05
Hex O 0 0.00016515360039193183
A O 0 3.638452471932396e-05
enzyme O 0 6.424114872061182e-06
activity O 0 3.467261922196485e-05
cause O 0 0.00552348094061017
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0003224527754355222
TSD B-Disease 1 0.9998036026954651
) O 0 5.421688547357917e-05
, O 0 1.1285965229035355e-05
the O 0 3.485007255221717e-05
fatal O 0 0.0025172256864607334
infantile B-Disease 0 0.0022927469108253717
form I-Disease 0 5.7924709835788235e-05
of I-Disease 0 0.0009420023416168988
G I-Disease 1 0.969180166721344
( I-Disease 0 0.000247315620072186
M2 I-Disease 1 0.9966325163841248
) I-Disease 0 4.2869203753070906e-05
gangliosidosis I-Disease 0 0.000543776957783848
, I-Disease 0 1.2120726751163602e-05
Type I-Disease 0 8.835488551994786e-05
1 I-Disease 0 0.0005012284382246435
. O 0 0.00017751277482602745

Less O 0 0.0014721796615049243
severe O 1 0.9852235317230225
, O 0 0.00020126477465964854
subacute O 1 0.9997953772544861
( O 0 0.00045757798943668604
juvenile O 1 0.9992799162864685
- O 0 0.0028596215415745974
onset O 1 0.9998849630355835
) O 0 8.196081034839153e-05
and O 0 7.492992153856903e-05
chronic O 1 1.0
( O 0 0.00031227743602357805
adult O 0 0.00012345729919616133
- O 0 0.00047266067122109234
onset O 0 0.011880401521921158
) O 0 9.318390766566154e-06
variants O 0 8.20667810330633e-06
are O 0 7.378588406936615e-07
characterized O 0 9.648463674238883e-06
by O 0 1.7330218042843626e-06
a O 0 5.23741391589283e-06
broad O 0 2.0393305021570995e-05
spectrum O 0 5.3455329179996625e-05
of O 0 8.715739386389032e-05
clinical O 0 0.0008989382768049836
manifestations O 0 0.003943956457078457
and O 0 2.352334740862716e-05
are O 0 2.5730555535119493e-06
associated O 0 4.881789664068492e-06
with O 0 2.1952948827674845e-06
residual O 0 0.00032423637458123267
levels O 0 0.00012878529378212988
of O 0 0.00010446725354995579
Hex O 0 0.000818076659925282
A O 0 0.00023572797363158315
enzyme O 0 1.9017035810975358e-05
activity O 0 7.096673652995378e-05
. O 0 7.426401862176135e-05

We O 0 9.371077612740919e-05
identified O 0 7.391563849523664e-05
a O 0 0.0001058316629496403
1422 O 0 0.024062732234597206
G O 0 0.0050607542507350445
- O 0 0.0008954714867286384
- O 0 0.0002448453160468489
> O 0 0.00010165590356336907
C O 0 0.0002733453584369272
( O 0 2.923365536844358e-05
amino O 0 2.971439971588552e-05
acid O 0 4.281372457626276e-05
W474C O 0 0.0005168846109881997
) O 0 7.75962234911276e-06
substitution O 0 6.5298045228701085e-06
in O 0 8.008136319404002e-06
the O 0 1.0086168913403526e-05
first O 0 1.7760285118129104e-05
position O 0 2.7063802917837165e-05
of O 0 7.472840661648661e-05
exon O 0 0.0004954776377417147
13 O 0 0.00013343605678528547
of O 0 0.0001946751872310415
HEXA O 0 0.028823815286159515
of O 0 0.00014569840277545154
a O 0 0.00011296109005343169
non O 0 0.0002938204270321876
- O 0 0.0002942574501503259
Jewish O 0 9.611259156372398e-05
proband O 0 0.0021354074124246836
who O 0 2.5769781132112257e-05
manifested O 0 0.00037332516512833536
a O 0 6.937111174920574e-05
subacute O 0 0.0031479867175221443
variant O 0 0.00015647156396880746
of O 0 0.0004030427662655711
G B-Disease 1 0.7922707796096802
( I-Disease 0 0.0003744941495824605
M2 I-Disease 1 0.9999392032623291
) I-Disease 0 0.00010403122723801062
gangliosidosis I-Disease 0 0.0028361657168716192
. O 0 0.00014602861483581364

On O 0 0.00021234485029708594
the O 0 3.277670111856423e-05
second O 0 0.00011040842218790203
maternally O 0 0.0005020895041525364
inherited O 0 0.003809556132182479
allele O 0 3.3602620533201844e-05
, O 0 5.880396201973781e-06
we O 0 2.550615590735106e-06
identified O 0 7.471842764061876e-06
the O 0 2.0043969925609417e-05
common O 0 0.00022681444534100592
infantile O 1 0.9999998807907104
disease O 1 1.0
- O 1 0.996566116809845
causing O 0 0.0030912430956959724
4 O 0 0.00041596314986236393
- O 0 0.00021818983077537268
bp O 0 4.9065180064644665e-05
insertion O 0 3.6309167626313865e-05
, O 0 2.1498473870451562e-05
+ O 0 0.0005288411630317569
TATC O 1 0.9923083782196045
1278 O 0 0.01611577533185482
, O 0 4.641748091671616e-05
in O 0 8.300028275698423e-05
exon O 0 0.0009189305128529668
11 O 0 0.0005569500499404967
. O 0 0.0002022213739110157

Pulse O 0 0.010067454539239407
- O 0 0.0006129490793682635
chase O 0 6.735071656294167e-05
analysis O 0 2.7839489575853804e-06
using O 0 1.2785377293766942e-05
proband O 0 0.0019443976925686002
fibroblasts O 0 0.0001899952912935987
revealed O 0 8.287705713883042e-05
that O 0 2.667846729309531e-06
the O 0 2.11977785511408e-05
W474C O 0 0.0004173977067694068
- O 0 7.501887012040243e-05
containing O 0 1.626861558179371e-05
alpha O 0 5.143828457221389e-05
- O 0 1.3610588212031871e-05
subunit O 0 3.2106299840961583e-06
precursor O 0 7.361709867836908e-05
was O 0 5.9343132306821644e-05
normally O 0 5.0947346608154476e-06
synthesized O 0 2.5977387849707156e-05
, O 0 2.03504214368877e-06
but O 0 1.077087176781788e-06
not O 0 1.3445481954477145e-06
phosphorylated O 0 2.770997343759518e-05
or O 0 1.553838410472963e-05
secreted O 0 3.4656026400625706e-05
, O 0 5.349520506570116e-06
and O 0 3.824186023848597e-06
the O 0 4.075150718563236e-05
mature O 0 0.00021808147721458226
lysosomal O 0 0.0019628729205578566
alpha O 0 0.00021810496400576085
- O 0 8.760193304624408e-05
subunit O 0 1.1339358934492338e-05
was O 0 9.322786354459822e-05
not O 0 9.079687515622936e-06
detected O 0 0.00018446856120135635
. O 0 9.1671543486882e-05

When O 0 0.00016804180631879717
the O 0 6.512858089990914e-05
W474C O 0 0.0008328984258696437
- O 0 8.352637814823538e-05
containing O 0 2.0801706341444515e-05
alpha O 0 7.666618330404162e-05
- O 0 3.955279680667445e-05
subunit O 0 1.0237783499178477e-05
was O 0 0.00013672036584466696
transiently O 0 0.0003864878381136805
co O 0 8.956609963206574e-05
- O 0 2.2717715182807297e-05
expressed O 0 3.5147977541782893e-06
with O 0 9.330165653409495e-07
the O 0 1.160851570602972e-05
beta O 0 4.584659109241329e-05
- O 0 1.9946874090237543e-05
subunit O 0 2.0356826553324936e-06
to O 0 2.9158284178265603e-06
produce O 0 5.47255831406801e-06
Hex O 0 0.00021131036919541657
A O 0 0.00017201859736815095
( O 0 2.6675397748476826e-05
alphabeta O 0 0.0007999601075425744
) O 0 1.8288363207830116e-05
in O 0 8.465929568046704e-05
COS O 1 0.854797899723053
- O 0 0.0005862547550350428
7 O 0 0.00018623551295604557
cells O 0 1.1989940503553953e-05
, O 0 2.3078921458363766e-06
the O 0 6.3591619436920155e-06
mature O 0 2.0491834220592864e-05
alpha O 0 3.153557190671563e-05
- O 0 1.0871949598367792e-05
subunit O 0 2.530023266444914e-06
was O 0 1.8838320102076977e-05
present O 0 3.8475468500109855e-06
, O 0 1.2912255442643072e-06
but O 0 3.061829829675844e-07
its O 0 1.1601359801716171e-06
level O 0 2.7917607440031134e-05
was O 0 6.611643038922921e-05
much O 0 8.714125215192325e-06
lower O 0 1.4536018170474563e-05
than O 0 1.0408550679130713e-06
that O 0 6.880887326587981e-07
from O 0 5.3810190365766175e-06
normal O 0 1.9206054275855422e-05
alpha O 0 5.926881931372918e-05
- O 0 4.0144768718164414e-05
subunit O 0 1.0763997124740854e-05
transfections O 0 0.0001779452431946993
, O 0 2.7576988941291347e-06
although O 0 1.4747381555935135e-06
higher O 0 5.861338649992831e-06
than O 0 1.5963034911692375e-06
in O 0 6.586104063899256e-06
those O 0 7.95080359239364e-06
cells O 0 3.015930087713059e-05
transfected O 0 0.00011677393194986507
with O 0 1.7973377453017747e-06
an O 0 4.636024641513359e-06
alpha O 0 7.287427433766425e-05
- O 0 4.2056595702888444e-05
subunit O 0 1.3811846656608395e-05
associated O 0 2.3132570277084596e-05
with O 0 5.896889342693612e-05
infantile O 1 0.9999349117279053
TSD B-Disease 1 0.9999994039535522
. O 0 0.0020793366711586714

Furthermore O 0 0.00039260313496924937
, O 0 1.886053905764129e-05
the O 0 1.4859225302643608e-05
precursor O 0 0.00012278447684366256
level O 0 7.143427501432598e-05
of O 0 3.458741775830276e-05
the O 0 5.437351137516089e-05
W474C O 0 0.0006514215492643416
alpha O 0 0.00012077362043783069
- O 0 3.805197775363922e-05
subunit O 0 5.443544068839401e-06
was O 0 3.329094033688307e-05
found O 0 2.0501663584582275e-06
to O 0 3.459203753664042e-06
accumulate O 0 2.5136518161161803e-05
in O 0 5.282353868096834e-06
comparison O 0 5.138220330991317e-06
to O 0 5.728756150347181e-06
the O 0 2.6191688448307104e-05
normal O 0 4.915341560263187e-05
alpha O 0 8.570894715376198e-05
- O 0 6.550079706357792e-05
subunit O 0 2.263601345475763e-05
precursor O 0 0.00031818635761737823
levels O 0 0.00022750470088794827
. O 0 0.00013126614794600755

We O 0 4.784662451129407e-05
conclude O 0 7.987352728378028e-05
that O 0 6.125341769802617e-06
the O 0 4.144014019402675e-05
1422 O 0 0.01477406919002533
G O 0 0.00267540430650115
- O 0 0.0006231592851690948
- O 0 0.00016790357767604291
> O 0 4.842644193558954e-05
C O 0 7.630209438502789e-05
mutation O 0 1.974600536414073e-06
is O 0 1.0707537967391545e-06
the O 0 3.823645783995744e-06
cause O 0 1.6669057004037313e-05
of O 0 3.9389324228977785e-05
Hex B-Disease 0 0.001984874252229929
A I-Disease 0 0.056145839393138885
enzyme I-Disease 1 0.9987672567367554
deficiency I-Disease 1 1.0
in O 0 0.0003532474220264703
the O 0 0.00041340693132951856
proband O 0 0.010667284950613976
. O 0 0.00024614459834992886

The O 0 0.0002265784132760018
resulting O 0 0.00021759378432761878
W474C O 0 0.0010586022399365902
substitution O 0 5.333434819476679e-05
clearly O 0 9.521867468720302e-05
interferes O 0 5.7207769714295864e-05
with O 0 5.332517503120471e-06
alpha O 0 9.171631245408207e-05
- O 0 3.210692011634819e-05
subunit O 0 4.7295179683715105e-06
processing O 0 1.3026841770624742e-05
, O 0 1.71051044617343e-06
but O 0 9.250056223208958e-07
because O 0 5.932448630119325e-07
the O 0 2.7359017167327693e-06
base O 0 9.760258762980811e-06
substitution O 0 1.507824708824046e-05
falls O 0 0.00024331054009962827
at O 0 2.6194560632575303e-05
the O 0 5.869751475984231e-06
first O 0 5.324854100763332e-06
position O 0 1.3077849871478975e-05
of O 0 3.438408384681679e-05
exon O 0 0.0003269605804234743
13 O 0 0.00011580609134398401
, O 0 1.066640925273532e-05
aberrant O 0 8.372366573894396e-05
splicing O 0 5.820139267598279e-05
may O 0 2.2758395061828196e-05
also O 0 4.810039172298275e-06
contribute O 0 1.1636957424343564e-05
to O 0 2.4585295250290073e-05
Hex B-Disease 0 0.002150760730728507
A I-Disease 0 0.005598243325948715
deficiency I-Disease 1 0.9999828338623047
in O 0 0.00010283347364747897
this O 0 2.7156929718330503e-05
proband O 0 0.0023907001595944166
. O 0 4.715511386166327e-05
. O 0 9.293122275266796e-05

Two O 0 7.64286596677266e-05
frequent O 0 0.00010498793562874198
missense O 0 0.0007292234804481268
mutations O 0 0.00043955998262390494
in O 0 0.005623981822282076
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.017371365800499916

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0002953705261461437
an O 0 0.0007412201375700533
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999998807907104
by O 0 0.0016901843482628465
early O 1 0.9999680519104004
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999998807907104
goiter B-Disease 1 1.0
. O 1 0.9968488812446594

A O 0 0.0005036782822571695
century O 0 0.000180237548192963
after O 0 1.7233378457603976e-05
its O 0 1.3361042192627792e-06
recognition O 0 8.645749403513037e-06
as O 0 3.272522735642269e-05
a O 0 0.0001626627054065466
syndrome O 1 0.999998927116394
by O 0 4.055309545947239e-05
Vaughan O 0 0.0006884584436193109
Pendred O 0 0.011897563934326172
, O 0 1.0782962817756925e-05
the O 0 4.085773980477825e-05
disease O 1 0.9995884299278259
gene O 0 5.898329254705459e-05
( O 0 7.205747533589602e-05
PDS O 1 0.5954270958900452
) O 0 1.813459130062256e-05
was O 0 9.20456659514457e-05
mapped O 0 4.2907406168524176e-05
to O 0 4.507016274146736e-05
chromosome O 0 0.0013417911250144243
7q22 O 0 0.006483503617346287
- O 0 0.002992750843986869
q31 O 0 0.003473003627732396
. O 0 0.0002592800883576274

1 O 0 0.0009978789603337646
and O 0 4.629736940842122e-05
, O 0 1.3796944585919846e-05
recently O 0 1.9648421584861353e-05
, O 0 2.2954197902436135e-06
found O 0 1.4811257642577402e-06
to O 0 2.4795176614134107e-06
encode O 0 1.4021456081536599e-05
a O 0 7.032653229543939e-05
putative O 0 0.0010116411140188575
sulfate O 0 0.007185014430433512
transporter O 0 0.06621000170707703
. O 0 0.0010005657095462084

We O 0 8.036257349886e-05
performed O 0 5.079232869320549e-05
mutation O 0 3.5874618333764374e-06
analysis O 0 1.2380654652588419e-06
of O 0 1.355747281195363e-05
the O 0 8.067137969192117e-05
PDS B-Disease 1 0.8081796169281006
gene O 0 4.2489067709539086e-05
in O 0 2.6120027541765012e-05
patients O 0 2.3183099983725697e-05
from O 0 4.281707151676528e-05
14 O 0 0.00019792946113739163
Pendred B-Disease 0 0.0013778911670669913
families O 0 7.5478160397324245e-06
originating O 0 1.885082747321576e-05
from O 0 4.828901182918344e-06
seven O 0 7.063847078825347e-06
countries O 0 1.5055551330078742e-06
and O 0 2.557025936766877e-06
identified O 0 8.97646532393992e-06
all O 0 9.50963658397086e-06
mutations O 0 0.00010099270002683625
. O 0 0.00020849965221714228

The O 0 0.00018917262786999345
mutations O 0 7.207232556538656e-05
include O 0 2.3425429390044883e-05
three O 0 2.8711605409625918e-05
single O 0 2.1474255845532753e-05
base O 0 5.094358493806794e-05
deletions O 0 6.804001168347895e-05
, O 0 7.159282631619135e-06
one O 0 4.475094101508148e-06
splice O 0 0.00011233399709453806
site O 0 9.937307913787663e-05
mutation O 0 1.1255892786721233e-05
and O 0 1.6406782378908247e-05
10 O 0 0.0001494272000854835
missense O 0 0.0008058716193772852
mutations O 0 0.0003764424182008952
. O 0 0.0004556237254291773

One O 0 0.00022353096574079245
missense O 0 0.0009575297008268535
mutation O 0 0.0001141977118095383
( O 0 0.00010287839540978894
L236P O 0 0.0009806961752474308
) O 0 2.12234281207202e-05
was O 0 7.626760634593666e-05
found O 0 2.3957256871653954e-06
in O 0 5.790521754533984e-06
a O 0 6.846177257102681e-06
homozygous O 0 1.0270288839819841e-05
state O 0 5.539474841498304e-06
in O 0 8.62511387822451e-06
two O 0 1.0276922694174573e-05
consanguineous O 0 0.00047962379176169634
families O 0 7.836218173906673e-06
and O 0 3.658744617496268e-06
in O 0 6.801255949540064e-06
a O 0 1.2502184290497098e-05
heterozygous O 0 6.809205842728261e-06
state O 0 3.1322922495746752e-06
in O 0 5.781235813628882e-06
five O 0 6.3262259573093615e-06
additional O 0 9.310369932791218e-06
non O 0 0.00044032034929841757
- O 0 0.000968204578384757
consanguineous O 0 0.0026269671507179737
families O 0 0.00012698030332103372
. O 0 0.00027177552692592144

Another O 0 0.0007815928547643125
missense O 0 0.0015387673629447818
mutation O 0 0.00013529702846426517
( O 0 0.00010581430979073048
T416P O 0 0.0007458601612597704
) O 0 1.4109344192547724e-05
was O 0 7.126852142391726e-05
found O 0 2.383440005360171e-06
in O 0 3.144491984130582e-06
a O 0 5.2457912715908606e-06
homozygous O 0 9.917816896631848e-06
state O 0 5.423962193162879e-06
in O 0 7.5712596299126744e-06
one O 0 6.48843797534937e-06
family O 0 1.1824473403976299e-05
and O 0 3.1807689993001986e-06
in O 0 7.16759041097248e-06
a O 0 1.2276143934286665e-05
heterozygous O 0 7.500764695578255e-06
state O 0 4.987720330973389e-06
in O 0 9.816267265705392e-06
four O 0 1.684108065092005e-05
families O 0 2.1379339159466326e-05
. O 0 0.00014218175783753395

Pendred B-Disease 1 0.8716835379600525
patients O 0 0.00048270547995343804
in O 0 0.00011858809739351273
three O 0 9.487535135122016e-05
non O 0 0.0005628045764751732
- O 0 0.0004024934896733612
consanguineous O 0 0.0002519519184716046
families O 0 3.348845211803564e-06
were O 0 4.247648575983476e-06
shown O 0 4.7893772716633976e-06
to O 0 4.729513420898002e-06
be O 0 8.672142030263785e-06
compound O 0 6.497628783108667e-05
heterozygotes O 0 0.00022848336084280163
for O 0 3.936570283258334e-05
L236P O 0 0.0015674559399485588
and O 0 7.335305417655036e-05
T416P O 0 0.0034194979816675186
. O 0 0.00027096259873360395

In O 0 9.791530465008691e-05
total O 0 4.7620025725336745e-05
, O 0 1.2219261407153681e-05
one O 0 2.198848505940987e-06
or O 0 1.759831093295361e-06
both O 0 1.5479947705898667e-06
of O 0 1.2926108865940478e-05
these O 0 5.744014288211474e-06
mutations O 0 1.880496711237356e-05
were O 0 1.8661690774024464e-05
found O 0 4.763099241245072e-06
in O 0 4.713802809419576e-06
nine O 0 1.323956712440122e-05
of O 0 1.2463708117138594e-05
the O 0 2.2502053980133496e-05
14 O 0 6.86302810208872e-05
families O 0 1.7015690900734626e-05
analyzed O 0 0.00020106357987970114
. O 0 0.00012538245937321335

The O 0 9.358021634398028e-05
identification O 0 2.3543992938357405e-05
of O 0 6.02764448558446e-05
two O 0 3.933853440685198e-05
frequent O 0 0.0001681360590737313
PDS B-Disease 1 0.9455126523971558
mutations O 0 4.132419780944474e-05
will O 0 6.326949915091973e-06
facilitate O 0 7.780088708386756e-06
the O 0 9.602748832548968e-06
molecular O 0 4.093059033039026e-05
diagnosis O 0 0.0016840460011735559
of O 1 0.9996228218078613
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.7629008293151855

Insertional O 0 0.005448881536722183
mutation O 0 2.7042493456974626e-05
by O 0 8.042883564485237e-06
transposable O 0 0.0005510053597390652
element O 0 0.00016156457422766834
, O 0 5.287714157020673e-05
L1 O 0 0.0022775460965931416
, O 0 1.5524017726420425e-05
in O 0 1.4803074918745551e-05
the O 0 7.21342075848952e-05
DMD B-Disease 1 0.9994970560073853
gene O 0 1.7236436178791337e-05
results O 0 1.0808350452862214e-05
in O 0 5.2794766816077754e-05
X B-Disease 1 0.7551279067993164
- I-Disease 1 0.9982497096061707
linked I-Disease 1 0.999632716178894
dilated I-Disease 1 0.9999407529830933
cardiomyopathy I-Disease 1 1.0
. O 0 0.005317509174346924

X B-Disease 1 0.9975716471672058
- I-Disease 1 0.9992690682411194
linked I-Disease 1 0.9995631575584412
dilated I-Disease 1 0.9999659061431885
cardiomyopathy I-Disease 1 1.0
( O 0 0.038444243371486664
XLDCM B-Disease 1 0.9999985694885254
) O 0 2.2794887627242133e-05
is O 0 3.473842525636428e-06
a O 0 3.515790240271599e-06
clinical O 0 2.526870957808569e-05
phenotype O 0 1.935491854965221e-05
of O 0 7.588513835798949e-05
dystrophinopathy B-Disease 0 0.012424475513398647
which O 0 1.075687487173127e-05
is O 0 3.9540682337246835e-06
characterized O 0 1.6810401575639844e-05
by O 0 1.0995488082699012e-05
preferential O 0 0.00042223933269269764
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.2000308483839035
without O 0 6.608856347156689e-05
any O 0 1.7848797142505646e-05
overt O 0 0.0003162616631016135
clinical O 0 0.0065216864459216595
signs O 1 0.9985893368721008
of O 1 0.9999974966049194
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9998776912689209

To O 0 4.3896408897126094e-05
date O 0 5.051963671576232e-05
, O 0 3.163344445056282e-06
several O 0 2.1365103748394176e-06
mutations O 0 1.524473827885231e-05
in O 0 5.024514757678844e-05
the O 0 0.07160729914903641
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.5351352691650391
, O 0 0.0005941718118265271
DMD O 1 1.0
, O 0 2.1078782083350234e-05
have O 0 2.3453851554222638e-06
been O 0 5.0598046072991565e-06
identified O 0 3.3110611639131093e-06
in O 0 6.2674480432178825e-06
patients O 0 2.1482386728166603e-05
with O 0 2.1857062165508978e-05
XLDCM B-Disease 1 0.9999934434890747
, O 0 2.748374390648678e-05
but O 0 2.7410728762333747e-06
a O 0 3.8288858377200086e-06
pathogenic O 0 8.643556611787062e-06
correlation O 0 6.973154086153954e-06
of O 0 1.4264661331253592e-05
these O 0 1.4144073247734923e-05
cardiospecific O 0 0.004356890916824341
mutations O 0 0.00011093715147580951
in O 0 0.00019428131054155529
DMD O 1 0.9999933242797852
with O 0 3.8871348806424066e-05
the O 0 0.00014084547001402825
XLDCM B-Disease 1 0.9996028542518616
phenotype O 0 8.714725845493376e-05
has O 0 1.1433187864895444e-05
remained O 0 0.00011432258179411292
to O 0 8.745903869566973e-06
be O 0 3.362512507010251e-05
elucidated O 0 0.002556030172854662
. O 0 0.00020222639432176948

We O 0 0.00010559668589849025
report O 0 9.955114364856854e-06
here O 0 7.3168657763744704e-06
the O 0 3.0000892365933396e-06
identification O 0 1.642351548980514e-06
of O 0 1.303607496083714e-05
a O 0 2.0448067516554147e-05
unique O 0 4.3223095417488366e-05
de O 0 0.0008989764610305429
novo O 0 0.0006801484851166606
L1 O 0 0.003498263191431761
insertion O 0 0.00013582376413978636
in O 0 4.7648507461417466e-05
the O 0 5.974908344796859e-05
muscle O 0 0.00022148818243294954
exon O 0 0.00036442879354581237
1 O 0 0.00022853237169329077
in O 0 0.00012549250095617026
DMD O 1 0.9999576807022095
in O 0 9.209078416461125e-05
three O 0 7.24083001841791e-05
XLDCM B-Disease 1 0.9989014863967896
patients O 0 5.470517135108821e-05
from O 0 3.199547791155055e-05
two O 0 1.3512735677068122e-05
unrelated O 0 0.00010081911750603467
Japanese O 0 0.00039507701876573265
families O 0 6.435801333282143e-05
. O 0 0.0001773050316842273

The O 0 0.00020435232727322727
insertion O 0 0.00015901649021543562
was O 0 0.00024818064412102103
a O 0 3.4870914532803e-05
5 O 0 5.7328845286974683e-05
- O 0 4.0926453948486596e-05
truncated O 0 2.0979334294679575e-05
form O 0 3.0257883736339863e-06
of O 0 3.8019625208107755e-05
human O 0 8.330095442943275e-05
L1 O 0 0.00332769937813282
inversely O 0 0.0002642592880874872
integrated O 0 6.159295298857614e-05
in O 0 1.8786666259984486e-05
the O 0 2.861399480025284e-05
5 O 0 0.00012453111412469298
- O 0 0.00014807548723183572
untranslated O 0 0.0010322354501113296
region O 0 0.00013545968977268785
in O 0 1.911804974952247e-05
the O 0 6.965702050365508e-05
muscle O 0 0.0002583892201073468
exon O 0 0.00023850781144574285
1 O 0 7.060357893351465e-05
, O 0 3.016683649548213e-06
which O 0 9.350920890938141e-07
affected O 0 1.6055831792982644e-06
the O 0 3.566574150681845e-06
transcription O 0 2.2078560505178757e-05
or O 0 4.30683940066956e-06
the O 0 1.2405390407366212e-05
stability O 0 0.00011698949674610049
of O 0 4.3744046706706285e-05
the O 0 8.89848088263534e-05
muscle O 0 0.00019370087829884142
form O 0 2.0319674149504863e-05
of O 0 0.00014093899517320096
dystrophin O 0 0.0007715472602285445
transcripts O 0 0.0001517299097031355
but O 0 1.8437965536577394e-06
not O 0 4.263681887550774e-07
that O 0 4.3420035922281386e-07
of O 0 1.1115776942460798e-05
the O 0 0.00018736494530458003
brain O 1 0.9997333884239197
or O 0 0.0005077479290775955
Purkinje O 1 0.9981033802032471
cell O 0 0.0006363009451888502
form O 0 3.7616060581058264e-05
, O 0 1.4363739865075331e-05
probably O 0 2.1789090169477277e-05
due O 0 1.559485463076271e-05
to O 0 2.0862280507571995e-06
its O 0 1.936838998517487e-06
unique O 0 3.6941703456250252e-06
site O 0 5.552317088586278e-05
of O 0 4.266983887646347e-05
integration O 0 0.00039626305806450546
. O 0 0.00030971039086580276

We O 0 0.00016137829516083002
speculate O 0 5.014659109292552e-05
that O 0 1.0238018148811534e-06
this O 0 8.468600753985811e-07
insertion O 0 1.0379405466665048e-05
of O 0 2.8721326088998467e-05
an O 0 2.1639702026732266e-05
L1 O 0 0.0034721919801086187
sequence O 0 7.748924690531567e-05
in O 0 0.00026849485584534705
DMD O 1 0.9999794960021973
is O 0 2.2683296265313402e-05
responsible O 0 8.262985829787795e-06
for O 0 1.1909858130820794e-06
some O 0 6.856787990727753e-07
of O 0 6.402505732694408e-06
the O 0 7.762005225231405e-06
population O 0 1.4352579000842525e-06
of O 0 1.1714231732184999e-05
Japanese O 0 0.00014485367864836007
patients O 0 2.9916303901700303e-05
with O 0 2.5693805582704954e-05
XLDCM B-Disease 1 0.9999914169311523
. O 0 0.00011311221169307828
. O 0 0.00013889958790969104

Severe O 1 0.9927512407302856
early O 0 0.029490845277905464
- O 1 0.9998700618743896
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9998956918716431
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.999995231628418
red O 1 0.9999980926513672
hair O 1 0.9629610776901245
pigmentation O 1 0.998087465763092
caused O 1 0.9977849721908569
by O 0 0.0002415771159576252
POMC O 1 0.9999042749404907
mutations O 0 0.00028040524921379983
in O 0 0.00023908226285129786
humans O 0 0.00043543087667785585
. O 0 0.0001552750909468159

Sequential O 0 0.0004022765497211367
cleavage O 0 0.00032991988700814545
of O 0 9.151746053248644e-05
the O 0 7.475649181287736e-05
precursor O 0 0.0003206321853213012
protein O 0 4.028359762742184e-05
pre O 0 0.000501862436067313
- O 0 0.0004866729723289609
pro O 0 0.0010043502552434802
- O 0 0.0008297758176922798
opiomelanocortin O 0 0.00304673844948411
( O 0 0.00012089656229363754
POMC O 0 0.0069710370153188705
) O 0 1.2182134014437906e-05
generates O 0 1.0478913281986024e-05
the O 0 2.9724291380262002e-05
melanocortin O 0 0.003345847362652421
peptides O 0 0.00013329260400496423
adrenocorticotrophin O 0 0.0036249044351279736
( O 0 0.00023398452321998775
ACTH O 0 0.0038023730739951134
) O 0 4.743438330478966e-05
, O 0 6.521322939079255e-05
melanocyte O 0 0.0074095833115279675
- O 0 0.002249365206807852
stimulating O 0 0.0020980790723115206
hormones O 0 0.00041378146852366626
( O 0 9.10137387108989e-05
MSH O 0 0.01014708448201418
) O 0 1.7078933524317108e-05
alpha O 0 4.1225332097383216e-05
, O 0 4.251588052284205e-06
beta O 0 1.676029569352977e-05
and O 0 2.7729684006772004e-06
gamma O 0 1.7454287444707006e-05
as O 0 6.458126790676033e-06
well O 0 2.3709508241154253e-06
as O 0 3.2541249765927205e-06
the O 0 9.053022040461656e-06
opioid O 0 0.00017925632710102946
- O 0 0.00015091957175172865
receptor O 0 4.485863973968662e-05
ligand O 0 0.00023086040164344013
beta O 0 0.0008249697275459766
- O 0 0.0012816325761377811
endorphin O 0 0.0029559528920799494
. O 0 0.00014755652227904648

While O 0 8.932046330301091e-05
a O 0 1.9530763893271796e-05
few O 0 6.182350261951797e-06
cases O 0 4.56300131190801e-06
of O 0 8.876006177160889e-05
isolated O 1 0.9992152452468872
ACTH B-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
have O 0 4.050022835144773e-05
been O 0 3.260156518081203e-05
reported O 0 3.087401273660362e-05
( O 0 7.097877823980525e-05
OMIM O 0 0.4204098582267761
201400 O 0 0.0014294383581727743
) O 0 1.3986387784825638e-05
, O 0 4.869858003075933e-06
an O 0 2.2565320250578225e-05
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9998167157173157
has O 0 6.549961835844442e-05
not O 0 7.54414577386342e-06
been O 0 1.3154101907275617e-05
described O 0 2.150093496311456e-05
so O 0 1.0125344488187693e-05
far O 0 4.37982271250803e-05
. O 0 5.924712240812369e-05

Recent O 0 0.0001182881387649104
studies O 0 2.54203023359878e-05
in O 0 1.795476237020921e-05
animal O 0 2.139335083484184e-05
models O 0 4.053151315019932e-06
elucidated O 0 0.00013457673776429147
a O 0 8.530059858458117e-06
central O 0 2.4806415240163915e-05
role O 0 2.91516389552271e-05
of O 0 8.463878475595266e-05
alpha O 0 0.0008612837991677225
- O 0 0.0009013625676743686
MSH O 0 0.007387102115899324
in O 0 9.527257134323008e-06
the O 0 7.73321880842559e-06
regulation O 0 6.762546490790555e-06
of O 0 9.666367077443283e-06
food O 0 1.907142905110959e-05
intake O 0 1.2039497960358858e-05
by O 0 9.067796327144606e-07
activation O 0 7.192226803454105e-06
of O 0 3.7154375604586676e-05
the O 0 0.00014510611072182655
brain O 0 0.0027883213479071856
melanocortin O 0 0.008920332416892052
- O 0 0.0002839242515619844
4 O 0 8.557827095501125e-05
- O 0 0.00012071614764863625
receptor O 0 5.15637184435036e-05
( O 0 5.745516682509333e-05
MC4 O 0 0.01442435197532177
- O 0 0.00041353917913511395
R O 0 0.0004553890321403742
; O 0 9.465503353567328e-06
refs O 0 0.00015722143871244043
3 O 0 5.415311534306966e-05
- O 0 6.279511580942199e-05
5 O 0 1.4442582141782623e-05
) O 0 1.3010821930947714e-06
and O 0 7.377920496765e-07
the O 0 4.647409696190152e-06
linkage O 0 7.856260344851762e-05
of O 0 5.461927139549516e-05
human O 0 0.00019038445316255093
obesity B-Disease 1 0.9999918937683105
to O 0 7.447330426657572e-05
chromosome O 0 7.793388067511842e-05
2 O 0 4.919993443763815e-05
in O 0 1.583218909217976e-05
close O 0 2.9489636290236376e-05
proximity O 0 3.17951817123685e-05
to O 0 1.0159808880416676e-05
the O 0 6.988123641349375e-05
POMC O 0 0.007984345778822899
locus O 0 5.525679443962872e-05
, O 0 5.691709247912513e-06
led O 0 1.0613906852086075e-05
to O 0 2.790051212286926e-06
the O 0 4.4808598431700375e-06
proposal O 0 2.3772472559357993e-06
of O 0 4.005387836514274e-06
an O 0 4.725708095065784e-06
association O 0 2.742211836448405e-05
of O 0 0.00019777269335463643
POMC O 1 0.9999758005142212
with O 0 9.209878044202924e-05
human O 0 0.0028624918777495623
obesity B-Disease 1 1.0
. O 0 0.000883071159478277

The O 0 0.00011360739881638438
dual O 0 4.643173815566115e-05
role O 0 9.01018429431133e-05
of O 0 0.00030831218464300036
alpha O 0 0.003084743395447731
- O 0 0.004288464784622192
MSH O 1 0.9643294215202332
in O 0 7.091430597938597e-05
regulating O 0 0.0002852048201020807
food O 0 7.788989751134068e-05
intake O 0 0.0001803780032787472
and O 0 4.33249915658962e-05
influencing O 0 0.0009523571934551001
hair O 0 0.0011813504388555884
pigmentation O 0 0.0008668325026519597
predicts O 0 0.00011471418110886589
that O 0 2.874513029382797e-06
the O 0 9.868380402622279e-06
phenotype O 0 1.8751819879980758e-05
associated O 0 8.508968676324002e-06
with O 0 3.999566615675576e-06
a O 0 6.005279647069983e-05
defect O 0 0.006358898710459471
in O 0 9.411106293555349e-05
POMC O 1 0.8655015230178833
function O 0 1.0649048817867879e-05
would O 0 6.824847787356703e-06
include O 0 4.3161064240848646e-05
obesity B-Disease 1 1.0
, O 0 4.895955134998076e-05
alteration O 0 0.0025598150677978992
in O 0 0.0010356728453189135
pigmentation O 1 0.9999051094055176
and O 1 0.9144837856292725
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00542902247980237

The O 0 0.00023030024021863937
observation O 0 0.0001840147888287902
of O 0 0.00011330501001793891
these O 0 3.317260416224599e-05
symptoms O 0 0.0010061768116429448
in O 0 0.00011811027070507407
two O 0 2.5102764993789606e-05
probands O 0 0.0008451833855360746
prompted O 0 3.0898107070242986e-05
us O 0 5.717430667573353e-06
to O 0 1.3353183021536097e-06
search O 0 3.2071075111161917e-06
for O 0 3.6279843698139302e-06
mutations O 0 1.8475106116966344e-05
within O 0 3.369985643075779e-05
their O 0 6.240951915970072e-05
POMC O 1 0.948763370513916
genes O 0 0.0002905766596086323
. O 0 0.0001784650085028261

Patient O 0 0.0006816476816311479
1 O 0 0.00031884494819678366
was O 0 0.0001441792701371014
found O 0 2.7702089937520213e-06
to O 0 2.664950443431735e-06
be O 0 2.178069507863256e-06
a O 0 9.448952368984465e-06
compound O 0 3.332117194077e-05
heterozygote O 0 4.198278475087136e-05
for O 0 2.7972314455837477e-06
two O 0 3.339984914418892e-06
mutations O 0 1.2079324733349495e-05
in O 0 4.496125620789826e-05
exon O 0 0.00024289658176712692
3 O 0 0.00011728336539817974
( O 0 2.4494471290381625e-05
G7013T O 0 0.00035166749148629606
, O 0 1.6035530279623345e-05
C7133delta O 0 0.0006975782453082502
) O 0 6.05730565439444e-06
which O 0 2.428642119411961e-06
interfere O 0 3.7004747355240397e-06
with O 0 5.16937348038482e-07
appropriate O 0 2.1407793155958643e-06
synthesis O 0 1.9685707229655236e-05
of O 0 0.00026116741355508566
ACTH O 0 0.010558237321674824
and O 0 0.00016558312927372754
alpha O 0 0.0024291120935231447
- O 0 0.004575707949697971
MSH O 1 0.9684861898422241
. O 0 0.00032699768780730665

Patient O 0 0.0007449547410942614
2 O 0 0.0003006822953466326
was O 0 0.0001638926478335634
homozygous O 0 1.2833518667321187e-05
for O 0 1.9409271772019565e-06
a O 0 7.37365371605847e-06
mutation O 0 3.891808319167467e-06
in O 0 1.0795967682497576e-05
exon O 0 0.00014712801203131676
2 O 0 7.197294326033443e-05
( O 0 2.0755496734636836e-05
C3804A O 0 0.0002993559464812279
) O 0 6.88711816110299e-06
which O 0 1.0563759133219719e-05
abolishes O 0 0.0010080784559249878
POMC O 0 0.31477823853492737
translation O 0 0.0004920097417198122
. O 0 0.00027582532493397593

These O 0 2.0053970729350112e-05
findings O 0 6.056595793779707e-06
represent O 0 4.59245165984612e-06
the O 0 4.3951899897365365e-06
first O 0 3.650623511930462e-06
examples O 0 3.257733169448329e-06
of O 0 1.8082057067658752e-05
a O 0 7.876581366872415e-05
genetic B-Disease 1 0.9992188215255737
defect I-Disease 1 0.9999722242355347
within O 0 0.00013618948287330568
the O 0 0.0001688152551651001
POMC O 1 0.7642537355422974
gene O 0 1.3455022781272419e-05
and O 0 1.6480344129377045e-06
define O 0 1.3205079994804692e-05
a O 0 1.884629818960093e-05
new O 0 0.00010673316137399524
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.002116977237164974
in O 0 0.00014871930761728436
early O 0 0.0011587891494855285
- O 1 0.9858205318450928
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9998155236244202
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999816417694092
red O 1 0.9999898672103882
hair O 1 0.7008197903633118
pigmentation O 0 0.42784571647644043
. O 0 0.0003726444556377828
. O 0 0.00039402907714247704

A O 0 0.0004069777496624738
European O 0 2.5836663553491235e-05
multicenter O 0 0.0002338172635063529
study O 0 2.098041477438528e-05
of O 0 0.0002505140146240592
phenylalanine B-Disease 1 0.9999889135360718
hydroxylase I-Disease 1 0.9999936819076538
deficiency I-Disease 1 1.0
: O 0 6.331432814477012e-05
classification O 0 6.286300049396232e-05
of O 0 6.207138358149678e-05
105 O 0 0.00016759216669015586
mutations O 0 1.5715337212895975e-05
and O 0 1.7554210671733017e-06
a O 0 2.4661439965711907e-06
general O 0 4.864019047090551e-06
system O 0 5.513240012078313e-06
for O 0 3.081426029893919e-06
genotype O 0 4.4328178773866966e-05
- O 0 4.2974155803676695e-05
based O 0 1.9964004422945436e-06
prediction O 0 3.3921398426173255e-05
of O 0 6.762254633940756e-05
metabolic O 1 0.9988586902618408
phenotype O 0 0.001123080844990909
. O 0 0.000537897867616266

Phenylketonuria B-Disease 1 0.9999469518661499
( O 0 0.002849612385034561
PKU B-Disease 1 0.999937891960144
) O 0 0.00010623865091474727
and O 0 3.3050433557946235e-05
mild B-Disease 0 0.060380589216947556
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.5205997824668884
MHP B-Disease 1 1.0
) O 0 6.998967728577554e-05
are O 0 1.2219389645906631e-05
allelic B-Disease 0 0.0037762613501399755
disorders I-Disease 1 1.0
caused O 0 0.26939767599105835
by O 0 1.680399145698175e-05
mutations O 0 7.750480108370539e-06
in O 0 8.278421773866285e-06
the O 0 6.330987616820494e-06
gene O 0 5.0869766710093245e-06
encoding O 0 1.5863897715462372e-05
phenylalanine O 0 0.0005022237310186028
hydroxylase O 0 0.003097349079325795
( O 0 0.0014762486098334193
PAH O 1 1.0
) O 0 0.0003449873474892229
. O 0 0.00017868808936327696

Previous O 0 0.00015145150246098638
studies O 0 1.8506299966247752e-05
have O 0 2.766480974969454e-06
suggested O 0 4.4728412831318565e-06
that O 0 4.858061970480776e-07
the O 0 2.681928435777081e-06
highly O 0 1.5231890756695066e-05
variable O 0 1.1088872270192951e-05
metabolic O 0 0.015006260015070438
phenotypes O 0 0.0021430107299238443
of O 1 0.9999872446060181
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.8087173700332642
with O 0 0.15063557028770447
PAH O 1 1.0
genotypes O 1 0.9835731387138367
. O 0 0.0011153834639117122

We O 0 4.836823791265488e-05
identified O 0 1.976254498003982e-05
both O 0 1.1470146091596689e-05
causative O 0 0.0004147182044107467
mutations O 0 9.043719910550863e-05
in O 0 0.00012634499580599368
686 O 0 0.002381583210080862
patients O 0 6.505173223558813e-05
from O 0 4.92046274302993e-05
seven O 0 3.663583629531786e-05
European O 0 3.081544491578825e-05
centers O 0 0.00016758800484240055
. O 0 0.00010277857654727995

On O 0 0.00015531803364865482
the O 0 9.12526866159169e-06
basis O 0 5.181414508115267e-06
of O 0 7.0173759922909085e-06
the O 0 7.291962447197875e-06
phenotypic O 0 4.7001980419736356e-05
characteristics O 0 3.3705706300679594e-05
of O 0 0.00011482131230877712
297 O 0 0.0010149359004572034
functionally O 0 0.0022650202736258507
hemizygous O 0 0.11340853571891785
patients O 0 4.9432444939156994e-05
, O 0 6.997282071097288e-06
105 O 0 1.8606036974233575e-05
of O 0 1.2753725968650542e-05
the O 0 1.829516804718878e-05
mutations O 0 6.846739324828377e-06
were O 0 7.560473932244349e-06
assigned O 0 8.630428965261672e-06
to O 0 5.734829301218269e-06
one O 0 3.650226517493138e-06
of O 0 1.1112501852039713e-05
four O 0 1.0792735338327475e-05
arbitrary O 0 1.5028760572022293e-05
phenotype O 0 0.00011030866880901158
categories O 0 0.00021031899086665362
. O 0 0.00039798306534066796

We O 0 8.060409891186282e-05
proposed O 0 3.7718295061495155e-05
and O 0 6.899279924255097e-06
tested O 0 1.961733869393356e-05
a O 0 3.940324859286193e-06
simple O 0 1.5173026213233243e-06
model O 0 1.3869243957742583e-06
for O 0 2.2398871806217358e-06
correlation O 0 1.883163713500835e-05
between O 0 9.688508725957945e-05
genotype O 0 9.514606790617108e-05
and O 0 1.6520392819074914e-05
phenotypic O 0 0.0002228393714176491
outcome O 0 0.0005097963148728013
. O 0 0.0002611126401461661

The O 0 0.0002166925696656108
observed O 0 0.00010699126141844317
phenotype O 0 7.967172132339329e-05
matched O 0 5.750077616539784e-05
the O 0 3.4296932426514104e-05
predicted O 0 9.972201951313764e-05
phenotype O 0 1.7852322343969718e-05
in O 0 9.83465179160703e-06
79 O 0 2.3664535547140986e-05
% O 0 4.298956355341943e-06
of O 0 1.939412140927743e-05
the O 0 3.3223572245333344e-05
cases O 0 1.3308444977155887e-05
, O 0 3.4481633974792203e-06
and O 0 2.1314408513717353e-06
in O 0 3.869765805575298e-06
only O 0 3.0115554636722663e-06
5 O 0 9.09461778064724e-06
of O 0 1.4546197235176805e-05
184 O 0 7.169209857238457e-05
patients O 0 2.726425555010792e-05
was O 0 7.927346450742334e-05
the O 0 1.0130869668500964e-05
observed O 0 9.962085641745944e-06
phenotype O 0 4.982043719792273e-06
more O 0 1.0354197002016008e-06
than O 0 9.375512490805704e-07
one O 0 1.6760110383984284e-06
category O 0 2.71067324320029e-06
away O 0 6.635075351368869e-06
from O 0 5.0152370931755286e-06
that O 0 2.2051569885661593e-06
expected O 0 7.406126678688452e-05
. O 0 6.119280442362651e-05

Among O 0 6.782378477510065e-05
the O 0 2.1318281142157502e-05
seven O 0 2.258377026009839e-05
contributing O 0 3.452309101703577e-05
centers O 0 1.3889222827856429e-05
, O 0 1.6437461454188451e-06
the O 0 3.111706973868422e-06
proportion O 0 5.763944045611424e-06
of O 0 1.7705220670904964e-05
patients O 0 2.5790581275941804e-05
for O 0 1.622616036911495e-05
whom O 0 5.2995161240687594e-05
the O 0 2.6323177735321224e-05
observed O 0 3.8821253838250414e-05
phenotype O 0 2.0162317014182918e-05
did O 0 8.763979167270008e-06
not O 0 2.3095255983207608e-06
match O 0 1.3774121725873556e-05
the O 0 1.2015581887681037e-05
predicted O 0 3.335843575769104e-05
phenotype O 0 1.113084999815328e-05
was O 0 9.061556193046272e-05
4 O 0 3.344229844515212e-05
% O 0 1.2582754607137758e-05
- O 0 5.513667201739736e-05
23 O 0 3.705946801346727e-05
% O 0 9.567228516971227e-06
( O 0 3.0898347176844254e-05
P O 0 0.0012433751253411174
< O 0 0.0008386283880099654
. O 0 3.461691812844947e-05
0001 O 0 0.002152285072952509
) O 0 9.588427928974852e-06
, O 0 3.392090320630814e-06
suggesting O 0 8.422614882874768e-06
that O 0 9.708315928946831e-07
differences O 0 7.838169040041976e-06
in O 0 4.639833150577033e-06
methods O 0 2.5576357529644156e-06
used O 0 3.677150743897073e-06
for O 0 6.118307283031754e-06
mutation O 0 1.8579190509626642e-05
detection O 0 6.062011743779294e-05
or O 0 2.166811827919446e-05
phenotype O 0 3.832102083833888e-05
classification O 0 4.838470704271458e-05
may O 0 2.7795194910140708e-05
account O 0 3.456592139627901e-06
for O 0 2.2053125121601624e-06
a O 0 5.772723852714989e-06
considerable O 0 4.5090881030773744e-05
proportion O 0 4.266906762495637e-05
of O 0 0.00014771841233596206
genotype O 0 0.0014427099376916885
- O 0 0.0025730624329298735
phenotype O 0 0.0004031514981761575
inconsistencies O 0 0.0029117779340595007
. O 0 0.000567828246857971

Our O 0 9.284442057833076e-05
data O 0 1.879600495158229e-05
indicate O 0 2.12687755265506e-05
that O 0 7.774599907861557e-06
the O 0 0.00022874079877510667
PAH O 1 1.0
- O 0 0.0006213598535396159
mutation O 0 5.159029569767881e-06
genotype O 0 6.5796630224213e-06
is O 0 1.4919281738912105e-06
the O 0 3.453856834312319e-06
main O 0 3.6512716178549454e-05
determinant O 0 0.00015106469800230116
of O 0 0.0001694180245976895
metabolic O 1 0.7150251865386963
phenotype O 0 0.00016134012548718601
in O 0 4.7135203203652054e-05
most O 0 4.163964695180766e-05
patients O 0 0.0005833496688865125
with O 1 0.9219892621040344
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9294194579124451

In O 0 0.00012199496268294752
the O 0 3.4431490348652005e-05
present O 0 1.991298449866008e-05
study O 0 6.708296041324502e-06
, O 0 1.6367226862712414e-06
the O 0 3.522233328112634e-06
classification O 0 2.901546031353064e-05
of O 0 0.00022446730872616172
105 O 0 0.009970979765057564
PAH O 1 1.0
mutations O 0 0.0001496316835982725
may O 0 2.2129803255666047e-05
allow O 0 1.3376571814660565e-06
the O 0 3.6841570363321807e-06
prediction O 0 1.2126832189096604e-05
of O 0 8.59592910273932e-06
the O 0 2.55021768680308e-05
biochemical O 0 0.0002250632969662547
phenotype O 0 8.162339508999139e-05
in O 0 5.095534288557246e-05
> O 0 0.0001548268337501213
10 O 0 4.0447735955240205e-05
, O 0 1.1002075552823953e-05
000 O 0 8.351578435394913e-05
genotypes O 0 9.68140666373074e-05
, O 0 5.124175459059188e-06
which O 0 3.1050017241796013e-06
may O 0 6.810114882682683e-06
be O 0 1.6847527604113566e-06
useful O 0 1.192681565953535e-06
for O 0 1.3912257372794556e-06
the O 0 1.3156975001038518e-05
management O 0 7.268445915542543e-05
of O 0 0.00024793704506009817
hyperphenylalaninemia B-Disease 1 0.9999991655349731
in O 0 0.0010013264836743474
newborns O 0 0.003249586559832096
. O 0 0.0004074759781360626

Somatic O 0 0.001581351738423109
instability O 0 0.0020959745161235332
of O 0 0.00027082650922238827
the O 0 0.00032532477052882314
CTG O 1 0.9242986440658569
repeat O 0 0.000321179541060701
in O 0 4.890859781880863e-05
mice O 0 0.000111005938379094
transgenic O 0 3.38454992743209e-05
for O 0 7.943119271658361e-06
the O 0 0.0009404204320162535
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.06616676598787308
is O 0 5.586339102592319e-05
age O 0 8.092155621852726e-05
dependent O 0 1.5189651094260626e-05
but O 0 1.9401202280278085e-06
not O 0 5.5920156682987e-07
correlated O 0 3.931387709599221e-06
to O 0 2.244262077510939e-06
the O 0 7.976961569511332e-06
relative O 0 3.6519821151159704e-05
intertissue O 0 0.0007612336194142699
transcription O 0 0.0003792437200900167
levels O 0 0.0004123681865166873
and O 0 0.000133414170704782
proliferative O 1 0.9994163513183594
capacities O 0 0.022589990869164467
. O 0 0.0009381772833876312

A O 0 0.0033377918880432844
( O 0 0.0006831437931396067
CTG O 0 0.04475551098585129
) O 0 6.943214248167351e-05
nexpansion O 0 0.0006534940912388265
in O 0 2.6531954063102603e-05
the O 0 2.9950901080155745e-05
3 O 0 0.0001210795235238038
- O 0 0.00018923197058029473
untranslated O 0 0.0013113480526953936
region O 0 0.00023940067330840975
( O 0 3.2208950869971886e-05
UTR O 0 0.0013279621489346027
) O 0 3.943967840314144e-06
of O 0 1.5439090930158272e-05
the O 0 5.541674545384012e-05
DM O 1 0.9999617338180542
protein O 0 7.904338417574763e-05
kinase O 0 6.656572804786265e-05
gene O 0 2.3086508008418605e-05
( O 0 2.9398375772871077e-05
DMPK O 0 0.0035483725368976593
) O 0 4.25987536800676e-06
is O 0 1.6150028159245267e-06
responsible O 0 7.83447740104748e-06
for O 0 5.7076609664363787e-05
causing O 1 0.9999997615814209
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999512434005737
DM B-Disease 1 1.0
) O 0 0.0008036342915147543
. O 0 0.000238655018620193

Major O 0 0.009783049114048481
instability O 0 0.0059857238084077835
, O 0 2.6087416699738242e-05
with O 0 6.322377430478809e-06
very O 0 1.3187787772039883e-05
large O 0 3.5861809010384604e-05
expansions O 0 0.00018508661014493555
between O 0 7.472498691640794e-05
generations O 0 7.75350708863698e-05
and O 0 6.5509243540873285e-06
high O 0 7.103077950887382e-05
levels O 0 4.0140865166904405e-05
of O 0 6.464619218604639e-05
somatic O 0 0.0006822277209721506
mosaicism O 0 0.02597956173121929
, O 0 3.4108405088773e-05
is O 0 7.543469564552652e-06
observed O 0 1.9006085494766012e-05
in O 0 5.524336302187294e-05
patients O 0 0.00023401284124702215
. O 0 0.0002978082047775388

There O 0 0.00011392449960112572
is O 0 9.393910659127869e-06
a O 0 8.724277904548217e-06
good O 0 1.0064991329272743e-05
correlation O 0 1.3682803000847343e-05
between O 0 7.431198173435405e-05
repeat O 0 0.0001487238478148356
size O 0 3.492516407277435e-05
( O 0 7.542735602328321e-06
at O 0 3.438637577346526e-05
least O 0 4.045674813824007e-06
in O 0 1.0252291758661158e-05
leucocytes O 0 0.0006773982313461602
) O 0 9.972027328331023e-06
, O 0 4.193041149846977e-06
clinical O 0 3.071341052418575e-05
severity O 0 0.00030513358069583774
and O 0 3.438545536482707e-05
age O 0 0.0003218415949959308
of O 0 0.0006294567137956619
onset O 1 0.9999979734420776
. O 0 0.001860107178799808

The O 0 0.0006175074959173799
trinucleotide O 1 0.9830588102340698
repeat O 0 0.0011159669375047088
instability O 0 0.0012897028354927897
mechanisms O 0 0.00010317803389625624
involved O 0 4.685139356297441e-05
in O 0 9.765868162503466e-05
DM B-Disease 1 1.0
and O 0 2.2854350390844047e-05
other O 0 8.616743798484094e-06
human O 0 0.0001565706479595974
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 0.00012250986765138805
unknown O 0 0.0009213889134116471
. O 0 0.00021237968758214265

We O 0 0.0001551774184918031
studied O 0 0.00030952561064623296
somatic O 0 0.0004901670617982745
instability O 0 0.0009032953530550003
by O 0 4.7041659854585305e-05
measuring O 0 0.0012068523792549968
the O 0 0.00031673599733039737
CTG O 0 0.024040011689066887
repeat O 0 0.00022152425663080066
length O 0 4.222763527650386e-05
at O 0 3.274161645094864e-05
several O 0 3.4010818126262166e-06
ages O 0 2.036617479461711e-05
in O 0 6.8666759034385905e-06
various O 0 1.0745370673248544e-05
tissues O 0 6.650709110544994e-05
of O 0 0.00013738186680711806
transgenic O 0 0.0010189552558586001
mice O 0 9.751554898684844e-05
carrying O 0 1.9185075871064328e-05
a O 0 2.77950366580626e-05
( O 0 8.048627933021635e-05
CTG O 0 0.02859359048306942
) O 0 3.6088895285502076e-05
55expansion O 0 0.0011427100980654359
surrounded O 0 0.00021561014000326395
by O 0 4.301031822251389e-06
45 O 0 1.703462294244673e-05
kb O 0 0.0002918087411671877
of O 0 6.988509994698688e-05
the O 0 0.00010376719001214951
human O 0 0.0002327722468180582
DM B-Disease 1 1.0
region O 0 0.0005533207440748811
, O 0 1.0921455213974696e-05
using O 0 7.196274964371696e-06
small O 0 3.113764978479594e-05
- O 0 0.00020309051615186036
pool O 0 0.00026896834606304765
PCR O 0 0.00027588920784182847
. O 0 0.00012635462917387486

These O 0 0.0001204298750963062
mice O 0 0.0001818084274418652
have O 0 4.0671025089977775e-06
been O 0 4.849303877563216e-06
shown O 0 5.721843990613706e-06
to O 0 6.809706064814236e-06
reproduce O 0 1.5135800822463352e-05
the O 0 1.38586337925517e-05
intergenerational O 0 0.00015086372150108218
and O 0 1.5601637642248534e-05
somatic O 0 0.0001153217745013535
instability O 0 0.00046548296813853085
of O 0 0.00010692059731809422
the O 0 0.00015221856301650405
55 O 0 0.0004993214970454574
CTG O 0 0.10505865514278412
repeat O 0 0.00020691884856205434
suggesting O 0 6.707393913529813e-05
that O 0 3.0181397505657515e-06
surrounding O 0 4.600565807777457e-05
sequences O 0 4.599639851221582e-06
and O 0 4.7005514716147445e-06
the O 0 1.4752719835087191e-05
chromatin O 0 0.00012929887452628464
environment O 0 1.8913167878054082e-05
are O 0 1.7572567685419926e-06
involved O 0 2.7289928766549565e-05
in O 0 0.00011894688213942572
instability O 0 0.0818515494465828
mechanisms O 0 0.002366019180044532
. O 0 0.0005674524581991136

As O 0 0.00012578722089529037
observed O 0 2.1373345589381643e-05
in O 0 6.546315489686094e-06
some O 0 1.3937076346337562e-06
of O 0 1.650395461183507e-05
the O 0 5.076501838630065e-05
tissues O 0 0.00012779183452948928
of O 0 0.0011006607674062252
DM B-Disease 1 1.0
patients O 0 0.0013898436445742846
, O 0 2.2350552171701565e-05
there O 0 7.745205039100256e-06
is O 0 4.931318926537642e-06
a O 0 9.066975508176256e-06
tendency O 0 2.667845183168538e-05
for O 0 1.5422245269292034e-05
repeat O 0 0.00029962064581923187
length O 0 8.850380982039496e-05
and O 0 3.2045310945250094e-05
somatic O 0 0.00019667261221911758
mosaicism O 0 0.0016004475764930248
to O 0 1.5707753846072592e-05
increase O 0 1.2850468920078129e-05
with O 0 2.4871908408385934e-06
the O 0 2.0440971638890915e-05
age O 0 7.152233592933044e-05
of O 0 9.725404379423708e-05
the O 0 0.00038100816891528666
mouse O 0 0.0005080448463559151
. O 0 0.00015221303328871727

Furthermore O 0 0.0006037945277057588
, O 0 1.7015367120620795e-05
we O 0 4.898139195574913e-06
observed O 0 3.807243047049269e-06
no O 0 3.174314315401716e-06
correlation O 0 5.952629180683289e-06
between O 0 3.269933586125262e-05
the O 0 2.5001396352308802e-05
somatic O 0 7.27789883967489e-05
mutation O 0 1.370347490592394e-05
rate O 0 4.889768024440855e-05
and O 0 4.92178623971995e-05
tissue O 0 0.1041184812784195
proliferation O 1 0.9998069405555725
capacity O 0 0.008556117303669453
. O 0 0.00036305058165453374

The O 0 0.00031433842377737164
somatic O 0 0.000422502780565992
mutation O 0 3.747914161067456e-05
rates O 0 1.8873026419896632e-05
in O 0 7.257225661305711e-06
different O 0 1.25247311189014e-06
tissues O 0 1.7020542145473883e-05
were O 0 1.0471881068951916e-05
also O 0 2.347130475754966e-06
not O 0 9.048299602909537e-07
correlated O 0 3.623727934609633e-06
to O 0 2.9374223231570795e-06
the O 0 1.4377881598193198e-05
relative O 0 0.00012447210610844195
inter O 0 0.009957972913980484
- O 0 0.0015325475251302123
tissue O 0 8.058980165515095e-05
difference O 0 1.646122836973518e-05
in O 0 7.4416352617845405e-06
transcriptional O 0 1.8149194147554226e-05
levels O 0 7.398949492198881e-06
of O 0 3.2356999781768536e-06
the O 0 4.737580184155377e-06
three O 0 4.507127414399292e-06
genes O 0 1.1416168490541168e-05
( O 0 2.3762617274769582e-05
DMAHP O 0 0.3025142252445221
, O 0 4.763574179378338e-05
DMPK O 0 0.010842743329703808
and O 0 1.97734607354505e-05
59 O 0 0.00011911395995412022
) O 0 1.859592339314986e-05
surrounding O 0 0.00014233791443984956
the O 0 7.4312265496701e-05
repeat O 0 0.0003777607053052634
. O 0 6.211064464878291e-05
. O 0 0.00012031452206429094

A O 0 0.0011888149892911315
novel O 0 0.000259515771176666
missense O 0 0.00039390436722896993
mutation O 0 2.4657212634338066e-05
in O 0 3.4234584745718166e-05
patients O 0 4.104621257283725e-05
from O 0 5.6240121921291575e-05
a O 0 0.00019532405713107437
retinoblastoma B-Disease 0 0.2551727294921875
pedigree O 0 0.0006672066519968212
showing O 0 0.00012701032392214984
only O 0 1.4929195458535105e-05
mild O 0 5.5573229474248365e-05
expression O 0 1.8049633581540547e-05
of O 0 9.834254888119176e-05
the O 0 0.0005815185722894967
tumor B-Disease 1 0.9999819993972778
phenotype O 0 0.0005413992330431938
. O 0 0.0002901935367844999

We O 0 0.00010286564793204889
have O 0 7.38532935429248e-06
used O 0 1.2299781701585744e-05
single O 0 2.048347050731536e-05
strand O 0 4.01267025154084e-05
conformation O 0 6.449657576013124e-06
polymorphism O 0 4.615722446033033e-06
analysis O 0 1.4673086070615682e-06
to O 0 3.395320163690485e-06
study O 0 2.9886068659834564e-06
the O 0 7.94989500718657e-06
27 O 0 5.654617416439578e-05
exons O 0 4.08707965107169e-05
of O 0 3.706265124492347e-05
the O 0 0.00011495211947476491
RB1 O 0 0.32466980814933777
gene O 0 1.2675251127802767e-05
in O 0 6.563831448147539e-06
individuals O 0 1.4542969211106538e-06
from O 0 8.365968824364245e-06
a O 0 2.831329038599506e-05
family O 0 2.5647832444519736e-05
showing O 0 0.000140655436553061
mild O 0 0.00014898955123499036
expression O 0 5.111487189424224e-05
of O 0 0.0002030568284681067
the O 0 0.0006863137241452932
retinoblastoma B-Disease 1 0.9938073754310608
phenotype O 0 0.0014908654848113656
. O 0 0.0006745108985342085

In O 0 7.09684900357388e-05
this O 0 5.816667453473201e-06
family O 0 1.1828071365016513e-05
affected O 0 1.2985685316380113e-05
individuals O 0 7.973037099873181e-06
developed O 0 0.0002674504357855767
unilateral B-Disease 0 0.0018483863677829504
tumors I-Disease 1 1.0
and O 0 7.380998431472108e-05
, O 0 6.419760211429093e-06
as O 0 4.7616003939765505e-06
a O 0 3.878950337821152e-06
result O 0 4.380461177788675e-06
of O 0 2.710388980631251e-05
linkage O 0 0.00016239337855949998
analysis O 0 5.87438853472122e-06
, O 0 1.2886156582680997e-05
unaffected O 0 0.00010983958054566756
mutation O 0 1.0370886229793541e-05
carriers O 0 1.4709775314258877e-05
were O 0 8.579918358009309e-06
also O 0 5.251076800050214e-06
identified O 0 1.2056490049872082e-05
within O 0 1.4927514712326229e-05
the O 0 5.7170302170561627e-05
pedigree O 0 0.0007419458124786615
. O 0 0.0002071589115075767

A O 0 0.0013378182193264365
single O 0 6.623443186981604e-05
band O 0 0.00011299923062324524
shift O 0 7.946321420604363e-05
using O 0 2.9054830520180985e-05
SSCP O 0 0.01226484403014183
was O 0 0.00015943367907311767
identified O 0 1.5903462553978898e-05
in O 0 2.092570321110543e-05
exon O 0 0.00018959354201797396
21 O 0 7.324569742195308e-05
which O 0 4.3364602788642514e-06
resulted O 0 3.2266558264382184e-05
in O 0 1.1578177691262681e-05
a O 0 7.398709840344964e-06
missense O 0 6.917314021848142e-05
mutation O 0 8.627424904261716e-06
converting O 0 0.00010770442895591259
a O 0 0.00013447270612232387
cys O 0 0.019302451983094215
- O 0 0.0008927775779739022
- O 0 0.0003805368032772094
> O 0 0.00011618526332313195
arg O 0 0.00015419845294672996
at O 0 7.090652798069641e-05
nucleotide O 0 1.6284695448121056e-05
position O 0 4.433291178429499e-05
28 O 0 0.00010696802200982347
in O 0 3.3080294087994844e-05
the O 0 0.00011410867591621354
exon O 0 0.002057076897472143
. O 0 0.00022300603450275958

The O 0 0.00030664828955195844
mutation O 0 8.95531993592158e-05
destroyed O 0 0.0008236092398874462
an O 0 3.412500154809095e-05
NdeI O 0 0.0024202161002904177
restriction O 0 7.868315879022703e-05
enzyme O 0 5.448484807857312e-05
site O 0 0.000639790843706578
. O 0 0.00019793228420894593

Analysis O 0 2.4607134037069045e-05
of O 0 5.80987507419195e-05
all O 0 1.3908151231589727e-05
family O 0 1.5787709344294854e-05
members O 0 2.535578914830694e-06
demonstrated O 0 2.0400502762640826e-05
that O 0 1.1152568504257943e-06
the O 0 9.21455466595944e-06
missense O 0 0.00016220023098867387
mutation O 0 4.7858309699222445e-05
co O 0 0.0003840358695015311
- O 0 0.0001497789635322988
segregated O 0 7.792436372255906e-05
with O 0 7.669470505788922e-06
patients O 0 0.00017277077131439
with O 0 0.000549656804651022
tumors B-Disease 1 1.0
or O 0 0.000561475579161197
who O 0 4.393250492285006e-05
, O 0 6.999511242611334e-06
as O 0 5.740410415455699e-06
a O 0 3.5033226595260203e-06
result O 0 4.011106284451671e-06
of O 0 1.900334973470308e-05
linkage O 0 0.0001528710563434288
analysis O 0 4.735656148113776e-06
had O 0 4.118944707443006e-05
been O 0 1.566386708873324e-05
predicted O 0 2.0445024347282015e-05
to O 0 5.595548827841412e-06
carry O 0 1.0478744115971494e-05
the O 0 4.8876143409870565e-05
predisposing O 0 0.0018771555041894317
mutation O 0 0.0003432718222029507
. O 0 0.00038698772550560534

These O 0 1.9207518562325276e-05
observations O 0 2.1399431716417894e-05
point O 0 4.907505717710592e-05
to O 0 7.767077477183193e-06
another O 0 8.305980372824706e-06
region O 0 5.7596262195147574e-05
of O 0 4.550288576865569e-05
the O 0 0.00013961851072963327
RB1 O 1 0.9789636135101318
gene O 0 3.558681419235654e-05
where O 0 1.2309133126109373e-05
mutations O 0 3.205618440915714e-06
only O 0 8.732757805773872e-07
modify O 0 2.4609587399027077e-06
the O 0 3.7304937450244324e-06
function O 0 3.399499519218807e-06
of O 0 1.2883527233498171e-05
the O 0 3.515214484650642e-05
gene O 0 1.5046040971355978e-05
and O 0 3.9460896914533805e-06
raise O 0 8.740325029066298e-06
important O 0 5.584018254012335e-06
questions O 0 2.499326910765376e-06
for O 0 1.5978173451003386e-06
genetic O 0 1.4001841918798164e-05
counseling O 0 2.946725726360455e-05
in O 0 1.369106576021295e-05
families O 0 5.171767952560913e-06
with O 0 2.639779950186494e-06
these O 0 5.953196705377195e-06
distinctive O 0 0.00013698605471290648
phenotypes O 0 0.00046755257062613964
. O 0 0.0001138621591962874
. O 0 0.00015868387708906084

Maternal B-Disease 0 0.04308246448636055
disomy I-Disease 1 0.9979907274246216
and O 0 0.002967729000374675
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.0021667268592864275
with O 0 9.098997543333098e-05
gamete O 0 0.0014374478487297893
complementation O 0 0.001891478430479765
in O 0 4.51682171842549e-05
a O 0 1.254246490134392e-05
case O 0 9.142986527876928e-06
of O 0 3.2674714020686224e-05
familial O 0 0.0006338955136016011
translocation O 0 0.001605519442819059
( O 0 9.731119644129649e-05
3 O 0 8.758046169532463e-05
; O 0 4.4659800551016815e-06
15 O 0 4.009052281617187e-05
) O 0 9.540486644254997e-06
( O 0 1.2890041034552269e-05
p25 O 0 0.0002958087425213307
; O 0 8.755308954278007e-06
q11 O 0 0.00040971976704895496
. O 0 1.3815206330036744e-05
2 O 0 0.0001578457304276526
) O 0 4.5554337702924386e-05
. O 0 9.376708476338536e-05

Maternal B-Disease 1 0.9073206782341003
uniparental I-Disease 1 0.9999699592590332
disomy I-Disease 1 0.9998362064361572
( I-Disease 0 0.0025569763965904713
UPD I-Disease 1 0.9999916553497314
) I-Disease 0 2.5291590645792894e-05
for I-Disease 0 1.2364876965875737e-05
chromosome I-Disease 0 9.284547559218481e-05
15 I-Disease 0 2.702802885323763e-05
is O 0 2.4361831947317114e-06
responsible O 0 3.1753256735100877e-06
for O 0 1.3362139270611806e-06
an O 0 2.187186737501179e-06
estimated O 0 1.2240840078447945e-05
30 O 0 5.107188371766824e-06
% O 0 6.361080977512756e-07
of O 0 4.201350748189725e-06
cases O 0 9.015782779897563e-06
of O 0 0.0004867379320785403
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999879598617554
PWS B-Disease 1 1.0
) O 0 0.0009624664671719074
. O 0 0.00031111223506741226

We O 0 0.00013446193770505488
report O 0 1.3617443073599134e-05
on O 0 1.6198655430343933e-05
an O 0 3.235832537029637e-06
unusual O 0 7.401729817502201e-06
case O 0 1.7427806596970186e-05
of O 0 5.5972603149712086e-05
maternal B-Disease 0 0.001154923578724265
disomy I-Disease 0 0.057036977261304855
15 I-Disease 0 0.0003756492806132883
in O 0 0.00021796132205054164
PWS B-Disease 1 0.9999997615814209
that O 0 8.037639418034814e-06
is O 0 4.208400696370518e-06
most O 0 2.719988060562173e-06
consistent O 0 9.220514584740158e-06
with O 0 5.1841134336427785e-06
adjacent O 0 0.0002755924069788307
- O 0 0.00017483132251072675
1 O 0 8.373946184292436e-05
segregation O 0 0.00017834219033829868
of O 0 2.3056894860928878e-05
a O 0 4.540661393548362e-05
paternal O 0 0.00028168389690108597
t O 0 0.00018675228056963533
( O 0 2.0387200493132696e-05
3 O 0 3.647718040156178e-05
; O 0 3.085086746068555e-06
15 O 0 3.0193201382644475e-05
) O 0 9.210020834871102e-06
( O 0 1.2923200301884208e-05
p25 O 0 0.00030325542320497334
; O 0 8.841868293529842e-06
q11 O 0 0.000167855090694502
. O 0 2.9010529942752328e-06
2 O 0 1.0609008313622326e-05
) O 0 1.3296659062689287e-06
with O 0 6.306909767772595e-07
simultaneous O 0 1.4292357263911981e-05
maternal O 0 0.0005870367167517543
meiotic O 0 0.008162369020283222
nondisjunction O 0 0.02732943557202816
for O 0 0.00012273764878045768
chromosome O 0 0.0014445397537201643
15 O 0 0.0007020627381280065
. O 0 0.00033793607144616544

The O 0 0.00036373810144141316
patient O 0 0.00024327344726771116
( O 0 9.725701966090128e-05
J O 0 0.0016793275717645884
. O 0 1.4345532690640539e-05
B O 0 0.00015390747284982353
. O 0 3.730016942427028e-06
) O 0 1.7039815247699153e-06
, O 0 1.3426390523818554e-06
a O 0 6.854532784927869e-06
17 O 0 8.128846093313769e-05
- O 0 0.000116774819616694
year O 0 4.9263035180047154e-05
- O 0 0.00018126108625438064
old O 0 0.00023276981664821506
white O 0 8.457029616693035e-05
male O 0 5.8995217841584235e-05
with O 0 7.786479545757174e-05
PWS B-Disease 1 1.0
, O 0 9.95726659311913e-05
was O 0 0.00019323454762343317
found O 0 5.2031468840141315e-06
to O 0 5.02805733049172e-06
have O 0 2.890393261623103e-06
47 O 0 1.9929075278923847e-05
chromosomes O 0 1.059898659150349e-05
with O 0 3.0315823096316308e-06
a O 0 3.444393951212987e-05
supernumerary O 0 0.0028398954309523106
, O 0 6.028403004165739e-05
paternal O 0 0.0006268264842219651
der O 1 0.9125813841819763
( O 0 4.398696182761341e-05
15 O 0 2.8543081498355605e-05
) O 0 2.5027138690347783e-06
consisting O 0 5.794510343548609e-06
of O 0 2.446845974191092e-05
the O 0 6.557641609106213e-05
short O 0 0.0001868694816948846
arm O 0 0.00022088522382546216
and O 0 1.4416435988096055e-05
the O 0 0.00010139914957107976
proximal O 1 0.9894800186157227
long O 0 0.0011235959827899933
arm O 0 0.0002936521195806563
of O 0 0.000165215038578026
chromosome O 0 0.0005963438889011741
15 O 0 0.0002201048337155953
, O 0 3.6351299058878794e-05
and O 0 8.168086787918583e-05
distal O 1 0.9999711513519287
chromosome O 1 0.9999277591705322
arm O 1 0.9996814727783203
3p O 1 0.9998576641082764
. O 0 0.0019325055181980133

The O 0 0.0005619466537609696
t O 0 0.0003399947308935225
( O 0 2.2194055418367498e-05
3 O 0 5.03948685945943e-05
; O 0 3.11838493871619e-06
15 O 0 2.6201507353107445e-05
) O 0 5.685112228093203e-06
was O 0 3.419764470891096e-05
present O 0 7.232863026729319e-06
in O 0 5.950551894784439e-06
the O 0 6.971651600906625e-06
balanced O 0 5.726860763388686e-06
state O 0 2.175622057620785e-06
in O 0 6.251379090826958e-06
the O 0 2.079252590192482e-05
patients O 0 5.215031706029549e-05
father O 0 0.00019598672224674374
and O 0 3.0410448744078167e-05
a O 0 0.00015862908912822604
sister O 0 0.0007147213909775019
. O 0 0.00020222061721142381

Fluorescent O 0 0.001403598696924746
in O 0 0.00012595189036801457
situ O 0 0.0005327226244844496
hybridization O 0 1.1874419215018861e-05
analysis O 0 4.337800419307314e-06
demonstrated O 0 3.306156213511713e-05
that O 0 7.094266948115546e-06
the O 0 0.00010275672684656456
PWS B-Disease 1 0.9999998807907104
critical O 0 0.00033839192474260926
region O 0 0.00032224535243585706
resided O 0 0.00036262895446270704
on O 0 3.485522393020801e-05
the O 0 1.544094629934989e-05
derivative O 0 0.00011285988875897601
chromosome O 0 0.00012360654363874346
3 O 0 4.289267599233426e-05
and O 0 3.862837729684543e-06
that O 0 1.2602321248778026e-06
there O 0 3.979801931563998e-06
was O 0 5.096714448882267e-05
no O 0 5.32756666871137e-06
deletion O 0 4.379956590128131e-05
of O 0 0.00010018983448389918
the O 0 0.0006883285823278129
PWS B-Disease 1 1.0
region O 0 0.0007124323165044188
on O 0 7.20428506610915e-05
the O 0 2.4348048100364394e-05
normal O 0 2.927846071543172e-05
pair O 0 1.3652967027155682e-05
of O 0 5.301700366544537e-05
15s O 0 0.0008675279095768929
present O 0 0.0001296167611144483
in O 0 0.00041790655814111233
J O 1 0.9963944554328918
. O 0 0.0005294898874126375

B O 0 0.11215140670537949
. O 0 0.001456348574720323

Methylation O 0 0.0001984122209250927
analysis O 0 1.629488542675972e-05
at O 0 0.00018411957717034966
exon O 0 0.0002164453617297113
alpha O 0 3.6660647310782224e-05
of O 0 1.367650202155346e-05
the O 0 1.6577776477788575e-05
small O 0 2.55885115620913e-05
nuclear O 0 0.0009019140852615237
ribonucleoprotein O 0 0.0026396634057164192
- O 0 9.330682951258495e-05
associated O 0 7.752639248792548e-06
polypeptide O 0 9.430448699276894e-05
N O 0 0.0003115411673206836
( O 0 5.543074803426862e-05
SNRPN O 0 0.17413906753063202
) O 0 1.194137439597398e-05
gene O 0 9.446105650567915e-06
showed O 0 2.3567175958305597e-05
a O 0 1.1937220733670983e-05
pattern O 0 3.171236312482506e-05
characteristic O 0 1.3566099369199947e-05
of O 0 2.7480704375193454e-05
only O 0 1.1149973033752758e-05
the O 0 3.9551741792820394e-05
maternal O 0 0.000321121042361483
chromosome O 0 0.0002943351573776454
15 O 0 0.00019109666754957289
in O 0 0.00017936149379238486
J O 0 0.3980075716972351
. O 0 0.0003728322044480592

B O 0 0.10787684470415115
. O 0 0.001520260120742023

Maternal B-Disease 0 0.011754825711250305
disomy I-Disease 0 0.013926342129707336
was O 0 0.0003456342383287847
confirmed O 0 2.362194391025696e-05
by O 0 3.403129312573583e-06
polymerase O 0 9.197599138133228e-05
chain O 0 3.531073161866516e-05
reaction O 0 3.054549097214476e-06
analysis O 0 1.5001404563008691e-06
of O 0 2.2173406250658445e-05
microsatellite O 0 0.0003761471598409116
repeats O 0 0.0001357054425170645
at O 0 0.00013408550876192749
the O 0 4.3229487346252427e-05
gamma O 0 0.00019389527733437717
- O 0 0.00021965807536616921
aminobutyric O 0 0.0004754487599711865
acid O 0 1.5878626072662883e-05
receptor O 0 2.4553966795792803e-05
beta3 O 0 0.0004563794063869864
subunit O 0 2.2874390197102912e-05
( O 0 3.629511411418207e-05
GABRB3 O 0 0.005935189314186573
) O 0 2.593451426946558e-05
locus O 0 0.00017172128718812019
. O 0 0.00012046650954289362

A O 0 0.0033915056847035885
niece O 0 0.001790734357200563
( O 0 6.691749149467796e-05
B O 0 0.00031428661895915866
. O 0 9.197434337693267e-06
B O 0 0.00011362267832737416
. O 0 3.0209387205104576e-06
) O 0 1.087300347535347e-06
with O 0 9.606105777493212e-07
45 O 0 1.299558425671421e-05
chromosomes O 0 9.091079846257344e-06
and O 0 2.4146904706867645e-06
the O 0 8.802426236798055e-06
derivative O 0 2.53470989264315e-05
3 O 0 3.9283273508772254e-05
but O 0 2.014625579249696e-06
without O 0 2.9058128347969614e-06
the O 0 3.829705747193657e-05
der O 0 0.05601085349917412
( O 0 3.9798731449991465e-05
15 O 0 6.730730819981545e-05
) O 0 1.0958681741612963e-05
demonstrated O 0 5.968695040792227e-05
a O 0 2.6062896722578444e-05
phenotype O 0 3.6815432395087555e-05
consistent O 0 1.1095473382738419e-05
with O 0 1.3185926945880055e-06
that O 0 1.619716613276978e-06
reported O 0 6.301790108409477e-06
for O 0 5.342209078662563e-06
haploinsufficiency O 0 0.0006939364247955382
of O 0 0.00023153579968493432
distal O 0 0.11448445916175842
3 O 0 0.004050613846629858
p O 0 0.0028912147972732782
. O 0 0.00037901944597251713

Uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999955892562866
associated O 0 0.0005574444658122957
with O 0 7.652492058696225e-05
unbalanced O 0 0.0012170416302978992
segregation O 0 0.002164689591154456
of O 0 0.0004910899442620575
non O 0 0.008978527039289474
- O 0 0.004220230504870415
Robertsonian O 0 0.00752823194488883
translocations O 0 0.00012796009832527488
has O 0 9.360822332382668e-06
been O 0 6.98565327184042e-06
reported O 0 7.83110772317741e-06
previously O 0 1.1977885151281953e-05
but O 0 1.5126360040085274e-06
has O 0 2.293542593179154e-06
not O 0 9.193639129989606e-07
, O 0 1.745035774547432e-06
to O 0 3.824594386969693e-06
our O 0 1.1848437679873314e-05
knowledge O 0 4.638655445887707e-05
, O 0 1.002655608317582e-05
been O 0 1.103690101444954e-05
observed O 0 6.40574899080093e-06
in O 0 4.121622168895556e-06
a O 0 1.2484407307056244e-05
case O 0 4.704820821643807e-05
of O 0 0.0005988896009512246
PWS B-Disease 1 1.0
. O 0 0.0015460985014215112

Furthermore O 0 0.0013429768150672317
, O 0 3.518477751640603e-05
our O 0 1.1016438293154351e-05
findings O 0 4.155137048655888e-06
are O 0 6.770204663553159e-07
best O 0 3.298643605376128e-06
interpreted O 0 7.559104233223479e-06
as O 0 8.785393220023252e-06
true O 0 3.843223748845048e-05
gamete O 0 0.0004161287797614932
complementation O 0 0.0008531582425348461
resulting O 0 0.00015777559019625187
in O 0 0.0003595300659071654
maternal B-Disease 1 0.97386234998703
UPD I-Disease 1 1.0
15 I-Disease 0 0.014319561421871185
and O 0 0.002004416659474373
PWS B-Disease 1 1.0

Schwartz B-Disease 0 0.1065085381269455
- I-Disease 1 0.9546716213226318
Jampel I-Disease 1 0.9999957084655762
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 0.0005378943169489503
2 I-Disease 0 0.0010452429996803403
and O 0 0.00012725230772048235
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999532699584961
Wiedemann I-Disease 1 0.9999958276748657
syndrome I-Disease 1 0.9999998807907104
: O 0 3.115294748567976e-05
a O 0 2.1880334315937944e-05
case O 0 1.7796295651351102e-05
for O 0 8.752135727263521e-06
" O 0 0.00011629243817878887
lumping O 0 0.000623089203145355
" O 0 0.00045787403360009193
. O 0 0.00011274543794570491

Recent O 0 0.00013146256969776005
studies O 0 2.1920352082815953e-05
demonstrated O 0 4.196576992399059e-05
the O 0 8.856433851178735e-06
existence O 0 3.101554830209352e-05
of O 0 2.0364115698612295e-05
a O 0 3.354556974954903e-05
genetically O 0 1.8720709704211913e-05
distinct O 0 5.8890054788207635e-06
, O 0 4.227732915751403e-06
usually O 0 2.817689164658077e-06
lethal O 0 4.899708983430173e-06
form O 0 1.16345654532779e-06
of O 0 8.724245162738953e-06
the O 0 4.312296732678078e-05
Schwartz B-Disease 0 0.0014386915136128664
- I-Disease 0 0.49046099185943604
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 0.0010729695204645395
SJS B-Disease 1 0.9999992847442627
) O 0 3.619035123847425e-05
of O 0 0.00026537850499153137
myotonia B-Disease 1 1.0
and O 0 0.004939215257763863
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.00023922933905851096
which O 0 3.745798676391132e-05
we O 0 3.393249789951369e-05
called O 0 0.00015500483277719468
SJS B-Disease 1 0.9979680180549622
type I-Disease 0 0.0003368085890542716
2 I-Disease 0 0.0010757523123174906
. O 0 0.00021187665697652847

This O 0 0.00040926068322733045
disorder O 1 0.9999896287918091
is O 0 0.00020419809152372181
reminiscent O 0 0.0007356874411925673
of O 0 0.00011868198635056615
another O 0 6.040314838173799e-05
rare O 0 5.439440792542882e-05
condition O 0 0.00011465489660622552
, O 0 8.682412044436205e-06
the O 0 4.1695271647768095e-05
Stuve B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999954700469971
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.004484159871935844
SWS B-Disease 1 0.9984104633331299
) O 0 1.8489981812308542e-05
, O 0 3.1432384730578633e-06
which O 0 2.0085460619156947e-06
comprises O 0 2.1759002265753224e-05
campomelia B-Disease 0 0.0007757465937174857
at O 0 0.00015454686945304275
birth O 0 0.00021704986284021288
with O 0 0.00014571841165889055
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9978489875793457
contractures B-Disease 1 0.9999998807907104
, O 0 0.00011087243183283135
and O 0 2.9907943826401606e-05
early B-Disease 0 0.00039935397217050195
death I-Disease 0 0.0017133697401732206
. O 0 0.0002953995135612786

To O 0 4.9872898671310395e-05
test O 0 8.56302085594507e-06
for O 0 6.267974185902858e-06
possible O 0 3.490385279292241e-05
nosologic O 0 0.0012178642209619284
identity O 0 5.461775799631141e-05
between O 0 0.0002258177410112694
these O 0 4.643364081857726e-05
disorders O 1 0.9999996423721313
, O 0 8.106652239803225e-05
we O 0 1.623331081646029e-05
reviewed O 0 1.6631676771794446e-05
the O 0 6.66418327455176e-06
literature O 0 7.509003353334265e-06
and O 0 1.9054731410506065e-06
obtained O 0 6.26406608716934e-06
a O 0 1.2041300578857772e-05
follow O 0 9.129777026828378e-06
- O 0 3.076127904932946e-05
up O 0 7.361646112258313e-06
of O 0 7.560826816188637e-06
the O 0 7.235588327603182e-06
only O 0 3.998510237579467e-06
two O 0 4.85328700960963e-06
surviving O 0 0.00024694710737094283
patients O 0 3.317063965369016e-05
, O 0 6.172888333821902e-06
one O 0 9.198873158311471e-06
with O 0 1.7666465282673016e-05
SJS B-Disease 1 0.9943124055862427
type I-Disease 0 0.00010425307118566707
2 I-Disease 0 0.00013688970648217946
at O 0 0.00011851575982291251
age O 0 4.1029230487765744e-05
10 O 0 1.1282049854344223e-05
years O 0 1.3885860425943974e-05
and O 0 1.849290697464312e-06
another O 0 8.086445632216055e-06
with O 0 1.0702508916438092e-05
SWS B-Disease 0 0.16406933963298798
at O 0 0.0005390289006754756
age O 0 0.00026432782760821283
7 O 0 0.0004783407784998417
years O 0 0.000561599968932569
. O 0 0.0002920119441114366

Patients O 0 0.0005305325612425804
reported O 0 8.685157808940858e-05
as O 0 2.767310434137471e-05
having O 0 6.85851409798488e-05
either O 0 0.0002322782966075465
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.0008563439478166401
SWS B-Disease 0 0.15421366691589355
presented O 0 4.533487663138658e-05
a O 0 8.56981841934612e-06
combination O 0 4.023036581202177e-06
of O 0 1.7036343706422485e-05
a O 0 4.911996074952185e-05
severe O 0 0.4744369089603424
, O 0 5.6012970162555575e-05
prenatal O 1 0.9893217086791992
- O 1 0.9999828338623047
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999760389328003
with O 1 0.9999963045120239
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9418378472328186
feeding O 0 0.3379315137863159
difficulties O 1 0.9890328645706177
, O 0 3.905299672624096e-05
tendency O 0 0.00010003595525631681
to O 0 8.108392648864537e-05
hyperthermia B-Disease 1 0.9981098175048828
, O 0 2.4963232135633007e-05
and O 0 1.000025531538995e-05
frequent O 0 2.9814826120855287e-05
death O 0 0.0002577661944087595
in O 0 6.684293475700542e-05
infancy O 0 0.0005337162292562425
) O 0 4.045304194733035e-06
with O 0 9.267131986234745e-07
a O 0 1.4899412235536147e-05
distinct O 0 4.8070636694319546e-05
campomelic B-Disease 1 0.9999676942825317
- I-Disease 1 0.9999836683273315
metaphyseal I-Disease 1 0.9999998807907104
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.013671332970261574

The O 0 9.465269977226853e-05
similarity O 0 5.943906944594346e-05
of O 0 6.981635669944808e-05
the O 0 7.421962800435722e-05
clinical O 0 0.00011718834866769612
and O 0 1.7350892449030653e-05
radiographic O 0 0.0003548811364453286
findings O 0 3.2946682040346786e-05
is O 0 7.49914124753559e-06
so O 0 4.033516233903356e-06
extensive O 0 2.6935782443615608e-05
that O 0 5.74815703657805e-06
these O 0 1.6080279237939976e-05
disorders O 1 0.9999939203262329
appear O 0 0.0002860623353626579
to O 0 4.027944669360295e-05
be O 0 1.7628595742280595e-05
a O 0 2.628344554977957e-05
single O 0 2.3941676772665232e-05
entity O 0 0.00013641927216667682
. O 0 0.00022673164494335651

The O 0 0.00021909228235017508
follow O 0 5.439036249299534e-05
- O 0 0.0001203426145366393
up O 0 1.1556798199308105e-05
observation O 0 2.154074900317937e-05
of O 0 1.5639358025509864e-05
an O 0 7.993959115992766e-06
identical O 0 1.1594841453188565e-05
and O 0 4.309259566070978e-06
unique O 0 1.620738476049155e-05
pattern O 0 0.00011831159645225853
of O 0 0.0011756971944123507
progressive O 1 0.9999997615814209
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999998807907104
in O 0 0.0002926568267866969
the O 0 8.767188410274684e-05
two O 0 1.555946801090613e-05
patients O 0 2.0799685444217175e-05
( O 0 7.0499231696885545e-06
one O 0 5.468113158713095e-06
with O 0 2.0958916138624772e-05
SJS B-Disease 1 0.9995962977409363
type I-Disease 0 0.0001075594118447043
2 I-Disease 0 0.00014610213111154735
, O 0 6.462871169787832e-06
one O 0 5.5119567150541116e-06
with O 0 1.4517038835037965e-05
SWS B-Disease 1 0.8851038217544556
) O 0 6.216800102265552e-05
surviving O 0 0.000577190425246954
beyond O 0 0.00036825210554525256
infancy O 0 0.00032976202783174813
adds O 0 4.980684934707824e-06
to O 0 3.1393681183544686e-06
the O 0 6.214086624822812e-06
evidence O 0 1.1449686098785605e-05
in O 0 8.316823368659243e-06
favor O 0 6.412539732991718e-06
of O 0 3.8927504647290334e-05
identity O 0 0.00021766830468550324
. O 0 0.0003216195327695459

The O 0 0.00027387149748392403
hypothesis O 0 0.0001793182163964957
that O 0 5.027716906624846e-05
SWS B-Disease 0 0.06383437663316727
and O 0 0.00012159231846453622
SJS B-Disease 1 0.9990099668502808
type I-Disease 0 0.00013779685832560062
2 I-Disease 0 7.760933658573776e-05
are O 0 1.5280745628842851e-06
the O 0 8.647844879305921e-06
same O 0 1.772833456925582e-05
disorder O 1 0.9994937181472778
should O 0 2.3642385713174008e-05
be O 0 4.714058832178125e-06
testable O 0 2.481817500665784e-05
by O 0 2.1472201297001448e-06
molecular O 0 1.623167008801829e-05
methods O 0 1.3329376088222489e-05
. O 0 4.2471729102544487e-05
. O 0 9.475537081016228e-05

A O 0 0.0010383421322330832
mouse O 0 0.00011316056043142453
model O 0 6.354221113724634e-06
of O 0 5.0250371714355424e-05
severe O 1 0.999998927116394
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.7200778722763062
defects O 1 0.9999991655349731
in O 0 0.006957977544516325
hemostasis O 1 0.9999997615814209
and O 0 0.2935217022895813
thrombosis B-Disease 1 1.0
. O 0 0.0068458812311291695

von B-Disease 1 0.9747765064239502
Willebrand I-Disease 1 0.9999986886978149
factor I-Disease 0 0.0021142952609807253
( I-Disease 0 0.0008739111945033073
vWf I-Disease 1 0.9994631409645081
) I-Disease 0 0.16085506975650787
deficiency I-Disease 1 1.0
causes O 1 0.9999699592590332
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.5229251980781555
humans O 0 0.0012253200402483344
. O 0 0.00021742208627983928

We O 0 0.0001261307334061712
generated O 0 4.1684215830173343e-05
a O 0 1.8692220692173578e-05
mouse O 0 1.2964193047082517e-05
model O 0 1.2023832596241846e-06
for O 0 1.404223553436168e-06
this O 0 5.1678239287866745e-06
disease O 0 0.00028248754097148776
by O 0 2.6616512514010537e-06
using O 0 5.573850557993865e-06
gene O 0 2.655250864336267e-05
targeting O 0 4.598732266458683e-05
. O 0 0.00013206717267166823

vWf B-Disease 1 0.9895882606506348
- I-Disease 1 0.9430288076400757
deficient I-Disease 1 0.8023114800453186
mice O 0 0.00016227280138991773
appeared O 0 5.591327862930484e-05
normal O 0 1.9158895156579092e-05
at O 0 6.0795187891926616e-05
birth O 0 2.9496894057956524e-05
; O 0 1.359295083602774e-06
they O 0 1.1943023991989321e-06
were O 0 1.4889496924297418e-05
viable O 0 0.0001427143724868074
and O 0 4.117896605748683e-05
fertile O 0 0.0027968494687229395
. O 0 0.00033717212500050664

Neither O 0 0.0027021346613764763
vWf O 0 0.012468175031244755
nor O 0 0.0008197071147151291
vWf O 0 0.007841585204005241
propolypeptide O 0 0.007508768234401941
( O 0 0.00019329204224050045
von B-Disease 0 0.020857829600572586
Willebrand I-Disease 1 0.9999548196792603
antigen O 0 0.002993076341226697
II O 1 1.0
) O 0 7.765243208268657e-05
were O 0 4.4807802623836324e-05
detectable O 0 0.0002339566417504102
in O 0 2.159019095415715e-05
plasma O 0 0.0001427983515895903
, O 0 1.3467013559420593e-05
platelets O 0 0.00019156697089783847
, O 0 1.5774347048136406e-05
or O 0 2.3893093384685926e-05
endothelial O 0 0.0003882907622028142
cells O 0 1.8245507817482576e-05
of O 0 3.083361661992967e-05
the O 0 3.90315217373427e-05
homozygous O 0 0.00012242206139490008
mutant O 0 0.0005587738123722374
mice O 0 0.0006595539744012058
. O 0 0.00012380188854876906

The O 0 0.0005303654470480978
mutant O 0 0.003999656531959772
mice O 0 0.002915476681664586
exhibited O 0 0.008324773982167244
defects O 1 0.9967668056488037
in O 0 0.00015585002256557345
hemostasis O 0 0.009097859263420105
with O 0 2.715905247896444e-05
a O 0 0.00012484178296290338
highly O 0 0.001982353860512376
prolonged O 1 0.9999756813049316
bleeding O 1 0.9999986886978149
time O 0 0.00037039577728137374
and O 0 0.00012463482562452555
spontaneous O 0 0.000950913003180176
bleeding O 1 0.9986721277236938
events O 0 9.711715392768383e-05
in O 0 2.43433823925443e-05
approximately O 0 2.8224278139532544e-05
10 O 0 2.514251355023589e-05
% O 0 1.4540703887178097e-05
of O 0 0.0002127175102941692
neonates O 0 0.004988996312022209
. O 0 0.0006303025875240564

As O 0 8.635410631541163e-05
in O 0 2.8161684895167127e-05
the O 0 5.1143637392669916e-05
human O 0 0.00011025628919014707
disease O 1 0.8584291934967041
, O 0 9.064970072358847e-06
the O 0 1.3025102816754952e-05
factor O 0 6.604389636777341e-05
VIII O 1 0.6426053643226624
level O 0 0.00019827019423246384
in O 0 1.8296666894457303e-05
these O 0 8.01478381617926e-06
mice O 0 4.189064202364534e-05
was O 0 4.068720227223821e-05
reduced O 0 8.390578841499519e-06
strongly O 0 3.51590097125154e-06
as O 0 4.685955445893342e-06
a O 0 3.3272553991992027e-06
result O 0 3.003143774549244e-06
of O 0 9.769460120878648e-06
the O 0 1.8526096027926542e-05
lack O 0 4.6053421101532876e-05
of O 0 7.016034214757383e-05
protection O 0 0.00017074002244044095
provided O 0 0.00010482798097655177
by O 0 9.310046880273148e-05
vWf O 0 0.005947481840848923
. O 0 0.0003113700950052589

Defective O 1 0.9999685287475586
thrombosis B-Disease 1 0.9999974966049194
in O 0 0.00130639283452183
mutant O 0 0.0021773744374513626
mice O 0 0.0002880992251448333
was O 0 8.513857028447092e-05
also O 0 4.611041276803007e-06
evident O 0 2.4262957595055923e-05
in O 0 2.6459924811206292e-06
an O 0 1.1436603699621628e-06
in O 0 5.9706580941565335e-06
vivo O 0 7.930552237667143e-05
model O 0 1.6954947568592615e-05
of O 0 0.0008215479319915175
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.006562094669789076

In O 0 9.322804544353858e-05
this O 0 9.749077435117215e-06
model O 0 1.0139462574443314e-05
, O 0 5.43711075806641e-06
the O 0 4.2833817133214325e-05
exteriorized O 0 0.004431942943483591
mesentery O 0 0.004487281199544668
was O 0 0.0007809045491740108
superfused O 0 0.0025667494628578424
with O 0 9.069222869584337e-05
ferric O 1 0.998837411403656
chloride O 0 0.0016101227374747396
and O 0 5.85315065109171e-05
the O 0 7.841231126803905e-05
accumulation O 0 0.0008893013000488281
of O 0 0.0003481761086732149
fluorescently O 0 0.007625711150467396
labeled O 0 0.0005048912717029452
platelets O 0 0.0003092421393375844
was O 0 0.0002077487442875281
observed O 0 3.1210034649120644e-05
by O 0 9.649880666984245e-06
intravital O 0 0.0018064703326672316
microscopy O 0 0.0003012389352079481
. O 0 0.0001919514761539176

We O 0 4.782746691489592e-05
conclude O 0 7.737125270068645e-05
that O 0 2.25039798351645e-06
these O 0 5.461088221636601e-06
mice O 0 5.0215407100040466e-05
very O 0 1.2136250006733462e-05
closely O 0 4.3069998355349526e-05
mimic O 0 0.0007865285151638091
severe O 1 0.984334409236908
human O 0 0.008532983250916004
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 8.333337609656155e-05
will O 0 1.3412668522505555e-05
be O 0 2.4419193778157933e-06
very O 0 1.0659883855623775e-06
useful O 0 2.1223943349468755e-06
for O 0 1.327348627455649e-06
investigating O 0 8.81956748344237e-06
the O 0 1.0277352885168511e-05
role O 0 4.828450255445205e-05
of O 0 9.653575398260728e-05
vWf O 0 0.0016108687268570065
in O 0 5.306100501911715e-05
normal O 0 0.00010696627577999607
physiology O 0 0.0001789260859368369
and O 0 2.3417611373588443e-05
in O 0 0.0001474217715440318
disease O 1 0.9996858835220337
models O 0 3.869536885758862e-05
. O 0 4.5589538785861805e-05
. O 0 9.565841901348904e-05

Oral O 0 0.48412010073661804
contraceptives O 0 0.003108213422819972
and O 0 1.3744087482336909e-05
the O 0 2.2275753508438356e-05
risk O 0 7.765243208268657e-05
of O 0 0.004804900381714106
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9993457198143005

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9998120665550232
Study O 0 0.0006779677933081985
Group O 0 0.0001724636385915801
. O 0 0.0001775962155079469

BACKGROUND O 0 0.0023127736058086157
Women O 0 7.031895074760541e-05
with O 0 1.1992857253062539e-05
mutations O 0 2.3078453523339704e-05
in O 0 2.1180016119615175e-05
either O 0 1.7577398466528393e-05
the O 0 5.0348804506938905e-05
BRCA1 O 0 0.00014851581363473088
or O 0 5.906002115807496e-06
the O 0 2.3408034394378774e-05
BRCA2 O 0 0.00013321483856998384
gene O 0 5.871856501471484e-06
have O 0 1.318170234299032e-06
a O 0 5.9513013184187e-06
high O 0 6.936470163054764e-05
lifetime O 0 9.989678073907271e-05
risk O 0 0.00032459545764140785
of O 1 0.9791962504386902
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.12232881784439087

Oral O 1 0.9991022348403931
contraceptives O 1 0.999800980091095
protect O 0 0.41417646408081055
against O 1 0.9999943971633911
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0002784952230285853
general O 0 7.649193867109716e-05
, O 0 6.952025614737067e-06
but O 0 8.612616397840611e-07
it O 0 4.819902414965327e-07
is O 0 5.57041630599997e-07
not O 0 4.956501129527169e-07
known O 0 5.562937531067291e-06
whether O 0 2.5027088668139186e-06
they O 0 1.2636620567718637e-06
also O 0 2.5201500193361426e-06
protect O 0 1.584409073984716e-05
against O 0 3.056967761949636e-05
hereditary B-Disease 1 0.9946969747543335
forms I-Disease 0 0.002914904383942485
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9668329358100891

METHODS O 0 0.0002782314259093255
We O 0 2.984873572131619e-05
enrolled O 0 7.110282604116946e-05
207 O 0 8.783698285697028e-05
women O 0 1.2180717021692544e-05
with O 0 3.1312079954659566e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0015152394771575928
161 O 0 0.00019916526798624545
of O 0 0.00010857112647499889
their O 0 3.9478636608691886e-05
sisters O 0 0.00018708090647123754
as O 0 2.0806666725547984e-05
controls O 0 2.3298838641494513e-05
in O 0 1.1326345884299371e-05
a O 0 2.8175656552775763e-05
case O 0 6.507209036499262e-05
- O 0 0.0002877380175050348
control O 0 0.00012057015555910766
study O 0 5.004011109122075e-05
. O 0 9.884752216748893e-05

All O 0 7.114507025107741e-05
the O 0 7.265521708177403e-05
patients O 0 3.244487743359059e-05
carried O 0 2.717900315474253e-05
a O 0 1.5545649148407392e-05
pathogenic O 0 2.3380616767099127e-05
mutation O 0 3.865181497531012e-06
in O 0 6.549275440193014e-06
either O 0 1.7830407159635797e-05
BRCA1 O 0 0.0001325223274761811
( O 0 1.7211867088917643e-05
179 O 0 4.2190164094790816e-05
women O 0 1.8100588931702077e-05
) O 0 1.000555948849069e-05
or O 0 2.3134951334213838e-05
BRCA2 O 0 0.0006993524730205536
( O 0 9.437689004698768e-05
28 O 0 0.0005635800189338624
women O 0 7.127191929612309e-05
) O 0 6.014329119352624e-05
. O 0 8.962496212916449e-05

The O 0 0.0002581397711765021
control O 0 0.0001636780652916059
women O 0 1.306373997067567e-05
were O 0 1.096058349503437e-05
enrolled O 0 4.3302890844643116e-05
regardless O 0 9.186424904328305e-06
of O 0 2.0751300326082855e-05
whether O 0 1.3284783562994562e-05
or O 0 7.875656592659652e-06
not O 0 3.5071234378847294e-06
they O 0 5.952391347818775e-06
had O 0 5.619841977022588e-05
either O 0 4.082766827195883e-05
mutation O 0 7.043411460472271e-05
. O 0 0.00022375787375494838

Lifetime O 0 0.0010059610940515995
histories O 0 0.00043909053783863783
of O 0 0.0008705345098860562
oral O 1 0.8877613544464111
- O 0 0.008428709581494331
contraceptive O 0 0.00015975814312696457
use O 0 2.3352035896095913e-06
were O 0 4.67595145892119e-06
obtained O 0 6.087123438192066e-06
by O 0 4.398175860842457e-06
interview O 0 2.5358171114930883e-05
or O 0 3.04785658045148e-06
by O 0 9.972275165637257e-07
written O 0 1.2355720855339314e-06
questionnaire O 0 3.7266038361849496e-06
and O 0 1.8213219163953909e-06
were O 0 8.685534339747392e-06
compared O 0 2.4186721930163912e-05
between O 0 0.00020934823260176927
patients O 0 0.00010648622992448509
and O 0 3.1702988053439185e-05
control O 0 0.00013364412006922066
women O 0 1.4345095223688986e-05
, O 0 4.939051905239467e-06
after O 0 2.5350072974106297e-05
adjustment O 0 5.743161091231741e-05
for O 0 8.652885298943147e-06
year O 0 3.0735765903955325e-05
of O 0 8.26358882477507e-05
birth O 0 0.0006453890237025917
and O 0 0.00015311453898902982
parity O 0 0.005016135051846504
. O 0 0.0005652062245644629

RESULTS O 0 0.00020067556761205196
The O 0 4.22176526626572e-05
adjusted O 0 9.179506014334038e-05
odds O 0 9.11580937099643e-05
ratio O 0 6.917775317560881e-05
for O 0 0.00021143531193956733
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.00015227704716380686
with O 0 9.198013685818296e-06
any O 0 8.885655006451998e-06
past O 0 1.631435407034587e-05
use O 0 3.3028113648470026e-06
of O 0 5.612953827949241e-05
oral O 0 0.004519772715866566
contraceptives O 0 0.036830734461545944
was O 0 0.0017828259151428938
0 O 0 0.00023879155924078077
. O 0 0.00019384278857614845

5 O 0 0.00038812050479464233
( O 0 3.660084621515125e-05
95 O 0 4.148743755649775e-05
percent O 0 3.5685981856659055e-05
confidence O 0 6.821556598879397e-05
interval O 0 2.758147456916049e-05
, O 0 6.66596315568313e-06
0 O 0 6.24278209215845e-06
. O 0 3.1150057111517526e-06
3 O 0 1.091210560844047e-05
to O 0 5.863585556653561e-06
0 O 0 1.6474969015689567e-05
. O 0 9.443475391890388e-06
8 O 0 0.00012152762792538851
) O 0 4.3616168113658205e-05
. O 0 0.00011951124179176986

The O 0 0.0005075860535725951
risk O 0 0.00032357466989196837
decreased O 0 0.0002470853505656123
with O 0 8.899053682398517e-06
increasing O 0 3.7321173294913024e-05
duration O 0 3.9072481740731746e-05
of O 0 2.6428870114614256e-05
use O 0 9.405026503372937e-06
( O 0 1.5119079762371257e-05
P O 0 0.0002877193328458816
for O 0 8.569221790821757e-06
trend O 0 3.537851443979889e-05
, O 0 6.037789262336446e-06
< O 0 6.732194015057757e-05
0 O 0 1.4876439308864065e-05
. O 0 3.5616183140518842e-06
001 O 0 0.00012505923223216087
) O 0 2.3589161628478905e-06
; O 0 3.1019126822684484e-07
use O 0 5.877587341274193e-07
for O 0 2.8537156140373554e-06
six O 0 1.271796918445034e-05
or O 0 3.1235044843924697e-06
more O 0 1.4290367289504502e-06
years O 0 1.8691776858759113e-05
was O 0 3.9002869016258046e-05
associated O 0 2.2210535917110974e-06
with O 0 9.525680866317998e-07
a O 0 7.036636816337705e-06
60 O 0 2.9030346922809258e-05
percent O 0 6.371457129716873e-05
reduction O 0 0.00010857329471036792
in O 0 0.00015508067735936493
risk O 0 0.000669224071316421
. O 0 0.00030994313419796526

Oral O 1 0.9439004063606262
- O 0 0.005986801814287901
contraceptive O 0 0.0005390889127738774
use O 0 2.561317160143517e-05
protected O 0 0.0012041274458169937
against O 1 0.8824337720870972
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.3564705265453085e-05
for O 0 9.788745956029743e-06
carriers O 0 1.324203003605362e-05
of O 0 1.576655631652102e-05
the O 0 6.285202834988013e-05
BRCA1 O 0 0.00032063861726783216
mutation O 0 1.2537203474494163e-05
( O 0 1.2156393495388329e-05
odds O 0 9.171420970233157e-05
ratio O 0 1.610728941159323e-05
, O 0 1.9653746221592883e-06
0 O 0 3.0430121569224866e-06
. O 0 8.108880251711525e-07
5 O 0 3.689132199724554e-06
; O 0 4.624666587460524e-07
95 O 0 6.074799784983043e-06
percent O 0 8.194727342925034e-06
confidence O 0 3.176417885697447e-05
interval O 0 1.7089036191464402e-05
, O 0 2.949591134893126e-06
0 O 0 4.017817900603404e-06
. O 0 9.17558679702779e-07
3 O 0 6.6540856096253265e-06
to O 0 2.8863028092018794e-06
0 O 0 5.3728040256828535e-06
. O 0 1.8985947463079356e-06
9 O 0 1.3015541298955213e-05
) O 0 9.679083632363472e-07
and O 0 6.787647635064786e-07
for O 0 1.5564249906674377e-06
carriers O 0 7.2798166002030484e-06
of O 0 1.1106367310276255e-05
the O 0 5.3591502364724874e-05
BRCA2 O 0 0.00030586402863264084
mutation O 0 8.984825399238616e-06
( O 0 9.906416380545124e-06
odds O 0 6.836964166723192e-05
ratio O 0 1.2235237591085024e-05
, O 0 1.1792902796514682e-06
0 O 0 1.788025315363484e-06
. O 0 7.483028525712143e-07
4 O 0 5.647911621053936e-06
; O 0 4.959811121807434e-07
95 O 0 9.46095406106906e-06
percent O 0 1.571617576701101e-05
confidence O 0 3.907479185727425e-05
interval O 0 3.086347714997828e-05
, O 0 6.093844149290817e-06
0 O 0 5.891511136724148e-06
. O 0 1.6309760439980892e-06
2 O 0 6.575422503374284e-06
to O 0 3.875112724927021e-06
1 O 0 3.3115516998805106e-05
. O 0 4.775876277562929e-06
1 O 0 7.184594869613647e-05
) O 0 4.259608977008611e-05
. O 0 7.909962732810527e-05

CONCLUSIONS O 0 0.0022686398588120937
Oral O 0 0.10637073218822479
- O 0 0.0029790662229061127
contraceptive O 0 0.00014190288493409753
use O 0 4.731078661279753e-06
may O 0 9.292982213082723e-06
reduce O 0 4.687899945565732e-06
the O 0 1.1613077731453814e-05
risk O 0 4.597250517690554e-05
of O 0 0.0016937508480623364
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0004326789057813585
women O 0 1.8383661881671287e-05
with O 0 3.1437602956430055e-06
pathogenic O 0 2.4069464416243136e-05
mutations O 0 1.1280833859927952e-05
in O 0 1.450474974262761e-05
the O 0 7.450370321748778e-05
BRCA1 O 0 0.0009561586193740368
or O 0 0.00018766298308037221
BRCA2 O 0 0.006481163669377565
gene O 0 0.0018299975199624896

A O 0 0.0007457833271473646
Japanese O 0 0.00035035941982641816
family O 0 4.844450450036675e-05
with O 0 2.8038952223141678e-05
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 7.929735875222832e-05
a O 0 9.235945617547259e-05
codon O 0 4.230558988638222e-05
291 O 0 5.605059050139971e-05
deletion O 0 4.9751575716072693e-05
: O 0 5.276397587294923e-06
a O 0 7.761442248011008e-06
clinical O 0 5.2362905989866704e-05
, O 0 3.09540810121689e-05
biochemical O 0 0.00041138468077406287
, O 0 7.776913844281808e-05
pathological O 1 0.8812596797943115
, O 0 5.676320142811164e-05
and O 0 2.803630559355952e-05
genetic O 0 0.00028652255423367023
report O 0 9.649358980823308e-05
. O 0 0.00017632382514420897

We O 0 4.271601210348308e-05
report O 0 3.9810925045458134e-06
a O 0 4.91749779030215e-06
Japanese O 0 4.4095486373407766e-05
family O 0 2.1465715690283105e-05
with O 0 6.063064211048186e-05
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9913091659545898
ALD B-Disease 1 1.0
) O 0 3.923303302144632e-05
with O 0 4.3022787394875195e-06
a O 0 1.696543040452525e-05
three O 0 1.4472004295384977e-05
base O 0 7.957794150570408e-05
pair O 0 4.220517075737007e-05
deletion O 0 0.0001604564458830282
( O 0 0.00010971554002026096
delGAG O 0 0.0017327845562249422
291 O 0 0.00012154639989603311
) O 0 1.2798002899216954e-05
in O 0 2.8564754757098854e-05
the O 0 0.0004086681001354009
ALD B-Disease 1 1.0
gene O 0 0.0013843838823959231
. O 0 0.0005706981755793095

A O 0 0.0005023970152251422
variety O 0 2.3619581043021753e-05
of O 0 6.149218825157732e-05
phenotypes O 0 0.00018093646212946624
were O 0 5.446582872536965e-05
observed O 0 2.3772001441102475e-05
within O 0 1.4422885215026326e-05
this O 0 8.069804607657716e-06
family O 0 8.358151535503566e-05
. O 0 0.00010640054824762046

While O 0 0.00015979867021087557
the O 0 6.758695963071659e-05
proband O 0 0.0029975404031574726
( O 0 5.247717854217626e-05
patient O 0 4.337732752901502e-05
1 O 0 7.517153426306322e-05
) O 0 7.3295345828228164e-06
was O 0 4.084278043592349e-05
classified O 0 2.723115358094219e-05
as O 0 9.103208867600188e-06
having O 0 1.2082608009222895e-05
a O 0 9.781374501471873e-06
rare O 0 2.3761891497997567e-05
intermediate O 0 0.00011235755664529279
type O 0 4.785461351275444e-05
of O 0 0.00014629481302108616
adult O 0 0.0003670823061838746
cerebral O 1 0.9989503026008606
and O 0 0.0006166323437355459
cerebello O 1 0.9999994039535522
- O 1 0.9998548030853271
brain O 1 0.991337776184082
stem O 0 0.000537026789970696
forms O 0 1.938935020007193e-05
, O 0 1.642869938223157e-05
his O 0 8.587560296291485e-05
younger O 0 0.00033181850449182093
brother O 0 0.00031673480407334864
( O 0 2.0715671780635603e-05
patient O 0 2.4255325115518644e-05
2 O 0 7.604552956763655e-05
) O 0 9.07645789993694e-06
and O 0 7.596762770845089e-06
nephew O 0 0.0005824334803037345
( O 0 2.1722036763094366e-05
patient O 0 2.7528023565537296e-05
3 O 0 5.4404576076194644e-05
) O 0 7.547384484496433e-06
had O 0 5.8904264733428136e-05
a O 0 0.0001756658311933279
childhood O 1 0.999967098236084
ALD B-Disease 1 1.0
type O 1 0.8674071431159973
. O 0 0.001388384378515184

Another O 0 0.0008732290589250624
nephew O 0 0.003977217245846987
( O 0 8.00209745648317e-05
patient O 0 4.708466076408513e-05
4 O 0 6.500251038232818e-05
) O 0 4.131129571760539e-06
of O 0 1.5265979527612217e-05
patient O 0 3.878063216689043e-05
1 O 0 7.968888530740514e-05
was O 0 0.0001244483864866197
classified O 0 3.74362753063906e-05
as O 0 7.299232947843848e-06
having O 0 1.938855530170258e-05
an O 0 1.3194128769100644e-05
adolescent O 0 0.0009634867892600596
form O 0 0.00022671434271614999
. O 0 0.0003724739362951368

The O 0 0.00042617268627509475
tau O 0 0.0010629009921103716
level O 0 0.00012352030898910016
in O 0 2.0017170754726976e-05
the O 0 4.7912875743350014e-05
cerebrospinal O 0 0.002532294951379299
fluid O 0 0.0015410849591717124
( O 0 0.00040493597043678164
CSF O 1 0.9989736080169678
) O 0 5.3377283620648086e-05
in O 0 3.4215197956655174e-05
patient O 0 3.605810707085766e-05
1 O 0 7.299111894099042e-05
was O 0 8.057412924245e-05
as O 0 6.390482667484321e-06
high O 0 1.1262141924817115e-05
as O 0 1.6216733911278425e-06
that O 0 3.2182646236833534e-07
of O 0 1.1564824490051251e-05
patients O 0 6.93986366968602e-05
with O 0 0.0005911497282795608
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0007061124779284
AD B-Disease 0 0.0035824025981128216
) O 0 0.00017343265062663704
. O 0 8.84424734977074e-05

His O 0 0.004041609354317188
brain O 1 0.9234898686408997
magnetic O 0 0.0012354119680821896
resonance O 0 0.0004388735396787524
image O 0 0.00035078133805654943
( O 0 9.962887997971848e-05
MRI O 0 0.0027032203506678343
) O 0 4.409578104969114e-05
showed O 0 0.00018337040091864765
abnormalities B-Disease 0 0.002160933567211032
in I-Disease 0 6.229856080608442e-05
the I-Disease 0 0.00015176927263382822
bilateral I-Disease 1 0.9923447966575623
cerebellar I-Disease 1 0.9999997615814209
hemispheres I-Disease 1 0.669169008731842
and O 0 0.0013258503749966621
brain O 1 0.9999990463256836
stem O 0 0.08038326352834702
, O 0 1.0329922588425688e-05
but O 0 1.8139753592549823e-06
not O 0 1.6352997818103177e-06
in O 0 1.4127977010502946e-05
the O 0 9.739845700096339e-05
cerebral O 1 0.6829438805580139
white O 0 0.00019318130216561258
matter O 0 4.473185254028067e-05
, O 0 4.398888904688647e-06
where O 0 6.204706551216077e-06
marked O 0 3.200881110387854e-05
reductions O 0 6.497015419881791e-05
of O 0 3.620709685492329e-05
the O 0 0.00012596581655088812
cerebral O 1 0.9913520812988281
blood O 0 0.0009308986482210457
flow O 0 0.0004015004087705165
and O 0 3.819012636085972e-05
oxygen O 0 0.00011395708861527964
metabolism O 0 7.018878386588767e-05
were O 0 2.1371532056946307e-05
clearly O 0 1.794846320990473e-05
demonstrated O 0 4.076036930200644e-05
by O 0 1.3229685464466456e-05
positron O 0 0.00040741017437539995
emission O 0 0.00011131800420116633
tomography O 0 0.00018466268375050277
( O 0 0.0002498249232303351
PET O 0 0.0016613116022199392
) O 0 9.377360402140766e-05
. O 0 0.00013061039499007165

In O 0 0.0003544086357578635
patients O 0 0.0001147606672020629
2 O 0 0.00011740947957150638
and O 0 1.341049573966302e-05
3 O 0 2.6808573238668032e-05
, O 0 2.8050076252839062e-06
the O 0 5.540247002500109e-06
autopsy O 0 2.784623757179361e-05
findings O 0 2.1182502678129822e-05
showed O 0 0.0001927913835970685
massive O 0 0.007342804688960314
demyelination B-Disease 1 0.9999994039535522
of I-Disease 0 0.0015400047414004803
the I-Disease 0 0.0024407266173511744
cerebral I-Disease 1 0.9998334646224976
white I-Disease 0 0.0003697069769259542
matter I-Disease 0 4.3202206143178046e-05
with O 0 3.913193268090254e-06
sparing O 0 5.743681685999036e-05
of O 0 9.618364128982648e-05
the O 0 0.000616347067989409
U O 1 0.9999980926513672
- O 0 0.42271584272384644
fibers O 0 0.0005407945136539638
, O 0 9.499539373791777e-06
compatible O 0 6.046634098311188e-06
with O 0 8.528755301995261e-07
the O 0 6.630470579693792e-06
findings O 0 8.153474482242018e-06
of O 0 0.00020759666222147644
childhood O 1 0.9999983310699463
ALD B-Disease 1 1.0
. O 0 0.0050287386402487755

Oleic O 0 0.017890330404043198
and O 0 0.0005607655039057136
erucic O 0 0.030273625627160072
acids O 0 0.0003799131663981825
( O 0 0.0001474501914344728
Lorenzos O 0 0.003903050906956196
Oil O 0 0.00017888341972138733
) O 0 2.763886186585296e-06
were O 0 3.448400320849032e-06
administered O 0 5.927624442847446e-06
to O 0 8.037884072109591e-06
patients O 0 1.2824745681427885e-05
1 O 0 9.9464479717426e-05
and O 0 1.005731519398978e-05
4 O 0 4.738086136057973e-05
, O 0 2.88574142359721e-06
but O 0 1.3277373227538192e-06
sufficient O 0 1.2849132872361224e-05
effectiveness O 0 3.3940785215236247e-05
was O 0 0.00013549816503655165
not O 0 6.4820928855624516e-06
obtained O 0 7.150870078476146e-05
. O 0 0.00012336081999819726

The O 0 0.00017085240688174963
findings O 0 3.433804158703424e-05
in O 0 1.8024675227934495e-05
this O 0 5.7401039157412015e-06
family O 0 1.3456960914481897e-05
suggest O 0 8.21173580334289e-06
that O 0 2.793459088934469e-06
delGAG291 O 0 0.00013623468112200499
is O 0 3.1140166356635746e-06
part O 0 4.235307642375119e-06
of O 0 1.373487521050265e-05
the O 0 2.4926073820097372e-05
cause O 0 6.497015419881791e-05
of O 0 0.0001888617262011394
Japanese O 1 0.8906431198120117
ALD B-Disease 1 1.0
with O 0 6.060324449208565e-05
phenotypic O 0 0.0010484172962605953
variations O 0 0.0011032756883651018
. O 0 0.000719115836545825

Moreover O 0 0.0009763508569449186
, O 0 1.691699435468763e-05
although O 0 5.183658231544541e-06
the O 0 5.071050054539228e-06
scale O 0 3.577535608201288e-05
of O 0 1.0908859621849842e-05
the O 0 1.2329152923484799e-05
study O 0 3.3360884117428213e-06
is O 0 1.5922363445497467e-06
limited O 0 2.8201220629853196e-06
, O 0 1.6811127352411859e-06
there O 0 2.900236950154067e-06
is O 0 2.283825324411737e-06
a O 0 6.148687589302426e-06
possibility O 0 3.145508162560873e-05
that O 0 1.2388530194584746e-05
PET O 0 0.00022462484776042402
can O 0 4.583324880513828e-06
detect O 0 0.00011503293353598565
an O 0 3.0184679417288862e-05
insidious B-Disease 0 0.06489340960979462
lesion I-Disease 0 0.4116654098033905
which O 0 2.9247290513012558e-05
is O 0 9.813722499529831e-06
undetectable O 0 9.088001388590783e-05
by O 0 1.8131763681594748e-06
computed O 0 1.7054713680408895e-05
tomogram O 0 0.0012290310114622116
( O 0 7.459698099410161e-05
CT O 0 0.0028119469061493874
) O 0 1.9991930457763374e-05
or O 0 1.625221011636313e-05
MRI O 0 0.0004251866484992206
analysis O 0 5.8065361372428015e-06
, O 0 5.557174063142156e-06
and O 0 2.3026245798973832e-06
that O 0 7.800271646374313e-07
the O 0 2.7584353574638953e-06
higher O 0 6.512273557746084e-06
level O 0 2.4550221496610902e-05
of O 0 1.7989608750212938e-05
tau O 0 0.00010966762783937156
reflects O 0 3.421071824050159e-06
the O 0 1.4681512539027608e-06
process O 0 2.642182835188578e-06
of O 0 8.807997801341116e-05
neuronal B-Disease 1 0.9786675572395325
degeneration I-Disease 1 1.0
in O 1 0.9999212026596069
ALD B-Disease 1 1.0
. O 0 0.005328870378434658

Lorenzos O 0 0.04648960009217262
Oil O 0 0.0006124944775365293
should O 0 6.231319730432006e-06
be O 0 2.3190891624835785e-06
given O 0 1.6478019233545638e-06
in O 0 3.681336693261983e-06
the O 0 9.659824172558729e-06
early O 0 5.9624035202432424e-05
stage O 0 0.00027796579524874687
. O 0 4.408140011946671e-05
. O 0 0.0001179087339551188

Nonsense O 0 0.0021661112550646067
mutation O 0 6.839188426965848e-05
in O 0 5.707280070055276e-05
exon O 0 0.00025481663760729134
4 O 0 5.218205478740856e-05
of O 0 4.358801379567012e-05
human O 0 4.430239641806111e-05
complement O 0 0.00012342471745796502
C9 O 0 0.16547365486621857
gene O 0 2.552626574470196e-05
is O 0 2.5752528927114327e-06
the O 0 6.470691005233675e-06
major O 0 3.839513010461815e-05
cause O 0 2.7179470635019243e-05
of O 0 4.3515708966879174e-05
Japanese O 0 0.021736787632107735
complement B-Disease 0 0.04724209010601044
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0024100153241306543

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 0.0006753467605449259
the I-Disease 0 0.00021687423577532172
ninth I-Disease 0 0.0006319279200397432
component I-Disease 0 5.276410956867039e-05
of I-Disease 0 2.8084203222533688e-05
human I-Disease 0 2.0712193872896023e-05
complement I-Disease 0 6.771056359866634e-05
( O 0 7.844124775147066e-05
C9 O 0 0.025875970721244812
) O 0 5.259265890344977e-06
is O 0 1.3420733466773527e-06
the O 0 2.710422450036276e-06
most O 0 4.530437308858382e-06
common O 0 2.412922003713902e-05
complement B-Disease 1 0.9999125003814697
deficiency I-Disease 1 1.0
in O 0 0.0008718157187104225
Japan O 0 0.0004102643870282918
but O 0 4.4231951505935285e-06
is O 0 2.012530558204162e-06
rare O 0 5.141514066053787e-06
in O 0 5.6828521337592974e-06
other O 0 2.6312068257539067e-06
countries O 0 1.4553133951267228e-05
. O 0 5.8624962548492476e-05

We O 0 3.6399207601789385e-05
studied O 0 3.1340401619672775e-05
the O 0 5.145674094819697e-06
molecular O 0 5.022167442803038e-06
basis O 0 1.623346543055959e-05
of O 0 0.0004941042279824615
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0002050084585789591
four O 0 9.572358248988166e-05
Japanese O 0 0.004108035005629063
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9928491115570068
deficient I-Disease 1 0.5638710260391235
patients O 0 0.00010812850814545527
who O 0 5.9882160712732e-05
had O 0 0.0004946680273860693
suffered O 1 0.9999992847442627
from O 1 0.9992899894714355
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.006684284191578627

Direct O 0 0.0001834146532928571
sequencing O 0 0.0001349389785900712
of O 0 0.0004336140991654247
amplified O 0 0.0015875922981649637
C9 O 0 0.00950627215206623
cDNA O 0 0.00010360850865254179
and O 0 6.291846602834994e-06
DNA O 0 1.4260594070947263e-05
revealed O 0 3.722175824805163e-05
a O 0 9.376958587381523e-06
nonsense O 0 5.127099939272739e-05
substitution O 0 2.313530603714753e-05
( O 0 7.715052197454497e-05
CGA O 0 0.0015369063476100564
- O 0 0.00036882443237118423
- O 0 0.00018698176427278668
> O 0 0.000152816268382594
TGA O 0 0.0009972469415515661
) O 0 1.0405362445453648e-05
at O 0 4.081117003806867e-05
codon O 0 7.5455413934832904e-06
95 O 0 2.1611820557154715e-05
in O 0 2.0990722987335175e-05
exon O 0 0.00013430009130388498
4 O 0 3.869345164275728e-05
in O 0 1.2734242773149163e-05
the O 0 4.2952851799782366e-05
four O 0 0.0001810793619370088
C9 B-Disease 1 0.9998356103897095
- I-Disease 0 0.011369864456355572
deficient I-Disease 0 0.004419135395437479
individuals O 0 6.234778265934438e-05
. O 0 0.0002910499752033502

An O 0 7.698897388763726e-05
allele O 0 4.106508640688844e-05
- O 0 6.390222551999614e-05
specific O 0 2.6329412321501877e-06
polymerase O 0 0.00013572046009358019
chain O 0 6.896118429722264e-05
reaction O 0 8.95104221854126e-06
system O 0 3.2928619475569576e-05
designed O 0 2.6336387236369774e-05
to O 0 1.4350513083627447e-05
detect O 0 6.602909706998616e-05
exclusively O 0 1.015440375340404e-05
only O 0 2.4061666863417486e-06
one O 0 1.351220930700947e-06
of O 0 5.618301202048315e-06
the O 0 1.3623989616462495e-05
normal O 0 1.3827108887198847e-05
and O 0 2.827762273227563e-06
mutant O 0 1.3179087545722723e-05
alleles O 0 2.77506364909641e-06
indicated O 0 5.8688110584625974e-06
that O 0 4.593624680637731e-07
all O 0 7.831555990378547e-07
the O 0 5.895934464206221e-06
four O 0 7.945558536448516e-06
patients O 0 1.1544526387297083e-05
were O 0 1.449596766178729e-05
homozygous O 0 1.0718044904933777e-05
for O 0 2.6188422452833038e-06
the O 0 1.7000833395286463e-05
mutation O 0 5.470043106470257e-06
in O 0 2.0383351511554793e-05
exon O 0 0.00014747100067324936
4 O 0 2.433470217511058e-05
and O 0 1.2941225122631295e-06
that O 0 6.509247896246961e-07
the O 0 4.631941465049749e-06
parents O 0 1.9315339159220457e-06
of O 0 1.5463110685232095e-05
patient O 0 6.482545722974464e-05
2 O 0 0.00018079072469845414
were O 0 0.00011662360338959843
heterozygous O 0 7.310682849492878e-05
. O 0 0.00013510197459254414

The O 0 0.00016981587396003306
common O 0 4.125152190681547e-05
mutation O 0 1.583291304996237e-05
at O 0 7.33771885279566e-05
codon O 0 1.279270691156853e-05
95 O 0 1.9468989194137976e-05
in O 0 1.8094960978487507e-05
exon O 0 0.0001006190650514327
4 O 0 3.89812994399108e-05
might O 0 6.3367442635353655e-06
be O 0 1.5206227317321463e-06
responsible O 0 6.346414465951966e-06
for O 0 5.1516544772312045e-06
most O 0 5.8165995142189786e-05
Japanese O 1 0.5845649242401123
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0003716452047228813
. O 0 0.0002445951977279037

BRCA1 O 0 0.0007964629912748933
required O 0 1.990567398024723e-05
for O 0 3.378175097168423e-05
transcription O 0 0.0017033005133271217
- O 0 0.0013129508588463068
coupled O 0 0.0002847906725946814
repair O 0 0.001011420856229961
of O 0 0.00025051136617548764
oxidative O 0 0.002906089648604393
DNA O 0 0.001967854332178831
damage O 1 0.8712936639785767
. O 0 0.00042657082667574286

The O 0 0.0008486490696668625
breast B-Disease 1 0.99998939037323
and I-Disease 1 0.9636080265045166
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.999909520149231
gene O 0 0.0005302464705891907
BRCA1 O 0 0.0008038844098336995
encodes O 0 7.579632801935077e-05
a O 0 8.908611198421568e-05
zinc O 0 0.002782833995297551
finger O 0 0.00027532927924767137
protein O 0 1.3227642739366274e-05
of O 0 4.11390901717823e-05
unknown O 0 0.00017421593656763434
function O 0 9.262104867957532e-05
. O 0 0.0001513596944278106

Association O 0 0.00013835100980941206
of O 0 7.612236368004233e-05
the O 0 7.282231672434136e-05
BRCA1 O 0 0.00020691253303084522
protein O 0 9.194312951876782e-06
with O 0 2.2763103970646625e-06
the O 0 1.7568951079738326e-05
DNA O 0 9.662895172368735e-05
repair O 0 0.0018265183316543698
protein O 0 0.00021206219389569014
Rad51 O 0 0.0012434112140908837
and O 0 4.736903065349907e-06
changes O 0 2.33586729336821e-06
in O 0 3.09433607981191e-06
the O 0 4.2091387513210066e-06
phosphorylation O 0 3.4682614113989985e-06
and O 0 4.850492587138433e-06
cellular O 0 3.085187927354127e-05
localization O 0 6.945524364709854e-05
of O 0 2.303144719917327e-05
the O 0 2.3617689294042066e-05
protein O 0 1.9333867385284975e-05
after O 0 5.0138365622842684e-05
exposure O 0 0.00010578466026345268
to O 0 2.1755453417426907e-05
DNA O 0 0.0002099026896758005
- O 0 0.0001861105702118948
damaging O 0 7.338690920732915e-05
agents O 0 5.408409379015211e-06
are O 0 6.485206540673971e-07
consistent O 0 3.455771320659551e-06
with O 0 1.059298938344e-06
a O 0 8.327872819791082e-06
role O 0 2.1877183826291002e-05
for O 0 1.8763483240036294e-05
BRCA1 O 0 0.00044417724711820483
in O 0 9.939147275872529e-05
DNA O 0 0.0005440483801066875
repair O 0 0.028122473508119583
. O 0 0.0005366049008443952

Here O 0 0.0002647671499289572
, O 0 6.011125606164569e-06
it O 0 1.0103469776368001e-06
is O 0 8.745292916501057e-07
shown O 0 6.275097803154495e-06
that O 0 4.901643933408195e-06
mouse O 0 0.00012892705854028463
embryonic O 0 0.0004472804139368236
stem O 0 0.0005467901355586946
cells O 0 0.0001166690926766023
deficient B-Disease 0 0.0005233437987044454
in I-Disease 0 4.207914025755599e-05
BRCA1 I-Disease 0 0.00019881140906363726
are O 0 4.043160060973605e-06
defective O 0 9.851083450485021e-05
in O 0 9.286772183259018e-06
the O 0 7.126455784600694e-06
ability O 0 2.3215832243295154e-06
to O 0 2.248542386951158e-06
carry O 0 2.4931184725573985e-06
out O 0 5.101628630654886e-06
transcription O 0 0.0001471002324251458
- O 0 0.0002675085561349988
coupled O 0 0.00015062425518408418
repair O 0 0.0004477652837522328
of O 0 0.00013260119885671884
oxidative O 0 0.0009208096889778972
DNA O 0 0.0007262172293849289
damage O 0 0.008703959174454212
, O 0 2.7365296773496084e-05
and O 0 1.38846426125383e-05
are O 0 1.0509768799238373e-05
hypersensitive O 0 0.0016965677496045828
to O 0 0.0003224654064979404
ionizing O 1 0.9878281354904175
radiation O 0 0.18502408266067505
and O 0 0.0001254018279723823
hydrogen O 0 0.0002037115191342309
peroxide O 0 0.0004661130078602582
. O 0 0.0003437571576796472

These O 0 1.0125335393240675e-05
results O 0 1.2345482900855131e-05
suggest O 0 1.7862741515273228e-05
that O 0 6.917120117577724e-06
BRCA1 O 0 0.00015304068801924586
participates O 0 3.010312320839148e-05
, O 0 5.604130819847342e-06
directly O 0 9.050837434187997e-06
or O 0 4.243421699356986e-06
indirectly O 0 4.612470729625784e-05
, O 0 6.900918378960341e-06
in O 0 1.4365326933329925e-05
transcription O 0 0.00042473195935599506
- O 0 0.00045285274973139167
coupled O 0 0.00014664199261460453
repair O 0 0.0005614859401248395
of O 0 0.0002299570624018088
oxidative O 0 0.002684445586055517
DNA O 0 0.0015607711393386126
damage O 0 0.178033709526062
. O 0 0.00015578139573335648
. O 0 0.00020130607299506664

Truncation O 0 0.002853566547855735
mutations O 0 0.00013434044376481324
in O 0 4.8508016334380955e-05
the O 0 7.211983029264957e-05
transactivation O 0 0.002225148491561413
region O 0 0.00022258584795054048
of O 0 0.0002542393049225211
PAX6 O 0 0.37037158012390137
result O 0 0.00017678120639175177
in O 0 0.0001606723089935258
dominant O 0 0.0012091000098735094
- O 0 0.0005200625164434314
negative O 0 6.960150494705886e-05
mutants O 0 0.0007991791935637593
. O 0 0.00012804871948901564

PAX6 O 0 0.024450991302728653
is O 0 3.393877705093473e-05
a O 0 1.4092748642724473e-05
transcription O 0 4.8379723011748865e-05
factor O 0 1.4216545423550997e-05
with O 0 1.385161112921196e-06
two O 0 5.916949703532737e-06
DNA O 0 7.241195999085903e-05
- O 0 7.961907977005467e-05
binding O 0 8.108933798212092e-06
domains O 0 7.344180630752817e-05
( O 0 5.987816257402301e-05
paired O 0 8.27555195428431e-05
box O 0 0.00018565361096989363
and O 0 1.577404691488482e-05
homeobox O 0 0.0005767705733887851
) O 0 1.5597830497426912e-05
and O 0 7.794004886818584e-06
a O 0 3.1672891054768115e-05
proline O 0 0.00040875384001992643
- O 0 0.0005390666192397475
serine O 0 0.00020673485414590687
- O 0 0.0003508480731397867
threonine O 0 0.00016991562733892351
( O 0 0.00013061476056464016
PST O 0 0.05223005637526512
) O 0 9.287505963584408e-05
- O 0 0.0004003054928034544
rich O 0 0.00011487267329357564
transactivation O 0 0.0018784443382173777
domain O 0 0.0008660325547680259
. O 0 0.0003022619348485023

PAX6 O 1 0.999955415725708
regulates O 0 0.007884662598371506
eye O 0 0.0051099578849971294
development O 0 0.0001706593029666692
in O 0 5.8543955674394965e-05
animals O 0 1.6345249605365098e-05
ranging O 0 6.799267430324107e-05
from O 0 7.988206198206171e-05
jellyfish O 0 3.748872040887363e-05
to O 0 1.5864170563872904e-05
Drosophila O 0 8.48611889523454e-05
to O 0 4.914385499432683e-05
humans O 0 0.00022017328592482954
. O 0 0.00011118559632450342

Heterozygous O 0 0.0002926166926044971
mutations O 0 5.9689682530006394e-05
in O 0 2.2670061298413202e-05
the O 0 3.7573365261778235e-05
human O 0 8.902861009119079e-05
PAX6 O 0 0.01177870761603117
gene O 0 2.9892204111092724e-05
result O 0 9.890199180517811e-06
in O 0 4.73582758786506e-06
various O 0 5.227922429185128e-06
phenotypes O 0 6.38335186522454e-05
, O 0 8.731377420190256e-06
including O 0 3.5637622204376385e-05
aniridia B-Disease 1 1.0
, O 0 0.00025496777379885316
Peters B-Disease 1 0.9999991655349731
anomaly I-Disease 1 0.9999995231628418
, O 0 0.0002297236496815458
autosomal B-Disease 1 0.9914907813072205
dominant I-Disease 1 0.9997499585151672
keratitis I-Disease 1 0.9999996423721313
, O 0 0.00038037868216633797
and O 0 0.00031003239564597607
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9889698028564453

It O 0 2.9081444154144265e-05
is O 0 6.1056935010128655e-06
believed O 0 9.307502295996528e-06
that O 0 5.831931275679381e-07
the O 0 4.174774403509218e-06
mutated O 0 1.1555376659089234e-05
allele O 0 6.015977760398528e-06
of O 0 6.693816249025986e-05
PAX6 O 0 0.012022283859550953
produces O 0 3.7413148675113916e-05
an O 0 1.375975989503786e-05
inactive O 0 0.0002667963854037225
protein O 0 7.511213334510103e-05
and O 0 3.9804497646400705e-05
aniridia B-Disease 1 0.9995500445365906
is O 0 3.5912671592086554e-05
caused O 0 7.969139551278204e-05
due O 0 7.91384227341041e-05
to O 0 3.595344242057763e-05
genetic O 0 0.00047891816939227283
haploinsufficiency O 0 0.25933027267456055
. O 0 0.00044532454921863973

However O 0 0.00011442662071203813
, O 0 1.2730904018098954e-05
several O 0 6.649492661381373e-06
truncation O 0 0.00017379534256178886
mutations O 0 2.4691191356396303e-05
have O 0 2.7453083930595312e-06
been O 0 4.065105258632684e-06
found O 0 1.3269209375721402e-06
to O 0 1.749755028868094e-06
occur O 0 1.8581350786917028e-06
in O 0 7.201313565019518e-06
the O 0 3.112511694780551e-05
C O 0 0.0007291759247891605
- O 0 0.00021708257554564625
terminal O 0 0.00023971886548679322
half O 0 2.6655920009943657e-05
of O 0 6.672561721643433e-05
PAX6 O 0 0.015723606571555138
in O 0 7.43922428227961e-05
patients O 0 5.6671906349947676e-05
with O 0 2.953787407022901e-05
Aniridia B-Disease 1 0.9999977350234985
resulting O 0 0.00011906103463843465
in O 0 2.5347533664898947e-05
mutant O 0 1.7524555005365983e-05
proteins O 0 1.1823059367088717e-06
that O 0 4.168772989032732e-07
retain O 0 6.084030246711336e-06
the O 0 1.0499380550754722e-05
DNA O 0 4.1052160668186843e-05
- O 0 6.310613389359787e-05
binding O 0 4.969791007169988e-06
domains O 0 2.7339268854120746e-05
but O 0 3.896223915944574e-06
have O 0 2.1987477794027654e-06
lost O 0 2.0802261133212596e-05
most O 0 1.8760460989142302e-06
of O 0 1.0054802260128781e-05
the O 0 4.8242160119116306e-05
transactivation O 0 0.002618136815726757
domain O 0 0.0007192189223133028
. O 0 0.0002643761981744319

It O 0 1.8550119420979172e-05
is O 0 4.499899205256952e-06
not O 0 1.2169291494501522e-06
clear O 0 3.3363810416631168e-06
whether O 0 2.7745741135731805e-06
such O 0 4.852518941333983e-06
mutants O 0 0.00022942903160583228
really O 0 4.5111355575500056e-05
behave O 0 2.4578612283221446e-05
as O 0 1.7139302144641988e-05
loss O 0 0.0002832518075592816
- O 0 0.00012715089542325586
of O 0 6.548418605234474e-05
- O 0 0.00019469074322842062
function O 0 1.7812188161769882e-05
mutants O 0 6.305416172835976e-05
as O 0 2.333677366550546e-05
predicted O 0 0.00011042106052627787
by O 0 3.116664447588846e-05
haploinsufficiency O 0 0.004855201113969088
. O 0 0.0002707970852497965

Contrary O 0 0.0002057357196463272
to O 0 9.458888598601334e-06
this O 0 6.492473403341137e-06
theory O 0 5.12656188220717e-05
, O 0 4.105123025510693e-06
our O 0 2.9815380457876017e-06
data O 0 3.5300045055919327e-06
showed O 0 9.558527381159365e-06
that O 0 8.346090112354432e-07
these O 0 1.2764829762090812e-06
mutants O 0 2.995881368406117e-05
are O 0 3.82159714718e-06
dominant O 0 0.00012285473349038512
- O 0 8.016730862436816e-05
negative O 0 7.672338142583612e-06
in O 0 1.3695243978872895e-05
transient O 0 0.00015494143008254468
transfection O 0 0.0001557897194288671
assays O 0 4.672465820476646e-06
when O 0 4.981302936357679e-06
they O 0 9.61735395321739e-07
are O 0 7.662324605917092e-07
coexpressed O 0 0.00027243082877248526
with O 0 1.5801688277861103e-05
wild O 0 0.00029410686693154275
- O 0 0.001007570419460535
type O 0 0.0007089034770615399
PAX6 O 1 0.9975583553314209
. O 0 0.0006476584239862859

We O 0 4.4116477511124685e-05
found O 0 5.86102532906807e-06
that O 0 1.2881531574748806e-06
the O 0 1.4362315596372355e-05
dominant O 0 0.00027746771229431033
- O 0 0.00014136808749753982
negative O 0 1.0211250810243655e-05
effects O 0 4.828003147849813e-05
result O 0 9.939330084307585e-06
from O 0 6.7191799644206185e-06
the O 0 9.397960639034864e-06
enhanced O 0 4.880758569925092e-05
DNA O 0 1.897716174426023e-05
binding O 0 3.259858885940048e-06
ability O 0 3.977460437454283e-06
of O 0 2.2643829652224667e-05
these O 0 2.445572317810729e-05
mutants O 0 0.0007558668730780482
. O 0 0.0001797427685232833

Kinetic O 0 0.00043786122114397585
studies O 0 1.766899185895454e-05
of O 0 3.386603566468693e-05
binding O 0 1.395896470057778e-05
and O 0 1.263949707208667e-05
dissociation O 0 7.48435195419006e-05
revealed O 0 8.626405178802088e-05
that O 0 2.596854528746917e-06
various O 0 5.165675702301087e-06
truncation O 0 9.355184738524258e-05
mutants O 0 0.00011974554945481941
have O 0 6.9061720751051325e-06
3 O 0 5.049935862189159e-05
- O 0 8.438203803962097e-05
5 O 0 4.0684255509404466e-05
- O 0 4.057630940224044e-05
fold O 0 1.5298277503461577e-05
higher O 0 5.330382464308059e-06
affinity O 0 4.3517802623682655e-06
to O 0 3.863703568640631e-06
various O 0 7.881230885686819e-06
DNA O 0 6.489313091151416e-05
- O 0 5.518170655705035e-05
binding O 0 2.3500265342590865e-06
sites O 0 7.691823157074396e-06
when O 0 5.009113920095842e-06
compared O 0 3.7455588426382747e-06
with O 0 2.0644772575906245e-06
the O 0 5.263184357318096e-05
wild O 0 0.0001999797095777467
- O 0 0.0005772526492364705
type O 0 0.000717058137524873
PAX6 O 1 0.9924377799034119
. O 0 0.0005810055299662054

These O 0 1.533063914394006e-05
results O 0 1.0379891136835795e-05
provide O 0 5.6044837037916295e-06
a O 0 9.73717396846041e-06
new O 0 4.598297437041765e-06
insight O 0 1.9681090634549037e-05
into O 0 6.512552772619529e-06
the O 0 8.222627911891323e-06
role O 0 3.285606362624094e-05
of O 0 9.87950261333026e-05
mutant O 0 0.0009756418294273317
PAX6 O 1 0.9880280494689941
in O 0 0.0005269080866128206
causing O 0 0.01692027412354946
aniridia B-Disease 1 0.9999954700469971
. O 0 0.00018559559248387814
. O 0 0.00014991556236054748

Reversal O 0 0.003073262283578515
of O 0 0.09529818594455719
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.007571119349449873
excellent O 0 0.0010155230993404984
neuropsychologic O 0 0.003712928155437112
outcome O 0 8.6164080130402e-05
in O 0 2.7384170607547276e-05
very B-Disease 0 2.2019892639946193e-05
- I-Disease 0 0.00013772396778222173
long I-Disease 0 0.00010835537977982312
- I-Disease 0 0.0001827675150707364
chain I-Disease 0 7.858133903937414e-05
acyl I-Disease 0 7.02325050951913e-05
- I-Disease 0 0.00019802367023658007
coenzyme I-Disease 0 3.0472630896838382e-05
A I-Disease 0 0.0016892007552087307
dehydrogenase I-Disease 0 0.02965966798365116
deficiency I-Disease 1 0.9999997615814209
. O 0 0.0010922170476987958

Very B-Disease 0 0.0007148365257307887
- I-Disease 0 0.0009931930107995868
long I-Disease 0 0.0002894308709073812
- I-Disease 0 0.0003021138545591384
chain I-Disease 0 7.910913700470701e-05
acyl I-Disease 0 3.995655424660072e-05
- I-Disease 0 6.296619540080428e-05
coenzyme I-Disease 0 8.014019840629771e-06
A I-Disease 0 9.537643927615136e-05
dehydrogenase I-Disease 0 7.954577449709177e-05
( I-Disease 0 0.00011481977708172053
VLCAD I-Disease 1 0.9999959468841553
) I-Disease 0 0.00021005846792832017
deficiency I-Disease 1 0.9999707937240601
is O 0 2.7515136025613174e-05
a O 0 7.34947607270442e-05
disorder O 1 0.9999079704284668
of O 0 0.0055815125815570354
fatty O 0 0.005285034887492657
acid O 0 0.00012440398859325796
beta O 0 0.00010286936594638973
oxidation O 0 1.9347886336618103e-05
that O 0 5.0512130655988585e-06
reportedly O 0 5.337707989383489e-05
has O 0 5.311920176609419e-06
high O 0 3.706095230882056e-05
rates O 0 1.2100803360226564e-05
of O 0 3.763637141673826e-05
morbidity O 0 0.0007406076183542609
and O 0 9.784165013115853e-05
mortality O 0 0.0021044020541012287
. O 0 0.0004090795118827373

We O 0 5.349122147890739e-05
describe O 0 1.5198228538793046e-05
the O 0 9.704904186946806e-06
outcome O 0 1.4428402209887281e-05
of O 0 2.263808528368827e-05
a O 0 4.8064859583973885e-05
5 O 0 7.465810631401837e-05
- O 0 7.801166066201404e-05
year O 0 2.9063587135169655e-05
- O 0 9.320936806034297e-05
old O 0 0.00014146327157504857
girl O 0 0.00011024746345356107
with O 0 6.528191443067044e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0005356028559617698
was O 0 0.0003487857466097921
first O 0 3.4654574847081676e-05
seen O 0 3.937809378840029e-05
at O 0 3.2406343962065876e-05
5 O 0 1.225663254444953e-05
months O 0 7.557496701338096e-06
of O 0 1.1179978173458949e-05
age O 0 0.00012707333371508867
with O 0 0.0001103049871744588
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999990463256836
hepatomegaly B-Disease 1 1.0
, O 1 0.999997615814209
encephalopathy B-Disease 1 1.0
, O 0 0.0010141931707039475
and O 0 0.00044872795115225017
hypotonia B-Disease 1 0.9981622099876404
. O 0 0.0011592491064220667

Biochemical O 0 0.001786735258065164
studies O 0 0.00040779696428216994
indicated O 1 0.9969847798347473
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9992604851722717
by O 0 5.176271224627271e-05
a O 0 7.97747343312949e-05
stable O 0 0.00019943150982726365
yet O 0 3.771153569687158e-05
inactive O 0 0.00026476263883523643
enzyme O 0 9.14959964575246e-05
. O 0 0.00017015413322951645

Molecular O 0 0.0003482501779217273
genetic O 0 9.159394539892673e-05
analysis O 0 1.4416490557778161e-05
of O 0 0.0001587330480106175
her O 0 0.00035672399098984897
VLCAD O 1 0.999137282371521
gene O 0 0.00012287384015507996
revealed O 0 0.00019231585611123592
a O 0 5.8144141803495586e-05
T1372C O 0 0.0004593091434799135
( O 0 5.296768358675763e-05
F458L O 0 0.0006687039276584983
) O 0 3.090830796281807e-05
missense O 0 0.00018085178453475237
mutation O 0 2.4315586415468715e-05
and O 0 3.6642057239077985e-05
a O 0 0.00032440954237245023
1668 O 1 0.9986590147018433
ACAG O 1 0.9999877214431763
1669 O 0 0.15576167404651642
splice O 0 0.0025752538349479437
site O 0 0.0009760978864505887
mutation O 0 0.00015881737635936588
. O 0 0.00014605310570914298

After O 0 0.0001769292721292004
initial O 0 3.2641852158121765e-05
treatment O 0 8.607227937318385e-05
with O 0 3.0647552193840966e-05
intravenous O 1 0.5156489610671997
glucose O 0 0.00183869490865618
and O 0 0.00014839632785879076
carnitine O 0 0.011265718378126621
, O 0 2.455125104461331e-05
the O 0 3.164110239595175e-05
patient O 0 4.779262962983921e-05
has O 0 1.9550852812244557e-05
thrived O 0 0.0002519194968044758
on O 0 2.9868155252188444e-05
a O 0 2.4151548132067546e-05
low O 0 0.00018686662951949984
- O 0 0.00032747656223364174
fat O 0 9.989296086132526e-05
diet O 0 1.929851532622706e-05
supplemented O 0 1.2546568541438319e-05
with O 0 4.713146154244896e-06
medium O 0 9.420517017133534e-05
- O 0 0.00024359558301512152
chain O 0 0.0001118731452152133
triglyceride O 0 0.00019281564163975418
oil O 0 0.00019329167844261974
and O 0 3.01288855553139e-05
carnitine O 0 0.0015314769698306918
and O 0 5.220679668127559e-05
avoidance O 0 0.0006775169749744236
of O 0 0.0006697441567666829
fasting O 0 0.002241425681859255
. O 0 0.00040697737131267786

Her O 0 0.010117056779563427
ventricular O 1 0.9999916553497314
hypertrophy O 1 0.9997828602790833
resolved O 0 0.003518364392220974
significantly O 0 0.00015052319213282317
over O 0 2.685150866454933e-05
1 O 0 6.980463513173163e-05
year O 0 2.547923031670507e-05
, O 0 9.183043403027114e-06
and O 0 1.707515366433654e-05
cognitively O 0 0.0010223016142845154
, O 0 2.1781652321806177e-05
she O 0 1.3534297067963053e-05
is O 0 2.7247597245150246e-06
in O 0 3.4416520975355525e-06
the O 0 1.1934385838685557e-05
superior O 0 7.944714889163151e-05
range O 0 3.931910760002211e-05
for O 0 3.267701686127111e-05
age O 0 0.0006370358169078827
. O 0 0.0003800627891905606

Clinical O 0 0.00030318694189190865
recognition O 0 0.0004998611402697861
of O 1 0.9999692440032959
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.00016150051669683307
important O 0 3.946783544961363e-05
because O 0 2.1057692265458172e-06
it O 0 3.349173027800134e-07
is O 0 2.8564855369950237e-07
one O 0 4.449500750070001e-07
of O 0 3.303491894257604e-06
the O 0 1.4386166185431648e-05
few O 0 3.224727333872579e-05
directly O 0 0.00015219024498946965
treatable O 1 0.9999995231628418
causes O 0 0.00403517484664917
of O 1 0.996991753578186
cardiomyopathy B-Disease 1 1.0
in O 1 0.8248710036277771
children O 0 0.0003722921828739345
. O 0 4.824432107852772e-05
. O 0 0.0001249828201252967

Cloning O 0 0.0003248155699111521
of O 0 5.601922021014616e-05
a O 0 1.9489794794935733e-05
novel O 0 1.8364424249739386e-05
member O 0 5.9571843848971184e-06
of O 0 1.3308089364727493e-05
the O 0 4.6234054025262594e-05
low O 0 0.00018488237401470542
- O 0 0.000159103685291484
density O 0 4.286315379431471e-05
lipoprotein O 0 0.0009459677385166287
receptor O 0 0.0003250587615184486
family O 0 0.00023591281205881387
. O 0 0.0001464578090235591

A O 0 0.0003688423603307456
gene O 0 9.62724971032003e-06
encoding O 0 6.428472261177376e-06
a O 0 1.9202978364774026e-05
novel O 0 5.3217696404317394e-05
transmembrane O 0 0.0004960878868587315
protein O 0 5.0215021474286914e-05
was O 0 7.035597809590399e-05
identified O 0 4.58666545455344e-06
by O 0 7.479233090634807e-07
DNA O 0 1.758113398864225e-06
sequence O 0 8.076110589172458e-07
analysis O 0 4.081207691797317e-07
within O 0 2.8592621674761176e-06
the O 0 1.949432771652937e-05
insulin B-Disease 0 0.00023081900144461542
- I-Disease 0 0.0010161870159208775
dependent I-Disease 0 0.0006380346603691578
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.00503165740519762
IDDM B-Disease 1 0.999976396560669
) O 0 3.456954436842352e-05
locus O 0 0.00014371232828125358
IDDM4 O 0 0.15297536551952362
on O 0 0.0003359405091032386
chromosome O 0 0.0013534686295315623
11q13 O 0 0.0037007525097578764
. O 0 0.0002827987482305616

Based O 0 3.540652323863469e-05
on O 0 4.71458952233661e-05
its O 0 1.1740738045773469e-05
chromosomal O 0 0.00017830240540206432
position O 0 4.519911453826353e-05
, O 0 4.4120724851381965e-06
this O 0 1.216314217344916e-06
gene O 0 2.3702634734945605e-06
is O 0 1.6768791510912706e-06
a O 0 1.3577842992162914e-06
candidate O 0 2.3302670797420433e-06
for O 0 1.3190177696742467e-06
conferring O 0 0.0002222016337327659
susceptibility O 0 0.0035834647715091705
to O 0 0.0018823649734258652
diabetes B-Disease 1 1.0
. O 0 0.0019813538528978825

The O 0 0.00023174763191491365
gene O 0 5.424543269327842e-05
, O 0 1.5035326214274392e-05
termed O 0 0.0001462755462853238
low O 0 0.00013920267520006746
- O 0 6.910508818691596e-05
density O 0 8.278406312456354e-06
lipoprotein O 0 0.00012593099381774664
receptor O 0 3.638202542788349e-05
related O 0 5.141622023074888e-05
protein O 0 2.5183189791277982e-05
5 O 0 8.349309064215049e-05
( O 0 3.341141200507991e-05
LRP5 O 0 0.0024949198123067617
) O 0 3.881208158418303e-06
, O 0 8.61882824665372e-07
encodes O 0 1.6055142850746051e-06
a O 0 4.904730303678662e-06
protein O 0 9.05695924302563e-06
of O 0 4.924049062537961e-05
1615 O 0 0.0019930966664105654
amino O 0 2.806998963933438e-05
acids O 0 4.063783308083657e-06
that O 0 1.2116322523070266e-06
contains O 0 6.054193363524973e-06
conserved O 0 2.1801728507853113e-05
modules O 0 1.9517990949680097e-05
which O 0 1.4113094266576809e-06
are O 0 2.7810327196675644e-07
characteristic O 0 4.358001660875743e-06
of O 0 1.668407094257418e-05
the O 0 5.426747156889178e-05
low O 0 0.00014303860371001065
- O 0 0.00010123781248694286
density O 0 3.396629836061038e-05
lipoprotein O 0 0.0008165366016328335
( O 0 0.00021225010277703404
LDL O 0 0.005261261481791735
) O 0 6.942769687157124e-05
receptor O 0 0.0001620546099729836
family O 0 0.00014995160745456815
. O 0 9.523193148197606e-05

These O 0 3.412285150261596e-05
modules O 0 0.00011765176896005869
include O 0 1.6568577848374844e-05
a O 0 1.4823871424596291e-05
putative O 0 6.230343569768593e-05
signal O 0 5.991248690406792e-05
peptide O 0 2.1750291125499643e-05
for O 0 4.726000952359755e-06
protein O 0 1.627730489417445e-05
export O 0 2.8086478778277524e-05
, O 0 3.712011448442354e-06
four O 0 1.220242484123446e-05
epidermal O 0 0.0006001716246828437
growth O 0 0.00014569562335964292
factor O 0 8.333782898262143e-05
( O 0 5.1835275371558964e-05
EGF O 0 0.0025373792741447687
) O 0 1.5090500710357446e-05
repeats O 0 2.9598500987049192e-05
with O 0 5.4444994930236135e-06
associated O 0 2.2475074729300104e-05
spacer O 0 0.00044243200682103634
domains O 0 0.0002682026824913919
, O 0 3.6215351428836584e-05
three O 0 6.0404585383366793e-05
LDL O 0 0.007256327196955681
- O 0 0.0008593401289545
receptor O 0 8.722008351469412e-05
( O 0 4.976960553904064e-05
LDLR O 0 0.006169789936393499
) O 0 1.1590849680942483e-05
repeats O 0 2.6336110749980435e-05
, O 0 3.5010416468139738e-06
a O 0 8.216247806558385e-06
single O 0 1.3395693713391665e-05
transmembrane O 0 0.0006056833080947399
spanning O 0 0.0011409486178308725
domain O 0 0.0001555034250486642
, O 0 1.4871529856463894e-05
and O 0 8.312906174978707e-06
a O 0 2.9399945560726337e-05
cytoplasmic O 0 0.0001815881987567991
domain O 0 0.0005514697986654937
. O 0 0.0003354822110850364

The O 0 7.411333353957161e-05
encoded O 0 2.6935062123811804e-05
protein O 0 1.1940395779674873e-05
has O 0 1.671511199674569e-06
a O 0 2.5745014227140928e-06
unique O 0 2.694099521249882e-06
organization O 0 8.838057510729413e-06
of O 0 7.458089385181665e-05
EGF O 1 0.9049792289733887
and O 0 0.00016036008310038596
LDLR O 1 0.9978693723678589
repeats O 0 0.0003215717151761055
; O 0 1.212877486977959e-05
therefore O 0 3.758544335141778e-05
, O 0 3.749576353584416e-05
LRP5 O 0 0.013812502846121788
likely O 0 3.389498670003377e-05
represents O 0 4.155049737164518e-06
a O 0 3.9142755667853635e-06
new O 0 1.4742319081051392e-06
category O 0 6.11326777288923e-06
of O 0 2.8383581593516283e-05
the O 0 0.00020058297377545387
LDLR O 1 0.9999576807022095
family O 0 0.0002448352752253413
. O 0 0.00013153202598914504

Both O 0 0.00015423257718794048
human O 0 0.0001342643954558298
and O 0 0.00013113116438034922
mouse O 0 0.0007734984392300248
LRP5 O 1 0.9996115565299988
cDNAs O 0 0.0024530268274247646
have O 0 5.6834969655028544e-06
been O 0 7.987382559804246e-06
isolated O 0 1.0018402463174425e-05
and O 0 8.256914725279785e-07
the O 0 3.864230620820308e-06
encoded O 0 6.190521617099876e-06
mature O 0 1.140068798122229e-05
proteins O 0 6.998770345489902e-07
are O 0 4.1033516140487336e-07
95 O 0 5.873514510312816e-06
% O 0 4.208055088383844e-06
identical O 0 6.146354280645028e-06
, O 0 4.354462362243794e-06
indicating O 0 3.2473606552230194e-05
a O 0 1.243780025106389e-05
high O 0 4.0915409044828266e-05
degree O 0 3.572990681277588e-05
of O 0 8.479591633658856e-05
evolutionary O 0 0.00018156139412894845
conservation O 0 0.0001074772808351554
. O 0 2.8776408726116642e-05
. O 0 6.712936738040298e-05

The O 0 0.0007541393279097974
APC B-Disease 0 0.002731125336140394
variants O 0 0.00012984870409127325
I1307K O 0 0.000734894594643265
and O 0 1.014261488307966e-05
E1317Q O 0 0.0001406350638717413
are O 0 1.7856565364127164e-06
associated O 0 3.977149026468396e-05
with O 0 0.06450062245130539
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0019940787460654974
but O 0 1.1868351066368632e-05
not O 0 2.652265720826108e-06
always O 0 5.427211362984963e-06
with O 0 2.558731239332701e-06
a O 0 2.932879033323843e-05
family O 0 5.176197373657487e-05
history O 0 0.0003826731408480555
. O 0 0.00019371455709915608

Classical O 0 0.0228634811937809
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.980252742767334
FAP B-Disease 1 0.9971453547477722
) O 0 3.2957366784103215e-05
is O 0 6.901832875882974e-06
a O 0 1.2999439604755025e-05
high O 0 0.0002708866377361119
- O 0 0.0009205465321429074
penetrance O 0 0.01188074890524149
autosomal B-Disease 1 0.999306321144104
dominant I-Disease 1 0.9999948740005493
disease I-Disease 1 1.0
that O 0 1.3885992302675731e-05
predisposes O 0 0.0003431342775002122
to O 0 1.1477060979814269e-05
hundreds O 0 1.5389819964184426e-05
or O 0 3.580219299692544e-06
thousands O 0 6.000941357342526e-05
of O 1 0.5841178297996521
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
carcinoma I-Disease 1 1.0
and O 0 0.00015470907965209335
that O 0 4.94676396556315e-06
results O 0 3.92305082641542e-06
from O 0 1.728298593661748e-05
truncating O 0 0.00022872857516631484
mutations O 0 2.780187423923053e-05
in O 0 4.215473018120974e-05
the O 0 0.0001598343369551003
APC B-Disease 0 0.002790751401335001
gene O 0 0.00017768835823517293
. O 0 0.0002280602348037064

A O 0 0.0004625667352229357
variant O 0 9.301287354901433e-05
of O 0 0.00015647006512153894
FAP B-Disease 1 0.7342798709869385
is O 0 0.000147855666000396
attenuated B-Disease 0 0.006643116474151611
adenomatous I-Disease 1 0.9999990463256836
polyposis I-Disease 1 0.9999983310699463
coli I-Disease 1 0.9963365793228149
, O 0 2.1965972337056883e-05
which O 0 2.6091972813446773e-06
results O 0 8.139272722473834e-06
from O 0 6.811039929743856e-05
germ O 1 0.9998986721038818
- O 0 0.0005245661013759673
line O 0 6.514361302834004e-05
mutations O 0 5.435975253931247e-06
in O 0 6.825570380897261e-06
the O 0 1.1648404324660078e-05
5 O 0 1.8994653146364726e-05
and O 0 2.5438284865231253e-06
3 O 0 1.5393958165077493e-05
regions O 0 8.218880793720018e-06
of O 0 3.352593193994835e-05
the O 0 0.00022876195725984871
APC B-Disease 0 0.0038963640108704567
gene O 0 0.0002179401199100539
. O 0 0.0001822946360334754

Attenuated B-Disease 1 0.9997959733009338
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.0007698983536101878
have O 0 2.1633390133501962e-05
" O 0 6.377694080583751e-05
multiple O 0 0.00016105394752230495
" O 1 0.9997878670692444
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.00026395582244731486
typically O 0 9.266317647416145e-06
fewer O 0 6.581859452126082e-06
than O 0 3.1158433557720855e-06
100 O 0 1.4010896848049015e-05
) O 0 2.9850345981685678e-06
without O 0 3.0462551876553334e-06
the O 0 2.6475945560378022e-05
florid O 0 0.000849258154630661
phenotype O 0 5.6639535614522174e-05
of O 0 0.00031024112831801176
classical O 0 0.004988665692508221
FAP B-Disease 1 0.9950297474861145
. O 0 0.0008055775542743504

Another O 0 0.000145327954669483
group O 0 1.75280001712963e-05
of O 0 7.49932587496005e-05
patients O 0 9.392637730343267e-05
with O 0 2.9151025955798104e-05
multiple O 0 0.0004580849199555814
adenomas B-Disease 1 0.9999916553497314
has O 0 3.154182923026383e-05
no O 0 8.102981155388989e-06
mutations O 0 4.2413180381117854e-06
in O 0 9.61845762503799e-06
the O 0 3.7347632314777e-05
APC B-Disease 0 0.0004769270890392363
gene O 0 1.4638180800830014e-05
, O 0 4.412708221934736e-06
and O 0 2.1649775590049103e-06
their O 0 4.488344529818278e-06
phenotype O 0 2.0080591639271006e-05
probably O 0 1.451724619982997e-05
results O 0 1.7834493064583512e-06
from O 0 5.271971076581394e-06
variation O 0 1.5326895663747564e-05
at O 0 8.748314576223493e-05
a O 0 1.569628329889383e-05
locus O 0 7.907934923423454e-05
, O 0 1.4241297321859747e-05
or O 0 2.0638315618271008e-05
loci O 0 7.514186290791258e-05
, O 0 1.3181752365198918e-05
elsewhere O 0 1.537432945042383e-05
in O 0 9.619338925404008e-06
the O 0 4.851337871514261e-05
genome O 0 0.0001205615553772077
. O 0 0.0001098478605854325

Recently O 0 0.0005307457176968455
, O 0 1.2844514458265621e-05
however O 0 4.85551845486043e-06
, O 0 2.75473917099589e-06
a O 0 6.022945854056161e-06
missense O 0 7.758328865747899e-05
variant O 0 7.827812805771828e-05
of O 0 0.0002793051826301962
APC B-Disease 0 0.007265968713909388
( O 0 0.00013056484749540687
I1307K O 0 0.0005943705327808857
) O 0 9.89753971225582e-06
was O 0 4.234053994878195e-05
described O 0 6.741027391399257e-06
that O 0 4.069578665166773e-07
confers O 0 5.313896508596372e-06
an O 0 8.740714747546008e-07
increased O 0 1.3149760889064055e-05
risk O 0 0.0001222081482410431
of O 1 0.9998868703842163
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0008368514245375991
including O 0 7.899312913650647e-05
multiple O 0 0.0007888553664088249
adenomas B-Disease 1 0.9999971389770508
, O 0 0.00019814753613900393
in O 0 0.00040292422636412084
Ashkenazim O 0 0.14818520843982697
. O 0 0.0005518457619473338

We O 0 5.046826117904857e-05
have O 0 2.9311402158782585e-06
studied O 0 1.435860394849442e-05
a O 0 2.9398406695690937e-06
set O 0 2.3049028641253244e-06
of O 0 6.717680662404746e-06
164 O 0 5.266527659841813e-05
patients O 0 2.008258343266789e-05
with O 0 2.1570062017417513e-05
multiple O 1 0.9999544620513916
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9998130202293396
/ I-Disease 1 0.9999970197677612
or I-Disease 1 0.9723000526428223
carcinoma I-Disease 1 1.0
and O 0 0.000253598002018407
analyzed O 0 0.00018377124797552824
codons O 0 0.00033074122620746493
1263 O 0 0.008123110979795456
- O 0 0.001529047847725451
1377 O 0 0.0069906809367239475
( O 0 8.290717232739553e-05
exon O 0 0.0004217244277242571
15G O 0 0.00023344413784798235
) O 0 2.479073145877919e-06
of O 0 9.513011718809139e-06
the O 0 6.085887071094476e-05
APC B-Disease 0 0.0007488310802727938
gene O 0 3.113242200925015e-05
for O 0 5.4522686696145684e-05
germ O 1 0.9999680519104004
- O 0 0.0024728456046432257
line O 0 0.0006800191476941109
variants O 0 0.00031081639463081956
. O 0 0.0002597323909867555

Three O 0 0.00022615495254285634
patients O 0 4.3626649130601436e-05
with O 0 6.1698101490037516e-06
the O 0 4.7993133193813264e-05
I1307K O 0 0.0005421317182481289
allele O 0 1.5731875464553013e-05
were O 0 2.595428486529272e-05
detected O 0 4.692548100138083e-05
, O 0 2.8628555810428225e-06
each O 0 7.962261747707089e-07
of O 0 3.723571353475563e-05
Ashkenazi O 0 0.0004926170222461224
descent O 0 0.0013765759067609906
. O 0 0.0007617931696586311

Four O 0 0.00017191020015161484
patients O 0 9.48464876273647e-05
had O 0 0.0001827504311222583
a O 0 0.0003028968349099159
germ O 1 0.9999983310699463
- O 0 0.0021069610957056284
line O 0 0.00046653824392706156
E1317Q O 0 0.0005189490620978177
missense O 0 0.00012240104842931032
variant O 0 3.275376366218552e-05
of O 0 8.402999810641631e-05
APC O 0 0.0006593819707632065
that O 0 4.823976723855594e-06
was O 0 4.259487468516454e-05
not O 0 1.530346821709827e-06
present O 0 5.305015292833559e-06
in O 0 7.111553713912144e-06
controls O 0 1.848157262429595e-05
; O 0 1.6169956325029489e-06
one O 0 2.602966333142831e-06
of O 0 8.498588613292668e-06
these O 0 3.875955371768214e-06
individuals O 0 3.3352994250890333e-06
had O 0 4.3187585106352344e-05
an O 0 9.935691196005791e-06
unusually O 0 4.29727224400267e-05
large O 0 1.0454757102706935e-05
number O 0 8.652926226204727e-06
of O 0 8.260563481599092e-05
metaplastic B-Disease 0 0.08873426914215088
polyps I-Disease 0 0.0017850165022537112
of I-Disease 0 0.00018648036348167807
the I-Disease 0 0.0004385040665511042
colorectum I-Disease 0 0.14121578633785248
. O 0 0.00042759947245940566

There O 0 6.52832823107019e-05
is O 0 7.137617558328202e-06
increasing O 0 5.931119176239008e-06
evidence O 0 6.118592864368111e-06
that O 0 1.6516847836101078e-06
there O 0 9.380428309668787e-06
exist O 0 6.169823609525338e-05
germ O 1 0.8448306322097778
- O 0 0.00018756405916064978
line O 0 4.018962863483466e-05
variants O 0 5.316228453011718e-06
of O 0 1.778204386937432e-05
the O 0 5.147803676663898e-05
APC B-Disease 0 0.00041555240750312805
gene O 0 1.0396019206382334e-05
that O 0 1.138583684223704e-06
predispose O 0 4.2653322452679276e-05
to O 0 3.025015075763804e-06
the O 0 4.94846199217136e-06
development O 0 1.1851567251142114e-05
of O 0 4.3322015699232e-05
multiple O 1 0.999887228012085
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.000978386029601097
but O 0 2.5012843252625316e-05
without O 0 2.171739652112592e-05
the O 0 4.692369111580774e-05
florid O 0 0.0007792353862896562
phenotype O 0 5.917812086408958e-05
of O 0 0.0001587225851835683
classical O 0 0.0014691413380205631
FAP B-Disease 0 0.39597082138061523
, O 0 1.149200033978559e-05
and O 0 1.6414309129686444e-06
possibly O 0 4.9647696869215e-06
with O 0 8.403322340200248e-07
importance O 0 0.00018482384621165693
for O 0 0.052307579666376114
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.05620606243610382
in O 0 3.365862357895821e-05
the O 0 1.3061298886896111e-05
general O 0 2.2420486857299693e-05
population O 0 6.732688689226052e-06
. O 0 1.5440358765772544e-05
. O 0 8.075996447587386e-05

Genomic O 0 0.00016931594291236252
structure O 0 9.962384501704946e-05
of O 0 5.714621511287987e-05
the O 0 0.0002884001296479255
human O 1 0.9997950196266174
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999969005584717
CLD B-Disease 1 0.9999998807907104
) O 0 0.00040413805982097983
gene O 0 0.0002470205654390156
. O 0 0.00024287852284032851

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999980926513672
CLD B-Disease 1 1.0
) O 0 8.640417945571244e-05
is O 0 1.4948172974982299e-05
caused O 0 3.9282447687583044e-05
by O 0 1.9933697785745608e-06
mutations O 0 3.028088940482121e-06
in O 0 4.080544840689981e-06
a O 0 5.342321401258232e-06
gene O 0 2.4926860078267055e-06
which O 0 1.436421939615684e-06
encodes O 0 9.791024240257684e-06
an O 0 3.539747922332026e-05
intestinal O 1 0.9999972581863403
anion O 0 0.03363947570323944
transporter O 1 0.9916503429412842
. O 0 0.0008046432049013674

We O 0 6.402684084605426e-05
report O 0 4.557891315926099e-06
here O 0 3.686835498228902e-06
the O 0 1.8034123741017538e-06
complete O 0 1.1236395039304625e-05
genomic O 0 2.007477087317966e-05
organization O 0 7.1347317316394765e-06
of O 0 2.3287999283638783e-05
the O 0 4.302721572457813e-05
human O 0 0.00014614129031542689
CLD B-Disease 1 0.6953127384185791
gene O 0 3.4754186344798654e-05
which O 0 5.516805686056614e-06
spans O 0 0.0001680809073150158
approximately O 0 5.979439083603211e-05
39kb O 0 0.0005258581368252635
, O 0 7.053931312839268e-06
and O 0 4.0300251384906005e-06
comprises O 0 5.317518662195653e-05
21 O 0 0.00030477045220322907
exons O 0 0.0007087012636475265
. O 0 0.00023679844161961228

All O 0 0.000524303934071213
exon O 0 0.0044907801784574986
/ O 0 0.0013223496498540044
intron O 0 0.001668199896812439
boundaries O 0 3.0823706765659153e-05
conform O 0 2.1662519429810345e-05
to O 0 1.766227069310844e-05
the O 0 8.244682248914614e-05
GT O 0 0.0042356643825769424
/ O 0 0.0036542899906635284
AG O 1 0.9979446530342102
rule O 0 0.0014737084275111556
. O 0 0.000445492216385901

An O 0 2.123002559528686e-05
analysis O 0 3.868861767841736e-06
of O 0 1.9764298485824838e-05
the O 0 6.527369987452403e-05
putative O 0 0.0004217826935928315
promoter O 0 0.00099857896566391
region O 0 5.9894329751841724e-05
sequence O 0 9.058108844328672e-06
shows O 0 2.0238659999449737e-05
a O 0 3.509517409838736e-05
putative O 0 0.0008000450907275081
TATA O 1 0.8185639381408691
box O 0 0.00024972681421786547
and O 0 5.6644394135219045e-06
predicts O 0 1.6670948753017e-05
multiple O 0 2.9691723284486216e-06
transcription O 0 0.00010072322766063735
factor O 0 9.171875717584044e-05
binding O 0 1.6734216842451133e-05
sites O 0 0.00011269847163930535
. O 0 0.0001205330336233601

The O 0 0.00018239321070723236
genomic O 0 0.00010389144881628454
structure O 0 0.00014809735876042396
was O 0 0.00011336445459164679
determined O 0 5.5700143093417864e-06
using O 0 1.3098742783768103e-06
DNA O 0 7.814762284397148e-06
from O 0 4.020930646220222e-06
several O 0 1.8348313233218505e-06
sources O 0 5.0264320634596515e-06
including O 0 4.492168500291882e-06
multiple O 0 4.5486704038921744e-05
large O 0 0.00034691838664002717
- O 0 0.000792111037299037
insert O 0 0.00022281943529378623
libaries O 0 0.0004261658468749374
and O 0 3.7910147057118593e-06
genomic O 0 1.4947174349799752e-05
DNA O 0 4.714562601293437e-05
from O 0 5.7126108004013076e-05
Finnish O 0 0.30182111263275146
CLD B-Disease 1 0.9999978542327881
patients O 0 0.0006744054844602942
and O 0 0.00010678496619220823
controls O 0 0.0004578524094540626
. O 0 0.0002720555057749152

Exon O 0 0.008580071851611137
- O 0 0.00034549340489320457
specific O 0 8.718414392205887e-06
primers O 0 6.650873547187075e-05
developed O 0 3.462187305558473e-05
in O 0 3.5111058878101176e-06
this O 0 7.940415116536315e-07
study O 0 1.5326485254263389e-06
will O 0 1.021668595058145e-06
facilitate O 0 1.1012362847395707e-05
mutation O 0 2.1105745418026345e-06
screening O 0 3.977525011578109e-06
studies O 0 5.714203780371463e-06
of O 0 2.6873283786699176e-05
patients O 0 3.861338700517081e-05
with O 0 2.0749243049067445e-05
the O 0 0.0012940511805936694
disease O 1 0.9999996423721313
. O 0 0.000734551518689841

Genomic O 0 9.528453665552661e-05
sequencing O 0 3.768198439502157e-05
of O 0 8.376997720915824e-05
a O 0 0.0002589048817753792
BAC O 1 0.995573878288269
clone O 0 0.007090406958013773
H O 1 0.9999909400939941
_ O 0 8.83296161191538e-05
RG364P16 O 0 0.00038816643063910306
revealed O 0 3.559944161679596e-05
the O 0 3.879043106280733e-06
presence O 0 4.195133442408405e-06
of O 0 9.628479347156826e-06
another O 0 1.348648493149085e-05
, O 0 4.624274879461154e-06
highly O 0 1.8936740161734633e-05
homologous O 0 2.7033416699850932e-05
gene O 0 1.1606479347392451e-05
3 O 0 2.6070254534715787e-05
of O 0 3.110926991212182e-05
the O 0 0.00012142546620452777
CLD B-Disease 0 0.48952770233154297
gene O 0 2.559727363404818e-05
, O 0 2.118709744536318e-06
with O 0 6.129311032054829e-07
a O 0 3.059700929952669e-06
similar O 0 9.033245191858441e-07
genomic O 0 2.297397077200003e-05
structure O 0 5.947592944721691e-05
, O 0 3.4854836030717706e-06
recently O 0 1.1113688742625527e-05
identified O 0 2.7849207526742248e-06
as O 0 3.6358608213049592e-06
the O 0 3.595598172978498e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.0013655637158080935
( O 0 0.0003827508189715445
PDS B-Disease 1 0.9997270703315735
) O 0 6.445855979109183e-05
. O 0 3.353904321556911e-05
. O 0 6.0539816331584007e-05

The O 0 0.0008041153778322041
APCI1307K O 1 0.9975773692131042
allele O 0 0.00013464156654663384
and O 0 9.66840743785724e-05
cancer B-Disease 1 0.9581258296966553
risk O 0 8.981942664831877e-05
in O 0 2.014803612837568e-05
a O 0 1.1919234566448722e-05
community O 0 5.748968305852031e-06
- O 0 1.4909787751093972e-05
based O 0 7.286716368071211e-07
study O 0 1.315200506724068e-06
of O 0 2.4834582291077822e-05
Ashkenazi O 0 0.0002937078243121505
Jews O 0 0.0013639356475323439
. O 0 0.00044541325769387186

Mutations O 0 0.00045636246795766056
in O 0 0.0001788073859643191
APC O 0 0.0009595576557330787
are O 0 5.524244443222415e-06
classically O 0 0.00014780463243369013
associated O 0 1.729114774207119e-05
with O 0 4.723959864350036e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999887228012085
FAP B-Disease 1 0.9999281167984009
) O 0 1.8074024410452694e-05
, O 0 2.339777665838483e-06
a O 0 6.522796411445597e-06
highly O 0 0.0003291520697530359
penetrant O 1 0.9999940395355225
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.999997615814209
by O 0 0.03088844008743763
multiple O 1 0.9999990463256836
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.00024771515745669603
, O 0 2.5129425921477377e-05
without O 0 2.7611287805484608e-05
surgical O 0 0.0006170765263959765
intervention O 0 0.00011462756083346903
, O 0 5.456309281726135e-06
the O 0 5.846973181178328e-06
development O 0 3.299333911854774e-05
of O 1 0.7053960561752319
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9997736811637878
CRC B-Disease 1 0.9998310804367065
) O 0 0.0002095767413266003
. O 0 0.0002057553647318855

APC B-Disease 0 0.004022305831313133
is O 0 7.548429857706651e-05
a O 0 0.00024545230553485453
tumour O 1 1.0
- O 0 0.18903487920761108
suppressor O 0 0.0007523300591856241
gene O 0 3.735364953172393e-05
, O 0 7.1297531576419715e-06
and O 0 1.142887140304083e-05
somatic O 0 0.00023461089585907757
loss O 0 0.015454351902008057
occurs O 0 0.0002794591709971428
in O 0 0.000747821235563606
tumours B-Disease 1 1.0
. O 0 0.0017469573067501187

The O 0 0.0012120334431529045
germline O 0 0.010511226952075958
T O 0 0.014844433404505253
- O 0 0.0003646981786005199
to O 0 4.16710608988069e-05
- O 0 0.0001588031300343573
A O 0 0.00016294771921820939
transversion O 0 0.00048086477909237146
responsible O 0 1.1756422281905543e-05
for O 0 5.467727532959543e-06
the O 0 5.506558591150679e-05
APC O 0 0.0007941648946143687
I1307K O 0 0.0003070397360716015
allele O 0 7.375454515567981e-06
converts O 0 1.8555816495791078e-05
the O 0 1.9833027181448415e-05
wild O 0 4.2024519643746316e-05
- O 0 1.611023981240578e-05
type O 0 2.1756945898232516e-06
sequence O 0 1.317010401180596e-06
to O 0 3.6633109630201943e-06
a O 0 4.561676178127527e-05
homopolymer O 1 0.9742810130119324
tract O 1 0.9997448325157166
( O 0 0.0002766158722806722
A8 O 0 0.0832039937376976
) O 0 1.6923835573834367e-05
that O 0 3.061355755562545e-06
is O 0 1.2771399269695394e-05
genetically O 0 0.00011550523777259514
unstable O 0 0.0006411244976334274
and O 0 4.670311318477616e-05
prone O 0 0.0009281123639084399
to O 0 5.159716965863481e-05
somatic O 0 0.0005801226943731308
mutation O 0 0.0002552207442931831
. O 0 0.0002997228875756264

The O 0 0.0003704619302880019
I1307K O 0 0.0012081641471013427
allele O 0 7.060209463816136e-05
was O 0 0.00019737707043532282
found O 0 1.884971425170079e-05
in O 0 3.998056490672752e-05
6 O 0 0.0006504580960609019
. O 0 0.0002357441553613171

1 O 0 0.0005969660123810172
% O 0 9.833504736889154e-05
of O 0 0.000316725141601637
unselected O 0 0.011293199844658375
Ashkenazi O 0 0.000615155731793493
Jews O 0 0.0005239946185611188
and O 0 3.496285353321582e-05
higher O 0 5.1223883929196745e-05
proportions O 0 0.00010834648855961859
of O 0 8.473407797282562e-05
Ashkenazim O 0 0.001622270094230771
with O 0 3.4414617402944714e-05
family O 0 4.554473707685247e-05
or O 0 1.1172218364663422e-05
personal O 0 9.047749335877597e-05
histories O 0 0.0003160937631037086
of O 0 0.002577204490080476
CRC B-Disease 1 0.9996803998947144
( O 0 0.00044003434595651925
ref O 0 0.003472869982942939
. O 0 3.4324977605137974e-05
2 O 0 0.00014157150872051716
) O 0 5.611412416328676e-05
. O 0 0.00010836013098014519

To O 0 4.9021222366718575e-05
evaluate O 0 2.0366096578072757e-05
the O 0 1.1744175026251469e-05
role O 0 2.8336602554190904e-05
of O 0 6.613156438106671e-05
I1307K O 0 0.0010622189147397876
in O 0 0.00012890125799458474
cancer B-Disease 0 0.017720729112625122
, O 0 2.105941530317068e-05
we O 0 2.105288876919076e-05
genotyped O 0 0.0011864501284435391
5 O 0 0.00016856304137036204
, O 0 3.116699735983275e-05
081 O 0 0.0018653005827218294
Ashkenazi O 0 0.00022422196343541145
volunteers O 0 6.433531234506518e-05
in O 0 2.1961552192806266e-05
a O 0 2.0729703464894556e-05
community O 0 1.5899731806712225e-05
survey O 0 6.073746408219449e-05
. O 0 0.00016286665049847215

Risk O 0 0.0004349782830104232
of O 0 0.0004131408059038222
developing O 1 0.999367892742157
colorectal B-Disease 1 1.0
, I-Disease 0 0.002658362966030836
breast I-Disease 1 0.9589665532112122
and I-Disease 0 2.973622758872807e-05
other I-Disease 0 2.0843170204898342e-05
cancers I-Disease 0 0.0878036841750145
were O 0 3.59823607141152e-05
compared O 0 6.584172660950571e-05
between O 0 0.00034570504794828594
genotyped O 0 0.01476872619241476
I1307K O 0 0.0016441377811133862
carriers O 0 8.37399493320845e-05
and O 0 1.6733929442125373e-05
non O 0 0.0001366896030958742
- O 0 0.0001670648343861103
carriers O 0 8.438179065706208e-06
and O 0 1.35372965814895e-06
their O 0 2.4001826659514336e-06
first O 0 3.1907537049846724e-05
- O 0 9.83663703664206e-05
degree O 0 0.0001593368942849338
relatives O 0 0.00025564691168256104
. O 0 0.00013385327474679798

Sperm O 0 0.00010368876246502623
DNA O 0 3.1160347134573385e-05
analysis O 0 3.7347833767853444e-06
in O 0 1.701074324955698e-05
a O 0 0.00019314870587550104
Friedreich B-Disease 1 0.9997115731239319
ataxia I-Disease 1 0.9999769926071167
premutation O 1 0.9998145699501038
carrier O 0 0.0013896259479224682
suggests O 0 7.817653386155143e-05
both O 0 2.113617301802151e-05
meiotic O 0 0.0013187890872359276
and O 0 5.343978773453273e-05
mitotic O 0 0.0002038176025962457
expansion O 0 0.0002016076323343441
in O 0 3.788823960348964e-05
the O 0 0.00010307518095942214
FRDA B-Disease 1 0.9712942242622375
gene O 0 0.00026931246975436807
. O 0 0.00017003994435071945

Friedreich B-Disease 1 0.9999973773956299
ataxia I-Disease 1 0.9999901056289673
is O 0 0.00027478247648105025
usually O 0 5.0063212256645784e-05
caused O 0 7.57076995796524e-05
by O 0 2.6514944693190046e-06
an O 0 3.0710464216099354e-06
expansion O 0 8.515424269717187e-05
of O 0 6.163102807477117e-05
a O 0 0.00017491867765784264
GAA O 0 0.004806656390428543
trinucleotide O 0 0.013635893352329731
repeat O 0 0.0003509464440867305
in O 0 3.646420736913569e-05
intron O 0 0.0005985849420540035
1 O 0 6.907149509061128e-05
of O 0 3.7323348806239665e-05
the O 0 0.00012536643771454692
FRDA B-Disease 1 0.9987049102783203
gene O 0 0.0002361697843298316
. O 0 0.00010669906623661518

Occasionally O 0 0.00024167733499780297
, O 0 1.6078622138593346e-05
a O 0 6.077946636651177e-06
fully O 0 2.5518087568343617e-05
expanded O 0 1.3799128282698803e-05
allele O 0 3.917210960935336e-06
has O 0 2.437466037008562e-06
been O 0 3.000601509484113e-06
found O 0 1.0872340681089554e-06
to O 0 3.936242137569934e-06
arise O 0 2.4695995307411067e-05
from O 0 1.853280991781503e-05
a O 0 3.118994936812669e-05
premutation O 0 0.00073926494223997
of O 0 0.00013273072545416653
100 O 0 0.00016677375242579728
or O 0 4.6833210944896564e-05
less O 0 0.00018781227117870003
triplet O 0 0.0017953695496544242
repeats O 0 0.0013043326325714588
. O 0 0.00045245193177834153

We O 0 6.858527194708586e-05
have O 0 4.69006863568211e-06
examined O 0 2.048085480055306e-05
the O 0 1.121159402828198e-05
sperm O 0 4.422469828568865e-06
DNA O 0 3.6547548916132655e-06
of O 0 1.093671380658634e-05
a O 0 7.284599996637553e-05
premutation O 0 0.006393765099346638
carrier O 0 0.0009660899522714317
. O 0 0.00021011354692745954

This O 0 4.187785816611722e-05
mans O 0 0.0005018226802349091
leucocyte O 0 0.0015766187570989132
DNA O 0 0.00012947851791977882
showed O 0 6.63789760437794e-05
one O 0 1.0735956493590493e-05
normal O 0 1.7091349945985712e-05
allele O 0 5.841288384544896e-06
and O 0 2.9751133752142778e-06
one O 0 4.020374490210088e-06
allele O 0 3.5756399938691175e-06
of O 0 1.5888819689280353e-05
approximately O 0 0.00013320289144758135
100 O 0 0.00012508512008935213
repeats O 0 0.00026985068689100444
. O 0 0.0001395322469761595

His O 0 0.0011106561869382858
sperm O 0 8.001410606084391e-05
showed O 0 4.092442395631224e-05
an O 0 4.279453150957124e-06
expanded O 0 3.648528581834398e-05
allele O 0 6.846562882856233e-06
in O 0 2.1922653104411438e-05
a O 0 5.519249680219218e-05
tight O 0 0.00019664746650960296
range O 0 3.7167486880207434e-05
centering O 0 0.00014544023724738508
on O 0 2.270307595608756e-05
a O 0 7.0571809374087024e-06
size O 0 5.028181931265863e-06
of O 0 2.1965342966723256e-05
approximately O 0 0.0002024834102485329
320 O 0 0.00035859248600900173
trinucleotide O 0 0.03342846781015396
repeats O 0 0.0008511493797414005
. O 0 0.0002816009218804538

His O 0 0.0014322275528684258
affected O 0 0.0006418722332455218
son O 0 0.0023108897730708122
has O 0 2.7685777240549214e-05
repeat O 0 0.00010966177796944976
sizes O 0 1.751536547089927e-05
of O 0 0.00013138637586962432
1040 O 0 0.0015913198003545403
and O 0 0.00018819481192622334
540 O 0 0.0024724784307181835
. O 0 0.0004817854496650398

These O 0 1.566016362630762e-05
data O 0 1.1992730833298992e-05
suggest O 0 8.56994120113086e-06
that O 0 2.4616347218398005e-06
expansion O 0 7.886878302088007e-05
occurs O 0 5.231643172010081e-06
in O 0 4.439350959728472e-06
two O 0 2.5739807369973278e-06
stages O 0 6.413996015908197e-05
, O 0 6.676084922219161e-06
the O 0 5.908430011913879e-06
first O 0 1.3087632396491244e-05
during O 0 9.589899855200201e-05
meiosis O 0 0.00015947961946949363
followed O 0 3.487377398414537e-05
by O 0 4.34353387390729e-06
a O 0 1.777360012056306e-05
second O 0 5.231588511378504e-05
mitotic O 0 0.0006812697392888367
expansion O 0 0.0014001202071085572
. O 0 0.00022167597489897162

We O 0 6.2980005168356e-05
also O 0 9.653103006712627e-06
show O 0 1.2601476555573754e-05
that O 0 1.1056664561692742e-06
in O 0 2.4719058728805976e-06
all O 0 1.5447783425770467e-06
informative O 0 2.1933276002528146e-05
carrier O 0 5.924983270233497e-05
father O 0 7.331207598326728e-05
to O 0 2.3310392862185836e-05
affected O 0 6.699723599012941e-05
child O 0 5.4022209951654077e-05
transmissions O 0 6.12675430602394e-05
, O 0 2.925080480054021e-06
with O 0 5.479574838318513e-07
the O 0 6.2744215938437264e-06
notable O 0 9.18302612262778e-06
exception O 0 6.635955287492834e-06
of O 0 2.054014112218283e-05
the O 0 7.073047891026363e-05
premutation O 0 0.0022898775059729815
carrier O 0 0.00013025867519900203
, O 0 5.816640168632148e-06
the O 0 8.700273610884324e-06
expansion O 0 8.631688251625746e-05
size O 0 2.103458609781228e-05
decreases O 0 7.06200153217651e-05
. O 0 1.8901482690125704e-05
. O 0 6.49004359729588e-05

The O 0 0.0004401805636007339
R496H O 0 0.001092446967959404
mutation O 0 2.4894525267882273e-05
of O 0 7.934145105537027e-05
arylsulfatase O 0 0.006657988298684359
A O 0 0.0003934693813789636
does O 0 1.0310633115295786e-05
not O 0 1.7681633835309185e-05
cause O 0 0.008340675383806229
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.0025883857160806656

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.007933230139315128
arylsulfatase I-Disease 1 0.9991620779037476
A I-Disease 0 0.006089902948588133
( O 0 0.0001850795524660498
ARSA O 1 0.602149486541748
) O 0 1.7600812498130836e-05
enzyme O 0 1.302229611610528e-05
activity O 0 7.589266897412017e-05
causes O 0 0.0014520245604217052
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.01993779093027115
MLD B-Disease 1 1.0
) O 0 0.0004120047378819436
. O 0 0.00021631272102240473

A O 0 0.00015277022612281144
number O 0 7.876437848608475e-06
of O 0 6.560519250342622e-05
ARSA O 1 0.9790652990341187
gene O 0 4.614688441506587e-05
mutations O 0 2.392127316852566e-05
responsible O 0 3.7868514482397586e-05
for O 0 5.9975536714773625e-05
MLD B-Disease 1 1.0
have O 0 4.016104867332615e-05
been O 0 6.844022573204711e-05
identified O 0 7.065787212923169e-05
. O 0 0.0001203022402478382

Recently O 0 0.0005391994491219521
, O 0 1.3864397260476835e-05
the O 0 1.5530133168795146e-05
R496H O 0 0.00033071311190724373
mutation O 0 8.35041737445863e-06
of O 0 7.94958759797737e-05
ARSA O 1 0.9027886390686035
was O 0 0.00012671637523453683
proposed O 0 4.773262844537385e-06
to O 0 2.030447831202764e-06
be O 0 2.393012891843682e-06
a O 0 6.014113296259893e-06
cause O 0 4.886905662715435e-05
of O 0 0.00034015002893283963
MLD B-Disease 1 1.0
( O 0 0.0003312960034236312
Draghia O 0 0.004728438798338175
et O 0 0.0007002061465755105
al O 0 0.00042727935942821205
. O 0 8.241013347287662e-06
, O 0 8.378040547540877e-06
1997 O 0 9.329988824902102e-05
) O 0 4.193940185359679e-05
. O 0 9.703116666059941e-05

We O 0 5.8962821640307084e-05
have O 0 4.744090801978018e-06
investigated O 0 3.3853924833238125e-05
the O 0 1.9671144400490448e-05
R496H O 0 0.00047500908840447664
mutation O 0 5.405707270256244e-06
and O 0 2.371819164181943e-06
found O 0 2.690494738999405e-06
this O 0 1.171593567050877e-06
mutation O 0 3.437689429119928e-06
at O 0 3.8743884942959994e-05
a O 0 1.2902904018119443e-05
relatively O 0 9.753112863108981e-06
high O 0 1.2483002137742005e-05
frequency O 0 1.7250807786695077e-06
in O 0 2.2015385638951557e-06
an O 0 1.6299203480230062e-06
African O 0 1.0032735190179665e-05
American O 0 5.42078214493813e-06
population O 0 1.2210443856019992e-06
( O 0 1.7781709402697743e-06
f O 0 1.1186974006704986e-05
= O 0 2.933100040536374e-05
0 O 0 1.4526872291753534e-05
. O 0 6.262823262659367e-06
09 O 0 0.00011820154031738639
, O 0 6.623556600970915e-06
n O 0 3.291640314273536e-05
= O 0 0.00012022918235743418
61 O 0 0.00013438425958156586
subjects O 0 0.0003077735600527376
) O 0 8.906292350729927e-05
. O 0 0.0001850795524660498

The O 0 0.000977281597442925
ARSA O 0 0.17037416994571686
enzyme O 0 5.9187030274188146e-05
activity O 0 3.694133920362219e-05
in O 0 1.557731411594432e-05
subjects O 0 3.9793038013158366e-05
with O 0 6.911885066074319e-06
and O 0 7.722650479990989e-06
without O 0 1.2058168977091555e-05
the O 0 3.907166319550015e-05
R496H O 0 0.00047236832324415445
mutation O 0 1.3057237993052695e-05
was O 0 5.134145249030553e-05
determined O 0 8.956754754763097e-06
and O 0 2.102460257447092e-06
found O 0 1.7783439716367866e-06
to O 0 5.266252628643997e-06
be O 0 1.536966738058254e-05
normal O 0 0.00010279328853357583
. O 0 8.891390461940318e-05

It O 0 3.0456072636297904e-05
is O 0 4.1480261643300764e-06
therefore O 0 5.474144927575253e-06
concluded O 0 1.598523886059411e-05
that O 0 1.0527808171900688e-06
the O 0 9.17603938432876e-06
R496H O 0 0.0003729818854480982
mutation O 0 2.2853088012197986e-05
of O 0 0.0001574798225192353
ARSA O 1 0.9957887530326843
does O 0 1.4186492080625612e-05
not O 0 2.0426721221156185e-06
negatively O 0 6.629079507547431e-06
influence O 0 1.2017324479529634e-05
the O 0 1.043305474013323e-05
activity O 0 2.2803151296102442e-05
of O 0 6.641285290243104e-05
ARSA O 1 0.51850426197052
and O 0 1.3578460311691742e-05
is O 0 5.596280061581638e-06
not O 0 2.6094112399732694e-06
a O 0 1.7983003999688663e-05
cause O 0 0.0001893233129521832
of O 0 0.0022247962187975645
MLD B-Disease 1 1.0

Down O 0 0.004275773651897907
- O 0 0.0002623526379466057
regulation O 0 2.4548300643800758e-05
of O 0 2.9951499527669512e-05
transmembrane O 0 0.002003695582970977
carbonic O 0 0.004040590953081846
anhydrases O 1 0.9044452905654907
in O 0 0.0016097566112875938
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999513626098633
lines O 0 0.00046350201591849327
by O 0 2.9636741601279937e-05
wild O 0 9.345653234049678e-05
- O 0 0.00018330241437070072
type O 0 0.00010078720515593886
von B-Disease 1 0.7722113132476807
Hippel I-Disease 1 0.999691367149353
- I-Disease 1 0.6843082904815674
Lindau I-Disease 1 0.9978870749473572
transgenes O 0 0.009858616627752781
. O 0 0.00032870963332243264

To O 0 7.995415217010304e-05
discover O 0 4.1974937630584463e-05
genes O 0 9.592333299224265e-06
involved O 0 9.735530511534307e-06
in O 0 3.4398079151287675e-05
von B-Disease 0 0.015528799034655094
Hippel I-Disease 1 0.9954524636268616
- I-Disease 0 0.0690726637840271
Lindau I-Disease 1 0.9979565143585205
( O 0 0.00030713458545506
VHL B-Disease 1 0.9826707243919373
) O 0 8.634800178697333e-05
- O 0 0.0002821895177476108
mediated O 0 0.0003052066022064537
carcinogenesis O 0 0.006643661297857761
, O 0 1.0307860975444783e-05
we O 0 7.71898339735344e-06
used O 0 0.00011081144475610927
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.1144794374704361
stably O 0 0.008473817259073257
transfected O 0 0.0006686028791591525
with O 0 1.4403299246623646e-05
wild O 0 0.00016657315427437425
- O 0 0.0005108696641400456
type O 0 0.0006572388228960335
VHL O 1 0.9999216794967651
- O 0 0.0025557749904692173
expressing O 0 0.0005752855213358998
transgenes O 0 0.0043382951989769936
. O 0 0.0003105542273260653

Large O 0 0.0006405479507520795
- O 0 0.0004049828858114779
scale O 0 0.00029309021192602813
RNA O 0 0.00020907536963932216
differential O 0 9.914932161336765e-05
display O 0 9.908355423249304e-05
technology O 0 6.074685006751679e-05
applied O 0 9.658258022682276e-06
to O 0 6.457030849560397e-06
these O 0 6.942511390661821e-06
cell O 0 5.886326835025102e-05
lines O 0 1.6044785297708586e-05
identified O 0 5.69335952604888e-06
several O 0 2.3606962713529356e-06
differentially O 0 8.088297181529924e-05
expressed O 0 1.0012031452788506e-05
genes O 0 5.541250175156165e-06
, O 0 2.183501919716946e-06
including O 0 1.8906085870185052e-06
an O 0 7.6183896453585476e-06
alpha O 0 0.00025227497098967433
carbonic O 0 0.0012417866382747889
anhydrase O 0 0.002339140744879842
gene O 0 6.423477316275239e-05
, O 0 3.496421777526848e-05
termed O 0 0.0007117710774764419
CA12 O 1 0.9993506073951721
. O 0 0.0006683136452920735

The O 0 0.0001139583982876502
deduced O 0 8.407986751990393e-05
protein O 0 6.807115369156236e-06
sequence O 0 5.869796495971968e-06
was O 0 6.113622657721862e-05
classified O 0 1.744824658089783e-05
as O 0 5.882639925403055e-06
a O 0 9.39567598834401e-06
one O 0 2.8103331715101376e-05
- O 0 0.0003608011465985328
pass O 0 0.0002949025365523994
transmembrane O 0 0.0033983588218688965
CA O 0 0.0024749906733632088
possessing O 0 0.0002000653330469504
an O 0 3.0240084015531465e-05
apparently O 0 0.0001427502720616758
intact O 0 0.00012857765250373632
catalytic O 0 4.248525874572806e-05
domain O 0 6.467837374657393e-05
in O 0 3.5059980291407555e-05
the O 0 9.627044346416369e-05
extracellular O 0 0.0015541325556114316
CA O 1 0.5442453622817993
module O 0 0.006131852976977825
. O 0 0.0002781945513561368

Reintroduced O 0 0.004059977829456329
wild O 0 0.0010880152694880962
- O 0 0.001140244654379785
type O 0 0.0005670629325322807
VHL B-Disease 1 0.9389457702636719
strongly O 0 0.00010263401782140136
inhibited O 0 5.970448546577245e-05
the O 0 1.2200260243844241e-05
overexpression O 0 4.521769369603135e-05
of O 0 3.920759991160594e-05
the O 0 6.352746277116239e-05
CA12 O 0 0.005926322657614946
gene O 0 7.2644479587324895e-06
in O 0 2.5572212507540826e-06
the O 0 1.5797497326275334e-05
parental O 0 0.00032685368205420673
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.7373449206352234
. O 0 0.0006478595896624029

Similar O 0 2.2187241484061815e-05
results O 0 6.10528559263912e-06
were O 0 1.4416463272937108e-05
obtained O 0 1.8170703697251156e-05
with O 0 1.4279959941632114e-05
CA9 O 0 0.025761481374502182
, O 0 1.351874198007863e-05
encoding O 0 2.9230894142528996e-05
another O 0 0.00010880380432354286
transmembrane O 0 0.002494711894541979
CA O 0 0.0009187282994389534
with O 0 1.1129066479043104e-05
an O 0 2.563477391959168e-05
intact O 0 0.0007057040929794312
catalytic O 0 0.00043344529694877565
domain O 0 0.0011536963284015656
. O 0 0.00041742000030353665

Although O 0 3.572854620870203e-05
both O 0 6.881360150146065e-06
domains O 0 4.852143320022151e-05
of O 0 0.00011305850057397038
the O 0 0.00020980786939617246
VHL B-Disease 1 0.8880950212478638
protein O 0 3.287700383225456e-05
contribute O 0 1.7939191820914857e-05
to O 0 1.0126145753019955e-05
regulation O 0 2.4837589080561884e-05
of O 0 6.28112320555374e-05
CA12 O 1 0.9883490800857544
expression O 0 4.044603701913729e-05
, O 0 5.460567535919836e-06
the O 0 1.9652281480375677e-05
elongin O 0 0.0005147596239112318
binding O 0 9.354147550766356e-06
domain O 0 6.881009903736413e-05
alone O 0 7.37266891519539e-05
could O 0 1.6939045963226818e-05
effectively O 0 0.00023957582016009837
regulate O 0 0.0006075507262721658
CA9 O 1 0.9874882698059082
expression O 0 0.0006211550789885223
. O 0 0.0004432486603036523

We O 0 0.0002503502182662487
mapped O 0 0.000927403976675123
CA12 O 1 0.9685176014900208
and O 0 0.00023810405400581658
CA9 O 1 0.9610718488693237
loci O 0 0.0004884938825853169
to O 0 0.00014024964184500277
chromosome O 0 0.0007551838643848896
bands O 0 0.0007007548701949418
15q22 O 0 0.003044735873118043
and O 0 0.00013560002844315022
17q21 O 0 0.0042917728424072266
. O 0 0.00028890545945614576

2 O 0 0.0005487301968969405
respectively O 0 0.00019794114632532
, O 0 1.871533640951384e-05
regions O 0 5.7377201301278546e-05
prone O 0 0.00020041243988089263
to O 0 1.0873214705497958e-05
amplification O 0 8.635690028313547e-05
in O 0 3.3008254831656814e-05
some O 0 3.021598604391329e-05
human O 0 0.0003074990527238697
cancers B-Disease 1 0.9997459053993225
. O 0 0.0009148820536211133

Additional O 0 7.797246507834643e-05
experiments O 0 7.175508653745055e-05
are O 0 2.5598610591259785e-06
needed O 0 8.283342140202876e-06
to O 0 2.0334475721028866e-06
define O 0 8.01568603492342e-06
the O 0 1.0761400517367292e-05
role O 0 6.362561543937773e-05
of O 0 0.00021826662123203278
CA O 1 0.8359545469284058
IX O 1 0.9999325275421143
and O 0 0.00024432013742625713
CA O 0 0.005058980081230402
XII O 1 0.9972264170646667
enzymes O 0 1.822081503632944e-05
in O 0 1.0020342415373307e-05
the O 0 8.752595022087917e-06
regulation O 0 1.3765035873802844e-05
of O 0 2.179258081014268e-05
pH O 0 0.00018743265536613762
in O 0 1.726624759612605e-05
the O 0 2.988661617564503e-05
extracellular O 0 0.00019983999663963914
microenvironment O 0 0.00041084500844590366
and O 0 6.482525350293145e-06
its O 0 6.427344032999827e-06
potential O 0 5.8719855587696657e-05
impact O 0 0.0001436026068404317
on O 0 0.00048321139183826745
cancer B-Disease 1 0.9998049139976501
cell O 0 0.0025613748002797365
growth O 0 0.0007582382531836629
. O 0 0.0001380122557748109

A O 0 0.0002808577264659107
gene O 0 1.0903639122261666e-05
encoding O 0 7.770627235004213e-06
a O 0 2.9564871510956436e-05
transmembrane O 0 0.00046557129826396704
protein O 0 2.7368661903892644e-05
is O 0 3.226403350709006e-06
mutated O 0 6.216433575900737e-06
in O 0 3.5617440516944043e-06
patients O 0 1.7166375982924365e-05
with O 0 6.780502735637128e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.002608755137771368
. O 0 0.0005168042844161391

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999922513961792
WFS B-Disease 1 1.0
; O 0 0.00033435982186347246
OMIM O 1 0.9999239444732666
222300 O 0 0.001403491827659309
) O 0 4.617474587575998e-06
is O 0 1.32243860662129e-06
an O 0 5.181676442589378e-06
autosomal B-Disease 1 0.9999936819076538
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.0563129186630249
by O 0 0.00011738675675587729
young O 0 0.0005115523235872388
- O 0 0.0009465506300330162
onset O 1 0.9999563694000244
non O 1 0.9045423269271851
- O 1 0.9879927635192871
immune O 0 0.24270136654376984
insulin B-Disease 0 0.000849320029374212
- I-Disease 0 0.10133949667215347
dependent I-Disease 0 0.0005636377609334886
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999947547912598
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.7310935854911804

Linkage O 0 0.004512529820203781
to O 0 0.00012700838851742446
markers O 0 0.0009792405180633068
on O 0 0.0005146092153154314
chromosome O 0 0.0016101128421723843
4p O 0 0.033211465924978256
was O 0 0.0003923872718587518
confirmed O 0 2.033236887655221e-05
in O 0 1.4573828593711369e-05
five O 0 1.853671346907504e-05
families O 0 2.009173658734653e-05
. O 0 7.944941899040714e-05

On O 0 0.00011348255793564022
the O 0 6.532906354550505e-06
basis O 0 9.20373531698715e-06
of O 0 0.0001306929043494165
meiotic O 1 0.9824192523956299
recombinants O 1 0.9999816417694092
and O 0 0.0019689437467604876
disease O 1 1.0
- O 0 0.0022201226092875004
associated O 0 5.458011582959443e-05
haplotypes O 0 0.0001750825613271445
, O 0 1.9117083866149187e-05
the O 0 8.359937055502087e-05
WFS B-Disease 1 0.7178599834442139
gene O 0 3.8217916880967095e-05
was O 0 9.417138790013269e-05
localized O 0 2.665297142812051e-05
to O 0 1.0105809451488312e-05
a O 0 9.078317089006305e-05
BAC O 0 0.1860508769750595
/ O 0 0.0008317651809193194
P1 O 0 0.006286130286753178
contig O 0 0.0011776882456615567
of O 0 5.258293094811961e-05
less O 0 3.527414446580224e-05
than O 0 9.206894901581109e-06
250 O 0 6.772141205146909e-05
kb O 0 0.002544255228713155
. O 0 0.00030390871688723564

Mutations O 0 0.00030237954342737794
in O 0 6.341862899716944e-05
a O 0 2.893548662541434e-05
novel O 0 5.4227122745942324e-05
gene O 0 2.8198823201819323e-05
( O 0 3.696804924402386e-05
WFS1 O 0 0.004030256997793913
) O 0 5.9446474551805295e-06
encoding O 0 5.88380726185278e-06
a O 0 2.4526070774300024e-05
putative O 0 0.00022181890381034464
transmembrane O 0 0.0005775030585937202
protein O 0 3.738896339200437e-05
were O 0 1.666187381488271e-05
found O 0 3.3452161005698144e-06
in O 0 2.195981551267323e-06
all O 0 1.5172939811236574e-06
affected O 0 5.7376410040888e-06
individuals O 0 1.6865885754668852e-06
in O 0 4.3474065023474395e-05
six O 0 0.00016376080748159438
WFS B-Disease 1 0.9881479144096375
families O 0 1.4366122741193976e-05
, O 0 4.698279099102365e-06
and O 0 1.4246891169023002e-06
these O 0 1.1993495263595833e-06
mutations O 0 9.843734005698934e-06
were O 0 1.6513933587702923e-05
associated O 0 1.0156438293051906e-05
with O 0 1.2803629942936823e-05
the O 0 0.000474482134450227
disease O 1 0.9999998807907104
phenotype O 0 0.0010038629407063127
. O 0 0.0005817888304591179

WFS1 O 1 0.9854196906089783
appears O 0 0.00012207025429233909
to O 0 6.269564437388908e-06
function O 0 8.220221388910431e-06
in O 0 9.887163287203293e-06
survival O 0 5.775790850748308e-05
of O 0 6.256696360651404e-05
islet O 0 0.001139574684202671
beta O 0 0.0005445730639621615
- O 0 0.0005837782518938184
cells O 0 3.403283335501328e-05
and O 0 1.5774257917655632e-05
neurons O 0 0.00016842165496200323
. O 0 4.4115466153016314e-05
. O 0 9.43779741646722e-05

Stable O 0 0.0013580924132838845
interaction O 0 3.322192424093373e-05
between O 0 6.001490692142397e-05
the O 0 1.6598183719906956e-05
products O 0 6.107114131737035e-06
of O 0 1.8758293663267978e-05
the O 0 5.053833592683077e-05
BRCA1 O 0 0.0007883860380388796
and O 0 8.028695447137579e-05
BRCA2 O 0 0.0031798919662833214
tumor B-Disease 1 0.9868009090423584
suppressor O 0 0.0006993644637987018
genes O 0 2.205118289566599e-05
in O 0 1.5538504158030264e-05
mitotic O 0 0.0002790283760987222
and O 0 6.782999844290316e-05
meiotic O 0 0.02315223589539528
cells O 0 0.0013484179507941008
. O 0 0.0004233468498568982

BRCA1 O 0 0.007538149133324623
and O 0 0.00010571708844508976
BRCA2 O 0 0.0002751778229139745
account O 0 6.345458587020403e-06
for O 0 2.3427496671502013e-06
most O 0 2.628793936310103e-06
cases O 0 2.8765421120624524e-06
of O 0 1.8004730009124614e-05
familial O 0 0.00032795677543617785
, O 0 3.0203567803255282e-05
early O 0 0.00023974671785254031
onset O 1 0.9999996423721313
breast B-Disease 1 0.9999340772628784
and I-Disease 0 0.0002636195858940482
/ I-Disease 1 0.9999854564666748
or I-Disease 1 0.9999504089355469
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00010229858889942989
encode O 0 3.627017213148065e-05
products O 0 1.1824473403976299e-05
that O 0 1.460356429561216e-06
each O 0 9.22012077353429e-07
interact O 0 8.145842912199441e-06
with O 0 1.5461162547580898e-05
hRAD51 O 0 0.0023825429379940033
. O 0 0.0002591140510048717

Results O 0 6.063595719751902e-05
presented O 0 9.69361062743701e-05
here O 0 3.218773053959012e-05
show O 0 3.066140925511718e-05
that O 0 8.648248694953509e-06
BRCA1 O 0 0.00029492026078514755
and O 0 4.654962322092615e-05
BRCA2 O 0 0.0005576860276050866
coexist O 0 0.00013555101759266108
in O 0 2.0526964362943545e-05
a O 0 4.230869672028348e-05
biochemical O 0 0.0003858386189676821
complex O 0 0.0014884381089359522
and O 0 0.00011067784362239763
colocalize O 0 0.00481764692813158
in O 0 0.00017707404913380742
subnuclear O 0 0.005318542942404747
foci O 0 0.0015649755951017141
in O 0 6.353376375045627e-05
somatic O 0 0.00018389150500297546
cells O 0 2.7937501727137715e-05
and O 0 3.6584094686986646e-06
on O 0 8.762792276684195e-06
the O 0 6.549450063175755e-06
axial O 0 1.6945412426139228e-05
elements O 0 1.3483384464052506e-05
of O 0 0.00011810193973360583
developing O 0 0.0006641351501457393
synaptonemal O 0 0.3510560691356659
complexes O 0 0.002124378690496087
. O 0 0.00022305556922219694

Like O 0 0.0016629272140562534
BRCA1 O 0 0.006769167259335518
and O 0 0.0004178507369942963
RAD51 O 1 0.9987812638282776
, O 0 0.00018458679551258683
BRCA2 O 0 0.0009443017770536244
relocates O 0 0.0003602670331019908
to O 0 4.7960969823179767e-05
PCNA O 0 0.0038555962964892387
+ O 0 7.197870581876487e-05
replication O 0 1.9934172087232582e-05
sites O 0 8.115927812468726e-06
following O 0 1.2702840649581049e-05
exposure O 0 8.44602836878039e-05
of O 0 6.111966649768874e-05
S O 0 0.0011713753920048475
phase O 0 0.0005256830481812358
cells O 0 4.9684389523463324e-05
to O 0 4.834397986996919e-05
hydroxyurea O 0 0.0024861027486622334
or O 0 0.00034665685961954296
UV O 1 0.5890269875526428
irradiation O 0 0.0014242801116779447
. O 0 0.0002966441388707608

Thus O 0 0.0007379188318736851
, O 0 9.165781375486404e-05
BRCA1 O 0 0.0006153674912638962
and O 0 3.834690141957253e-05
BRCA2 O 0 0.00022267672466114163
participate O 0 1.8350399841438048e-05
, O 0 5.640850304189371e-06
together O 0 6.274229690461652e-06
, O 0 2.0379243323986884e-06
in O 0 5.1278911996632814e-06
a O 0 1.2651581528189126e-05
pathway O 0 4.641451596398838e-05
( O 0 1.5504057955695316e-05
s O 0 7.385292701655999e-05
) O 0 2.4719292923691683e-06
associated O 0 1.7106735867855605e-06
with O 0 1.0716752285588882e-06
the O 0 8.409508154727519e-06
activation O 0 2.708797183004208e-05
of O 0 0.00016389921074733138
double O 0 0.000529404089320451
- O 0 0.0013966105179861188
strand O 0 0.00023766927188262343
break O 0 0.0002514343068469316
repair O 0 0.001078449422493577
and O 0 3.521311009535566e-05
/ O 0 0.0002702425408642739
or O 0 5.5653788876952603e-05
homologous O 0 0.0002686349325813353
recombination O 0 0.00045439903624355793
. O 0 0.0003330561157781631

Dysfunction O 1 0.9990967512130737
of O 0 0.0008446432184427977
this O 0 0.00011456320498837158
pathway O 0 0.0004118473152630031
may O 0 4.337923019193113e-05
be O 0 4.5027368287264835e-06
a O 0 5.6528479035478085e-06
general O 0 1.2279095244593918e-05
phenomenon O 0 2.8578242563526146e-05
in O 0 2.012488494074205e-06
the O 0 1.5843069149923394e-06
majority O 0 5.073587203696661e-07
of O 0 3.604467792683863e-06
cases O 0 8.532052561349701e-06
of O 0 0.00013990316074341536
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.8384977579116821
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0017477025976404548
. O 0 0.00028409023070707917

A O 0 0.0015036944532766938
novel O 0 0.00031241856049746275
Arg362Ser O 0 0.0019193087937310338
mutation O 0 1.84731852641562e-05
in O 0 1.1791703400376718e-05
the O 0 3.25576365867164e-05
sterol O 0 0.00022280628036241978
27 O 0 0.00028642642428167164
- O 0 0.00025516035384498537
hydroxylase O 0 0.00027841932023875415
gene O 0 6.216053589014336e-05
( O 0 5.73512697883416e-05
CYP27 O 0 0.008819066919386387
) O 0 1.1432555766077712e-05
: O 0 2.5099036520259688e-06
its O 0 3.1636823223379906e-06
effects O 0 3.910342275048606e-05
on O 0 7.965553231770173e-05
pre O 0 0.00040048413211479783
- O 0 0.00014094772632233799
mRNA O 0 2.4219729311880656e-05
splicing O 0 1.7899663362186402e-05
and O 0 6.973725248826668e-06
enzyme O 0 1.9872708435286768e-05
activity O 0 8.789774437900633e-05
. O 0 0.00015598026220686734

A O 0 0.0009152500424534082
novel O 0 0.00013996001507621258
C O 0 0.00018733422621153295
to O 0 1.4315301996248309e-05
A O 0 7.084988465066999e-05
mutation O 0 2.9304414965736214e-06
in O 0 5.265750587568618e-06
the O 0 1.4133192962617613e-05
sterol O 0 0.00011872795585077256
27 O 0 0.00014187827764544636
- O 0 0.0001222699211211875
hydroxylase O 0 0.00011667343642329797
gene O 0 2.2364238247973844e-05
( O 0 2.828830292855855e-05
CYP27 O 0 0.006414270028471947
) O 0 8.615568731329404e-06
was O 0 3.772225318243727e-05
identified O 0 4.1431235331401695e-06
by O 0 1.7564793779456522e-06
sequencing O 0 3.6226647353032604e-05
amplified O 0 0.0003202695806976408
CYP27 O 0 0.006948905996978283
gene O 0 2.0029487131978385e-05
products O 0 5.106335720483912e-06
from O 0 4.619950232154224e-06
a O 0 9.765426511876285e-06
patient O 0 3.235268377466127e-05
with O 0 3.617790207499638e-05
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 1.0
( O 0 0.003738491563126445
CTX B-Disease 1 0.9999867677688599
) O 0 0.00043020735029131174
. O 0 0.0002227801305707544

The O 0 0.00021345603454392403
mutation O 0 3.674079925986007e-05
changed O 0 5.6583605328341946e-05
the O 0 2.8719574402202852e-05
adrenodoxin O 0 0.0006097379955463111
cofactor O 0 0.0002003845729632303
binding O 0 2.4830060283420607e-05
residue O 0 0.0001647999742999673
362Arg O 0 0.000612352043390274
to O 0 7.146003190428019e-05
362Ser O 0 0.0023203943856060505
( O 0 0.00032564313733018935
CGT O 1 0.6413166522979736
362Arg O 0 0.0026456788182258606
to O 0 0.00018409710901323706
AGT O 1 0.9999316930770874
362Ser O 0 0.0029424556996673346
) O 0 2.0402876543812454e-05
, O 0 4.891324351774529e-06
and O 0 2.9371340133366175e-06
was O 0 8.394383621634915e-05
responsible O 0 4.5061220589559525e-05
for O 0 7.774978439556435e-05
deficiency O 1 0.9999984502792358
in O 0 0.0001863929210230708
the O 0 0.00012159254401922226
sterol O 0 0.00030215707374736667
27 O 0 0.00036478735273703933
- O 0 0.00021844003640580922
hydroxylase O 0 8.075620280578732e-05
activity O 0 9.587833119439892e-06
, O 0 2.1419230051833438e-06
as O 0 2.4960352220659843e-06
confirmed O 0 3.545683284755796e-06
by O 0 1.0143901363335317e-06
expression O 0 2.8353099423839012e-06
of O 0 2.314166158612352e-05
mutant O 0 0.0001299916475545615
cDNA O 0 0.00022417877335101366
into O 0 0.00011524681031005457
COS O 0 0.03802839294075966
- O 0 0.0007413246785290539
1 O 0 0.00037048119702376425
cells O 0 0.00015773587801959366
. O 0 0.00010252798529108986

Quantitative O 0 0.00012563689961098135
analysis O 0 7.3489359238010366e-06
showed O 0 2.183368633268401e-05
that O 0 1.023788058773789e-06
the O 0 4.2420947465870995e-06
expression O 0 5.379197318688966e-06
of O 0 4.969420115230605e-05
CYP27 O 0 0.009986908175051212
gene O 0 1.6397178114857525e-05
mRNA O 0 1.736893864290323e-05
in O 0 5.182264430914074e-06
the O 0 1.580345087859314e-05
patient O 0 3.297408693470061e-05
represented O 0 4.5710388803854585e-05
52 O 0 0.00038521914393641055
. O 0 0.00023398541088681668

5 O 0 0.0003297909570392221
% O 0 2.5095489036175422e-05
of O 0 8.425900887232274e-05
the O 0 0.0001990713062696159
normal O 0 0.0002997726551257074
level O 0 0.0010504594538360834
. O 0 0.00022597734641749412

As O 0 9.476396371610463e-05
the O 0 2.8922411729581654e-05
mutation O 0 1.3229874639364425e-05
occurred O 0 9.334670176031068e-05
at O 0 3.473709512036294e-05
the O 0 7.3922774390666746e-06
penultimate O 0 0.00010941327491309494
nucleotide O 0 8.248577614722308e-06
of O 0 1.930372673086822e-05
exon O 0 0.00020169570052530617
6 O 0 9.707596473162994e-05
( O 0 1.5081105630088132e-05
- O 0 4.7564884880557656e-05
2 O 0 1.8609212929732166e-05
position O 0 1.5456180335604586e-05
of O 0 3.6553370591718704e-05
exon O 0 0.000343894847901538
6 O 0 0.00029267274658195674
- O 0 0.00025573442690074444
intron O 0 0.0008468896267004311
6 O 0 0.00011665630154311657
splice O 0 0.00010096371988765895
site O 0 4.788578735315241e-05
) O 0 2.618327926029451e-06
of O 0 5.656730536429677e-06
the O 0 1.8100226952810772e-05
gene O 0 1.4408987226488534e-05
, O 0 4.452100256457925e-06
we O 0 3.228086825401988e-06
hypothesized O 0 2.186285928473808e-05
that O 0 1.1379128181943088e-06
the O 0 1.2318751942075323e-05
mutation O 0 1.4667723007733002e-05
may O 0 4.660905688069761e-05
partially O 0 0.00013860533363185823
affect O 0 4.9440186558058485e-06
the O 0 4.354935299488716e-06
normal O 0 5.086511009722017e-06
splicing O 0 7.516705409216229e-06
efficiency O 0 1.9337649064254947e-05
in O 0 2.1345502318581566e-05
exon O 0 0.00023062060063239187
6 O 0 0.00013341530575416982
and O 0 1.1364897545718122e-05
cause O 0 3.913322871085256e-05
alternative O 0 1.2064680049661547e-05
splicing O 0 4.5646003854926676e-05
elsewhere O 0 1.940644324349705e-05
, O 0 1.6894251757548773e-06
which O 0 8.297789122480026e-07
resulted O 0 2.1492078303708695e-05
in O 0 1.8933957107947208e-05
decreased O 0 0.00019625092681962997
transcript O 0 0.00019027049711439759
in O 0 3.038563227164559e-05
the O 0 0.00010149154695682228
patient O 0 0.00024733354803174734
. O 0 0.00016668329772073776

Transfection O 0 0.004504409618675709
of O 0 0.0006687755812890828
constructed O 0 0.05643247067928314
minigenes O 0 0.007235972210764885
, O 0 1.591644831933081e-05
with O 0 6.1227078731462825e-06
or O 0 8.519346010871232e-06
without O 0 7.444147286150837e-06
the O 0 1.7255350030609407e-05
mutation O 0 1.381927722832188e-05
, O 0 1.3442980161926243e-05
into O 0 6.38498313492164e-05
COS O 1 0.8164373636245728
- O 0 0.0002865402784664184
1 O 0 6.718713120790198e-05
cells O 0 5.389420493884245e-06
confirmed O 0 2.231988901257864e-06
that O 0 4.135345363920351e-07
the O 0 3.194454848198802e-06
mutant O 0 5.819162470288575e-05
minigene O 0 0.0005317804752849042
was O 0 4.870733027928509e-05
responsible O 0 6.7465643951436505e-06
for O 0 2.829499635481625e-06
a O 0 5.6802246035658754e-06
mRNA O 0 5.699519988411339e-06
species O 0 2.438335116039525e-07
alternatively O 0 3.212727960999473e-06
spliced O 0 4.5209591917227954e-05
at O 0 5.436531500890851e-05
an O 0 1.2839957889809739e-05
activated O 0 0.0009539060411043465
cryptic O 0 0.0005686620716005564
5 O 0 0.00012017416884191334
splice O 0 0.00022585090482607484
site O 0 0.00012712349416688085
88 O 0 7.768812065478414e-05
bp O 0 0.0001170862524304539
upstream O 0 6.708955334033817e-05
from O 0 5.273539954941953e-06
the O 0 6.6220909502590075e-06
3 O 0 1.842924757511355e-05
end O 0 3.46955748682376e-05
of O 0 6.360347470035776e-05
exon O 0 0.0008647952345199883
6 O 0 0.0009037486161105335
. O 0 0.00023693642287980765

Our O 0 0.0001353709667455405
data O 0 2.0767734895343892e-05
suggest O 0 1.4107043170952238e-05
that O 0 1.6386437664550613e-06
the O 0 1.0407773515908048e-05
C O 0 0.0001360194873996079
to O 0 8.76361082191579e-06
A O 0 6.923728506080806e-05
mutation O 0 3.2868424568732735e-06
at O 0 1.8542988982517272e-05
the O 0 6.733176633133553e-06
penultimate O 0 0.00010161326645174995
nucleotide O 0 9.846175998973195e-06
of O 0 2.475164001225494e-05
exon O 0 0.0001613367348909378
6 O 0 4.771462408825755e-05
of O 0 1.8837708921637386e-05
the O 0 6.519270391436294e-05
CYP27 O 1 0.5667046308517456
gene O 0 1.1548072507139295e-05
not O 0 1.925782498801709e-06
only O 0 4.979013738193316e-06
causes O 0 3.7060883187223226e-05
the O 0 0.0001132883844547905
deficiency B-Disease 1 0.9999865293502808
in I-Disease 0 0.00010036043386207893
the I-Disease 0 8.082977728918195e-05
sterol I-Disease 0 0.00038990186294540763
27 I-Disease 0 0.00035837889299727976
- I-Disease 0 0.0003000863071065396
hydroxylase I-Disease 0 0.00016958512424025685
activity I-Disease 0 3.104555435129441e-05
, O 0 6.415903953893576e-06
but O 0 1.820102852434502e-06
also O 0 4.584504949889379e-06
partially O 0 5.0761238526320085e-05
leads O 0 1.25252181533142e-05
to O 0 6.482599474111339e-06
alternative O 0 6.868529453640804e-06
pre O 0 0.00015335020725615323
- O 0 5.8364239521324635e-05
mRNA O 0 9.368109203933273e-06
splicing O 0 6.0258071243879385e-06
of O 0 1.2321629583311733e-05
the O 0 3.658458444988355e-05
gene O 0 0.00010794481204356998
. O 0 0.00012757183867506683

To O 0 0.00011190547229489312
our O 0 4.57788300991524e-05
knowledge O 0 4.757972419611178e-05
, O 0 5.813850293634459e-06
this O 0 1.4436978972298675e-06
is O 0 1.654080733715091e-06
the O 0 2.4815094548102934e-06
first O 0 5.346903435565764e-06
report O 0 2.6839493330044206e-06
regarding O 0 1.0798891707963776e-05
effects O 0 7.565422129118815e-05
on O 0 8.8198394223582e-05
pre O 0 0.0003078581066802144
- O 0 7.263679435709491e-05
mRNA O 0 6.472072982433019e-06
splicing O 0 5.337361471902113e-06
of O 0 5.781984782515792e-06
a O 0 8.083608008746523e-06
mutation O 0 4.969383553543594e-06
at O 0 4.3779185944003984e-05
the O 0 2.014077290368732e-05
- O 0 3.002911944349762e-05
2 O 0 1.7014264813042246e-05
position O 0 6.9446832640096545e-06
of O 0 9.673375643615145e-06
a O 0 3.903818651451729e-05
5 O 0 0.00010008260869653895
splice O 0 0.0004057468322571367
site O 0 0.0006960518658161163
. O 0 0.00011688879021676257

ATM O 0 0.01563216745853424
germline O 0 0.0031514018774032593
mutations O 0 0.00010350847151130438
in O 0 0.00014451457536779344
classical O 0 0.09640717506408691
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.00017501764523331076
in O 0 4.674152296502143e-05
the O 0 4.706418621935882e-05
Dutch O 0 0.0002283435605932027
population O 0 2.7003938157577068e-05
. O 0 7.398537854896858e-05

Germline O 0 0.007843113504350185
mutations O 0 0.0001325341872870922
in O 0 4.79498557979241e-05
the O 0 4.007901588920504e-05
ATM O 0 0.0003244287509005517
gene O 0 2.6477166557015153e-06
are O 0 1.8627306985763425e-07
responsible O 0 1.5070145309437066e-06
for O 0 1.2420508710420108e-06
the O 0 0.00010238699906039983
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.05644004046916962
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999556541442871
T I-Disease 1 0.9999958276748657
) O 0 0.00010501617362024263
. O 0 9.7391486633569e-05

In O 0 0.00015715908375568688
our O 0 2.316979407623876e-05
study O 0 4.77335788673372e-06
, O 0 1.5355219602497527e-06
we O 0 8.260143431471079e-07
have O 0 2.4728885250624444e-07
determined O 0 2.370168431298225e-06
the O 0 6.2932385844760574e-06
ATM O 0 0.00022861694742459804
mutation O 0 3.166960595990531e-06
spectrum O 0 1.9137254639645107e-05
in O 0 1.5094215086719487e-05
19 O 0 7.737331907264888e-05
classical O 0 0.0001892552390927449
A B-Disease 1 0.9999603033065796
- I-Disease 1 0.9998724460601807
T I-Disease 1 0.9999992847442627
patients O 0 4.1914256144082174e-05
, O 0 5.993357262923382e-06
including O 0 3.836547421087744e-06
some O 0 6.0052238950447645e-06
immigrant O 0 2.1729578293161467e-05
populations O 0 7.0070582296466455e-06
, O 0 2.8121644390921574e-06
as O 0 4.142760644754162e-06
well O 0 2.92659842671128e-06
as O 0 4.425929546414409e-06
12 O 0 9.080076779355295e-06
of O 0 1.4067021766095422e-05
Dutch O 0 0.00017444266995880753
ethnic O 0 5.4408679716289043e-05
origin O 0 3.825697422144003e-05
. O 0 0.0001562401739647612

Both O 0 3.224401734769344e-05
the O 0 2.0789630070794374e-05
protein O 0 1.6009753380785696e-05
truncation O 0 8.971396891865879e-05
test O 0 2.9568565878435038e-05
( O 0 3.6007077142130584e-05
PTT O 0 0.0003014443500433117
) O 0 3.894054771080846e-06
and O 0 1.43396516705252e-06
the O 0 7.053910849208478e-06
restriction O 0 1.6981228327495046e-05
endonuclease O 0 0.0001696592225925997
fingerprinting O 0 0.0002979973505716771
( O 0 0.00012269460421521217
REF O 0 0.005542001221328974
) O 0 5.195362518861657e-06
method O 0 1.3365630593398237e-06
were O 0 6.1344794630713295e-06
used O 0 4.935708602715749e-06
and O 0 5.3442781791090965e-06
compared O 0 1.0860943802981637e-05
for O 0 3.475028961474891e-06
their O 0 8.50854667078238e-06
detection O 0 4.46747217210941e-05
efficiency O 0 4.1136379877571017e-05
, O 0 5.3047579058329575e-06
identifying O 0 9.662624506745487e-06
76 O 0 4.7033765440573916e-05
% O 0 5.482337201101473e-06
and O 0 3.2576244848314673e-06
60 O 0 9.710383892524987e-06
% O 0 2.270705635964987e-06
of O 0 2.157491871912498e-05
the O 0 7.264573650900275e-05
mutations O 0 5.443332338472828e-05
, O 0 4.286196417524479e-05
respectively O 0 0.00016371021047234535
. O 0 0.00015284892288036644

Most O 0 0.00015428509504999965
patients O 0 4.7401194024132565e-05
were O 0 2.2874108253745362e-05
found O 0 7.655074114154559e-06
to O 0 1.1427279787312727e-05
be O 0 2.741939897532575e-05
compound O 0 0.00033039393019862473
heterozygote O 0 0.0018152419943362474
. O 0 0.0003194526070728898

Seventeen O 0 0.0007136330823414028
mutations O 0 5.6869175750762224e-05
were O 0 1.9378128854441456e-05
distinct O 0 6.271202892094152e-06
, O 0 3.5863567973137833e-06
of O 0 1.0188489795837086e-05
which O 0 6.340196250675945e-06
10 O 0 1.5108802472241223e-05
were O 0 5.591713488684036e-06
not O 0 2.1660430320480373e-06
reported O 0 2.1824402210768312e-05
previously O 0 8.583015733165666e-05
. O 0 8.507866732543334e-05

Mutations O 0 0.00028429049416445196
are O 0 1.1418455869716126e-05
small O 0 1.7191490769619122e-05
deletions O 0 6.876536644995213e-05
or O 0 2.3692604372627102e-05
point O 0 0.000258489279076457
mutations O 0 3.6554658436216414e-05
frequently O 0 2.240464891656302e-05
affecting O 0 7.336089765885845e-05
splice O 0 0.0005349834682419896
sites O 0 0.00022086921671871096
. O 0 0.00015847910253796726

Moreover O 0 0.0011412007734179497
, O 0 6.448222120525315e-05
a O 0 8.863538823788986e-05
16 O 0 0.0005028521991334856
. O 0 0.0002612874668557197

7 O 0 0.001529540168121457
- O 0 0.0003059007867705077
kb O 0 0.00018516463751439005
genomic O 0 1.3240261978353374e-05
deletion O 0 2.2133137463242747e-05
of O 0 3.892424138030037e-05
the O 0 2.5988787456299178e-05
3 O 0 3.264773840783164e-05
end O 0 2.874911660910584e-05
of O 0 1.4847638340143021e-05
the O 0 2.2029891624697484e-05
gene O 0 9.048153515323065e-06
, O 0 2.145641701645218e-06
most O 0 1.688487600404187e-06
likely O 0 3.582596491469303e-06
a O 0 1.8178582195105264e-06
result O 0 2.4814787593641086e-06
of O 0 1.1039743185392581e-05
recombination O 0 1.5914931282168254e-05
between O 0 8.078623795881867e-05
two O 0 1.6061088899732567e-05
LINE O 0 0.0006083894986659288
elements O 0 2.5277482563978992e-05
, O 0 1.3615132047561929e-05
was O 0 0.00019900145707651973
identified O 0 6.570737605215982e-05
. O 0 0.00011730752885341644

The O 0 0.00012785629951395094
most O 0 1.667862852627877e-05
frequently O 0 1.0615434803185053e-05
found O 0 4.410016117617488e-06
mutation O 0 2.219558609795058e-06
, O 0 1.6239994238276267e-06
identified O 0 3.5859463878296083e-06
in O 0 5.743537258240394e-06
three O 0 6.6595325733942445e-06
unrelated O 0 3.3360407542204484e-05
Turkish O 0 0.0003464944602455944
A B-Disease 1 0.9998072981834412
- I-Disease 1 0.8167286515235901
T I-Disease 1 0.9989767074584961
individuals O 0 7.305221515707672e-06
, O 0 7.675836059206631e-06
was O 0 6.106560613261536e-05
previously O 0 1.1963739780185279e-05
described O 0 4.259071374690393e-06
to O 0 1.3694076415049494e-06
be O 0 1.5713212633272633e-06
a O 0 3.7537693060585298e-06
Turkish O 0 0.00010027300595538691
A B-Disease 1 0.9868418574333191
- I-Disease 1 0.9840099215507507
T I-Disease 1 0.9999948740005493
founder O 0 0.0030956873670220375
mutation O 0 0.00013682468852493912
. O 0 0.00015462766168639064

The O 0 6.853989907540381e-05
presence O 0 2.0871257220278494e-05
of O 0 2.8200087399454787e-05
a O 0 6.383838626788929e-05
founder O 0 0.00026257586432620883
mutation O 0 7.6046198955737054e-06
among O 0 4.963302217220189e-06
relatively O 0 5.192643129703356e-06
small O 0 1.4081285826250678e-06
ethnic O 0 1.4567579000868136e-06
population O 0 1.4010452105139848e-06
groups O 0 6.663977956122835e-07
in O 0 8.70845906320028e-06
Western O 0 4.627706584869884e-05
Europe O 0 3.845815808745101e-05
could O 0 4.705220362666296e-06
indicate O 0 5.429784323496278e-06
a O 0 6.416705673473189e-06
high O 0 3.839025885099545e-05
carrier O 0 1.3557963939092588e-05
frequency O 0 3.433141955611063e-06
in O 0 8.4823941506329e-06
such O 0 5.114840860187542e-06
communities O 0 3.831948561128229e-05
. O 0 0.0001349531376035884

In O 0 0.0003052039828617126
patients O 0 4.15149079344701e-05
of O 0 4.7889621782815084e-05
Dutch O 0 0.00014277995796874166
ethnic O 0 1.4066484254726674e-05
origin O 0 9.066232451004907e-06
, O 0 5.239531674305908e-06
however O 0 4.220820301270578e-06
, O 0 2.2052411168260733e-06
no O 0 4.1400430745852645e-06
significant O 0 3.879727955791168e-05
founder O 0 0.0003552897251211107
effect O 0 5.3452375141205266e-05
could O 0 1.7086851585190743e-05
be O 0 8.438485565420706e-06
identified O 0 4.8187259380938485e-05
. O 0 7.27027581888251e-05

The O 0 0.00010619053500704467
observed O 0 9.174132719635963e-05
genetic O 0 7.903118239482865e-05
heterogeneity O 0 0.00010049296543002129
including O 0 1.2511666682257783e-05
the O 0 3.256477793911472e-05
relative O 0 6.456892879214138e-05
high O 0 9.062956087291241e-05
percentage O 0 2.8854365154984407e-05
of O 0 4.492011066759005e-05
splice O 0 0.001248980057425797
- O 0 0.00041293742833659053
site O 0 0.0001245241001015529
mutations O 0 2.335685712751001e-05
had O 0 2.504640542611014e-05
no O 0 1.1165124305989593e-05
reflection O 0 5.348790728021413e-05
on O 0 9.564766514813527e-05
the O 0 9.560243779560551e-05
phenotype O 0 0.0003220846992917359
. O 0 0.0002175861009163782

All O 0 0.00012659440108109266
patients O 0 0.00016184906417038292
manifested O 0 0.000979942618869245
classical O 0 0.001506326487287879
A B-Disease 1 0.9999459981918335
- I-Disease 1 0.9519109725952148
T I-Disease 1 0.9979535341262817
and O 0 1.3276830031827558e-05
increased O 0 6.135547300800681e-05
cellular O 0 0.0003633776505012065
radioresistant O 0 0.0015549050876870751
DNA O 0 0.0002622415777295828
synthesis O 0 0.00035292949178256094
. O 0 0.0003235635522287339

Determination O 0 0.0003431772638577968
of O 0 9.894587856251746e-05
the O 0 2.6224457542411983e-05
genomic O 0 3.156421735184267e-05
structure O 0 4.831578189623542e-05
of O 0 4.078961501363665e-05
the O 0 7.059994095470756e-05
COL4A4 O 1 0.6934517621994019
gene O 0 6.993439001234947e-06
and O 0 9.481107667852484e-07
of O 0 6.710074103466468e-06
novel O 0 3.733352787094191e-05
mutations O 0 0.0001751820818753913
causing O 1 0.966218888759613
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9991858601570129

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0024670930579304695
a O 0 0.0006135911680757999
progressive O 1 0.9998701810836792
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9989345669746399
by O 0 0.0011287502711638808
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999998807907104
membrane I-Disease 1 0.9989359974861145
abnormalities I-Disease 1 0.9998413324356079
and O 0 3.1134855817072093e-05
associated O 0 1.8084214389091358e-05
with O 0 7.994935003807768e-06
mutations O 0 1.9825311028398573e-05
in O 0 2.8475329600041732e-05
either O 0 2.510894410079345e-05
the O 0 7.372403342742473e-05
COL4A3 O 1 0.6362947225570679
or O 0 2.205387681897264e-05
the O 0 6.214732275111601e-05
COL4A4 O 0 0.0651388168334961
gene O 0 1.720740328892134e-05
, O 0 2.084295374515932e-06
which O 0 9.311009989687591e-07
encode O 0 2.9206096314737806e-06
the O 0 1.6408503142884e-05
alpha3 O 0 0.0008153781527653337
and O 0 2.860065251297783e-05
alpha4 O 0 0.005563301965594292
type O 0 0.005423770751804113
IV O 1 1.0
collagen O 1 0.9999996423721313
chains O 0 0.007109217345714569
, O 0 0.00012996859732083976
respectively O 0 0.0003959201567340642
. O 0 0.00020707555813714862

To O 0 8.835884364088997e-05
date O 0 0.00012913155660498887
, O 0 6.2514627643395215e-06
mutation O 0 1.9364770196261816e-06
screening O 0 3.844557795673609e-06
in O 0 4.5999818212294485e-06
the O 0 6.097744062572019e-06
two O 0 3.6393573736859253e-06
genes O 0 7.120437203411711e-06
has O 0 5.753959612775361e-06
been O 0 1.0996809578500688e-05
hampered O 0 9.56217700149864e-05
by O 0 1.3831256637786282e-06
the O 0 6.374475105985766e-06
lack O 0 1.8473096133675426e-05
of O 0 2.554955062805675e-05
genomic O 0 9.28708104765974e-05
structure O 0 0.00037058081943541765
information O 0 0.00010986167762894183
. O 0 0.00031867664074525237

We O 0 8.021289249882102e-05
report O 0 8.466133294859901e-06
here O 0 4.847791842621518e-06
the O 0 1.7724482859193813e-06
complete O 0 6.05940340392408e-06
characterization O 0 1.5379871911136433e-05
of O 0 2.339073944312986e-05
the O 0 1.851579872891307e-05
48 O 0 2.2936976165510714e-05
exons O 0 3.368514444446191e-05
of O 0 2.1528920115088113e-05
the O 0 6.808545731473714e-05
COL4A4 O 1 0.6170443296432495
gene O 0 2.330279312445782e-05
, O 0 2.7759822387452004e-06
a O 0 4.070109298481839e-06
comprehensive O 0 2.8707361707347445e-05
gene O 0 8.812639862298965e-06
screen O 0 3.038435897906311e-05
, O 0 3.308712621219456e-06
and O 0 1.1266654382779961e-06
the O 0 3.156744924126542e-06
subsequent O 0 1.434577916370472e-05
detection O 0 2.0109948309254833e-05
of O 0 2.9022487069596536e-05
10 O 0 3.5453966120257974e-05
novel O 0 1.8563852790975943e-05
mutations O 0 4.324393103161128e-06
in O 0 5.022833647672087e-06
eight O 0 3.350787301314995e-05
patients O 0 0.0001623278803890571
diagnosed O 1 0.9999996423721313
with O 0 0.0033072330988943577
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998730421066284

Furthermore O 0 0.0005797225167043507
, O 0 2.5834939151536673e-05
we O 0 9.644341844250448e-06
identified O 0 6.845237294328399e-06
a O 0 7.545469998149201e-06
glycine O 0 2.095353920594789e-05
to O 0 1.4702846783620771e-05
alanine O 0 2.9595425075967796e-05
substitution O 0 2.5888903110171668e-05
in O 0 5.532380964723416e-05
the O 0 8.362024527741596e-05
collagenous O 0 0.0016099578933790326
domain O 0 6.880459113745019e-05
that O 0 4.817613898921991e-06
is O 0 5.9310737015039194e-06
apparently O 0 1.790102760423906e-05
silent O 0 4.749445361085236e-05
in O 0 4.084472948306939e-06
the O 0 5.190790943743195e-06
heterozygous O 0 7.971653758431785e-06
carriers O 0 1.5498100765398704e-05
, O 0 6.037173079675995e-06
in O 0 3.123305214103311e-05
11 O 0 0.00040124767110683024
. O 0 0.0002298987383255735

5 O 0 0.00016275301459245384
% O 0 1.4186560292728245e-05
of O 0 2.0188848793623038e-05
all O 0 9.862376828095876e-06
control O 0 5.5224190873559564e-05
individuals O 0 4.843443093704991e-06
, O 0 4.996098596166121e-06
and O 0 2.8885224310215563e-06
in O 0 7.715303581790067e-06
one O 0 3.6152914617559873e-06
control O 0 1.152367167378543e-05
individual O 0 6.190021508700738e-07
homozygous O 0 5.481213065650081e-06
for O 0 2.3300003704207484e-06
this O 0 3.2688744795450475e-06
glycine O 0 6.955108983675018e-05
substitution O 0 9.871424117591232e-05
. O 0 0.0002957309188786894

There O 0 0.00012122045882279053
has O 0 2.7721547667169943e-05
been O 0 1.2309533303778153e-05
no O 0 3.2980365176626947e-06
previous O 0 4.759039711643709e-06
finding O 0 6.01341935180244e-06
of O 0 1.0437423952680547e-05
a O 0 1.602533484401647e-05
glycine O 0 2.276369195897132e-05
substitution O 0 1.2014092135359533e-05
that O 0 2.668823981366586e-06
is O 0 3.0508983854815597e-06
not O 0 9.983436939364765e-07
associated O 0 3.6377853120939108e-06
with O 0 2.031842541327933e-06
any O 0 1.1587899280129932e-05
obvious O 0 0.00016295113891828805
phenotype O 0 8.46006951178424e-05
in O 0 6.296919309534132e-05
homozygous O 0 0.00011534025543369353
individuals O 0 3.6878052924294025e-05
. O 0 0.0003161929489579052

Founder O 0 0.032732415944337845
BRCA1 O 0 0.0021191027481108904
and O 0 5.851549212820828e-05
BRCA2 O 0 0.00035676429979503155
mutations O 0 2.2985213945503347e-05
in O 0 2.2048681785236113e-05
French O 0 0.00013092126755509526
Canadian O 0 0.0003815871896222234
breast B-Disease 1 0.9999426603317261
and I-Disease 1 0.9723551273345947
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0014295806176960468
. O 0 0.000547632691450417

We O 0 6.865293107694015e-05
have O 0 5.731963938160334e-06
identified O 0 6.90158958605025e-06
four O 0 3.657439719972899e-06
mutations O 0 4.874611477134749e-06
in O 0 2.5302742869826034e-06
each O 0 3.5948380627814913e-07
of O 0 1.2584267096826807e-05
the O 0 0.0001596278016222641
breast B-Disease 1 0.9999966621398926
cancer I-Disease 1 0.9999992847442627
- O 0 0.037183187901973724
susceptibility O 0 0.00045637981384061277
genes O 0 4.6496741560986266e-05
, O 0 2.491877785359975e-05
BRCA1 O 0 0.00019279947446193546
and O 0 1.854601396189537e-05
BRCA2 O 0 0.0001676893443800509
, O 0 2.658434368640883e-06
in O 0 4.912566510029137e-06
French O 0 3.6609435483114794e-05
Canadian O 0 0.00018643344810698181
breast B-Disease 1 0.9999847412109375
cancer I-Disease 1 0.999998927116394
and O 0 0.0009801507694646716
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00020957794913556427
from O 0 0.00040583289228379726
Quebec O 0 0.0022346845362335443
. O 0 0.00022215142962522805

To O 0 0.00024338737421203405
identify O 0 0.00035049975849688053
founder O 0 0.00247638369910419
effects O 0 0.00042983939056284726
, O 0 1.711956792860292e-05
we O 0 5.481459083966911e-06
examined O 0 1.2914871149405371e-05
independently O 0 4.270882982382318e-06
ascertained O 0 4.961806189385243e-05
French O 0 5.0460948841646314e-05
Canadian O 0 8.202023309422657e-05
cancer B-Disease 0 0.0003565230581443757
families O 0 2.7893408969248412e-06
for O 0 2.187706058975891e-06
the O 0 7.792199539835565e-06
distribution O 0 2.5210154035448795e-06
of O 0 1.4284222743299324e-05
these O 0 8.99391216080403e-06
eight O 0 0.00012145927757956088
mutations O 0 0.00013428331294562668
. O 0 0.0001846829109126702

Mutations O 0 0.0002439609816065058
were O 0 4.658368197851814e-05
found O 0 1.2830434570787475e-05
in O 0 1.0556990673649125e-05
41 O 0 4.046355388709344e-05
of O 0 7.643201388418674e-05
97 O 0 0.0005323995719663799
families O 0 8.550885104341432e-05
. O 0 0.0002765475946944207

Six O 0 0.00011111554340459406
of O 0 4.3649164581438527e-05
eight O 0 7.651544001419097e-05
mutations O 0 2.217670771642588e-05
were O 0 2.0491717805271037e-05
observed O 0 3.374620428076014e-05
at O 0 0.00015784391143824905
least O 0 3.3010204788297415e-05
twice O 0 0.00014811247820034623
. O 0 0.00012024729221593589

The O 0 0.0007443402428179979
BRCA1 O 0 0.002845723880454898
C4446T O 0 0.0015706636477261782
mutation O 0 4.147454092162661e-05
was O 0 0.00011055875802412629
the O 0 1.7908012523548678e-05
most O 0 5.904064437345369e-06
common O 0 7.1188546826306265e-06
mutation O 0 8.453305781586096e-06
found O 0 5.629381576000014e-06
, O 0 2.752108002823661e-06
followed O 0 1.0695917808334343e-05
by O 0 4.954751602781471e-06
the O 0 6.329971802188084e-05
BRCA2 O 0 0.0010938742198050022
8765delAG O 0 0.0031215008348226547
mutation O 0 0.00018947318312712014
. O 0 0.0002124781021848321

Together O 0 0.00017319088510703295
, O 0 1.5270565199898556e-05
these O 0 2.5539502530591562e-06
mutations O 0 1.1533456927281804e-05
were O 0 1.171447820524918e-05
found O 0 3.476520305412123e-06
in O 0 6.454136837419355e-06
28 O 0 3.4765456803143024e-05
of O 0 1.8108306903741322e-05
41 O 0 2.9018226996413432e-05
families O 0 3.0237749797379365e-06
identified O 0 3.899216153513407e-06
to O 0 3.537145403242903e-06
have O 0 5.708223397959955e-06
a O 0 3.107392694801092e-05
mutation O 0 6.462806777562946e-05
. O 0 0.00018031780200544745

The O 0 0.0002773426240310073
odds O 0 0.0003078604640904814
of O 0 3.262097015976906e-05
detection O 0 3.2857755286386237e-05
of O 0 1.9898347090929747e-05
any O 0 5.479817900777562e-06
of O 0 1.9098295524599962e-05
the O 0 2.9797087336191908e-05
four O 0 4.326652197050862e-05
BRCA1 O 0 0.000347462366335094
mutations O 0 4.869683471042663e-05
was O 0 0.0005408826982602477
18 O 0 0.0003105323121417314
. O 0 0.00022879487369209528

7x O 0 0.028451476246118546
greater O 0 0.00022860561148263514
if O 0 1.0289317287970334e-05
one O 0 2.3594918729941128e-06
or O 0 1.3101941931381589e-06
more O 0 6.078799970055115e-07
cases O 0 8.175883522199001e-06
of O 0 0.003482396248728037
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0002456576330587268
also O 0 1.8572882254375145e-05
present O 0 1.3093449524603784e-05
in O 0 2.9826824174961075e-05
the O 0 6.849938654340804e-05
family O 0 0.00013224761642049998
. O 0 0.0001483451051171869

The O 0 0.000209169476875104
odds O 0 0.0002064518048427999
of O 0 3.0957387934904546e-05
detection O 0 2.5951290808734484e-05
of O 0 1.8230688510811888e-05
any O 0 7.899380761955399e-06
of O 0 2.0800796846742742e-05
the O 0 3.395839667064138e-05
four O 0 3.060204835492186e-05
BRCA2 O 0 0.00040226159035228193
mutations O 0 8.311219426104799e-05
was O 0 0.000500520458444953
5 O 0 0.0003200186765752733
. O 0 0.00020208876230753958

3x O 0 0.007796267047524452
greater O 0 0.00014889541489537805
if O 0 1.1032334441551939e-05
there O 0 4.4469866224972066e-06
were O 0 5.488274382514646e-06
at O 0 1.6622672774246894e-05
least O 0 1.8696376855587005e-06
five O 0 2.5568062937963987e-06
cases O 0 4.306662958697416e-06
of O 0 0.000218222921830602
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999722242355347
in O 0 0.00020723514899145812
the O 0 0.00016443958156742156
family O 0 0.00014021941751707345
. O 0 0.00010639648826327175

Interestingly O 0 0.0006764550344087183
, O 0 1.4438175639952533e-05
the O 0 4.75106344310916e-06
presence O 0 1.2846669960708823e-05
of O 0 4.022912253276445e-05
a O 0 0.00026548607274889946
breast B-Disease 1 0.9998773336410522
cancer I-Disease 1 0.9994109869003296
case O 0 0.00016404745110776275
< O 0 0.0003513238625600934
36 O 0 4.3202457163715735e-05
years O 0 2.0548664906527847e-05
of O 0 2.760296774795279e-05
age O 0 9.214304736815393e-05
was O 0 0.00012167048407718539
strongly O 0 5.3841190492676105e-06
predictive O 0 6.783435765100876e-06
of O 0 1.609439277672209e-05
the O 0 1.837994386733044e-05
presence O 0 1.442490793124307e-05
of O 0 1.1440037269494496e-05
any O 0 4.353440544946352e-06
of O 0 1.8527298379922286e-05
the O 0 4.143188562011346e-05
eight O 0 7.596804789500311e-05
mutations O 0 4.7700385039206594e-05
screened O 0 0.0005334365414455533
. O 0 0.00016592341125942767

Carriers O 0 0.00015475126565434039
of O 0 3.996737359557301e-05
the O 0 2.5491404812783003e-05
same O 0 1.308793252974283e-05
mutation O 0 5.416844032879453e-06
, O 0 1.9039581502511282e-06
from O 0 2.4694788862689165e-06
different O 0 3.6505085176941066e-07
families O 0 2.276060740769026e-06
, O 0 2.7432852220954373e-06
shared O 0 7.235374596348265e-06
similar O 0 6.179443971632281e-06
haplotypes O 0 0.00015784437709953636
, O 0 6.239930826268392e-06
indicating O 0 2.080321246467065e-05
that O 0 1.5408352282975102e-06
the O 0 3.6763092339242576e-06
mutant O 0 1.680030436546076e-05
alleles O 0 6.761927579645999e-06
were O 0 8.396646080655046e-06
likely O 0 8.584190254623536e-06
to O 0 4.127947704546386e-06
be O 0 3.4965569284395315e-06
identical O 0 2.8657402708631707e-06
by O 0 1.7757441810317687e-06
descent O 0 1.9336042896611616e-05
for O 0 5.827317181683611e-06
a O 0 2.149052124877926e-05
mutation O 0 7.989660844032187e-06
in O 0 1.5204373994492926e-05
the O 0 4.7314391849795356e-05
founder O 0 0.0005486534209921956
population O 0 3.2041643862612545e-05
. O 0 0.00014514263602904975

The O 0 5.332590808393434e-05
identification O 0 1.2983879059902392e-05
of O 0 9.24024498090148e-05
common O 0 0.00021939245925750583
BRCA1 O 0 0.00210168631747365
and O 0 8.11082063592039e-05
BRCA2 O 0 0.0005539682460948825
mutations O 0 2.244765892100986e-05
will O 0 7.43996770324884e-06
facilitate O 0 1.6073594451881945e-05
carrier O 0 1.80429397005355e-05
detection O 0 5.529953341465443e-06
in O 0 3.0216244795155944e-06
French O 0 2.184130971727427e-05
Canadian O 0 0.0001349306112388149
breast B-Disease 1 0.9999798536300659
cancer I-Disease 1 0.9999985694885254
and O 0 0.0022250397596508265
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0015184285584837198
. O 0 0.0004417613090481609

Are O 0 0.00013741935254074633
Dp71 O 0 0.011989894323050976
and O 0 0.00015655752213206142
Dp140 O 0 0.020427342504262924
brain O 0 0.02017124369740486
dystrophin O 0 0.0005553444498218596
isoforms O 0 3.998049214715138e-05
related O 0 4.156921568210237e-05
to O 0 4.3142750655533746e-05
cognitive B-Disease 1 0.9775891900062561
impairment I-Disease 1 1.0
in O 1 1.0
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998095631599426

Molecular O 0 0.00047824709326960146
study O 0 4.6823162847431377e-05
and O 0 1.0912282050412614e-05
neuropsychological O 0 8.626865746919066e-05
analysis O 0 2.4663156636961503e-06
were O 0 9.279246114601847e-06
performed O 0 1.7296870282734744e-05
concurrently O 0 1.147509192378493e-05
on O 0 1.368459197692573e-05
49 O 0 6.508574733743444e-05
patients O 0 0.00023723411140963435
with O 0 0.41457152366638184
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999984502792358
DMD B-Disease 1 1.0
) O 0 7.905145321274176e-05
in O 0 1.2100884305255022e-05
order O 0 3.357665036674007e-06
to O 0 3.5849272990162717e-06
find O 0 7.3333794716745615e-06
a O 0 4.832706508750562e-06
molecular O 0 1.0663581633707508e-05
explanation O 0 6.973725248826668e-06
for O 0 4.3887653191632126e-06
the O 0 3.5275625123176724e-05
cognitive B-Disease 0 0.0013864454813301563
impairment I-Disease 1 0.9908668994903564
observed O 0 0.0005227694055065513
in O 0 0.0003164499066770077
most O 0 0.001036735950037837
DMD B-Disease 1 1.0
patients O 0 0.009461309760808945
. O 0 0.0009266412234865129

Complete O 0 0.00011703802738338709
analysis O 0 8.720975529286079e-06
of O 0 3.846476101898588e-05
the O 0 5.92232245253399e-05
dystrophin O 0 0.00039795844350010157
gene O 0 3.2411848224001005e-05
was O 0 6.243368989089504e-05
performed O 0 1.644884468987584e-05
to O 0 4.256752617948223e-06
define O 0 1.3197401131037623e-05
the O 0 1.884586708911229e-05
localization O 0 0.00016977508494164795
of O 0 6.796155503252521e-05
deletions O 0 0.00015663786325603724
and O 0 2.28931603487581e-05
duplications O 0 0.00021985566127113998
in O 0 2.2619698938797228e-05
relation O 0 3.6232449929229915e-05
to O 0 1.1406678822822869e-05
the O 0 3.326573641970754e-05
different O 0 3.281294630141929e-05
DMD B-Disease 1 1.0
promoters O 1 0.7921901941299438
. O 0 0.0007989442674443126

Qualitative O 0 0.00014086347073316574
analysis O 0 1.3768815733783413e-05
of O 0 8.231248648371547e-05
the O 0 0.0001325580815318972
Dp71 O 0 0.004379581194370985
transcript O 0 0.00015337186050601304
and O 0 3.39038251695456e-06
testing O 0 1.5244386304402724e-06
for O 0 8.282830208372616e-07
the O 0 5.0099065447284374e-06
specific O 0 1.5242205790855223e-06
first O 0 2.6099582100869156e-05
exon O 0 9.40914178499952e-05
of O 0 4.022548091597855e-05
Dp140 O 0 0.0004956620396114886
were O 0 2.245872929051984e-05
also O 0 8.713211173017044e-06
carried O 0 4.331540549173951e-05
out O 0 3.1421561288880184e-05
. O 0 8.792187145445496e-05

Neuropsychological O 0 0.0021923126187175512
analysis O 0 2.6639379939297214e-05
assessed O 0 0.00011067215382354334
verbal O 0 0.00015684141544625163
and O 0 0.0001254764647455886
visuospatial O 0 0.012533196248114109
intelligence O 0 0.0001659653353272006
, O 0 2.782975570880808e-05
verbal O 0 0.00022171657474245876
memory O 1 0.9887633323669434
, O 0 0.0001209272159030661
and O 0 5.6252782087540254e-05
reading O 0 0.0007235624361783266
skills O 0 0.001826137537136674
. O 0 0.00040151452412828803

Comparison O 0 0.00014348476543091238
of O 0 0.0001068658457370475
molecular O 0 0.00011607418855419382
and O 0 1.551889545226004e-05
psychometric O 0 0.000234471372095868
findings O 0 2.2431117031374015e-05
demonstrated O 0 6.505061901407316e-05
that O 0 3.1711676911072573e-06
deletions O 0 3.8313861296046525e-05
and O 0 8.366112524527125e-06
duplications O 0 0.00022408475342672318
that O 0 3.255372803323553e-06
were O 0 1.2043299648212269e-05
localized O 0 5.1886960136471316e-05
in O 0 1.8067716155201197e-05
the O 0 2.4363263946725056e-05
distal O 0 0.00030503611196763813
part O 0 3.28514252032619e-05
of O 0 3.36371231242083e-05
the O 0 5.223139305599034e-05
gene O 0 1.996919854718726e-05
seemed O 0 2.3124408471630886e-05
to O 0 1.8148059552913764e-06
be O 0 2.0934548956574872e-06
preferentially O 0 8.181249540939461e-06
associated O 0 1.0726633263402618e-05
with O 0 1.8101607565768063e-05
cognitive B-Disease 1 0.7653047442436218
impairment I-Disease 1 0.9999995231628418
. O 0 0.3701331615447998

Two O 0 0.00013595359632745385
altered O 0 0.0004772490938194096
Dp71 O 0 0.0030278710182756186
transcripts O 0 0.00022194247867446393
and O 0 8.196479029720649e-06
two O 0 6.229965492821066e-06
deleted O 0 6.164825754240155e-05
Dp140 O 0 0.00015958519361447543
DNA O 0 5.895557478652336e-06
sequences O 0 2.045564997388283e-06
were O 0 6.14298505752231e-06
found O 0 1.4653536482001073e-06
in O 0 3.545821755324141e-06
four O 0 1.097001677408116e-05
patients O 0 4.923748565488495e-05
with O 0 0.00018712872406467795
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9996007084846497

These O 0 2.3098862584447488e-05
findings O 0 1.5135698959056754e-05
suggest O 0 5.461536147777224e-06
that O 0 5.486435270540824e-07
some O 0 7.401656603178708e-07
sequences O 0 7.4977538133680355e-06
located O 0 7.746736810076982e-05
in O 0 8.980130587588064e-06
the O 0 2.5330813514301553e-05
distal O 0 0.0003455793485045433
part O 0 5.28720993315801e-05
of O 0 4.977928620064631e-05
the O 0 4.036689279018901e-05
gene O 0 2.0089782992727123e-05
and O 0 5.392196726461407e-06
, O 0 3.4253912417625543e-06
in O 0 4.999797511118231e-06
particular O 0 6.644871518801665e-06
, O 0 6.0533038777066395e-06
some O 0 1.1046041436202358e-05
DMD B-Disease 1 0.9992953538894653
isoforms O 0 1.9343255189596675e-05
expressed O 0 1.8334812921239063e-05
in O 0 2.008742740144953e-05
the O 0 6.355460936902091e-05
brain O 0 0.0018239505589008331
may O 0 2.0409064745763317e-05
be O 0 2.4491209842381068e-06
related O 0 4.385903139336733e-06
to O 0 4.6522436605300754e-06
the O 0 3.4192657039966434e-05
cognitive B-Disease 0 0.001201017526909709
impairment I-Disease 1 0.9997844099998474
associated O 0 0.003840419929474592
with O 0 0.001656757784076035
DMD B-Disease 1 1.0
. O 0 0.000645723077468574
. O 0 0.000281167944194749

I1307K O 0 0.019058670848608017
APC O 0 0.005090772639960051
and O 0 7.79838374000974e-05
hMLH1 O 0 0.0011289691319689155
mutations O 0 5.589323700405657e-05
in O 0 2.4433344151475467e-05
a O 0 4.15012109442614e-05
non O 0 7.702019502175972e-05
- O 0 6.0090380429755896e-05
Jewish O 0 7.4360518738103565e-06
family O 0 5.079452876088908e-06
with O 0 4.237242592353141e-06
hereditary B-Disease 1 0.9999978542327881
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9966601133346558

We O 0 4.025563976028934e-05
describe O 0 2.0682016838691197e-05
a O 0 1.1392753549444024e-05
French O 0 4.651230847230181e-05
Canadian O 0 7.620902033522725e-05
hereditary B-Disease 1 0.9999730587005615
non I-Disease 1 0.9999909400939941
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999988079071045
HNPCC B-Disease 1 1.0
) O 0 0.000253234087722376
kindred O 0 0.0005881435354240239
which O 0 1.538406650070101e-05
carries O 0 3.108305827481672e-05
a O 0 2.2783044187235646e-05
novel O 0 4.5603537728311494e-05
truncating O 0 0.000346546177752316
mutation O 0 7.972300954861566e-05
in O 0 0.00021254722378216684
hMLH1 O 0 0.006467284634709358
. O 0 0.0004472895816434175

Interestingly O 0 0.0016684968722984195
, O 0 5.7712819398147985e-05
the O 0 9.885628242045641e-05
I1307K O 0 0.002077744109556079
APC O 0 0.0006732200854457915
polymorphism O 0 4.2553539969958365e-05
, O 0 5.224662800173974e-06
associated O 0 1.9262324713054113e-06
with O 0 4.868836640525842e-07
an O 0 2.3172963210527087e-06
increased O 0 2.5265962904086336e-05
risk O 0 0.00012086358765373006
of O 1 0.9995367527008057
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.00018071886734105647
is O 0 1.2535768291854765e-05
also O 0 3.7984445953043178e-06
present O 0 7.51414609112544e-06
in O 0 1.3559529179474339e-05
this O 0 1.2752717339026276e-05
family O 0 8.516423258697614e-05
. O 0 7.92631835793145e-05

The O 0 0.00042985109030269086
I1307K O 0 0.0011895145289599895
polymorphism O 0 3.974070932599716e-05
has O 0 7.49132823330001e-06
previously O 0 1.3723916708840989e-05
only O 0 1.9667731976369396e-06
been O 0 5.194039204070577e-06
identified O 0 4.490065293794032e-06
in O 0 3.5309503800817765e-06
individuals O 0 1.7705663140077377e-06
of O 0 6.173879228299484e-05
self O 0 0.0005949005717411637
- O 0 0.0008956891251727939
reported O 0 7.828141679055989e-05
Ashkenazi O 0 0.00010130076407222077
Jewish O 0 0.00012634258018806577
origins O 0 0.0006705312989652157
. O 0 0.0003720427630469203

In O 0 9.348068124381825e-05
addition O 0 1.6988322386168875e-05
, O 0 4.378289304440841e-06
in O 0 5.332482032827102e-06
this O 0 2.9012271625106223e-06
family O 0 9.459068678552285e-06
, O 0 1.6189752614081954e-06
there O 0 3.5868836221197853e-06
appears O 0 7.184945843619062e-06
to O 0 1.3389296782406745e-06
be O 0 3.0254739158408483e-06
no O 0 4.0302093111677095e-06
relationship O 0 1.703433008515276e-05
between O 0 5.225834684097208e-05
the O 0 5.9043115470558405e-05
I1307K O 0 0.0004877255414612591
polymorphism O 0 1.814147617551498e-05
and O 0 5.733604666602332e-06
the O 0 1.0616357030812651e-05
presence O 0 2.582646266091615e-05
or O 0 1.4912533515598625e-05
absence O 0 0.0002838056825567037
of O 0 0.001317432033829391
cancer B-Disease 1 0.9999951124191284
. O 0 0.0002901317784562707
. O 0 0.0002567176998127252

Identification O 0 4.330301453592256e-05
of O 0 9.40953686949797e-05
a O 0 3.824471787083894e-05
novel O 0 3.6946625186828896e-05
mutation O 0 5.029582553106593e-06
of O 0 1.880145282484591e-05
the O 0 7.609325984958559e-05
CPO O 0 0.0017648148350417614
gene O 0 1.6472675270051695e-05
in O 0 1.3937814401288051e-05
a O 0 2.825594856403768e-05
Japanese O 0 0.0006199248600751162
hereditary B-Disease 1 0.9997689127922058
coproporphyria I-Disease 1 0.9997974038124084
family O 0 0.0014659835724160075
. O 0 0.0005429545417428017

Hereditary B-Disease 1 0.999998927116394
coproporphyria I-Disease 1 0.9999969005584717
( O 0 0.025465823709964752
HCP B-Disease 1 0.9999933242797852
) O 0 3.263849066570401e-05
is O 0 9.271197086491156e-06
an O 0 1.3569321708928328e-05
autosomal B-Disease 1 0.9993046522140503
dominant I-Disease 1 0.9999980926513672
disease I-Disease 1 1.0
characterized O 0 0.0014217497082427144
by O 0 3.579539043130353e-05
a O 0 0.00020003292593173683
deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 0.005211676470935345
coproporphyrinogen I-Disease 1 0.9999474287033081
oxidase I-Disease 0 0.0005139040877111256
( O 0 0.00015739843365736306
CPO O 0 0.003980844281613827
) O 0 2.9517204893636517e-05
caused O 0 5.323474761098623e-05
by O 0 3.236236807424575e-06
a O 0 9.344642421638127e-06
mutation O 0 3.839402324956609e-06
in O 0 1.854707625170704e-05
the O 0 9.905482147587463e-05
CPO O 0 0.008194169029593468
gene O 0 0.00021120018209330738
. O 0 0.0001592589687788859

Only O 0 3.5930694139096886e-05
11 O 0 4.874771548202261e-05
mutations O 0 3.0968633382144617e-06
of O 0 6.658363872702466e-06
the O 0 1.600030554982368e-05
gene O 0 5.579237949859817e-06
have O 0 1.5127138794923667e-06
been O 0 9.24324649531627e-06
reported O 0 2.0318027964094654e-05
in O 0 0.00015061879821587354
HCP B-Disease 1 0.999997615814209
patients O 0 0.0016864752396941185
. O 0 0.0005340296775102615

We O 0 5.697883170796558e-05
report O 0 6.743451194779482e-06
another O 0 8.117646757455077e-06
mutation O 0 2.231116241091513e-06
in O 0 6.078381375118624e-06
a O 0 2.8872476832475513e-05
Japanese O 0 0.00041186262387782335
family O 0 0.00016591628082096577
. O 0 0.00011197914136573672

Polymerase O 0 0.004968754481524229
chain O 0 0.001003942801617086
reaction O 0 0.00013761867012362927
- O 0 0.0004730171640403569
single O 0 3.123579153907485e-05
strand O 0 2.303439032402821e-05
conformational O 0 8.154002898663748e-06
polymorphism O 0 7.985638148966245e-06
and O 0 1.7955303519556765e-06
direct O 0 1.9087324290012475e-06
sequence O 0 2.749233090071357e-06
analyses O 0 4.4272887862462085e-06
demonstrated O 0 2.762343137874268e-05
a O 0 2.294051955686882e-05
C O 0 0.00019587053975556046
to O 0 3.97899275412783e-05
T O 0 0.0003372603969182819
substitution O 0 1.1084305697295349e-05
in O 0 1.352258459519362e-05
exon O 0 5.7160923461196944e-05
1 O 0 1.928593155753333e-05
of O 0 1.1210802767891437e-05
the O 0 3.409767305129208e-05
CPO O 0 0.0005433720070868731
gene O 0 6.042022960173199e-06
at O 0 3.0481931389658712e-05
nucleotide O 0 9.108296580961905e-06
position O 0 1.7999098417931236e-05
85 O 0 2.653726733115036e-05
, O 0 4.727343821286922e-06
which O 0 5.981509730190737e-06
lies O 0 8.482606790494174e-05
in O 0 1.111163328459952e-05
the O 0 2.5407069188077003e-05
putative O 0 0.00019213258929084986
presequence O 0 0.00046445400221273303
for O 0 1.3844407476426568e-05
targeting O 0 3.124765134998597e-05
to O 0 7.180561078712344e-05
mitochondria O 0 0.0007506043184548616
. O 0 0.00015730962331872433

This O 0 2.9403141525108367e-05
mutation O 0 1.2717266145045869e-05
changes O 0 3.2295404253090965e-06
the O 0 1.2011400940536987e-05
codon O 0 7.835186806914862e-06
for O 0 4.371080194687238e-06
glutamine O 0 1.2464765859476756e-05
to O 0 1.238854292751057e-05
a O 0 2.3855251129134558e-05
termination O 0 9.774569480214268e-05
codon O 0 5.6121400120900944e-05
at O 0 0.00024948312784545124
amino O 0 3.7717145460192114e-05
acid O 0 6.978453893680125e-05
position O 0 0.0003173731965944171
29 O 0 0.0011966468300670385
. O 0 0.00028385926270857453

MaeI O 0 0.006151233799755573
restriction O 0 3.4061824408126995e-05
analysis O 0 4.6875425141479354e-06
showed O 0 1.7083071725210175e-05
two O 0 2.814573690557154e-06
other O 0 2.9189779979788e-06
carriers O 0 1.1489961252664216e-05
in O 0 1.3853070413460955e-05
the O 0 5.607037019217387e-05
family O 0 9.958871669368818e-05
. O 0 0.00013089469575788826

The O 0 0.0008492764318361878
C O 0 0.04589051753282547
- O 0 0.004541776143014431
T O 0 0.002108932239934802
mutation O 0 1.010274536383804e-05
is O 0 4.232509581925115e-06
located O 0 3.1359028071165085e-05
within O 0 4.34962294093566e-06
a O 0 7.839611498638988e-06
recently O 0 1.436743787053274e-05
proposed O 0 9.245943147107027e-06
putative O 0 3.5338995076017454e-05
alternative O 0 4.8555652938375715e-06
translation O 0 2.59044627455296e-05
initiation O 0 0.00011708780948538333
codon O 0 8.700551552465186e-05
( O 0 7.778003782732412e-05
TIC O 0 0.007603454869240522
- O 0 0.00015392067143693566
1 O 0 5.318715557223186e-05
) O 0 4.94389632876846e-06
, O 0 2.9341269964788808e-06
supporting O 0 1.1263366104685701e-05
that O 0 1.6232737834798172e-05
TIC O 0 0.020807145163416862
- O 0 0.0001288135099457577
1 O 0 4.2459985706955194e-05
is O 0 3.1032757306093117e-06
the O 0 8.817153684503864e-06
real O 0 0.00020823600061703473
TIC O 0 0.0214863158762455
rather O 0 3.913483305950649e-05
than O 0 4.7599824029020965e-05
TIC O 0 0.4797021448612213
- O 0 0.000408497522585094
2 O 0 0.00013590707385446876
. O 0 3.0119175789877772e-05
. O 0 8.182461897376925e-05

Human B-Disease 0 8.738859469303861e-05
complement I-Disease 0 0.00014646367344539613
factor I-Disease 0 0.02340424619615078
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.2362017035484314
with O 1 0.9999589920043945
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999836683273315

This O 0 2.0470914023462683e-05
study O 0 7.589723281853367e-06
reports O 0 3.8235511965467595e-06
on O 0 1.2081260138074867e-05
six O 0 1.2747256732836831e-05
cases O 0 1.3104217941872776e-05
of O 0 0.00034944311482831836
deficiency B-Disease 1 0.9999996423721313
in I-Disease 0 8.684992644703016e-05
the I-Disease 0 2.0389959900057875e-05
human I-Disease 0 3.782741032409831e-06
complement I-Disease 0 5.216238605498802e-06
regulatory I-Disease 0 1.644214898988139e-05
protein I-Disease 0 1.8583054043119773e-05
Factor I-Disease 0 0.00019357091514393687
H I-Disease 1 0.9997262358665466
( O 0 9.024596511153504e-05
FH O 0 0.0011130202328786254
) O 0 2.458842800479033e-06
in O 0 9.388969601786812e-07
the O 0 7.90343392509385e-07
context O 0 1.4219634749679244e-06
of O 0 1.1792197255999781e-05
an O 0 0.00014466415450442582
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999675750732422

Five O 0 6.104592466726899e-05
of O 0 2.9356802770053037e-05
the O 0 1.5154837456066161e-05
cases O 0 4.4503512981464155e-06
were O 0 1.0866828233702108e-05
observed O 0 6.083954758651089e-06
in O 0 3.2731795727158897e-06
children O 0 3.0955818601796636e-06
presenting O 0 3.488528454909101e-05
with O 0 0.00018304777040611953
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 0.025476356968283653
. O 0 0.0007748388452455401

Two O 0 1.827262167353183e-05
of O 0 3.7295842048479244e-05
the O 0 6.337280501611531e-05
children O 0 2.0410934666870162e-05
exhibited O 0 0.00033402882399968803
a O 0 0.00022438405721914023
homozygous O 0 0.043459296226501465
deficiency O 1 1.0
characterized O 0 0.0004009786352980882
by O 0 1.4433769138122443e-05
the O 0 1.8073902538162656e-05
absence O 0 2.92928143608151e-05
of O 0 2.362413033552002e-05
the O 0 2.600614243419841e-05
150 O 0 3.577791721909307e-05
- O 0 6.22418083366938e-05
kD O 0 0.00018319566152058542
form O 0 4.372701823740499e-06
of O 0 3.903267497662455e-05
Factor O 0 0.00033456264645792544
H O 1 0.9991995692253113
and O 0 6.967789431655547e-06
the O 0 9.059732292371336e-06
presence O 0 1.0942578228423372e-05
, O 0 2.051371211564401e-06
upon O 0 1.6572954336879775e-05
immunoblotting O 0 0.00030299017089419067
, O 0 2.3574227725475794e-06
of O 0 7.035428552626399e-06
the O 0 1.8547181753092445e-05
42 O 0 0.0001229801564477384
- O 0 0.00022479327162727714
kD O 0 0.0014457618817687035
Factor O 0 0.00023735493596177548
H O 0 0.030432702973484993
- O 0 0.00012200252240290865
like O 0 9.728977602208033e-06
protein O 0 1.2686014088103548e-05
1 O 0 8.187769708456472e-05
( O 0 3.31522969645448e-05
FHL O 0 0.00405107019469142
- O 0 8.482623525196686e-05
1 O 0 3.857923002215102e-05
) O 0 4.17175397160463e-06
and O 0 3.1464298899663845e-06
other O 0 7.494336387026124e-06
FH O 0 0.0037520185578614473
- O 0 0.0001434248551959172
related O 0 3.5349137760931626e-05
protein O 0 6.601272616535425e-05
( O 0 6.081206083763391e-05
FHR O 1 0.6799818277359009
) O 0 6.330497126327828e-05
bands O 0 0.0004143431724514812
. O 0 0.00021329469745978713

Southern O 0 0.0015971146058291197
blot O 0 0.0004860897024627775
and O 0 1.1620833902270533e-05
PCR O 0 7.842048944439739e-06
analysis O 0 8.015325647647842e-07
of O 0 8.554899068258237e-06
DNA O 0 2.026964102697093e-05
of O 0 2.4877768737496808e-05
one O 0 1.4501983059744816e-05
patient O 0 3.046815618290566e-05
with O 0 1.8399623513687402e-05
homozygous O 0 0.002453806111589074
deficiency O 1 0.9999996423721313
ruled O 0 0.00044474037713371217
out O 0 1.2878636880486738e-05
the O 0 7.684332558710594e-06
presence O 0 5.8798132158699445e-06
of O 0 1.1357942639733665e-05
a O 0 8.165637154888827e-06
large O 0 7.4470021900197025e-06
deletion O 0 1.4783141523366794e-05
of O 0 2.3238480935106054e-05
the O 0 7.41589319659397e-05
FH O 0 0.004228996112942696
gene O 0 9.433537343284115e-06
as O 0 6.4205073613265995e-06
the O 0 1.4072817975829821e-05
underlying O 0 0.0006001838482916355
defect O 0 0.0016647577285766602
for O 0 8.837494533509016e-05
the O 0 0.09490076452493668
deficiency O 1 1.0
. O 0 0.0035064779222011566

The O 0 5.966105527477339e-05
other O 0 5.0935495892190374e-06
four O 0 5.189939656702336e-06
children O 0 5.212707947066519e-06
presented O 0 2.486967969161924e-05
with O 0 2.6071100364788435e-05
heterozygous O 0 0.0009510447271168232
deficiency O 1 1.0
and O 0 0.0001995680941035971
exhibited O 0 0.00643717497587204
a O 0 0.00017892505275085568
normal O 0 0.00016964141104836017
immunoblotting O 0 0.00117030693218112
pattern O 0 5.460853935801424e-05
of O 0 2.7218171453569084e-05
proteins O 0 1.3323302482604049e-05
of O 0 8.105268352665007e-05
the O 0 0.00031516782473772764
FH O 1 0.9631693363189697
family O 0 0.0006440845318138599
. O 0 0.0003429496136959642

Factor B-Disease 1 0.9970912933349609
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.3614794625027571e-05
the O 0 1.0815547284437343e-05
only O 0 1.6922125723795034e-05
complement B-Disease 1 0.9997040629386902
deficiency I-Disease 1 1.0
associated O 0 0.01930171810090542
with O 0 0.002332651289179921
HUS B-Disease 1 1.0
. O 0 0.004086594097316265

These O 0 4.25618163717445e-05
observations O 0 4.6890727389836684e-05
suggest O 0 1.7598831618670374e-05
a O 0 9.687186320661567e-06
role O 0 2.632583891681861e-05
for O 0 3.0315417461679317e-05
FH O 0 0.1227010115981102
and O 0 8.949352923082188e-05
/ O 0 0.0005876045906916261
or O 0 0.00010694261436583474
FH O 0 0.015025668777525425
receptors O 0 4.996653296984732e-05
in O 0 2.8205035050632432e-05
the O 0 8.531345520168543e-05
pathogenesis O 1 0.9983876943588257
of O 0 0.005889376625418663
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.003903115401044488
. O 0 0.0005711890989914536

Further O 0 5.899420284549706e-05
evidence O 0 1.3388107618084177e-05
for O 0 2.411358309473144e-06
a O 0 1.0050162927655037e-05
major O 0 7.834983262000605e-05
ancient O 0 0.0005399874062277377
mutation O 0 0.0010639739921316504
underlying O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9290914535522461
linkage O 1 0.8354530930519104
disequilibrium O 0 0.015474395826458931
studies O 0 5.315591624821536e-05
in O 0 3.64389707101509e-05
the O 0 4.736387199955061e-05
Japanese O 0 0.0002808863646350801
population O 0 2.930505434051156e-05
. O 0 7.88278121035546e-05

The O 1 0.9940547347068787
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9925664663314819
DM B-Disease 1 1.0
) O 0 0.00016271685308311135
mutation O 0 1.539084769319743e-05
is O 0 8.231933861679863e-06
an O 0 1.5078461728990078e-05
unstable O 0 0.0016768521163612604
( O 0 0.00022311194334179163
CTG O 0 0.07395002245903015
) O 0 2.5314777303719893e-05
n O 0 3.880068470607512e-05
repeat O 0 0.00011231386451981962
, O 0 5.0701942200248595e-06
present O 0 8.228794285969343e-06
at O 0 4.8715275624999776e-05
a O 0 8.215565685532056e-06
copy O 0 1.1620146324275993e-05
number O 0 4.4586940930457786e-06
of O 0 5.1252518460387364e-05
5 O 0 0.000180745410034433
- O 0 0.00017013175238389522
37 O 0 3.5277073038741946e-05
repeats O 0 2.640997445269022e-05
on O 0 3.5333265259396285e-05
normal O 0 1.509086177975405e-05
chromosomes O 0 8.053712917899247e-06
but O 0 1.7155716705019586e-06
amplified O 0 1.9513505321810953e-05
to O 0 6.485975973191671e-06
50 O 0 2.50740340561606e-05
- O 0 4.739012001664378e-05
3000 O 0 5.931902342126705e-05
copies O 0 2.3619782950845547e-05
on O 0 0.00038589289761148393
DM B-Disease 1 0.9999974966049194
chromosomes O 0 0.000962908670771867
. O 0 0.00023850190336816013

Previous O 0 0.0001271916407858953
findings O 0 2.6934651032206602e-05
in O 0 2.4459966880385764e-05
Caucasian O 0 0.00010666406888049096
populations O 0 6.529269285238115e-06
of O 0 3.186101821484044e-05
a O 0 0.0003452044620644301
DM B-Disease 1 1.0
founder O 1 0.8773462772369385
chromosome O 0 0.00033767372951842844
raise O 0 4.1747873183339834e-05
a O 0 7.672440005990211e-06
question O 0 7.1980316533881705e-06
about O 0 2.769099637589534e-06
the O 0 4.096808424947085e-06
molecular O 0 1.1505037946335506e-05
events O 0 1.0767785170173738e-05
involved O 0 1.629849248274695e-05
in O 0 1.133655860030558e-05
the O 0 3.255356932641007e-05
expansion O 0 0.0004176122311037034
mutation O 0 6.519326416309923e-05
. O 0 0.00011584662570385262

To O 0 7.632101915078238e-05
investigate O 0 5.876927025383338e-05
whether O 0 9.334062269772403e-06
a O 0 2.0310702893766575e-05
founder O 0 0.0002882099652197212
chromosome O 0 5.6062996009131894e-05
for O 0 1.0864963769563474e-05
the O 0 0.00019741698633879423
DM B-Disease 1 0.9999998807907104
mutation O 0 4.836473453906365e-05
exists O 0 2.5499843104626052e-05
in O 0 5.756287009717198e-06
the O 0 6.063484306650935e-06
Japanese O 0 3.6758254282176495e-05
population O 0 2.5498009108559927e-06
, O 0 3.630514356700587e-06
we O 0 3.829236447927542e-06
genotyped O 0 0.00019176908244844526
families O 0 2.964382247228059e-06
using O 0 3.865546204906423e-06
polymorphic O 0 4.603594425134361e-05
markers O 0 0.00038467918056994677
near O 0 0.0007162794354371727
the O 0 0.00012450249050743878
( O 0 0.00010591546015348285
CTG O 0 0.006798535585403442
) O 0 1.4984909284976311e-05
n O 0 3.886986451107077e-05
repeat O 0 0.0001557122013764456
region O 0 0.0002358849160373211
and O 0 4.540479130810127e-05
constructed O 0 0.003545372514054179
haplotypes O 0 0.0027053244411945343
. O 0 0.0004079600621480495

Six O 0 7.202175765996799e-05
different O 0 4.218285084789386e-06
haplotypes O 0 9.377486276207492e-05
were O 0 2.628487527545076e-05
found O 0 1.8191178241977468e-05
and O 0 3.978435051976703e-05
DM B-Disease 1 0.9999978542327881
alleles O 0 5.1908340537920594e-05
were O 0 7.530010043410584e-05
always O 0 6.143469363451004e-05
haplotype O 0 0.0004031149728689343
A O 0 0.0013367902720347047
. O 0 0.00037188210990279913

To O 0 8.152989175869152e-05
find O 0 1.3884484360460192e-05
an O 0 1.562022134748986e-06
origin O 0 2.4192775072151562e-06
of O 0 2.344198765058536e-05
the O 0 7.659354741917923e-05
( O 0 0.00013419141760095954
CTG O 0 0.011880189180374146
) O 0 2.4104932890622877e-05
n O 0 5.086435339762829e-05
repeat O 0 0.00012382998829707503
mutation O 0 7.464151167368982e-06
and O 0 3.2740131246100646e-06
to O 0 5.587171472143382e-06
investigate O 0 1.7212227248819545e-05
the O 0 1.1132325198559556e-05
mechanism O 0 1.434348087059334e-05
of O 0 1.1884865671163425e-05
the O 0 2.0942392438882962e-05
expansion O 0 8.812937448965386e-05
mutation O 0 3.315927642688621e-06
in O 0 3.7422098557726713e-06
the O 0 3.7127053928998066e-06
Japanese O 0 2.0002113160444424e-05
population O 0 4.5686780936193827e-07
we O 0 5.077527021057904e-07
have O 0 3.32974593675317e-07
studied O 0 1.5123983757803217e-05
90 O 0 2.7218222385272384e-05
Japanese O 0 0.00032600905979052186
DM B-Disease 1 0.9999076128005981
families O 0 1.9435485228314064e-05
comprising O 0 3.896249836543575e-05
190 O 0 7.753315003355965e-05
affected O 0 5.824680920341052e-05
and O 0 1.7539134205435403e-05
130 O 0 0.0001431507698725909
unaffected O 0 0.00040826978511177003
members O 0 6.41381848254241e-05
. O 0 0.00022933827131055295

The O 0 0.00010950648720609024
results O 0 2.305377165612299e-05
suggest O 0 1.6821468307171017e-05
that O 0 2.3725294795440277e-06
a O 0 9.23206789593678e-06
few O 0 1.4913841368979774e-05
common O 0 1.39805206345045e-05
ancestral O 0 0.0004671739006880671
mutations O 0 4.6049121010582894e-05
in O 0 3.795767406700179e-05
both O 0 2.1929468857706524e-05
Caucasian O 0 0.00020530853362288326
and O 0 1.5955720300553367e-05
Japanese O 0 0.00011468179582152516
populations O 0 2.4950118131528143e-06
have O 0 7.512610409321496e-07
originated O 0 6.482988737843698e-06
by O 0 7.699491675339232e-07
expansion O 0 2.4099141228361987e-05
of O 0 1.3305399079399649e-05
an O 0 6.902754648763221e-06
ancestral O 0 0.0002225262433057651
n O 0 9.630772547097877e-05
= O 0 6.95225753588602e-05
5 O 0 2.8906006264151074e-05
repeat O 0 2.8356744223856367e-05
to O 0 6.9004968281660695e-06
n O 0 2.6785264708450995e-05
= O 0 6.360578117892146e-05
19 O 0 0.00015004014130681753
- O 0 0.00014726708468515426
37 O 0 6.630432471865788e-05
copies O 0 8.221490861615166e-05
. O 0 0.0001282651355722919

These O 0 1.438144772691885e-05
data O 0 1.1423770956753287e-05
support O 0 9.252965355699416e-06
multistep O 0 0.00012756527576129884
models O 0 2.0800202037207782e-05
of O 0 0.00014777772594243288
triplet O 0 0.0013846588553860784
repeat O 0 0.00034667225554585457
expansion O 0 0.00014238132280297577
that O 0 1.7444400555177708e-06
have O 0 6.232290843399824e-07
been O 0 1.1110721516160993e-06
proposed O 0 1.2894264500573627e-06
for O 0 2.1040509636804927e-06
both O 0 2.370928632444702e-05
DM B-Disease 1 1.0
and O 0 0.00048230713582597673
Friedreichs B-Disease 1 0.9999805688858032
ataxia I-Disease 1 0.9999210834503174
. O 0 0.0004061620566062629
. O 0 0.00035424629459157586

The O 0 4.225921293254942e-05
molecular O 0 2.5588706193957478e-05
basis O 0 7.272633956745267e-05
of O 0 0.46918103098869324
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0002681490150280297
the O 0 5.260916441329755e-05
western O 0 7.886765524744987e-05
Cape O 0 0.0002740726340562105
, O 0 7.857568562030792e-06
South O 0 0.00010421929619042203
Africa O 0 0.0001092642851290293
. O 0 4.036157770315185e-05

Deficiency B-Disease 1 0.9999970197677612
of I-Disease 0 0.0006071883835829794
the I-Disease 0 0.00015910353977233171
sixth I-Disease 0 0.0003975004074163735
component I-Disease 0 5.165314723853953e-05
of I-Disease 0 4.164019992458634e-05
human I-Disease 0 3.499040030874312e-05
complement I-Disease 0 8.659785817144439e-05
( O 0 0.0001990325836231932
C6 O 1 0.9956583976745605
) O 0 1.466038065700559e-05
has O 0 3.851922883768566e-06
been O 0 3.247818995077978e-06
reported O 0 2.691516101549496e-06
in O 0 1.5819606460354407e-06
a O 0 1.8811017525877105e-06
number O 0 1.092287106985168e-06
of O 0 4.961617378285155e-06
families O 0 2.60183469436015e-06
from O 0 1.2912333659187425e-05
the O 0 2.3010632503428496e-05
western O 0 6.755860522389412e-05
Cape O 0 0.0004209115286357701
, O 0 2.8280912374611944e-05
South O 0 0.00033546332269907
Africa O 0 0.00030569321825169027
. O 0 0.0001025485253194347

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.0002150273066945374
endemic O 0 0.00016300490824505687
in O 0 1.8874485249398276e-05
the O 0 2.9360526241362095e-05
Cape O 0 0.00016887996753212065
and O 0 1.3882873872717028e-06
almost O 0 2.382946831858135e-06
all O 0 9.671923635323765e-07
pedigrees O 0 3.682020542328246e-05
of O 0 8.429920126218349e-05
total O 1 0.992652416229248
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.2444838434457779
C6Q0 O 1 0.9999758005142212
) O 0 2.4626075173728168e-05
have O 0 2.879608018702129e-06
been O 0 7.241836101457011e-06
ascertained O 0 5.1492614147718996e-05
because O 0 7.816766810719855e-06
of O 0 0.0001975090563064441
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.004365668166428804

We O 0 3.8960453821346164e-05
have O 0 2.7656633392325602e-06
sequenced O 0 8.785954378254246e-06
the O 0 2.7306441552354954e-06
expressed O 0 7.854159775888547e-06
exons O 0 6.021715671522543e-05
of O 0 7.251865463331342e-05
the O 0 0.0002564537280704826
C6 O 1 0.9912653565406799
gene O 0 3.554638897185214e-05
from O 0 9.70662495092256e-06
selected O 0 9.522443178866524e-06
cases O 0 3.902102889696835e-06
and O 0 1.775967803041567e-06
have O 0 6.904031693011348e-07
found O 0 1.3351374263947946e-06
three O 0 3.693508006108459e-06
molecular O 0 0.00011178389831911772
defects O 0 0.32409238815307617
leading O 0 0.000314669479848817
to O 0 4.142410398344509e-05
total O 0 0.001039791968651116
deficiency O 1 1.0
879delG O 0 0.0902508795261383
, O 0 2.2002030164003372e-05
which O 0 4.526343673205702e-06
is O 0 2.9751188321824884e-06
the O 0 7.020522389211692e-06
common O 0 2.2049796825740486e-05
defect O 0 0.001051365863531828
in O 0 8.378492202609777e-05
the O 0 9.717338980408385e-05
Cape O 0 0.0008470651227980852
and O 0 2.6361134587205015e-05
hitherto O 0 0.00043448529322631657
unreported O 0 0.00027409876929596066
, O 0 1.4999250197433867e-05
and O 0 1.2265015357115772e-05
1195delC O 0 0.0005594850517809391
and O 0 2.589537325548008e-05
1936delG O 0 0.00044104960397817194
, O 0 4.301490662328433e-06
which O 0 2.091004716930911e-06
have O 0 1.2401217190927127e-06
been O 0 4.6365908019652124e-06
previously O 0 1.1575616554182488e-05
reported O 0 1.3106656297168229e-05
in O 0 2.23333336180076e-05
African O 0 0.0002568700001575053
- O 0 0.0006073446711525321
Americans O 0 0.00018353047198615968
. O 0 0.00013586314162239432

We O 0 5.640055314870551e-05
also O 0 4.220820301270578e-06
show O 0 7.63814114179695e-06
that O 0 8.3061183886457e-07
the O 0 9.25943641050253e-06
879delG O 0 0.0005152443773113191
and O 0 3.333070708322339e-05
1195delC O 0 0.021013565361499786
defects O 0 0.01797810196876526
are O 0 4.3067407204944175e-06
associated O 0 1.1424392141634598e-05
with O 0 1.939136564033106e-05
characteristic O 1 0.9639776945114136
C6 O 1 1.0
/ O 1 0.9999897480010986
C7 O 1 0.9999985694885254
region O 0 0.0007047147955745459
DNA O 0 0.00013985221448820084
marker O 0 0.00022547457774635404
haplotypes O 0 0.00010045417002402246
, O 0 7.1820545599621255e-06
although O 0 7.004419330769451e-06
small O 0 1.1789814379881136e-05
variations O 0 3.399280831217766e-05
were O 0 7.554615149274468e-05
observed O 0 0.00015450535283889621
. O 0 0.0001585610443726182

The O 0 0.0008453766349703074
1936delG O 0 0.024333573877811432
defect O 0 0.05309532955288887
was O 0 0.0005604970501735806
observed O 0 3.397550244699232e-05
only O 0 5.340487405192107e-06
once O 0 3.223362364224158e-05
in O 0 6.33540275885025e-06
the O 0 1.4364971320901532e-05
Cape O 0 0.00014956903760321438
, O 0 2.448359737172723e-06
but O 0 8.121456289700291e-07
its O 0 2.7122146093461197e-06
associated O 0 1.1874861229443923e-05
haplotype O 0 0.00014949246542528272
could O 0 5.68603900319431e-05
be O 0 2.692859197850339e-05
deduced O 0 0.00017627724446356297
. O 0 6.743026460753754e-05

The O 0 0.00010853324056370184
data O 0 1.923578565765638e-05
from O 0 1.1581048966036178e-05
the O 0 1.675320163485594e-05
haplotypes O 0 8.564342715544626e-05
indicate O 0 2.142119592463132e-05
that O 0 1.4586221368517727e-06
these O 0 1.213690779877652e-06
three O 0 8.404913387494162e-06
molecular O 0 0.00013074572780169547
defects O 0 0.0020516053773462772
account O 0 1.9036106095882133e-05
for O 0 2.506176861061249e-05
the O 0 0.00017492736515123397
defects O 0 0.006176999304443598
in O 0 2.970493551401887e-05
all O 0 6.130110705271363e-06
the O 0 1.8182456187787466e-05
38 O 0 7.784771878505126e-05
unrelated O 0 0.0001298717106692493
C6Q0 O 1 0.8411470651626587
individuals O 0 4.5544975364464335e-06
we O 0 8.905233698897064e-06
have O 0 2.4306809791596606e-06
studied O 0 4.445025842869654e-05
from O 0 3.860064680338837e-05
the O 0 0.00010482098150532693
Cape O 0 0.0023372764699161053
. O 0 0.00015400053234770894

We O 0 7.220391853479668e-05
have O 0 5.236864126345608e-06
also O 0 3.974844275944633e-06
observed O 0 8.102300853352062e-06
the O 0 1.8934895706479438e-05
879delG O 0 0.000960622332058847
defect O 0 0.0006181481294333935
in O 0 3.8143025449244305e-05
two O 0 3.587251921999268e-05
Dutch O 1 0.9932616353034973
C6 B-Disease 1 1.0
- I-Disease 1 0.9999804496765137
deficient I-Disease 1 0.9999897480010986
kindreds O 0 0.0008083634893409908
, O 0 1.3024071449763142e-05
but O 0 3.1193251288641477e-06
the O 0 2.4655684683239087e-05
879delG O 0 0.0021753376349806786
defect O 0 0.0012478848220780492
in O 0 7.693863881286234e-05
the O 0 8.354597230209038e-05
Cape O 0 0.0005937544628977776
probably O 0 5.15065185027197e-05
did O 0 5.244911335466895e-06
not O 0 1.0737099955804297e-06
come O 0 3.7700315260735806e-06
from O 0 4.7395910769409966e-06
The O 0 3.497122452245094e-05
Netherlands O 0 0.00037501612678170204
. O 0 4.5744702219963074e-05
. O 0 5.932796557317488e-05

Complement B-Disease 1 0.9999923706054688
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.00025921882479451597
seven O 0 9.409222548129037e-05
further O 0 0.00012200775381643325
molecular O 0 0.0008424644474871457
defects O 0 0.30884286761283875
and O 0 1.6877158486749977e-05
their O 0 1.3718511581828352e-05
associated O 0 8.683319902047515e-05
marker O 0 0.0017694194102659822
haplotypes O 0 0.002097851363942027
. O 0 0.000562183209694922

Seven O 0 7.823917985660955e-05
further O 0 2.8016285796184093e-05
molecular O 0 4.750346488435753e-05
bases O 0 0.00011292017734376714
of O 1 0.9908767342567444
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.000245869712671265
described O 0 0.00047516688937321305
. O 0 0.0002064080908894539

All O 0 2.012234108406119e-05
these O 0 3.2086340979731176e-06
new O 0 1.6964879250735976e-05
molecular O 0 0.00030597313889302313
defects O 0 0.0027358762454241514
involve O 0 0.00010619904060149565
single O 0 7.673390791751444e-05
- O 0 0.00018891936633735895
nucleotide O 0 1.0877424756472465e-05
events O 0 2.7841617338708602e-05
, O 0 9.848870831774548e-06
deletions O 0 3.8986319850664586e-05
and O 0 8.58310977491783e-06
substitutions O 0 2.6718707886175252e-05
, O 0 5.649161721521523e-06
some O 0 1.1131506880701636e-06
of O 0 9.921961463987827e-06
which O 0 9.669815881352406e-06
alter O 0 3.7307898310245946e-05
splice O 0 9.093757398659363e-05
sites O 0 3.3179814636241645e-05
, O 0 8.734051334613468e-06
and O 0 1.040457846102072e-05
others O 0 4.140735836699605e-05
codons O 0 0.0003324910649098456
. O 0 0.00024656785535626113

They O 0 1.3798155123367906e-05
are O 0 9.919414196701837e-07
distributed O 0 1.7217606682606856e-06
along O 0 1.502850227552699e-05
the O 0 7.113468745956197e-05
C7 O 1 0.987699031829834
gene O 0 2.5830257072811946e-05
, O 0 3.899461717082886e-06
but O 0 9.601343435861054e-07
predominantly O 0 2.1830230707564624e-06
towards O 0 1.699731728876941e-05
the O 0 2.2359205104294233e-05
3 O 0 0.00011964088480453938
end O 0 0.0006231334991753101
. O 0 0.00015252758748829365

All O 0 7.061691576382145e-05
were O 0 6.0764290537917987e-05
found O 0 1.4635947991337162e-05
in O 0 2.3836879336158745e-05
compound O 0 0.0001384486531605944
heterozygous O 0 3.100265530520119e-05
individuals O 0 2.7793284971266985e-05
. O 0 0.00022711112978868186

The O 0 0.00606371508911252
C6 O 1 1.0
/ O 1 0.9997389912605286
C7 O 1 0.9999916553497314
marker O 0 0.0017723763594403863
haplotypes O 0 0.00032468614517711103
associated O 0 4.3780150008387864e-05
with O 0 2.764968121482525e-05
most O 0 0.0005589043721556664
C7 B-Disease 1 1.0
defects I-Disease 1 0.999976396560669
are O 0 3.5868513805326074e-05
tabulated O 0 0.00045095625682733953
. O 0 4.6936358558014035e-05
. O 0 0.0001127385621657595

A O 0 0.0015094501432031393
genome O 0 0.00023282594338525087
- O 0 8.51154254633002e-05
wide O 0 1.1720421753125265e-05
search O 0 2.4588287033111556e-06
for O 0 3.083621777477674e-06
chromosomal O 0 0.0005390559090301394
loci O 0 0.0007245529559440911
linked O 0 0.33379098773002625
to O 0 0.00026110492763109505
mental O 1 0.9999998807907104
health O 0 0.07262808829545975
wellness O 0 0.001129461801610887
in O 0 3.303909034002572e-05
relatives O 0 4.22882403654512e-05
at O 0 6.552947161253542e-05
high O 0 7.479969644919038e-05
risk O 0 2.9257696951390244e-05
for O 0 9.201108332490548e-05
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.915177047252655
the O 0 0.0007315896800719202
Old O 0 0.001409405143931508
Order O 0 8.384878310607746e-05
Amish O 0 0.0003802802530117333
. O 0 9.412551298737526e-05

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 0.9998055100440979
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0001093160972231999
is O 0 8.504555808031e-06
characterized O 0 1.0102514352183789e-05
by O 0 1.436986394764972e-06
episodes O 0 3.6413894122233614e-05
of O 0 0.00020774042059201747
mania B-Disease 1 0.9999970197677612
and O 0 0.00019245693692937493
/ O 0 0.06454000622034073
or O 0 0.0002103635051753372
hypomania B-Disease 1 0.9998786449432373
interspersed O 0 0.0010104981483891606
with O 0 2.5910416297847405e-05
periods O 0 0.0004113489994779229
of O 0 0.001712082070298493
depression B-Disease 1 0.9999998807907104
. O 0 0.0017543145222589374

Compelling O 0 0.0005430307937785983
evidence O 0 9.805002628127113e-05
supports O 0 2.202713949372992e-05
a O 0 9.10687322175363e-06
significant O 0 1.9581904780352488e-05
genetic O 0 3.0152685212669894e-05
component O 0 5.217229772824794e-05
in O 0 1.6269794286927208e-05
the O 0 2.6700698072090745e-05
susceptibility O 0 0.00024250688147731125
to O 0 0.0001684158924035728
develop O 0 0.017953073605895042
BPAD B-Disease 1 1.0
. O 0 0.0012667103437706828

To O 0 7.30839601601474e-05
date O 0 0.00011954692308790982
, O 0 1.3263870641821995e-05
however O 0 8.95081120688701e-06
, O 0 8.225984856835566e-06
linkage O 0 8.954192890087143e-05
studies O 0 7.755479600746185e-06
have O 0 2.511368847990525e-06
attempted O 0 2.973395930894185e-05
only O 0 2.4511937226634473e-06
to O 0 5.361676358006662e-06
identify O 0 2.933119685621932e-05
chromosomal O 0 0.0004178770468570292
loci O 0 0.00019654849893413484
that O 0 2.5058781830011867e-05
cause O 0 0.00010750485671451315
or O 0 8.938518476497848e-06
increase O 0 9.348145795229357e-06
the O 0 2.7761070668930188e-05
risk O 0 3.425843169679865e-05
of O 0 0.00017261679749935865
developing O 0 0.00478716567158699
BPAD B-Disease 1 1.0
. O 0 0.0008331567514687777

To O 0 2.799040885292925e-05
determine O 0 1.1780238310166169e-05
whether O 0 4.859526143263793e-06
there O 0 4.912763415632071e-06
could O 0 5.384858468460152e-06
be O 0 3.6835458558925893e-06
protective O 0 2.4629152903798968e-05
alleles O 0 5.496807716554031e-06
that O 0 3.9965125324670225e-06
prevent O 0 4.842048292630352e-05
or O 0 1.10140008473536e-05
reduce O 0 2.91393280349439e-05
the O 0 2.49362965405453e-05
risk O 0 4.1161849367199466e-05
of O 0 0.0001029910781653598
developing O 0 0.0009979369351640344
BPAD B-Disease 1 1.0
, O 0 1.2268583304830827e-05
similar O 0 1.0794771014843718e-06
to O 0 2.3483305540139554e-06
what O 0 1.1237701755817397e-06
is O 0 7.499410230593639e-07
observed O 0 1.5015489225334022e-06
in O 0 3.85343309972086e-06
other O 0 1.072851682692999e-05
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 0.0005932895583100617
we O 0 4.8126315959962085e-05
used O 0 0.0001705031463643536
mental O 1 0.9999996423721313
health O 1 0.91957026720047
wellness O 0 0.010363016277551651
( O 0 4.2100415157619864e-05
absence O 0 7.278988778125495e-05
of O 0 4.658661418943666e-05
any O 0 7.306054612854496e-05
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
) O 0 0.00021190958796069026
as O 0 3.729865056811832e-05
the O 0 2.0157338440185413e-05
phenotype O 0 1.3976560694572981e-05
in O 0 1.3241196029412095e-05
our O 0 3.766042573261075e-05
genome O 0 0.00012734638585243374
- O 0 0.00029029641882516444
wide O 0 0.0001804268395062536
linkage O 0 0.00023897879873402417
scan O 0 5.70408083149232e-05
of O 0 6.0214861150598153e-05
several O 0 3.735920836334117e-05
large O 0 0.00015698505740147084
multigeneration O 0 0.003610912710428238
Old O 0 0.0006773077766411006
Order O 0 4.584335329127498e-05
Amish O 0 0.0001790837850421667
pedigrees O 0 0.00013520997890736908
exhibiting O 0 0.00013567996211349964
an O 0 1.959423207154032e-05
extremely O 0 0.00010483248479431495
high O 0 0.0004524247196968645
incidence O 0 0.0014985670568421483
of O 0 0.005122365429997444
BPAD B-Disease 1 1.0
. O 0 0.0015567983500659466

We O 0 6.092217154218815e-05
have O 0 3.120910832876689e-06
found O 0 1.35315133320546e-06
strong O 0 1.3471357078742585e-06
evidence O 0 4.1875264287227765e-06
for O 0 1.58969487529248e-06
a O 0 7.334022939176066e-06
locus O 0 3.237292548874393e-05
on O 0 7.462422945536673e-05
chromosome O 0 0.00029041821835562587
4p O 0 0.011145474389195442
at O 0 0.0005655985441990197
D4S2949 O 0 0.0006227872800081968
( O 0 2.7213445719098672e-05
maximum O 0 0.00014271341206040233
GENEHUNTER O 0 0.12007354944944382
- O 0 0.0003376876120455563
PLUS O 0 0.0002642073668539524
nonparametric O 0 9.168517863145098e-05
linkage O 0 0.00015797400556039065
score O 0 3.44307700288482e-05
= O 0 5.1480292313499376e-05
4 O 0 5.165309630683623e-05
. O 0 7.013095000729663e-06
05 O 0 0.0003179019258823246
, O 0 1.2663290362979751e-05
P O 0 0.00022317875118460506
= O 0 3.066743374802172e-05
5 O 0 1.4330847989185713e-05
. O 0 2.061105533357477e-06
22 O 0 1.1593514500418678e-05
x O 0 9.608171239960939e-06
10 O 0 1.5577106751152314e-05
( O 0 9.983360541809816e-06
- O 0 5.628154758596793e-05
4 O 0 3.1611332815373316e-05
) O 0 6.257463155634468e-06
; O 0 4.370804617792601e-06
SIBPAL O 0 0.0026085118297487497
Pempirical O 0 0.0005721058114431798
value O 0 2.2436530343838967e-05
< O 0 6.716253119520843e-05
3 O 0 1.6996667909552343e-05
x O 0 1.4598311281588394e-05
10 O 0 1.82913809112506e-05
( O 0 1.0084110726893414e-05
- O 0 5.510982373380102e-05
5 O 0 2.221679824288003e-05
) O 0 4.01219313062029e-06
) O 0 3.647797484518378e-06
and O 0 3.3009846447384916e-06
suggestive O 0 4.4924610847374424e-05
evidence O 0 1.1989826816716231e-05
for O 0 3.763382437682594e-06
a O 0 1.808236811484676e-05
locus O 0 9.506852074991912e-05
on O 0 0.00029153068317100406
chromosome O 0 0.0010707755573093891
4q O 0 0.001864042249508202
at O 0 0.0006586452946066856
D4S397 O 0 0.0010661626001819968
( O 0 6.079008380766027e-05
maximum O 0 0.0001914917229441926
GENEHUNTER O 0 0.26015493273735046
- O 0 0.0004193863132968545
PLUS O 0 0.000175459252204746
nonparametric O 0 9.464637696510181e-05
linkage O 0 9.772126941243187e-05
score O 0 1.883023651316762e-05
= O 0 3.264207043685019e-05
3 O 0 2.3330097974394448e-05
. O 0 4.889990123047028e-06
29 O 0 4.698163320426829e-05
, O 0 5.669573511113413e-06
P O 0 0.0001156709113274701
= O 0 2.7672736905515194e-05
2 O 0 2.0532699636532925e-05
. O 0 2.090366479023942e-06
57 O 0 7.648637620150112e-06
x O 0 1.610254548722878e-05
10 O 0 2.8582793675013818e-05
( O 0 1.676247120485641e-05
- O 0 8.366676047444344e-05
3 O 0 4.2250034312019125e-05
) O 0 8.184542821254581e-06
; O 0 4.237226221448509e-06
SIBPAL O 0 0.0040904623456299305
Pempirical O 0 0.0009360731928609312
value O 0 3.366607052157633e-05
< O 0 0.00012986948422621936
1 O 0 5.418524597189389e-05
x O 0 3.121506597381085e-05
10 O 0 2.645050517458003e-05
( O 0 1.2465288818930276e-05
- O 0 4.485928002395667e-05
3 O 0 1.9171140593243763e-05
) O 0 2.5134102088486543e-06
) O 0 8.520024152858241e-07
that O 0 3.771049534861959e-07
are O 0 9.682831887403154e-07
linked O 0 8.799375791568309e-05
to O 0 0.00016350053192581981
mental O 1 0.9999996423721313
health O 1 0.9978110194206238
wellness O 1 0.9671173095703125
. O 0 0.0009137181914411485

These O 0 2.1532328901230358e-05
findings O 0 1.3298636986291967e-05
are O 0 1.5096557035576552e-06
consistent O 0 9.402416253578849e-06
with O 0 1.4986534324634704e-06
the O 0 1.3765692528977524e-05
hypothesis O 0 1.0009233847085852e-05
that O 0 8.529503929821658e-07
certain O 0 1.9751994386751903e-06
alleles O 0 1.5870162314968184e-05
could O 0 2.8856899007223547e-05
prevent O 0 6.087768269935623e-05
or O 0 5.987462373013841e-06
modify O 0 1.084318500943482e-05
the O 0 9.934544323186856e-06
clinical O 0 6.604516238439828e-05
manifestations O 0 0.0009232307784259319
of O 0 0.03334350883960724
BPAD B-Disease 1 1.0
and O 0 4.058509512105957e-05
perhaps O 0 3.554333670763299e-05
other O 0 1.3094361747789662e-05
related O 0 0.3355511724948883
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9987263083457947

Segregation O 1 0.9999690055847168
distortion O 1 0.9999959468841553
in O 1 0.9999774694442749
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.1288483887910843

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9997186064720154
DM B-Disease 1 1.0
) O 0 6.620836211368442e-05
is O 0 8.457192052446771e-06
an O 0 1.45700487337308e-05
autosomal B-Disease 1 0.9680187106132507
dominant I-Disease 1 0.9999961853027344
disease I-Disease 1 1.0
which O 0 5.840109952259809e-05
, O 0 9.909922482620459e-06
in O 0 6.870750439702533e-06
the O 0 1.985959715966601e-05
typical O 0 3.627802288974635e-05
pedigree O 0 9.920096636051312e-05
, O 0 5.215796136326389e-06
shows O 0 6.288306849455694e-06
a O 0 1.2150795555498917e-05
three O 0 2.1161060431040823e-05
generation O 0 0.00041569696622900665
anticipation O 0 0.0009194078156724572
cascade O 0 0.005629304796457291
. O 0 0.00029739257297478616

This O 0 1.0990770533680916e-05
results O 0 1.0974065844493452e-05
in O 0 0.00017737453163135797
infertility B-Disease 1 0.9999998807907104
and O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
CDM B-Disease 1 0.99998939037323
) O 0 1.615403925825376e-05
with O 0 1.4955836604713113e-06
the O 0 1.237975538970204e-05
disappearance O 0 0.0001066315162461251
of O 0 0.000163343342137523
DM B-Disease 1 1.0
in O 0 0.00019258743850514293
that O 0 2.254194077977445e-05
pedigree O 0 0.0004674124647863209
. O 0 0.00012055626575602219

The O 0 0.00013944886450190097
concept O 0 7.371432729996741e-05
of O 0 0.00022934986918698996
segregation O 0 0.24301640689373016
distortion O 0 0.0048256078734993935
, O 0 2.341801518923603e-05
where O 0 9.568670066073537e-06
there O 0 3.958705747209024e-06
is O 0 2.5767562874534633e-06
preferential O 0 1.3456460692395922e-05
transmission O 0 3.445754191488959e-05
of O 0 1.599560710019432e-05
the O 0 1.0250747436657548e-05
larger O 0 1.0766131708805915e-05
allele O 0 4.304150024836417e-06
at O 0 5.189180956222117e-05
the O 0 6.993162969592959e-05
DM B-Disease 1 0.9999964237213135
locus O 0 0.00013206162839196622
, O 0 9.8985037766397e-06
has O 0 4.275712399248732e-06
been O 0 7.153959359129658e-06
put O 0 1.1690750397974625e-05
forward O 0 1.1666492355288938e-05
to O 0 6.572827260242775e-06
explain O 0 4.732504385174252e-05
partially O 0 8.570175123168156e-05
the O 0 1.6880554539966397e-05
maintenance O 0 0.00019586044072639197
of O 0 0.000327391637256369
DM B-Disease 1 1.0
in O 0 0.0001857549068517983
the O 0 6.879823195049539e-05
population O 0 3.281798854004592e-05
. O 0 8.043502020882443e-05

In O 0 0.00016061592032201588
a O 0 4.8057067033369094e-05
survey O 0 2.8868485969724134e-05
of O 0 0.00021923605527263135
DM B-Disease 1 0.9999908208847046
in O 0 0.00016265246085822582
Northern O 0 0.00012046535266563296
Ireland O 0 4.4917753257323056e-05
, O 0 6.325188223854639e-06
59 O 0 5.3776107961311936e-05
pedigrees O 0 0.00026383253862150013
were O 0 0.00014518942043650895
ascertained O 0 0.0007778466097079217
. O 0 0.00024593627313151956

Sibships O 0 0.011483878828585148
where O 0 6.863053567940369e-05
the O 0 6.167604169604601e-06
status O 0 5.057059752289206e-06
of O 0 7.05622551322449e-06
all O 0 1.92746551874734e-06
the O 0 8.303192771563772e-06
members O 0 2.096009893648443e-06
had O 0 1.3693023902305868e-05
been O 0 7.8557768574683e-06
identified O 0 3.556242063496029e-06
were O 0 4.905693458567839e-06
examined O 0 1.2094667908968404e-05
to O 0 2.8933029625477502e-06
determine O 0 3.6755416203959612e-06
the O 0 6.792964541091351e-06
transmission O 0 3.46698725479655e-05
of O 0 3.938996451324783e-05
the O 0 0.00016226769366767257
DM B-Disease 1 0.9999997615814209
expansion O 0 0.0006573268910869956
from O 0 4.868569885729812e-05
affected O 0 3.0563143809558824e-05
parents O 0 5.572431291511748e-06
to O 0 1.0804742487380281e-05
their O 0 3.4982600482180715e-05
offspring O 0 0.0004119643126614392
. O 0 0.00020425337424967438

Where O 0 0.00016589539882261306
the O 0 7.821202598279342e-05
transmitting O 0 0.0012894399696961045
parent O 0 8.68269125930965e-05
was O 0 0.0004091175796929747
male O 0 8.762908692006022e-05
, O 0 3.216186087229289e-05
58 O 0 0.0003363772702869028
. O 0 0.00018860711134038866

3 O 0 0.0002872095792554319
% O 0 1.5941621313686483e-05
of O 0 4.3695476051652804e-05
the O 0 7.298882701434195e-05
offspring O 0 0.00010027778625953943
were O 0 2.235148895124439e-05
affected O 0 2.3651904484722763e-05
, O 0 3.642030833361787e-06
and O 0 1.8855848793464247e-06
in O 0 4.369062480691355e-06
the O 0 7.288715551112546e-06
case O 0 6.5849735619849525e-06
of O 0 9.79307878878899e-06
a O 0 3.759239916689694e-05
female O 0 9.220193169312552e-05
transmitting O 0 0.001043807016685605
parent O 0 7.729131903033704e-05
, O 0 3.584519072319381e-05
68 O 0 0.0003917529829777777
. O 0 0.00017479597590863705

7 O 0 0.0011408475693315268
% O 0 0.00014722540799994022
were O 0 0.00024209247203543782
affected O 0 0.00045468242024071515
. O 0 0.0002945058513432741

Studies O 0 0.0002311015414306894
on O 0 0.00033933910890482366
meiotic O 0 0.0035417424514889717
drive O 0 0.0004201754927635193
in O 0 0.00010500896314624697
DM B-Disease 1 0.9999992847442627
have O 0 6.006850526318885e-06
shown O 0 8.110047929221764e-06
increased O 0 1.1405853001633659e-05
transmission O 0 1.095205698220525e-05
of O 0 4.8051424528239295e-06
the O 0 6.415353254851652e-06
larger O 0 6.624567049584584e-06
allele O 0 3.0083292585914023e-06
at O 0 5.227568908594549e-05
the O 0 6.249862053664401e-05
DM B-Disease 1 0.9997720122337341
locus O 0 0.00020427207346074283
in O 0 8.568655175622553e-05
non O 0 0.000952155445702374
- O 0 0.008199736475944519
DM O 1 0.9999997615814209
heterozygotes O 0 0.0014622053131461143
for O 0 0.000150409119669348
CTGn O 1 0.660374104976654
. O 0 0.00034209605655632913

This O 0 2.0723733541672118e-05
study O 0 4.878192157775629e-06
provides O 0 1.326178221461305e-06
further O 0 3.5577957078203326e-06
evidence O 0 6.111227321525803e-06
that O 0 3.4765071177389473e-06
the O 0 8.02063150331378e-05
DM B-Disease 1 0.9999992847442627
expansion O 0 0.0007387349614873528
tends O 0 5.482832420966588e-05
to O 0 1.2638100088224746e-05
be O 0 1.4100814951234497e-05
transmitted O 0 0.00012822283315472305
preferentially O 0 7.265410386025906e-05
. O 0 6.718879012623802e-05

Diagnosis O 1 0.997418999671936
of O 1 0.998386025428772
hemochromatosis B-Disease 1 1.0
. O 1 0.7643051147460938

If O 0 0.0012795402435585856
untreated O 1 1.0
, O 0 0.1348128616809845
hemochromatosis B-Disease 1 1.0
can O 0 0.07445786893367767
cause O 1 0.9999830722808838
serious O 1 0.9999982118606567
illness O 1 0.9999998807907104
and O 0 8.802070806268603e-05
early B-Disease 0 0.00021622612257488072
death I-Disease 0 0.0001934659230755642
, O 0 6.443767688324442e-06
but O 0 2.387364247624646e-06
the O 0 2.8535570891108364e-05
disease O 1 0.5358120203018188
is O 0 1.1879901649081148e-05
still O 0 2.1978838049108163e-05
substantially O 0 8.662395703140646e-05
under O 0 0.0003412956721149385
- O 0 0.18666274845600128
diagnosed O 1 0.9999715089797974
. O 0 0.0007882399950176477

The O 0 0.0003217167395632714
cornerstone O 0 0.009337871335446835
of O 0 0.00011192170495633036
screening O 0 4.254720624885522e-05
and O 0 1.3444479009194765e-05
case O 0 2.224838681286201e-05
detection O 0 3.173789809807204e-05
is O 0 3.0819255698588677e-06
the O 0 5.88440207138774e-06
measurement O 0 2.5988687411881983e-05
of O 0 9.083981422008947e-05
serum O 0 0.0010146532440558076
transferrin O 0 0.0014718595193699002
saturation O 0 0.0002502540301065892
and O 0 2.008786759688519e-05
the O 0 7.453853322658688e-05
serum O 0 0.0014935609651729465
ferritin O 0 0.005308306310325861
level O 0 0.0015441065188497305
. O 0 0.00033638757304288447

Once O 0 0.0004711254150606692
the O 0 4.374947093310766e-05
diagnosis O 0 0.0002734060981310904
is O 0 2.3629740098840557e-05
suspected O 0 0.00012521173630375415
, O 0 8.02262184151914e-06
physicians O 0 1.6144629626069218e-05
must O 0 1.1946421182074118e-05
use O 0 1.755905213940423e-05
serum O 0 0.000693962792865932
ferritin O 0 0.005073983687907457
levels O 0 0.0006411740323528647
and O 0 0.00012763436825480312
hepatic O 1 0.9999927282333374
iron O 1 0.9999997615814209
stores O 0 0.00034913388662971556
on O 0 0.0008058270905166864
liver O 1 0.8755090832710266
biopsy O 0 0.0006867152987979352
specimens O 0 6.875291001051664e-05
to O 0 1.575286478328053e-05
assess O 0 3.897706119460054e-05
patients O 0 1.1116550012957305e-05
for O 0 3.887305410898989e-06
the O 0 3.59271616616752e-05
presence O 0 9.10187663976103e-05
of O 0 0.0012233107117936015
iron B-Disease 1 1.0
overload I-Disease 1 0.9999978542327881
. O 0 0.0013157404027879238

Liver O 1 0.999992847442627
biopsy O 0 0.010949662886559963
is O 0 5.7560620916774496e-05
also O 0 7.648798600712325e-06
used O 0 2.314173343620496e-06
to O 0 3.7121035347809084e-06
establish O 0 1.0346130693505984e-05
the O 0 8.101164894469548e-06
presence O 0 8.145601896103472e-06
or O 0 7.229635684780078e-06
absence O 0 7.61763149057515e-05
of O 0 0.00034215624327771366
cirrhosis B-Disease 1 1.0
, O 0 0.00010236658999929205
which O 0 1.4322581591841299e-05
can O 0 5.037330083723646e-06
affect O 0 5.5590880947420374e-05
prognosis O 0 0.008604176342487335
and O 0 0.00011525439185788855
management O 0 0.0010691650677472353
. O 0 0.00030129923834465444

A O 0 0.0010066886898130178
DNA O 0 0.00019279155822005123
- O 0 4.317411730880849e-05
based O 0 1.028777660394553e-06
test O 0 1.1246257827224326e-06
for O 0 1.436649426977965e-06
the O 0 2.840974229911808e-05
HFE O 0 0.007846210151910782
gene O 0 2.07149005291285e-05
is O 0 4.187494596408214e-06
commercially O 0 9.012061127577908e-06
available O 0 1.0203921192442067e-06
, O 0 7.304479368031025e-07
but O 0 2.6061084668072e-07
its O 0 6.191899615259899e-07
place O 0 4.561757123155985e-06
in O 0 4.0429981709166896e-06
the O 0 1.009255811368348e-05
diagnosis O 0 0.0003844897437375039
of O 0 0.00147703115362674
hemochromatosis B-Disease 1 1.0
is O 0 0.0004316740669310093
still O 0 9.472582314629108e-05
being O 0 7.219262624857947e-05
evaluated O 0 0.00015686385449953377
. O 0 9.256992052542046e-05

Currently O 0 0.0002477078523952514
, O 0 1.5699202776886523e-05
the O 0 8.010060810192954e-06
most O 0 2.7791156753664836e-06
useful O 0 6.091432624089066e-06
role O 0 1.2246128790138755e-05
for O 0 2.419217480564839e-06
this O 0 1.5601908671669662e-06
test O 0 2.2310184704110725e-06
is O 0 1.1402461268517072e-06
in O 0 1.733144131321751e-06
the O 0 5.035044068790739e-06
detection O 0 4.5690736442338675e-05
of O 0 0.00015245808754116297
hemochromatosis B-Disease 1 1.0
in O 0 0.00015015619283076376
the O 0 4.6299224777612835e-05
family O 0 1.4127626855042763e-05
members O 0 2.020927695411956e-06
of O 0 1.4897181245032698e-05
patients O 0 8.797407645033672e-06
with O 0 5.092228548164712e-06
a O 0 2.7998712539556436e-05
proven O 0 0.00021628527611028403
case O 0 9.669363862485625e-06
of O 0 3.710346209118143e-05
the O 0 0.00046395199024118483
disease O 1 0.9999979734420776
. O 0 0.0005982540897093713

It O 0 1.4809387721470557e-05
is O 0 3.6779297261091415e-06
crucial O 0 4.628743772627786e-05
to O 0 7.766782073304057e-05
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999997615814209
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999772310256958
because O 0 0.0009129141690209508
phlebotomy O 1 0.9999122619628906
therapy O 0 0.36518505215644836
can O 0 2.94824658340076e-05
avert O 1 0.9998522996902466
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 9.728613804327324e-05
can O 0 6.19805950918817e-06
even O 0 6.7847427089873236e-06
lead O 0 1.2576791959872935e-05
to O 0 6.605912858503871e-06
normal O 0 5.7087007007794455e-05
life O 0 0.00010692028445191681
expectancy O 0 0.0002821715024765581
. O 0 1.9721017451956868e-05
. O 0 7.964026735862717e-05

Prevalence O 0 0.0021687978878617287
of O 0 0.0002115567185683176
the O 0 0.00034310482442379
I1307K O 0 0.003680097870528698
APC B-Disease 0 0.0018969797529280186
gene O 0 3.934205960831605e-05
variant O 0 2.4327277060365304e-05
in O 0 9.785684596863575e-06
Israeli O 0 1.4762783393962309e-05
Jews O 0 2.9097645892761648e-05
of O 0 1.1482042282295879e-05
differing O 0 4.521864866546821e-06
ethnic O 0 7.827971785445698e-06
origin O 0 5.157415671419585e-06
and O 0 8.911919394449797e-06
risk O 0 0.00020270419190637767
for O 0 0.028910968452692032
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9688146114349365

BACKGROUND O 0 0.0038878063205629587
& O 0 0.002274902770295739
AIMS O 0 0.0005821433151140809
Israeli O 0 2.834949737007264e-05
Jews O 0 6.20834034634754e-05
of O 0 4.201763294986449e-05
European O 0 3.479092993075028e-05
birth O 0 0.00011480851389933378
, O 0 1.2940143278683536e-05
i O 0 3.324642239022069e-05
. O 0 3.3745889140845975e-06
e O 0 1.626422454137355e-05
. O 0 3.5748730624618474e-06
, O 0 4.2965789361915085e-06
Ashkenazim O 0 0.00021274428581818938
, O 0 3.8187808968359604e-06
have O 0 1.3279108088681824e-06
the O 0 1.8380645997240208e-05
highest O 1 0.999815046787262
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9708705544471741
of O 0 0.0001658352994127199
any O 0 1.6231824702117592e-05
Israeli O 0 2.8505026421044022e-05
ethnic O 0 4.3570020352490246e-05
group O 0 6.18417834630236e-05
. O 0 0.00012421340215951204

The O 0 0.0007500400533899665
I1307K O 0 0.0049940976314246655
APC B-Disease 0 0.0018688925774767995
gene O 0 7.467413524864241e-05
variant O 0 9.643445810070261e-05
was O 0 0.00023984209110494703
found O 0 1.9569153664633632e-05
in O 0 5.363066520658322e-05
6 O 0 0.0007119667716324329
. O 0 0.00020461672102101147

1 O 0 0.000185903933015652
% O 0 1.4723893400514498e-05
of O 0 2.9357028324739076e-05
American O 0 2.3562772184959613e-05
Jews O 0 4.887054819846526e-05
, O 0 4.295108283258742e-06
28 O 0 1.2227013939991593e-05
% O 0 2.2771896510676015e-06
of O 0 1.3611184840556234e-05
their O 0 6.213801680132747e-05
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.6291555762290955
, O 0 5.052903725299984e-05
but O 0 4.671984243032057e-06
not O 0 2.057837264146656e-06
in O 0 1.949912439158652e-05
non O 0 0.00023719726596027613
- O 0 0.0005104663432575762
Jews O 0 0.0007658146787434816
. O 0 0.000315822078846395

We O 0 0.00017119453696068376
assessed O 0 0.00012769890599884093
the O 0 6.682100502075627e-05
I1307K O 0 0.0006317984079942107
prevalence O 0 0.00012198588956380263
in O 0 1.0120565093529876e-05
Israeli O 0 1.2122692169214133e-05
Jews O 0 2.4094359105220065e-05
of O 0 8.941852684074547e-06
differing O 0 2.852241095752106e-06
ethnic O 0 6.269612185860751e-06
origin O 0 5.73991837882204e-06
and O 0 1.6730977222323418e-05
risk O 0 0.0003193387237843126
for O 0 0.024700341746211052
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9563667178153992

METHODS O 0 0.0002767308906186372
DNA O 0 8.614190301159397e-05
samples O 0 1.0516637303226162e-05
from O 0 1.4904017007211223e-05
500 O 0 2.603199754958041e-05
unrelated O 0 1.490882186772069e-05
Jews O 0 4.0231156162917614e-05
of O 0 4.1369548853253946e-05
European O 0 3.177478356519714e-05
or O 0 3.3385425922460854e-05
non O 0 0.00013877276796847582
- O 0 5.734197111451067e-05
European O 0 3.658852392618428e-06
origin O 0 2.381265858275583e-06
, O 0 1.3733440482610604e-06
with O 0 1.1614654340519337e-06
or O 0 4.2503797885729e-06
without O 0 8.53180063131731e-06
a O 0 1.191087176266592e-05
personal O 0 8.068553870543838e-05
and O 0 4.130599700147286e-05
/ O 0 0.0005151802324689925
or O 0 4.05030841648113e-05
family O 0 4.395505311549641e-05
history O 0 0.00016401286120526493
of O 0 0.0002777455956675112
neoplasia B-Disease 1 0.9186869859695435
, O 0 5.3282492444850504e-05
were O 0 2.1424015358206816e-05
examined O 0 3.792619827436283e-05
for O 0 5.1160309340048116e-06
the O 0 3.57718781742733e-05
I1307K O 0 0.0003438899293541908
variant O 0 3.385344098205678e-05
by O 0 6.4461773945367895e-06
the O 0 1.1772196558013093e-05
allele O 0 1.0389121598564088e-05
- O 0 4.5747015974484384e-05
specific O 0 3.806219183388748e-06
oligonucleotide O 0 0.00021473554079420865
( O 0 0.00020740438776556402
ASO O 1 0.7314053177833557
) O 0 4.989149238099344e-05
method O 0 3.17148442263715e-05
. O 0 9.130425314651802e-05

RESULTS O 0 0.00021515179832931608
In O 0 3.186490721418522e-05
persons O 0 1.4960436601541005e-05
at O 0 4.801181057700887e-05
average O 0 1.3600493730336893e-05
risk O 0 5.2448565838858485e-05
for O 0 0.0002776595647446811
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0003312403568997979
I1307K O 0 0.0014561815187335014
was O 0 0.00025465484941378236
found O 0 9.945341844286304e-06
in O 0 3.053209002246149e-05
5 O 0 0.00021269885473884642
. O 0 0.00010611826292006299

0 O 0 0.00013758403656538576
% O 0 2.3038213839754462e-05
of O 0 0.00010069412383018062
120 O 0 0.00014420156367123127
European O 0 6.655354081885889e-05
and O 0 4.6216551709221676e-05
1 O 0 0.000585136644076556
. O 0 0.00026817890466190875

6 O 0 0.0004978812648914754
% O 0 3.0638784664915875e-05
of O 0 8.84697146830149e-05
188 O 0 0.00023229380894917995
non O 0 0.0002357504708925262
- O 0 0.00010440072219353169
European O 0 7.698648914811201e-06
Jews O 0 8.766736573306844e-05
( O 0 2.2669630197924562e-05
P O 0 0.00034888717345893383
= O 0 5.540976781048812e-05
0 O 0 2.7172784029971808e-05
. O 0 9.266600500268396e-06
08 O 0 0.00034226226853206754
) O 0 5.38572967343498e-05
. O 0 9.652644803281873e-05

It O 0 8.58918865560554e-05
occurred O 0 0.0006806966848671436
in O 0 6.965244392631575e-05
15 O 0 0.00025108669069595635
. O 0 0.0001272183289984241

4 O 0 0.00012474681716412306
% O 0 7.534224096161779e-06
of O 0 2.6022713427664712e-05
52 O 0 6.283147376962006e-05
Ashkenazi O 0 6.188898987602443e-05
Israelis O 0 2.6690768208936788e-05
with O 0 1.933080784510821e-05
familial O 1 0.9970468878746033
cancer B-Disease 1 0.9999994039535522
( O 0 0.00033124577021226287
P O 0 0.0029591417405754328
= O 0 9.132942068390548e-05
0 O 0 1.838766002038028e-05
. O 0 7.083997843437828e-06
02 O 0 0.0002837894717231393
) O 0 5.280454388412181e-06
and O 0 2.5155206913041184e-06
was O 0 4.6462431782856584e-05
not O 0 1.6462860230603837e-06
detected O 0 1.556432107463479e-05
in O 0 5.497420715983026e-06
51 O 0 3.918984657502733e-05
non O 0 5.8777786762220785e-05
- O 0 2.3249742298503406e-05
European O 0 1.967219304788159e-06
Jews O 0 2.3947613954078406e-05
at O 0 0.00012878872803412378
increased O 0 0.00032939063385128975
cancer B-Disease 1 0.9993172883987427
risk O 0 0.0006928810034878552
. O 0 0.00020968506578356028

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999997615814209
occurred O 1 0.9992676377296448
personally O 0 0.0030546507332473993
or O 0 2.0066654542461038e-05
in O 0 1.0509147614357062e-05
the O 0 8.536114364687819e-06
families O 0 2.145649887097534e-06
of O 0 1.4379527783603407e-05
13 O 0 7.412570994347334e-05
of O 0 9.080342715606093e-05
20 O 0 0.00022773584350943565
Ashkenazi O 0 0.00028091584681533277
I1307K O 0 0.000800933048594743
carriers O 0 3.2289925002260134e-05
, O 0 4.627768703358015e-06
8 O 0 1.6009951650630683e-05
of O 0 1.66878253367031e-05
whom O 0 4.482434451347217e-05
also O 0 1.2889327081211377e-05
had O 0 3.327246304252185e-05
a O 0 1.295402216783259e-05
personal O 0 7.833548443159088e-05
or O 0 2.631968709465582e-05
family O 0 5.292436253512278e-05
history O 0 0.0002547536860220134
of O 0 0.0011683651246130466
noncolonic O 1 0.9998874664306641
neoplasia B-Disease 1 0.9999582767486572
. O 0 0.003796330885961652

CONCLUSIONS O 0 0.0005712530692107975
The O 0 0.00017975698574446142
I1307K O 0 0.0022532748989760876
APC O 0 0.0010605200659483671
variant O 0 3.619204289861955e-05
may O 0 1.3472703358274885e-05
represent O 0 5.017815510655055e-06
a O 0 9.047057574207429e-06
susceptibility O 0 6.958903395570815e-05
gene O 0 2.4158782252925448e-05
for O 0 5.521650018636137e-05
colorectal B-Disease 1 1.0
, I-Disease 0 6.523574120365083e-05
or I-Disease 0 1.548034379084129e-05
other I-Disease 0 1.2685869478445966e-05
, I-Disease 0 4.749440631712787e-05
cancers I-Disease 0 0.058611951768398285
in O 0 7.459313928848132e-05
Ashkenazi O 0 0.0001929642603499815
Jews O 0 0.00032474406179971993
, O 0 2.8028633096255362e-05
and O 0 1.550612796563655e-05
partially O 0 8.257460285676643e-05
explains O 0 9.504877198196482e-06
the O 0 5.0900725909741595e-06
higher O 0 3.317453229101375e-05
incidence O 0 0.0009089953382499516
of O 1 0.9754294157028198
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0011740195332095027
European O 0 0.000143943281727843
Israelis O 0 0.00023578148102387786
. O 0 0.0002516635868232697

Systematic O 0 9.049501386471093e-05
analysis O 0 1.3555170880863443e-05
of O 0 0.00012910348596051335
coproporphyrinogen O 0 0.3632658123970032
oxidase O 0 0.0010926058748736978
gene O 0 0.0005972359795123339
defects O 1 0.7935678958892822
in O 0 0.00037311328924261034
hereditary B-Disease 1 0.9999910593032837
coproporphyria I-Disease 1 0.9999338388442993
and O 0 0.00014836039918009192
mutation O 0 9.695265180198476e-05
update O 0 0.00032961147371679544
. O 0 0.00023056913050822914

Hereditary B-Disease 1 0.9999985694885254
coproporphyria I-Disease 1 0.9999864101409912
( O 0 0.0044736010022461414
HC B-Disease 1 1.0
) O 0 0.00015402610006276518
is O 0 2.3460370357497595e-05
an O 0 3.1591505830874667e-05
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9998375177383423
autosomal O 1 0.9999998807907104
dominant O 1 0.9999990463256836
inheritance O 1 0.999686598777771
caused O 1 0.9975802898406982
by O 0 4.9580597988097e-05
deficient B-Disease 0 0.0005081151030026376
activity I-Disease 0 1.8981088942382485e-05
of I-Disease 0 8.219749724958092e-05
coproporphyrinogen I-Disease 1 0.5942217111587524
III I-Disease 1 0.9999996423721313
oxidase I-Disease 0 0.0005285257357172668
( O 0 0.00021342530089896172
CPO O 0 0.0050149220041930676
) O 0 8.89586954144761e-05
. O 0 0.00010188998567173257

Clinical O 0 0.0010402342304587364
manifestations O 0 0.0025880371686071157
of O 0 0.0012550594983622432
the O 1 0.9014852643013
disease O 1 0.9999998807907104
are O 0 7.218481641757535e-06
characterized O 0 3.970161560573615e-05
by O 0 1.2983098713448271e-05
acute O 1 0.9999604225158691
attacks O 0 0.00022342571173794568
of O 1 0.9998370409011841
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.004016247112303972
precipitated O 1 0.9858893156051636
by O 0 2.1528099750867113e-05
drugs O 0 8.4652507212013e-05
, O 0 1.3574810509453528e-05
fasting O 0 9.32716138777323e-05
, O 0 3.14937460643705e-05
cyclical O 1 0.9102156162261963
hormonal O 0 0.45400601625442505
changes O 0 5.6392756960121915e-05
, O 0 9.874201350612566e-05
or O 1 0.8394380211830139
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.005034221336245537

Skin O 1 0.999998927116394
photosensitivity O 1 0.9999912977218628
may O 0 0.001581761403940618
also O 0 4.8456415242981166e-05
be O 0 1.9190640159649774e-05
present O 0 5.35875151399523e-05
. O 0 0.00012046823394484818

The O 0 0.00018003879813477397
seven O 0 8.469109889119864e-05
exons O 0 0.0001491308503318578
, O 0 9.904697435558774e-06
the O 0 3.799012119998224e-05
exon O 0 0.0006724473205395043
/ O 0 0.00035150611074641347
intron O 0 0.0005528160254471004
boundaries O 0 7.965588338265661e-06
and O 0 2.0626216610253323e-06
part O 0 7.590158020320814e-06
of O 0 2.07130033231806e-05
3 O 0 5.1455164793878794e-05
noncoding O 0 0.00012738608347717673
sequence O 0 7.5432822086440865e-06
of O 0 3.165380621794611e-05
the O 0 0.00012322291149757802
CPO O 0 0.0018585179932415485
gene O 0 1.4025896234670654e-05
were O 0 1.2139953469159082e-05
systematically O 0 1.5217082363960799e-05
analyzed O 0 7.4831741585512646e-06
by O 0 2.628979473229265e-06
an O 0 7.990033736859914e-06
exon O 0 0.00047463347436860204
- O 0 0.00017901224782690406
by O 0 2.069296533591114e-05
- O 0 0.0003838247212115675
exon O 0 0.00040075700962916017
denaturing O 0 0.0012518489966169
gradient O 0 0.0008630611118860543
gel O 0 0.0012999391183257103
electrophoresis O 0 0.0009350632317364216
( O 0 0.00030769966542720795
DGGE O 0 0.07827544212341309
) O 0 1.751137460814789e-05
strategy O 0 1.6063082512118854e-05
followed O 0 6.038975243427558e-06
by O 0 9.248327046407212e-07
direct O 0 1.9943834104196867e-06
sequencing O 0 8.345075912075117e-06
in O 0 1.1558848200365901e-05
seven O 0 3.2515374186914414e-05
unrelated O 0 0.00013024028157815337
heterozygous O 0 0.00018077640561386943
HC B-Disease 1 0.9999767541885376
patients O 0 0.0006107427761889994
from O 0 0.0002458957314956933
France O 0 0.0004180336545687169
, O 0 3.837031181319617e-05
Holland O 0 0.00035318374284543097
, O 0 1.711068944132421e-05
and O 0 1.7535723600303754e-05
Czech O 0 0.0010671340860426426
Republic O 0 0.0010025922674685717
. O 0 0.00032008092966862023

Seven O 0 0.0003447202034294605
novel O 0 0.00012489060463849455
mutations O 0 1.8014314264291897e-05
and O 0 3.9943179217516445e-06
two O 0 4.001607976533705e-06
new O 0 1.0731443580880295e-05
polymorphisms O 0 0.00016620209498796612
were O 0 0.00013113742170389742
detected O 0 0.0013121076626703143
. O 0 0.00026828350382857025

Among O 0 0.00010799393203342333
these O 0 5.3617372941516805e-06
mutations O 0 1.108244396164082e-05
two O 0 5.556935775530292e-06
are O 0 2.700937102417811e-06
missense O 0 9.126681834459305e-05
( O 0 3.863585880026221e-05
G197W O 0 0.000771685503423214
, O 0 2.3384473024634644e-05
W427R O 0 0.00027124278130941093
) O 0 6.432421741919825e-06
, O 0 2.5653448574303184e-06
two O 0 1.7486839851699187e-06
are O 0 1.5745630435048952e-06
nonsense O 0 0.00011972158245043829
( O 0 3.701913374243304e-05
Q306X O 0 0.0005523780710063875
, O 0 2.1958723664283752e-05
Q385X O 0 0.00020131834025960416
) O 0 3.956286491302308e-06
, O 0 1.288928501708142e-06
two O 0 1.0075526688524405e-06
are O 0 8.613355362285802e-07
small O 0 1.0434895557409618e-05
deletions O 0 9.821490675676614e-05
( O 0 5.145477189216763e-05
662de14bp O 0 0.0007180180982686579
; O 0 1.9936147509724833e-05
1168del3bp O 0 0.0010289987549185753
removing O 0 0.00012100773892598227
a O 0 2.48261058004573e-05
glycine O 0 3.0206332667148672e-05
at O 0 9.338695235783234e-05
position O 0 3.471397940302268e-05
390 O 0 7.181458204286173e-05
) O 0 4.328015165810939e-06
, O 0 1.853392063821957e-06
and O 0 1.225510118274542e-06
one O 0 1.4663937690784223e-06
is O 0 1.5520998886131565e-06
a O 0 4.373531737655867e-06
splicing O 0 2.62676094280323e-05
mutation O 0 1.5135252397158183e-05
( O 0 4.732603701995686e-05
IVS1 O 0 0.39279690384864807
- O 0 0.0009277614299207926
15c O 0 0.0012064633192494512
- O 0 0.00022735181846655905
- O 0 0.00011557529796846211
> O 0 7.357414870057255e-05
g O 0 5.116247484693304e-05
) O 0 7.579712473670952e-06
which O 0 2.924522505054483e-06
creates O 0 9.936960850609466e-06
a O 0 6.86361818225123e-06
new O 0 4.906844878860284e-06
acceptor O 0 1.3108530765748583e-05
splice O 0 0.0008934978977777064
site O 0 0.0014262829208746552
. O 0 0.000299780658679083

The O 0 0.0002023424895014614
pathological O 0 0.0009758979431353509
significance O 0 0.0002472484193276614
of O 0 8.678543235873803e-05
the O 0 0.0001132546822191216
point O 0 0.00029231718508526683
mutations O 0 5.735137892770581e-05
G197W O 0 0.0004951537703163922
, O 0 1.604359204065986e-05
W427R O 0 0.0002040552208200097
, O 0 5.592273282672977e-06
and O 0 2.7163430331711425e-06
the O 0 1.7239790395251475e-05
in O 0 5.568845881498419e-05
- O 0 0.00025928873219527304
frame O 0 0.00010282798029948026
deletion O 0 0.00010446166561450809
390delGly O 0 0.0004871609853580594
were O 0 2.1272384401527233e-05
assessed O 0 2.189766200899612e-05
by O 0 2.2142307898320723e-06
their O 0 1.4467162827713764e-06
respective O 0 1.3036535165156238e-05
expression O 0 1.632322346267756e-05
in O 0 1.80281149368966e-05
a O 0 1.5836265447433107e-05
prokaryotic O 0 2.6234261895297095e-05
system O 0 2.6501862521399744e-05
using O 0 7.724550414422993e-06
site O 0 0.00032751186517998576
- O 0 0.00030010408954694867
directed O 0 6.576635496458039e-05
mutagenesis O 0 0.0010002432391047478
. O 0 0.00020197665435262024

These O 0 3.4579796192701906e-05
mutations O 0 6.739413947798312e-05
resulted O 0 8.199786680052057e-05
in O 0 2.4977040084195323e-05
the O 0 2.9237418857519515e-05
absence O 0 7.02995021129027e-05
or O 0 6.579813543794444e-06
a O 0 1.44247696880484e-05
dramatic O 0 9.952842083293945e-05
decrease O 0 0.00020627469348255545
of O 0 0.0004958251374773681
CPO O 1 0.857634425163269
activity O 0 0.0006305351271294057
. O 0 0.00023724632046651095

The O 0 9.92169589153491e-05
two O 0 1.77714664459927e-05
polymorphisms O 0 7.466985698556527e-05
were O 0 4.4988017180003226e-05
localized O 0 0.00010316300176782534
in O 0 2.100664278259501e-05
noncoding O 0 0.00016888028767425567
part O 0 1.9939951016567647e-05
of O 0 1.6519730706932023e-05
the O 0 1.1630078915914055e-05
gene O 0 4.536689175438369e-06
1 O 0 1.663104194449261e-05
) O 0 2.0438744741113624e-06
a O 0 7.229215043480508e-06
C O 0 0.0003774378274101764
/ O 0 0.0001913721498567611
G O 0 0.0003393758670426905
polymorphism O 0 2.723458055697847e-05
in O 0 2.3418393539031968e-05
the O 0 6.252746970858425e-05
promotor O 0 0.004364253021776676
region O 0 0.0003242521488573402
, O 0 2.3219163267640397e-05
142 O 0 6.362834392348304e-05
bp O 0 0.0001229932822752744
upstream O 0 5.640415474772453e-05
from O 0 2.8399347229424166e-06
the O 0 4.9495661187393125e-06
transcriptional O 0 4.015514787170105e-05
initiation O 0 6.814312655478716e-05
site O 0 9.951323590939865e-05
( O 0 1.5860539861023426e-05
- O 0 8.47192932269536e-05
142C O 0 0.0004041666106786579
/ O 0 0.00018817794625647366
G O 0 0.0003817645483650267
) O 0 7.630824256921187e-06
, O 0 3.126380534013151e-06
and O 0 4.173429260845296e-06
2 O 0 3.189987182850018e-05
) O 0 4.391469701658934e-06
a O 0 1.5191157217486762e-05
6 O 0 8.90246155904606e-05
bp O 0 8.59933570609428e-05
deletion O 0 2.7045123715652153e-05
polymorphism O 0 1.8001604985329323e-05
in O 0 1.1074351277784444e-05
the O 0 7.9501669461024e-06
3 O 0 2.23313327296637e-05
noncoding O 0 8.351697761099786e-05
part O 0 1.1087085113103967e-05
of O 0 2.9963270208099857e-05
the O 0 5.567459811572917e-05
CPO O 0 0.002519028028473258
gene O 0 3.8668516936013475e-05
, O 0 1.4184191968524829e-05
574 O 0 0.00040612861630506814
bp O 0 0.00022190986783243716
downstream O 0 7.575955532956868e-05
of O 0 1.0159498742723372e-05
the O 0 1.8519966033636592e-05
last O 0 1.487500594521407e-05
base O 0 7.543339961557649e-06
of O 0 1.2791084373020567e-05
the O 0 1.923534546222072e-05
normal O 0 2.4476163162034936e-05
termination O 0 4.1561688703950495e-05
codon O 0 4.549351433524862e-05
( O 0 4.116349737159908e-05
+ O 0 0.0002758153132162988
574 O 0 0.0015627227257937193
delATTCTT O 0 0.0067433640360832214
) O 0 0.00019579395302571356
. O 0 0.0002068825560854748

Five O 0 0.0010458724573254585
intragenic O 0 0.014749775640666485
dimorphisms O 0 0.004155819304287434
are O 0 1.2111806427128613e-05
now O 0 2.557802145020105e-05
well O 0 8.963342224888038e-06
characterized O 0 3.752735210582614e-05
and O 0 6.366389243339654e-06
the O 0 1.9441768017713912e-05
high O 0 0.00010957335325656459
degree O 0 6.000460416544229e-05
of O 0 0.00010819678573170677
allelic O 0 0.0009081785683520138
heterogeneity O 0 0.0008424483821727335
in O 0 0.00023375931777991354
HC B-Disease 1 0.9999756813049316
is O 0 0.00011565480235731229
demonstrated O 0 7.542939420090988e-05
with O 0 2.9554253160313237e-06
seven O 0 6.51529808237683e-06
new O 0 1.6696058082743548e-06
different O 0 3.257989362737135e-07
mutations O 0 2.2936167169973487e-06
making O 0 4.058640115545131e-06
a O 0 4.967772383679403e-06
total O 0 1.1093251487181988e-05
of O 0 8.359554340131581e-05
nineteen O 0 0.002588608069345355
CPO O 1 0.9970914125442505
gene B-Disease 0 0.0008410988375544548
defects I-Disease 0 0.03521236777305603
reported O 0 0.00010240877600153908
so O 0 1.6469739421154372e-05
far O 0 2.907021189457737e-05
. O 0 1.4591212675441056e-05
. O 0 7.510432624258101e-05

Coincidence O 0 0.0004264222225174308
of O 0 8.694870484760031e-05
two O 0 2.1218853362370282e-05
novel O 0 6.625395326409489e-05
arylsulfatase O 0 0.0006301206885837018
A O 0 0.00011089252075180411
alleles O 0 7.352427019213792e-06
and O 0 8.289521247206721e-06
mutation O 0 1.6705818779882975e-05
459 O 0 0.00044639623956754804
+ O 0 0.0008163320017047226
1G O 0 0.0026673502288758755
> O 0 7.323130557779223e-05
A O 0 5.5657452321611345e-05
within O 0 8.822562449495308e-06
a O 0 8.022477231861558e-06
family O 0 1.613262611499522e-05
with O 0 3.194285454810597e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999991655349731
: O 0 2.769512684608344e-05
molecular O 0 1.6924932424444705e-05
basis O 0 9.903545105771627e-06
of O 0 5.710633922717534e-05
phenotypic O 0 0.0007088585989549756
heterogeneity O 0 0.00478794751688838
. O 0 0.001296506728976965

In O 0 0.00017591255891602486
a O 0 4.793623520527035e-05
family O 0 1.3819146261084825e-05
with O 0 4.042674390802858e-06
three O 0 1.9387945940252393e-05
siblings O 0 7.892107532825321e-05
, O 0 4.131200512347277e-06
one O 0 3.035684812857653e-06
developed O 0 2.903012682509143e-05
classical O 0 0.00014249244122765958
late O 0 0.00733809033408761
infantile O 1 0.9999966621398926
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.012564883567392826
MLD B-Disease 1 1.0
) O 0 0.00011841872037621215
, O 0 2.4878550902940333e-05
fatal O 0 0.0007139330846257508
at O 0 0.0002628042420838028
age O 0 0.0001024421799229458
5 O 0 7.153816113714129e-05
years O 0 4.664925654651597e-05
, O 0 5.843088274559705e-06
with O 0 1.5308214642573148e-05
deficient O 0 0.007577202282845974
arylsulfatase O 0 0.03155279904603958
A O 0 0.0015869983471930027
( O 0 0.00011618714779615402
ARSA O 0 0.024097537621855736
) O 0 8.561339200241491e-06
activity O 0 5.992008937028004e-06
and O 0 3.3549413274158724e-06
increased O 0 4.115431511308998e-05
galactosylsulfatide O 0 0.004705832339823246
( O 0 0.0002679248864296824
GS O 1 0.9999310970306396
) O 0 0.000141321710543707
excretion O 0 0.000765657692681998
. O 0 0.00023026687267702073

The O 0 0.00017438014037907124
two O 0 2.122180740116164e-05
other O 0 1.1308246030239388e-05
siblings O 0 0.00021242139337118715
, O 0 1.8119277228834108e-05
apparently O 0 7.273729715961963e-05
healthy O 0 7.193534838734195e-05
at O 0 9.058073919732124e-05
12 O 0 3.507248766254634e-05
( O 0 5.738424079027027e-06
1 O 0 5.2570041589206085e-05
/ O 0 5.0621925765881315e-05
2 O 0 3.631716754171066e-05
) O 0 3.399924253244535e-06
and O 0 3.630791297837277e-06
15 O 0 1.8887105397880077e-05
years O 0 2.288709038111847e-05
, O 0 5.035918093199143e-06
respectively O 0 1.6842945115058683e-05
, O 0 3.6903672935295617e-06
and O 0 2.752725094978814e-06
their O 0 6.378396847139811e-06
father O 0 0.00014246214414015412
, O 0 1.9472554413368925e-05
apparently O 0 4.937633639201522e-05
healthy O 0 3.1552779546473175e-05
as O 0 6.684060736006359e-06
well O 0 6.913236575201154e-06
, O 0 6.041429514880292e-06
presented O 0 0.0001669976336415857
ARSA O 1 0.9985039234161377
and O 0 0.00014396331971511245
GS O 1 0.9966078996658325
values O 0 6.746121016476536e-06
within O 0 6.997028322075494e-06
the O 0 9.78230673354119e-06
range O 0 5.169537689653225e-05
of O 0 0.00042539689457044005
MLD B-Disease 1 1.0
patients O 0 0.005656866356730461
. O 0 0.0009736277861520648

Mutation O 0 7.101364462869242e-05
screening O 0 1.2586786397150718e-05
and O 0 2.8206304705236107e-06
sequence O 0 4.30671616413747e-06
analysis O 0 2.0236991531419335e-06
disclosed O 0 5.594810863840394e-05
the O 0 5.9823137235071044e-06
involvement O 0 2.3729735403321683e-05
of O 0 2.0717567167594098e-05
three O 0 1.2683643944910727e-05
different O 0 7.179809017543448e-06
ARSA O 0 0.15617363154888153
mutations O 0 2.843961374310311e-05
being O 0 9.878050150291529e-06
the O 0 5.2887403398926836e-06
molecular O 0 5.738648269471014e-06
basis O 0 9.187002433463931e-06
of O 0 0.00012194855662528425
intrafamilial O 0 0.005960302893072367
phenotypic O 0 0.0014283442869782448
heterogeneity O 0 0.004417998716235161
. O 0 0.0012933471007272601

The O 0 0.001119210384786129
late O 0 0.010877791792154312
infantile O 1 0.999686598777771
patient O 0 0.002958552213385701
inherited O 1 0.9997455477714539
from O 0 0.0003558626340236515
his O 0 0.0003149233525618911
mother O 0 0.00013408306404016912
the O 0 3.490438757580705e-05
frequent O 0 2.878812847484369e-05
0 O 0 6.158702308312058e-05
- O 0 9.058825526153669e-05
type O 0 2.674644383660052e-05
mutation O 0 9.573096576787066e-06
459 O 0 0.00016162777319550514
+ O 0 0.0003388409677427262
1G O 0 0.0027378778904676437
> O 0 0.00013754940300714225
A O 0 0.00017956990632228553
, O 0 8.430345587839838e-06
and O 0 4.10737857237109e-06
from O 0 1.7826394469011575e-05
his O 0 0.00010359704174334183
father O 0 0.00012974029232282192
a O 0 2.3624377718078904e-05
novel O 0 2.7146103093400598e-05
, O 0 7.156183528422844e-06
single O 0 1.4214497241482604e-05
basepair O 0 0.0010620362590998411
microdeletion O 0 0.0006524852360598743
of O 0 6.110439426265657e-05
guanine O 0 4.488918784772977e-05
at O 0 6.853015656815842e-05
nucleotide O 0 2.046457120741252e-05
7 O 0 3.465321788098663e-05
in O 0 1.2397808859532233e-05
exon O 0 0.0001265601022168994
1 O 0 0.00012567956582643092
( O 0 5.7011988246813416e-05
7delG O 0 0.0012882847804576159
) O 0 0.00010960291547235101
. O 0 0.0001353134139208123

The O 0 0.00028529996052384377
two O 0 0.00010026095696957782
clinically O 0 0.011399478651583195
unaffected O 0 0.0009362155105918646
siblings O 0 0.0001295748515985906
carried O 0 1.3785698683932424e-05
the O 0 1.662172144278884e-05
maternal O 0 0.00012785557191818953
mutation O 0 2.34894087043358e-05
459 O 0 0.00040504138451069593
+ O 0 0.00078479980584234
1G O 0 0.00408973591402173
> O 0 0.00015319910016842186
A O 0 0.00015256597544066608
and O 0 6.987052529439097e-06
, O 0 4.730077307613101e-06
on O 0 1.4624339200963732e-05
their O 0 6.106753062340431e-06
paternal O 0 7.563863618997857e-05
allele O 0 9.00632130651502e-06
, O 0 7.191184522525873e-06
a O 0 9.078656148631126e-06
novel O 0 1.4046941032574978e-05
cytosine O 0 9.590723493602127e-06
to O 0 4.51725281891413e-06
thymidine O 0 4.0590311982668936e-05
transition O 0 0.00011572076618904248
at O 0 0.00021944058244116604
nucleotide O 0 0.00013120370567776263
2435 O 0 0.0018153985729441047
in O 0 6.51172740617767e-05
exon O 0 0.0003206334076821804
8 O 0 6.871706136735156e-05
, O 0 3.907793143298477e-06
resulting O 0 7.849771463952493e-06
in O 0 5.666795459546847e-06
substitution O 0 5.860421879333444e-06
of O 0 8.334196172654629e-05
alanine O 0 0.00011497413652250543
464 O 0 0.0006050540832802653
by O 0 8.219797746278346e-05
valine O 0 0.0009427596814930439
( O 0 0.0001842338970163837
A464V O 0 0.002732696942985058
) O 0 0.00012438157864380628
. O 0 0.00019670336041599512

The O 0 0.00041874160524457693
fathers O 0 0.00021079096768517047
genotype O 0 0.00011388192797312513
thus O 0 0.00011574361269595101
was O 0 0.0008729117689654231
7delG O 0 0.0074778166599571705
/ O 0 0.003924362827092409
A464V O 0 0.00622613774612546
. O 0 0.00039312674198299646

Mutation O 0 0.0007302919984795153
A464V O 0 0.002344347769394517
was O 0 0.00022435560822486877
not O 0 2.2585013539355714e-06
found O 0 2.393432851022226e-06
in O 0 7.244059816002846e-06
18 O 0 0.00012778806558344513
unrelated O 0 0.0022731211502104998
MLD B-Disease 1 1.0
patients O 0 0.00031413862598128617
and O 0 4.582622568705119e-05
50 O 0 0.00017623035819269717
controls O 0 0.0001871471176855266
. O 0 0.00018582685152068734

A464V O 0 0.004978916607797146
, O 0 3.362951974850148e-05
although O 0 2.4638877221150324e-05
clearly O 0 0.00012697036436293274
modifying O 0 0.000477576075354591
ARSA O 1 0.998877227306366
and O 0 0.0007070204592309892
GS O 1 0.999998927116394
levels O 0 0.0006495802663266659
, O 0 4.1994800994871184e-05
apparently O 0 7.973061292432249e-05
bears O 0 9.973001579055563e-05
little O 0 1.7968193787964992e-05
significance O 0 3.014049434568733e-05
for O 0 1.162136595667107e-05
clinical O 0 0.00015421508578583598
manifestation O 0 0.019491547718644142
of O 1 0.8040923476219177
MLD B-Disease 1 1.0
, O 0 0.0003037716669496149
mimicking O 0 0.0006539837922900915
the O 0 0.0001411654957337305
frequent O 0 0.0004377543809823692
ARSA O 1 0.998832643032074
pseudodeficiency O 0 0.02749306708574295
allele O 0 0.0005643615731969476
. O 0 0.0004066620604135096

Our O 0 8.116746903397143e-05
results O 0 1.2702501408057287e-05
demonstrate O 0 2.5820945666055195e-05
that O 0 9.64587457019661e-07
in O 0 2.7190853870706633e-06
certain O 0 3.7763791169709293e-06
genetic O 0 0.0001912526786327362
conditions O 0 0.004982544109225273
MLD B-Disease 1 1.0
- O 0 0.13629886507987976
like O 0 0.00021875581296626478
ARSA O 1 0.998759388923645
and O 0 0.00010402646148577332
GS O 1 0.9982176423072815
values O 0 1.3328245586308185e-05
need O 0 5.444416274258401e-06
not O 0 9.019162803269865e-07
be O 0 1.6524442116860882e-06
paralleled O 0 4.49577382823918e-05
by O 0 7.184055448306026e-06
clinical O 0 0.002271730452775955
disease O 1 0.999996542930603
, O 0 1.8195065422332846e-05
a O 0 1.2204006452520844e-05
finding O 0 1.9262201021774672e-05
with O 0 1.0655367077561095e-05
serious O 0 0.001206024899147451
diagnostic O 0 0.0008351348224096
and O 0 0.0002655903808772564
prognostic O 1 0.9999449253082275
implications O 0 0.48640522360801697
. O 0 0.0011915931245312095

Moreover O 0 0.0008293631253764033
, O 0 3.054991611861624e-05
further O 0 7.121430826373398e-05
ARSA O 0 0.014583640731871128
alleles O 0 4.4429492845665663e-05
functionally O 0 0.00015378132229670882
similar O 0 8.584362149122171e-06
to O 0 1.773049916664604e-05
A464V O 0 0.0002997814735863358
might O 0 8.78286300576292e-06
exist O 0 2.786397772069904e-06
which O 0 1.1859059441121644e-06
, O 0 6.11491941526765e-07
together O 0 1.1699121387209743e-06
with O 0 1.8653597635420738e-06
0 O 0 4.835140498471446e-05
- O 0 0.00016508040425833315
type O 0 5.018644515075721e-05
mutations O 0 3.5406930692261085e-05
, O 0 2.8262471460038796e-05
may O 0 0.00013327937631402165
cause O 0 0.000722464406862855
pathological O 1 0.9999254941940308
ARSA O 1 0.9999996423721313
and O 0 0.0005480917752720416
GS O 1 0.9999997615814209
levels O 0 0.00024343330005649477
, O 0 3.4141721698688343e-06
but O 0 5.176497097636457e-07
not O 0 3.8508176203322364e-07
clinical O 0 1.161562522611348e-05
outbreak O 0 0.0001239302655449137
of O 0 0.00010216590453637764
the O 0 0.0008098327089101076
disease O 1 0.9999974966049194
. O 0 8.958924445323646e-05
. O 0 0.00016116823826450855

Human O 1 0.9997016787528992
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999858140945435
to O 0 0.012593834660947323
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 1.0
and O 0 0.0019761030562222004
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.6687188148498535
1 I-Disease 1 0.6604633331298828
. O 0 0.0006036270642653108

Heterozygous O 0 0.004621943458914757
germ O 1 0.9997871518135071
- O 0 0.001508059329353273
line O 0 0.0001682162401266396
mutations O 0 9.386872079630848e-06
in O 0 4.565983090287773e-06
the O 0 1.224073457706254e-05
DNA O 0 4.9597336328588426e-05
mismatch O 0 0.0027999840676784515
repair O 0 0.001380619709379971
genes O 0 2.5951487259590067e-05
lead O 0 4.792535401065834e-05
to O 0 7.950148574309424e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9910849928855896

The O 0 0.0020007877610623837
disease O 1 0.9999983310699463
susceptibility O 0 0.0012526708887889981
of O 0 0.0003663004608824849
individuals O 0 4.1347695514559746e-05
who O 0 6.393898365786299e-05
constitutionally O 0 0.0002883448905777186
lack O 0 0.00010901992936851457
both O 0 2.5560029826010577e-05
wild O 0 9.715134365251288e-05
- O 0 8.792053267825395e-05
type O 0 2.185898119932972e-05
alleles O 0 1.1622772035480011e-05
is O 0 3.0022303690202534e-05
unknown O 0 0.0002270762633997947
. O 0 0.00012006295582978055

We O 0 4.258130502421409e-05
have O 0 2.509343630663352e-06
identified O 0 3.9199912862386554e-06
three O 0 2.363870407862123e-06
offspring O 0 1.0007984201365616e-05
in O 0 3.4769977901305538e-06
a O 0 3.626387479016557e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9917657971382141
who O 0 0.00017843200475908816
developed O 0 0.006333583500236273
hematological B-Disease 1 0.9999644756317139
malignancy I-Disease 1 0.9999938011169434
at O 0 0.001042855903506279
a O 0 2.046488407358993e-05
very O 0 5.8642685871745925e-06
early O 0 2.5908364477800205e-05
age O 0 4.62781245005317e-05
, O 0 4.751697360916296e-06
and O 0 3.6720625757880043e-06
at O 0 3.823724182439037e-05
least O 0 2.6706802600529045e-06
two O 0 6.579434739251155e-07
of O 0 6.894169018778484e-06
them O 0 4.71121438749833e-06
displayed O 0 0.00013077068433631212
signs O 0 0.00028684749850071967
of O 0 0.000317042984534055
neurofibromatosis B-Disease 1 0.999962329864502
type I-Disease 0 0.0009052089299075305
1 I-Disease 0 0.003467955393716693
( O 0 0.0004228555771987885
NF1 B-Disease 1 0.6926388740539551
) O 0 0.00017486834258306772
. O 0 0.00011857611389132217

DNA O 0 4.7724588512210175e-05
sequence O 0 6.816002041887259e-06
analysis O 0 2.6256068395014154e-06
and O 0 3.3774479106796207e-06
allele O 0 6.266252967179753e-06
- O 0 2.266206320200581e-05
specific O 0 1.4268524637373048e-06
amplification O 0 2.867562034225557e-05
in O 0 1.837938543758355e-05
two O 0 1.1335608178342227e-05
siblings O 0 0.0001255590614164248
revealed O 0 0.00014962168643251061
a O 0 5.8862486184807494e-05
homozygous O 0 0.00034951872657984495
MLH1 O 0 0.03628377988934517
mutation O 0 0.00013405457139015198
( O 0 0.00010062511137221009
C676T O 0 0.0014912302140146494
- O 0 0.0007329938816837966
- O 0 0.00037644169060513377
> O 0 0.0003597258182708174
Arg226Stop O 0 0.004988167900592089
) O 0 0.00010984198161168024
. O 0 0.00010233828652417287

Thus O 0 0.00018436551908962429
, O 0 1.895444256660994e-05
a O 0 4.450896813068539e-05
homozygous O 0 0.0006883249152451754
germ O 1 0.9999982118606567
- O 0 0.03590138629078865
line O 0 0.0015227078692987561
MLH1 O 1 0.9620243310928345
mutation O 0 4.534313848125748e-05
and O 0 2.9585011361632496e-05
consequent O 1 0.9984719157218933
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.00011812130833277479
in O 0 6.12079820712097e-05
a O 0 5.297915413393639e-05
mutator O 0 0.0030044326558709145
phenotype O 0 4.421136327437125e-05
characterized O 0 7.621555414516479e-05
by O 0 3.97457079088781e-05
leukemia B-Disease 1 1.0
and O 0 0.0013407442020252347
/ O 1 0.9999971389770508
or O 1 0.9995269775390625
lymphoma B-Disease 1 1.0
associated O 1 0.705924391746521
with O 0 0.0005419793305918574
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.25226256251335144
1 I-Disease 0 0.0433419868350029
. O 0 9.089231753023341e-05
. O 0 0.0001025923338602297

Missense O 0 0.0038402993232011795
mutations O 0 0.00011008988076355308
in O 0 3.2199121051235124e-05
the O 0 1.7831867808126844e-05
most O 0 6.220596787898103e-06
ancient O 0 3.668939825729467e-05
residues O 0 1.9618351871031336e-05
of O 0 2.546999712649267e-05
the O 0 0.00011644690675893798
PAX6 O 1 0.9777522683143616
paired O 0 9.052106906892732e-05
domain O 0 3.971880869357847e-05
underlie O 0 0.0001993835758185014
a O 0 1.66682293638587e-05
spectrum O 0 0.0002706194936763495
of O 1 0.6854922771453857
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9985735416412354

Mutations O 0 8.26836476335302e-05
of O 0 5.201879685046151e-05
the O 0 6.744422717019916e-05
human O 0 8.888084266800433e-05
PAX6 O 1 0.999583899974823
gene O 0 0.0010064883390441537
underlie O 1 0.9999727010726929
aniridia B-Disease 1 1.0
( O 1 0.9997946619987488
congenital B-Disease 1 1.0
absence I-Disease 0 0.31843602657318115
of I-Disease 0 0.001434280420653522
the I-Disease 0 0.0005457750521600246
iris I-Disease 0 0.0008995646494440734
) O 0 2.5336416001664475e-05
, O 0 7.0785013122076634e-06
a O 0 2.5075754820136353e-05
rare O 0 0.00024358397058676928
dominant O 1 0.6892077326774597
malformation B-Disease 1 0.9999997615814209
of I-Disease 1 0.8175542950630188
the I-Disease 1 0.9818359613418579
eye I-Disease 1 0.999603807926178
. O 0 0.0008141164435073733

The O 0 0.00014926728908903897
spectrum O 0 0.00041730920202098787
of O 0 0.0005054221255704761
PAX6 O 1 0.9996324777603149
mutations O 0 0.0003343968419358134
in O 0 0.00041579033131711185
aniridia B-Disease 1 0.9999996423721313
patients O 0 0.00020376902830321342
is O 0 1.6672427591402084e-05
highly O 0 3.565876977518201e-05
biased O 0 1.1375503163435496e-05
, O 0 1.7004848587021115e-06
with O 0 6.890126087455428e-07
92 O 0 2.834733277268242e-05
% O 0 3.7257543681334937e-06
of O 0 1.7076392396120355e-05
all O 0 7.637719136255328e-06
reported O 0 3.487171125016175e-05
mutations O 0 1.4054498024052009e-05
leading O 0 6.671556911896914e-05
to O 0 1.698004598438274e-05
premature O 0 8.376974437851459e-05
truncation O 0 6.02678774157539e-05
of O 0 4.2893985664704815e-05
the O 0 4.810273094335571e-05
protein O 0 4.391080801724456e-05
( O 0 1.623086427571252e-05
nonsense O 0 0.00011773807636927813
, O 0 1.092023649107432e-05
splicing O 0 2.797783599817194e-05
, O 0 7.8481843956979e-06
insertions O 0 7.012121204752475e-05
and O 0 1.3755495274381246e-05
deletions O 0 7.590323366457596e-05
) O 0 1.1312215974612627e-05
and O 0 5.962714567431249e-06
just O 0 2.5107721739914268e-05
2 O 0 1.4664198715763632e-05
% O 0 4.10549091611756e-06
leading O 0 2.3461736418539658e-05
to O 0 3.554248678483418e-06
substitution O 0 3.318958533782279e-06
of O 0 1.9803617760771886e-05
one O 0 1.0759028555185068e-05
amino O 0 7.413132152578328e-06
acid O 0 1.268804680876201e-05
by O 0 7.221532086987281e-06
another O 0 3.326770456624217e-05
( O 0 4.849062315770425e-05
missense O 0 0.0004730031650979072
) O 0 9.335364302387461e-05
. O 0 0.00013890143600292504

The O 0 0.00019706210878212005
extraordinary O 0 0.00017255014972761273
conservation O 0 4.426236773724668e-05
of O 0 2.5499501134618185e-05
the O 0 5.749605770688504e-05
PAX6 O 0 0.006053615361452103
protein O 0 4.651354902307503e-05
at O 0 6.327485607471317e-05
the O 0 2.3288708689506166e-05
amino O 0 1.457813868910307e-05
acid O 0 2.3355252778856084e-05
level O 0 0.00019701136625371873
amongst O 0 0.00018223431834485382
vertebrates O 0 0.00022869478561915457
predicts O 0 6.867480260552838e-05
that O 0 5.098817837279057e-06
pathological O 0 0.000843895017169416
missense O 0 0.0006477953284047544
mutations O 0 7.687725155847147e-05
should O 0 2.2295158487395383e-05
in O 0 1.5858799088164233e-05
fact O 0 1.3867967936675996e-05
be O 0 4.916006673738593e-06
common O 0 5.91933167015668e-06
even O 0 4.769590304931626e-06
though O 0 2.8129852580605075e-06
they O 0 1.2430250535544474e-06
are O 0 1.028140218295448e-06
hardly O 0 5.2836519898846745e-05
ever O 0 7.749168435111642e-05
seen O 0 9.882952872430906e-05
in O 0 0.00012367185263428837
aniridia B-Disease 1 0.9999983310699463
patients O 0 0.0014948409516364336
. O 0 0.0005254345596767962

This O 0 2.4108172510750592e-05
indicates O 0 3.5025357647100464e-05
that O 0 1.3920498531660996e-06
there O 0 4.362368144938955e-06
is O 0 5.159984084457392e-06
a O 0 2.057401798083447e-05
heavy O 0 0.0003816522948909551
ascertainment O 0 0.002824497641995549
bias O 0 6.580405897693709e-05
in O 0 1.1986921890638769e-05
the O 0 6.530527116410667e-06
selection O 0 4.3906320570386015e-06
of O 0 2.9550385079346597e-05
patients O 0 5.608576611848548e-05
for O 0 4.144219929003157e-05
PAX6 O 0 0.3424281179904938
mutation O 0 1.2068075193383265e-05
analysis O 0 2.587221160865738e-06
and O 0 1.637433001633326e-06
that O 0 1.555454559820646e-06
the O 0 1.9552941012079827e-05
missing O 0 0.0002560489228926599
PAX6 O 1 0.9210709929466248
missense O 0 0.0011453523766249418
mutations O 0 0.00021062804444227368
frequently O 0 0.00011268138769082725
may O 0 0.0001500299695180729
underlie O 0 0.002140260301530361
phenotypes O 0 0.000393842434277758
distinct O 0 0.00015396704839076847
from O 0 0.0006300179520621896
textbook O 0 0.01553534809499979
aniridia B-Disease 1 0.9999960660934448
. O 0 0.0009811135241761804

Here O 0 0.00022871766122989357
we O 0 7.028407253528712e-06
present O 0 9.278856850869488e-06
four O 0 2.3116954253055155e-05
novel O 0 0.00015451153740286827
PAX6 O 0 0.023079970851540565
missense O 0 0.00048206953215412796
mutations O 0 3.929773811250925e-05
, O 0 7.753586032777093e-06
two O 0 2.741410071394057e-06
in O 0 8.080347470240667e-06
association O 0 1.1752386853913777e-05
with O 0 8.534876542398706e-06
atypical O 0 0.0016450445400550961
phenotypes O 0 0.0015249011339619756
ectopia B-Disease 1 0.998798131942749
pupillae I-Disease 1 0.7106730341911316
( O 0 5.8729376178234816e-05
displaced B-Disease 0 9.804104774957523e-05
pupils I-Disease 0 0.00013093510642647743
) O 0 0.000134924310259521
and O 0 0.0004801468166988343
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999674558639526
( O 0 0.0018944587791338563
searching B-Disease 0 0.0008654749253764749
gaze I-Disease 0 0.0013859601458534598
) O 0 2.8436847060220316e-05
, O 0 6.004931947245495e-06
and O 0 2.47273555942229e-06
two O 0 3.6533399452309823e-06
in O 0 1.539271033834666e-05
association O 0 1.3748373930866364e-05
with O 0 6.881668923597317e-06
more O 0 2.3183099983725697e-05
recognizable O 0 0.0069642807357013226
aniridia B-Disease 1 0.9999994039535522
phenotypes O 0 0.004191994201391935
. O 0 0.0007286595064215362

Strikingly O 0 0.0012411794159561396
, O 0 1.616712506802287e-05
all O 0 3.4324937132623745e-06
four O 0 1.0042766007245518e-05
mutations O 0 1.1950216503464617e-05
are O 0 2.9303323572094087e-06
located O 0 6.317934457911178e-05
within O 0 2.085931737383362e-05
the O 0 8.472050103591755e-05
PAX6 O 0 0.00991025846451521
paired O 0 8.434856135863811e-05
domain O 0 3.739260137081146e-05
and O 0 8.538939255231526e-06
affect O 0 1.949053694261238e-05
amino O 0 7.474672202079091e-06
acids O 0 4.768612143379869e-06
which O 0 4.052861640957417e-06
are O 0 8.300322065224464e-07
highly O 0 1.4462995750363916e-05
conserved O 0 2.655478601809591e-05
in O 0 8.121548489725683e-06
all O 0 5.578333457378903e-06
known O 0 4.0796538087306544e-05
paired O 0 4.782309042639099e-05
domain O 0 8.310529665322974e-05
proteins O 0 6.454916729126126e-05
. O 0 0.00012738218356389552

Our O 0 5.135492028784938e-05
results O 0 3.2599273254163563e-06
support O 0 4.4346666072669905e-06
the O 0 7.582582838949747e-06
hypothesis O 0 4.2387382563902065e-06
that O 0 2.6835144240067166e-07
the O 0 1.892314912765869e-06
under O 0 1.1703267773555126e-05
- O 0 1.6288546248688363e-05
representation O 0 2.182614935009042e-06
of O 0 3.082735202042386e-05
missense O 0 0.0004253560910001397
mutations O 0 6.113266863394529e-05
is O 0 1.5889092537690885e-05
caused O 0 8.912161865737289e-05
by O 0 1.3092064364172984e-05
ascertainment O 0 0.0016978126950562
bias O 0 8.095072553260252e-05
and O 0 9.77056879492011e-06
suggest O 0 8.665710083732847e-06
that O 0 1.36773303438531e-06
a O 0 3.6599028589989757e-06
substantial O 0 2.6605865059536882e-05
burden O 0 0.00014576580724678934
of O 0 0.0003637044574134052
PAX6 B-Disease 1 0.9999996423721313
- I-Disease 1 0.9976418018341064
related I-Disease 0 0.009335114620625973
disease I-Disease 1 0.9999808073043823
remains O 0 0.0003570519620552659
to O 0 1.6322102965204976e-05
be O 0 1.855263144534547e-05
uncovered O 0 0.0003918956790585071
. O 0 3.24178472510539e-05
. O 0 8.32052028272301e-05

The O 0 0.00019320579303894192
chromosomal O 0 0.0003876231494359672
order O 0 1.5878489648457617e-05
of O 0 2.9126073059160262e-05
genes O 0 2.8256110454094596e-05
controlling O 0 0.00015040409925859421
the O 0 7.095549517543986e-05
major O 0 0.0015056243864819407
histocompatibility O 1 0.999994158744812
complex O 0 0.0029808995313942432
, O 0 2.6851559596252628e-05
properdin O 0 0.0007548655266873538
factor O 0 9.386308374814689e-05
B O 0 0.0009105569333769381
, O 0 1.7345415471936576e-05
and O 0 1.706242619547993e-05
deficiency B-Disease 1 0.9987201690673828
of I-Disease 0 0.00011825419642264023
the I-Disease 0 5.48096104466822e-05
second I-Disease 0 6.233850581338629e-05
component I-Disease 0 6.169459084048867e-05
of I-Disease 0 7.681306306039914e-05
complement I-Disease 0 0.00020923768170177937
. O 0 0.0002261566842207685

The O 0 0.00010826438665390015
relationship O 0 1.6915735614020377e-05
of O 0 1.5041062397358473e-05
the O 0 1.2140694707341027e-05
genes O 0 5.6407802730973344e-06
coding O 0 1.453804270568071e-05
for O 0 1.3334411960386205e-05
HLA O 0 0.0014646337367594242
to O 0 1.1257610822212882e-05
those O 0 2.8086453767173225e-06
coding O 0 1.2722554856736679e-05
for O 0 9.294675692217425e-06
properdin O 0 0.0011373927118256688
Factor O 0 0.00015238324704114348
B O 0 0.0009543706546537578
allotypes O 0 0.0009066771599464118
and O 0 1.0495776223251596e-05
for O 0 2.093300827255007e-05
deficiency B-Disease 1 0.9995008707046509
of I-Disease 0 0.0001284825411858037
the I-Disease 0 5.7011715398402885e-05
second I-Disease 0 3.8848145777592435e-05
component I-Disease 0 3.7355326639954e-05
of I-Disease 0 3.845016544801183e-05
complement I-Disease 0 0.00013488235708791763
( O 0 0.0001383345079375431
C2 O 0 0.020160473883152008
) O 0 2.6382840587757528e-05
was O 0 6.910666706971824e-05
studied O 0 1.8391325284028426e-05
in O 0 2.973099526570877e-06
families O 0 1.2893231087218737e-06
of O 0 1.9052342395298183e-05
patients O 0 0.00020584325829986483
with O 0 0.015296310186386108
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9999926090240479

Patients O 0 0.0003033442480955273
were O 0 3.404308881727047e-05
selected O 0 9.936913556884974e-06
because O 0 2.3547399905510247e-06
they O 0 8.022743713809177e-07
were O 0 2.4914359073591186e-06
heterozygous O 0 2.445428663122584e-06
or O 0 5.945503744442249e-06
homozygous O 0 0.00018392181664239615
for O 0 0.002769945655018091
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9353702664375305

12 O 0 0.00025953014846891165
families O 0 1.3399527233559638e-05
with O 0 4.3978739086014684e-06
15 O 0 7.018014730419964e-05
matings O 0 0.00024159302120096982
informative O 0 0.00023299918393604457
for O 0 0.001150691183283925
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.024233058094978333
found O 0 0.00022155216720420867
. O 0 0.00013311553630046546

Of O 0 0.000741883588489145
57 O 0 0.0006801435956731439
informative O 0 0.00035020429641008377
meioses O 0 0.0017893302720040083
, O 0 6.754219157301122e-06
two O 0 1.5284069831977831e-06
crossovers O 0 1.1821023690572474e-05
were O 0 6.618971838179277e-06
noted O 0 1.5579691535094753e-05
between O 0 9.035428229253739e-05
the O 0 0.0019452798878774047
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.00020107126329094172
and O 0 3.398379703867249e-05
the O 0 9.206698450725526e-05
HLA O 1 0.7642613053321838
- O 0 0.0005586353945545852
B O 0 0.00023199344286695123
gene O 0 4.577802883432014e-06
, O 0 7.806061148585286e-07
with O 0 3.6451228879741393e-07
a O 0 4.053924385516439e-06
recombinant O 0 7.919308700365946e-06
fraction O 0 1.769745722413063e-05
of O 0 7.2439645009581e-05
0 O 0 0.0002852792968042195
. O 0 0.00025448595988564193

035 O 0 0.33725279569625854
. O 0 0.0027061004657298326

A O 0 0.0012897881679236889
lod O 0 0.001110354671254754
score O 0 2.6669040380511433e-05
of O 0 2.883219531213399e-05
13 O 0 2.833614416886121e-05
was O 0 2.022071748797316e-05
calculated O 0 1.7450024643039797e-06
for O 0 4.175459253019653e-06
linkage O 0 0.0008791926084086299
between O 1 0.9999535083770752
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.8701255321502686
HLA O 1 0.9999972581863403
- O 0 0.004411786329001188
B O 0 0.0004456072929315269
at O 0 4.014729711343534e-05
a O 0 3.290173026471166e-06
maximum O 0 3.2563107197347563e-06
likelihood O 0 3.1179092729871627e-06
value O 0 2.99512635137944e-06
of O 0 6.85718032400473e-06
the O 0 8.425972737313714e-06
recombinant O 0 1.2272877938812599e-05
fraction O 0 1.20595259431866e-05
of O 0 4.883588553639129e-05
0 O 0 0.0002160188159905374
. O 0 0.0001688793272478506

04 O 0 0.0868750661611557
. O 0 0.00316203897818923

18 O 0 0.0004134451155550778
families O 0 2.2425685529015027e-05
with O 0 7.473268397006905e-06
21 O 0 0.00010920451313722879
informative O 0 3.733637640834786e-05
matings O 0 5.099490954307839e-05
for O 0 3.930772891180823e-06
both O 0 1.1544108929228969e-05
properdin O 0 0.0009043820900842547
Factor O 0 0.00013825210044160485
B O 0 0.0004603734705597162
allotype O 0 0.0010496065951883793
and O 0 4.539730434771627e-05
HLA O 1 0.683636486530304
- O 0 0.0010471437126398087
B O 0 0.0008839613292366266
were O 0 5.9936031902907416e-05
found O 0 3.870769796776585e-05
. O 0 8.623913890914991e-05

Of O 0 0.0011492124758660793
72 O 0 0.0013223137939348817
informative O 0 0.0006012946832925081
meioses O 0 0.0028426030185073614
, O 0 3.192567965015769e-05
three O 0 1.61060943355551e-05
recombinants O 0 0.0009459069697186351
were O 0 3.667351484182291e-05
found O 0 9.520190360490233e-06
, O 0 3.0453604722424643e-06
giving O 0 2.5791803182073636e-06
a O 0 5.537003289646236e-06
recombinant O 0 1.1421995623095427e-05
fraction O 0 3.11851326841861e-05
of O 0 9.527844667900354e-05
0 O 0 0.00031064634094946086
. O 0 0.00023761193733662367

042 O 0 0.09943921118974686
. O 0 0.0019902274943888187

A O 0 0.0011317844036966562
lod O 0 0.0014768271939828992
score O 0 3.663940151454881e-05
of O 0 4.818142406293191e-05
16 O 0 0.00011387758422642946
between O 0 0.00034667173167690635
HLA O 1 0.992337167263031
- O 0 0.0010003423085436225
B O 0 0.0003312473127152771
and O 0 1.0049156117020175e-05
Factor O 0 5.1967919716844335e-05
B O 0 0.00043552881106734276
allotypes O 0 0.0005162080633454025
was O 0 6.462202145485207e-05
calculated O 0 1.102352234738646e-05
at O 0 1.869919287855737e-05
a O 0 3.1897302505967673e-06
maximum O 0 5.0901649046863895e-06
likelihood O 0 4.51320511274389e-06
value O 0 6.23612368144677e-06
of O 0 6.96126062393887e-06
the O 0 1.1631187589955516e-05
recombinant O 0 2.068881985906046e-05
fraction O 0 3.225074760848656e-05
of O 0 9.724838309921324e-05
0 O 0 0.00018036819528788328
. O 0 0.0001487364643253386

04 O 0 0.10539980977773666
. O 0 0.0029972558841109276

A O 0 0.0007356958813033998
crossover O 0 0.00014413542521651834
was O 0 0.00011131396604469046
shown O 0 1.0555389962974004e-05
to O 0 2.5891959012369625e-06
have O 0 1.55387408540264e-06
occurred O 0 2.517173379601445e-05
between O 0 8.686445653438568e-06
genes O 0 2.122297246387461e-06
for O 0 2.9930647542641964e-06
Factor O 0 4.638796599465422e-05
B O 0 0.0002528828044887632
and O 0 4.160161915933713e-05
HLA O 0 0.07730273902416229
- O 0 0.0009406274184584618
D O 0 0.0008607656927779317
, O 0 6.869636763440212e-06
in O 0 7.1978397500060964e-06
which O 0 1.561503449920565e-05
HLA O 0 0.04311676323413849
- O 0 0.001033175503835082
D O 0 0.002998994430527091
segregared O 0 0.0011662461329251528
with O 0 2.783641502901446e-05
HLA O 1 0.8538191914558411
- O 0 0.0006640845676884055
A O 0 0.00028108511469326913
and O 0 3.4980097552761436e-05
B O 0 0.00149828742723912
. O 0 0.0001132955148932524

These O 0 2.7909913114854135e-05
studies O 0 9.016453986987472e-06
suggest O 0 3.5447262689558556e-06
that O 0 5.099441864331311e-07
the O 0 2.4284545361297205e-06
genes O 0 1.4422942058445187e-06
for O 0 3.178009819748695e-06
Factor O 0 0.00019851629622280598
B O 1 0.8365646600723267
and O 0 0.0010217562085017562
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.7817702832398936e-05
located O 0 8.8180648162961e-05
outside O 0 1.6377362044295296e-05
those O 0 2.3556069663754897e-06
for O 0 1.2339833119767718e-05
HLA O 0 0.02251926064491272
, O 0 9.311496796726715e-06
that O 0 8.106792392936768e-07
the O 0 2.5147794531221734e-06
order O 0 2.462165411998285e-06
of O 0 2.6518877348280512e-05
genese O 0 0.0016176053322851658
is O 0 7.191832992248237e-05
HLA O 0 0.006253248546272516
- O 0 0.000229945668252185
A O 0 0.000122310288134031
, O 0 4.826673375646351e-06
- O 0 3.8183206925168633e-05
B O 0 0.0001538321957923472
, O 0 9.319741366198286e-06
- O 0 6.08097980148159e-05
D O 0 0.0001562839897815138
, O 0 4.011427790828748e-06
Factor O 0 2.473688800819218e-05
B O 0 0.0012032727245241404
allotype O 1 0.9359034895896912
, O 0 0.0006551616825163364
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 2.5864026611088775e-05
that O 0 1.1492144267322146e-06
the O 0 3.025491196240182e-06
genes O 0 4.77214734928566e-06
coding O 0 6.297712388914078e-05
for O 0 0.0002861182438209653
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.00034997332841157913
Factor O 0 0.00043408581404946744
B O 0 0.0007530387956649065
allotypes O 0 0.0003015567490365356
are O 0 1.9390902252780506e-06
approximately O 0 2.0712037439807318e-05
3 O 0 5.604845500783995e-05
- O 0 8.468376472592354e-05
- O 0 4.643346255761571e-05
5 O 0 1.8849317712010816e-05
centimorgans O 0 0.00014154719247017056
from O 0 7.8889161159168e-06
the O 0 4.044758316013031e-05
HLA O 0 0.0059366971254348755
- O 0 0.00025144126266241074
A O 0 0.00020895779016427696
and O 0 5.40359178557992e-05
HLA O 1 0.8657100200653076
- O 0 0.0014271914260461926
B O 0 0.0010272719664499164
loci O 0 4.327522765379399e-05
, O 0 4.7233697841875255e-06
and O 0 1.65107542215992e-06
that O 0 9.321414040641685e-07
the O 0 7.968703357619233e-06
apparent O 0 6.0079375543864444e-05
lack O 0 2.850521559594199e-05
of O 0 3.12363299599383e-05
recombinants O 0 0.000596129335463047
between O 0 2.2896589143783785e-05
the O 0 9.16360477276612e-06
Factor O 0 2.5135846954071894e-05
B O 0 0.0003334519569762051
gene O 0 6.826149910921231e-05
and O 0 0.0002668880042620003
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.90029696165584e-05
suggests O 0 1.1415972949180286e-05
that O 0 3.9156097386694455e-07
these O 0 1.910107698677166e-07
two O 0 1.3818863635606249e-06
genes O 0 4.823139533982612e-06
lie O 0 7.215519872261211e-05
in O 0 8.829615580907557e-06
close O 0 2.707134080992546e-05
proximity O 0 3.8556947401957586e-05
to O 0 1.0972506970574614e-05
one O 0 1.2208722182549536e-05
another O 0 5.9288828197168186e-05
. O 0 0.00012541594333015382

Distribution O 0 0.00015245706890709698
of O 0 0.0003047074133064598
emerin O 0 0.036459360271692276
and O 0 7.175364589784294e-05
lamins O 0 0.0018276071641594172
in O 0 2.253323509648908e-05
the O 0 4.494822132983245e-05
heart O 0 0.0010194566566497087
and O 0 1.6397490981034935e-05
implications O 0 0.00021730955631937832
for O 0 0.00015324234846048057
Emery B-Disease 1 0.9999455213546753
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.033443618565797806

Emerin O 0 0.00867923442274332
is O 0 5.2871997468173504e-05
a O 0 3.535281211952679e-05
nuclear O 0 0.00032114493660628796
membrane O 0 4.7415116569027305e-05
protein O 0 6.7412329372018576e-06
which O 0 2.932946699729655e-06
is O 0 4.1019925447471905e-06
missing O 0 3.146198287140578e-05
or O 0 2.059735925286077e-05
defective O 0 0.0005341707146726549
in O 0 0.0003444779140409082
Emery B-Disease 1 0.9985899329185486
- I-Disease 1 0.9999984502792358
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998308420181274
EDMD B-Disease 1 1.0
) O 0 0.0008187710773199797
. O 0 0.00039338317583315074

It O 0 2.0611742002074607e-05
is O 0 5.369750851969002e-06
one O 0 2.424603735562414e-06
member O 0 3.916336936526932e-06
of O 0 9.938013135979418e-06
a O 0 2.2237272787606344e-05
family O 0 2.598011451482307e-05
of O 0 8.274154970422387e-05
lamina O 0 0.40920981764793396
- O 0 0.00035918114008381963
associated O 0 9.238637176167686e-06
proteins O 0 3.7930724374746205e-06
which O 0 2.3690927264397033e-06
includes O 0 1.2010564205411356e-05
LAP1 O 0 0.26354023814201355
, O 0 5.2848918130621314e-05
LAP2 O 0 0.014317206107079983
and O 0 3.365496377227828e-05
lamin O 0 0.0008989875786937773
B O 0 0.0012192298891022801
receptor O 0 0.00036088787601329386
( O 0 0.000174322776729241
LBR O 1 0.9718228578567505
) O 0 0.00011727240053005517
. O 0 0.00017124906298704445

A O 0 0.00043602901860140264
panel O 0 3.1216586648952216e-05
of O 0 4.4515163608593866e-05
16 O 0 0.0001710731303319335
monoclonal O 0 9.006352775031701e-05
antibodies O 0 7.369268132606521e-05
( O 0 7.115803600754589e-05
mAbs O 0 0.0005011934554204345
) O 0 1.3098658200760838e-05
has O 0 4.094293217349332e-06
been O 0 5.926799076405587e-06
mapped O 0 1.5791834812262096e-05
to O 0 2.9538953185692662e-06
six O 0 4.282559984858381e-06
specific O 0 7.425433068419807e-07
sites O 0 6.965032298467122e-06
throughout O 0 6.032361397956265e-06
the O 0 1.7001968444674276e-05
emerin O 0 0.0007819936727173626
molecule O 0 1.4511058907373808e-05
using O 0 1.6939271517912857e-05
phage O 0 0.00032487043063156307
- O 0 9.189542470267043e-05
displayed O 0 6.369913899106905e-05
peptide O 0 4.286707553546876e-05
libraries O 0 1.5437239198945463e-05
and O 0 2.46487661570427e-06
has O 0 2.288796395077952e-06
been O 0 3.5228713386459276e-06
used O 0 4.849918695981614e-06
to O 0 2.3554728613817133e-05
localize O 0 0.001572712091729045
emerin O 0 0.004408353008329868
in O 0 0.0001212771239806898
human O 0 0.00012348074233159423
and O 0 0.00012220653297845274
rabbit O 0 0.0028330332133919
heart O 1 0.9531470537185669
. O 0 0.00043340789852663875

Several O 0 0.0003387303731869906
mAbs O 0 0.0019469730323180556
against O 0 0.0001324374316027388
different O 0 1.9343900930834934e-05
emerin O 0 0.0037849305663257837
epitopes O 0 0.0006617645267397165
did O 0 2.841960667865351e-05
not O 0 5.800746748718666e-06
recognize O 0 4.8537862312514335e-05
intercalated O 0 0.001471413066610694
discs O 0 0.0016262703575193882
in O 0 6.762539123883471e-05
the O 0 0.0001249792258022353
heart O 0 0.002374522155150771
, O 0 1.1633229405560996e-05
though O 0 3.7580957723548636e-06
they O 0 2.511340198907419e-06
recognized O 0 3.0825056455796584e-05
cardiomyocyte O 0 0.0011418272042647004
nuclei O 0 0.00015188219549600035
strongly O 0 2.652668990776874e-05
, O 0 8.236519533966202e-06
both O 0 6.993465831328649e-06
at O 0 0.00016633066115900874
the O 0 9.321434481535107e-05
rim O 0 0.0006102357292547822
and O 0 1.352431263512699e-05
in O 0 7.127872231649235e-05
intranuclear O 0 0.0035480018705129623
spots O 0 0.0003063353360630572
or O 0 5.6276610848726705e-05
channels O 0 0.00029962320695631206
. O 0 0.0001972228055819869

A O 0 0.006633353419601917
polyclonal O 0 0.00764260720461607
rabbit O 0 0.0016466586384922266
antiserum O 0 0.0007666228921152651
against O 0 0.00024205668887589127
emerin O 0 0.002572680590674281
did O 0 3.048675716854632e-05
recognize O 0 2.373281131440308e-05
both O 0 1.1059163625759538e-05
nuclear O 0 0.0011515322839841247
membrane O 0 0.00010941025539068505
and O 0 1.9579363652155735e-05
intercalated O 0 0.0006213889573700726
discs O 0 0.0004858041647821665
but O 0 3.9072419895092025e-06
, O 0 1.84143834758288e-06
after O 0 7.065188128763111e-06
affinity O 0 1.1665958481898997e-05
purification O 0 0.00013478568871505558
against O 0 0.0001071868246071972
a O 0 0.00011195801198482513
pure O 0 0.0005902494885958731
- O 0 0.0009287090506404638
emerin O 0 0.0018472325755283237
band O 0 0.00023487636644858867
on O 0 6.498874427052215e-05
a O 0 2.6883377358899452e-05
western O 0 6.38741985312663e-05
blot O 0 0.00029363224166445434
, O 0 1.8707451090449467e-05
it O 0 9.537692676531151e-06
stained O 0 0.00026352761778980494
only O 0 7.605098744534189e-06
the O 0 4.538193388725631e-05
nuclear O 0 0.002317457925528288
membrane O 0 0.0005753510631620884
. O 0 0.00010727383778430521

These O 0 1.8837206880562007e-05
results O 0 8.89094462763751e-06
would O 0 4.521002210822189e-06
not O 0 1.9170254290656885e-06
be O 0 2.4076127829175675e-06
expected O 0 1.0023209142673295e-05
if O 0 8.808826351014432e-06
immunostaining O 0 0.0007589100860059261
at O 0 0.00040601944783702493
intercalated O 0 0.002215662971138954
discs O 0 0.0007895593298599124
were O 0 3.631623258115724e-05
due O 0 4.768146391143091e-05
to O 0 6.199312338139862e-06
a O 0 7.546923370682634e-06
product O 0 4.541502676147502e-06
of O 0 1.5834859368624166e-05
the O 0 7.4946932727471e-05
emerin O 0 0.002296647522598505
gene O 0 1.8885375538957305e-05
and O 0 6.680505066469777e-06
, O 0 4.4103098844061606e-06
therefore O 0 6.740609478583792e-06
, O 0 1.7338880979878013e-06
cast O 0 3.192262283846503e-06
some O 0 1.2729817626677686e-06
doubt O 0 1.345471537206322e-05
upon O 0 5.0209368964715395e-06
the O 0 7.484951311198529e-06
hypothesis O 0 3.1415929697686806e-05
that O 0 2.129629319824744e-05
cardiac B-Disease 1 0.9999985694885254
defects I-Disease 1 0.9999984502792358
in O 0 0.1477980762720108
EDMD B-Disease 1 1.0
are O 0 3.1492061680182815e-05
caused O 0 0.00017007530550472438
by O 0 8.887112016964238e-06
absence O 0 0.00017497874796390533
of O 0 0.0003672816092148423
emerin O 1 0.7725655436515808
from O 0 0.001283075544051826
intercalated O 0 0.0644109696149826
discs O 0 0.47457948327064514
. O 0 0.0011136289685964584

Although O 0 0.0008264780044555664
emerin O 0 0.005521402228623629
was O 0 0.0003812123031821102
abundant O 0 3.7509318644879386e-05
in O 0 7.951077350298874e-06
the O 0 1.5623347280779853e-05
membranes O 0 4.872824138146825e-05
of O 0 0.00011477182852104306
cardiomyocyte O 0 0.011334008537232876
nuclei O 0 0.00042251995182596147
, O 0 1.3691640560864471e-05
it O 0 2.813377022903296e-06
was O 0 5.7474837376503274e-05
absent O 0 4.310220538172871e-05
from O 0 1.6810177839943208e-05
many O 0 1.4067209122003987e-05
non O 0 0.0005126990145072341
- O 0 0.0014145605964586139
myocyte O 0 0.011203252710402012
cells O 0 7.252453360706568e-05
in O 0 4.001557681476697e-05
the O 0 0.0001481458020862192
heart O 0 0.016296805813908577
. O 0 0.00035847080289386213

This O 0 2.4131568352459e-05
distribution O 0 2.4953520551207475e-05
of O 0 0.00012540971511043608
emerin O 0 0.0030026708263903856
was O 0 0.000167091769981198
similar O 0 2.954151796075166e-06
to O 0 4.82404129797942e-06
that O 0 1.5141370113269659e-06
of O 0 4.942773375660181e-05
lamin O 0 0.0011611012741923332
A O 0 0.0002386581909377128
, O 0 5.265343588689575e-06
a O 0 3.9558185562782455e-06
candidate O 0 4.73847467219457e-06
gene O 0 2.0651646082114894e-06
for O 0 1.227774987455632e-06
an O 0 6.743959602317773e-06
autosomal O 0 0.00017218923312611878
form O 0 0.00013623441918753088
of O 1 0.9971898198127747
EDMD B-Disease 1 1.0
. O 0 0.00514237442985177

In O 0 0.00034916188451461494
contrast O 0 0.0002480072434991598
, O 0 0.00014175224350765347
lamin O 0 0.011008040979504585
B1 O 1 0.999961256980896
was O 0 0.0013779753353446722
absent O 0 0.00025817181449383497
from O 0 5.7341203500982374e-05
cardiomyocyte O 0 0.0020358727779239416
nuclei O 0 0.0002336363249924034
, O 0 1.5262427041307092e-05
showing O 0 8.92321695573628e-05
that O 0 2.3852977392380126e-05
lamin O 0 0.0016096200561150908
B1 O 1 0.7289596796035767
is O 0 8.914580575947184e-06
not O 0 1.0538627748246654e-06
essential O 0 4.235254891682416e-06
for O 0 2.942735591204837e-06
localization O 0 0.00013857969315722585
of O 0 7.175494829425588e-05
emerin O 0 0.0017145395977422595
to O 0 5.9994876210112125e-05
the O 0 0.00013017759192734957
nuclear O 0 0.004146353807300329
lamina O 0 0.01080755889415741
. O 0 0.0003113923594355583

Lamin O 1 0.7997069954872131
B1 O 1 0.9997099041938782
is O 0 4.536653432296589e-05
also O 0 9.600953490007669e-06
almost O 0 1.5950092347338796e-05
completely O 0 9.611020504962653e-05
absent O 0 0.0002750857674982399
from O 0 0.0004993048496544361
skeletal O 1 0.9999910593032837
muscle O 1 0.9988112449645996
nuclei O 1 0.8675447702407837
. O 0 0.00285152904689312

In O 0 0.001413744525052607
EDMD B-Disease 1 0.999997615814209
, O 0 1.347281886410201e-05
the O 0 2.1439584543259116e-06
additional O 0 1.6112829825942754e-06
absence O 0 5.2546936785802245e-05
of O 0 0.00018340363749302924
lamin O 1 0.5426848530769348
B1 O 1 0.9999996423721313
from O 0 0.0010428890818729997
heart O 1 0.9999946355819702
and O 0 0.0017843965906649828
skeletal O 1 1.0
muscle O 1 0.9998617172241211
nuclei O 0 0.007035006769001484
which O 0 5.836680065840483e-05
already O 0 7.697120599914342e-05
lack O 0 0.00013532709272112697
emerin O 0 0.0019983400125056505
may O 0 2.8557291443576105e-05
offer O 0 2.3706252250121906e-06
an O 0 2.294001660629874e-06
alternative O 0 3.489508117127116e-06
explanation O 0 9.172733371087816e-06
of O 0 2.6281339160050265e-05
why O 0 5.478410457726568e-05
these O 0 1.1175010513397865e-05
tissues O 0 8.272055856650695e-05
are O 0 5.05096750202938e-06
particularly O 0 4.615146099240519e-05
affected O 0 6.981275510042906e-05
. O 0 3.0461065762210637e-05
. O 0 7.293900853255764e-05

Genetic O 0 0.00021111783280503005
mapping O 0 0.00016808668442536145
of O 0 0.00035604616277851164
the O 0 0.0010000740876421332
copper B-Disease 1 0.9997819066047668
toxicosis I-Disease 1 0.9687809348106384
locus O 0 0.0007709842757321894
in O 0 0.00036317226476967335
Bedlington O 0 0.007502704858779907
terriers O 0 0.0018584083300083876
to O 0 6.630584539379925e-05
dog O 0 0.00029888711287640035
chromosome O 0 8.630749653093517e-05
10 O 0 2.791635415633209e-05
, O 0 3.716985020218999e-06
in O 0 4.550286575977225e-06
a O 0 8.264215466624591e-06
region O 0 0.00010378371371189132
syntenic O 0 0.000576881633605808
to O 0 2.057513665931765e-05
human O 0 5.143378075445071e-05
chromosome O 0 0.00040287658339366317
region O 0 0.00085543590830639
2p13 O 0 0.0057586245238780975
- O 0 0.002870960393920541
p16 O 0 0.0024944983888417482
. O 0 0.00021364662097766995

Abnormal O 1 0.9999895095825195
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999996423721313
accumulation I-Disease 0 0.3421894907951355
is O 0 1.80944443854969e-05
recognized O 0 7.146376447053626e-06
as O 0 6.567519903910579e-06
an O 0 2.480260627635289e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9994568228721619
man O 1 0.6933466196060181
, O 0 6.940611638128757e-05
mouse O 0 0.0001927877019625157
, O 0 6.51690861559473e-05
rat O 0 0.0015775002539157867
and O 0 5.092871651868336e-05
dog O 0 0.0011573127703741193
. O 0 0.00019505158707033843

The O 0 0.00021233674488030374
major O 0 0.0008440430392511189
cause O 0 0.0006200572242960334
of O 0 0.013298624195158482
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9998725652694702
in O 0 0.00015190508565865457
man O 0 0.00011832536256406456
is O 0 3.5004807159566553e-06
a O 0 1.079197318176739e-05
dysfunctional O 0 0.0004584894049912691
ATP7B O 1 0.9935086965560913
gene O 0 5.163398600416258e-05
, O 0 2.5142799131572247e-05
causing O 0 0.002100206445902586
Wilson B-Disease 1 0.9992639422416687
disease I-Disease 1 0.9999997615814209
( O 0 0.0007137333159334958
WD B-Disease 1 0.9998928308486938
) O 0 0.00033433432690799236
. O 0 0.00021672934235539287

Mutations O 0 0.00019969636923633516
in O 0 4.044565503136255e-05
the O 0 5.524705193238333e-05
ATP7B O 0 0.06901871412992477
genes O 0 5.724676611862378e-06
have O 0 8.851806114762439e-07
also O 0 1.208904905070085e-06
been O 0 6.314628535619704e-06
demonstrated O 0 5.6088010751409456e-05
in O 0 6.721859972458333e-05
mouse O 0 0.0003328669408801943
and O 0 0.0001284230238525197
rat O 0 0.004600128158926964
. O 0 0.00021028911578468978

The O 0 0.0008403946994803846
ATP7B O 1 0.9666383266448975
gene O 0 3.7373632949311286e-05
has O 0 5.004472768632695e-06
been O 0 5.02761622556136e-06
excluded O 0 7.732495760137681e-06
in O 0 3.893612756655784e-06
the O 0 8.490010259265546e-06
much O 0 3.584457590477541e-05
rarer O 0 0.0005207706126384437
human O 0 0.0004075519391335547
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 0 0.013677223585546017
- I-Disease 0 0.001331035397015512
Indian I-Disease 0 9.441272413823754e-05
childhood I-Disease 0 0.06627485901117325
cirrhosis I-Disease 1 0.9999998807907104
, O 0 8.641999738756567e-05
indicating O 0 0.00032622640719637275
genetic O 0 0.00034768087789416313
heterogeneity O 0 0.002106002764776349
. O 0 0.0006585615337826312

By O 0 2.8243177439435385e-05
investigating O 0 3.857782940031029e-05
the O 0 3.815233867499046e-05
common O 0 0.00011620532313827425
autosomal O 1 0.9994903802871704
recessive O 1 0.9999997615814209
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 0.001983216032385826
CT B-Disease 1 0.9844710826873779
) O 0 6.350486364681274e-05
in O 0 0.00010360060696257278
Bedlington O 0 0.005883851554244757
terriers O 0 0.0017977296374738216
, O 0 9.541697181703057e-06
we O 0 3.1088179639482405e-06
have O 0 1.2572886589623522e-06
identified O 0 2.5352017019031337e-06
a O 0 2.230158997917897e-06
new O 0 1.486607970946352e-06
locus O 0 1.693637932476122e-05
involved O 0 4.197365706204437e-05
in O 0 0.00036969658685848117
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.1883183717727661

We O 0 0.00010564594413153827
examined O 0 6.78838332532905e-05
whether O 0 7.739267857687082e-06
the O 0 3.242817547288723e-05
WD B-Disease 0 0.49002429842948914
gene O 0 0.00017254224803764373
ATP7B O 1 0.7842326164245605
was O 0 0.00022701910347677767
also O 0 1.2709287148027215e-05
causative O 0 6.475898408098146e-05
for O 0 1.4176051081449259e-05
CT B-Disease 0 0.0007087463745847344
by O 0 4.393480139697203e-06
investigating O 0 1.579549461894203e-05
the O 0 3.811371425399557e-05
chromosomal O 0 0.001731301425024867
co O 0 0.0018807827727869153
- O 0 0.0006339885294437408
localization O 0 0.0007362847100012004
of O 0 0.0003340864786878228
ATP7B O 1 0.9995846152305603
and O 0 7.985677075339481e-05
C04107 O 0 0.0004985057166777551
, O 0 6.451915851357626e-06
using O 0 3.475708354017115e-06
fluorescence O 0 2.116570067300927e-05
in O 0 6.527811638079584e-05
situ O 0 0.0017729365499690175
hybridization O 0 0.00013854639837518334
( O 0 0.00010585477866698056
FISH O 0 0.0003965561045333743
) O 0 2.6624520614859648e-05
. O 0 4.8643327318131924e-05

C04107 O 0 0.005713998805731535
is O 0 4.116608761250973e-05
an O 0 1.1697732588800136e-05
anonymous O 0 5.0022266805171967e-05
microsatellite O 0 0.0005999408313073218
marker O 0 0.0005558766424655914
closely O 0 0.00010272282088408247
linked O 0 0.0003469742659945041
to O 0 0.00019258707470726222
CT B-Disease 1 0.9587923884391785
. O 0 0.0004458337789401412

However O 0 0.00020836450858041644
, O 0 0.00010006324737332761
BAC O 0 0.013263885863125324
clones O 0 0.0008443212718702853
containing O 0 0.00033334773615933955
ATP7B O 1 0.9714946746826172
and O 0 3.5166096495231614e-05
C04107 O 0 0.00025530566927045584
mapped O 0 3.081278191530146e-05
to O 0 1.1218214240216184e-05
the O 0 4.127820284338668e-05
canine O 0 0.0004713963426183909
chromosome O 0 0.00028580910293385386
regions O 0 0.0001345540367765352
CFA22q11 O 0 0.01662646047770977
and O 0 8.64139074110426e-05
CFA10q26 O 0 0.004325899761170149
, O 0 1.6569272702326998e-05
respectively O 0 2.2918871763977222e-05
, O 0 4.104997969989199e-06
demonstrating O 0 5.813343886984512e-05
that O 0 1.291923126700567e-05
WD B-Disease 0 0.0034121039789170027
cannot O 0 2.051833325822372e-05
be O 0 7.668943908356596e-06
homologous O 0 7.696048851357773e-05
to O 0 0.0001322869793511927
CT B-Disease 0 0.24289348721504211
. O 0 0.000551096280105412

The O 0 0.0006902262684889138
copper O 0 0.04472331702709198
transport O 0 0.000548075302504003
genes O 0 0.00017266272334381938
CTR1 O 1 0.9882936477661133
and O 0 0.00010484586528036743
CTR2 O 1 0.9829221963882446
were O 0 4.453596557141282e-05
also O 0 7.89289697422646e-06
excluded O 0 1.5641713616787456e-05
as O 0 5.109740413899999e-06
candidate O 0 6.706651674903696e-06
genes O 0 3.6234443996363552e-06
for O 0 8.568535122321919e-06
CT B-Disease 0 0.0016197606455534697
since O 0 3.8784924981882796e-05
they O 0 1.0877390650421148e-06
both O 0 1.4613874554925133e-06
mapped O 0 2.419334305159282e-05
to O 0 4.5133510866435245e-05
canine O 0 0.0014035177882760763
chromosome O 0 0.0016824130434542894
region O 0 0.0033214078284800053
CFA11q22 O 1 0.9516206979751587
. O 0 0.0005217658472247422

2 O 0 0.0034028131049126387
- O 0 0.002130857901647687
22 O 0 0.0008741561323404312
. O 0 0.0002890492614824325

5 O 0 0.003975872881710529
. O 0 0.0007641881820745766

A O 0 0.0007894085138104856
transcribed O 0 0.00019937938486691564
sequence O 0 1.6881665942491964e-05
identified O 0 2.0297651644796133e-05
from O 0 1.4498664313578047e-05
the O 0 4.772477041115053e-05
C04107 O 0 0.0012312890030443668
- O 0 0.0002625130000524223
containing O 0 0.00010614709026413038
BAC O 0 0.0029536753427237272
was O 0 0.0001112528407247737
found O 0 3.467844635451911e-06
to O 0 2.2396905023924774e-06
be O 0 2.015888185269432e-06
homologous O 0 5.544929081224836e-06
to O 0 3.923065378330648e-06
a O 0 7.014961283857701e-06
gene O 0 5.701455393136712e-06
expressed O 0 8.346253707713913e-06
from O 0 3.210483555449173e-05
human O 0 8.18627086118795e-05
chromosome O 0 0.0005361912772059441
2p13 O 0 0.00209998176433146
- O 0 0.000763063202612102
p16 O 0 0.00017660394951235503
, O 0 4.939423888572492e-06
a O 0 9.892095476971008e-06
region O 0 8.305625669891015e-05
devoid O 0 0.00019045453518629074
of O 0 3.355120134074241e-05
any O 0 3.151609780616127e-05
positional O 0 0.0005506158340722322
candidate O 0 0.0003221964871045202
genes O 0 0.00017481499526184052
. O 0 0.00015044283645693213

Molecular O 0 7.234734221128747e-05
analysis O 0 5.271272129903082e-06
of O 0 3.016137270606123e-05
the O 0 0.00010041596397059038
APC B-Disease 0 0.0007163757109083235
gene O 0 1.1927809282497037e-05
in O 0 9.390668310516048e-06
205 O 0 1.9593297110986896e-05
families O 0 2.8093793389416533e-06
: O 0 4.012292720290134e-06
extended O 0 6.026196206221357e-05
genotype O 0 0.00033975523547269404
- O 0 0.0005435510538518429
phenotype O 0 8.165532199200243e-05
correlations O 0 0.0002324969827895984
in O 0 0.0001508066343376413
FAP B-Disease 0 0.0019152096938341856
and O 0 8.2778142314055e-06
evidence O 0 6.138323897175724e-06
for O 0 1.7375099332639365e-06
the O 0 5.463516117742984e-06
role O 0 1.5156109839153942e-05
of O 0 3.389650737517513e-05
APC B-Disease 0 0.00038160302210599184
amino O 0 1.125539893109817e-05
acid O 0 2.1015299353166483e-05
changes O 0 3.102537084487267e-05
in O 0 0.017112107947468758
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.006201550830155611

BACKGROUND O 0 0.0025384025648236275
/ O 0 0.0007720076246187091
AIMS O 0 0.00037293939385563135
The O 0 2.6872436137637123e-05
development O 0 9.611341374693438e-05
of O 0 0.006315714213997126
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.000100471886980813
a O 0 2.7085776309832e-05
variable O 0 6.12518442721921e-06
range O 0 1.2065290320606437e-05
of O 0 5.150086872163229e-05
extracolonic O 0 0.007796982303261757
manifestations O 0 0.0014488243032246828
in O 0 0.0005358739872463048
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9916602969169617
FAP B-Disease 1 0.9953109622001648
) O 0 2.565683280408848e-05
is O 0 2.9448356144712307e-06
the O 0 2.6568834528006846e-06
result O 0 2.2900496787769953e-06
of O 0 9.233546734321862e-06
the O 0 2.3739421521895565e-05
dominant O 0 0.00013370630040299147
inheritance O 0 0.00017662181926425546
of O 0 0.0006053041433915496
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999994039535522
( O 0 0.0011552332434803247
APC B-Disease 0 0.003315512789413333
) O 0 4.966387859894894e-05
gene O 0 7.536188786616549e-05
mutations O 0 0.00019549939315766096
. O 0 0.000305335532175377

In O 0 9.476993000134826e-05
this O 0 4.312827968533384e-06
study O 0 4.902045930066379e-06
, O 0 1.377220996801043e-06
direct O 0 1.2512815601439797e-06
mutation O 0 5.99793850142305e-07
analysis O 0 3.44938939633721e-07
of O 0 8.175938091881108e-06
the O 0 7.377761357929558e-05
APC B-Disease 0 0.0005527470493689179
gene O 0 1.843636709963903e-05
was O 0 6.883241439936683e-05
performed O 0 1.8653401639312506e-05
to O 0 6.375100838340586e-06
determine O 0 2.8194654078106396e-05
genotype O 0 0.00015094173431862146
- O 0 0.0001938098866958171
phenotype O 0 2.3628297640243545e-05
correlations O 0 4.405370418680832e-05
for O 0 1.724692810967099e-05
nine O 0 0.0001704636524664238
extracolonic O 0 0.0031067850068211555
manifestations O 0 0.0003157296741846949
and O 0 1.1419239854149055e-05
to O 0 8.22057427285472e-06
investigate O 0 2.949320878542494e-05
the O 0 2.0426530682016164e-05
incidence O 0 0.0001241193967871368
of O 0 0.00014020070375408977
APC B-Disease 0 0.0015393808716908097
mutations O 0 5.397545101004653e-05
in O 0 9.425628377357498e-05
non O 0 0.10862569510936737
- O 1 0.9999935626983643
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0047727711498737335

METHODS O 0 0.00038290119846351445
The O 0 0.00018737012578640133
APC B-Disease 0 0.0008242998737841845
gene O 0 2.4670007405802608e-05
was O 0 6.167413084767759e-05
analysed O 0 2.360082362429239e-05
in O 0 1.2386853086354677e-05
190 O 0 3.847396874334663e-05
unrelated O 0 6.369452603394166e-05
FAP B-Disease 0 0.0009498349973000586
and O 0 1.279714979318669e-05
15 O 0 0.00012535208952613175
non O 0 0.4775982201099396
- O 1 0.9999984502792358
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.003987815696746111
using O 0 9.363733988720924e-05
denaturing O 0 0.0018081141170114279
gradient O 0 0.0010979034705087543
gel O 0 0.0007614719215780497
electrophoresis O 0 0.00012243035598658025
, O 0 9.836377103056293e-06
the O 0 1.039127164403908e-05
protein O 0 6.029025826137513e-06
truncation O 0 4.8496633098693565e-05
test O 0 6.961752205825178e-06
, O 0 2.358281790293404e-06
and O 0 1.829999519031844e-06
direct O 0 1.1131211067549884e-05
sequencing O 0 7.902281504357234e-05
. O 0 0.00011982185242231935

RESULTS O 0 0.001939315814524889
Chain O 0 0.00079866754822433
terminating O 0 0.0002425052662147209
signals O 0 0.00016092990699689835
were O 0 1.767935827956535e-05
only O 0 4.4719117795466445e-06
identified O 0 1.0082937478728127e-05
in O 0 8.263506060757209e-06
patients O 0 9.411064638698008e-06
belonging O 0 1.1254132004978601e-05
to O 0 7.779487532388885e-06
the O 0 2.760217830655165e-05
FAP B-Disease 0 0.0017051761969923973
group O 0 1.614275242900476e-05
( O 0 1.9895463992725126e-05
105 O 0 0.00017468600708525628
patients O 0 0.00012128427624702454
) O 0 7.249064947245643e-05
. O 0 0.00019531177531462163

Amino O 0 0.00039378160727210343
acid O 0 7.62473137001507e-05
changes O 0 1.6033360225264914e-05
were O 0 3.2105053833220154e-05
identified O 0 1.638773755985312e-05
in O 0 9.528892405796796e-06
four O 0 1.2259507457201835e-05
patients O 0 1.790152418834623e-05
, O 0 4.832670128962491e-06
three O 0 2.9589505174953956e-06
of O 0 3.0981194868218154e-05
whom O 0 4.717058618552983e-05
belonged O 0 0.00012089977826690301
to O 0 7.779599400237203e-06
the O 0 2.0823339582420886e-05
non O 0 0.0001477602490922436
- O 0 0.00036029331386089325
FAP O 0 0.0016476809978485107
group O 0 2.278906322317198e-05
of O 0 0.4202268719673157
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999992847442627
. O 0 0.001729831681586802

Genotype O 0 0.008821805939078331
- O 0 0.0022626197896897793
phenotype O 0 0.0001125252601923421
correlations O 0 0.00012970341776963323
identified O 0 4.223496580380015e-05
significant O 0 3.825048406724818e-05
differences O 0 5.2210030844435096e-05
in O 0 2.094482806569431e-05
the O 0 2.3756001610308886e-05
nature O 0 2.3895168851595372e-05
of O 0 3.463792018010281e-05
certain O 0 7.01334502082318e-05
extracolonic O 1 0.590596079826355
manifestations O 0 0.010038872249424458
in O 0 0.000843251938931644
FAP B-Disease 1 0.9972930550575256
patients O 0 0.00011809203715529293
belonging O 0 5.134546518092975e-05
to O 0 1.8353568520979024e-05
three O 0 2.6992973289452493e-05
mutation O 0 7.723900489509106e-05
subgroups O 0 0.0009440305875614285
. O 0 0.00031999486964195967

CONCLUSIONS O 0 0.0006958866724744439
Extended O 0 0.0007911408902145922
genotype O 0 0.0008485770667903125
- O 0 0.0005446044960990548
phenotype O 0 4.606774018611759e-05
correlations O 0 3.800592094194144e-05
made O 0 1.5005874047346879e-05
in O 0 9.90482931229053e-06
this O 0 1.8801547412294894e-06
study O 0 2.328640675841598e-06
may O 0 5.902533303014934e-06
have O 0 7.531864412158029e-07
the O 0 2.6711666123446776e-06
potential O 0 5.307707397150807e-06
to O 0 8.724500162315962e-07
determine O 0 1.4705458397656912e-06
the O 0 3.6189203456160612e-06
most O 0 1.9908525246137287e-06
appropriate O 0 3.2726925383030903e-06
surveillance O 0 5.093454456073232e-05
and O 0 1.370619338558754e-05
prophylactic O 0 0.001261474913917482
treatment O 0 0.0005195202538743615
regimens O 0 0.0001971929013961926
for O 0 9.825163942878135e-06
those O 0 1.1756937965401448e-05
patients O 0 1.754715049173683e-05
with O 0 8.675202479935251e-06
mutations O 0 4.383570558275096e-05
associated O 0 6.034563557477668e-05
with O 0 3.2500676752533764e-05
life O 0 0.0008711236296221614
threatening O 0 0.0018294679466634989
conditions O 0 0.0015618050238117576
. O 0 0.0005683446070179343

This O 0 2.3334794605034404e-05
study O 0 8.319314474647399e-06
also O 0 2.2686731426802e-06
provided O 0 3.978598670073552e-06
evidence O 0 3.824032773991348e-06
for O 0 3.5034026950597763e-06
the O 0 3.170716081513092e-05
pathological O 0 0.001008580788038671
nature O 0 4.423561040312052e-05
of O 0 4.746542981592938e-05
amino O 0 2.4424374714726582e-05
acid O 0 2.5108680347329937e-05
changes O 0 1.0987921086780261e-05
in O 0 3.1985593523131683e-05
APC O 0 0.00016391985991504043
associated O 0 5.21892570759519e-06
with O 0 2.26154020310787e-06
both O 0 1.6674177459208295e-05
FAP B-Disease 0 0.007120822090655565
and O 0 3.202856896677986e-05
non O 1 0.9930126070976257
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9986305236816406
. O 0 0.00023164134472608566
. O 0 0.00020580104319378734

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9997178912162781
cancer B-Disease 1 1.0
risk O 0 0.00069144630106166
of O 0 0.00034006827627308667
the O 0 0.0008171062800101936
APC O 0 0.009532042779028416
I1307K O 0 0.0031948161777108908
polymorphism O 0 0.0003465997288003564
. O 0 0.00028794328682124615

Germ O 1 0.9999986886978149
- O 0 0.0061421687714755535
line O 0 0.0005135328974574804
and O 0 2.2195239580469206e-05
somatic O 0 0.00010345360351493582
truncating O 0 0.00041157903615385294
mutations O 0 2.6088360755238682e-05
of O 0 4.4909913412993774e-05
the O 0 0.00011668043589452282
APC B-Disease 0 0.0005406749551184475
gene O 0 1.0712322364270221e-05
are O 0 1.296031882702664e-06
thought O 0 8.041472938202787e-06
to O 0 1.399309894623002e-05
initiate O 0 0.0005017318180762231
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999997615814209
formation O 0 0.36422038078308105
in O 0 0.002779049100354314
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.999881386756897
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.0014527906896546483
respectively O 0 0.001309504033997655
. O 0 0.0003823292499873787

Recently O 0 0.0010266887256875634
, O 0 2.8295211450313218e-05
an O 0 3.8093367038527504e-05
isoleucine O 0 0.0029231440275907516
- O 0 0.0013031554408371449
- O 0 0.000714212073944509
> O 0 0.00021709498832933605
lysine O 0 0.00015795954095665365
polymorphism O 0 5.8930672821588814e-05
at O 0 0.00028056761948391795
codon O 0 8.210741361835971e-05
1307 O 0 0.0015087833162397146
( O 0 3.101235051872209e-05
I1307K O 0 0.00026396967587061226
) O 0 4.462156994122779e-06
of O 0 1.2972318472748157e-05
the O 0 4.462286233319901e-05
APC B-Disease 0 0.00038059864891692996
gene O 0 1.0046684110420756e-05
has O 0 2.4730045424803393e-06
been O 0 3.2621198897686554e-06
identified O 0 2.7455805593490368e-06
in O 0 3.926913450413849e-06
6 O 0 2.782908995868638e-05
% O 0 9.045306796906516e-06
- O 0 4.2931187635986134e-05
7 O 0 1.8305636331206188e-05
% O 0 1.922606088555767e-06
of O 0 9.764671631273814e-06
the O 0 2.7115525881526992e-05
Ashkenazi O 0 7.929357525426894e-05
Jewish O 0 6.635454337811098e-05
population O 0 1.6890458937268704e-05
. O 0 6.226506957318634e-05

To O 0 8.328777039423585e-05
assess O 0 8.600663568358868e-05
the O 0 1.865243939391803e-05
risk O 0 1.1255205208726693e-05
of O 0 1.1305442058073822e-05
this O 0 8.338441148225684e-06
common O 0 2.685952313186135e-05
APC B-Disease 0 0.0005891310283914208
allelic O 0 0.0003367474128026515
variant O 0 0.0003616148605942726
in O 0 0.0011050669709220529
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 9.97302049654536e-05
we O 0 1.1075280781369656e-05
have O 0 1.8411644759908086e-06
analyzed O 0 1.4194964023772627e-05
a O 0 1.0204573300143238e-05
large O 0 2.6702709874371067e-05
cohort O 0 0.00014025512791704386
of O 0 5.8186298701912165e-05
unselected O 0 0.004190891515463591
Ashkenazi O 0 0.00030763132963329554
Jewish O 0 8.94889235496521e-05
subjects O 0 0.00013674265937879682
with O 0 6.607217801501974e-05
adenomatous B-Disease 1 0.9998235106468201
polyps I-Disease 1 0.8472080826759338
and O 0 4.338576763984747e-05
. O 0 5.729272015742026e-05
or O 1 0.9713393449783325
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.00010077433398691937
for O 0 1.490006525273202e-05
the O 0 0.00016542847151868045
APC O 0 0.0034071069676429033
I1307K O 0 0.0020659940782934427
polymorphism O 0 0.00041017113835550845
. O 0 0.00033942825393751264

The O 0 0.0006477661081589758
APC O 0 0.003419645829126239
I1307K O 0 0.0009806514717638493
allele O 0 2.0551407942548394e-05
was O 0 0.0001022050782921724
identified O 0 1.09873762994539e-05
in O 0 9.231161129719112e-06
48 O 0 1.8750191884464584e-05
( O 0 5.344584224076243e-06
10 O 0 9.874215720628854e-06
. O 0 1.3197802672948455e-06
1 O 0 1.2637471627385821e-05
% O 0 3.3213902952411445e-06
) O 0 3.715223783729016e-06
of O 0 6.449680222431198e-05
476 O 0 0.002119214739650488
patients O 0 0.000673455186188221
. O 0 0.00045849420712329447

Compared O 0 0.00011432933388277888
with O 0 6.045504051144235e-06
the O 0 1.2744898413075134e-05
frequency O 0 6.1493792600231245e-06
in O 0 2.441956667098566e-06
two O 0 5.077096147942939e-07
separate O 0 4.919571097161679e-07
population O 0 6.17101875377557e-07
control O 0 8.590848665335216e-06
groups O 0 6.434738111238403e-07
, O 0 2.792612121993443e-06
the O 0 2.9823526347172447e-05
APC O 0 0.0007590113673359156
I1307K O 0 0.00033787250868044794
allele O 0 9.217428669217043e-06
is O 0 3.303973471702193e-06
associated O 0 3.322733618915663e-06
with O 0 1.0565969432718703e-06
an O 0 3.4980778309545713e-06
estimated O 0 2.9431477742036805e-05
relative O 0 4.2960058635799214e-05
risk O 0 4.2989315261365846e-05
of O 0 0.00014420320803765208
1 O 0 0.001623064512386918
. O 0 0.00036447253660298884

5 O 0 0.002272919751703739
- O 0 0.0016028312966227531
1 O 0 0.0006786033045500517
. O 0 0.00015416598762385547

7 O 0 0.001309855142608285
for O 0 0.0004105732950847596
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999895095825195
( O 0 0.00028220380772836506
both O 0 8.648676885059103e-05
P O 0 0.0033866739831864834
= O 0 0.0002714880683925003
. O 0 2.933866562671028e-05
01 O 0 0.0015544046182185411
) O 0 9.453488746657968e-05
. O 0 0.0001378490123897791

Furthermore O 0 0.0002217749279225245
, O 0 1.3097121154714841e-05
compared O 0 1.9479202819638886e-05
with O 0 1.3814771591569297e-05
noncarriers O 0 0.008767091669142246
, O 0 9.129545651376247e-05
APC O 0 0.0014552305219694972
I1307K O 0 0.0006433664239011705
carriers O 0 2.4721068257349543e-05
had O 0 1.6555783076910302e-05
increased O 0 6.507511443487601e-06
numbers O 0 4.798323971044738e-06
of O 0 0.00012184277875348926
adenomas B-Disease 1 0.9999747276306152
and O 0 0.011249598115682602
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.00028553017182275653
patient O 0 0.00023159233387559652
( O 0 4.8171314119827e-05
P O 0 0.0009540187893435359
= O 0 0.00012891500955447555
. O 0 1.2556240108096972e-05
03 O 0 0.0002533751539885998
) O 0 5.433731075754622e-06
, O 0 1.4263993080021464e-06
as O 0 4.303238711145241e-06
well O 0 4.131799414608395e-06
as O 0 7.99487406766275e-06
a O 0 2.2894644644111395e-05
younger O 0 0.00011902811820618808
age O 0 0.00018040310533251613
at O 0 0.0011024794075638056
diagnosis O 0 0.006646644789725542
. O 0 0.0004987740539945662

We O 0 7.00652672094293e-05
conclude O 0 0.00011280889884801582
that O 0 5.5861592045403086e-06
the O 0 4.1896477341651917e-05
APC O 0 0.0011141637805849314
I1307K O 0 0.0007961770170368254
variant O 0 7.050615386106074e-05
leads O 0 6.291265890467912e-05
to O 0 4.877873288933188e-05
increased O 0 0.0005003539845347404
adenoma B-Disease 1 0.9999994039535522
formation O 0 0.0010379237355664372
and O 0 2.6915444323094562e-05
directly O 0 1.6261543350992724e-05
contributes O 0 1.430995234841248e-05
to O 0 6.0181691878824495e-06
3 O 0 1.7320888218819164e-05
% O 0 7.108611043804558e-06
- O 0 2.8704898795695044e-05
4 O 0 8.764664926275145e-06
% O 0 1.425030177415465e-06
of O 0 4.595553036779165e-06
all O 0 7.963697498780675e-06
Ashkenazi O 0 0.0006513060652650893
Jewish O 1 0.9561397433280945
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.022780271247029305

The O 0 9.503898036200553e-05
estimated O 0 9.645653335610405e-05
relative O 0 6.254333129618317e-05
risk O 0 3.7686335417674854e-05
for O 0 1.0443119208503049e-05
carriers O 0 3.87576365028508e-05
may O 0 2.4729604774620384e-05
justify O 0 2.0025629055453464e-05
specific O 0 1.3760604815615807e-06
clinical O 0 1.3238507563073654e-05
screening O 0 9.234172466676682e-06
for O 0 3.5315567856741836e-06
the O 0 1.6217030861298554e-05
360 O 0 3.899208240909502e-05
, O 0 3.405443976589595e-06
000 O 0 3.317785740364343e-05
Americans O 0 5.418631644715788e-06
expected O 0 1.0259980626869947e-05
to O 0 8.909803000278771e-06
harbor O 0 0.0002759021008387208
this O 0 4.246032858645776e-06
allele O 0 4.563236416288419e-06
, O 0 2.727315177253331e-06
and O 0 2.093338935083011e-06
genetic O 0 1.3954505448054988e-05
testing O 0 9.44904240895994e-06
in O 0 1.0249466868117452e-05
the O 0 9.179760127153713e-06
setting O 0 2.0018143914057873e-05
of O 0 4.5987500925548375e-05
long O 0 0.0002439449162920937
- O 0 0.0001388448872603476
term O 0 5.705581861548126e-05
- O 0 2.5820012524491176e-05
outcome O 0 4.468817678571213e-06
studies O 0 2.6262805477017537e-06
may O 0 4.133241873205407e-06
impact O 0 1.0631502846081275e-05
significantly O 0 6.634985766140744e-05
on O 0 0.0020497834775596857
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9777318835258484
in O 0 6.467331695603207e-05
this O 0 1.3453457540890668e-05
population O 0 1.5124718629522249e-05
. O 0 5.1815208280459046e-05

Localization O 0 0.002264847746118903
of O 0 0.00038931111339479685
human O 0 0.00015980322496034205
BRCA1 O 0 0.00035027842386625707
and O 0 7.588196694996441e-06
its O 0 5.299200893205125e-06
loss O 0 0.0001194256910821423
in O 0 3.2143128919415176e-05
high O 0 0.00022567977430298924
- O 0 0.0001274597307201475
grade O 0 0.00031954707810655236
, O 0 1.751067247823812e-05
non B-Disease 0 0.00035753671545535326
- I-Disease 1 0.8442013263702393
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.003105993615463376

Although O 0 4.5348802814260125e-05
the O 0 1.8509195797378197e-05
link O 0 0.00010954932076856494
between O 0 8.59859719639644e-05
the O 0 0.0001696436811471358
BRCA1 O 1 0.967593252658844
tumour B-Disease 1 1.0
- O 0 0.17015738785266876
suppressor O 0 0.0007731196819804609
gene O 0 3.342734635225497e-05
and O 0 2.4709141143830493e-05
hereditary B-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.0001698984851827845
established O 0 6.166125240270048e-05
, O 0 2.444990514050005e-06
the O 0 3.1968106668500695e-06
role O 0 1.6054105799412355e-05
, O 0 2.603326493044733e-06
if O 0 7.42539100428985e-07
any O 0 1.018472971736628e-06
, O 0 1.8043654108623741e-06
of O 0 2.4200888219638728e-05
BRCA1 O 0 0.00045406390563584864
in O 0 0.0001177188751171343
non B-Disease 0 0.0048134904354810715
- I-Disease 1 0.9535902142524719
familial I-Disease 1 0.9998757839202881
cancers I-Disease 1 0.9999990463256836
is O 0 0.0002997097617480904
unclear O 0 0.0003687762364279479
. O 0 0.00016163424879778177

BRCA1 O 0 0.0049680969677865505
mutations O 0 9.24960695556365e-05
are O 0 5.39277289135498e-06
rare O 0 4.3594125600066036e-05
in O 0 4.049868221045472e-05
sporadic B-Disease 0 0.0018419165862724185
cancers I-Disease 1 0.9995885491371155
, O 0 3.250256850151345e-05
but O 0 6.74268585498794e-06
loss O 0 0.00013552505697589368
of O 0 0.0002303810470039025
BRCA1 O 0 0.0011195654515177011
resulting O 0 0.0001065955511876382
from O 0 4.564017217489891e-05
reduced O 0 6.380237027769908e-05
expression O 0 2.2989532226347364e-05
or O 0 1.491744023951469e-05
incorrect O 0 3.86140491173137e-05
subcellular O 0 0.00023783676442690194
localization O 0 0.0002371357404626906
is O 0 7.40270434107515e-06
postulated O 0 2.771705294435378e-05
to O 0 1.5131957979974686e-06
be O 0 1.2364101849016151e-06
important O 0 2.9958748655189993e-06
in O 0 5.3581288739223965e-06
non B-Disease 0 0.00011749962868634611
- I-Disease 0 0.0017941369442269206
familial I-Disease 1 0.999873161315918
breast I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9958872199058533

Epigenetic O 0 0.025295183062553406
loss O 0 0.014268032275140285
, O 0 9.379928087582812e-05
however O 0 2.3401182261295617e-05
, O 0 5.479127594298916e-06
has O 0 1.5207562000796315e-06
not O 0 5.2632725555668e-07
received O 0 3.2054165330919204e-06
general O 0 1.507733941252809e-05
acceptance O 0 6.689049769192934e-05
due O 0 0.00012953706027474254
to O 0 1.7980364646064118e-05
controversy O 0 7.063347584335133e-05
regarding O 0 1.3561326341005042e-05
the O 0 2.1032961740274914e-05
subcellular O 0 0.0002667292719706893
localization O 0 0.00028209862648509443
of O 0 0.0001429033582098782
BRCA1 O 0 0.0004366707871668041
proteins O 0 1.17201316243154e-05
, O 0 2.040612116616103e-06
reports O 0 1.2810108955818578e-06
of O 0 4.032769993500551e-06
which O 0 4.133486072532833e-06
have O 0 2.5943072614609264e-06
ranged O 0 5.531431452254765e-05
from O 0 1.0948465387627948e-05
exclusively O 0 2.4791988835204393e-05
nuclear O 0 0.00012052453530486673
, O 0 2.0920458609907655e-06
to O 0 3.1304589356295764e-06
conditionally O 0 3.429189382586628e-05
nuclear O 0 8.53220044518821e-05
, O 0 2.101740619764314e-06
to O 0 4.7304470172093716e-06
the O 0 5.243475970928557e-05
ER O 1 0.9983648657798767
/ O 0 0.000904630811419338
golgi O 0 0.0021451201755553484
, O 0 2.0542374841170385e-05
to O 0 1.9111341316602193e-05
cytoplasmic O 0 0.00010810603998834267
invaginations O 0 0.0009500803425908089
into O 0 4.924302629660815e-05
the O 0 7.854642171878368e-05
nucleus O 0 0.0006416906835511327
. O 0 0.00015908987552393228

In O 0 9.94381116470322e-05
an O 0 1.3169779776944779e-05
attempt O 0 4.508353231358342e-05
to O 0 9.498045073996764e-06
resolve O 0 6.61395097267814e-05
this O 0 2.6915804482996464e-06
issue O 0 9.624211088521406e-06
, O 0 1.6040741002143477e-06
we O 0 9.826904943111003e-07
have O 0 1.3364891628953046e-06
comprehensively O 0 0.0002397163480054587
characterized O 0 7.607294537592679e-05
19 O 0 0.00040419414290226996
anti O 0 0.0029005128890275955
- O 0 0.003762220498174429
BRCA1 O 0 0.001330936443991959
antibodies O 0 0.0001612180203665048
. O 0 0.00022342168085742742

These O 0 6.935212877579033e-05
reagents O 0 0.0003705232811626047
detect O 0 0.0003874718677252531
a O 0 0.00014675418788101524
220 O 0 0.00027965373010374606
- O 0 0.0004970059380866587
kD O 0 0.002397331641986966
protein O 0 4.1441249777562916e-05
localized O 0 4.825444193556905e-05
in O 0 1.1740469744836446e-05
discrete O 0 4.063675442012027e-05
nuclear O 0 0.0006770283216610551
foci O 0 0.0007820994942449033
in O 0 3.9478338294429705e-05
all O 0 3.1270039471564814e-05
epithelial O 0 0.006519373506307602
cell O 0 0.0005624053883366287
lines O 0 5.159382271813229e-05
, O 0 3.573921731003793e-06
including O 0 2.6534951302892296e-06
those O 0 8.433899893134367e-06
derived O 0 6.100786049501039e-05
from O 0 0.0003836197138298303
breast B-Disease 1 0.9996910095214844
malignancies I-Disease 1 0.9997507929801941
. O 0 0.0011156315449625254

Immunohistochemical O 0 0.019400252029299736
staining O 0 0.0023389451671391726
of O 0 0.0013466905802488327
human O 0 0.0022345122415572405
breast O 0 0.40588444471359253
specimens O 0 0.00011079876276198775
also O 0 3.2088002626551315e-05
revealed O 0 0.00038034908357076347
BRCA1 O 0 0.0009708205470815301
nuclear O 0 0.0019827554933726788
foci O 0 0.0016609651502221823
in O 0 0.00023260939633473754
benign O 1 0.9999806880950928
breast O 1 0.9999955892562866
, O 0 0.0040859947912395
invasive B-Disease 1 0.9999992847442627
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.0008849114528857172
low B-Disease 1 0.9885178804397583
- I-Disease 1 0.9980785846710205
grade I-Disease 1 0.9999934434890747
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.002342968713492155

Conversely O 0 0.0018141233595088124
, O 0 0.0001355427666567266
BRCA1 O 0 0.0005674164858646691
expression O 0 7.566923159174621e-05
was O 0 0.00028658536029979587
reduced O 0 3.722119072335772e-05
or O 0 1.4910557183611672e-05
undetectable O 0 0.00014891725732013583
in O 0 4.589902800944401e-06
the O 0 1.916208475449821e-06
majority O 0 1.1472028518255684e-06
of O 0 1.8656637621461414e-05
high O 0 0.0005904418649151921
- O 0 0.00073793571209535
grade O 0 0.035841941833496094
, O 0 0.00023160359705798328
ductal B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 0 5.674577550962567e-05
suggesting O 0 2.98766990454169e-05
that O 0 2.4710241177672287e-06
absence O 0 6.108820525696501e-05
of O 0 0.00011311404523439705
BRCA1 O 0 0.0008594547980464995
may O 0 3.3803178666858e-05
contribute O 0 1.227022130478872e-05
to O 0 5.3910962378722616e-06
the O 0 1.395643539581215e-05
pathogenesis O 0 0.0004610432079061866
of O 0 1.1282286322966684e-05
a O 0 9.936828064383008e-06
significant O 0 1.1621631529123988e-05
percentage O 0 5.174973193788901e-05
of O 0 0.00011078958050347865
sporadic B-Disease 1 0.9844157099723816
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
. O 0 0.0004027049581054598
. O 0 0.00033032396459020674

